data_6r8n_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6r8n _Structure_validation_residue.Date_analyzed 2019-08-09 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 114.229 1.196 . . . . 20.0 114.229 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 82.24 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.88 -1.526 . . . . 20.0 106.88 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.94 -34.53 66.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.942 -1.026 . . . . 20.0 110.16 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.53 12.3 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.48 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.155 0.982 . . . . 20.0 111.59 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -38.69 32.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.766 0.257 . . . . 20.0 111.226 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.51 37.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.613 -1.254 . . . . 20.0 107.613 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.96 112.14 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 20.0 110.928 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.66 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.5 -0.773 . . . . 20.0 111.882 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.13 -45.19 74.29 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.486 -0.486 . . . . 20.0 111.206 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.11 97.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 121.036 -0.265 . . . . 20.0 111.163 -172.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.742 -0.383 . . . . 20.0 111.172 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.42 90.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.642 -0.423 . . . . 20.0 110.513 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.04 -42.89 91.35 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.667 -0.242 . . . . 20.0 111.555 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.546 HG21 ' N ' ' A' ' 16' ' ' VAL . 16.4 m -77.95 -40.03 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 119.515 -0.874 . . . . 20.0 110.67 -171.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.546 ' N ' HG21 ' A' ' 15' ' ' VAL . 2.0 p -86.06 -32.11 6.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 119.009 -1.076 . . . . 20.0 111.027 -162.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 68.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.311 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.42 70.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.493 -0.483 . . . . 20.0 109.765 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.13 144.78 9.57 Favored 'Trans proline' 0 C--N 1.33 -0.412 0 C-N-CA 120.249 0.633 . . . . 20.0 112.119 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.98 38.27 3.39 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 117.284 1.674 . . . . 20.0 117.284 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.78 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 159.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.05 171.21 8.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.396 0.617 . . . . 20.0 110.707 -166.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.049 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.307 1.051 . . . . 20.0 109.563 172.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.97 -13.11 3.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.882 -1.054 . . . . 20.0 113.438 169.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -88.02 9.08 23.62 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 119.714 1.143 . . . . 20.0 113.746 178.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.71 11.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.426 1.639 . . . . 20.0 115.426 -154.09 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -53.18 -26.84 29.72 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 116.023 1.169 . . . . 20.0 116.023 -172.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.62 -35.76 61.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 118.088 0.944 . . . . 20.0 110.655 -178.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.44 61.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.873 0.368 . . . . 20.0 110.369 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.25 -40.64 74.47 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.348 -0.387 . . . . 20.0 110.938 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.6 82.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.043 0.449 . . . . 20.0 110.305 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.23 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 119.692 -0.803 . . . . 20.0 110.336 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.78 -29.42 20.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 118.731 -1.188 . . . . 20.0 111.176 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -62.59 -30.91 71.68 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.816 -0.354 . . . . 20.0 111.101 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.92 -56.78 3.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.196 0.443 . . . . 20.0 112.196 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.4 44.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.461 -0.336 . . . . 20.0 111.514 -164.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -26.38 63.67 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.943 -0.703 . . . . 20.0 112.229 -162.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.55 63.05 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 118.926 -1.11 . . . . 20.0 111.716 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.86 -6.94 22.94 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.534 0.939 . . . . 20.0 113.534 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.5 152.68 22.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.53 -0.915 . . . . 20.0 108.53 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.17 -42.57 88.76 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 20.0 111.468 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.32 35.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.554 -0.906 . . . . 20.0 108.554 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.22 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.17 159.26 44.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.5 0.667 . . . . 20.0 110.469 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.07 128.93 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -176.15 5.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.806 0.812 . . . . 20.0 108.904 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.52 62.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.089 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.23 10.83 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.636 0.976 . . . . 20.0 113.636 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.59 83.41 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.104 -0.831 . . . . 20.0 114.498 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.51 35.87 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.463 1.132 . . . . 20.0 110.212 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.36 140.23 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.172 -1.418 . . . . 20.0 107.172 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.22 115.62 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.332 -1.359 . . . . 20.0 107.332 -174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.76 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.663 -0.495 . . . . 20.0 109.663 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 99.96 8.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.599 -0.889 . . . . 20.0 108.599 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.57 145.38 31.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.792 -1.559 . . . . 20.0 106.792 163.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.54 154.48 20.32 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.459 0.474 . . . . 20.0 109.723 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.07 23.66 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.146 -0.781 . . . . 20.0 111.146 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.11 105.59 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.946 0.898 . . . . 20.0 109.049 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.54 33.52 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.082 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.77 165.27 32.67 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 CA-C-O 121.784 0.66 . . . . 20.0 112.066 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -92.03 111.38 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.932 -1.031 . . . . 20.0 109.249 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.71 137.97 30.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.715 -0.846 . . . . 20.0 108.715 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.84 124.04 46.19 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.023 0.929 . . . . 20.0 108.994 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.28 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 108.116 -1.068 . . . . 20.0 108.116 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.57 124.65 51.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.57 45.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.91 0.884 . . . . 20.0 108.947 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' NE2' ' OD1' ' A' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.46 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 20.0 110.57 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 11.9 t0 -97.41 68.01 2.14 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.65 -0.657 . . . . 20.0 112.461 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.88 28.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.196 -1.038 . . . . 20.0 108.196 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.717 0.807 . . . . 20.0 109.164 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.91 -175.76 27.28 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.594 -1.002 . . . . 20.0 110.594 173.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.01 161.49 26.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.339 0.59 . . . . 20.0 109.981 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.14 131.29 48.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.985 -1.007 . . . . 20.0 109.721 -174.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.03 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.897 -0.779 . . . . 20.0 108.897 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.05 -29.31 7.04 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.106 0.78 . . . . 20.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.04 174.45 13.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.139 -1.06 . . . . 20.0 108.139 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.05 108.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.317 -0.994 . . . . 20.0 108.317 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.75 166.31 5.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.838 0.828 . . . . 20.0 109.971 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -27.11 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.716 -0.794 . . . . 20.0 112.725 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.54 9.18 4.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.364 0.876 . . . . 20.0 113.364 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.72 81.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 118.95 -0.917 . . . . 20.0 115.067 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.78 145.02 34.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.331 1.065 . . . . 20.0 110.244 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.54 27.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.245 -0.889 . . . . 20.0 112.568 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.45 174.61 6.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.83 -1.174 . . . . 20.0 107.83 158.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.75 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.649 0.737 . . . . 20.0 109.482 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.2 129.4 15.7 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.026 -0.988 . . . . 20.0 109.812 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -79.88 160.25 24.33 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-O 122.26 0.858 . . . . 20.0 112.701 -171.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.79 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 113.708 -1.587 . . . . 20.0 107.359 165.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.89 47.57 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.231 -0.895 . . . . 20.0 112.161 -168.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.223 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.92 152.65 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.644 1.222 . . . . 20.0 109.25 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.66 130.95 22.21 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 108.467 -0.938 . . . . 20.0 108.467 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.1 -7.96 13.06 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 CA-C-N 120.59 1.246 . . . . 20.0 114.778 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.16 59.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.188 0.903 . . . . 20.0 111.786 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.52 35.51 0.82 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.626 0.77 . . . . 20.0 112.424 178.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.24 -66.46 0.37 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.963 1.305 . . . . 20.0 113.423 -173.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.17 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 109.04 -0.726 . . . . 20.0 109.04 174.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.86 -19.02 5.83 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.533 1.133 . . . . 20.0 111.254 158.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' C' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.65 2.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.746 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.84 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 115.247 1.573 . . . . 20.0 115.247 150.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.26 36.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.249 0.932 . . . . 20.0 109.411 160.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.31 37.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.56 -0.745 . . . . 20.0 109.375 -173.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.46 110.78 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.172 -1.047 . . . . 20.0 108.172 -178.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.04 6.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.23 -0.285 . . . . 20.0 110.23 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.2 mt -51.95 -54.19 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 123.34 0.4 . . . . 20.0 110.351 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.54 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.446 -0.946 . . . . 20.0 108.446 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.475 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.2 11.22 75.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.894 -0.948 . . . . 20.0 115.322 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.0 15.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.47 1.135 . . . . 20.0 108.609 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.5 37.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.52 43.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.652 -0.87 . . . . 20.0 108.652 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.72 149.41 31.17 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.993 -1.003 . . . . 20.0 110.305 -172.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' PHE . . . -147.94 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.322 -1.111 . . . . 20.0 110.322 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 m -128.7 154.46 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.34 -0.985 . . . . 20.0 108.34 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.31 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.308 -0.86 . . . . 20.0 114.56 -168.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.94 69.42 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.399 1.259 . . . . 20.0 114.399 -156.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.15 11.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.518 1.054 . . . . 20.0 112.649 -155.369 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.13 35.48 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 102.63 -3.1 . . . . 20.0 102.63 159.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 CA-C-N 120.733 1.298 . . . . 20.0 110.553 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.276 0 CA-C-N 119.223 0.758 . . . . 20.0 110.65 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.799 0.809 . . . . 20.0 109.974 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.162 -1.051 . . . . 20.0 108.162 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.77 19.5 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.791 -0.363 . . . . 20.0 110.722 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.84 -43.63 1.52 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.948 0.899 . . . . 20.0 113.119 -170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -24.89 59.03 Favored 'Trans proline' 0 C--N 1.358 1.073 0 CA-C-N 120.855 1.341 . . . . 20.0 111.968 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.5 -26.55 30.1 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.823 0.305 . . . . 20.0 111.823 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.93 69.16 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.724 -0.791 . . . . 20.0 110.256 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 111.892 0.33 . . . . 20.0 111.892 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -78.48 90.96 4.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.229 -0.656 . . . . 20.0 109.229 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.122 0.415 . . . . 20.0 112.122 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.53 87.27 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 108.507 -0.923 . . . . 20.0 108.507 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.76 153.61 75.36 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 119.629 0.903 . . . . 20.0 112.384 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.66 42.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.544 -1.207 . . . . 20.0 107.98 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -12.19 59.95 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 118.794 -0.622 . . . . 20.0 112.362 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 138' ' ' GLN . 14.1 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.888 -0.577 . . . . 20.0 111.354 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLN . . . . . 0.41 ' N ' ' OD1' ' A' ' 137' ' ' ASP . 3.9 tp-100 174.68 174.12 0.2 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 103.13 -2.915 . . . . 20.0 103.13 133.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.85 168.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.107 0.963 . . . . 20.0 108.978 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.993 0.917 . . . . 20.0 110.509 177.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 30.2 mt -124.64 147.49 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.607 -0.886 . . . . 20.0 108.607 -177.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -119.09 134.72 55.03 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.662 0.785 . . . . 20.0 109.636 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.91 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 O-C-N 123.679 0.612 . . . . 20.0 111.777 166.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 142' ' ' ASP . . . 86.82 -6.49 82.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 115.486 0.954 . . . . 20.0 115.486 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.49 1.145 . . . . 20.0 110.263 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.83 33.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.42 162.62 40.21 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.976 0.893 . . . . 20.0 111.412 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.47 80.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.263 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.42 -47.03 87.87 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.827 -0.349 . . . . 20.0 110.91 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.33 -35.24 76.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.54 -0.464 . . . . 20.0 110.807 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.58 84.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.032 -0.667 . . . . 20.0 111.141 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.34 58.52 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.346 -0.941 . . . . 20.0 110.999 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.63 -30.11 66.65 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.797 -0.761 . . . . 20.0 110.665 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.57 -40.6 92.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.57 -0.452 . . . . 20.0 111.659 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.79 6.71 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 118.936 -0.925 . . . . 20.0 114.652 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.68 133.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.454 1.127 . . . . 20.0 108.548 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.92 9.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.746 -1.205 . . . . 20.0 107.746 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.3 147.32 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.628 -1.249 . . . . 20.0 107.628 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.823 -1.711 . . . . 20.0 108.823 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.46 113.61 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 165.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -19.97 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 113.759 1.022 . . . . 20.0 113.759 -166.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.7 155.63 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 121.662 -0.649 . . . . 20.0 111.772 -159.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 164' ' ' TRP . 3.5 t -145.33 -166.39 2.42 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.308 1.043 . . . . 20.0 110.423 171.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' TRP . . . . . 0.542 ' N ' ' OG1' ' A' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.85 16.74 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.211 0.819 . . . . 20.0 113.211 -160.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' O ' ' NE2' ' C' ' 101' ' ' GLN . 7.5 t70 63.66 61.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.224 0.535 . . . . 20.0 112.317 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.84 158.63 29.63 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 148.35 37.67 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.725 -1.213 . . . . 20.0 107.725 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.58 30.38 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.069 -0.968 . . . . 20.0 110.263 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.944 0.878 . . . . 20.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.2 34.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.216 -1.356 . . . . 20.0 109.465 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 151.6 29.1 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.509 -0.552 . . . . 20.0 109.509 168.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 175' ' ' ARG . . . 57.01 68.64 1.59 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.95 4.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.75 0.648 . . . . 20.0 112.75 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -63.02 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.736 -0.786 . . . . 20.0 111.206 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.9 ptt-85 -169.84 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.587 0.631 . . . . 20.0 112.655 172.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.842 2.457 . . . . 20.0 106.263 157.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.7 145.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.23 -64.39 1.17 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.32 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.776 0.716 . . . . 20.0 112.144 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.75 36.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.62 -66.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.594 0.634 . . . . 20.0 111.8 -162.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.38 127.88 32.91 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.123 0.963 . . . . 20.0 110.665 -152.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.73 1.04 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.339 1.456 . . . . 20.0 113.166 174.659 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.8 83.88 1.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.171 0.986 . . . . 20.0 110.819 157.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 104.475 -2.417 . . . . 20.0 104.475 149.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.725 ' O ' ' OG1' ' A' ' 189' ' ' THR . . . -50.09 -43.02 51.3 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.32 -0.855 . . . . 20.0 111.502 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.86 -36.09 76.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.33 -0.948 . . . . 20.0 110.118 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.87 -38.57 91.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.12 -1.032 . . . . 20.0 110.546 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' THR . . . . . 0.725 ' OG1' ' O ' ' A' ' 186' ' ' ALA . 25.2 p -59.16 -48.57 81.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.82 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.35 -50.53 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.875 0.369 . . . . 20.0 110.467 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.18 96.18 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.95 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.88 -36.51 84.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.954 -0.699 . . . . 20.0 110.37 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.6 t -60.57 -44.82 97.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.06 0.457 . . . . 20.0 110.082 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.33 75.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.222 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.55 -38.16 71.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.876 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.68 -26.18 41.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.55 0.574 . . . . 20.0 112.55 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.54 122.79 27.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.3 -0.63 . . . . 20.0 109.3 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.43 -57.05 2.33 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.288 0.367 . . . . 20.0 110.113 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.36 17.49 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.691 -0.485 . . . . 20.0 109.691 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.24 4.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.189 -0.671 . . . . 20.0 109.189 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.74 -14.57 59.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.036 -0.666 . . . . 20.0 111.349 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.66 30.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.912 -0.773 . . . . 20.0 108.912 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' A' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.96 16.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -174.5 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.54 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -170.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.92 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.046 -0.724 . . . . 20.0 109.046 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.87 125.37 31.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.92 150.16 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.887 -0.783 . . . . 20.0 108.887 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.32 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.86 159.95 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.882 0.849 . . . . 20.0 111.113 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.43 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.22 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.19 29.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.478 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.51 13.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.966 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -20.4 64.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.272 -0.571 . . . . 20.0 111.442 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 89.1 t -131.15 121.13 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.09 60.95 6.21 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 119.65 -1.262 . . . . 20.0 111.406 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.05 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.474 0.916 . . . . 20.0 113.474 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.51 -4.52 2.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.7 -40.48 40.92 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 119.7 -1.238 . . . . 20.0 112.001 168.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' A' ' 222' ' ' SER . . . -65.28 -37.06 86.02 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.287 -0.537 . . . . 20.0 111.361 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.72 -36.7 57.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.173 0.434 . . . . 20.0 112.173 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 76.0 p -58.48 -45.85 87.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.054 -0.658 . . . . 20.0 110.83 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 219' ' ' ALA . 2.1 p -58.01 -35.82 71.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 20.0 111.378 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.12 -33.43 75.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.853 -165.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.72 74.95 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 118.965 -1.588 . . . . 20.0 112.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.03 -45.63 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 112.007 0.373 . . . . 20.0 112.007 -158.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLU . . . . . 0.504 ' OE1' ' OG1' ' A' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.63 99.79 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 118.204 2.668 . . . . 20.0 118.204 -158.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.96 143.71 2.98 Favored 'Trans proline' 0 C--O 1.232 0.209 0 N-CA-C 116.005 1.502 . . . . 20.0 116.005 -134.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.18 -4.77 0.77 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.231 1.412 . . . . 20.0 113.403 162.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.25 11.48 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.124 -0.63 . . . . 20.0 111.808 167.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.5 16.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.91 -0.662 . . . . 20.0 112.285 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.77 170.73 15.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.77 -0.826 . . . . 20.0 108.77 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.03 23.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.201 0.524 . . . . 20.0 110.39 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.18 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.568 -1.271 . . . . 20.0 107.568 172.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 68' ' ' HIS . 25.4 t0 -135.16 173.21 11.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.983 -1.488 . . . . 20.0 106.983 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.692 0.758 . . . . 20.0 111.432 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.62 122.79 1.46 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.342 -1.355 . . . . 20.0 107.342 164.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.53 151.87 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -161.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.24 9.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.862 -1.533 . . . . 20.0 106.862 158.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.5 110.02 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.989 0.737 . . . . 20.0 112.989 -155.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.33 36.19 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.936 1.295 . . . . 20.0 112.472 158.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.45 78.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 105.118 -2.178 . . . . 20.0 105.118 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 CA-C-N 120.825 1.33 . . . . 20.0 112.348 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.23 45.22 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.048 -0.978 . . . . 20.0 114.922 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.16 164.51 22.98 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.638 1.219 . . . . 20.0 110.632 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.01 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.328 -0.543 0 CA-C-O 121.904 0.71 . . . . 20.0 111.962 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.718 -1.128 . . . . 20.0 112.035 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.33 -18.67 63.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.821 -0.751 . . . . 20.0 112.846 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.734 ' O ' ' OG1' ' A' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.252 0.834 . . . . 20.0 113.252 170.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -37.76 88.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.279 -0.569 . . . . 20.0 111.349 -172.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -20.94 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.092 -1.043 . . . . 20.0 111.937 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.734 ' OG1' ' O ' ' A' ' 249' ' ' LYS . 39.5 p -57.17 -31.85 65.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.462 0.574 . . . . 20.0 111.329 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.391 0.615 . . . . 20.0 110.363 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.3 3.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.979 -1.009 . . . . 20.0 112.305 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.3 35.97 5.83 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 126.165 1.84 . . . . 20.0 111.542 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.21 10.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.655 -0.868 . . . . 20.0 108.655 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.27 3.34 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 122.667 1.148 . . . . 20.0 113.348 169.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.569 -0.9 . . . . 20.0 108.569 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 316' ' ' SER . . . -126.4 120.35 29.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.128 -0.942 . . . . 20.0 109.422 -169.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.02 139.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.85 122.64 42.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.75 -40.29 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 20.0 109.612 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.402 0.62 . . . . 20.0 109.343 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.07 -169.95 2.85 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.784 -1.098 . . . . 20.0 108.209 165.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.97 -56.27 21.5 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.782 -0.645 . . . . 20.0 110.262 163.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.15 11.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.667 0.988 . . . . 20.0 113.667 -165.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.83 143.66 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -163.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.21 103.98 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.172 -1.788 . . . . 20.0 106.172 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.1 56.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.286 0.565 . . . . 20.0 111.317 -171.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.11 109.71 2.01 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.166 -0.924 . . . . 20.0 108.681 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -67.5 -19.96 48.24 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 N-CA-C 114.845 1.056 . . . . 20.0 114.845 -160.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.65 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.168 -0.613 . . . . 20.0 110.587 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.54 -48.38 77.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.14 0.495 . . . . 20.0 110.136 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.16 -52.47 60.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.823 0.344 . . . . 20.0 110.723 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.43 -31.93 70.88 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.881 -0.728 . . . . 20.0 110.493 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.45 -47.99 65.72 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.013 179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.72 89.78 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.982 -0.687 . . . . 20.0 110.752 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.63 -47.9 78.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.518 -0.473 . . . . 20.0 110.123 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.84 -40.4 88.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.877 -0.329 . . . . 20.0 110.741 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.112 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.06 -31.73 73.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.004 -0.678 . . . . 20.0 111.02 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.77 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.141 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.88 -37.63 73.06 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.88 -0.728 . . . . 20.0 110.98 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.63 15.48 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.8 32.14 13.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.705 0.764 . . . . 20.0 111.546 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.28 143.42 34.47 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.338 -0.986 . . . . 20.0 108.338 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.19 149.34 13.42 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 CA-C-N 119.195 0.748 . . . . 20.0 111.389 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.02 148.11 23.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.679 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.98 175.1 5.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.735 -1.209 . . . . 20.0 107.735 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.69 113.73 17.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.864 -1.162 . . . . 20.0 107.864 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.69 43.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.06 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.68 12.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.46 0.648 . . . . 20.0 110.281 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.77 -18.53 21.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.83 -1.077 . . . . 20.0 112.186 165.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.963 -0.855 . . . . 20.0 110.963 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.56 144.81 15.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.652 -0.774 . . . . 20.0 112.674 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.337 -1.105 . . . . 20.0 110.337 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' THR . . . . . . . . . . . . . 20.4 p -110.21 172.94 6.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.015 0.912 . . . . 20.0 111.411 -174.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.379 -1.282 . . . . 20.0 111.261 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.33 74.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 111.768 0.285 . . . . 20.0 111.768 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.12 96.89 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.173 -1.013 . . . . 20.0 112.083 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.31 -26.87 65.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.21 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.95 -34.43 55.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.115 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.15 60.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.315 0.857 . . . . 20.0 113.315 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.77 -8.93 19.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.724 1.009 . . . . 20.0 113.724 -167.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' THR . . . . . 0.504 ' OG1' ' OE1' ' A' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.619 0.723 . . . . 20.0 110.557 171.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.68 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.235 -0.893 . . . . 20.0 113.324 -161.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.85 -25.25 66.33 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.79 65.1 1.94 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.829 -0.701 . . . . 20.0 113.311 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.21 139.57 52.62 Favored Pre-proline 0 C--O 1.239 0.505 0 CA-C-N 117.585 0.692 . . . . 20.0 111.161 -163.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.5 141.69 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 CA-C-N 119.509 0.86 . . . . 20.0 110.046 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.7 m -140.46 135.87 32.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.311 -0.859 . . . . 20.0 111.202 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.66 162.57 12.34 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 109.164 -1.575 . . . . 20.0 109.164 164.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.0 27.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 20.0 110.089 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.27 21.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.594 -1.184 . . . . 20.0 109.254 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' ALA . 4.2 m -138.47 133.5 32.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.32 -0.855 . . . . 20.0 109.5 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.44 108.59 51.23 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 107.254 -1.387 . . . . 20.0 107.254 177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.34 -168.95 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.618 1.007 . . . . 20.0 113.608 -154.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.72 35.54 0.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 113.554 -1.657 . . . . 20.0 115.308 161.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.66 157.59 33.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.751 0.786 . . . . 20.0 110.044 176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.1 166.14 11.71 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.809 -1.552 . . . . 20.0 106.809 160.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.21 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.15 0.98 . . . . 20.0 108.423 -163.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.54 -7.49 3.28 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.433 1.271 . . . . 20.0 114.433 -140.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.47 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.651 0.611 . . . . 20.0 112.651 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -102.01 -56.15 2.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.996 1.48 . . . . 20.0 114.996 -152.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.96 50.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.433 -1.321 . . . . 20.0 107.433 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -142.56 52.8 1.42 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.812 -1.54 . . . . 20.0 109.964 -153.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.05 149.41 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.393 0.616 . . . . 20.0 111.961 -171.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.35 179.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.886 0.851 . . . . 20.0 109.472 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.12 27.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.605 -1.18 . . . . 20.0 108.884 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.11 -32.03 53.83 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.825 0.703 . . . . 20.0 111.514 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ARG . . . . . 0.439 ' NH2' ' OE2' ' C' ' 146' ' ' GLU . 10.3 mtm180 -68.6 -44.81 73.52 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.345 -0.542 . . . . 20.0 110.253 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.94 -45.05 83.25 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.777 -0.369 . . . . 20.0 111.049 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.57 -41.3 92.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.464 -0.495 . . . . 20.0 110.518 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -34.68 71.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 118.831 -1.148 . . . . 20.0 110.119 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.39 93.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.038 -0.665 . . . . 20.0 110.446 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.52 -43.84 80.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.74 0.305 . . . . 20.0 110.903 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' VAL . . . . . 0.703 ' O ' ' OG1' ' A' ' 342' ' ' THR . 42.6 t -60.15 -48.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.994 0.426 . . . . 20.0 110.248 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' GLU . . . . . 0.782 ' OE1' ' NZ ' ' A' ' 343' ' ' LYS . 1.3 mm-40 -54.89 -46.86 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.967 0.413 . . . . 20.0 110.771 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -55.15 37.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 20.0 111.403 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.21 -40.32 89.68 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.203 -0.599 . . . . 20.0 110.785 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' A' ' 338' ' ' VAL . 1.3 m -56.53 -44.96 81.33 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.121 0.486 . . . . 20.0 110.411 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' LYS . . . . . 0.782 ' NZ ' ' OE1' ' A' ' 339' ' ' GLU . 34.6 mttp -74.24 -37.47 63.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.961 -0.696 . . . . 20.0 110.76 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.53 97.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.538 -0.465 . . . . 20.0 111.1 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.99 -50.4 74.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.555 -0.458 . . . . 20.0 110.782 -179.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.06 90.93 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.7 -0.8 . . . . 20.0 110.594 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.47 4.77 30.2 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.446 -0.901 . . . . 20.0 112.568 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.2 -23.67 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 119.574 -0.85 . . . . 20.0 110.886 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.83 -27.27 69.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.786 -0.765 . . . . 20.0 111.235 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -85.94 -18.83 31.6 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.058 -0.401 . . . . 20.0 111.467 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.131 0.419 . . . . 20.0 112.131 -173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.026 1.862 . . . . 20.0 116.026 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 124.99 1.316 . . . . 20.0 108.381 -174.706 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 114.257 1.206 . . . . 20.0 114.257 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.07 82.22 2.92 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 106.878 -1.527 . . . . 20.0 106.878 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.93 -34.52 66.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 114.904 -1.044 . . . . 20.0 110.198 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -107.0 -23.53 12.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.61 0.967 . . . . 20.0 113.61 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.24 19.89 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.147 0.979 . . . . 20.0 111.623 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.71 32.45 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 122.275 -0.266 . . . . 20.0 111.24 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.43 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.655 -1.239 . . . . 20.0 107.655 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.87 112.21 12.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.309 0.576 . . . . 20.0 110.943 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.468 -0.787 . . . . 20.0 111.83 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.08 -45.23 74.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.251 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -43.1 97.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 121.049 -0.26 . . . . 20.0 111.195 -172.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.85 -30.59 70.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.786 -0.366 . . . . 20.0 111.167 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.4 90.78 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.639 -0.424 . . . . 20.0 110.498 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.03 -42.99 91.54 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.676 -0.238 . . . . 20.0 111.476 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.87 -40.1 26.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.532 -0.867 . . . . 20.0 110.661 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 119.042 -1.063 . . . . 20.0 111.001 -162.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -26.01 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.966 -0.693 . . . . 20.0 111.293 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.42 70.56 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.801 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -85.18 144.73 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.459 0 CA-C-O 121.709 0.629 . . . . 20.0 112.145 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.83 38.23 3.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 117.277 1.671 . . . . 20.0 117.277 -159.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.2 8.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 20.0 110.713 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.032 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.41 0.18 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.28 1.038 . . . . 20.0 109.568 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.87 -13.2 3.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.891 -1.049 . . . . 20.0 113.465 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' B' ' 28' ' ' GLY . 0.0 OUTLIER -87.92 8.97 23.73 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.712 1.142 . . . . 20.0 113.806 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.66 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.433 1.642 . . . . 20.0 115.433 -154.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 26' ' ' PHE . . . -53.07 -26.99 29.42 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 119.775 1.171 . . . . 20.0 116.023 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.57 -35.75 61.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 118.06 0.93 . . . . 20.0 110.643 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.36 -52.4 61.73 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.895 0.379 . . . . 20.0 110.403 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.58 74.42 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.33 -0.395 . . . . 20.0 110.984 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.3 -49.54 82.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.039 0.447 . . . . 20.0 110.338 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.21 -39.74 86.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.709 -0.797 . . . . 20.0 110.309 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.47 20.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 118.72 -1.192 . . . . 20.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.53 -30.95 71.67 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.0 0.364 . . . . 20.0 111.08 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.68 3.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.184 0.438 . . . . 20.0 112.184 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.34 -28.43 44.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.492 -0.322 . . . . 20.0 111.53 -164.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.34 -26.41 63.74 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.97 -0.692 . . . . 20.0 112.244 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.1 -23.56 63.07 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 118.914 -1.114 . . . . 20.0 111.726 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.94 22.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.479 0.918 . . . . 20.0 113.479 -176.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.57 152.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.08 -42.65 89.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.168 -0.924 . . . . 20.0 111.474 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.3 35.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.548 -0.908 . . . . 20.0 108.548 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.46 147.21 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.12 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.518 0.675 . . . . 20.0 110.443 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.06 129.02 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.351 -1.351 . . . . 20.0 107.351 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.12 5.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.811 0.815 . . . . 20.0 108.857 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.51 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.133 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.24 10.86 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.631 0.975 . . . . 20.0 113.631 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.67 83.35 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 119.124 -0.82 . . . . 20.0 114.458 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.44 35.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.457 1.128 . . . . 20.0 110.239 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.37 140.27 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.28 115.67 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 -174.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.677 -0.49 . . . . 20.0 109.677 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.93 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.6 -0.889 . . . . 20.0 108.6 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 145.37 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.745 -1.576 . . . . 20.0 106.745 163.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.52 20.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.492 0.495 . . . . 20.0 109.74 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.62 10.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.829 0.852 . . . . 20.0 108.978 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.53 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.093 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.76 165.22 32.81 Favored 'Trans proline' 0 C--N 1.331 -0.378 0 CA-C-O 121.76 0.65 . . . . 20.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.92 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.995 -1.002 . . . . 20.0 109.255 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.74 137.96 30.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.777 -0.824 . . . . 20.0 108.777 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.09 46.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.083 0.953 . . . . 20.0 109.026 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -116.28 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.075 -1.083 . . . . 20.0 108.075 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.63 124.65 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.329 0.393 . . . . 20.0 110.968 -168.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.5 154.59 45.97 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.887 0.875 . . . . 20.0 108.925 167.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' B' ' 235' ' ' ASP . 0.0 OUTLIER -105.03 146.46 29.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.99 -0.55 . . . . 20.0 110.534 177.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.188 -0.915 . . . . 20.0 109.711 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.645 -0.66 . . . . 20.0 112.445 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.93 28.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.234 -1.025 . . . . 20.0 108.234 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.8 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.778 0.831 . . . . 20.0 109.127 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.79 -175.7 27.09 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.576 -1.01 . . . . 20.0 110.576 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -125.06 161.45 26.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.356 0.598 . . . . 20.0 109.954 178.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.09 131.39 49.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 20.0 109.709 -174.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.54 137.08 23.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.862 -0.792 . . . . 20.0 108.862 168.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.1 -29.26 7.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.102 0.778 . . . . 20.0 113.102 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.06 174.42 13.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.132 -1.062 . . . . 20.0 108.132 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.6 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.832 0.825 . . . . 20.0 109.998 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.02 60.32 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.705 -0.798 . . . . 20.0 112.687 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.53 9.12 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.317 0.858 . . . . 20.0 113.317 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.8 81.74 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 118.99 -0.894 . . . . 20.0 115.079 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.83 145.04 34.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.335 1.067 . . . . 20.0 110.218 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.5 28.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.235 -0.893 . . . . 20.0 112.604 -172.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.883 -1.154 . . . . 20.0 107.883 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.76 163.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.654 0.74 . . . . 20.0 109.433 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.29 129.31 15.56 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 114.997 -1.002 . . . . 20.0 109.828 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.77 160.24 24.67 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.268 0.862 . . . . 20.0 112.721 -171.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.77 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 113.711 -1.586 . . . . 20.0 107.364 165.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.02 140.97 47.51 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.258 -0.883 . . . . 20.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.19 22.2 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 118.938 -0.923 . . . . 20.0 115.252 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.82 152.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 118.639 1.219 . . . . 20.0 109.258 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.92 22.25 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 108.473 -0.936 . . . . 20.0 108.473 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.04 -7.95 13.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 CA-C-N 120.575 1.241 . . . . 20.0 114.83 -170.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.2 -15.34 59.75 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.149 0.886 . . . . 20.0 111.781 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.38 35.48 0.81 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.666 0.786 . . . . 20.0 112.458 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.28 -66.41 0.38 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.985 1.314 . . . . 20.0 113.395 -173.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.21 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.95 -19.04 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.628 -1.169 . . . . 20.0 111.242 158.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.31 141.65 2.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.665 -0.865 . . . . 20.0 108.665 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 74.53 0.38 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 115.242 1.571 . . . . 20.0 115.242 150.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' B' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.23 36.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.236 0.925 . . . . 20.0 109.442 160.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.79 140.23 37.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.571 -0.741 . . . . 20.0 109.404 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' VAL . . . . . . . . . . . . . 50.4 t -117.38 110.78 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.242 -1.021 . . . . 20.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.56 83.05 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.255 -0.276 . . . . 20.0 110.255 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -51.91 -54.18 14.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.378 0.424 . . . . 20.0 110.377 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.63 177.48 10.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.388 -0.967 . . . . 20.0 108.388 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.34 27.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.891 -1.05 . . . . 20.0 110.463 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.28 74.98 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 118.83 -0.984 . . . . 20.0 115.308 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.05 113.97 15.81 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.508 1.154 . . . . 20.0 108.592 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.26 141.51 37.8 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.658 -0.867 . . . . 20.0 108.658 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.68 149.4 31.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.992 -1.004 . . . . 20.0 110.32 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 103' ' ' PHE . . . -147.95 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.288 -1.125 . . . . 20.0 110.288 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.4 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.363 -0.977 . . . . 20.0 108.363 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.321 -0.854 . . . . 20.0 114.565 -168.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.98 69.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 114.326 1.232 . . . . 20.0 114.326 -156.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.58 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.549 1.068 . . . . 20.0 112.706 -155.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.12 35.51 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 102.616 -3.105 . . . . 20.0 102.616 159.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.85 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 120.677 1.278 . . . . 20.0 110.548 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.79 149.73 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 CA-C-N 119.209 0.753 . . . . 20.0 110.692 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.03 165.4 7.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.832 . . . . 20.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.138 -1.06 . . . . 20.0 108.138 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.88 19.78 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.818 0.342 . . . . 20.0 110.764 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.01 -43.6 1.47 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.93 0.892 . . . . 20.0 113.074 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.02 -24.92 59.41 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.879 1.35 . . . . 20.0 111.998 170.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.51 30.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 111.807 0.299 . . . . 20.0 111.807 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.98 69.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.251 168.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.96 62.73 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.953 0.353 . . . . 20.0 111.953 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.41 90.85 4.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.262 -0.644 . . . . 20.0 109.262 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.41 7.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.125 0.417 . . . . 20.0 112.125 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.21 142.58 87.36 Favored Pre-proline 0 N--CA 1.444 -0.728 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.82 153.64 75.12 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 CA-C-N 119.646 0.909 . . . . 20.0 112.329 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.69 153.66 42.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.481 -1.236 . . . . 20.0 107.935 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.27 59.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.85 -0.595 . . . . 20.0 112.405 -175.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 138' ' ' GLN . 14.2 p30 -55.3 -66.39 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.91 -0.567 . . . . 20.0 111.409 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 138' ' ' GLN . . . . . 0.419 ' N ' ' OD1' ' B' ' 137' ' ' ASP . 3.9 tp-100 174.66 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.079 -2.934 . . . . 20.0 103.079 133.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.86 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.124 0.97 . . . . 20.0 108.918 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.84 161.47 18.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.947 0.899 . . . . 20.0 110.536 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 141' ' ' ILE . . . . . . . . . . . . . 30.5 mt -124.67 147.46 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' B' ' 144' ' ' GLY . 0.5 OUTLIER -119.06 134.81 54.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.578 0.751 . . . . 20.0 109.577 175.16 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.83 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 123.663 0.602 . . . . 20.0 111.818 166.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' B' ' 142' ' ' ASP . . . 86.89 -6.62 82.72 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.11 144.0 54.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.476 1.138 . . . . 20.0 110.353 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 146' ' ' GLU . . . . . 0.4 ' OE2' ' NH2' ' D' ' 332' ' ' ARG . 94.2 mt-10 -83.32 -20.9 33.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.624 0.972 . . . . 20.0 113.624 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.61 40.2 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.982 0.896 . . . . 20.0 111.403 -173.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.4 -41.46 80.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.867 -1.515 . . . . 20.0 111.26 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.48 -46.98 88.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.83 -0.348 . . . . 20.0 110.905 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.33 -35.19 76.71 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.472 -0.491 . . . . 20.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.61 84.28 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.122 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.35 58.49 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.388 -0.925 . . . . 20.0 111.009 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.11 66.61 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 119.782 -0.767 . . . . 20.0 110.61 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.57 -40.67 92.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.569 -0.452 . . . . 20.0 111.614 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.75 6.69 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 118.952 -0.915 . . . . 20.0 114.606 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.68 133.56 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 118.447 1.124 . . . . 20.0 108.567 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.747 -1.205 . . . . 20.0 107.747 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.65 -1.241 . . . . 20.0 107.65 174.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.36 169.34 15.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 108.81 -1.716 . . . . 20.0 108.81 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.41 113.59 17.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.656 -1.238 . . . . 20.0 107.656 165.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 113.713 1.005 . . . . 20.0 113.713 -166.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.64 155.63 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.691 -0.631 . . . . 20.0 111.79 -159.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 163' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 164' ' ' TRP . 3.5 t -145.34 -166.32 2.4 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.272 1.029 . . . . 20.0 110.465 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 164' ' ' TRP . . . . . 0.555 ' N ' ' OG1' ' B' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.91 16.7 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 113.221 0.823 . . . . 20.0 113.221 -160.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.68 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.227 0.536 . . . . 20.0 112.268 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.94 158.61 29.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.133 -1.187 . . . . 20.0 110.133 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 148.31 37.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 170.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.58 30.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.068 -0.969 . . . . 20.0 110.216 -167.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -129.41 159.75 35.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.913 0.863 . . . . 20.0 110.002 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.2 34.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 20.0 109.471 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.64 28.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.528 -0.545 . . . . 20.0 109.528 168.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 172' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' B' ' 175' ' ' ARG . . . 56.89 68.72 1.55 Allowed Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -170.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.92 4.25 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.785 0.661 . . . . 20.0 112.785 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.17 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.69 -0.804 . . . . 20.0 111.208 157.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 175' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' B' ' 172' ' ' GLY . 6.8 ptt-85 -169.82 122.01 0.7 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.632 0.651 . . . . 20.0 112.605 172.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.89 2.476 . . . . 20.0 106.278 157.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.69 145.81 20.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.458 -0.942 . . . . 20.0 108.458 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.16 -64.51 1.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.415 2.006 . . . . 20.0 116.415 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 118.715 0.689 . . . . 20.0 112.125 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.92 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.359 1.244 . . . . 20.0 114.359 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 181' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -84.68 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.641 0.655 . . . . 20.0 111.723 -162.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.29 127.83 32.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.085 0.945 . . . . 20.0 110.655 -152.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 183' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' B' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.74 1.04 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.353 1.461 . . . . 20.0 113.157 174.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 122.212 1.006 . . . . 20.0 110.809 157.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.15 -41.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 104.468 -2.419 . . . . 20.0 104.468 149.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 186' ' ' ALA . . . . . 0.703 ' O ' ' OG1' ' B' ' 189' ' ' THR . . . -50.18 -42.93 52.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.401 -0.818 . . . . 20.0 111.488 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.092 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.66 91.93 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.151 -1.02 . . . . 20.0 110.539 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 189' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' B' ' 186' ' ' ALA . 25.2 p -59.09 -48.58 81.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.458 -0.897 . . . . 20.0 110.84 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.55 64.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.966 0.412 . . . . 20.0 110.504 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.17 96.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.069 -0.652 . . . . 20.0 110.918 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.56 84.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.951 -0.7 . . . . 20.0 110.34 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.56 -44.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 20.0 110.074 177.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.31 75.48 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.19 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.61 -38.2 70.85 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.878 -0.729 . . . . 20.0 110.777 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.61 -26.16 41.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.76 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.258 -0.645 . . . . 20.0 109.258 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.08 2.32 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.277 0.361 . . . . 20.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.39 17.52 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.0 91.28 4.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.221 -0.659 . . . . 20.0 109.221 -174.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.55 59.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.034 -0.667 . . . . 20.0 111.312 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.69 30.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.914 -0.772 . . . . 20.0 108.914 172.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 203' ' ' ASP . . . . . 0.643 ' N ' ' OD1' ' B' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.02 16.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.487 -0.931 . . . . 20.0 108.487 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.59 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.593 -0.891 . . . . 20.0 108.593 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.96 106.58 8.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 20.0 109.009 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.88 125.4 31.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.774 -0.825 . . . . 20.0 108.774 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.96 150.17 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.38 98.78 5.17 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.4 -1.333 . . . . 20.0 107.4 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 34.5 p -85.85 159.96 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.889 0.852 . . . . 20.0 111.129 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.82 166.41 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.19 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.22 29.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.743 -1.117 . . . . 20.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.0 -49.51 13.92 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.387 -0.525 . . . . 20.0 110.974 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -20.42 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.461 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.16 121.09 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.582 -0.895 . . . . 20.0 108.582 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.93 6.26 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.71 -1.233 . . . . 20.0 111.473 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.01 -25.51 0.82 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.458 0.91 . . . . 20.0 113.458 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.52 2.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.358 0.503 . . . . 20.0 112.358 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.53 40.82 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.715 -1.231 . . . . 20.0 112.003 168.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' B' ' 222' ' ' SER . . . -65.27 -37.07 86.04 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 122.247 -0.561 . . . . 20.0 111.37 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.68 -36.73 57.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 75.8 p -58.4 -45.84 87.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.034 -0.666 . . . . 20.0 110.886 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 219' ' ' ALA . 2.1 p -58.0 -35.79 71.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.741 -0.384 . . . . 20.0 111.462 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.63 -49.95 69.3 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.605 0.594 . . . . 20.0 112.605 -169.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 224' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.19 -33.45 75.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.78 -0.768 . . . . 20.0 111.771 -165.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.68 74.92 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.953 -1.594 . . . . 20.0 112.12 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.01 -45.58 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.004 0.372 . . . . 20.0 112.004 -158.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 227' ' ' GLU . . . . . 0.503 ' OE1' ' OG1' ' B' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 118.223 2.675 . . . . 20.0 118.223 -158.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -43.89 143.67 2.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 N-CA-C 115.964 1.486 . . . . 20.0 115.964 -134.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.18 -4.78 0.77 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.205 1.402 . . . . 20.0 113.405 162.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.86 171.25 11.5 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.043 -0.663 . . . . 20.0 111.749 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.52 151.42 16.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.943 -0.646 . . . . 20.0 112.323 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.66 170.76 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.785 0.834 . . . . 20.0 108.825 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.06 23.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 20.0 110.403 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 234' ' ' ILE . . . . . . . . . . . . . 51.8 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' B' ' 68' ' ' HIS . 25.6 t0 -135.17 173.22 11.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.945 -1.502 . . . . 20.0 106.945 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.624 0.726 . . . . 20.0 111.441 -172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.62 122.71 1.45 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.353 -1.351 . . . . 20.0 107.353 164.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 238' ' ' ILE . . . . . . . . . . . . . 18.0 mm -145.49 151.92 14.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -161.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.869 -1.53 . . . . 20.0 106.869 158.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.04 18.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.985 0.735 . . . . 20.0 112.985 -155.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.32 36.13 22.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.92 1.288 . . . . 20.0 112.528 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.91 128.44 79.05 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 105.173 -2.158 . . . . 20.0 105.173 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.06 165.56 12.14 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 120.889 1.353 . . . . 20.0 112.408 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.31 45.22 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.126 -0.943 . . . . 20.0 114.952 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.13 164.49 23.08 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 118.59 1.195 . . . . 20.0 110.702 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.96 -172.65 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.586 0 CA-C-O 121.858 0.691 . . . . 20.0 111.94 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.85 59.56 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.026 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.3 -18.68 63.11 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.838 -0.745 . . . . 20.0 112.865 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 249' ' ' LYS . . . . . 0.723 ' O ' ' OG1' ' B' ' 252' ' ' THR . 16.9 mttt -98.78 -15.16 19.4 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.238 0.829 . . . . 20.0 113.238 170.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.82 88.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.364 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 119.076 -1.05 . . . . 20.0 111.898 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 252' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' B' ' 249' ' ' LYS . 39.2 p -57.14 -31.83 65.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.473 0.579 . . . . 20.0 111.325 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.303 0.573 . . . . 20.0 110.434 176.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.45 -1.3 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.987 -1.006 . . . . 20.0 112.275 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 126.204 1.859 . . . . 20.0 111.573 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.38 129.23 10.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.05 174.25 3.35 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-O 122.712 1.173 . . . . 20.0 113.307 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 259' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' B' ' 316' ' ' SER . . . -126.42 120.35 29.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.135 -0.939 . . . . 20.0 109.427 -169.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.0 139.95 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.86 122.65 42.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.001 -0.741 . . . . 20.0 109.001 -177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.8 -40.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.862 -0.608 . . . . 20.0 109.598 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.57 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.337 -0.616 . . . . 20.0 109.337 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.97 2.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.817 -1.083 . . . . 20.0 108.231 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.798 -0.637 . . . . 20.0 110.261 163.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.1 11.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.82 143.63 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.427 -0.583 . . . . 20.0 109.427 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 104.03 14.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.14 -1.8 . . . . 20.0 106.14 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.39 137.08 56.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.288 0.566 . . . . 20.0 111.305 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.65 1.97 Allowed Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.154 -0.93 . . . . 20.0 108.656 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 271' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -67.41 -20.07 48.63 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.851 1.058 . . . . 20.0 114.851 -160.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.591 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.36 77.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.073 0.463 . . . . 20.0 110.104 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.19 -52.52 59.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 120.823 0.344 . . . . 20.0 110.663 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.36 -31.9 70.77 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.825 -0.75 . . . . 20.0 110.569 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -47.98 65.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.094 -0.642 . . . . 20.0 110.976 179.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.75 89.88 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.039 -0.664 . . . . 20.0 110.736 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.57 -48.01 78.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.578 -0.449 . . . . 20.0 110.111 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.75 -40.52 88.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.884 -0.326 . . . . 20.0 110.71 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.23 -45.03 78.0 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.303 -0.559 . . . . 20.0 111.077 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.71 73.0 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.052 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.36 -31.85 65.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.176 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.71 73.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.872 -0.731 . . . . 20.0 111.008 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 284' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -102.56 15.44 29.26 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.33 0.863 . . . . 20.0 113.33 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.85 32.13 13.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.734 0.778 . . . . 20.0 111.555 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.29 143.41 34.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.288 -1.004 . . . . 20.0 108.288 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.21 149.37 13.4 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.164 0.737 . . . . 20.0 111.357 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.12 23.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.639 -0.71 . . . . 20.0 109.702 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.99 175.13 5.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.63 113.73 17.11 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.892 -1.151 . . . . 20.0 107.892 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.65 43.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.577 . . . . 20.0 109.441 -172.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.08 157.03 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.688 -1.226 . . . . 20.0 107.688 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.67 12.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.458 0.647 . . . . 20.0 110.292 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.73 -18.55 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.157 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.964 -0.854 . . . . 20.0 110.964 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.5 144.73 15.5 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.648 -0.776 . . . . 20.0 112.689 -178.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.346 -1.101 . . . . 20.0 110.346 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 298' ' ' THR . . . . . . . . . . . . . 20.4 p -110.22 172.88 6.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.086 0.946 . . . . 20.0 111.367 -174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.89 -33.72 76.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.388 -1.278 . . . . 20.0 111.229 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.35 74.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 111.83 0.308 . . . . 20.0 111.83 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.14 96.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.167 -1.016 . . . . 20.0 112.103 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.33 -26.9 65.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.165 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.85 -34.51 56.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.154 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -14.08 59.9 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.287 0.847 . . . . 20.0 113.287 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.78 -8.9 19.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.662 0.986 . . . . 20.0 113.662 -167.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' THR . . . . . 0.503 ' OG1' ' OE1' ' B' ' 227' ' ' GLU . 0.5 OUTLIER -58.36 157.62 8.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 20.0 110.556 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.79 -29.86 70.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.304 -0.862 . . . . 20.0 113.313 -161.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.2 66.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.76 65.16 1.94 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.869 -0.681 . . . . 20.0 113.332 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.3 139.61 52.29 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 117.582 0.691 . . . . 20.0 111.104 -163.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 CA-C-N 119.476 0.849 . . . . 20.0 110.025 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.46 135.78 32.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.355 -0.839 . . . . 20.0 111.239 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.6 12.32 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.144 -1.582 . . . . 20.0 109.144 164.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.01 27.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.463 0.649 . . . . 20.0 110.033 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -103.98 153.22 21.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.617 -1.174 . . . . 20.0 109.231 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' SER . . . . . 0.411 ' N ' ' O ' ' B' ' 259' ' ' ALA . 4.2 m -138.49 133.55 32.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.286 -0.87 . . . . 20.0 109.474 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.47 108.65 51.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.218 -1.401 . . . . 20.0 107.218 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.652 1.022 . . . . 20.0 113.603 -154.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.88 35.4 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.594 -1.639 . . . . 20.0 115.269 160.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.59 157.59 33.61 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.71 0.767 . . . . 20.0 110.118 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.11 166.19 11.66 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.811 -1.552 . . . . 20.0 106.811 160.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.2 113.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.137 0.975 . . . . 20.0 108.447 -163.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.6 -7.39 3.27 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.46 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.69 0.626 . . . . 20.0 112.69 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -102.0 -56.16 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.006 1.484 . . . . 20.0 115.006 -152.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.97 50.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.454 -1.313 . . . . 20.0 107.454 174.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -142.59 52.85 1.42 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.856 -1.52 . . . . 20.0 109.926 -153.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.04 149.41 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.412 0.625 . . . . 20.0 111.925 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.38 179.42 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.904 0.859 . . . . 20.0 109.465 175.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.16 27.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.636 -1.166 . . . . 20.0 108.868 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.09 -32.07 53.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.885 0.741 . . . . 20.0 111.495 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.59 -44.84 73.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.337 -0.545 . . . . 20.0 110.192 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.88 83.38 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.057 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.73 -41.24 91.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 120.397 -0.521 . . . . 20.0 110.456 -173.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -34.7 71.59 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.888 -1.125 . . . . 20.0 110.115 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.04 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.422 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.84 80.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.826 0.346 . . . . 20.0 110.937 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' VAL . . . . . 0.692 ' O ' ' OG1' ' B' ' 342' ' ' THR . 42.7 t -60.16 -48.94 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.014 0.435 . . . . 20.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLU . . . . . 0.786 ' OE1' ' NZ ' ' B' ' 343' ' ' LYS . 1.3 mm-40 -54.86 -46.96 74.76 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.982 0.42 . . . . 20.0 110.752 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.14 37.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.375 -0.375 . . . . 20.0 111.452 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.15 -40.33 89.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.199 -0.6 . . . . 20.0 110.813 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' THR . . . . . 0.692 ' OG1' ' O ' ' B' ' 338' ' ' VAL . 1.3 m -56.51 -45.03 81.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.15 0.5 . . . . 20.0 110.398 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' LYS . . . . . 0.786 ' NZ ' ' OE1' ' B' ' 339' ' ' GLU . 34.6 mttp -74.14 -37.49 64.04 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.779 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.577 -0.449 . . . . 20.0 111.122 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.98 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.829 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.706 -0.797 . . . . 20.0 110.587 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.53 4.8 30.26 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.42 -0.912 . . . . 20.0 112.479 -178.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.21 -23.62 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 119.118 0.872 . . . . 20.0 110.936 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.43 69.19 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.785 -0.766 . . . . 20.0 111.245 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.81 -18.85 31.74 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.111 -0.368 . . . . 20.0 111.485 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.122 0.416 . . . . 20.0 112.122 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.03 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.057 1.873 . . . . 20.0 116.057 -169.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 124.933 1.293 . . . . 20.0 108.405 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 114.277 1.214 . . . . 20.0 114.277 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.14 82.23 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.898 -1.519 . . . . 20.0 106.898 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.92 -34.46 66.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 114.869 -1.06 . . . . 20.0 110.222 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.07 -23.48 12.3 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.586 0.958 . . . . 20.0 113.586 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.33 30.37 20.07 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.155 0.982 . . . . 20.0 111.667 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -38.64 32.07 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.115 -0.234 . . . . 20.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.12 117.41 37.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.678 -1.23 . . . . 20.0 107.678 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.2 12.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.386 0.612 . . . . 20.0 110.915 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.55 72.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.821 . . . . 20.0 111.869 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.14 -45.18 74.31 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.548 -0.461 . . . . 20.0 111.21 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -43.12 97.11 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.026 -0.27 . . . . 20.0 111.182 -172.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.6 70.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.766 -0.374 . . . . 20.0 111.155 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.37 90.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.588 -0.445 . . . . 20.0 110.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.92 91.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.632 -0.258 . . . . 20.0 111.524 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.94 -40.06 26.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.505 -0.878 . . . . 20.0 110.7 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.053 -1.059 . . . . 20.0 110.996 -162.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -25.99 68.04 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.948 -0.701 . . . . 20.0 111.298 174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.4 70.61 Favored Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 120.518 -0.473 . . . . 20.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -85.13 144.74 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 120.29 0.66 . . . . 20.0 112.151 -172.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.26 3.4 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 117.269 1.668 . . . . 20.0 117.269 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.71 119.81 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.14 -1.429 . . . . 20.0 107.14 159.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 171.18 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.375 0.607 . . . . 20.0 110.708 -166.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.02 -33.35 2.9 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.487 -0.779 . . . . 20.0 114.026 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.35 0.17 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.291 1.043 . . . . 20.0 109.588 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.93 -13.16 3.99 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.913 -1.04 . . . . 20.0 113.467 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 26' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' C' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 9.07 23.56 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.643 1.11 . . . . 20.0 113.748 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 11.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.42 1.637 . . . . 20.0 115.42 -154.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 28' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' C' ' 26' ' ' PHE . . . -53.2 -26.85 29.94 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 116.009 1.164 . . . . 20.0 116.009 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.57 -35.83 61.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 118.095 0.948 . . . . 20.0 110.64 -178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.24 -52.48 61.22 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.875 0.369 . . . . 20.0 110.442 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.57 74.45 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.328 -0.396 . . . . 20.0 111.007 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.23 -49.64 82.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.048 0.451 . . . . 20.0 110.304 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.22 -39.75 86.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 119.737 -0.785 . . . . 20.0 110.261 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.67 -29.5 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 118.757 -1.177 . . . . 20.0 111.191 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.55 -30.92 71.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.804 -0.358 . . . . 20.0 111.147 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.93 -56.77 3.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.192 0.441 . . . . 20.0 112.192 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.49 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.473 -0.331 . . . . 20.0 111.525 -164.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -26.36 63.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.929 -0.708 . . . . 20.0 112.235 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.49 63.03 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 118.875 -1.13 . . . . 20.0 111.708 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.88 22.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.57 152.67 22.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.59 88.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.195 -0.911 . . . . 20.0 111.441 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.63 158.3 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -173.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.51 147.18 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.25 44.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.467 0.651 . . . . 20.0 110.441 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.1 128.99 74.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.341 -1.355 . . . . 20.0 107.341 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 -176.15 5.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.837 0.827 . . . . 20.0 108.881 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.55 -34.63 62.99 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.099 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.81 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.706 1.002 . . . . 20.0 113.706 -171.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.6 83.42 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 119.134 -0.814 . . . . 20.0 114.521 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.47 35.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.427 1.114 . . . . 20.0 110.235 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 53' ' ' ILE . . . . . . . . . . . . . 31.4 mm -130.29 115.6 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.304 -1.369 . . . . 20.0 107.304 -174.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.73 36.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.654 -0.499 . . . . 20.0 109.654 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.95 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.613 -0.884 . . . . 20.0 108.613 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.65 145.35 31.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 163.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.46 20.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.675 -0.491 . . . . 20.0 109.675 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.08 23.7 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.099 -0.8 . . . . 20.0 111.099 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.14 105.59 10.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.931 0.893 . . . . 20.0 109.003 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.769 -0.729 . . . . 20.0 114.105 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.27 32.65 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.769 0.654 . . . . 20.0 112.105 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.99 111.34 22.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.007 -0.997 . . . . 20.0 109.271 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 137.92 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.756 -0.831 . . . . 20.0 108.756 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.73 124.08 46.41 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.023 0.929 . . . . 20.0 109.032 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.32 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.071 -1.085 . . . . 20.0 108.071 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.58 51.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.285 0.366 . . . . 20.0 110.993 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.61 45.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.896 0.879 . . . . 20.0 108.924 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 68' ' ' HIS . . . . . 0.494 ' NE2' ' OD1' ' C' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.38 29.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 20.0 110.556 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.85 21.34 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.756 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 70' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' C' ' 183' ' ' ASP . 12.0 t0 -97.44 68.03 2.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.601 -0.687 . . . . 20.0 112.388 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.34 144.87 28.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.713 0.805 . . . . 20.0 109.128 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 -175.68 27.13 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.59 -1.004 . . . . 20.0 110.59 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.03 161.44 26.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.262 0.553 . . . . 20.0 110.008 178.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.11 131.32 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.273 1.029 . . . . 20.0 109.713 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.56 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 108.815 -0.809 . . . . 20.0 108.815 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.08 -29.39 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.058 0.762 . . . . 20.0 113.058 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.121 -1.066 . . . . 20.0 108.121 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.346 -0.983 . . . . 20.0 108.346 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.77 166.36 5.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.838 0.828 . . . . 20.0 109.958 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -26.99 60.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.645 -0.822 . . . . 20.0 112.724 -169.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.12 4.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.78 81.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 118.974 -0.903 . . . . 20.0 115.125 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.8 145.04 34.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.337 1.069 . . . . 20.0 110.227 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.46 28.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.236 -0.893 . . . . 20.0 112.617 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.39 174.56 6.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.69 163.8 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.676 0.75 . . . . 20.0 109.463 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.35 15.62 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.811 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.83 160.2 24.49 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 CA-C-O 122.267 0.861 . . . . 20.0 112.742 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 90' ' ' ILE . . . . . . . . . . . . . 9.3 mt -88.7 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 113.78 -1.554 . . . . 20.0 107.425 165.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.96 140.92 47.48 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 20.0 112.168 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.85 -24.08 22.39 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-O 118.965 -0.908 . . . . 20.0 115.244 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.89 152.62 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.613 1.206 . . . . 20.0 109.214 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.73 130.99 22.18 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 108.412 -0.959 . . . . 20.0 108.412 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.05 -8.03 13.11 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.562 1.236 . . . . 20.0 114.846 -170.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.18 -15.26 59.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.162 0.892 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.48 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.666 0.786 . . . . 20.0 112.399 178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.28 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.991 1.317 . . . . 20.0 113.363 -173.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.23 156.04 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.036 -0.727 . . . . 20.0 109.036 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.85 -19.0 5.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.648 -1.16 . . . . 20.0 111.303 158.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 101' ' ' GLN . . . . . 0.403 ' NE2' ' O ' ' A' ' 165' ' ' ASP . 0.0 OUTLIER -169.41 141.67 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.672 -0.862 . . . . 20.0 108.672 176.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.85 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.234 1.568 . . . . 20.0 115.234 150.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 103' ' ' PHE . . . . . 0.589 ' O ' ' N ' ' C' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.22 36.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.3 37.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.553 -0.749 . . . . 20.0 109.397 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -117.45 110.72 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.213 -1.032 . . . . 20.0 108.213 -178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.53 83.03 6.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.58 -0.282 . . . . 20.0 110.304 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.95 -54.17 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 123.331 0.394 . . . . 20.0 110.357 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.49 10.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.433 -0.951 . . . . 20.0 108.433 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.3 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.887 -1.051 . . . . 20.0 110.478 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.18 11.28 75.13 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.908 -0.94 . . . . 20.0 115.335 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.06 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.455 1.128 . . . . 20.0 108.586 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.3 141.55 37.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.352 -0.61 . . . . 20.0 109.352 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.67 142.55 43.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.679 -0.86 . . . . 20.0 108.679 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.77 149.45 31.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.002 -0.999 . . . . 20.0 110.295 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 115' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' C' ' 103' ' ' PHE . . . -147.94 157.77 27.46 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.301 -1.119 . . . . 20.0 110.301 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.338 -0.846 . . . . 20.0 114.597 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.17 -47.99 69.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.344 1.239 . . . . 20.0 114.344 -156.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.56 1.073 . . . . 20.0 112.69 -155.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.14 35.57 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.653 -3.092 . . . . 20.0 102.653 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.11 123.82 11.06 Favored 'Trans proline' 0 C--N 1.327 -0.563 0 CA-C-N 120.765 1.309 . . . . 20.0 110.585 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.84 149.79 89.88 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 CA-C-N 119.2 0.75 . . . . 20.0 110.673 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.33 7.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.818 0.818 . . . . 20.0 109.941 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.91 3.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.153 -1.054 . . . . 20.0 108.153 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.81 19.52 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.783 -0.367 . . . . 20.0 110.701 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.93 -43.65 1.49 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.938 0.895 . . . . 20.0 113.053 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.92 59.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 120.872 1.347 . . . . 20.0 111.998 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.51 30.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 111.8 0.296 . . . . 20.0 111.8 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -32.01 69.18 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.203 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.83 62.59 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 111.949 0.351 . . . . 20.0 111.949 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.55 90.92 4.53 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.187 -0.672 . . . . 20.0 109.187 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.29 7.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.112 0.412 . . . . 20.0 112.112 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.14 142.5 87.44 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.533 -0.914 . . . . 20.0 108.533 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.71 153.62 75.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 119.639 0.907 . . . . 20.0 112.391 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.61 42.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.516 -1.22 . . . . 20.0 107.964 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -12.24 59.95 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.784 -0.627 . . . . 20.0 112.369 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 137' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' C' ' 138' ' ' GLN . 14.0 p30 -55.37 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.387 0 CA-C-O 118.939 -0.553 . . . . 20.0 111.375 -175.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 138' ' ' GLN . . . . . 0.411 ' N ' ' OD1' ' C' ' 137' ' ' ASP . 3.9 tp-100 174.64 174.1 0.2 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 103.125 -2.917 . . . . 20.0 103.125 133.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.85 168.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.102 0.961 . . . . 20.0 108.947 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.87 161.44 18.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.951 0.9 . . . . 20.0 110.511 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 141' ' ' ILE . . . . . . . . . . . . . 30.0 mt -124.66 147.45 29.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.602 -0.888 . . . . 20.0 108.602 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 142' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' C' ' 144' ' ' GLY . 0.5 OUTLIER -119.01 134.75 55.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.655 0.782 . . . . 20.0 109.608 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.93 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.943 -0.571 . . . . 20.0 111.817 166.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 144' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' C' ' 142' ' ' ASP . . . 86.81 -6.6 82.58 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 115.498 0.959 . . . . 20.0 115.498 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.02 54.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.493 1.146 . . . . 20.0 110.273 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 146' ' ' GLU . . . . . 0.439 ' OE2' ' NH2' ' A' ' 332' ' ' ARG . 94.2 mt-10 -83.44 -20.87 33.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.561 0.949 . . . . 20.0 113.561 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.39 162.65 40.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.939 0.876 . . . . 20.0 111.44 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.37 -41.5 80.3 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 113.892 -1.504 . . . . 20.0 111.268 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.4 -46.97 88.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.0 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.4 -35.14 76.67 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.554 -0.459 . . . . 20.0 110.799 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.61 84.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.08 -0.648 . . . . 20.0 111.077 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.32 58.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.355 -0.938 . . . . 20.0 111.013 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.12 66.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.63 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.61 92.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.554 -0.458 . . . . 20.0 111.63 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.71 6.71 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 118.915 -0.936 . . . . 20.0 114.588 -172.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.72 133.51 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.485 1.142 . . . . 20.0 108.56 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.9 9.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.32 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.37 169.36 15.76 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.833 -1.707 . . . . 20.0 108.833 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.5 113.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.622 -1.251 . . . . 20.0 107.622 165.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.68 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 113.711 1.004 . . . . 20.0 113.711 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.67 -0.644 . . . . 20.0 111.76 -159.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 163' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' C' ' 164' ' ' TRP . 3.5 t -145.38 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.263 1.025 . . . . 20.0 110.458 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 164' ' ' TRP . . . . . 0.551 ' N ' ' OG1' ' C' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.93 16.74 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.213 0.82 . . . . 20.0 113.213 -160.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 165' ' ' ASP . . . . . 0.429 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 7.5 t70 63.69 61.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.848 -0.533 . . . . 20.0 112.323 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.91 158.63 29.54 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.071 -1.212 . . . . 20.0 110.071 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.39 148.35 37.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.677 -1.231 . . . . 20.0 107.677 170.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.58 30.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.107 -0.952 . . . . 20.0 110.208 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.39 159.76 35.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.905 0.86 . . . . 20.0 109.954 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.197 -1.365 . . . . 20.0 109.484 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.59 29.01 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.51 -0.552 . . . . 20.0 109.51 168.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 172' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' C' ' 175' ' ' ARG . . . 56.92 68.71 1.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.754 0.649 . . . . 20.0 112.754 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.99 1.29 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.719 -0.792 . . . . 20.0 111.254 157.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 175' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' C' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.583 0.629 . . . . 20.0 112.653 172.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.54 169.43 0.35 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.839 2.456 . . . . 20.0 106.244 157.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 46.0 t -144.7 145.78 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.13 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 116.445 2.017 . . . . 20.0 116.445 -166.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 22.25 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.746 0.703 . . . . 20.0 112.157 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.68 36.65 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.396 1.258 . . . . 20.0 114.396 -170.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.66 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.602 0.637 . . . . 20.0 111.806 -162.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.26 127.8 32.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.021 0.915 . . . . 20.0 110.711 -152.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 183' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' C' ' 70' ' ' ASP . 0.6 OUTLIER 69.93 -6.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.371 1.468 . . . . 20.0 113.161 174.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.16 0.981 . . . . 20.0 110.776 157.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 186' ' ' ALA . . . . . 0.722 ' O ' ' OG1' ' C' ' 189' ' ' THR . . . -50.18 -42.88 51.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.334 -0.848 . . . . 20.0 111.565 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.89 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 119.288 -0.965 . . . . 20.0 110.102 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.84 -38.59 91.67 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.126 -1.03 . . . . 20.0 110.51 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 189' ' ' THR . . . . . 0.722 ' OG1' ' O ' ' C' ' 186' ' ' ALA . 25.2 p -59.14 -48.54 81.23 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.853 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.36 -50.58 64.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 20.0 110.458 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.21 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.106 -0.638 . . . . 20.0 110.953 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.92 -36.53 84.24 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.93 -0.708 . . . . 20.0 110.287 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 193' ' ' VAL . . . . . . . . . . . . . 11.6 t -60.53 -44.85 97.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.053 0.454 . . . . 20.0 110.113 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.39 75.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.27 -0.572 . . . . 20.0 111.206 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.57 -38.16 70.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.895 -0.722 . . . . 20.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.64 -26.15 41.19 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.619 0.6 . . . . 20.0 112.619 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.55 122.82 27.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.317 -0.623 . . . . 20.0 109.317 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 198' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -112.49 -56.99 2.34 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.292 0.37 . . . . 20.0 110.146 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.23 105.37 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.32 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.81 -14.5 59.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.015 -0.674 . . . . 20.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.67 30.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 203' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' C' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.0 16.3 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.482 -0.933 . . . . 20.0 108.482 -174.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.583 -0.895 . . . . 20.0 108.583 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 205' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -128.94 106.66 9.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.016 -0.735 . . . . 20.0 109.016 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.32 31.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.745 -0.835 . . . . 20.0 108.745 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.9 150.18 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.852 -0.796 . . . . 20.0 108.852 174.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.84 5.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.401 -1.333 . . . . 20.0 107.401 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.87 159.97 19.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.845 0.831 . . . . 20.0 111.131 -165.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.74 166.44 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 114.626 -1.17 . . . . 20.0 108.255 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.64 40.16 29.44 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.808 -1.087 . . . . 20.0 111.508 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.03 -49.53 13.83 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.357 -0.537 . . . . 20.0 110.922 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.42 64.76 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.227 -0.589 . . . . 20.0 111.491 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 214' ' ' VAL . . . . . . . . . . . . . 88.6 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.529 -0.915 . . . . 20.0 108.529 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.98 6.2 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.697 -1.24 . . . . 20.0 111.432 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.99 -25.61 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.428 0.899 . . . . 20.0 113.428 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.49 2.84 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.57 40.92 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.765 -1.207 . . . . 20.0 111.945 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 219' ' ' ALA . . . . . 0.444 ' O ' ' OG ' ' C' ' 222' ' ' SER . . . -65.28 -37.0 85.81 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.248 -0.56 . . . . 20.0 111.406 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.72 -36.72 57.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.42 -45.87 87.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.045 -0.662 . . . . 20.0 110.854 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 222' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' C' ' 219' ' ' ALA . 2.1 p -58.01 -35.78 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.759 -0.376 . . . . 20.0 111.439 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.97 69.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.545 0.572 . . . . 20.0 112.545 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.22 -33.36 75.62 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.82 -0.752 . . . . 20.0 111.855 -165.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.75 74.93 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.964 -1.588 . . . . 20.0 112.109 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -127.01 -45.61 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 111.987 0.365 . . . . 20.0 111.987 -158.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 227' ' ' GLU . . . . . 0.495 ' OE1' ' OG1' ' C' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.69 99.78 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.88 143.75 2.86 Favored 'Trans proline' 0 N--CA 1.472 0.206 0 N-CA-C 115.99 1.496 . . . . 20.0 115.99 -134.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.76 0.78 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.208 1.403 . . . . 20.0 113.362 162.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.21 11.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.081 -0.648 . . . . 20.0 111.767 167.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.49 151.5 16.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.267 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.73 170.69 15.61 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.786 0.834 . . . . 20.0 108.809 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.63 149.05 23.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.139 0.495 . . . . 20.0 110.378 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 20.0 107.527 172.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 235' ' ' ASP . . . . . 0.494 ' OD1' ' NE2' ' C' ' 68' ' ' HIS . 25.5 t0 -135.18 173.26 11.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.918 -1.512 . . . . 20.0 106.918 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.23 149.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.687 0.756 . . . . 20.0 111.417 -172.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.59 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.5 151.88 14.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.238 -1.023 . . . . 20.0 108.238 -161.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.24 9.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.842 -1.54 . . . . 20.0 106.842 158.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.03 18.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.39 36.13 22.21 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.926 1.29 . . . . 20.0 112.482 158.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.99 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 105.158 -2.164 . . . . 20.0 105.158 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.01 165.54 12.07 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 CA-C-N 120.838 1.335 . . . . 20.0 112.372 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.38 45.41 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.056 -0.975 . . . . 20.0 114.885 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.12 164.49 23.1 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.588 1.194 . . . . 20.0 110.678 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 246' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.92 -172.63 0.72 Allowed 'Trans proline' 0 C--N 1.327 -0.558 0 CA-C-O 121.877 0.699 . . . . 20.0 111.978 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.737 -1.12 . . . . 20.0 112.065 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.72 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.855 -0.738 . . . . 20.0 112.84 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 249' ' ' LYS . . . . . 0.715 ' O ' ' OG1' ' C' ' 252' ' ' THR . 16.9 mttt -98.79 -15.09 19.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.221 0.822 . . . . 20.0 113.221 170.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.81 88.78 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.26 -0.576 . . . . 20.0 111.392 -172.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.6 -21.04 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.186 -1.006 . . . . 20.0 111.87 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 252' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' C' ' 249' ' ' LYS . 39.7 p -57.11 -31.85 65.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.486 0.585 . . . . 20.0 111.375 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.39 132.07 4.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.353 0.597 . . . . 20.0 110.369 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.015 -0.993 . . . . 20.0 112.34 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.94 5.83 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.216 1.865 . . . . 20.0 111.55 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.37 129.23 10.2 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.08 174.24 3.37 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 122.667 1.149 . . . . 20.0 113.333 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 258' ' ' THR . . . . . . . . . . . . . 6.1 t -98.75 175.03 6.11 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 259' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' C' ' 316' ' ' SER . . . -126.36 120.3 29.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.159 -0.928 . . . . 20.0 109.404 -169.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 85.2 mt -98.0 139.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.813 -1.18 . . . . 20.0 107.813 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.83 122.65 42.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 -177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.78 -40.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.353 0.597 . . . . 20.0 109.645 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.426 0.632 . . . . 20.0 109.378 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.14 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.831 -1.077 . . . . 20.0 108.194 165.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.3 21.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.79 -0.641 . . . . 20.0 110.265 163.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.88 -46.18 11.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.644 0.979 . . . . 20.0 113.644 -165.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.66 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.386 -0.598 . . . . 20.0 109.386 -163.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.146 -1.798 . . . . 20.0 106.146 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 269' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.39 137.12 56.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 20.0 111.303 -171.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -58.05 109.63 1.95 Allowed Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.144 -0.934 . . . . 20.0 108.708 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.46 -20.01 48.42 Favored 'Trans proline' 0 CA--C 1.513 -0.549 0 N-CA-C 114.8 1.038 . . . . 20.0 114.8 -160.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.95 74.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.167 -0.613 . . . . 20.0 110.578 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.66 -48.3 77.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.085 0.469 . . . . 20.0 110.063 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 274' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.25 -52.43 60.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 120.815 0.34 . . . . 20.0 110.685 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.4 -31.9 70.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.92 65.77 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.098 -0.641 . . . . 20.0 110.999 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.15 -38.66 89.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.718 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.66 -47.98 78.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.608 -0.437 . . . . 20.0 110.067 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.78 -40.44 88.3 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.821 -0.352 . . . . 20.0 110.726 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.35 -44.9 77.88 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.235 -0.586 . . . . 20.0 111.073 -172.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.7 72.99 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.02 -0.672 . . . . 20.0 110.992 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.8 65.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.998 -0.681 . . . . 20.0 111.113 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.65 73.19 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 119.866 -0.734 . . . . 20.0 110.973 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.51 29.08 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.32 0.859 . . . . 20.0 113.32 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.12 13.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.702 0.763 . . . . 20.0 111.57 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.32 143.36 34.29 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.272 -1.01 . . . . 20.0 108.272 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.1 149.37 13.56 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 119.173 0.74 . . . . 20.0 111.369 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.17 23.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.613 -0.721 . . . . 20.0 109.7 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.09 5.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.899 -1.148 . . . . 20.0 107.899 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.62 43.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.49 -0.559 . . . . 20.0 109.49 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.67 -1.234 . . . . 20.0 107.67 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.56 168.7 12.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.533 0.682 . . . . 20.0 110.262 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.79 -18.5 21.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.798 -1.092 . . . . 20.0 112.146 165.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.07 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.983 -0.847 . . . . 20.0 110.983 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.48 144.79 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 114.657 -0.772 . . . . 20.0 112.642 -179.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.64 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.313 -1.115 . . . . 20.0 110.313 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 298' ' ' THR . . . . . . . . . . . . . 20.2 p -110.3 172.86 6.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.047 0.927 . . . . 20.0 111.345 -174.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.68 76.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.226 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.31 74.05 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 111.76 0.281 . . . . 20.0 111.76 -171.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.16 96.88 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.2 -1.0 . . . . 20.0 112.044 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.37 -26.85 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.204 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -14.06 59.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.75 -8.92 19.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.758 1.022 . . . . 20.0 113.758 -167.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 306' ' ' THR . . . . . 0.495 ' OG1' ' OE1' ' C' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.58 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.709 . . . . 20.0 110.566 171.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' C' C ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.66 -29.94 70.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.267 -0.878 . . . . 20.0 113.33 -161.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.23 66.29 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.7 -0.8 . . . . 20.0 111.2 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.81 65.13 1.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.853 -0.689 . . . . 20.0 113.315 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.32 139.65 52.23 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 117.599 0.7 . . . . 20.0 111.106 -163.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 311' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.547 0 CA-C-N 119.43 0.832 . . . . 20.0 110.045 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.47 135.81 32.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.326 -0.852 . . . . 20.0 111.175 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.17 -1.572 . . . . 20.0 109.17 164.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.02 27.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.486 0.66 . . . . 20.0 110.045 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.0 153.26 21.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.578 -1.192 . . . . 20.0 109.209 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 316' ' ' SER . . . . . 0.407 ' N ' ' O ' ' C' ' 259' ' ' ALA . 4.1 m -138.47 133.55 32.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.419 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 317' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.45 108.57 51.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.32 -168.98 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 CA-C-O 122.667 1.028 . . . . 20.0 113.582 -154.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.87 35.4 0.15 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.589 -1.641 . . . . 20.0 115.256 161.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.58 157.57 33.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.689 0.757 . . . . 20.0 110.101 176.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.07 166.19 11.65 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.828 -1.545 . . . . 20.0 106.828 160.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.23 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.18 0.992 . . . . 20.0 108.429 -163.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.52 -7.4 3.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.48 1.289 . . . . 20.0 114.48 -140.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.641 0.608 . . . . 20.0 112.641 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 325' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -102.02 -56.09 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.033 1.494 . . . . 20.0 115.033 -152.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.97 50.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.462 -1.311 . . . . 20.0 107.462 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.57 52.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.862 -1.517 . . . . 20.0 109.941 -153.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.05 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.432 0.634 . . . . 20.0 111.954 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.38 179.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.917 0.865 . . . . 20.0 109.463 175.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.51 119.18 27.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.839 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.16 -32.03 54.24 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.84 0.713 . . . . 20.0 111.479 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.76 73.51 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.263 -0.575 . . . . 20.0 110.202 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.06 -44.89 83.23 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.044 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.69 -41.28 92.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.446 -0.502 . . . . 20.0 110.467 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.67 71.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 118.803 -1.159 . . . . 20.0 110.164 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.39 93.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.473 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.53 -43.85 80.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.78 0.324 . . . . 20.0 110.922 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 338' ' ' VAL . . . . . 0.688 ' O ' ' OG1' ' C' ' 342' ' ' THR . 42.5 t -60.19 -48.93 86.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.977 0.417 . . . . 20.0 110.25 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 339' ' ' GLU . . . . . 0.786 ' OE1' ' NZ ' ' C' ' 343' ' ' LYS . 1.3 mm-40 -54.84 -46.97 74.7 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.988 0.423 . . . . 20.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.325 -0.398 . . . . 20.0 111.412 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.1 -40.38 89.44 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.211 -0.595 . . . . 20.0 110.814 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 342' ' ' THR . . . . . 0.688 ' OG1' ' O ' ' C' ' 338' ' ' VAL . 1.3 m -56.43 -45.03 80.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.081 0.467 . . . . 20.0 110.422 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 343' ' ' LYS . . . . . 0.786 ' NZ ' ' OE1' ' C' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.46 63.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.926 -0.71 . . . . 20.0 110.761 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.52 97.81 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.585 -0.446 . . . . 20.0 111.082 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.95 -50.48 73.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.77 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.7 -39.01 90.79 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 119.708 -0.797 . . . . 20.0 110.563 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.53 4.83 30.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.408 -0.917 . . . . 20.0 112.525 -178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.2 -23.71 33.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 119.141 0.882 . . . . 20.0 110.911 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.799 -0.761 . . . . 20.0 111.248 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.92 -18.76 31.81 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.152 -0.343 . . . . 20.0 111.495 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.79 -28.74 65.99 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.146 0.425 . . . . 20.0 112.146 -173.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.069 1.877 . . . . 20.0 116.069 -169.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' C' C ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 125.011 1.325 . . . . 20.0 108.393 -174.678 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 114.239 1.2 . . . . 20.0 114.239 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.22 2.93 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.897 -1.52 . . . . 20.0 106.897 -170.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.91 -34.53 66.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.177 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 113.583 0.957 . . . . 20.0 113.583 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.31 19.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.125 0.97 . . . . 20.0 111.608 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.69 32.09 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 117.782 0.265 . . . . 20.0 111.176 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.41 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.656 -1.239 . . . . 20.0 107.656 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.93 112.18 12.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.371 0.605 . . . . 20.0 110.885 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.67 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.457 -0.792 . . . . 20.0 111.892 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.19 -45.11 74.28 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.471 -0.492 . . . . 20.0 111.212 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.05 97.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 121.019 -0.273 . . . . 20.0 111.209 -172.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.54 70.96 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.699 -0.401 . . . . 20.0 111.174 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -46.4 90.81 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.643 -0.423 . . . . 20.0 110.521 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.0 -42.92 91.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.713 -0.222 . . . . 20.0 111.552 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.96 -40.07 26.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 119.5 -0.88 . . . . 20.0 110.653 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.01 -32.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.006 -162.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.05 68.11 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.987 -0.685 . . . . 20.0 111.265 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.37 70.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 120.553 -0.459 . . . . 20.0 109.794 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.12 144.69 9.54 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 120.271 0.647 . . . . 20.0 112.194 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.26 3.4 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 117.274 1.669 . . . . 20.0 117.274 -159.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 107.141 -1.429 . . . . 20.0 107.141 159.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.06 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.619 . . . . 20.0 110.684 -166.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.35 2.88 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.505 -0.771 . . . . 20.0 114.035 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.307 1.051 . . . . 20.0 109.531 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -58.01 -13.03 3.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.852 -1.067 . . . . 20.0 113.481 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' D' ' 28' ' ' GLY . 0.0 OUTLIER -88.04 9.03 23.85 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.711 1.141 . . . . 20.0 113.741 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.32 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.413 1.634 . . . . 20.0 115.413 -154.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' D' ' 26' ' ' PHE . . . -53.15 -26.87 29.61 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 119.813 1.188 . . . . 20.0 115.994 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.66 -35.78 61.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.079 0.94 . . . . 20.0 110.595 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.23 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.929 0.395 . . . . 20.0 110.453 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.59 74.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.294 -0.412 . . . . 20.0 110.975 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.3 -49.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.055 0.455 . . . . 20.0 110.276 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.72 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 119.696 -0.802 . . . . 20.0 110.298 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.7 -29.58 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 118.8 -1.16 . . . . 20.0 111.096 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.45 -30.9 71.58 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.989 0.358 . . . . 20.0 111.179 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 -56.73 3.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.111 0.412 . . . . 20.0 112.111 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.42 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.543 -0.298 . . . . 20.0 111.521 -164.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.37 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.888 -0.725 . . . . 20.0 112.263 -162.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.08 -23.49 63.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 118.874 -1.13 . . . . 20.0 111.757 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.92 -6.91 22.92 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.496 0.924 . . . . 20.0 113.496 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 22.7 t -119.55 152.59 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.559 -0.904 . . . . 20.0 108.559 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.13 -42.62 88.89 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.205 -0.907 . . . . 20.0 111.425 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.59 158.31 35.34 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.514 -0.921 . . . . 20.0 108.514 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.47 147.19 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.261 -1.014 . . . . 20.0 108.261 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.16 159.31 44.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.508 0.67 . . . . 20.0 110.417 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.13 129.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.16 5.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.785 0.803 . . . . 20.0 108.926 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.54 62.88 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.904 -0.718 . . . . 20.0 111.12 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.79 9.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.696 0.999 . . . . 20.0 113.696 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.63 83.38 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-O 119.162 -0.799 . . . . 20.0 114.516 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.49 35.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.473 1.136 . . . . 20.0 110.218 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.28 33.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.131 -1.433 . . . . 20.0 107.131 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.301 -1.37 . . . . 20.0 107.301 -174.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.78 36.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.624 -0.51 . . . . 20.0 109.624 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.93 8.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.638 -0.875 . . . . 20.0 108.638 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.59 145.4 31.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.723 -1.584 . . . . 20.0 106.723 163.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.59 154.43 20.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.676 -0.49 . . . . 20.0 109.676 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.09 23.68 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.883 0.873 . . . . 20.0 108.98 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.57 33.53 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.715 -0.755 . . . . 20.0 114.03 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.72 165.22 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.763 0.651 . . . . 20.0 112.071 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.98 111.39 22.92 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.0 -1.0 . . . . 20.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.72 137.9 30.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.752 -0.833 . . . . 20.0 108.752 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.74 124.05 46.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.074 0.95 . . . . 20.0 109.003 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.25 114.33 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.108 -1.071 . . . . 20.0 108.108 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.61 51.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.245 0.341 . . . . 20.0 110.918 -168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.873 0.869 . . . . 20.0 108.916 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' D' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.967 -0.56 . . . . 20.0 110.541 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.197 -0.911 . . . . 20.0 109.696 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' D' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.64 -0.663 . . . . 20.0 112.455 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.91 28.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.185 -1.043 . . . . 20.0 108.185 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.78 148.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.73 0.812 . . . . 20.0 109.14 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.83 -175.71 27.15 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.588 -1.005 . . . . 20.0 110.588 173.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -124.99 161.45 26.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 20.0 109.992 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.15 131.37 48.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.006 -0.997 . . . . 20.0 109.67 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.866 -0.791 . . . . 20.0 108.866 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.03 -29.34 7.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.1 0.778 . . . . 20.0 113.1 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 32.6 mm -127.07 108.96 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.322 -0.992 . . . . 20.0 108.322 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.789 0.804 . . . . 20.0 110.002 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -27.11 60.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.687 -0.805 . . . . 20.0 112.745 -169.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.14 4.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.346 0.869 . . . . 20.0 113.346 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.75 81.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 118.906 -0.941 . . . . 20.0 115.027 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.78 145.04 34.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.409 1.105 . . . . 20.0 110.23 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.48 28.05 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.246 -0.888 . . . . 20.0 112.61 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.63 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.856 -1.164 . . . . 20.0 107.856 158.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.82 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.681 0.753 . . . . 20.0 109.46 -170.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.24 129.35 15.63 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.992 -1.004 . . . . 20.0 109.814 171.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.84 160.22 24.45 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-O 122.289 0.871 . . . . 20.0 112.765 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.78 150.29 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.739 -1.573 . . . . 20.0 107.396 165.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.97 140.91 47.51 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.281 -0.872 . . . . 20.0 112.122 -168.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.86 -24.12 22.29 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 118.931 -0.927 . . . . 20.0 115.206 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.64 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 118.671 1.235 . . . . 20.0 109.275 -169.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 108.387 -0.968 . . . . 20.0 108.387 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 95' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.09 -7.95 13.07 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 CA-C-N 120.557 1.235 . . . . 20.0 114.854 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.21 -15.24 59.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.151 0.887 . . . . 20.0 111.844 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 97' ' ' THR . . . . . . . . . . . . . 44.8 p -89.48 35.49 0.82 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.648 0.779 . . . . 20.0 112.421 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.21 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.983 1.313 . . . . 20.0 113.386 -173.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.21 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.92 -19.09 5.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.668 -1.151 . . . . 20.0 111.288 158.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 141.62 2.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.95 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.204 1.557 . . . . 20.0 115.204 150.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 103' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' D' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.24 36.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 119.276 0.944 . . . . 20.0 109.367 160.399 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.32 37.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.474 -0.784 . . . . 20.0 109.367 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.41 110.71 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.236 -1.024 . . . . 20.0 108.236 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.06 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.206 -0.294 . . . . 20.0 110.206 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -52.0 -54.18 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.322 0.389 . . . . 20.0 110.338 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.5 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.423 -0.954 . . . . 20.0 108.423 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.09 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.458 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.19 11.18 75.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 118.888 -0.951 . . . . 20.0 115.35 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -128.97 114.0 15.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.465 1.132 . . . . 20.0 108.575 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.28 141.55 37.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.392 -0.595 . . . . 20.0 109.392 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.64 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.699 -0.852 . . . . 20.0 108.699 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.65 149.39 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.008 -0.996 . . . . 20.0 110.296 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 115' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' D' ' 103' ' ' PHE . . . -147.92 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.323 -1.111 . . . . 20.0 110.323 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.38 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.385 -0.968 . . . . 20.0 108.385 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.25 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.317 -0.856 . . . . 20.0 114.584 -168.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.19 -47.91 69.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.374 1.25 . . . . 20.0 114.374 -156.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.541 1.064 . . . . 20.0 112.695 -155.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.14 35.36 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 102.634 -3.098 . . . . 20.0 102.634 159.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.8 11.03 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 CA-C-N 120.744 1.302 . . . . 20.0 110.554 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 122' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 149.8 89.87 Favored 'Trans proline' 0 CA--C 1.519 -0.228 0 CA-C-N 119.164 0.737 . . . . 20.0 110.677 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.1 165.39 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.852 0.834 . . . . 20.0 109.948 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.18 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 20.0 108.182 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.97 160.84 19.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.793 -0.363 . . . . 20.0 110.724 169.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.68 1.5 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.978 0.911 . . . . 20.0 113.079 -170.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.01 -24.91 59.49 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.826 1.331 . . . . 20.0 112.011 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.59 30.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.776 0.287 . . . . 20.0 111.776 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -31.98 69.03 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.28 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.85 62.56 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 111.947 0.351 . . . . 20.0 111.947 172.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.49 90.97 4.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.216 -0.661 . . . . 20.0 109.216 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.17 14.32 7.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.095 0.406 . . . . 20.0 112.095 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.54 87.36 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.61 75.29 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 CA-C-N 119.641 0.908 . . . . 20.0 112.363 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.58 153.61 42.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.956 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -12.31 59.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.863 -0.589 . . . . 20.0 112.43 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' D' ' 138' ' ' GLN . 14.2 p30 -55.29 -66.39 0.42 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.909 -0.567 . . . . 20.0 111.408 -175.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 138' ' ' GLN . . . . . 0.419 ' N ' ' OD1' ' D' ' 137' ' ' ASP . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 103.091 -2.929 . . . . 20.0 103.091 133.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.88 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.128 0.971 . . . . 20.0 108.938 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.81 161.5 18.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.943 0.897 . . . . 20.0 110.508 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 141' ' ' ILE . . . . . . . . . . . . . 30.3 mt -124.68 147.45 29.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -177.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' D' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.77 55.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.646 0.778 . . . . 20.0 109.6 175.137 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.18 7.82 6.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.875 -0.602 . . . . 20.0 111.759 166.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' D' ' 142' ' ' ASP . . . 86.91 -6.57 82.87 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 115.484 0.953 . . . . 20.0 115.484 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.12 144.01 54.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.444 1.122 . . . . 20.0 110.312 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.34 -20.97 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.577 0.954 . . . . 20.0 113.577 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.66 40.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.967 0.889 . . . . 20.0 111.377 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.52 80.52 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.845 -1.525 . . . . 20.0 111.232 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.38 -46.99 87.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.797 -0.361 . . . . 20.0 110.983 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -61.34 -35.14 76.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.828 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.81 -40.58 83.85 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.056 -0.658 . . . . 20.0 111.095 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.31 58.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.344 -0.942 . . . . 20.0 111.058 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.69 -30.07 66.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 119.757 -0.777 . . . . 20.0 110.638 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.62 -40.57 92.35 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.511 -0.476 . . . . 20.0 111.67 171.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.73 6.71 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.596 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.71 133.49 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 118.469 1.135 . . . . 20.0 108.565 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.86 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.27 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.691 -1.226 . . . . 20.0 107.691 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.39 169.29 15.7 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.786 -1.726 . . . . 20.0 108.786 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 113.52 17.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.62 -20.02 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 113.732 1.012 . . . . 20.0 113.732 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.69 155.64 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.701 -0.624 . . . . 20.0 111.734 -159.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' D' ' 164' ' ' TRP . 3.5 t -145.33 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.287 1.035 . . . . 20.0 110.476 171.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' D' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.93 16.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.237 0.828 . . . . 20.0 113.237 -160.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.72 61.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 20.0 112.298 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.122 -1.191 . . . . 20.0 110.122 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 148.27 37.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.709 -1.219 . . . . 20.0 107.709 170.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.65 30.5 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.131 -0.941 . . . . 20.0 110.208 -167.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.46 159.78 35.22 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.899 0.857 . . . . 20.0 109.973 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.33 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.247 -1.342 . . . . 20.0 109.515 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.62 29.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.538 -0.542 . . . . 20.0 109.538 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' D' ' 175' ' ' ARG . . . 56.95 68.68 1.58 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.217 -1.553 . . . . 20.0 109.217 -171.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.93 4.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.781 0.659 . . . . 20.0 112.781 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.0 1.29 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.731 -0.788 . . . . 20.0 111.178 157.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' D' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.95 0.7 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.653 0.66 . . . . 20.0 112.663 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.855 2.462 . . . . 20.0 106.222 157.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 177' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.68 145.76 20.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.493 -0.928 . . . . 20.0 108.493 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.11 -64.47 1.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 116.437 2.014 . . . . 20.0 116.437 -166.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 20.0 112.115 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.68 36.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.398 1.258 . . . . 20.0 114.398 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.66 -66.96 0.83 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.607 0.64 . . . . 20.0 111.766 -162.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.29 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 122.092 0.949 . . . . 20.0 110.685 -152.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' D' ' 70' ' ' ASP . 0.6 OUTLIER 69.89 -6.63 1.04 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.326 1.451 . . . . 20.0 113.193 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.87 83.88 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.213 1.006 . . . . 20.0 110.82 157.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.08 -41.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.496 -2.409 . . . . 20.0 104.496 149.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 186' ' ' ALA . . . . . 0.721 ' O ' ' OG1' ' D' ' 189' ' ' THR . . . -50.13 -42.95 51.53 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.349 -0.841 . . . . 20.0 111.54 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.92 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 119.283 -0.967 . . . . 20.0 110.122 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.82 -38.66 91.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.146 -1.022 . . . . 20.0 110.477 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 189' ' ' THR . . . . . 0.721 ' OG1' ' O ' ' D' ' 186' ' ' ALA . 25.2 p -59.13 -48.61 80.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.453 -0.899 . . . . 20.0 110.831 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.24 -50.56 63.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.941 0.401 . . . . 20.0 110.503 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.21 95.99 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.106 -0.637 . . . . 20.0 110.898 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.59 84.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 120.022 -0.671 . . . . 20.0 110.291 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.52 -44.83 97.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.061 0.458 . . . . 20.0 110.085 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.34 75.53 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.174 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.56 -38.24 71.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.919 -0.712 . . . . 20.0 110.794 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.63 -26.15 41.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.588 0.588 . . . . 20.0 112.588 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.77 27.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.301 -0.629 . . . . 20.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.42 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.293 0.371 . . . . 20.0 110.154 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.2 105.42 17.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.727 -0.471 . . . . 20.0 109.727 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.28 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.191 -0.67 . . . . 20.0 109.191 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.48 59.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 119.993 -0.683 . . . . 20.0 111.358 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.87 141.66 30.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.969 -0.752 . . . . 20.0 108.969 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 203' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' D' ' 203' ' ' ASP . 0.0 OUTLIER -78.6 113.03 16.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.489 -0.93 . . . . 20.0 108.489 -174.466 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -103.02 151.6 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.9 106.56 8.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.91 125.35 31.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.75 -0.833 . . . . 20.0 108.75 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.91 150.24 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.836 -0.801 . . . . 20.0 108.836 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.42 98.8 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.37 -1.344 . . . . 20.0 107.37 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.86 159.97 19.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.859 0.837 . . . . 20.0 111.115 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.8 166.45 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 114.631 -1.168 . . . . 20.0 108.232 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.18 29.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.839 -1.073 . . . . 20.0 111.462 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.406 -0.518 . . . . 20.0 110.962 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.44 64.76 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.219 -0.592 . . . . 20.0 111.467 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 214' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.13 121.17 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.499 -0.926 . . . . 20.0 108.499 173.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.07 60.94 6.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.684 -1.246 . . . . 20.0 111.405 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -25.49 0.84 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.465 0.913 . . . . 20.0 113.465 -179.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.56 -4.53 2.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.313 0.486 . . . . 20.0 112.313 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.52 40.77 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.721 -1.228 . . . . 20.0 112.022 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 219' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' D' ' 222' ' ' SER . . . -65.28 -37.02 85.88 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 122.241 -0.564 . . . . 20.0 111.375 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.71 -36.77 57.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 112.139 0.422 . . . . 20.0 112.139 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 221' ' ' THR . . . . . . . . . . . . . 75.5 p -58.42 -45.79 87.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 120.001 -0.68 . . . . 20.0 110.867 -173.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 222' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' D' ' 219' ' ' ALA . 2.1 p -58.01 -35.83 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.771 -0.372 . . . . 20.0 111.433 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.61 -50.03 69.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.582 0.586 . . . . 20.0 112.582 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.13 -33.43 75.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.795 -0.762 . . . . 20.0 111.84 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.71 74.95 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.93 -1.605 . . . . 20.0 112.099 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.94 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 112.03 0.382 . . . . 20.0 112.03 -158.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 227' ' ' GLU . . . . . 0.488 ' OE1' ' OG1' ' D' ' 306' ' ' THR . 3.0 pt-20 -56.42 -46.67 99.78 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 118.187 2.662 . . . . 20.0 118.187 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 C--O 1.232 0.214 0 N-CA-C 115.988 1.495 . . . . 20.0 115.988 -134.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.172 1.389 . . . . 20.0 113.413 162.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.065 -0.654 . . . . 20.0 111.708 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.49 16.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.906 -0.664 . . . . 20.0 112.256 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.7 170.71 15.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.801 0.84 . . . . 20.0 108.83 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.08 23.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.199 0.523 . . . . 20.0 110.406 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 234' ' ' ILE . . . . . . . . . . . . . 51.5 mt -133.22 90.39 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.552 -1.277 . . . . 20.0 107.552 172.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' D' ' 68' ' ' HIS . 25.5 t0 -135.11 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.96 -1.496 . . . . 20.0 106.96 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.14 149.4 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.636 0.731 . . . . 20.0 111.414 -172.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.67 122.7 1.44 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.46 151.88 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.268 -1.012 . . . . 20.0 108.268 -161.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.22 9.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.871 -1.529 . . . . 20.0 106.871 159.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.06 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.983 0.734 . . . . 20.0 112.983 -155.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.12 22.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.915 1.286 . . . . 20.0 112.448 158.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 128.4 79.09 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.22 -2.141 . . . . 20.0 105.22 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.55 12.09 Favored 'Trans proline' 0 CA--C 1.516 -0.381 0 CA-C-N 120.871 1.347 . . . . 20.0 112.311 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.38 -5.21 45.46 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.063 -0.971 . . . . 20.0 114.928 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 33.3 p -92.17 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.595 1.197 . . . . 20.0 110.678 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.871 0.696 . . . . 20.0 111.968 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.768 -1.106 . . . . 20.0 112.087 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.83 -0.748 . . . . 20.0 112.862 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 249' ' ' LYS . . . . . 0.716 ' O ' ' OG1' ' D' ' 252' ' ' THR . 16.9 mttt -98.79 -15.14 19.4 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.234 0.828 . . . . 20.0 113.234 170.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.86 88.96 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.299 -0.56 . . . . 20.0 111.368 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.125 -1.03 . . . . 20.0 111.844 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 252' ' ' THR . . . . . 0.716 ' OG1' ' O ' ' D' ' 249' ' ' LYS . 39.2 p -57.12 -31.84 65.72 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.5 0.591 . . . . 20.0 111.347 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.4 132.08 4.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.316 0.579 . . . . 20.0 110.37 176.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.32 3.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.279 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.33 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.688 0 C-N-CA 126.162 1.839 . . . . 20.0 111.56 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.22 10.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.12 174.27 3.41 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-O 122.643 1.135 . . . . 20.0 113.366 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.82 175.09 6.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.52 -0.919 . . . . 20.0 108.52 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' D' ' 316' ' ' SER . . . -126.38 120.34 29.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.123 -0.944 . . . . 20.0 109.391 -169.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 260' ' ' ILE . . . . . . . . . . . . . 85.6 mt -98.02 139.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.77 -1.196 . . . . 20.0 107.77 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.81 122.62 42.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.991 -0.744 . . . . 20.0 108.991 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.73 -40.31 10.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.89 -0.595 . . . . 20.0 109.625 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.61 34.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.326 -0.62 . . . . 20.0 109.326 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -170.0 2.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.23 165.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.25 21.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.802 -0.635 . . . . 20.0 110.281 163.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.17 11.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -165.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.66 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 103.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.13 -1.804 . . . . 20.0 106.13 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.07 56.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.552 . . . . 20.0 111.341 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.144 -0.935 . . . . 20.0 108.67 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 271' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -67.45 -20.0 48.48 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 114.865 1.063 . . . . 20.0 114.865 -160.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -43.0 74.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.149 -0.62 . . . . 20.0 110.599 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.57 -48.38 77.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.111 0.481 . . . . 20.0 110.095 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.09 -52.55 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.838 0.351 . . . . 20.0 110.725 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.34 -31.93 70.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.807 -0.757 . . . . 20.0 110.55 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.96 65.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.012 179.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.08 -38.69 89.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.765 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -47.94 78.64 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.097 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.47 88.4 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.839 -0.344 . . . . 20.0 110.737 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.95 77.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.291 -0.563 . . . . 20.0 111.053 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.18 -31.63 72.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.009 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.43 -31.78 65.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.04 -0.664 . . . . 20.0 111.127 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.87 -37.67 73.06 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.902 -0.719 . . . . 20.0 110.939 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 284' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -102.6 15.48 29.16 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.367 0.877 . . . . 20.0 113.367 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.78 32.09 13.76 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.744 0.783 . . . . 20.0 111.626 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.28 143.41 34.46 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.331 -0.989 . . . . 20.0 108.331 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 287' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.16 149.35 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 CA-C-N 119.177 0.742 . . . . 20.0 111.345 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.97 148.13 23.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.67 -0.695 . . . . 20.0 109.725 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.96 175.16 5.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.731 -1.211 . . . . 20.0 107.731 168.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.72 113.78 17.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.67 43.75 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 20.0 109.481 -172.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.642 -1.244 . . . . 20.0 107.642 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.71 12.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.56 0.695 . . . . 20.0 110.245 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.74 -18.6 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.827 -1.079 . . . . 20.0 112.181 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.981 -0.847 . . . . 20.0 110.981 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.49 144.83 15.64 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.637 -0.781 . . . . 20.0 112.624 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.84 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.359 -1.097 . . . . 20.0 110.359 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 298' ' ' THR . . . . . . . . . . . . . 20.2 p -110.3 172.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.037 0.922 . . . . 20.0 111.371 -174.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.69 76.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.222 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.41 74.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.788 0.292 . . . . 20.0 111.788 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.18 96.84 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.198 -1.001 . . . . 20.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.34 -26.87 65.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.119 -0.633 . . . . 20.0 111.186 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.127 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -14.2 60.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.368 0.877 . . . . 20.0 113.368 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.75 -8.82 19.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 306' ' ' THR . . . . . 0.488 ' OG1' ' OE1' ' D' ' 227' ' ' GLU . 0.5 OUTLIER -58.39 157.56 8.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.55 0.691 . . . . 20.0 110.543 171.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' D' D ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -161.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.89 -25.24 66.3 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.215 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.871 -0.681 . . . . 20.0 113.301 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.25 139.6 52.48 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-N 117.648 0.724 . . . . 20.0 111.14 -163.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.46 141.72 9.06 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 CA-C-N 119.502 0.858 . . . . 20.0 110.031 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.51 135.81 32.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.327 -0.851 . . . . 20.0 111.203 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.61 12.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.155 -1.578 . . . . 20.0 109.155 164.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.05 27.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.465 0.65 . . . . 20.0 110.049 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.04 153.23 21.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.629 -1.168 . . . . 20.0 109.228 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' D' ' 259' ' ' ALA . 4.2 m -138.41 133.57 33.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.311 -0.859 . . . . 20.0 109.453 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 317' ' ' VAL . . . . . . . . . . . . . 92.2 t -99.51 108.58 51.38 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.242 -1.392 . . . . 20.0 107.242 177.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.704 0 CA-C-O 122.693 1.039 . . . . 20.0 113.599 -154.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.78 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 113.532 -1.667 . . . . 20.0 115.269 161.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 157.62 33.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.709 0.766 . . . . 20.0 110.103 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.18 166.16 11.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.21 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.123 0.969 . . . . 20.0 108.417 -163.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.37 3.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.49 -59.96 4.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.677 0.621 . . . . 20.0 112.677 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -102.02 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.997 1.48 . . . . 20.0 114.997 -152.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.54 151.01 50.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.445 -1.317 . . . . 20.0 107.445 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.59 52.87 1.42 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.806 -1.543 . . . . 20.0 109.904 -153.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 328' ' ' VAL . . . . . . . . . . . . . 53.5 t -51.09 149.38 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.423 0.63 . . . . 20.0 111.932 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.36 179.38 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.884 0.849 . . . . 20.0 109.459 175.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.47 119.17 27.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.589 -1.187 . . . . 20.0 108.871 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.05 -32.11 53.55 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.819 0.699 . . . . 20.0 111.545 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 332' ' ' ARG . . . . . 0.4 ' NH2' ' OE2' ' B' ' 146' ' ' GLU . 10.3 mtm180 -68.59 -44.76 73.66 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.295 -0.562 . . . . 20.0 110.259 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 333' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.97 -45.03 83.21 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.788 -0.365 . . . . 20.0 111.053 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.58 -41.27 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 120.45 -0.5 . . . . 20.0 110.541 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.68 71.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 118.842 -1.143 . . . . 20.0 110.148 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.42 93.2 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.425 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -43.83 80.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.789 0.328 . . . . 20.0 110.951 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' D' ' 342' ' ' THR . 42.6 t -60.23 -48.94 86.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.978 0.418 . . . . 20.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' D' ' 343' ' ' LYS . 1.3 mm-40 -54.85 -46.88 74.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.027 0.441 . . . . 20.0 110.779 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.424 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 341' ' ' MET . . . . . . . . . . . . . 32.0 tpp -60.12 -40.35 89.45 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 120.17 -0.612 . . . . 20.0 110.8 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' D' ' 338' ' ' VAL . 1.3 m -56.49 -45.04 81.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.109 0.48 . . . . 20.0 110.401 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' D' ' 339' ' ' GLU . 34.5 mttp -74.16 -37.47 63.99 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 119.971 -0.691 . . . . 20.0 110.79 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.47 97.73 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.546 -0.461 . . . . 20.0 111.119 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.02 -50.42 74.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.549 -0.461 . . . . 20.0 110.781 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.08 90.97 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.693 -0.803 . . . . 20.0 110.583 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.47 4.79 30.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.435 -0.906 . . . . 20.0 112.54 -178.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.22 -23.68 33.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.098 0.863 . . . . 20.0 110.893 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 349' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -63.71 -27.36 69.16 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.272 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 122.083 -0.386 . . . . 20.0 111.484 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -173.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' D' D ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.037 1.866 . . . . 20.0 116.037 -169.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' D' D ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.997 1.319 . . . . 20.0 108.371 -174.707 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 114.244 1.201 . . . . 20.0 114.244 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 82.22 2.95 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.912 -1.514 . . . . 20.0 106.912 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.7 t -62.93 -34.48 66.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 114.836 -1.075 . . . . 20.0 110.23 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.01 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.569 0.952 . . . . 20.0 113.569 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.5 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.109 0.964 . . . . 20.0 111.644 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -38.72 32.29 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.302 -0.249 . . . . 20.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.08 117.41 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.683 -1.229 . . . . 20.0 107.683 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.88 112.19 12.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 20.0 110.879 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.51 72.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.397 -0.82 . . . . 20.0 111.864 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.21 -45.13 74.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.527 -0.469 . . . . 20.0 111.207 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -43.03 97.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.982 -0.287 . . . . 20.0 111.189 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.58 70.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.755 -0.378 . . . . 20.0 111.178 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.39 90.82 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.628 -0.429 . . . . 20.0 110.504 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -42.91 91.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.735 -0.212 . . . . 20.0 111.53 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.93 -40.09 26.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 119.529 -0.869 . . . . 20.0 110.676 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.05 -32.13 6.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.056 -1.057 . . . . 20.0 111.024 -162.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -25.94 67.99 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.997 -0.681 . . . . 20.0 111.26 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.47 70.35 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 120.5 -0.48 . . . . 20.0 109.797 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.18 144.76 9.5 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 120.259 0.639 . . . . 20.0 112.149 -172.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.28 3.39 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 117.273 1.669 . . . . 20.0 117.273 -159.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.78 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.168 -1.419 . . . . 20.0 107.168 159.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 171.17 8.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 20.0 110.714 -166.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.29 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.515 -0.766 . . . . 20.0 114.048 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.25 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.326 1.06 . . . . 20.0 109.592 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.17 4.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.878 -1.055 . . . . 20.0 113.445 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 26' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' E' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 8.96 23.93 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.652 1.115 . . . . 20.0 113.71 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 11.35 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.401 1.63 . . . . 20.0 115.401 -154.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' E' ' 26' ' ' PHE . . . -53.2 -26.86 29.93 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 119.83 1.196 . . . . 20.0 116.02 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.64 -35.73 61.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 118.059 0.929 . . . . 20.0 110.648 -178.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.43 61.53 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.848 0.356 . . . . 20.0 110.424 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.62 74.51 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.298 -0.41 . . . . 20.0 110.939 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.28 -49.58 82.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.036 0.446 . . . . 20.0 110.277 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.73 86.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 119.683 -0.807 . . . . 20.0 110.31 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.73 -29.43 20.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 118.692 -1.203 . . . . 20.0 111.177 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.51 -30.96 71.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.974 0.352 . . . . 20.0 111.1 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.7 3.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.166 0.432 . . . . 20.0 112.166 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.5 45.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.48 -0.327 . . . . 20.0 111.518 -164.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -26.36 63.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.896 -0.721 . . . . 20.0 112.226 -162.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.2 -23.45 62.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 118.84 -1.144 . . . . 20.0 111.71 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.95 22.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.532 0.938 . . . . 20.0 113.532 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.53 152.7 22.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.532 -0.914 . . . . 20.0 108.532 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.16 -42.6 88.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.197 -0.91 . . . . 20.0 111.458 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.65 158.33 35.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.52 147.18 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.536 0.684 . . . . 20.0 110.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 128.99 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.3 -176.14 5.83 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.811 0.815 . . . . 20.0 108.929 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.57 -34.6 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.957 -0.697 . . . . 20.0 111.13 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.16 10.82 9.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -171.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.64 83.37 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 119.096 -0.836 . . . . 20.0 114.446 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.544 1.172 . . . . 20.0 110.205 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.28 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.104 -1.443 . . . . 20.0 107.104 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 53' ' ' ILE . . . . . . . . . . . . . 31.1 mm -130.21 115.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.33 -1.359 . . . . 20.0 107.33 -174.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.672 -0.492 . . . . 20.0 109.672 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 100.03 8.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.56 145.4 31.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.76 -1.57 . . . . 20.0 106.76 163.243 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.55 154.48 20.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.711 -0.477 . . . . 20.0 109.711 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.053 -0.819 . . . . 20.0 111.053 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.876 0.87 . . . . 20.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.03 -168.6 33.51 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.742 -0.742 . . . . 20.0 114.08 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.73 165.2 32.84 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 CA-C-O 121.733 0.639 . . . . 20.0 112.085 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.93 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.293 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.7 138.0 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.82 124.05 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.015 0.926 . . . . 20.0 109.001 -175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.3 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.62 124.62 51.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.317 0.386 . . . . 20.0 110.97 -168.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.942 0.897 . . . . 20.0 108.92 167.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' E' ' 235' ' ' ASP . 0.0 OUTLIER -105.07 146.44 29.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.935 -0.575 . . . . 20.0 110.549 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.32 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.239 -0.891 . . . . 20.0 109.735 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' E' ' 183' ' ' ASP . 12.0 t0 -97.35 67.97 2.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.597 -0.689 . . . . 20.0 112.449 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.33 144.93 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.266 -1.013 . . . . 20.0 108.266 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.85 148.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.692 0.797 . . . . 20.0 109.14 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.88 -175.69 27.17 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.576 -1.009 . . . . 20.0 110.576 173.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -125.05 161.46 26.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.364 0.602 . . . . 20.0 109.989 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.08 131.33 49.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.228 1.011 . . . . 20.0 109.681 -174.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.5 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.11 -29.29 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.08 0.77 . . . . 20.0 113.08 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.48 13.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.104 -1.073 . . . . 20.0 108.104 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 mm -127.03 108.93 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.337 -0.986 . . . . 20.0 108.337 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.31 5.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.782 0.801 . . . . 20.0 109.972 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.05 60.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.698 -0.801 . . . . 20.0 112.733 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.15 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.354 0.872 . . . . 20.0 113.354 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.75 81.79 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 118.998 -0.89 . . . . 20.0 115.108 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.75 145.03 34.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.341 1.071 . . . . 20.0 110.222 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.08 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.27 -0.877 . . . . 20.0 112.567 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.42 174.69 6.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.841 -1.17 . . . . 20.0 107.841 158.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.8 163.79 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.652 0.739 . . . . 20.0 109.476 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.27 15.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.019 -0.991 . . . . 20.0 109.808 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -79.78 160.17 24.64 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-O 122.32 0.883 . . . . 20.0 112.735 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.75 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.72 -1.582 . . . . 20.0 107.367 165.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.89 47.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.243 -0.889 . . . . 20.0 112.171 -168.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.18 22.12 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.231 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.91 152.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 118.649 1.225 . . . . 20.0 109.232 -169.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.69 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 108.435 -0.95 . . . . 20.0 108.435 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.11 -7.91 13.05 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.544 1.23 . . . . 20.0 114.81 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.15 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.212 0.915 . . . . 20.0 111.805 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.54 35.52 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.676 0.79 . . . . 20.0 112.394 178.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.32 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.007 1.323 . . . . 20.0 113.344 -172.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.19 156.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.91 -19.06 5.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.673 -1.148 . . . . 20.0 111.254 158.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.38 141.6 2.51 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.671 -0.863 . . . . 20.0 108.671 176.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.96 74.5 0.38 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 115.238 1.569 . . . . 20.0 115.238 150.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' E' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.309 0.959 . . . . 20.0 109.379 160.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.28 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.492 -0.777 . . . . 20.0 109.414 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.41 110.78 32.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.04 6.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.238 -0.282 . . . . 20.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.2 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 O-C-N 123.378 0.424 . . . . 20.0 110.389 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.57 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.416 -0.957 . . . . 20.0 108.416 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.05 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.945 -1.025 . . . . 20.0 110.498 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.19 75.18 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.337 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.03 114.01 15.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.474 1.137 . . . . 20.0 108.563 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.28 141.52 37.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.362 -0.607 . . . . 20.0 109.362 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.62 142.56 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.71 -0.848 . . . . 20.0 108.71 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 114' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.78 149.48 31.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.991 -1.004 . . . . 20.0 110.269 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' E' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.28 -1.128 . . . . 20.0 110.28 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.76 154.38 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.24 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.582 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.91 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.371 1.248 . . . . 20.0 114.371 -156.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.13 11.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.538 1.063 . . . . 20.0 112.651 -155.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.1 35.61 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 102.653 -3.091 . . . . 20.0 102.653 159.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.07 123.83 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.545 0 CA-C-N 120.743 1.301 . . . . 20.0 110.599 -178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.84 149.75 89.97 Favored 'Trans proline' 0 CA--C 1.518 -0.284 0 CA-C-N 119.245 0.766 . . . . 20.0 110.701 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.38 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.814 0.816 . . . . 20.0 109.949 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.11 91.85 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -175.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.82 19.57 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.89 0.376 . . . . 20.0 110.702 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.85 -43.69 1.51 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 123.983 0.913 . . . . 20.0 113.116 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.94 -25.01 59.95 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.823 1.33 . . . . 20.0 112.006 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.54 -26.51 30.06 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 111.803 0.297 . . . . 20.0 111.803 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.94 69.13 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.735 -0.786 . . . . 20.0 110.265 168.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.84 62.47 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 111.921 0.341 . . . . 20.0 111.921 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.52 90.95 4.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.193 -0.669 . . . . 20.0 109.193 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.25 7.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.37 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.531 -0.915 . . . . 20.0 108.531 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.84 153.63 75.11 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 CA-C-N 119.635 0.905 . . . . 20.0 112.343 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.62 42.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.509 -1.223 . . . . 20.0 107.912 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -12.28 59.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 118.829 -0.605 . . . . 20.0 112.4 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' E' ' 138' ' ' GLN . 14.0 p30 -55.4 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-O 118.87 -0.586 . . . . 20.0 111.353 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 138' ' ' GLN . . . . . 0.414 ' N ' ' OD1' ' E' ' 137' ' ' ASP . 3.9 tp-100 174.63 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 103.082 -2.933 . . . . 20.0 103.082 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.81 168.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.108 0.963 . . . . 20.0 109.007 -179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.85 161.44 18.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.91 0.884 . . . . 20.0 110.514 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 141' ' ' ILE . . . . . . . . . . . . . 30.2 mt -124.61 147.46 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.896 0.879 . . . . 20.0 108.646 -177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' E' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.72 55.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.638 0.775 . . . . 20.0 109.578 175.172 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.12 7.81 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.683 0.614 . . . . 20.0 111.783 166.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' E' ' 142' ' ' ASP . . . 86.85 -6.51 82.82 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 115.488 0.955 . . . . 20.0 115.488 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.01 53.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.502 1.151 . . . . 20.0 110.323 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.31 -20.95 33.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.62 0.97 . . . . 20.0 113.62 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.65 40.11 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.992 0.901 . . . . 20.0 111.395 -173.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 148' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -57.37 -41.52 80.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.25 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -47.01 87.93 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.811 -0.356 . . . . 20.0 110.945 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.31 -35.18 76.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.509 -0.477 . . . . 20.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.56 84.11 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.142 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.85 -23.28 58.41 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.337 -0.945 . . . . 20.0 110.956 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.74 -30.04 66.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.77 -0.772 . . . . 20.0 110.637 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.59 92.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.564 -0.454 . . . . 20.0 111.666 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.12 -8.8 6.7 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-O 118.898 -0.946 . . . . 20.0 114.594 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.68 133.52 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 118.497 1.149 . . . . 20.0 108.514 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.738 -1.208 . . . . 20.0 107.738 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.702 -1.222 . . . . 20.0 107.702 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.31 15.73 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.778 -1.729 . . . . 20.0 108.778 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.44 113.61 17.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 165.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -19.99 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 113.766 1.024 . . . . 20.0 113.766 -166.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.69 155.6 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 121.674 -0.641 . . . . 20.0 111.81 -159.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' E' ' 164' ' ' TRP . 3.5 t -145.29 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.299 1.04 . . . . 20.0 110.473 171.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' E' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.94 16.7 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 -160.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.71 61.65 0.97 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.221 0.534 . . . . 20.0 112.333 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.56 29.54 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.064 -1.214 . . . . 20.0 110.064 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.32 37.68 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.721 -1.214 . . . . 20.0 107.721 170.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.63 30.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.129 -0.942 . . . . 20.0 110.198 -167.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.46 159.74 35.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.861 0.839 . . . . 20.0 109.982 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.17 34.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.224 -1.353 . . . . 20.0 109.494 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.66 28.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.522 -0.547 . . . . 20.0 109.522 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' E' ' 175' ' ' ARG . . . 56.88 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.187 -1.565 . . . . 20.0 109.187 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.91 4.25 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.813 0.672 . . . . 20.0 112.813 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -63.05 1.27 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 119.743 -0.783 . . . . 20.0 111.237 157.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' E' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.96 0.7 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.583 0.629 . . . . 20.0 112.649 172.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.41 0.35 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.786 2.434 . . . . 20.0 106.213 157.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.66 145.79 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.478 -0.934 . . . . 20.0 108.478 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.13 -64.47 1.16 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 116.446 2.017 . . . . 20.0 116.446 -166.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.86 22.37 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 118.726 0.694 . . . . 20.0 112.124 -171.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.07 -0.7 36.74 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.6 -67.05 0.83 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.599 0.636 . . . . 20.0 111.755 -162.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.24 127.78 32.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.078 0.942 . . . . 20.0 110.727 -152.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' E' ' 70' ' ' ASP . 0.6 OUTLIER 69.99 -6.7 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.348 1.459 . . . . 20.0 113.135 174.669 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.152 0.977 . . . . 20.0 110.779 157.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.06 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.5 -2.407 . . . . 20.0 104.5 149.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 186' ' ' ALA . . . . . 0.706 ' O ' ' OG1' ' E' ' 189' ' ' THR . . . -50.1 -42.96 51.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.342 -0.844 . . . . 20.0 111.55 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.93 -36.08 76.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.25 -0.98 . . . . 20.0 110.105 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.551 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 189' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' E' ' 186' ' ' ALA . 25.3 p -59.06 -48.66 80.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.491 -0.884 . . . . 20.0 110.862 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.24 -50.6 63.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.946 0.403 . . . . 20.0 110.5 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.17 96.22 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.064 -0.655 . . . . 20.0 110.961 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.56 84.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.014 -0.674 . . . . 20.0 110.284 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 193' ' ' VAL . . . . . . . . . . . . . 11.8 t -60.49 -44.81 97.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.08 0.467 . . . . 20.0 110.159 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.3 75.46 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.223 -0.591 . . . . 20.0 111.227 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.6 -38.17 70.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.877 -0.729 . . . . 20.0 110.811 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.11 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.555 0.576 . . . . 20.0 112.555 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.55 122.83 27.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.31 -0.626 . . . . 20.0 109.31 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.47 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.294 0.371 . . . . 20.0 110.085 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.18 105.41 17.56 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.689 -0.486 . . . . 20.0 109.689 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.07 91.33 4.27 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.974 -0.691 . . . . 20.0 111.376 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.65 30.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 203' ' ' ASP . . . . . 0.652 ' N ' ' OD1' ' E' ' 203' ' ' ASP . 0.0 OUTLIER -78.59 113.02 16.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.491 -0.929 . . . . 20.0 108.491 -174.49 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.92 106.6 9.0 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.987 -0.745 . . . . 20.0 108.987 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.38 31.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.91 150.19 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.77 5.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.432 -1.321 . . . . 20.0 107.432 171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.81 159.98 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.851 0.834 . . . . 20.0 111.106 -165.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.252 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.6 40.19 29.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.83 -1.077 . . . . 20.0 111.492 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.361 -0.536 . . . . 20.0 110.922 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.45 64.8 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.218 -0.593 . . . . 20.0 111.519 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.13 121.18 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.93 6.25 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.435 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.04 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.55 2.89 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.349 0.5 . . . . 20.0 112.349 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.5 40.82 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.708 -1.234 . . . . 20.0 112.017 168.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 219' ' ' ALA . . . . . 0.464 ' O ' ' OG ' ' E' ' 222' ' ' SER . . . -65.27 -37.06 86.01 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 122.27 -0.547 . . . . 20.0 111.412 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.67 -36.73 57.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.191 0.441 . . . . 20.0 112.191 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 221' ' ' THR . . . . . . . . . . . . . 74.5 p -58.43 -45.81 87.73 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.991 -0.684 . . . . 20.0 110.838 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 222' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' E' ' 219' ' ' ALA . 2.1 p -58.05 -35.79 71.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.728 -0.389 . . . . 20.0 111.425 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.23 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.548 0.573 . . . . 20.0 112.548 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.14 -33.44 75.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.818 -0.753 . . . . 20.0 111.805 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.71 74.93 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 118.92 -1.609 . . . . 20.0 112.14 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.99 -45.64 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 111.97 0.359 . . . . 20.0 111.97 -158.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 227' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' E' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.71 99.78 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 118.21 2.67 . . . . 20.0 118.21 -158.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.94 143.74 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 N-CA-C 115.957 1.483 . . . . 20.0 115.957 -134.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.82 0.77 Allowed 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.219 1.408 . . . . 20.0 113.391 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.17 11.54 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.104 -0.638 . . . . 20.0 111.77 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.47 151.48 16.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 20.0 112.255 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.45 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.78 0.832 . . . . 20.0 108.812 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.06 23.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.487 . . . . 20.0 110.42 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.19 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.58 -1.267 . . . . 20.0 107.58 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' E' ' 68' ' ' HIS . 25.5 t0 -135.19 173.23 11.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.979 -1.489 . . . . 20.0 106.979 173.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.763 . . . . 20.0 111.411 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.61 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.368 -1.345 . . . . 20.0 107.368 164.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.48 151.93 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.32 105.28 9.71 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.861 -1.533 . . . . 20.0 106.861 159.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.53 110.01 18.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.033 0.753 . . . . 20.0 113.033 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.11 22.17 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.902 1.281 . . . . 20.0 112.5 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.92 128.41 79.09 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 120.83 1.332 . . . . 20.0 112.396 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.26 45.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.069 -0.969 . . . . 20.0 114.94 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 245' ' ' THR . . . . . . . . . . . . . 33.5 p -92.18 164.54 22.82 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.616 1.208 . . . . 20.0 110.679 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.0 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-O 121.833 0.68 . . . . 20.0 111.922 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -10.9 59.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.081 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.64 63.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.859 -0.737 . . . . 20.0 112.885 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 249' ' ' LYS . . . . . 0.726 ' O ' ' OG1' ' E' ' 252' ' ' THR . 16.9 mttt -98.85 -15.11 19.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -37.89 89.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.278 -0.569 . . . . 20.0 111.394 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.56 -21.02 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.107 -1.037 . . . . 20.0 111.907 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 252' ' ' THR . . . . . 0.726 ' OG1' ' O ' ' E' ' 249' ' ' LYS . 39.4 p -57.17 -31.82 65.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.46 0.573 . . . . 20.0 111.304 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.35 132.08 4.52 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.283 0.563 . . . . 20.0 110.427 176.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 20.0 112.307 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.31 35.92 5.84 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 126.175 1.845 . . . . 20.0 111.57 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.2 10.15 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.619 -0.882 . . . . 20.0 108.619 -167.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.24 3.41 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-O 122.642 1.134 . . . . 20.0 113.305 169.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.76 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.545 -0.909 . . . . 20.0 108.545 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.38 120.33 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.439 -169.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.04 139.9 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.755 -1.202 . . . . 20.0 107.755 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.81 122.64 42.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.97 -0.752 . . . . 20.0 108.97 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.74 -40.31 10.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.838 -0.619 . . . . 20.0 109.6 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.406 0.622 . . . . 20.0 109.329 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.97 2.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.78 -1.1 . . . . 20.0 108.183 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.28 21.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.783 -0.644 . . . . 20.0 110.278 163.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.14 11.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.67 0.989 . . . . 20.0 113.67 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 143.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.02 14.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.155 -1.795 . . . . 20.0 106.155 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.38 137.11 56.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.232 0.539 . . . . 20.0 111.278 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.1 109.64 1.96 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.112 -0.949 . . . . 20.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.41 -20.07 48.66 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 N-CA-C 114.816 1.045 . . . . 20.0 114.816 -160.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.558 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.6 -48.35 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.124 0.488 . . . . 20.0 110.099 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.15 -52.52 59.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.799 0.333 . . . . 20.0 110.698 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.92 70.82 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.814 -0.755 . . . . 20.0 110.56 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -47.96 65.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.09 -0.644 . . . . 20.0 110.988 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.0 -38.75 89.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.068 -0.653 . . . . 20.0 110.769 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.61 -47.97 78.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.583 -0.447 . . . . 20.0 110.116 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.48 88.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.876 -0.33 . . . . 20.0 110.719 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.92 77.91 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.079 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.68 72.96 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.995 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.4 -31.82 65.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.124 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.68 73.19 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.884 -0.727 . . . . 20.0 110.972 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.63 15.47 29.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.81 32.08 13.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.75 0.786 . . . . 20.0 111.614 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.25 143.39 34.47 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 20.0 108.304 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.15 149.35 13.49 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 CA-C-N 119.145 0.73 . . . . 20.0 111.333 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.18 23.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.667 -0.697 . . . . 20.0 109.676 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.02 175.12 5.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.67 113.72 17.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 167.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.68 43.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.59 168.72 12.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.469 0.652 . . . . 20.0 110.241 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.73 -18.63 21.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.824 -1.08 . . . . 20.0 112.144 165.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.57 -176.03 20.04 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.97 -0.852 . . . . 20.0 110.97 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.51 144.74 15.5 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.62 -0.79 . . . . 20.0 112.66 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.79 119.63 4.11 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.324 -1.11 . . . . 20.0 110.324 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 298' ' ' THR . . . . . . . . . . . . . 20.4 p -110.27 172.86 6.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.013 0.911 . . . . 20.0 111.363 -174.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.87 -33.74 76.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.215 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.34 74.11 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 111.73 0.27 . . . . 20.0 111.73 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.15 96.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.197 -1.001 . . . . 20.0 112.028 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.92 65.9 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.187 -0.605 . . . . 20.0 111.236 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 303' ' ' ILE . . . . . . . . . . . . . 13.2 mm -70.88 -34.44 55.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.122 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.21 60.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.311 0.856 . . . . 20.0 113.311 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.87 19.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.697 0.999 . . . . 20.0 113.697 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 306' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' E' ' 227' ' ' GLU . 0.5 OUTLIER -58.37 157.56 8.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.534 0.683 . . . . 20.0 110.572 171.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' E' E ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.343 0.868 . . . . 20.0 113.343 -161.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.2 66.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.716 -0.794 . . . . 20.0 111.201 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.72 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.831 -0.699 . . . . 20.0 113.367 -171.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.28 139.58 52.36 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.558 0.679 . . . . 20.0 111.131 -163.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.45 141.68 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 CA-C-N 119.482 0.851 . . . . 20.0 110.039 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.48 135.79 32.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.323 -0.853 . . . . 20.0 111.201 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.58 162.6 12.32 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.166 -1.574 . . . . 20.0 109.166 164.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.03 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.464 0.649 . . . . 20.0 110.082 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.04 153.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.62 -1.173 . . . . 20.0 109.258 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.55 32.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.283 -0.871 . . . . 20.0 109.417 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 317' ' ' VAL . . . . . . . . . . . . . 92.6 t -99.48 108.61 51.45 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.285 -1.376 . . . . 20.0 107.285 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.31 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 CA-C-O 122.626 1.011 . . . . 20.0 113.589 -154.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.84 35.44 0.15 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.604 -1.634 . . . . 20.0 115.282 161.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.57 157.56 33.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.759 0.79 . . . . 20.0 110.119 176.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 106.797 -1.557 . . . . 20.0 106.797 160.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.23 113.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.199 1.0 . . . . 20.0 108.379 -163.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.54 -7.44 3.23 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.45 1.278 . . . . 20.0 114.45 -140.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.665 0.617 . . . . 20.0 112.665 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 325' ' ' ASN . . . . . . . . . . . . . 35.0 p-10 -102.0 -56.09 2.35 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 115.007 1.484 . . . . 20.0 115.007 -152.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.93 50.78 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.442 -1.318 . . . . 20.0 107.442 174.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.55 52.84 1.42 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.817 -1.538 . . . . 20.0 109.94 -153.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.06 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.403 0.621 . . . . 20.0 111.939 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.4 179.41 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.919 0.866 . . . . 20.0 109.427 175.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.18 27.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.818 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.06 -32.1 53.6 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.835 0.71 . . . . 20.0 111.51 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.73 73.56 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.308 -0.557 . . . . 20.0 110.214 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.05 -44.89 83.24 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.779 -0.368 . . . . 20.0 111.064 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.66 -41.27 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 120.435 -0.506 . . . . 20.0 110.496 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 118.837 -1.145 . . . . 20.0 110.152 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.4 -40.42 93.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.459 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.6 -43.81 80.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.76 0.314 . . . . 20.0 110.924 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 338' ' ' VAL . . . . . 0.705 ' O ' ' OG1' ' E' ' 342' ' ' THR . 42.7 t -60.17 -48.95 86.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.034 0.445 . . . . 20.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' E' ' 343' ' ' LYS . 1.3 mm-40 -54.78 -47.02 74.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.99 0.424 . . . . 20.0 110.726 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -55.14 37.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.332 -0.395 . . . . 20.0 111.456 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.19 -40.32 89.64 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.216 -0.594 . . . . 20.0 110.783 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 342' ' ' THR . . . . . 0.705 ' OG1' ' O ' ' E' ' 338' ' ' VAL . 1.3 m -56.52 -45.01 81.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.164 0.507 . . . . 20.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' E' ' 339' ' ' GLU . 34.6 mttp -74.23 -37.42 63.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.935 -0.706 . . . . 20.0 110.756 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.59 -0.444 . . . . 20.0 111.128 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.05 -50.39 74.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.53 -0.468 . . . . 20.0 110.806 -179.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.71 -39.0 90.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.669 -0.812 . . . . 20.0 110.574 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.51 4.76 30.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.471 -0.892 . . . . 20.0 112.522 -178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.13 -23.8 34.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 119.095 0.861 . . . . 20.0 110.877 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.241 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.8 31.77 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 122.153 -0.342 . . . . 20.0 111.453 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.154 0.428 . . . . 20.0 112.154 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' E' E ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.7 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.028 1.862 . . . . 20.0 116.028 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' E' E ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 124.956 1.302 . . . . 20.0 108.387 -174.683 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.301 1.223 . . . . 20.0 114.301 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.21 2.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.886 -1.524 . . . . 20.0 106.886 -170.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.93 -34.5 66.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.891 -1.049 . . . . 20.0 110.206 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.0 -23.54 12.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.45 30.32 19.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.146 0.978 . . . . 20.0 111.588 -173.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.65 32.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.765 0.257 . . . . 20.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.44 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.644 -1.243 . . . . 20.0 107.644 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.94 112.19 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.579 . . . . 20.0 110.92 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.427 -0.806 . . . . 20.0 111.874 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.16 -45.16 74.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.515 -0.474 . . . . 20.0 111.202 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.08 97.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 121.024 -0.27 . . . . 20.0 111.162 -172.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -30.55 70.95 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.731 -0.388 . . . . 20.0 111.189 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.85 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.633 -0.427 . . . . 20.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -43.0 91.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.651 -0.249 . . . . 20.0 111.484 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.67 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.02 -32.15 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.054 -1.059 . . . . 20.0 111.015 -162.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.93 67.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.289 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.06 160.4 70.72 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.837 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 19' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -85.13 144.72 9.55 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 120.299 0.666 . . . . 20.0 112.202 -172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.2 3.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 117.303 1.681 . . . . 20.0 117.303 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 159.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.1 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.367 0.604 . . . . 20.0 110.697 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.31 2.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.453 -0.794 . . . . 20.0 114.039 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.36 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.358 1.075 . . . . 20.0 109.569 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.93 -13.15 3.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.057 . . . . 20.0 113.437 169.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 26' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' F' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.01 23.8 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.705 1.139 . . . . 20.0 113.733 178.546 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.405 1.631 . . . . 20.0 115.405 -154.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 28' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' F' ' 26' ' ' PHE . . . -53.17 -26.9 29.84 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.783 1.174 . . . . 20.0 116.005 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.54 -35.85 61.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.096 0.948 . . . . 20.0 110.597 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -54.31 -52.39 61.64 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.881 0.372 . . . . 20.0 110.412 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.64 74.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.248 -0.433 . . . . 20.0 110.946 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.6 82.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.077 0.465 . . . . 20.0 110.327 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.67 86.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 119.703 -0.799 . . . . 20.0 110.31 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.74 -29.49 20.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 118.75 -1.18 . . . . 20.0 111.149 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.52 -30.93 71.64 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 117.988 0.358 . . . . 20.0 111.143 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.94 -56.79 3.23 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.145 0.424 . . . . 20.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.515 -0.311 . . . . 20.0 111.499 -164.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -26.35 63.65 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.891 -0.724 . . . . 20.0 112.243 -162.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.17 -23.48 62.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.881 -1.127 . . . . 20.0 111.662 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.88 -7.02 22.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.51 152.68 22.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.584 -0.895 . . . . 20.0 108.584 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.11 -42.63 88.99 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.25 -0.886 . . . . 20.0 111.475 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.32 35.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.542 -0.91 . . . . 20.0 108.542 -173.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.56 147.16 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.274 -1.01 . . . . 20.0 108.274 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.15 159.22 44.17 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.473 0.654 . . . . 20.0 110.442 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 129.01 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.31 -176.13 5.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.828 0.823 . . . . 20.0 108.882 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.63 62.97 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.086 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.83 9.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.692 0.997 . . . . 20.0 113.692 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.58 83.44 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 119.125 -0.819 . . . . 20.0 114.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.21 151.49 35.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.473 1.136 . . . . 20.0 110.194 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.25 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.127 -1.434 . . . . 20.0 107.127 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.24 115.61 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.345 -1.354 . . . . 20.0 107.345 -174.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.83 36.57 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.667 -0.494 . . . . 20.0 109.667 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 145.35 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.759 -1.571 . . . . 20.0 106.759 163.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.49 20.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.674 -0.491 . . . . 20.0 109.674 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.43 -161.08 23.71 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.125 -0.79 . . . . 20.0 111.125 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.58 10.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.91 0.884 . . . . 20.0 109.002 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.693 -0.765 . . . . 20.0 114.07 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.74 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.76 0.65 . . . . 20.0 112.067 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -91.98 111.34 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.188 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.7 137.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.776 -0.824 . . . . 20.0 108.776 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.69 124.09 46.51 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.055 0.942 . . . . 20.0 109.072 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.26 114.3 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.082 -1.081 . . . . 20.0 108.082 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.64 51.42 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.274 0.359 . . . . 20.0 110.973 -168.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.57 45.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.914 0.885 . . . . 20.0 108.957 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' F' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.41 29.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.265 0.555 . . . . 20.0 110.58 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 21.26 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.205 -0.907 . . . . 20.0 109.695 -178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 70' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' F' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.667 -0.646 . . . . 20.0 112.45 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.86 28.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.256 -1.016 . . . . 20.0 108.256 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.8 148.84 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.717 0.807 . . . . 20.0 109.154 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.83 -175.74 27.18 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.605 -0.998 . . . . 20.0 110.605 173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -125.05 161.5 26.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.346 0.593 . . . . 20.0 109.954 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.15 131.28 48.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.205 1.002 . . . . 20.0 109.698 -174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.06 23.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.892 -0.781 . . . . 20.0 108.892 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.33 7.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.085 0.772 . . . . 20.0 113.085 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.01 174.47 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.11 -1.07 . . . . 20.0 108.11 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.05 108.96 19.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.32 5.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.845 0.831 . . . . 20.0 110.0 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -27.09 60.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.7 -0.8 . . . . 20.0 112.739 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.19 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.348 0.87 . . . . 20.0 113.348 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 12.8 81.84 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 119.009 -0.884 . . . . 20.0 115.105 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.8 145.05 34.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.352 1.076 . . . . 20.0 110.228 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.48 28.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.265 -0.879 . . . . 20.0 112.6 -172.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.7 163.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.654 0.74 . . . . 20.0 109.461 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.36 15.66 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.838 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.89 160.21 24.29 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-O 122.27 0.862 . . . . 20.0 112.71 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.76 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.726 -1.579 . . . . 20.0 107.377 165.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.04 140.94 47.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.259 -0.882 . . . . 20.0 112.112 -168.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.22 22.02 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.936 -0.924 . . . . 20.0 115.24 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.9 152.66 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 118.648 1.224 . . . . 20.0 109.209 -169.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 130.97 22.19 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.466 -0.938 . . . . 20.0 108.466 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.11 -7.93 13.05 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 CA-C-N 120.543 1.23 . . . . 20.0 114.792 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.29 59.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.19 0.905 . . . . 20.0 111.788 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.4 35.49 0.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.632 0.773 . . . . 20.0 112.44 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.26 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.017 1.327 . . . . 20.0 113.331 -172.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.19 156.07 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.965 -0.754 . . . . 20.0 108.965 174.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.93 -18.93 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.666 -1.152 . . . . 20.0 111.289 157.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 101' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' H' ' 165' ' ' ASP . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.691 -0.855 . . . . 20.0 108.691 176.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 74.55 0.38 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.205 1.557 . . . . 20.0 115.205 150.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 103' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' F' ' 115' ' ' GLY . 0.5 OUTLIER -79.33 134.19 36.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 119.278 0.945 . . . . 20.0 109.442 160.368 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.77 140.33 37.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.556 -0.747 . . . . 20.0 109.426 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 105' ' ' VAL . . . . . . . . . . . . . 50.4 t -117.4 110.73 32.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.08 6.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.237 -0.283 . . . . 20.0 110.237 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.95 -54.25 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 123.379 0.424 . . . . 20.0 110.303 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.401 -0.963 . . . . 20.0 108.401 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.13 126.35 27.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.886 -1.052 . . . . 20.0 110.473 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.31 74.99 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 118.854 -0.97 . . . . 20.0 115.33 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.12 113.96 15.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.149 . . . . 20.0 108.556 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.27 141.54 37.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.409 -0.589 . . . . 20.0 109.409 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.68 142.53 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.44 31.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.97 -1.014 . . . . 20.0 110.257 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 115' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' F' ' 103' ' ' PHE . . . -147.95 157.73 27.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.279 -1.128 . . . . 20.0 110.279 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.587 -168.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.96 69.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.363 1.246 . . . . 20.0 114.363 -156.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.59 121.13 11.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 119.519 1.054 . . . . 20.0 112.65 -155.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.11 35.61 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 102.668 -3.086 . . . . 20.0 102.668 159.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 CA-C-N 120.766 1.309 . . . . 20.0 110.548 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.75 149.74 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.268 0 CA-C-N 119.191 0.747 . . . . 20.0 110.684 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.05 165.36 7.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.8 0.809 . . . . 20.0 109.99 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.17 91.91 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.192 -1.04 . . . . 20.0 108.192 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.79 19.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.761 -0.376 . . . . 20.0 110.704 169.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.88 -43.62 1.51 Allowed Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 123.937 0.895 . . . . 20.0 113.085 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.96 59.32 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 120.843 1.337 . . . . 20.0 111.975 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.47 30.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 111.778 0.288 . . . . 20.0 111.778 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.94 69.18 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.772 -0.771 . . . . 20.0 110.243 168.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.91 62.48 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.887 0.329 . . . . 20.0 111.887 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.45 90.93 4.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.205 -0.665 . . . . 20.0 109.205 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.25 7.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.075 0.398 . . . . 20.0 112.075 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.54 87.52 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.72 153.62 75.46 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 CA-C-N 119.613 0.898 . . . . 20.0 112.384 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.66 42.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.938 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -12.26 59.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 118.837 -0.601 . . . . 20.0 112.382 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' F' ' 138' ' ' GLN . 14.1 p30 -55.32 -66.42 0.42 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.898 -0.572 . . . . 20.0 111.363 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 138' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' F' ' 137' ' ' ASP . 3.9 tp-100 174.65 174.13 0.2 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.121 -2.918 . . . . 20.0 103.121 133.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.84 168.1 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.153 0.981 . . . . 20.0 108.94 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.86 161.45 18.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.924 0.89 . . . . 20.0 110.495 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.6 147.48 29.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.575 -0.898 . . . . 20.0 108.575 -177.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 142' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' F' ' 144' ' ' GLY . 0.5 OUTLIER -119.07 134.72 55.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.678 0.791 . . . . 20.0 109.615 175.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.668 0.605 . . . . 20.0 111.777 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 144' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' F' ' 142' ' ' ASP . . . 86.8 -6.47 82.8 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 115.489 0.956 . . . . 20.0 115.489 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.05 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.51 1.155 . . . . 20.0 110.254 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.41 -20.85 33.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.593 0.96 . . . . 20.0 113.593 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.37 162.65 40.12 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.967 0.889 . . . . 20.0 111.46 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.44 -41.5 80.61 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 113.937 -1.483 . . . . 20.0 111.214 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.35 -47.06 87.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.824 -0.351 . . . . 20.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.3 -35.19 76.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.511 -0.476 . . . . 20.0 110.807 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.59 83.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.09 -0.644 . . . . 20.0 111.072 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.31 58.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.377 -0.929 . . . . 20.0 111.03 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.74 -30.09 66.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.587 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.59 -40.55 92.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.516 -0.474 . . . . 20.0 111.705 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.13 -8.74 6.7 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 118.903 -0.943 . . . . 20.0 114.554 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.5 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.494 1.147 . . . . 20.0 108.553 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.99 9.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.707 -1.22 . . . . 20.0 107.707 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.35 147.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.76 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 108.749 -1.74 . . . . 20.0 108.749 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.38 113.58 17.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.63 -1.248 . . . . 20.0 107.63 165.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.66 -20.02 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -166.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.72 155.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.587 0.631 . . . . 20.0 111.722 -159.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 163' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' F' ' 164' ' ' TRP . 3.5 t -145.34 -166.33 2.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.235 1.014 . . . . 20.0 110.476 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 164' ' ' TRP . . . . . 0.547 ' N ' ' OG1' ' F' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.9 16.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.7 61.72 0.97 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.844 -0.535 . . . . 20.0 112.262 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 148.35 37.69 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.61 30.43 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.109 -0.95 . . . . 20.0 110.23 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.41 159.76 35.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.858 0.837 . . . . 20.0 110.012 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.12 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.254 -1.339 . . . . 20.0 109.52 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.9 151.64 28.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.5 -0.556 . . . . 20.0 109.5 168.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 172' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' F' ' 175' ' ' ARG . . . 56.93 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.219 -1.552 . . . . 20.0 109.219 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.85 4.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.812 0.671 . . . . 20.0 112.812 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -63.03 1.28 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.749 -0.78 . . . . 20.0 111.233 157.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 175' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' F' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.98 0.7 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.56 0.618 . . . . 20.0 112.653 172.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.51 169.36 0.35 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.844 2.458 . . . . 20.0 106.256 157.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.66 145.82 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.494 -0.928 . . . . 20.0 108.494 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.21 -64.43 1.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 116.421 2.008 . . . . 20.0 116.421 -165.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.33 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.772 0.714 . . . . 20.0 112.137 -171.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.65 36.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.388 1.255 . . . . 20.0 114.388 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.71 -66.92 0.84 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.592 0.633 . . . . 20.0 111.75 -162.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.29 127.82 32.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.094 0.949 . . . . 20.0 110.697 -152.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 183' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' F' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.75 1.03 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.329 1.452 . . . . 20.0 113.191 174.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.77 83.88 1.16 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.14 0.972 . . . . 20.0 110.805 157.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.1 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 186' ' ' ALA . . . . . 0.695 ' O ' ' OG1' ' F' ' 189' ' ' THR . . . -50.09 -42.98 51.17 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.351 -0.84 . . . . 20.0 111.542 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.85 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 119.292 -0.963 . . . . 20.0 110.133 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.68 92.01 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.206 -0.997 . . . . 20.0 110.481 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 189' ' ' THR . . . . . 0.695 ' OG1' ' O ' ' F' ' 186' ' ' ALA . 25.2 p -59.1 -48.58 81.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.437 -0.905 . . . . 20.0 110.861 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.34 -50.55 64.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.955 0.407 . . . . 20.0 110.49 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.17 96.13 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.025 -0.67 . . . . 20.0 110.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.84 -36.6 84.46 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.98 -0.688 . . . . 20.0 110.339 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 t -60.45 -44.9 97.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.022 0.439 . . . . 20.0 110.103 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.26 75.35 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.234 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.63 -38.12 70.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.809 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.77 -26.09 40.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.557 0.577 . . . . 20.0 112.557 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.56 122.78 27.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.298 -0.63 . . . . 20.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.286 0.366 . . . . 20.0 110.08 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.14 105.38 17.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.3 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.224 -0.658 . . . . 20.0 109.224 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.54 59.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.001 -0.68 . . . . 20.0 111.349 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.957 -0.757 . . . . 20.0 108.957 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' F' ' 203' ' ' ASP . 0.0 OUTLIER -78.64 112.96 16.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 -174.508 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.61 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.577 -0.897 . . . . 20.0 108.577 -170.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.91 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.042 -0.725 . . . . 20.0 109.042 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.4 31.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.727 -0.842 . . . . 20.0 108.727 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 108.884 -0.784 . . . . 20.0 108.884 174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.37 98.79 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.39 -1.337 . . . . 20.0 107.39 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.88 159.95 19.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.91 0.862 . . . . 20.0 111.066 -165.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.77 166.45 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.227 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.17 29.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.778 -1.101 . . . . 20.0 111.481 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.96 -49.57 13.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.331 -0.548 . . . . 20.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.43 64.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.495 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 214' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.691 -1.243 . . . . 20.0 111.441 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -25.6 0.85 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.999 0.92 . . . . 20.0 113.411 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.46 -4.53 2.83 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.368 0.507 . . . . 20.0 112.368 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.64 -40.58 40.7 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 119.754 -1.212 . . . . 20.0 111.973 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' F' ' 222' ' ' SER . . . -65.27 -37.05 86.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 122.298 -0.531 . . . . 20.0 111.378 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.7 -36.75 57.8 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.43 -45.8 87.75 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.856 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' F' ' 219' ' ' ALA . 2.1 p -58.02 -35.8 71.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.81 -0.356 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.7 -49.97 69.41 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.546 0.573 . . . . 20.0 112.546 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 224' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -64.12 -33.48 75.88 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.852 -0.739 . . . . 20.0 111.799 -165.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.72 74.92 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 118.906 -1.616 . . . . 20.0 112.112 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.008 0.373 . . . . 20.0 112.008 -158.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 227' ' ' GLU . . . . . 0.499 ' OE1' ' OG1' ' F' ' 306' ' ' THR . 3.0 pt-20 -56.45 -46.69 99.79 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 118.218 2.673 . . . . 20.0 118.218 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.88 143.66 2.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 N-CA-C 115.974 1.49 . . . . 20.0 115.974 -134.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.24 -4.77 0.77 Allowed 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.201 1.4 . . . . 20.0 113.366 162.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.2 11.47 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.124 -0.631 . . . . 20.0 111.793 167.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.45 151.49 16.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.935 -0.65 . . . . 20.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 232' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.814 0.846 . . . . 20.0 108.825 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.01 23.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.173 0.511 . . . . 20.0 110.379 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.18 90.43 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.55 -1.278 . . . . 20.0 107.55 172.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' F' ' 68' ' ' HIS . 25.5 t0 -135.12 173.24 11.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.948 -1.501 . . . . 20.0 106.948 173.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.18 149.37 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.656 0.741 . . . . 20.0 111.436 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.63 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.354 -1.35 . . . . 20.0 107.354 164.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 238' ' ' ILE . . . . . . . . . . . . . 18.0 mm -145.5 151.92 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.254 -1.017 . . . . 20.0 108.254 -161.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.18 9.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.852 -1.536 . . . . 20.0 106.852 159.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.02 18.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.038 0.755 . . . . 20.0 113.038 -155.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.43 36.09 22.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.92 1.288 . . . . 20.0 112.458 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.53 12.12 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 CA-C-N 120.823 1.33 . . . . 20.0 112.383 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.45 -5.29 45.51 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-O 118.856 -0.969 . . . . 20.0 114.909 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.15 164.51 22.96 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 118.606 1.203 . . . . 20.0 110.65 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.92 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.326 -0.612 0 CA-C-O 121.877 0.699 . . . . 20.0 111.943 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.724 -1.125 . . . . 20.0 112.058 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.26 -18.71 63.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.832 -0.747 . . . . 20.0 112.858 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 249' ' ' LYS . . . . . 0.73 ' O ' ' OG1' ' F' ' 252' ' ' THR . 16.9 mttt -98.78 -15.11 19.41 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.88 89.04 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.305 -0.558 . . . . 20.0 111.347 -172.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.62 -20.94 25.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 119.054 -1.058 . . . . 20.0 111.92 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 252' ' ' THR . . . . . 0.73 ' OG1' ' O ' ' F' ' 249' ' ' LYS . 39.3 p -57.16 -31.83 65.8 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.501 0.591 . . . . 20.0 111.299 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.343 0.592 . . . . 20.0 110.407 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.36 -1.3 3.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.968 -1.014 . . . . 20.0 112.308 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 126.188 1.851 . . . . 20.0 111.582 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.4 129.23 10.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.22 3.31 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-O 122.695 1.164 . . . . 20.0 113.371 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.12 6.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.525 -0.917 . . . . 20.0 108.525 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.43 120.3 29.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.936 . . . . 20.0 109.424 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.0 139.96 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.781 -1.192 . . . . 20.0 107.781 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.83 122.68 42.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.79 -40.33 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.903 -0.589 . . . . 20.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.59 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.319 -0.622 . . . . 20.0 109.319 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.08 -169.92 2.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.792 -1.095 . . . . 20.0 108.231 165.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.03 -56.21 22.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.781 -0.645 . . . . 20.0 110.271 163.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.15 11.56 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 267' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.76 143.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.411 -0.589 . . . . 20.0 109.411 -163.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 268' ' ' ILE . . . . . . . . . . . . . 9.8 mm -121.31 104.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.099 -1.815 . . . . 20.0 106.099 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.3 137.1 56.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 20.0 111.339 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.67 1.98 Allowed Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 20.0 108.66 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 271' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -67.52 -20.0 48.06 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 N-CA-C 114.77 1.027 . . . . 20.0 114.77 -160.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.196 -0.601 . . . . 20.0 110.561 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.61 -48.36 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.108 0.48 . . . . 20.0 110.092 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.13 -52.5 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.831 0.348 . . . . 20.0 110.742 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.33 -31.94 70.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.801 -0.759 . . . . 20.0 110.581 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.46 -47.99 65.68 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.944 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.99 -38.76 89.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.024 -0.67 . . . . 20.0 110.765 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.58 -48.04 78.26 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.625 -0.43 . . . . 20.0 110.049 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.83 -40.43 88.44 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.855 -0.338 . . . . 20.0 110.706 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.28 -44.94 78.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.243 -0.583 . . . . 20.0 111.118 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.72 73.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.989 -0.684 . . . . 20.0 111.028 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.37 -31.8 65.9 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.198 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.66 73.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.885 -0.726 . . . . 20.0 111.031 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.58 15.43 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.16 13.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.672 0.748 . . . . 20.0 111.562 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.35 143.41 34.33 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.32 -0.993 . . . . 20.0 108.32 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.21 149.35 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.176 0.741 . . . . 20.0 111.349 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.12 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.625 -0.716 . . . . 20.0 109.679 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.95 175.1 5.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.689 -1.226 . . . . 20.0 107.689 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.65 113.76 17.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.889 -1.152 . . . . 20.0 107.889 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.73 43.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.403 -0.591 . . . . 20.0 109.403 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.02 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.659 -1.238 . . . . 20.0 107.659 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.55 168.67 12.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.484 0.659 . . . . 20.0 110.245 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.78 -18.53 21.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.832 -1.077 . . . . 20.0 112.143 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.52 144.76 15.52 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.679 -0.761 . . . . 20.0 112.666 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.335 -1.106 . . . . 20.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 298' ' ' THR . . . . . . . . . . . . . 20.3 p -110.28 172.9 6.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.028 0.918 . . . . 20.0 111.382 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.88 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.378 -1.283 . . . . 20.0 111.236 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.63 -35.31 74.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.764 0.283 . . . . 20.0 111.764 -171.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.16 96.87 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.176 -1.011 . . . . 20.0 112.059 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.31 -26.87 65.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.165 -0.614 . . . . 20.0 111.216 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.92 -34.47 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.144 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.18 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.304 0.853 . . . . 20.0 113.304 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.75 -8.9 19.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.699 1.0 . . . . 20.0 113.699 -167.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 306' ' ' THR . . . . . 0.499 ' OG1' ' OE1' ' F' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.6 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.564 0.697 . . . . 20.0 110.551 171.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' F' F ' 307' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -61.78 -29.8 70.38 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 -160.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.15 66.2 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.666 -0.814 . . . . 20.0 111.215 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.875 -0.678 . . . . 20.0 113.299 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 117.593 0.696 . . . . 20.0 111.13 -163.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 311' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -84.46 141.73 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.492 0.854 . . . . 20.0 110.063 168.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.48 135.8 32.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.354 -0.839 . . . . 20.0 111.186 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.63 12.32 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 109.125 -1.59 . . . . 20.0 109.125 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.02 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.452 0.644 . . . . 20.0 110.029 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -103.99 153.19 21.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.593 -1.185 . . . . 20.0 109.228 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.54 32.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.329 -0.851 . . . . 20.0 109.444 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 317' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.46 108.62 51.47 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-O 122.645 1.019 . . . . 20.0 113.622 -154.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.79 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 113.592 -1.64 . . . . 20.0 115.265 161.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.66 157.56 33.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.712 0.768 . . . . 20.0 110.113 176.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.07 166.17 11.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.814 -1.55 . . . . 20.0 106.814 160.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.22 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.146 0.978 . . . . 20.0 108.426 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.53 -7.41 3.2 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.438 1.273 . . . . 20.0 114.438 -140.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.57 -59.91 4.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.671 0.619 . . . . 20.0 112.671 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 325' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -101.98 -56.13 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.062 1.504 . . . . 20.0 115.062 -152.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.98 50.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 327' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -142.57 52.82 1.42 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.811 -1.541 . . . . 20.0 109.924 -153.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.05 149.4 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.454 0.645 . . . . 20.0 111.934 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.39 179.38 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.901 0.858 . . . . 20.0 109.479 175.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 119.24 27.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.833 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.13 -32.05 54.02 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.878 0.736 . . . . 20.0 111.528 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.74 73.56 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.326 -0.549 . . . . 20.0 110.223 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 333' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -66.0 -45.01 83.14 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.029 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.41 -0.516 . . . . 20.0 110.506 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.67 71.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 118.838 -1.145 . . . . 20.0 110.128 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.05 -0.66 . . . . 20.0 110.441 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.55 -43.84 80.33 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.713 0.292 . . . . 20.0 110.872 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 338' ' ' VAL . . . . . 0.699 ' O ' ' OG1' ' F' ' 342' ' ' THR . 42.6 t -60.19 -48.91 86.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.022 0.439 . . . . 20.0 110.278 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 339' ' ' GLU . . . . . 0.779 ' OE1' ' NZ ' ' F' ' 343' ' ' LYS . 1.3 mm-40 -54.93 -46.84 74.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.971 0.415 . . . . 20.0 110.757 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.16 37.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.371 -0.377 . . . . 20.0 111.397 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 341' ' ' MET . . . . . . . . . . . . . 31.8 tpp -60.19 -40.32 89.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.245 -0.582 . . . . 20.0 110.799 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 342' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' F' ' 338' ' ' VAL . 1.3 m -56.52 -45.02 81.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.166 0.508 . . . . 20.0 110.402 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 343' ' ' LYS . . . . . 0.779 ' NZ ' ' OE1' ' F' ' 339' ' ' GLU . 34.4 mttp -74.17 -37.48 63.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.999 -0.681 . . . . 20.0 110.764 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.55 97.83 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.109 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -58.97 -50.42 74.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.809 -179.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.69 -39.02 90.83 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.628 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.53 4.83 30.16 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.501 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.21 -23.68 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.129 0.877 . . . . 20.0 110.908 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.33 69.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.796 -0.762 . . . . 20.0 111.248 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.93 -18.77 31.77 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.102 -0.374 . . . . 20.0 111.487 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.76 -28.77 66.05 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' F' F ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.71 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.065 1.876 . . . . 20.0 116.065 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' F' F ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.944 1.298 . . . . 20.0 108.359 -174.696 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.242 1.201 . . . . 20.0 114.242 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.18 2.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 -170.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.88 -34.5 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.89 -1.05 . . . . 20.0 110.215 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.55 12.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.623 0.972 . . . . 20.0 113.623 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.41 30.33 20.01 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.136 0.975 . . . . 20.0 111.62 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -38.66 32.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 117.74 0.246 . . . . 20.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.45 37.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.14 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.375 0.607 . . . . 20.0 110.94 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.65 -31.58 72.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.429 -0.805 . . . . 20.0 111.896 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.12 -45.21 74.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.5 -0.48 . . . . 20.0 111.176 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -43.14 97.3 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.055 -0.258 . . . . 20.0 111.163 -172.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -30.58 70.95 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.736 -0.386 . . . . 20.0 111.181 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.35 91.0 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.541 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.03 -42.97 91.5 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.699 -0.228 . . . . 20.0 111.531 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.9 -40.06 26.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 119.509 -0.876 . . . . 20.0 110.692 -171.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.03 -32.16 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.036 -1.066 . . . . 20.0 111.039 -162.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -25.97 68.02 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.281 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.4 70.65 Favored Pre-proline 0 N--CA 1.448 -0.562 0 C-N-CA 120.506 -0.478 . . . . 20.0 109.825 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.15 144.71 9.52 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.328 0.685 . . . . 20.0 112.163 -172.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 117.285 1.674 . . . . 20.0 117.285 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 20.0 107.117 159.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.374 0.606 . . . . 20.0 110.73 -166.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.36 2.88 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.499 -0.773 . . . . 20.0 114.04 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.23 -178.36 0.17 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.356 1.074 . . . . 20.0 109.551 172.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.92 -13.16 3.98 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.879 -1.055 . . . . 20.0 113.459 169.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' G' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.02 23.77 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.735 1.152 . . . . 20.0 113.71 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.67 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.443 1.645 . . . . 20.0 115.443 -154.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' G' ' 26' ' ' PHE . . . -53.11 -26.97 29.66 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 116.032 1.173 . . . . 20.0 116.032 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.56 -35.78 61.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 118.078 0.939 . . . . 20.0 110.646 -178.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.26 -52.46 61.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.934 0.397 . . . . 20.0 110.435 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.52 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.295 -0.411 . . . . 20.0 110.933 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.26 -49.57 82.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.024 0.44 . . . . 20.0 110.291 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 119.702 -0.799 . . . . 20.0 110.293 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.48 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 118.681 -1.208 . . . . 20.0 111.162 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -31.01 71.68 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.995 0.362 . . . . 20.0 111.102 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.96 -56.69 3.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.173 0.435 . . . . 20.0 112.173 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.514 -0.312 . . . . 20.0 111.528 -164.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -26.29 63.55 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.899 -0.72 . . . . 20.0 112.191 -162.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.5 63.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 118.922 -1.111 . . . . 20.0 111.71 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.97 22.86 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.492 0.923 . . . . 20.0 113.492 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.55 152.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.04 -42.66 89.25 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.214 -0.903 . . . . 20.0 111.498 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.61 158.3 35.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.541 -0.911 . . . . 20.0 108.541 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.47 147.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.14 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.474 0.654 . . . . 20.0 110.454 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.385 -1.339 . . . . 20.0 107.385 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.13 5.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.786 0.803 . . . . 20.0 108.923 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.61 62.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.913 -0.715 . . . . 20.0 111.155 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.11 10.84 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.691 0.996 . . . . 20.0 113.691 -171.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.7 83.29 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 119.121 -0.822 . . . . 20.0 114.527 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.09 151.48 35.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.43 1.115 . . . . 20.0 110.24 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.161 -1.422 . . . . 20.0 107.161 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.17 115.64 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.359 -1.349 . . . . 20.0 107.359 -174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.79 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.634 -0.506 . . . . 20.0 109.634 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.99 100.0 8.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.626 -0.879 . . . . 20.0 108.626 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.64 145.37 31.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.77 -1.566 . . . . 20.0 106.77 163.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.56 154.44 20.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.507 0.505 . . . . 20.0 109.726 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.06 23.62 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.104 -0.798 . . . . 20.0 111.104 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.64 10.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.844 0.858 . . . . 20.0 108.977 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.58 33.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.761 -0.733 . . . . 20.0 114.097 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.71 165.21 32.78 Favored 'Trans proline' 0 CA--C 1.517 -0.354 0 CA-C-O 121.751 0.646 . . . . 20.0 112.12 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.95 111.39 22.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.016 -0.993 . . . . 20.0 109.278 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.94 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.726 -0.842 . . . . 20.0 108.726 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.71 124.03 46.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.074 0.949 . . . . 20.0 109.058 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.33 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.081 -1.081 . . . . 20.0 108.081 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.63 51.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.257 0.348 . . . . 20.0 110.954 -168.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.47 154.61 45.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.936 0.894 . . . . 20.0 108.943 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' G' ' 235' ' ' ASP . 0.0 OUTLIER -105.08 146.46 29.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 20.0 110.473 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 21.33 5.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.751 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' G' ' 183' ' ' ASP . 12.0 t0 -97.41 67.96 2.14 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.605 -0.684 . . . . 20.0 112.478 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.24 144.89 28.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.79 148.8 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 123.747 0.819 . . . . 20.0 109.117 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 -175.67 27.13 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 20.0 110.592 173.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.07 161.47 26.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.35 0.595 . . . . 20.0 109.944 178.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.15 131.35 48.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.623 -174.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.02 -29.31 7.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.129 0.789 . . . . 20.0 113.129 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.42 13.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.143 -1.058 . . . . 20.0 108.143 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.92 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 166.31 5.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.758 0.79 . . . . 20.0 110.001 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -26.99 60.33 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 119.637 -0.825 . . . . 20.0 112.763 -169.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.58 9.18 4.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.316 0.858 . . . . 20.0 113.316 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.24 12.78 81.82 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 119.018 -0.879 . . . . 20.0 115.099 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.76 145.0 34.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.358 1.079 . . . . 20.0 110.251 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.49 28.03 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.265 -0.88 . . . . 20.0 112.629 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -97.41 174.64 6.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.846 -1.168 . . . . 20.0 107.846 158.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.75 163.81 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.669 0.747 . . . . 20.0 109.5 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.36 15.62 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.03 -0.987 . . . . 20.0 109.78 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.85 160.22 24.42 Favored 'Trans proline' 0 CA--C 1.508 -0.821 0 CA-C-O 122.306 0.877 . . . . 20.0 112.737 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.77 150.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 113.694 -1.594 . . . . 20.0 107.419 165.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.99 140.9 47.55 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.314 -0.857 . . . . 20.0 112.18 -168.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.91 -24.19 22.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 118.962 -0.91 . . . . 20.0 115.232 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.86 152.61 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 118.686 1.243 . . . . 20.0 109.26 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 108.405 -0.961 . . . . 20.0 108.405 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.11 -8.0 13.04 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 CA-C-N 120.542 1.229 . . . . 20.0 114.797 -170.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.15 -15.28 59.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.218 0.917 . . . . 20.0 111.815 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.45 35.47 0.82 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.606 0.763 . . . . 20.0 112.468 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.22 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.961 1.304 . . . . 20.0 113.368 -172.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.18 156.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.89 -19.07 5.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.675 -1.148 . . . . 20.0 111.21 158.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.39 141.61 2.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 20.0 108.667 176.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.93 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 115.2 1.556 . . . . 20.0 115.2 150.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 103' ' ' PHE . . . . . 0.583 ' O ' ' N ' ' G' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.24 36.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.412 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.3 37.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.534 -0.757 . . . . 20.0 109.405 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -117.43 110.79 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.17 -1.048 . . . . 20.0 108.17 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.6 83.05 6.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.249 -0.278 . . . . 20.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -52.0 -54.18 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.35 0.406 . . . . 20.0 110.303 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.46 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.406 -0.961 . . . . 20.0 108.406 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.08 126.32 27.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.95 -1.023 . . . . 20.0 110.476 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 11.27 75.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-O 118.913 -0.937 . . . . 20.0 115.333 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.04 114.04 15.89 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.491 1.145 . . . . 20.0 108.587 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.31 141.57 37.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.36 -0.607 . . . . 20.0 109.36 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.684 -0.858 . . . . 20.0 108.684 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.67 149.43 31.25 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.026 -0.988 . . . . 20.0 110.309 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 115' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' G' ' 103' ' ' PHE . . . -147.92 157.79 27.47 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.314 -1.114 . . . . 20.0 110.314 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.73 154.41 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.29 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.336 -0.847 . . . . 20.0 114.554 -168.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.2 -47.97 69.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.342 1.238 . . . . 20.0 114.342 -156.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.525 1.057 . . . . 20.0 112.665 -155.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 136.14 35.5 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 102.627 -3.101 . . . . 20.0 102.627 159.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.15 123.79 11.02 Favored 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 120.728 1.296 . . . . 20.0 110.597 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.78 149.79 89.94 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 CA-C-N 119.242 0.765 . . . . 20.0 110.693 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.35 7.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.8 0.81 . . . . 20.0 109.974 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.197 -1.038 . . . . 20.0 108.197 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.94 160.86 19.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.801 -0.36 . . . . 20.0 110.716 169.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.03 -43.55 1.47 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 123.932 0.893 . . . . 20.0 113.061 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -25.01 59.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 CA-C-N 120.885 1.352 . . . . 20.0 111.968 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.53 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 111.798 0.295 . . . . 20.0 111.798 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -31.94 69.15 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 119.767 -0.773 . . . . 20.0 110.24 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.87 62.6 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.937 0.347 . . . . 20.0 111.937 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -78.5 90.96 4.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.181 -0.674 . . . . 20.0 109.181 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.3 7.98 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.099 0.407 . . . . 20.0 112.099 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.36 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 153.62 75.4 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-N 119.659 0.914 . . . . 20.0 112.383 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.62 42.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.541 -1.208 . . . . 20.0 107.962 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 118.797 -0.62 . . . . 20.0 112.386 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' G' ' 138' ' ' GLN . 14.3 p30 -55.33 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-O 118.954 -0.546 . . . . 20.0 111.4 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 138' ' ' GLN . . . . . 0.41 ' N ' ' OD1' ' G' ' 137' ' ' ASP . 3.9 tp-100 174.58 174.05 0.2 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.101 -2.926 . . . . 20.0 103.101 133.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.77 168.05 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.166 0.986 . . . . 20.0 108.981 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.96 0.904 . . . . 20.0 110.539 177.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.67 147.44 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.622 -0.881 . . . . 20.0 108.622 -177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' G' ' 144' ' ' GLY . 0.5 OUTLIER -119.04 134.79 54.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.593 0.757 . . . . 20.0 109.591 175.164 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 123.67 0.606 . . . . 20.0 111.842 166.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' G' ' 142' ' ' ASP . . . 86.87 -6.59 82.72 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 115.496 0.959 . . . . 20.0 115.496 172.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.476 1.138 . . . . 20.0 110.297 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.9 33.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.588 0.959 . . . . 20.0 113.588 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.32 162.65 40.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.978 0.894 . . . . 20.0 111.415 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.53 80.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.881 -1.508 . . . . 20.0 111.241 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.33 -46.99 87.97 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.81 -0.356 . . . . 20.0 110.983 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.38 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.489 -0.484 . . . . 20.0 110.795 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.6 84.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.033 -0.667 . . . . 20.0 111.127 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.78 -23.3 58.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.408 -0.917 . . . . 20.0 110.994 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.8 -30.04 66.39 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.714 -0.795 . . . . 20.0 110.613 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.62 92.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.522 -0.471 . . . . 20.0 111.69 171.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.76 6.69 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.603 -172.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.67 133.49 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 118.419 1.11 . . . . 20.0 108.574 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.84 175.91 9.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.745 -1.206 . . . . 20.0 107.745 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.34 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.34 169.29 15.67 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.771 -1.732 . . . . 20.0 108.771 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.35 113.61 17.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.69 -1.226 . . . . 20.0 107.69 165.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -20.02 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 113.702 1.001 . . . . 20.0 113.702 -166.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.65 155.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.669 -0.644 . . . . 20.0 111.805 -159.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 163' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' G' ' 164' ' ' TRP . 3.5 t -145.29 -166.31 2.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.3 1.04 . . . . 20.0 110.449 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 164' ' ' TRP . . . . . 0.548 ' N ' ' OG1' ' G' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.96 16.72 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.213 0.819 . . . . 20.0 113.213 -160.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.69 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.219 0.533 . . . . 20.0 112.299 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.9 158.61 29.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.092 -1.203 . . . . 20.0 110.092 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.41 148.3 37.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.704 -1.221 . . . . 20.0 107.704 170.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.64 30.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.102 -0.954 . . . . 20.0 110.149 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.48 159.79 35.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.891 0.853 . . . . 20.0 109.963 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.23 34.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.191 -1.368 . . . . 20.0 109.508 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.59 29.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.502 -0.555 . . . . 20.0 109.502 168.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 172' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' G' ' 175' ' ' ARG . . . 56.9 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.54 -21.87 4.28 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.748 0.647 . . . . 20.0 112.748 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -63.0 1.29 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.764 -0.775 . . . . 20.0 111.179 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 175' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' G' ' 172' ' ' GLY . 6.8 ptt-85 -169.85 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.626 0.648 . . . . 20.0 112.651 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.37 0.35 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.833 2.453 . . . . 20.0 106.245 157.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.65 145.8 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.458 -0.941 . . . . 20.0 108.458 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.16 -64.49 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 116.435 2.013 . . . . 20.0 116.435 -166.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.31 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.707 0.685 . . . . 20.0 112.089 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.66 36.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.65 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.626 0.648 . . . . 20.0 111.727 -162.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.26 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.059 0.933 . . . . 20.0 110.694 -152.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' G' ' 70' ' ' ASP . 0.6 OUTLIER 69.92 -6.69 1.03 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.361 1.464 . . . . 20.0 113.161 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.176 0.989 . . . . 20.0 110.799 157.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.07 -41.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.477 -2.416 . . . . 20.0 104.477 149.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' G' ' 189' ' ' THR . . . -50.12 -42.95 51.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.377 -0.829 . . . . 20.0 111.524 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.91 -36.07 76.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.263 -0.975 . . . . 20.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.86 -38.6 91.71 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 119.163 -1.015 . . . . 20.0 110.488 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' G' ' 186' ' ' ALA . 25.3 p -59.11 -48.61 80.99 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.513 -0.875 . . . . 20.0 110.827 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.55 64.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.92 0.39 . . . . 20.0 110.498 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.22 96.05 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 120.091 -0.644 . . . . 20.0 110.923 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.81 -36.6 84.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.011 -0.676 . . . . 20.0 110.303 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 193' ' ' VAL . . . . . . . . . . . . . 11.6 t -60.53 -44.82 97.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.027 0.441 . . . . 20.0 110.114 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.31 75.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.209 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.16 70.91 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.767 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.13 40.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 20.0 112.544 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.83 27.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.275 -0.639 . . . . 20.0 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.45 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.27 0.357 . . . . 20.0 110.132 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.33 17.46 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.27 4.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.187 -0.671 . . . . 20.0 109.187 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.78 -14.56 59.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.344 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.78 141.71 30.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.92 -0.77 . . . . 20.0 108.92 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 203' ' ' ASP . . . . . 0.644 ' OD1' ' N ' ' G' ' 203' ' ' ASP . 0.0 OUTLIER -78.61 112.96 16.23 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 -174.525 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.96 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.95 106.6 9.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 20.0 109.021 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 206' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -82.94 125.39 31.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.685 -0.858 . . . . 20.0 108.685 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.96 150.17 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.845 -0.798 . . . . 20.0 108.845 174.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.76 5.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.436 -1.32 . . . . 20.0 107.436 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.85 159.98 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.935 0.874 . . . . 20.0 111.102 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.48 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.621 -1.172 . . . . 20.0 108.222 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.55 40.22 29.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.801 -1.09 . . . . 20.0 111.524 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.53 13.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.418 -0.513 . . . . 20.0 110.95 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -20.43 64.77 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.228 -0.589 . . . . 20.0 111.458 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.19 121.14 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.06 60.96 6.21 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.663 -1.256 . . . . 20.0 111.419 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.08 -25.48 0.86 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.486 0.921 . . . . 20.0 113.486 -179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.324 0.49 . . . . 20.0 112.324 173.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.56 40.92 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.769 -1.205 . . . . 20.0 111.967 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 219' ' ' ALA . . . . . 0.465 ' O ' ' OG ' ' G' ' 222' ' ' SER . . . -65.29 -37.02 85.86 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.275 -0.544 . . . . 20.0 111.352 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.78 -36.68 58.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 112.161 0.43 . . . . 20.0 112.161 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 221' ' ' THR . . . . . . . . . . . . . 75.0 p -58.46 -45.77 87.93 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 119.989 -0.684 . . . . 20.0 110.871 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 222' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' G' ' 219' ' ' ALA . 2.1 p -58.06 -35.81 71.89 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.775 -0.37 . . . . 20.0 111.408 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.95 69.4 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.573 0.583 . . . . 20.0 112.573 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 224' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -64.21 -33.4 75.73 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.809 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.71 74.88 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.949 -1.596 . . . . 20.0 112.133 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.03 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 112.0 0.37 . . . . 20.0 112.0 -158.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 227' ' ' GLU . . . . . 0.493 ' OE1' ' OG1' ' G' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.68 99.78 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 118.225 2.676 . . . . 20.0 118.225 -158.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.74 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.198 0 N-CA-C 115.95 1.481 . . . . 20.0 115.95 -134.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.15 -4.76 0.78 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.23 1.412 . . . . 20.0 113.397 162.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.27 11.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.766 167.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.55 151.46 16.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.884 -0.674 . . . . 20.0 112.258 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.563 -0.819 . . . . 20.0 108.824 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.61 149.05 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.147 0.499 . . . . 20.0 110.409 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 234' ' ' ILE . . . . . . . . . . . . . 51.7 mt -133.2 90.41 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.586 -1.264 . . . . 20.0 107.586 172.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' G' ' 68' ' ' HIS . 25.5 t0 -135.2 173.24 11.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.949 -1.5 . . . . 20.0 106.949 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.628 0.727 . . . . 20.0 111.426 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.61 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.324 -1.361 . . . . 20.0 107.324 164.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.48 151.94 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 -161.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.881 -1.526 . . . . 20.0 106.881 159.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.41 110.03 18.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.01 0.744 . . . . 20.0 113.01 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.14 22.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.97 1.308 . . . . 20.0 112.434 158.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.38 79.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 105.182 -2.155 . . . . 20.0 105.182 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.98 165.56 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 CA-C-N 120.812 1.326 . . . . 20.0 112.385 -178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.26 45.41 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.912 -0.938 . . . . 20.0 114.926 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.19 164.55 22.74 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 118.572 1.186 . . . . 20.0 110.619 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.67 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-O 121.83 0.679 . . . . 20.0 111.944 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.84 59.56 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.736 -1.12 . . . . 20.0 112.067 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.72 63.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.854 -0.738 . . . . 20.0 112.872 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 249' ' ' LYS . . . . . 0.724 ' O ' ' OG1' ' G' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.83 88.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.297 -0.561 . . . . 20.0 111.345 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 251' ' ' VAL . . . . . . . . . . . . . 10.6 m -68.64 -21.0 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.855 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 252' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' G' ' 249' ' ' LYS . 39.6 p -57.09 -31.86 65.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.537 0.608 . . . . 20.0 111.383 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.328 0.585 . . . . 20.0 110.411 176.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.37 -1.31 3.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.973 -1.012 . . . . 20.0 112.325 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.29 35.96 5.83 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 126.155 1.836 . . . . 20.0 111.57 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.19 10.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.662 -0.866 . . . . 20.0 108.662 -167.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.11 174.29 3.41 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-O 122.706 1.17 . . . . 20.0 113.309 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.07 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.42 120.3 29.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 20.0 109.441 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 260' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.93 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.831 -1.174 . . . . 20.0 107.831 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.85 122.59 42.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.014 -0.735 . . . . 20.0 109.014 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.76 -40.27 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.873 -0.603 . . . . 20.0 109.647 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.59 34.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.428 0.632 . . . . 20.0 109.363 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.13 -169.92 2.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.77 -1.105 . . . . 20.0 108.235 165.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.06 -56.15 22.96 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.829 -0.623 . . . . 20.0 110.272 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -46.11 11.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.659 0.985 . . . . 20.0 113.659 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.419 -0.586 . . . . 20.0 109.419 -163.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.128 -1.805 . . . . 20.0 106.128 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.08 56.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.279 0.561 . . . . 20.0 111.313 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.0 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.669 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 271' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.56 -19.96 47.88 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 N-CA-C 114.834 1.052 . . . . 20.0 114.834 -160.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -42.96 74.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.177 -0.609 . . . . 20.0 110.587 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.59 -48.36 77.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.1 0.476 . . . . 20.0 110.119 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.16 -52.5 60.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.822 0.344 . . . . 20.0 110.723 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.38 -31.88 70.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.528 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -47.96 65.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.97 179.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.69 89.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.004 -0.679 . . . . 20.0 110.757 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.6 -48.0 78.39 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.594 -0.442 . . . . 20.0 110.098 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.46 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.926 -0.31 . . . . 20.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.3 -44.96 77.92 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.257 -0.577 . . . . 20.0 111.072 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.64 72.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.022 -0.671 . . . . 20.0 111.052 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.45 -31.76 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.976 -0.69 . . . . 20.0 111.144 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.63 73.12 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.89 -0.724 . . . . 20.0 110.974 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.5 29.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.334 0.864 . . . . 20.0 113.334 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.77 32.14 13.75 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.717 0.77 . . . . 20.0 111.588 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.3 143.41 34.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.347 -0.983 . . . . 20.0 108.347 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.17 149.38 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.187 0.746 . . . . 20.0 111.353 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.04 148.08 23.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.648 -0.705 . . . . 20.0 109.728 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.97 175.11 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.75 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.851 -1.166 . . . . 20.0 107.851 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.67 43.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.04 25.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.73 12.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.517 0.675 . . . . 20.0 110.28 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.54 21.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.805 -1.089 . . . . 20.0 112.1 165.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.02 20.09 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.993 -0.843 . . . . 20.0 110.993 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.5 144.77 15.55 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.685 -0.758 . . . . 20.0 112.684 -178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.321 -1.112 . . . . 20.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 298' ' ' THR . . . . . . . . . . . . . 20.5 p -110.26 172.83 6.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.002 0.906 . . . . 20.0 111.384 -174.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.81 -33.71 76.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.358 -1.292 . . . . 20.0 111.274 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.36 74.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 -171.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.11 96.81 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.184 -1.007 . . . . 20.0 112.072 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.32 -26.94 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.199 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.83 -34.52 56.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.051 -0.66 . . . . 20.0 110.139 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.297 0.851 . . . . 20.0 113.297 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.74 -8.94 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.717 1.006 . . . . 20.0 113.717 -167.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 306' ' ' THR . . . . . 0.493 ' OG1' ' OE1' ' G' ' 227' ' ' GLU . 0.5 OUTLIER -58.27 157.54 8.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.547 0.689 . . . . 20.0 110.596 171.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' G' G ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.75 -29.85 70.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.314 -0.857 . . . . 20.0 113.309 -160.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.21 66.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.708 -0.797 . . . . 20.0 111.217 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.83 65.08 1.94 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.814 -0.708 . . . . 20.0 113.308 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 310' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.22 139.58 52.56 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 117.626 0.713 . . . . 20.0 111.158 -163.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 311' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -84.47 141.73 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.448 0.838 . . . . 20.0 110.038 168.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.316 -0.856 . . . . 20.0 111.214 -169.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.63 162.57 12.33 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.129 -1.589 . . . . 20.0 109.129 164.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 135.99 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -0.647 . . . . 20.0 110.073 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.28 21.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.618 -1.174 . . . . 20.0 109.252 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.47 133.53 32.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.275 -0.875 . . . . 20.0 109.434 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 317' ' ' VAL . . . . . . . . . . . . . 91.8 t -99.5 108.58 51.34 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.237 -1.394 . . . . 20.0 107.237 177.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -83.25 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 CA-C-O 122.653 1.022 . . . . 20.0 113.644 -155.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.76 35.49 0.15 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 113.562 -1.654 . . . . 20.0 115.304 161.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.66 157.62 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.714 0.769 . . . . 20.0 110.112 176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.1 166.19 11.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 160.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.23 113.58 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.169 0.988 . . . . 20.0 108.441 -163.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 323' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.49 -7.42 3.14 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.49 1.293 . . . . 20.0 114.49 -140.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -59.99 4.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.652 0.612 . . . . 20.0 112.652 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -101.99 -56.13 2.34 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 115.031 1.493 . . . . 20.0 115.031 -152.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.94 50.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.42 -1.326 . . . . 20.0 107.42 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.57 52.78 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.848 -1.524 . . . . 20.0 109.957 -153.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.0 149.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.431 0.634 . . . . 20.0 111.943 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.34 179.4 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.937 0.875 . . . . 20.0 109.464 175.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.604 -1.18 . . . . 20.0 108.903 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.08 -32.01 53.49 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.864 0.727 . . . . 20.0 111.505 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.82 73.39 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.353 -0.539 . . . . 20.0 110.205 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.0 -44.95 83.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.769 -0.372 . . . . 20.0 111.069 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.474 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -34.6 71.28 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 118.785 -1.166 . . . . 20.0 110.12 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.073 -0.651 . . . . 20.0 110.438 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.51 -43.89 80.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.737 0.303 . . . . 20.0 110.912 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 338' ' ' VAL . . . . . 0.699 ' O ' ' OG1' ' G' ' 342' ' ' THR . 42.6 t -60.17 -48.95 86.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 120.958 0.409 . . . . 20.0 110.231 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' G' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.93 74.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.015 0.436 . . . . 20.0 110.752 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.2 37.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.322 -0.399 . . . . 20.0 111.424 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.15 -40.29 89.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.218 -0.593 . . . . 20.0 110.87 -179.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 342' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' G' ' 338' ' ' VAL . 1.3 m -56.52 -45.03 81.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.132 0.491 . . . . 20.0 110.392 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' G' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.44 63.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 119.925 -0.71 . . . . 20.0 110.767 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.48 97.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.58 -0.448 . . . . 20.0 111.135 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.05 -50.41 74.18 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.563 -0.455 . . . . 20.0 110.766 -179.01 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.11 91.15 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.686 -0.806 . . . . 20.0 110.631 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.44 4.78 30.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.444 -0.902 . . . . 20.0 112.48 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.24 -23.66 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 20.0 110.903 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 349' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -63.69 -27.41 69.2 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.277 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.7 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.111 -0.368 . . . . 20.0 111.468 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.71 -28.82 66.15 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' G' G ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.06 -26.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.01 1.856 . . . . 20.0 116.01 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' G' G ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 20.0 108.406 -174.663 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 114.267 1.21 . . . . 20.0 114.267 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.24 2.93 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -62.96 -34.49 66.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.86 -1.064 . . . . 20.0 110.185 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.02 -23.59 12.27 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.568 0.951 . . . . 20.0 113.568 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.3 19.96 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.129 0.971 . . . . 20.0 111.623 -173.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.72 32.42 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 122.303 -0.248 . . . . 20.0 111.251 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.43 37.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.15 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 20.0 110.915 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.69 -31.52 72.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.448 -0.796 . . . . 20.0 111.861 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.19 -45.11 74.33 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.477 -0.489 . . . . 20.0 111.244 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.12 97.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 121.05 -0.26 . . . . 20.0 111.17 -172.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.53 70.96 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.7 -0.4 . . . . 20.0 111.174 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.32 91.18 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.514 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.09 -42.92 91.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.686 -0.234 . . . . 20.0 111.499 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.06 26.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.512 -0.875 . . . . 20.0 110.716 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.1 -32.12 6.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 119.047 -1.061 . . . . 20.0 111.0 -162.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.97 68.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.946 -0.702 . . . . 20.0 111.256 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.43 70.33 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.572 -0.451 . . . . 20.0 109.794 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -85.21 144.76 9.47 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 CA-C-O 121.718 0.632 . . . . 20.0 112.17 -172.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.21 3.42 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 117.272 1.669 . . . . 20.0 117.272 -159.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.122 -1.436 . . . . 20.0 107.122 159.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.23 8.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.41 0.624 . . . . 20.0 110.668 -166.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.472 -0.786 . . . . 20.0 114.019 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.295 1.045 . . . . 20.0 109.584 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.16 4.03 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.86 -1.064 . . . . 20.0 113.417 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' H' ' 28' ' ' GLY . 0.0 OUTLIER -87.93 8.99 23.65 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.702 1.137 . . . . 20.0 113.773 178.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.386 1.624 . . . . 20.0 115.386 -154.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' H' ' 26' ' ' PHE . . . -53.09 -26.91 29.3 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 116.052 1.181 . . . . 20.0 116.052 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.64 -35.76 61.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 118.039 0.92 . . . . 20.0 110.604 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.4 61.61 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.886 0.374 . . . . 20.0 110.425 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.3 -40.6 74.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.309 -0.405 . . . . 20.0 110.967 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.57 82.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.034 0.445 . . . . 20.0 110.357 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.7 86.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 119.711 -0.795 . . . . 20.0 110.273 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.76 -29.46 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 118.736 -1.186 . . . . 20.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.5 -30.98 71.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.036 0.38 . . . . 20.0 111.124 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -86.94 -56.8 3.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.24 -28.43 44.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.481 -0.327 . . . . 20.0 111.536 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.39 63.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.946 -0.702 . . . . 20.0 112.207 -162.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.54 63.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 118.876 -1.13 . . . . 20.0 111.704 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.88 -6.87 23.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.68 22.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.57 88.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.115 -0.948 . . . . 20.0 111.462 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.27 35.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.572 -0.899 . . . . 20.0 108.572 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.49 147.2 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.224 -1.028 . . . . 20.0 108.224 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.15 159.28 44.11 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.513 0.673 . . . . 20.0 110.46 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 46' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.13 128.99 74.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -176.11 5.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.834 0.826 . . . . 20.0 108.882 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.56 62.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.906 -0.718 . . . . 20.0 111.122 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.83 9.26 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.61 83.4 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.113 -0.826 . . . . 20.0 114.462 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.19 151.53 35.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.494 1.147 . . . . 20.0 110.199 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.27 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.314 -1.365 . . . . 20.0 107.314 -174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.81 36.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.647 -0.501 . . . . 20.0 109.647 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.91 99.97 8.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.646 -0.872 . . . . 20.0 108.646 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.6 145.39 31.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.781 -1.563 . . . . 20.0 106.781 163.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.57 154.5 20.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.68 -0.489 . . . . 20.0 109.68 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.1 23.71 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.076 -0.809 . . . . 20.0 111.076 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.19 105.56 10.35 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.915 0.886 . . . . 20.0 109.043 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.56 33.52 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.724 -0.751 . . . . 20.0 114.048 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.347 0 CA-C-O 121.767 0.653 . . . . 20.0 112.06 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.95 111.37 22.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.033 -0.985 . . . . 20.0 109.242 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.98 30.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.76 -0.83 . . . . 20.0 108.76 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.79 124.07 46.33 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.015 0.926 . . . . 20.0 109.009 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 65' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.27 114.26 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.094 -1.076 . . . . 20.0 108.094 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.55 124.6 51.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.256 0.347 . . . . 20.0 111.0 -168.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.58 45.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.935 0.894 . . . . 20.0 108.965 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 68' ' ' HIS . . . . . 0.485 ' NE2' ' OD1' ' H' ' 235' ' ' ASP . 0.0 OUTLIER -104.99 146.44 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 20.0 110.537 177.403 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 21.36 5.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.23 -0.895 . . . . 20.0 109.657 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' H' ' 183' ' ' ASP . 12.0 t0 -97.44 68.01 2.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 121.582 -0.699 . . . . 20.0 112.421 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 144.83 28.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.73 148.82 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.729 0.812 . . . . 20.0 109.176 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.85 -175.72 27.17 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.611 -0.996 . . . . 20.0 110.611 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.01 161.43 26.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.309 0.576 . . . . 20.0 110.0 178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 75' ' ' MET . . . . . . . . . . . . . 10.5 ttm -128.11 131.4 49.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.004 -0.998 . . . . 20.0 109.705 -174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.55 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.858 -0.793 . . . . 20.0 108.858 168.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.07 -29.34 7.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.072 0.767 . . . . 20.0 113.072 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.42 13.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.0 108.96 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.28 5.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.827 0.822 . . . . 20.0 110.007 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -27.01 60.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.661 -0.816 . . . . 20.0 112.732 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.16 4.23 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.332 0.864 . . . . 20.0 113.332 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.79 81.76 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 118.973 -0.904 . . . . 20.0 115.067 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.78 145.02 34.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.372 1.086 . . . . 20.0 110.221 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.29 -0.868 . . . . 20.0 112.602 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.61 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.825 -1.176 . . . . 20.0 107.825 158.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.79 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.598 0.713 . . . . 20.0 109.492 -170.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.23 129.31 15.63 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 115.009 -0.996 . . . . 20.0 109.808 171.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.84 160.2 24.44 Favored 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-O 122.275 0.864 . . . . 20.0 112.749 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 90' ' ' ILE . . . . . . . . . . . . . 9.3 mt -88.72 150.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 113.722 -1.581 . . . . 20.0 107.441 165.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.05 141.0 47.5 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.288 -0.869 . . . . 20.0 112.131 -168.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.16 22.26 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.235 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.672 1.236 . . . . 20.0 109.233 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.91 22.27 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 108.464 -0.939 . . . . 20.0 108.464 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.03 -7.96 13.13 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 CA-C-N 120.598 1.249 . . . . 20.0 114.839 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.19 59.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.201 0.909 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 97' ' ' THR . . . . . . . . . . . . . 44.8 p -89.48 35.5 0.82 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.657 0.783 . . . . 20.0 112.462 178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.25 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.017 1.327 . . . . 20.0 113.364 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.14 156.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.002 -0.74 . . . . 20.0 109.002 174.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.94 -19.0 5.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.702 -1.135 . . . . 20.0 111.262 158.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.37 141.66 2.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.659 -0.867 . . . . 20.0 108.659 176.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.9 74.54 0.38 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.258 1.577 . . . . 20.0 115.258 150.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 103' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' H' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.281 0.946 . . . . 20.0 109.417 160.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.34 37.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 20.0 109.392 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 105' ' ' VAL . . . . . . . . . . . . . 50.3 t -117.49 110.74 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.175 -1.046 . . . . 20.0 108.175 -178.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.54 83.02 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.245 -0.28 . . . . 20.0 110.245 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 107' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.92 -54.22 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 123.334 0.396 . . . . 20.0 110.353 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.403 -0.962 . . . . 20.0 108.403 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.12 126.34 27.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.915 -1.039 . . . . 20.0 110.447 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.25 75.21 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 118.896 -0.946 . . . . 20.0 115.319 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.01 113.99 15.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.483 1.142 . . . . 20.0 108.565 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.3 141.55 37.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.334 -0.617 . . . . 20.0 109.334 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.66 142.49 43.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.69 149.46 31.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.971 -1.013 . . . . 20.0 110.264 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 115' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' H' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.3 -1.12 . . . . 20.0 110.3 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.74 154.39 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.357 -0.979 . . . . 20.0 108.357 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.328 -0.851 . . . . 20.0 114.604 -168.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.15 -48.01 69.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -156.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 121.15 11.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.526 1.057 . . . . 20.0 112.707 -155.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.52 136.13 35.44 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 102.632 -3.099 . . . . 20.0 102.632 159.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.84 11.09 Favored 'Trans proline' 0 C--O 1.239 0.527 0 CA-C-N 120.737 1.299 . . . . 20.0 110.561 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.82 149.81 89.86 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 CA-C-N 119.228 0.76 . . . . 20.0 110.725 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 20.0 109.971 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.194 -1.039 . . . . 20.0 108.194 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.78 19.51 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.779 -0.368 . . . . 20.0 110.708 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.87 -43.66 1.51 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.943 0.897 . . . . 20.0 113.091 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.96 -24.96 59.81 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.849 1.339 . . . . 20.0 112.03 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.57 -26.49 30.01 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 111.753 0.279 . . . . 20.0 111.753 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.97 69.15 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 119.817 -0.753 . . . . 20.0 110.231 168.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.89 62.58 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.943 0.349 . . . . 20.0 111.943 172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.51 90.94 4.5 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.132 0.419 . . . . 20.0 112.132 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.56 87.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 108.502 -0.925 . . . . 20.0 108.502 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.59 75.37 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 CA-C-N 119.647 0.91 . . . . 20.0 112.357 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.6 42.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.494 -1.23 . . . . 20.0 107.957 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -12.19 59.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 118.839 -0.6 . . . . 20.0 112.423 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' H' ' 138' ' ' GLN . 14.1 p30 -55.41 -66.35 0.43 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.355 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 138' ' ' GLN . . . . . 0.409 ' N ' ' OD1' ' H' ' 137' ' ' ASP . 3.9 tp-100 174.62 174.11 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.108 -2.923 . . . . 20.0 103.108 133.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.83 168.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.151 0.98 . . . . 20.0 108.976 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.8 161.47 18.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.958 0.903 . . . . 20.0 110.533 177.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.67 147.5 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -177.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 142' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' H' ' 144' ' ' GLY . 0.5 OUTLIER -119.15 134.74 55.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.633 0.773 . . . . 20.0 109.561 175.196 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.15 7.83 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.88 -0.6 . . . . 20.0 111.795 166.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 144' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' H' ' 142' ' ' ASP . . . 86.89 -6.58 82.79 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 115.467 0.947 . . . . 20.0 115.467 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.16 144.04 53.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.486 1.143 . . . . 20.0 110.314 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.88 33.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.562 0.949 . . . . 20.0 113.562 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.38 162.65 40.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.007 0.908 . . . . 20.0 111.406 -173.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.49 80.5 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.862 -1.517 . . . . 20.0 111.245 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.38 -47.05 87.76 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.788 -0.365 . . . . 20.0 110.941 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.32 -35.19 76.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.523 -0.471 . . . . 20.0 110.834 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.58 84.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.03 -0.668 . . . . 20.0 111.105 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.35 58.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.394 -0.922 . . . . 20.0 110.971 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.78 -29.99 66.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.765 -0.774 . . . . 20.0 110.609 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.56 92.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.567 -0.453 . . . . 20.0 111.701 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.76 6.71 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.901 -0.944 . . . . 20.0 114.589 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 118.462 1.131 . . . . 20.0 108.544 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.99 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.756 -1.202 . . . . 20.0 107.756 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.33 147.26 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.47 169.33 15.78 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.776 -1.729 . . . . 20.0 108.776 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 113.58 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 165.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.65 -20.07 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 113.736 1.013 . . . . 20.0 113.736 -166.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.66 155.62 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.708 -0.62 . . . . 20.0 111.757 -159.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' H' ' 164' ' ' TRP . 3.5 t -145.3 -166.35 2.41 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.331 1.052 . . . . 20.0 110.492 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' H' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.87 16.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.23 0.826 . . . . 20.0 113.23 -160.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 165' ' ' ASP . . . . . 0.428 ' O ' ' NE2' ' F' ' 101' ' ' GLN . 7.5 t70 63.63 61.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 20.0 112.291 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.88 158.63 29.58 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.113 -1.195 . . . . 20.0 110.113 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.42 148.36 37.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 170.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.04 117.64 30.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.128 -0.942 . . . . 20.0 110.168 -167.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.45 159.8 35.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.882 0.848 . . . . 20.0 110.011 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.38 117.21 34.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.294 -1.321 . . . . 20.0 109.491 -173.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.57 29.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.493 -0.558 . . . . 20.0 109.493 168.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' H' ' 175' ' ' ARG . . . 56.96 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.89 4.26 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.823 0.675 . . . . 20.0 112.823 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.01 1.29 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.202 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' H' ' 172' ' ' GLY . 6.8 ptt-85 -169.78 121.94 0.7 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.635 0.652 . . . . 20.0 112.663 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.829 2.452 . . . . 20.0 106.218 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.68 145.76 20.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.492 -0.929 . . . . 20.0 108.492 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.47 1.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 116.395 1.998 . . . . 20.0 116.395 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.752 0.706 . . . . 20.0 112.076 -170.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.73 37.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.58 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.601 0.637 . . . . 20.0 111.778 -162.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.26 127.84 32.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.06 0.933 . . . . 20.0 110.711 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' H' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.301 1.44 . . . . 20.0 113.181 174.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.183 0.992 . . . . 20.0 110.805 157.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.517 -2.401 . . . . 20.0 104.517 149.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 186' ' ' ALA . . . . . 0.723 ' O ' ' OG1' ' H' ' 189' ' ' THR . . . -50.12 -42.98 51.57 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.306 -0.861 . . . . 20.0 111.511 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -35.99 76.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.129 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.86 -38.64 91.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.131 -1.027 . . . . 20.0 110.486 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 189' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' H' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.489 -0.885 . . . . 20.0 110.824 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.25 -50.55 63.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 20.0 110.553 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.12 96.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.052 -0.659 . . . . 20.0 110.958 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.52 84.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.945 -0.702 . . . . 20.0 110.317 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.59 -44.75 97.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.035 0.445 . . . . 20.0 110.14 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.26 75.37 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.243 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.64 -38.18 70.75 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.757 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.65 -26.16 41.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.56 122.8 27.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.265 -0.643 . . . . 20.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.1 2.32 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.286 0.366 . . . . 20.0 110.119 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.34 17.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.729 -0.471 . . . . 20.0 109.729 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.3 4.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.161 -0.681 . . . . 20.0 109.161 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.8 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.965 -0.694 . . . . 20.0 111.344 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.84 141.72 30.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.91 -0.774 . . . . 20.0 108.91 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 203' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' H' ' 203' ' ' ASP . 0.0 OUTLIER -78.65 112.97 16.29 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.456 -0.942 . . . . 20.0 108.456 -174.47 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.53 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.578 -0.897 . . . . 20.0 108.578 -170.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 205' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -128.88 106.64 9.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.009 -0.737 . . . . 20.0 109.009 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.88 125.37 31.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.77 5.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.437 -1.32 . . . . 20.0 107.437 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.77 159.94 19.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.879 0.847 . . . . 20.0 111.15 -165.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.83 166.46 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.217 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.17 29.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.485 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.52 13.96 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.388 -0.525 . . . . 20.0 111.007 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -20.41 64.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.215 -0.594 . . . . 20.0 111.46 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.12 121.17 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.564 -0.902 . . . . 20.0 108.564 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.672 -1.251 . . . . 20.0 111.423 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.0 -25.59 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.473 0.916 . . . . 20.0 113.473 -179.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.48 -4.52 2.85 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.32 0.489 . . . . 20.0 112.32 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.69 -40.53 41.0 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 119.728 -1.225 . . . . 20.0 111.979 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 219' ' ' ALA . . . . . 0.463 ' O ' ' OG ' ' H' ' 222' ' ' SER . . . -65.25 -37.05 86.03 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.29 -0.535 . . . . 20.0 111.365 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.75 -36.66 58.23 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.184 0.439 . . . . 20.0 112.184 -174.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.43 -45.83 87.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.883 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 222' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' H' ' 219' ' ' ALA . 2.1 p -58.0 -35.85 71.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.405 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.66 -49.93 69.41 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.21 -33.39 75.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.842 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.72 74.98 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 118.962 -1.589 . . . . 20.0 112.102 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 226' ' ' ILE . . . . . . . . . . . . . 25.0 mm -126.97 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.033 0.383 . . . . 20.0 112.033 -158.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 227' ' ' GLU . . . . . 0.49 ' OE1' ' OG1' ' H' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 118.182 2.66 . . . . 20.0 118.182 -158.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 228' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -43.86 143.65 2.89 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 N-CA-C 115.982 1.493 . . . . 20.0 115.982 -134.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.17 -4.68 0.77 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.254 1.422 . . . . 20.0 113.389 162.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.24 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.116 -0.634 . . . . 20.0 111.784 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.43 16.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.919 -0.658 . . . . 20.0 112.289 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.44 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.777 0.831 . . . . 20.0 108.812 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.68 149.1 23.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.201 0.524 . . . . 20.0 110.348 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.24 90.46 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.503 -1.295 . . . . 20.0 107.503 172.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 235' ' ' ASP . . . . . 0.485 ' OD1' ' NE2' ' H' ' 68' ' ' HIS . 25.6 t0 -135.21 173.19 11.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.905 -1.517 . . . . 20.0 106.905 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.13 149.41 14.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.674 0.749 . . . . 20.0 111.424 -173.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.62 122.69 1.45 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 164.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 238' ' ' ILE . . . . . . . . . . . . . 18.0 mm -145.44 151.93 14.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 -161.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.23 9.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.846 -1.539 . . . . 20.0 106.846 159.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.0 18.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.032 0.752 . . . . 20.0 113.032 -155.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.35 36.11 22.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.896 1.278 . . . . 20.0 112.504 158.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.95 128.46 78.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 105.167 -2.16 . . . . 20.0 105.167 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.57 12.08 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 120.816 1.327 . . . . 20.0 112.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.47 -5.38 45.0 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.097 -0.956 . . . . 20.0 114.92 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.13 164.54 22.91 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 118.618 1.209 . . . . 20.0 110.664 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.05 -172.66 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.593 0 CA-C-O 121.825 0.677 . . . . 20.0 111.949 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.88 59.56 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.765 -1.107 . . . . 20.0 112.003 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.68 63.13 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.908 -0.717 . . . . 20.0 112.847 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 249' ' ' LYS . . . . . 0.71 ' O ' ' OG1' ' H' ' 252' ' ' THR . 16.9 mttt -98.73 -15.24 19.41 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 170.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.84 88.88 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.337 -0.545 . . . . 20.0 111.328 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.62 -20.96 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.038 -1.065 . . . . 20.0 111.896 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 252' ' ' THR . . . . . 0.71 ' OG1' ' O ' ' H' ' 249' ' ' LYS . 39.4 p -57.14 -31.85 65.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.497 0.59 . . . . 20.0 111.339 173.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.37 132.04 4.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.313 0.578 . . . . 20.0 110.448 176.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.4 -1.24 3.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.001 -1.0 . . . . 20.0 112.289 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 126.134 1.826 . . . . 20.0 111.515 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.24 10.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -167.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.25 3.33 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-O 122.695 1.164 . . . . 20.0 113.354 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.11 6.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' H' ' 316' ' ' SER . . . -126.44 120.3 29.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.104 -0.953 . . . . 20.0 109.381 -169.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 260' ' ' ILE . . . . . . . . . . . . . 85.4 mt -98.01 139.98 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.787 -1.19 . . . . 20.0 107.787 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.91 122.64 42.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 -177.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.71 -40.32 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.844 -0.616 . . . . 20.0 109.653 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.55 147.56 34.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.433 0.635 . . . . 20.0 109.324 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.9 2.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.748 -1.114 . . . . 20.0 108.248 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.0 -56.27 21.56 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.827 -0.624 . . . . 20.0 110.272 163.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.14 11.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -165.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.66 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.158 -1.793 . . . . 20.0 106.158 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.08 56.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.207 0.527 . . . . 20.0 111.303 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.73 2.02 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.162 -0.926 . . . . 20.0 108.673 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.54 -19.98 47.95 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 N-CA-C 114.798 1.038 . . . . 20.0 114.798 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -43.03 74.71 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.587 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.5 -48.37 77.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.111 0.481 . . . . 20.0 110.121 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.2 -52.51 59.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.798 0.332 . . . . 20.0 110.657 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.35 -31.92 70.78 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 20.0 110.568 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -47.96 65.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.061 -0.655 . . . . 20.0 110.983 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.05 -38.74 89.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.73 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.59 -47.94 78.46 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.561 -0.456 . . . . 20.0 110.143 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.86 -40.42 88.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.828 -0.349 . . . . 20.0 110.68 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.92 78.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.281 -0.568 . . . . 20.0 111.141 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.67 72.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.001 -0.679 . . . . 20.0 111.021 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.86 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.035 -0.666 . . . . 20.0 111.141 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.69 73.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.872 -0.731 . . . . 20.0 110.989 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.58 15.48 29.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.362 0.875 . . . . 20.0 113.362 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.78 32.14 13.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.709 0.766 . . . . 20.0 111.574 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.39 34.46 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.305 -0.998 . . . . 20.0 108.305 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.17 149.31 13.44 Favored 'Trans proline' 0 CA--C 1.517 -0.375 0 CA-C-N 119.167 0.738 . . . . 20.0 111.409 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.99 148.19 23.46 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.652 -0.704 . . . . 20.0 109.687 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.15 5.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.69 113.71 17.04 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.877 -1.157 . . . . 20.0 107.877 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.03 157.05 25.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.505 0.669 . . . . 20.0 110.261 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.58 21.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.176 165.055 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.0 20.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.45 144.74 15.55 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.666 -0.767 . . . . 20.0 112.704 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.57 4.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.338 -1.105 . . . . 20.0 110.338 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 298' ' ' THR . . . . . . . . . . . . . 20.2 p -110.28 172.88 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.038 0.923 . . . . 20.0 111.374 -174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.69 76.61 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.346 -1.297 . . . . 20.0 111.281 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.3 74.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 111.815 0.302 . . . . 20.0 111.815 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.21 96.85 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.192 -1.004 . . . . 20.0 112.058 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.28 -26.9 65.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.201 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.48 56.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.119 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -14.17 60.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.341 0.867 . . . . 20.0 113.341 -174.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.76 -8.89 19.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -167.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 306' ' ' THR . . . . . 0.49 ' OG1' ' OE1' ' H' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.54 8.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.523 0.677 . . . . 20.0 110.558 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' H' H ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.82 70.35 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -161.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.93 -25.23 66.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.183 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.06 1.95 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.805 -0.712 . . . . 20.0 113.317 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.21 139.61 52.61 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 117.598 0.699 . . . . 20.0 111.128 -163.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 311' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -84.49 141.67 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.568 0 CA-C-N 119.51 0.861 . . . . 20.0 110.041 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.43 135.81 32.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.314 -0.857 . . . . 20.0 111.212 -169.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.55 12.34 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.183 -1.567 . . . . 20.0 109.183 164.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.39 136.07 27.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.9 -0.65 . . . . 20.0 110.087 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -104.04 153.2 21.15 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.246 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' H' ' 259' ' ' ALA . 4.2 m -138.46 133.54 32.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.258 -0.883 . . . . 20.0 109.452 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 317' ' ' VAL . . . . . . . . . . . . . 92.6 t -99.43 108.58 51.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.276 -1.379 . . . . 20.0 107.276 177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.96 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.642 1.018 . . . . 20.0 113.593 -154.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.73 35.52 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.537 -1.665 . . . . 20.0 115.313 161.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.64 157.55 33.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.733 0.778 . . . . 20.0 110.091 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.08 166.13 11.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.825 -1.546 . . . . 20.0 106.825 160.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.14 113.61 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.156 0.982 . . . . 20.0 108.462 -163.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.53 -7.42 3.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.442 1.275 . . . . 20.0 114.442 -140.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.682 0.623 . . . . 20.0 112.682 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -101.98 -56.23 2.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 114.963 1.468 . . . . 20.0 114.963 -152.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 151.02 50.82 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.62 52.82 1.41 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.834 -1.53 . . . . 20.0 109.911 -153.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.06 149.43 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.392 0.615 . . . . 20.0 111.981 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.927 0.87 . . . . 20.0 109.462 175.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.57 119.16 27.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.617 -1.174 . . . . 20.0 108.87 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.0 -32.12 53.15 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.793 0.683 . . . . 20.0 111.519 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.8 73.52 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.324 -0.55 . . . . 20.0 110.202 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.02 -44.95 83.24 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.761 -0.376 . . . . 20.0 111.025 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.26 92.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.44 -0.504 . . . . 20.0 110.55 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 118.853 -1.139 . . . . 20.0 110.112 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.37 93.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.072 -0.651 . . . . 20.0 110.458 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.81 80.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.698 0.285 . . . . 20.0 110.889 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 338' ' ' VAL . . . . . 0.704 ' O ' ' OG1' ' H' ' 342' ' ' THR . 42.5 t -60.16 -49.05 85.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.02 0.438 . . . . 20.0 110.221 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 339' ' ' GLU . . . . . 0.793 ' OE1' ' NZ ' ' H' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.92 74.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.951 0.405 . . . . 20.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -55.13 38.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.355 -0.384 . . . . 20.0 111.414 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.2 -40.34 89.71 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.2 -0.6 . . . . 20.0 110.828 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 342' ' ' THR . . . . . 0.704 ' OG1' ' O ' ' H' ' 338' ' ' VAL . 1.3 m -56.47 -45.03 81.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.136 0.493 . . . . 20.0 110.437 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 343' ' ' LYS . . . . . 0.793 ' NZ ' ' OE1' ' H' ' 339' ' ' GLU . 34.6 mttp -74.16 -37.45 63.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 119.937 -0.705 . . . . 20.0 110.821 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.49 97.73 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.589 -0.444 . . . . 20.0 111.128 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.04 -50.45 74.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.613 -0.435 . . . . 20.0 110.769 -179.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.65 -39.12 91.07 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.725 -0.79 . . . . 20.0 110.554 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 347' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -84.46 4.8 30.04 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.449 -0.9 . . . . 20.0 112.56 -178.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.22 -23.64 33.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.82 -27.28 69.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.775 -0.77 . . . . 20.0 111.238 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.89 -18.79 31.79 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 122.077 -0.389 . . . . 20.0 111.484 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -28.75 65.98 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.142 0.423 . . . . 20.0 112.142 -173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' H' H ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.15 -26.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.016 1.858 . . . . 20.0 116.016 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' H' H ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.977 1.311 . . . . 20.0 108.402 -174.69 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 114.25 1.204 . . . . 20.0 114.25 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.27 2.91 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.902 -1.518 . . . . 20.0 106.902 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -63.03 -34.45 66.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.895 -1.048 . . . . 20.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.96 -23.56 12.3 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 113.653 0.983 . . . . 20.0 113.653 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.111 0.965 . . . . 20.0 111.65 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.78 32.34 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.758 0.254 . . . . 20.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.05 117.46 37.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.15 12.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.324 0.583 . . . . 20.0 110.958 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.65 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.45 -0.795 . . . . 20.0 111.888 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.15 -45.2 74.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.236 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.04 97.39 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 121.06 -0.256 . . . . 20.0 111.196 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -30.65 71.0 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.79 -0.364 . . . . 20.0 111.158 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -46.44 90.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.616 -0.434 . . . . 20.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -58.96 -42.97 91.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.648 -0.251 . . . . 20.0 111.564 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.03 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 119.492 -0.883 . . . . 20.0 110.713 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 119.007 -1.077 . . . . 20.0 110.966 -162.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -25.98 68.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.945 -0.702 . . . . 20.0 111.284 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.41 70.56 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 120.522 -0.471 . . . . 20.0 109.83 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 19' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -85.09 144.7 9.59 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 C-N-CA 120.32 0.68 . . . . 20.0 112.216 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.91 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 117.309 1.684 . . . . 20.0 117.309 -159.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.14 -1.43 . . . . 20.0 107.14 159.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.15 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 20.0 110.696 -166.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.29 2.89 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.478 -0.783 . . . . 20.0 113.988 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.42 0.17 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.312 1.053 . . . . 20.0 109.567 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.14 3.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.888 -1.051 . . . . 20.0 113.434 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' I' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.02 23.69 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.738 1.153 . . . . 20.0 113.732 178.535 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 11.34 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.419 1.637 . . . . 20.0 115.419 -154.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' I' ' 26' ' ' PHE . . . -53.13 -26.93 29.63 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.752 1.16 . . . . 20.0 115.996 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.57 -35.81 61.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 118.062 0.931 . . . . 20.0 110.618 -178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.22 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.951 0.405 . . . . 20.0 110.428 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.299 -0.41 . . . . 20.0 110.945 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.25 -49.58 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 20.0 110.288 -174.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.71 86.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.711 -0.796 . . . . 20.0 110.32 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.72 -29.5 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 118.735 -1.186 . . . . 20.0 111.134 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.44 -31.03 71.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.996 0.362 . . . . 20.0 111.131 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.96 -56.68 3.27 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.174 0.435 . . . . 20.0 112.174 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.46 44.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.53 -0.305 . . . . 20.0 111.539 -164.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -26.37 63.69 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.922 -0.711 . . . . 20.0 112.254 -162.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.14 -23.48 63.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 118.879 -1.128 . . . . 20.0 111.735 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.9 -6.93 22.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.493 0.923 . . . . 20.0 113.493 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.61 152.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -66.08 -42.59 89.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.16 -0.927 . . . . 20.0 111.529 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.64 158.28 35.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.519 -0.919 . . . . 20.0 108.519 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.21 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.208 -1.034 . . . . 20.0 108.208 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.19 159.21 44.18 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.527 0.68 . . . . 20.0 110.429 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.03 129.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.358 -1.349 . . . . 20.0 107.358 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.09 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.784 0.802 . . . . 20.0 108.893 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.59 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.923 -0.711 . . . . 20.0 111.105 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.86 9.16 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-O 119.151 -0.805 . . . . 20.0 114.51 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.47 35.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.481 1.141 . . . . 20.0 110.221 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.33 140.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.187 -1.412 . . . . 20.0 107.187 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 53' ' ' ILE . . . . . . . . . . . . . 31.1 mm -130.22 115.65 33.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.296 -1.372 . . . . 20.0 107.296 -174.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.79 36.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.668 -0.493 . . . . 20.0 109.668 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.97 99.97 8.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.615 -0.883 . . . . 20.0 108.615 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.53 145.37 31.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.804 -1.554 . . . . 20.0 106.804 163.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.522 0.514 . . . . 20.0 109.667 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.41 -161.09 23.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.117 -0.793 . . . . 20.0 111.117 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.66 10.45 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.88 0.872 . . . . 20.0 108.997 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.53 33.49 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.075 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.78 165.24 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.763 0.651 . . . . 20.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.94 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.973 -1.012 . . . . 20.0 109.231 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 63' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.73 137.88 30.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.784 -0.821 . . . . 20.0 108.784 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.7 124.1 46.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.039 0.936 . . . . 20.0 109.049 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.27 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.07 -1.085 . . . . 20.0 108.07 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.53 124.58 51.39 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.295 0.372 . . . . 20.0 111.015 -168.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.9 0.88 . . . . 20.0 108.925 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 68' ' ' HIS . . . . . 0.49 ' NE2' ' OD1' ' I' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 20.0 110.52 177.415 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.16 -0.927 . . . . 20.0 109.705 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' I' ' 183' ' ' ASP . 12.0 t0 -97.42 68.04 2.14 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.622 -0.673 . . . . 20.0 112.434 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.88 28.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.77 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.758 0.823 . . . . 20.0 109.123 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.79 -175.72 27.12 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.553 -1.019 . . . . 20.0 110.553 173.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 74' ' ' LEU . . . . . . . . . . . . . 5.1 mt -125.03 161.45 26.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.33 0.586 . . . . 20.0 109.989 178.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.12 131.35 49.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.227 1.011 . . . . 20.0 109.696 -174.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.49 137.11 23.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.38 7.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.091 0.774 . . . . 20.0 113.091 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.98 174.45 13.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.127 -1.064 . . . . 20.0 108.127 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.06 108.9 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.72 166.28 5.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.806 0.812 . . . . 20.0 109.999 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -27.02 60.33 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.632 -0.827 . . . . 20.0 112.72 -169.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.47 9.11 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.36 0.874 . . . . 20.0 113.36 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.83 81.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 118.944 -0.92 . . . . 20.0 115.062 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.83 145.02 34.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.351 1.075 . . . . 20.0 110.208 178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.86 142.5 28.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.588 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.6 6.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.855 -1.165 . . . . 20.0 107.855 158.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.84 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.64 0.733 . . . . 20.0 109.478 -170.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 129.27 15.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.772 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.79 160.24 24.61 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 CA-C-O 122.31 0.879 . . . . 20.0 112.734 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.81 150.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 113.703 -1.59 . . . . 20.0 107.373 165.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.09 140.94 47.56 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.114 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.2 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 118.96 -0.911 . . . . 20.0 115.216 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.88 152.63 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.67 1.235 . . . . 20.0 109.227 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.68 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.42 -0.955 . . . . 20.0 108.42 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.14 -7.98 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 CA-C-N 120.626 1.259 . . . . 20.0 114.78 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.22 -15.18 59.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.207 0.912 . . . . 20.0 111.83 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.51 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.668 0.787 . . . . 20.0 112.406 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.25 -66.41 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.973 1.309 . . . . 20.0 113.429 -173.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.24 156.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.043 -0.725 . . . . 20.0 109.043 174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.91 -19.0 5.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.642 -1.163 . . . . 20.0 111.275 158.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.34 141.7 2.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.666 -0.864 . . . . 20.0 108.666 176.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.87 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 115.239 1.57 . . . . 20.0 115.239 150.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' I' ' 115' ' ' GLY . 0.5 OUTLIER -79.39 134.23 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.298 0.954 . . . . 20.0 109.369 160.432 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.75 140.27 37.25 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.492 -0.776 . . . . 20.0 109.425 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 105' ' ' VAL . . . . . . . . . . . . . 50.2 t -117.43 110.74 32.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.56 83.07 6.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.2 -0.296 . . . . 20.0 110.2 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.94 -54.24 14.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 O-C-N 123.373 0.42 . . . . 20.0 110.321 170.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.55 10.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.11 126.3 27.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 20.0 110.458 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-O 118.842 -0.977 . . . . 20.0 115.326 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.07 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.464 1.132 . . . . 20.0 108.524 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.29 141.56 37.76 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.69 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.39 31.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.287 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' I' ' 103' ' ' PHE . . . -147.9 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.307 -1.117 . . . . 20.0 110.307 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.75 154.43 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.374 -0.973 . . . . 20.0 108.374 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.27 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.331 -0.85 . . . . 20.0 114.559 -168.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.16 -47.95 69.46 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -156.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.13 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.513 1.051 . . . . 20.0 112.694 -155.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.16 35.45 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.218 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.8 11.05 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 120.749 1.303 . . . . 20.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.77 149.75 90.04 Favored 'Trans proline' 0 C--O 1.233 0.27 0 CA-C-N 119.209 0.753 . . . . 20.0 110.731 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.11 165.37 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.811 0.815 . . . . 20.0 109.984 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.235 -1.024 . . . . 20.0 108.235 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.88 19.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.861 0.362 . . . . 20.0 110.715 169.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.73 1.5 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.001 0.921 . . . . 20.0 113.068 -170.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -24.86 59.6 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 120.849 1.339 . . . . 20.0 112.015 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 -26.53 30.0 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 111.799 0.296 . . . . 20.0 111.799 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.97 69.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.821 -0.751 . . . . 20.0 110.206 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.97 62.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.913 0.338 . . . . 20.0 111.913 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.44 90.93 4.46 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.199 -0.667 . . . . 20.0 109.199 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.33 7.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.16 142.57 87.45 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.56 75.49 Favored 'Trans proline' 0 C--N 1.326 -0.605 0 CA-C-N 119.661 0.915 . . . . 20.0 112.387 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.64 42.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.561 -1.199 . . . . 20.0 107.943 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 118.826 -0.607 . . . . 20.0 112.382 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' I' ' 138' ' ' GLN . 14.0 p30 -55.42 -66.34 0.43 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.927 -0.558 . . . . 20.0 111.392 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 138' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' I' ' 137' ' ' ASP . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 103.124 -2.917 . . . . 20.0 103.124 133.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.85 168.07 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.138 0.975 . . . . 20.0 108.952 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.47 18.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.956 0.902 . . . . 20.0 110.455 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 141' ' ' ILE . . . . . . . . . . . . . 30.2 mt -124.63 147.51 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.606 -0.887 . . . . 20.0 108.606 -177.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' I' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.79 54.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 20.0 109.618 175.117 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.22 7.87 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 123.701 0.626 . . . . 20.0 111.781 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' I' ' 142' ' ' ASP . . . 86.83 -6.55 82.73 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 115.504 0.962 . . . . 20.0 115.504 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.0 54.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.462 1.131 . . . . 20.0 110.305 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.36 -20.9 33.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.558 0.947 . . . . 20.0 113.558 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.41 162.63 40.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.994 0.902 . . . . 20.0 111.4 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.42 -41.48 80.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.832 -1.531 . . . . 20.0 111.278 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.34 -47.02 87.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.818 -0.353 . . . . 20.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.38 -35.14 76.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.487 -0.485 . . . . 20.0 110.806 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.64 84.24 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.107 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.77 -23.27 58.5 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.359 -0.936 . . . . 20.0 111.008 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.77 -30.02 66.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.78 -0.768 . . . . 20.0 110.622 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.6 -40.55 92.23 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.545 -0.462 . . . . 20.0 111.676 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.75 6.71 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.566 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.78 133.52 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 118.485 1.143 . . . . 20.0 108.565 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.85 175.95 9.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.737 -1.209 . . . . 20.0 107.737 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.22 147.29 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.733 -1.747 . . . . 20.0 108.733 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.39 113.59 17.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 165.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.7 -20.03 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.68 155.61 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 121.64 -0.663 . . . . 20.0 111.776 -159.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 163' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' I' ' 164' ' ' TRP . 3.5 t -145.31 -166.29 2.39 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.279 1.032 . . . . 20.0 110.514 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 164' ' ' TRP . . . . . 0.561 ' N ' ' OG1' ' I' ' 163' ' ' THR . 2.5 t-105 -100.82 -17.92 16.67 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.228 0.825 . . . . 20.0 113.228 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 165' ' ' ASP . . . . . 0.45 ' O ' ' NE2' ' K' ' 101' ' ' GLN . 7.5 t70 63.72 61.71 0.97 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.827 -0.545 . . . . 20.0 112.284 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.93 158.62 29.52 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.134 -1.186 . . . . 20.0 110.134 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.43 148.32 37.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.722 -1.214 . . . . 20.0 107.722 170.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.63 30.47 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.145 -0.934 . . . . 20.0 110.191 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -129.42 159.76 35.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.896 0.855 . . . . 20.0 109.986 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.4 117.15 34.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.268 -1.333 . . . . 20.0 109.508 -173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.88 151.61 28.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.521 -0.548 . . . . 20.0 109.521 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' I' ' 175' ' ' ARG . . . 56.97 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.215 -1.554 . . . . 20.0 109.215 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.773 0.657 . . . . 20.0 112.773 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.703 -0.799 . . . . 20.0 111.236 157.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' I' ' 172' ' ' GLY . 6.8 ptt-85 -169.8 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.609 0.64 . . . . 20.0 112.634 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.49 169.4 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 127.836 2.454 . . . . 20.0 106.213 157.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.7 145.82 20.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.418 -0.956 . . . . 20.0 108.418 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.17 -64.44 1.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.736 0.698 . . . . 20.0 112.094 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.15 -0.65 36.9 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 181' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -84.67 -66.93 0.84 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.606 0.639 . . . . 20.0 111.768 -162.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.24 127.86 32.84 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.069 0.938 . . . . 20.0 110.715 -152.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' I' ' 70' ' ' ASP . 0.6 OUTLIER 69.94 -6.73 1.03 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.374 1.47 . . . . 20.0 113.199 174.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.78 83.87 1.16 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.155 0.978 . . . . 20.0 110.805 157.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.524 -2.399 . . . . 20.0 104.524 149.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 186' ' ' ALA . . . . . 0.723 ' O ' ' OG1' ' I' ' 189' ' ' THR . . . -50.2 -42.88 52.18 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.336 -0.847 . . . . 20.0 111.536 173.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.05 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.096 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.84 -38.62 91.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.173 -1.011 . . . . 20.0 110.471 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 189' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' I' ' 186' ' ' ALA . 25.2 p -59.14 -48.56 81.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.456 -0.898 . . . . 20.0 110.886 172.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.59 63.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.954 0.407 . . . . 20.0 110.53 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.03 -43.21 96.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.058 -0.657 . . . . 20.0 111.0 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.85 -36.56 84.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 119.955 -0.698 . . . . 20.0 110.329 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.55 -44.82 97.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.081 0.467 . . . . 20.0 110.104 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.36 75.59 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.28 -0.568 . . . . 20.0 111.171 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.14 70.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.854 -0.738 . . . . 20.0 110.799 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.15 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.538 0.57 . . . . 20.0 112.538 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.75 27.4 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.349 -0.612 . . . . 20.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.38 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.323 0.389 . . . . 20.0 110.135 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.37 17.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.7 -0.482 . . . . 20.0 109.7 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.26 4.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.18 -0.674 . . . . 20.0 109.18 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.5 59.92 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.985 -0.686 . . . . 20.0 111.378 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.67 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.894 -0.78 . . . . 20.0 108.894 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 203' ' ' ASP . . . . . 0.657 ' N ' ' OD1' ' I' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.05 16.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.451 -0.944 . . . . 20.0 108.451 -174.475 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.53 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.557 -0.905 . . . . 20.0 108.557 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.89 106.67 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.004 -0.739 . . . . 20.0 109.004 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -83.0 125.42 31.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.709 -0.849 . . . . 20.0 108.709 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.92 150.22 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.848 -0.797 . . . . 20.0 108.848 174.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.8 5.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.87 159.98 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.872 0.844 . . . . 20.0 111.075 -165.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.44 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.648 -1.16 . . . . 20.0 108.236 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.16 29.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.502 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.84 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.347 -0.541 . . . . 20.0 110.928 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -20.36 64.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.468 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 214' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.11 121.11 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.12 60.9 6.26 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.397 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.03 -25.53 0.84 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.501 0.926 . . . . 20.0 113.501 -179.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.5 2.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.347 0.499 . . . . 20.0 112.347 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.58 40.89 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 119.739 -1.22 . . . . 20.0 111.969 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 219' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' I' ' 222' ' ' SER . . . -65.26 -36.97 85.76 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.307 -0.525 . . . . 20.0 111.41 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 220' ' ' ARG . . . . . . . . . . . . . 16.5 ttm180 -52.76 -36.75 58.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -174.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 221' ' ' THR . . . . . . . . . . . . . 74.9 p -58.4 -45.79 87.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.866 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 222' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' I' ' 219' ' ' ALA . 2.1 p -58.04 -35.81 71.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.8 -0.36 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.97 69.3 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.56 0.578 . . . . 20.0 112.56 -169.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 224' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.23 -33.36 75.63 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 20.0 111.804 -165.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.99 -16.72 75.0 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.091 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.97 -45.67 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 111.985 0.365 . . . . 20.0 111.985 -158.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 227' ' ' GLU . . . . . 0.5 ' OE1' ' OG1' ' I' ' 306' ' ' THR . 3.0 pt-20 -56.36 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 228' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -43.86 143.73 2.85 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.977 1.491 . . . . 20.0 115.977 -134.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.12 -4.73 0.78 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.283 1.433 . . . . 20.0 113.382 162.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.105 -0.638 . . . . 20.0 111.774 167.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.46 151.46 16.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.928 -0.653 . . . . 20.0 112.266 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.72 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.817 0.847 . . . . 20.0 108.797 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.65 149.03 23.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.438 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.15 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 235' ' ' ASP . . . . . 0.49 ' OD1' ' NE2' ' I' ' 68' ' ' HIS . 25.4 t0 -135.16 173.25 11.93 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.981 -1.488 . . . . 20.0 106.981 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.636 0.732 . . . . 20.0 111.447 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.64 122.68 1.45 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.356 -1.35 . . . . 20.0 107.356 164.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 238' ' ' ILE . . . . . . . . . . . . . 18.0 mm -145.48 151.85 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.249 -1.019 . . . . 20.0 108.249 -161.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.19 105.2 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 158.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.47 110.01 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.37 36.18 22.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.959 1.304 . . . . 20.0 112.463 158.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.97 128.45 78.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.16 -2.163 . . . . 20.0 105.16 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.57 12.05 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 120.857 1.342 . . . . 20.0 112.369 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.28 44.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.081 -0.963 . . . . 20.0 114.904 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 245' ' ' THR . . . . . . . . . . . . . 33.6 p -92.09 164.56 22.89 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 118.643 1.221 . . . . 20.0 110.724 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.05 -172.61 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.569 0 CA-C-O 121.893 0.706 . . . . 20.0 111.925 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.725 -1.125 . . . . 20.0 111.992 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 248' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -70.22 -18.71 63.17 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.824 -0.751 . . . . 20.0 112.882 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 249' ' ' LYS . . . . . 0.715 ' O ' ' OG1' ' I' ' 252' ' ' THR . 16.9 mttt -98.76 -15.13 19.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.87 89.02 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.306 -0.558 . . . . 20.0 111.337 -172.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.087 -1.045 . . . . 20.0 111.88 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 252' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' I' ' 249' ' ' LYS . 39.5 p -57.11 -31.85 65.71 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.467 0.576 . . . . 20.0 111.352 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.39 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.317 0.58 . . . . 20.0 110.382 176.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.39 -1.31 3.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.974 -1.012 . . . . 20.0 112.306 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.37 35.9 5.83 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 126.151 1.834 . . . . 20.0 111.566 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.22 10.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 -167.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.15 174.23 3.42 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-O 122.695 1.164 . . . . 20.0 113.307 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.79 175.16 6.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' I' ' 316' ' ' SER . . . -126.4 120.3 29.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.122 -0.944 . . . . 20.0 109.399 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.01 139.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.89 122.59 42.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.971 -0.751 . . . . 20.0 108.971 -177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.22 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.876 -0.602 . . . . 20.0 109.647 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.63 147.52 34.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.35 -0.611 . . . . 20.0 109.35 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.94 2.85 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.804 -1.089 . . . . 20.0 108.243 165.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.822 -0.626 . . . . 20.0 110.261 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -46.17 11.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -165.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.77 143.67 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 20.0 109.373 -163.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.28 104.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.117 -1.808 . . . . 20.0 106.117 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 269' ' ' CYS . . . . . . . . . . . . . 69.5 m -66.29 137.02 56.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.214 0.53 . . . . 20.0 111.379 -171.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.03 109.66 1.97 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.211 -0.904 . . . . 20.0 108.72 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.47 -19.98 48.4 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.832 1.051 . . . . 20.0 114.832 -160.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -43.01 74.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.11 -0.636 . . . . 20.0 110.579 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 273' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.55 -48.33 77.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.098 0.475 . . . . 20.0 110.123 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.21 -52.47 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 120.82 0.343 . . . . 20.0 110.674 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.38 -31.92 70.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.509 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.47 -48.0 65.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.01 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.01 -38.73 89.73 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.046 -0.662 . . . . 20.0 110.759 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -48.0 78.5 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.624 -0.431 . . . . 20.0 110.037 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.45 88.36 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.701 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.31 -44.91 78.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.292 -0.563 . . . . 20.0 111.109 -172.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.008 -0.677 . . . . 20.0 111.032 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.48 -31.76 65.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.118 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.73 73.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.898 -0.721 . . . . 20.0 110.976 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.55 15.42 29.3 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.324 0.861 . . . . 20.0 113.324 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.82 32.16 13.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.733 0.778 . . . . 20.0 111.586 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.33 143.41 34.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.3 -1.0 . . . . 20.0 108.3 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 287' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.21 149.33 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 119.193 0.747 . . . . 20.0 111.346 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 148.14 23.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.636 -0.711 . . . . 20.0 109.689 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.94 175.13 5.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.71 -1.219 . . . . 20.0 107.71 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.63 113.78 17.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.882 -1.155 . . . . 20.0 107.882 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.65 43.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.447 -0.575 . . . . 20.0 109.447 -172.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.02 157.03 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.68 -1.23 . . . . 20.0 107.68 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.72 12.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.517 0.675 . . . . 20.0 110.282 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.81 -18.53 21.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.814 -1.085 . . . . 20.0 112.117 165.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.6 -176.01 20.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.99 -0.844 . . . . 20.0 110.99 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.47 144.79 15.6 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.638 -0.781 . . . . 20.0 112.691 -178.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.51 4.06 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.36 -1.096 . . . . 20.0 110.36 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 298' ' ' THR . . . . . . . . . . . . . 20.4 p -110.23 172.92 6.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.004 0.907 . . . . 20.0 111.397 -174.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.95 -33.63 76.49 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.37 -1.286 . . . . 20.0 111.264 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 -35.4 74.19 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 111.777 0.288 . . . . 20.0 111.777 -171.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.22 96.85 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.211 -0.995 . . . . 20.0 112.032 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.2 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.193 -0.603 . . . . 20.0 111.215 179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.84 -34.49 56.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 120.044 -0.662 . . . . 20.0 110.171 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.23 60.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.309 0.855 . . . . 20.0 113.309 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.74 -8.93 19.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -167.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 306' ' ' THR . . . . . 0.5 ' OG1' ' OE1' ' I' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.708 . . . . 20.0 110.572 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' I' I ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.62 -29.92 70.36 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.378 0.881 . . . . 20.0 113.378 -161.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.17 66.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.664 -0.814 . . . . 20.0 111.236 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.701 . . . . 20.0 113.332 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 310' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.37 139.61 52.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.571 0.686 . . . . 20.0 111.105 -163.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.47 141.71 9.04 Favored 'Trans proline' 0 CA--C 1.513 -0.538 0 CA-C-N 119.453 0.84 . . . . 20.0 110.058 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.47 135.79 32.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.31 -0.859 . . . . 20.0 111.212 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.56 12.34 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 109.161 -1.576 . . . . 20.0 109.161 164.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.06 27.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.465 0.65 . . . . 20.0 110.066 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.05 153.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.622 -1.172 . . . . 20.0 109.211 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' I' ' 259' ' ' ALA . 4.2 m -138.46 133.51 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.256 -0.884 . . . . 20.0 109.459 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 317' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.46 108.56 51.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.245 -1.391 . . . . 20.0 107.245 177.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.638 1.016 . . . . 20.0 113.614 -154.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.8 35.44 0.15 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.29 161.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.59 157.62 33.56 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.712 0.768 . . . . 20.0 110.082 176.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.805 -1.554 . . . . 20.0 106.805 160.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.23 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.196 0.999 . . . . 20.0 108.383 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.56 -7.41 3.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.5 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.642 0.608 . . . . 20.0 112.642 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -102.03 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.017 1.488 . . . . 20.0 115.017 -152.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.97 50.79 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.447 -1.316 . . . . 20.0 107.447 174.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.57 52.81 1.42 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.849 -1.523 . . . . 20.0 109.932 -153.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.09 149.44 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.429 0.633 . . . . 20.0 111.919 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.37 179.44 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.909 0.862 . . . . 20.0 109.463 175.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.56 119.19 27.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.614 -1.175 . . . . 20.0 108.85 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.12 -32.07 53.98 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.821 0.7 . . . . 20.0 111.449 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 332' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -68.66 -44.77 73.38 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.167 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.04 -44.9 83.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.074 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.64 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.497 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.836 -1.146 . . . . 20.0 110.096 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.413 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.55 -43.83 80.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.79 0.329 . . . . 20.0 110.917 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 338' ' ' VAL . . . . . 0.699 ' O ' ' OG1' ' I' ' 342' ' ' THR . 42.5 t -60.24 -48.91 86.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.956 0.407 . . . . 20.0 110.23 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' I' ' 343' ' ' LYS . 1.3 mm-40 -54.81 -46.96 74.59 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.028 0.442 . . . . 20.0 110.738 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -55.16 37.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.363 -0.38 . . . . 20.0 111.414 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.14 -40.34 89.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.864 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 342' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' I' ' 338' ' ' VAL . 1.3 m -56.57 -44.93 81.48 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.112 0.482 . . . . 20.0 110.42 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' I' ' 339' ' ' GLU . 34.6 mttp -74.21 -37.5 63.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 119.967 -0.693 . . . . 20.0 110.726 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.582 -0.447 . . . . 20.0 111.142 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.02 -50.44 74.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.577 -0.449 . . . . 20.0 110.801 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.03 90.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.668 -0.813 . . . . 20.0 110.619 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.54 4.84 30.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.517 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.22 -23.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.539 -0.864 . . . . 20.0 110.883 179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.76 -27.37 69.15 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.756 -0.778 . . . . 20.0 111.211 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.84 -18.8 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.159 -0.338 . . . . 20.0 111.493 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.81 -28.75 65.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.129 0.418 . . . . 20.0 112.129 -173.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' I' I ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.13 -26.66 0.1 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.038 1.866 . . . . 20.0 116.038 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' I' I ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.007 1.323 . . . . 20.0 108.401 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 114.293 1.22 . . . . 20.0 114.293 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.13 2.91 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.934 -1.506 . . . . 20.0 106.934 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.87 -34.52 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.917 -1.038 . . . . 20.0 110.223 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.99 -23.52 12.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.44 30.27 19.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.123 0.969 . . . . 20.0 111.621 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -38.71 32.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.785 0.266 . . . . 20.0 111.207 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.09 117.45 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.667 -1.234 . . . . 20.0 107.667 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.21 12.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 20.0 110.919 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.76 -31.49 72.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.448 -0.797 . . . . 20.0 111.884 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.12 -45.21 74.27 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.553 -0.459 . . . . 20.0 111.233 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -43.13 97.29 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.985 -0.286 . . . . 20.0 111.18 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.5 70.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.719 -0.392 . . . . 20.0 111.184 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.41 90.71 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.02 -42.95 91.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.639 -0.255 . . . . 20.0 111.545 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.08 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.518 -0.873 . . . . 20.0 110.645 -171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 119.03 -1.068 . . . . 20.0 111.029 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -26.0 68.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 119.937 -0.705 . . . . 20.0 111.291 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.95 160.39 70.2 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 120.489 -0.484 . . . . 20.0 109.822 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 19' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.11 144.77 9.58 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.287 0.658 . . . . 20.0 112.158 -172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.97 38.23 3.41 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 117.248 1.659 . . . . 20.0 117.248 -159.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.83 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 159.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.23 8.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.333 0.587 . . . . 20.0 110.721 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.91 -33.25 2.88 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.525 -0.762 . . . . 20.0 114.051 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.34 0.17 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.305 1.05 . . . . 20.0 109.515 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.14 4.0 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.836 -1.075 . . . . 20.0 113.438 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 26' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' J' ' 28' ' ' GLY . 0.0 OUTLIER -88.05 9.06 23.78 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 119.699 1.136 . . . . 20.0 113.705 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.27 0.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' J' ' 26' ' ' PHE . . . -53.08 -26.94 29.31 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 116.025 1.17 . . . . 20.0 116.025 -172.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.58 -35.79 61.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 118.079 0.939 . . . . 20.0 110.621 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.29 -52.46 61.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.902 0.382 . . . . 20.0 110.396 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.6 74.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.287 -0.415 . . . . 20.0 110.963 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.26 -49.55 82.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.031 0.443 . . . . 20.0 110.287 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.27 -39.71 86.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.729 -0.788 . . . . 20.0 110.304 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.78 -29.48 20.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 118.724 -1.19 . . . . 20.0 111.09 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.47 -30.97 71.64 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.979 0.354 . . . . 20.0 111.144 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.94 -56.69 3.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.243 0.46 . . . . 20.0 112.243 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.33 -28.44 44.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.447 -0.342 . . . . 20.0 111.521 -164.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.44 63.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.911 -0.716 . . . . 20.0 112.202 -162.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.05 -23.52 63.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 118.914 -1.115 . . . . 20.0 111.744 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.9 -6.92 22.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.62 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.544 -0.91 . . . . 20.0 108.544 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.6 88.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.175 -0.92 . . . . 20.0 111.467 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.3 35.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.524 -0.917 . . . . 20.0 108.524 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.16 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.233 -1.025 . . . . 20.0 108.233 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.13 159.26 44.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.438 0.637 . . . . 20.0 110.466 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.399 -1.334 . . . . 20.0 107.399 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -176.16 5.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.789 0.804 . . . . 20.0 108.929 177.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.57 62.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.908 -0.717 . . . . 20.0 111.145 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.89 9.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.718 1.007 . . . . 20.0 113.718 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.51 -6.7 83.31 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.138 -0.812 . . . . 20.0 114.483 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.47 35.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.433 1.117 . . . . 20.0 110.245 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.42 140.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mm -130.23 115.62 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.91 119.85 36.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.639 -0.504 . . . . 20.0 109.639 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 100.0 8.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.565 -0.902 . . . . 20.0 108.565 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.742 -1.577 . . . . 20.0 106.742 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.525 0.516 . . . . 20.0 109.667 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.13 23.82 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.13 -0.788 . . . . 20.0 111.13 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.08 105.62 10.44 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.892 0.877 . . . . 20.0 109.039 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.04 -168.52 33.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.064 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.77 165.2 32.89 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.78 0.658 . . . . 20.0 112.08 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 62' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -91.94 111.37 22.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.001 -0.999 . . . . 20.0 109.207 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.69 137.92 30.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.773 -0.825 . . . . 20.0 108.773 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.08 46.36 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.038 0.935 . . . . 20.0 109.034 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.31 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.57 51.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 123.285 0.366 . . . . 20.0 110.977 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.857 0.863 . . . . 20.0 108.942 167.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' J' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.45 29.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.963 -0.562 . . . . 20.0 110.523 177.46 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.27 5.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.257 -0.883 . . . . 20.0 109.702 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' J' ' 183' ' ' ASP . 12.1 t0 -97.42 68.01 2.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.649 -0.657 . . . . 20.0 112.439 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.85 28.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.743 0.817 . . . . 20.0 109.133 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.82 -175.72 27.14 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.591 -1.004 . . . . 20.0 110.591 173.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.01 161.48 26.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.295 0.569 . . . . 20.0 110.038 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.12 131.34 49.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.208 1.003 . . . . 20.0 109.711 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.49 137.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.85 -0.796 . . . . 20.0 108.85 168.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.15 -29.33 7.0 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.09 0.774 . . . . 20.0 113.09 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.46 13.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.118 -1.068 . . . . 20.0 108.118 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.96 19.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.369 -0.974 . . . . 20.0 108.369 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 166.29 5.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.798 0.808 . . . . 20.0 109.986 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.08 60.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 119.724 -0.79 . . . . 20.0 112.691 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.5 9.16 4.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.356 0.873 . . . . 20.0 113.356 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.69 81.9 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.006 -0.886 . . . . 20.0 115.106 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 84' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -107.72 145.01 34.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.379 1.09 . . . . 20.0 110.262 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.85 142.48 28.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.305 -0.862 . . . . 20.0 112.571 -172.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.46 174.66 6.56 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.85 -1.167 . . . . 20.0 107.85 158.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.77 163.79 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.606 0.717 . . . . 20.0 109.47 -170.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.26 129.31 15.59 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.804 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.85 160.24 24.41 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 CA-C-O 122.358 0.899 . . . . 20.0 112.693 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 90' ' ' ILE . . . . . . . . . . . . . 9.3 mt -88.76 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.716 -1.584 . . . . 20.0 107.376 165.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.91 47.55 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.263 -0.881 . . . . 20.0 112.172 -168.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.19 22.06 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.983 -0.898 . . . . 20.0 115.219 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.78 152.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.659 1.229 . . . . 20.0 109.27 -169.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.99 22.19 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.431 -0.952 . . . . 20.0 108.431 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.1 -7.89 13.07 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 CA-C-N 120.574 1.241 . . . . 20.0 114.822 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.28 -15.2 59.69 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.192 0.905 . . . . 20.0 111.792 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 97' ' ' THR . . . . . . . . . . . . . 44.8 p -89.53 35.55 0.82 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.62 0.768 . . . . 20.0 112.422 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.21 -66.5 0.37 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.984 1.314 . . . . 20.0 113.389 -173.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.14 156.11 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.98 -0.748 . . . . 20.0 108.98 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.96 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 20.0 111.253 157.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.93 74.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.22 1.563 . . . . 20.0 115.22 150.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 103' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' J' ' 115' ' ' GLY . 0.5 OUTLIER -79.31 134.21 36.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.257 0.935 . . . . 20.0 109.415 160.406 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.81 140.35 37.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.502 -0.772 . . . . 20.0 109.378 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 105' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.42 110.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 106' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.63 83.09 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.209 -0.293 . . . . 20.0 110.209 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.26 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 O-C-N 123.327 0.392 . . . . 20.0 110.278 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.53 177.5 10.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.437 -0.949 . . . . 20.0 108.437 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.03 126.29 27.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.93 -1.032 . . . . 20.0 110.505 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.23 75.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.88 -0.956 . . . . 20.0 115.328 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.0 114.01 15.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.489 1.144 . . . . 20.0 108.565 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.53 37.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.346 -0.612 . . . . 20.0 109.346 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.57 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.698 -0.853 . . . . 20.0 108.698 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.7 149.45 31.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 115' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' J' ' 103' ' ' PHE . . . -147.95 157.76 27.46 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.336 -1.106 . . . . 20.0 110.336 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.42 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.371 -0.974 . . . . 20.0 108.371 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.324 -0.853 . . . . 20.0 114.552 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.9 69.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.405 1.261 . . . . 20.0 114.405 -156.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.17 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.515 1.052 . . . . 20.0 112.646 -155.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.13 35.38 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 102.602 -3.11 . . . . 20.0 102.602 159.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.79 11.02 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 120.711 1.29 . . . . 20.0 110.596 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.78 149.8 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.279 0 CA-C-N 119.199 0.75 . . . . 20.0 110.663 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.08 165.38 7.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.831 0.824 . . . . 20.0 109.945 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.82 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.191 -1.04 . . . . 20.0 108.191 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.79 19.69 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.826 -0.35 . . . . 20.0 110.765 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.83 -43.77 1.52 Allowed Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 124.03 0.932 . . . . 20.0 113.06 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.98 -24.91 59.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 120.861 1.343 . . . . 20.0 112.012 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 128' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -83.53 -26.51 30.07 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.795 0.294 . . . . 20.0 111.795 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -32.02 69.16 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 119.847 -0.741 . . . . 20.0 110.247 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.71 -36.91 62.71 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.969 0.359 . . . . 20.0 111.969 172.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.47 90.97 4.48 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.235 -0.654 . . . . 20.0 109.235 174.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.21 14.34 7.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.088 0.403 . . . . 20.0 112.088 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.25 142.57 87.22 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 108.495 -0.928 . . . . 20.0 108.495 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.73 153.67 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.621 0.9 . . . . 20.0 112.334 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.61 42.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.561 -1.2 . . . . 20.0 107.898 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.62 -12.3 59.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.838 -0.601 . . . . 20.0 112.374 -175.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' J' ' 138' ' ' GLN . 14.1 p30 -55.35 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.918 -0.563 . . . . 20.0 111.378 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 138' ' ' GLN . . . . . 0.419 ' N ' ' OD1' ' J' ' 137' ' ' ASP . 3.9 tp-100 174.69 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 103.087 -2.931 . . . . 20.0 103.087 133.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.84 168.14 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.097 0.959 . . . . 20.0 108.964 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.5 18.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.962 0.905 . . . . 20.0 110.507 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.69 147.47 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -177.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 142' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' J' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.75 55.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.631 0.773 . . . . 20.0 109.609 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.8 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.669 0.606 . . . . 20.0 111.816 166.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 144' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' J' ' 142' ' ' ASP . . . 86.89 -6.61 82.73 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.05 143.93 54.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.469 1.134 . . . . 20.0 110.323 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.24 -20.99 33.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 113.63 0.974 . . . . 20.0 113.63 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.66 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.987 0.898 . . . . 20.0 111.395 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.39 -41.53 80.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.847 -1.524 . . . . 20.0 111.207 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.4 -47.02 87.9 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.834 -0.346 . . . . 20.0 110.981 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.29 -35.18 76.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.509 -0.476 . . . . 20.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.56 83.94 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.066 -0.654 . . . . 20.0 111.086 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.36 58.49 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.445 -0.902 . . . . 20.0 110.984 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.05 66.49 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.747 -0.781 . . . . 20.0 110.661 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.63 92.26 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.662 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.07 -8.64 6.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.965 -0.908 . . . . 20.0 114.651 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.76 133.52 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 118.452 1.126 . . . . 20.0 108.545 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.94 9.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.72 -1.215 . . . . 20.0 107.72 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.31 15.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 108.853 -1.699 . . . . 20.0 108.853 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.44 113.58 17.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -20.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 113.72 1.008 . . . . 20.0 113.72 -166.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.67 155.64 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.66 -0.65 . . . . 20.0 111.744 -159.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 163' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' J' ' 164' ' ' TRP . 3.5 t -145.36 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.286 1.034 . . . . 20.0 110.421 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 164' ' ' TRP . . . . . 0.552 ' N ' ' OG1' ' J' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.89 16.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.207 0.817 . . . . 20.0 113.207 -160.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 165' ' ' ASP . . . . . 0.425 ' O ' ' NE2' ' L' ' 101' ' ' GLN . 7.5 t70 63.68 61.73 0.97 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.214 0.531 . . . . 20.0 112.261 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.92 158.62 29.53 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.05 -1.22 . . . . 20.0 110.05 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.44 148.33 37.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 170.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.61 30.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.06 -0.973 . . . . 20.0 110.199 -167.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.858 0.837 . . . . 20.0 110.024 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.45 117.23 34.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.258 -1.337 . . . . 20.0 109.476 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.58 29.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.53 -0.545 . . . . 20.0 109.53 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' J' ' 175' ' ' ARG . . . 56.93 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.194 -1.562 . . . . 20.0 109.194 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.88 4.22 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.811 0.671 . . . . 20.0 112.811 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.97 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.681 -0.808 . . . . 20.0 111.215 157.378 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 175' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' J' ' 172' ' ' GLY . 6.8 ptt-85 -169.86 121.94 0.69 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.595 0.634 . . . . 20.0 112.621 172.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.845 2.458 . . . . 20.0 106.234 157.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 177' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.71 145.76 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.438 -0.949 . . . . 20.0 108.438 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.08 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 116.467 2.025 . . . . 20.0 116.467 -166.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.707 0.685 . . . . 20.0 112.117 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.05 -0.73 36.83 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.369 1.248 . . . . 20.0 114.369 -170.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.7 -66.93 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.6 0.636 . . . . 20.0 111.717 -162.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.27 127.84 32.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.058 0.932 . . . . 20.0 110.697 -152.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' J' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.48 . . . . 20.0 113.149 174.653 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.74 83.83 1.16 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.152 0.977 . . . . 20.0 110.801 157.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.03 -41.14 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.518 -2.401 . . . . 20.0 104.518 149.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' J' ' 189' ' ' THR . . . -50.08 -42.97 51.12 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.324 -0.853 . . . . 20.0 111.504 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.12 76.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 119.254 -0.979 . . . . 20.0 110.084 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.159 -1.017 . . . . 20.0 110.492 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' J' ' 186' ' ' ALA . 25.4 p -59.12 -48.63 80.91 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.843 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.26 -50.54 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.897 0.38 . . . . 20.0 110.494 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.1 -43.13 96.28 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.987 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.96 -36.54 84.32 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.995 -0.682 . . . . 20.0 110.256 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 193' ' ' VAL . . . . . . . . . . . . . 11.6 t -60.53 -44.83 97.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.05 0.453 . . . . 20.0 110.091 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.37 75.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.234 -0.586 . . . . 20.0 111.187 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.53 -38.21 71.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.859 -0.737 . . . . 20.0 110.812 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.67 -26.13 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.556 0.576 . . . . 20.0 112.556 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.56 122.82 27.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.303 -0.628 . . . . 20.0 109.303 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.275 0.359 . . . . 20.0 110.133 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.41 17.56 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.72 -0.474 . . . . 20.0 109.72 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.03 91.32 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.188 -0.671 . . . . 20.0 109.188 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.55 59.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.034 -0.666 . . . . 20.0 111.343 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.961 -0.755 . . . . 20.0 108.961 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 203' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' J' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.04 16.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 -174.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.99 151.6 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.91 106.56 8.98 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.038 -0.727 . . . . 20.0 109.038 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.89 125.37 31.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.757 -0.831 . . . . 20.0 108.757 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.9 150.21 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.873 -0.788 . . . . 20.0 108.873 174.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.414 -1.328 . . . . 20.0 107.414 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.86 160.0 19.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.912 0.863 . . . . 20.0 111.1 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.87 166.43 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 114.635 -1.166 . . . . 20.0 108.213 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.18 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.472 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.53 13.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.333 -0.547 . . . . 20.0 110.999 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -20.41 64.81 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.542 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 214' ' ' VAL . . . . . . . . . . . . . 88.4 t -131.14 121.13 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.58 -0.896 . . . . 20.0 108.58 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.97 6.22 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.686 -1.245 . . . . 20.0 111.453 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.02 -25.57 0.84 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.461 0.911 . . . . 20.0 113.461 -179.123 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.46 2.83 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.382 0.512 . . . . 20.0 112.382 173.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.53 40.92 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 119.736 -1.221 . . . . 20.0 112.024 168.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 219' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' J' ' 222' ' ' SER . . . -65.24 -37.1 86.18 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.25 -0.559 . . . . 20.0 111.341 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.72 -36.72 58.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.157 0.429 . . . . 20.0 112.157 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.47 -45.79 87.93 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.056 -0.658 . . . . 20.0 110.862 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 222' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' J' ' 219' ' ' ALA . 2.1 p -58.08 -35.74 71.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.724 -0.39 . . . . 20.0 111.44 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.98 69.33 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.558 0.577 . . . . 20.0 112.558 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.11 -33.45 75.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.802 -0.759 . . . . 20.0 111.833 -165.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.72 74.94 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 118.95 -1.595 . . . . 20.0 112.124 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.57 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 111.999 0.37 . . . . 20.0 111.999 -158.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 227' ' ' GLU . . . . . 0.499 ' OE1' ' OG1' ' J' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 118.214 2.672 . . . . 20.0 118.214 -158.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.989 1.496 . . . . 20.0 115.989 -134.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.277 1.431 . . . . 20.0 113.376 162.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.85 171.27 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.079 -0.649 . . . . 20.0 111.793 167.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.44 16.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.95 -0.643 . . . . 20.0 112.311 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.72 170.76 15.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.768 -0.827 . . . . 20.0 108.768 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.05 23.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.124 -0.489 . . . . 20.0 110.393 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 234' ' ' ILE . . . . . . . . . . . . . 51.7 mt -133.22 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.492 -1.299 . . . . 20.0 107.492 172.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' J' ' 68' ' ' HIS . 25.5 t0 -135.21 173.23 11.95 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.93 -1.507 . . . . 20.0 106.93 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.42 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.672 0.749 . . . . 20.0 111.394 -172.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.66 122.69 1.44 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.315 -1.365 . . . . 20.0 107.315 164.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.48 151.91 14.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.2 9.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.831 -1.544 . . . . 20.0 106.831 159.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 109.98 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.057 0.762 . . . . 20.0 113.057 -155.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.37 36.19 22.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.0 1.32 . . . . 20.0 112.459 158.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.96 128.4 79.01 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.152 -2.166 . . . . 20.0 105.152 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.96 165.54 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 CA-C-N 120.834 1.334 . . . . 20.0 112.373 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.32 45.0 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.046 -0.979 . . . . 20.0 114.939 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.609 1.205 . . . . 20.0 110.663 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.66 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.592 0 CA-C-O 121.841 0.684 . . . . 20.0 111.957 171.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.037 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.7 63.12 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 119.862 -0.735 . . . . 20.0 112.868 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 249' ' ' LYS . . . . . 0.726 ' O ' ' OG1' ' J' ' 252' ' ' THR . 16.9 mttt -98.7 -15.26 19.44 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.247 0.832 . . . . 20.0 113.247 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -37.86 88.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.277 -0.569 . . . . 20.0 111.382 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.59 -21.03 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.122 -1.031 . . . . 20.0 111.859 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 252' ' ' THR . . . . . 0.726 ' OG1' ' O ' ' J' ' 249' ' ' LYS . 39.4 p -57.12 -31.87 65.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.485 0.584 . . . . 20.0 111.307 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.33 132.09 4.54 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.317 0.58 . . . . 20.0 110.374 176.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.3 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.038 -0.983 . . . . 20.0 112.308 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 35.94 5.84 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 126.133 1.825 . . . . 20.0 111.583 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.28 10.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.618 -0.882 . . . . 20.0 108.618 -167.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.22 3.32 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-O 122.706 1.17 . . . . 20.0 113.316 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.1 6.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.543 -0.91 . . . . 20.0 108.543 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.37 120.32 29.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.175 -0.92 . . . . 20.0 109.45 -169.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.97 140.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.819 -1.178 . . . . 20.0 107.819 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.88 122.58 42.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.978 -0.749 . . . . 20.0 108.978 -177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.27 10.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 20.0 109.6 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.64 147.58 34.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.434 0.635 . . . . 20.0 109.324 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.764 -1.107 . . . . 20.0 108.197 165.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.22 22.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.766 -0.652 . . . . 20.0 110.257 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.21 11.51 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.619 0.97 . . . . 20.0 113.619 -165.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.8 143.68 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.391 -0.596 . . . . 20.0 109.391 -163.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.131 -1.803 . . . . 20.0 106.131 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.41 137.06 56.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 20.0 111.314 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.97 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 115.165 -0.925 . . . . 20.0 108.695 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.53 -19.96 48.02 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 N-CA-C 114.819 1.046 . . . . 20.0 114.819 -160.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -42.97 74.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.117 -0.633 . . . . 20.0 110.585 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.57 -48.36 77.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.103 0.478 . . . . 20.0 110.083 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.17 -52.44 60.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.833 0.349 . . . . 20.0 110.7 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.45 -31.85 70.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.823 -0.751 . . . . 20.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.53 -47.94 65.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.097 -0.641 . . . . 20.0 110.997 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.76 89.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.991 -0.683 . . . . 20.0 110.746 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.56 -47.99 78.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.113 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.81 -40.44 88.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.873 -0.331 . . . . 20.0 110.712 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.063 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.018 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.81 65.85 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.147 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.67 73.28 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.849 -0.741 . . . . 20.0 111.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.58 15.4 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.325 0.861 . . . . 20.0 113.325 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.2 13.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.732 0.777 . . . . 20.0 111.564 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.31 143.36 34.32 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.341 -0.985 . . . . 20.0 108.341 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.15 149.39 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.161 0.736 . . . . 20.0 111.37 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.19 23.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.599 0.714 . . . . 20.0 109.657 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.05 175.1 5.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.74 17.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.856 -1.165 . . . . 20.0 107.856 168.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.463 -0.569 . . . . 20.0 109.463 -172.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.01 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.7 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.473 0.654 . . . . 20.0 110.31 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.49 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.816 -1.084 . . . . 20.0 112.166 165.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.01 20.08 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.982 -0.847 . . . . 20.0 110.982 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.47 144.82 15.63 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.653 -0.773 . . . . 20.0 112.664 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.33 -1.108 . . . . 20.0 110.33 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 298' ' ' THR . . . . . . . . . . . . . 20.3 p -110.31 172.87 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.011 0.91 . . . . 20.0 111.357 -174.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.75 76.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.397 -1.274 . . . . 20.0 111.229 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.37 74.08 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.784 0.29 . . . . 20.0 111.784 -171.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.2 96.9 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.234 -0.984 . . . . 20.0 111.994 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.88 65.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.226 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.44 55.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 119.997 -0.681 . . . . 20.0 110.179 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.17 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.283 0.846 . . . . 20.0 113.283 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.71 -8.91 19.52 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.761 1.023 . . . . 20.0 113.761 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 306' ' ' THR . . . . . 0.499 ' OG1' ' OE1' ' J' ' 227' ' ' GLU . 0.5 OUTLIER -58.34 157.6 8.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.609 0.719 . . . . 20.0 110.537 171.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' J' J ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.88 70.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.215 -0.902 . . . . 20.0 113.357 -161.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.84 -25.24 66.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.693 -0.803 . . . . 20.0 111.238 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.19 1.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.857 -0.687 . . . . 20.0 113.311 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 310' ' ' VAL . . . . . . . . . . . . . 20.4 t -80.35 139.64 52.09 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.593 0.697 . . . . 20.0 111.092 -163.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.49 141.75 9.03 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 CA-C-N 119.479 0.85 . . . . 20.0 110.011 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.55 135.82 32.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.302 -0.863 . . . . 20.0 111.192 -169.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.57 12.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.189 -1.564 . . . . 20.0 109.189 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.02 27.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.455 0.645 . . . . 20.0 110.112 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.05 153.22 21.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.648 -1.16 . . . . 20.0 109.203 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.42 133.53 32.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.455 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 317' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.43 108.57 51.13 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.262 -1.384 . . . . 20.0 107.262 177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.3 -169.03 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-O 122.652 1.022 . . . . 20.0 113.624 -154.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.86 35.45 0.15 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.565 -1.652 . . . . 20.0 115.271 161.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.65 157.57 33.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.709 0.766 . . . . 20.0 110.12 176.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.07 166.17 11.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.779 -1.563 . . . . 20.0 106.779 160.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.2 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.113 0.965 . . . . 20.0 108.446 -163.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.39 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.488 1.292 . . . . 20.0 114.488 -140.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.48 -60.06 4.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.618 0.599 . . . . 20.0 112.618 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 325' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -101.94 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.01 1.485 . . . . 20.0 115.01 -152.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.97 50.8 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.451 -1.314 . . . . 20.0 107.451 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.6 52.88 1.41 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.826 -1.534 . . . . 20.0 109.905 -153.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.08 149.41 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.395 0.617 . . . . 20.0 111.951 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.41 179.42 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.929 0.871 . . . . 20.0 109.419 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.17 27.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.597 -1.183 . . . . 20.0 108.853 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.13 -32.07 54.11 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.839 0.712 . . . . 20.0 111.442 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.76 73.48 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.319 -0.552 . . . . 20.0 110.198 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -65.98 -44.97 83.31 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.784 -0.366 . . . . 20.0 111.066 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.31 92.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 120.452 -0.499 . . . . 20.0 110.491 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.69 71.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 118.859 -1.137 . . . . 20.0 110.155 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.46 93.35 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.085 -0.646 . . . . 20.0 110.425 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.51 -43.84 80.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.751 0.31 . . . . 20.0 110.903 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 338' ' ' VAL . . . . . 0.691 ' O ' ' OG1' ' J' ' 342' ' ' THR . 42.7 t -60.17 -48.98 85.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 120.99 0.424 . . . . 20.0 110.279 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' J' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.91 74.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.934 0.397 . . . . 20.0 110.765 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -55.13 38.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.367 -0.379 . . . . 20.0 111.436 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.21 -40.3 89.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.811 -179.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 342' ' ' THR . . . . . 0.691 ' OG1' ' O ' ' J' ' 338' ' ' VAL . 1.3 m -56.49 -44.99 81.21 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.122 0.487 . . . . 20.0 110.438 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' J' ' 339' ' ' GLU . 34.6 mttp -74.2 -37.49 63.89 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.968 -0.693 . . . . 20.0 110.795 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.5 97.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.595 -0.442 . . . . 20.0 111.095 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.03 -50.42 74.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.56 -0.456 . . . . 20.0 110.775 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.09 91.13 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.704 -0.798 . . . . 20.0 110.605 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.49 4.79 30.21 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.457 -0.897 . . . . 20.0 112.485 -178.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.23 -23.65 33.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 119.111 0.869 . . . . 20.0 110.902 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.3 69.09 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.263 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.9 -18.81 31.71 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.082 -0.387 . . . . 20.0 111.49 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -28.78 66.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' J' J ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.044 1.868 . . . . 20.0 116.044 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' J' J ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.999 1.319 . . . . 20.0 108.385 -174.671 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 114.282 1.216 . . . . 20.0 114.282 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.08 82.23 2.92 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.916 -1.512 . . . . 20.0 106.916 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -62.87 -34.56 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.862 -1.063 . . . . 20.0 110.222 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -106.97 -23.59 12.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.564 0.95 . . . . 20.0 113.564 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.49 30.28 19.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.093 0.957 . . . . 20.0 111.615 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.75 32.37 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.725 0.238 . . . . 20.0 111.237 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.07 117.44 37.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.673 -1.232 . . . . 20.0 107.673 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.97 112.16 12.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.365 0.602 . . . . 20.0 110.899 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.489 -0.778 . . . . 20.0 111.902 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 10' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.13 -45.26 74.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.557 -0.457 . . . . 20.0 111.217 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -43.11 97.34 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 121.007 -0.277 . . . . 20.0 111.165 -172.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.802 -0.359 . . . . 20.0 111.2 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.569 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.02 -42.94 91.39 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.659 -0.246 . . . . 20.0 111.531 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.9 -40.08 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 119.516 -0.874 . . . . 20.0 110.7 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 119.0 -1.08 . . . . 20.0 111.009 -162.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 67.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.907 -0.717 . . . . 20.0 111.306 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.38 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 120.533 -0.467 . . . . 20.0 109.798 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.13 144.68 9.53 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 120.32 0.68 . . . . 20.0 112.155 -172.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.19 3.43 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.312 1.685 . . . . 20.0 117.312 -159.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.72 119.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 159.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.391 0.615 . . . . 20.0 110.683 -166.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.28 2.88 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.488 -0.778 . . . . 20.0 114.043 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.28 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 20.0 109.561 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.95 -13.18 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.865 -1.061 . . . . 20.0 113.455 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 26' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' K' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.04 23.6 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.713 1.142 . . . . 20.0 113.717 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 11.36 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.422 1.638 . . . . 20.0 115.422 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' K' ' 26' ' ' PHE . . . -53.2 -26.82 29.82 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.793 1.179 . . . . 20.0 116.021 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.61 -35.86 61.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 118.088 0.944 . . . . 20.0 110.63 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.21 -52.43 61.29 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.935 0.398 . . . . 20.0 110.466 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.62 74.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.284 -0.416 . . . . 20.0 110.944 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.59 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.088 0.47 . . . . 20.0 110.358 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.71 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.286 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.68 -29.53 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 118.776 -1.17 . . . . 20.0 111.144 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.46 -31.01 71.67 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.995 0.361 . . . . 20.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.89 -56.77 3.24 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.189 0.441 . . . . 20.0 112.189 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.44 44.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.487 -0.324 . . . . 20.0 111.526 -164.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.4 63.72 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.858 -0.737 . . . . 20.0 112.255 -162.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.06 -23.49 63.1 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 118.861 -1.135 . . . . 20.0 111.75 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.89 -6.99 22.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.49 152.64 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.61 88.88 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.201 -0.908 . . . . 20.0 111.48 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.31 35.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.539 -0.911 . . . . 20.0 108.539 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.18 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.248 -1.019 . . . . 20.0 108.248 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.27 44.11 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.46 0.648 . . . . 20.0 110.46 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.12 128.97 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.371 -1.344 . . . . 20.0 107.371 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.874 0.845 . . . . 20.0 108.858 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.63 -34.56 62.8 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.098 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.14 10.87 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.671 0.989 . . . . 20.0 113.671 -171.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.63 83.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.112 -0.827 . . . . 20.0 114.481 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.475 1.137 . . . . 20.0 110.237 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.4 140.23 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 53' ' ' ILE . . . . . . . . . . . . . 31.3 mm -130.17 115.68 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.312 -1.366 . . . . 20.0 107.312 -174.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.76 36.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.656 -0.498 . . . . 20.0 109.656 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.92 100.0 8.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.774 -1.565 . . . . 20.0 106.774 163.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.5 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.661 -0.496 . . . . 20.0 109.661 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.07 23.72 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.58 10.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.846 0.858 . . . . 20.0 108.996 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.55 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.763 -0.732 . . . . 20.0 114.064 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.8 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.769 0.654 . . . . 20.0 112.066 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.93 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.286 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.73 137.96 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.766 -0.827 . . . . 20.0 108.766 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.76 124.04 46.3 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.066 0.946 . . . . 20.0 109.028 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 65' ' ' ILE . . . . . . . . . . . . . 29.1 mm -116.22 114.29 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.107 -1.072 . . . . 20.0 108.107 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.6 51.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.65 45.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.873 0.869 . . . . 20.0 108.908 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' K' ' 235' ' ' ASP . 0.0 OUTLIER -105.05 146.44 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.947 -0.569 . . . . 20.0 110.575 177.394 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 21.42 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.247 -0.888 . . . . 20.0 109.73 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 70' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' K' ' 183' ' ' ASP . 12.0 t0 -97.39 67.97 2.14 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.618 -0.676 . . . . 20.0 112.442 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.3 144.87 28.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.245 -1.02 . . . . 20.0 108.245 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.684 0.793 . . . . 20.0 109.13 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.87 -175.7 27.18 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.544 -1.022 . . . . 20.0 110.544 173.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.03 161.48 26.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.296 0.57 . . . . 20.0 109.957 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.16 131.33 48.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.22 1.008 . . . . 20.0 109.67 -174.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.48 137.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 168.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.13 -29.33 7.01 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.061 0.763 . . . . 20.0 113.061 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.46 13.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.155 -1.054 . . . . 20.0 108.155 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.347 -0.982 . . . . 20.0 108.347 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.78 166.32 5.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.818 0.818 . . . . 20.0 109.948 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.01 60.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.714 -0.794 . . . . 20.0 112.724 -169.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.57 9.21 4.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.349 0.87 . . . . 20.0 113.349 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.71 81.86 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.125 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.76 145.05 34.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.328 1.064 . . . . 20.0 110.23 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.5 28.05 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.586 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.37 174.59 6.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.902 -1.148 . . . . 20.0 107.902 158.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.67 163.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.664 0.745 . . . . 20.0 109.479 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.36 15.6 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.785 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.82 160.16 24.52 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.29 0.871 . . . . 20.0 112.727 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 90' ' ' ILE . . . . . . . . . . . . . 9.3 mt -88.73 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 113.756 -1.565 . . . . 20.0 107.418 165.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.92 140.93 47.41 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.16 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 118.993 -0.893 . . . . 20.0 115.215 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.93 152.7 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.631 1.215 . . . . 20.0 109.241 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.94 22.24 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.07 -7.96 13.09 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 CA-C-N 120.568 1.239 . . . . 20.0 114.805 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.26 59.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.177 0.898 . . . . 20.0 111.783 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 97' ' ' THR . . . . . . . . . . . . . 44.8 p -89.39 35.46 0.81 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.661 0.784 . . . . 20.0 112.429 178.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.2 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.954 1.302 . . . . 20.0 113.397 -173.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.2 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 174.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.97 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.644 -1.162 . . . . 20.0 111.215 158.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 101' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' I' ' 165' ' ' ASP . 0.0 OUTLIER -169.42 141.61 2.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.89 74.61 0.37 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.211 1.559 . . . . 20.0 115.211 150.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' K' ' 115' ' ' GLY . 0.5 OUTLIER -79.41 134.26 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.298 0.954 . . . . 20.0 109.371 160.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.29 37.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.481 -0.781 . . . . 20.0 109.436 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 105' ' ' VAL . . . . . . . . . . . . . 50.6 t -117.4 110.75 32.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.242 -1.022 . . . . 20.0 108.242 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.12 6.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.246 -0.279 . . . . 20.0 110.246 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -52.01 -54.2 14.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 O-C-N 123.372 0.42 . . . . 20.0 110.32 170.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.58 177.51 10.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.428 -0.953 . . . . 20.0 108.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.12 126.38 27.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.481 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.24 75.05 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.898 -0.945 . . . . 20.0 115.347 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.04 114.07 15.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.438 1.119 . . . . 20.0 108.555 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.33 141.49 37.68 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.341 -0.615 . . . . 20.0 109.341 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.5 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 108.704 -0.851 . . . . 20.0 108.704 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.67 149.44 31.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' K' ' 103' ' ' PHE . . . -147.92 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.277 -1.129 . . . . 20.0 110.277 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.77 154.38 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.372 -0.974 . . . . 20.0 108.372 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.26 1.75 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.395 -0.82 . . . . 20.0 114.584 -168.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.24 -47.99 69.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.291 1.219 . . . . 20.0 114.291 -156.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 121.17 11.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.564 1.075 . . . . 20.0 112.684 -155.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.19 35.48 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 102.607 -3.108 . . . . 20.0 102.607 159.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.21 123.83 11.03 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 CA-C-N 120.766 1.309 . . . . 20.0 110.57 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.81 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 CA-C-N 119.193 0.747 . . . . 20.0 110.691 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.38 7.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.822 0.82 . . . . 20.0 109.94 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.9 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.184 -1.043 . . . . 20.0 108.184 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.93 160.83 19.61 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.784 -0.367 . . . . 20.0 110.757 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.92 -43.66 1.5 Allowed Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.961 0.905 . . . . 20.0 113.081 -170.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.96 59.51 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.839 1.335 . . . . 20.0 111.995 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.46 -26.55 30.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 111.817 0.303 . . . . 20.0 111.817 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.9 69.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.733 -0.787 . . . . 20.0 110.226 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.914 0.339 . . . . 20.0 111.914 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.5 91.01 4.5 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.24 14.34 7.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.065 0.394 . . . . 20.0 112.065 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.13 142.52 87.48 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 108.563 -0.903 . . . . 20.0 108.563 172.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.72 153.59 75.5 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 CA-C-N 119.664 0.916 . . . . 20.0 112.381 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.6 153.65 42.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.554 -1.203 . . . . 20.0 107.935 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 118.77 -0.633 . . . . 20.0 112.347 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' K' ' 138' ' ' GLN . 14.0 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.913 -0.565 . . . . 20.0 111.349 -175.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 138' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' K' ' 137' ' ' ASP . 3.9 tp-100 174.64 174.13 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.138 -2.912 . . . . 20.0 103.138 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.86 168.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.181 0.992 . . . . 20.0 108.937 -179.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.81 161.45 18.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.007 0.923 . . . . 20.0 110.508 177.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 141' ' ' ILE . . . . . . . . . . . . . 30.4 mt -124.64 147.5 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -177.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' K' ' 144' ' ' GLY . 0.5 OUTLIER -119.12 134.76 55.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 20.0 109.582 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.82 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 115.888 -0.596 . . . . 20.0 111.814 166.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' K' ' 142' ' ' ASP . . . 86.89 -6.57 82.81 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 115.447 0.939 . . . . 20.0 115.447 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 144.01 54.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.498 1.149 . . . . 20.0 110.322 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.32 -20.92 33.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.593 0.961 . . . . 20.0 113.593 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.36 162.61 40.2 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.996 0.903 . . . . 20.0 111.44 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.49 80.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.896 -1.502 . . . . 20.0 111.256 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -46.96 88.15 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.96 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.41 -35.2 76.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.485 -0.486 . . . . 20.0 110.787 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.6 84.29 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.112 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.33 58.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.357 -0.937 . . . . 20.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.0 66.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.751 -0.779 . . . . 20.0 110.68 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.62 92.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.65 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.15 -8.73 6.69 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-O 118.914 -0.937 . . . . 20.0 114.559 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 156' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 133.54 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 118.496 1.148 . . . . 20.0 108.565 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.35 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.706 -1.22 . . . . 20.0 107.706 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.3 15.7 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.783 -1.727 . . . . 20.0 108.783 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.44 113.55 17.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.696 -1.224 . . . . 20.0 107.696 165.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.63 -19.98 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.784 1.031 . . . . 20.0 113.784 -166.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.72 155.67 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.696 -0.627 . . . . 20.0 111.75 -159.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 163' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' K' ' 164' ' ' TRP . 3.5 t -145.35 -166.31 2.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.233 1.013 . . . . 20.0 110.446 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 164' ' ' TRP . . . . . 0.559 ' N ' ' OG1' ' K' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.87 16.73 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 -160.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.67 61.69 0.98 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.215 0.531 . . . . 20.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.6 29.56 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.121 -1.192 . . . . 20.0 110.121 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.31 37.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.726 -1.213 . . . . 20.0 107.726 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.65 30.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.147 -0.933 . . . . 20.0 110.176 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.49 159.77 35.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 20.0 109.949 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.4 117.23 34.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.225 -1.352 . . . . 20.0 109.482 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.58 29.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.479 -0.563 . . . . 20.0 109.479 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 172' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' K' ' 175' ' ' ARG . . . 56.88 68.75 1.54 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.96 4.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.761 0.652 . . . . 20.0 112.761 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -62.95 1.32 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.684 -0.806 . . . . 20.0 111.215 157.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 175' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' K' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.92 0.7 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.623 0.647 . . . . 20.0 112.669 172.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.835 2.454 . . . . 20.0 106.265 157.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.68 145.78 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.436 -0.949 . . . . 20.0 108.436 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.15 -64.41 1.17 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 116.47 2.026 . . . . 20.0 116.47 -166.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 118.741 0.7 . . . . 20.0 112.113 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.65 36.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 181' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -84.66 -66.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.595 0.634 . . . . 20.0 111.754 -162.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.3 127.8 32.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.111 0.958 . . . . 20.0 110.692 -152.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 183' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' K' ' 70' ' ' ASP . 0.6 OUTLIER 69.98 -6.67 1.05 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.375 1.47 . . . . 20.0 113.148 174.688 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.84 83.89 1.16 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.187 0.994 . . . . 20.0 110.779 157.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 104.499 -2.408 . . . . 20.0 104.499 149.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 186' ' ' ALA . . . . . 0.712 ' O ' ' OG1' ' K' ' 189' ' ' THR . . . -50.13 -42.93 51.54 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.338 -0.846 . . . . 20.0 111.532 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.1 76.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.094 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 188' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.75 -38.71 92.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.181 -1.007 . . . . 20.0 110.489 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 189' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 186' ' ' ALA . 25.3 p -59.1 -48.56 81.14 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.446 -0.902 . . . . 20.0 110.86 172.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.56 64.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.961 0.41 . . . . 20.0 110.476 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.072 -0.651 . . . . 20.0 111.007 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.87 -36.59 84.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.988 -0.685 . . . . 20.0 110.314 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 193' ' ' VAL . . . . . . . . . . . . . 11.6 t -60.55 -44.85 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 120.992 0.425 . . . . 20.0 110.078 177.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.26 75.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.67 -38.1 70.7 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.866 -0.733 . . . . 20.0 110.778 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.18 40.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.529 0.566 . . . . 20.0 112.529 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.53 122.79 27.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.342 -0.614 . . . . 20.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.11 2.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.239 0.337 . . . . 20.0 110.131 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.15 105.4 17.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.721 -0.474 . . . . 20.0 109.721 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.31 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.237 -0.653 . . . . 20.0 109.237 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 201' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -76.73 -14.61 59.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.041 -0.663 . . . . 20.0 111.38 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.72 30.5 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.876 -0.787 . . . . 20.0 108.876 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 203' ' ' ASP . . . . . 0.653 ' N ' ' OD1' ' K' ' 203' ' ' ASP . 0.0 OUTLIER -78.62 112.99 16.27 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.95 151.55 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 108.577 -0.898 . . . . 20.0 108.577 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.87 106.61 9.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.013 -0.736 . . . . 20.0 109.013 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.94 125.35 31.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.764 -0.828 . . . . 20.0 108.764 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 207' ' ' VAL . . . . . . . . . . . . . 34.0 m -119.9 150.17 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.811 -0.811 . . . . 20.0 108.811 174.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.84 159.98 19.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.942 0.877 . . . . 20.0 111.08 -165.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.81 166.46 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 114.609 -1.178 . . . . 20.0 108.236 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.2 29.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.813 -1.085 . . . . 20.0 111.504 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.81 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.351 -0.54 . . . . 20.0 110.926 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.41 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.236 -0.586 . . . . 20.0 111.48 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 214' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.1 121.17 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.536 -0.912 . . . . 20.0 108.536 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.01 60.95 6.24 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.696 -1.24 . . . . 20.0 111.421 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.99 -25.6 0.83 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.469 0.914 . . . . 20.0 113.469 -179.139 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.47 -4.5 2.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.333 0.494 . . . . 20.0 112.333 173.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 119.695 -1.241 . . . . 20.0 112.003 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 219' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' K' ' 222' ' ' SER . . . -65.28 -37.04 85.94 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.279 -0.542 . . . . 20.0 111.391 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.74 -36.72 58.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.171 0.434 . . . . 20.0 112.171 -174.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 221' ' ' THR . . . . . . . . . . . . . 75.3 p -58.38 -45.84 87.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.856 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 222' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' K' ' 219' ' ' ALA . 2.1 p -58.07 -35.77 71.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.433 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.08 68.85 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.559 0.577 . . . . 20.0 112.559 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 224' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.16 -33.43 75.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.79 -0.764 . . . . 20.0 111.799 -165.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.73 74.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.122 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -127.0 -45.6 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 112.044 0.387 . . . . 20.0 112.044 -158.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 227' ' ' GLU . . . . . 0.503 ' OE1' ' OG1' ' K' ' 306' ' ' THR . 3.0 pt-20 -56.46 -46.61 99.79 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 118.229 2.678 . . . . 20.0 118.229 -158.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.87 143.7 2.87 Favored 'Trans proline' 0 N--CA 1.472 0.21 0 N-CA-C 116.016 1.506 . . . . 20.0 116.016 -134.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.16 -4.74 0.78 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.252 1.421 . . . . 20.0 113.353 162.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.083 -0.647 . . . . 20.0 111.77 167.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.47 16.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.69 15.62 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.827 0.851 . . . . 20.0 108.806 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.1 23.4 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.177 0.513 . . . . 20.0 110.391 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 234' ' ' ILE . . . . . . . . . . . . . 51.6 mt -133.21 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.512 -1.292 . . . . 20.0 107.512 172.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' K' ' 68' ' ' HIS . 25.4 t0 -135.18 173.2 11.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.996 -1.483 . . . . 20.0 106.996 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.41 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.64 0.733 . . . . 20.0 111.407 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 237' ' ' THR . . . . . . . . . . . . . 9.2 t -165.61 122.7 1.46 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.379 -1.341 . . . . 20.0 107.379 164.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.5 151.86 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.267 -1.012 . . . . 20.0 108.267 -161.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.18 9.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.889 -1.522 . . . . 20.0 106.889 158.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.42 109.95 18.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.067 0.766 . . . . 20.0 113.067 -155.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.14 22.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.947 1.299 . . . . 20.0 112.461 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 105.13 -2.174 . . . . 20.0 105.13 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.98 165.54 12.03 Favored 'Trans proline' 0 CA--C 1.517 -0.37 0 CA-C-N 120.837 1.335 . . . . 20.0 112.408 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.42 -5.28 45.29 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.093 -0.958 . . . . 20.0 114.914 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.54 22.83 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 118.593 1.197 . . . . 20.0 110.665 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.589 0 CA-C-O 121.835 0.681 . . . . 20.0 111.969 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.85 59.57 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.726 -1.125 . . . . 20.0 112.06 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.82 -0.752 . . . . 20.0 112.912 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 249' ' ' LYS . . . . . 0.712 ' O ' ' OG1' ' K' ' 252' ' ' THR . 16.9 mttt -98.76 -15.17 19.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.234 0.827 . . . . 20.0 113.234 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.256 -0.578 . . . . 20.0 111.324 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.106 -1.038 . . . . 20.0 111.872 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 252' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 249' ' ' LYS . 39.5 p -57.12 -31.84 65.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.538 0.608 . . . . 20.0 111.366 173.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 253' ' ' HIS . . . . . . . . . . . . . 16.7 t-80 -162.37 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.349 0.595 . . . . 20.0 110.395 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.31 3.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.287 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 36.0 5.82 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.223 1.868 . . . . 20.0 111.563 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.44 129.19 10.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.14 174.25 3.43 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-O 122.71 1.172 . . . . 20.0 113.309 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 259' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' K' ' 316' ' ' SER . . . -126.42 120.3 29.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.15 -0.932 . . . . 20.0 109.425 -169.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.96 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.8 -1.185 . . . . 20.0 107.8 175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.85 122.62 42.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.81 -40.25 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.893 -0.594 . . . . 20.0 109.593 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.63 34.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.316 -0.624 . . . . 20.0 109.316 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.93 2.86 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.738 -1.119 . . . . 20.0 108.26 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.24 21.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.625 . . . . 20.0 110.262 163.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -46.22 11.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 113.669 0.989 . . . . 20.0 113.669 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.69 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.0 14.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.139 -1.8 . . . . 20.0 106.139 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.37 137.1 56.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.309 0.576 . . . . 20.0 111.3 -171.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.01 109.64 1.95 Allowed Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.687 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.4 -20.09 48.69 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 N-CA-C 114.837 1.053 . . . . 20.0 114.837 -160.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.96 74.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.183 -0.607 . . . . 20.0 110.557 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.59 -48.4 77.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.098 0.475 . . . . 20.0 110.074 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 274' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.19 -52.44 60.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.823 0.344 . . . . 20.0 110.709 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.43 -31.87 70.82 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.832 -0.747 . . . . 20.0 110.525 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.5 -47.97 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.088 -0.645 . . . . 20.0 110.991 179.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.1 -38.66 89.73 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.978 -0.689 . . . . 20.0 110.726 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.6 -47.99 78.41 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.631 -0.427 . . . . 20.0 110.084 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.44 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.9 -0.32 . . . . 20.0 110.7 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.9 77.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.261 -0.575 . . . . 20.0 111.098 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.71 73.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.062 -0.655 . . . . 20.0 111.003 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.83 65.86 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.133 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.86 -37.66 73.1 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 119.874 -0.73 . . . . 20.0 110.963 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.6 15.51 29.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.359 0.874 . . . . 20.0 113.359 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.17 13.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.736 0.779 . . . . 20.0 111.59 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 286' ' ' ILE . . . . . . . . . . . . . 23.7 mm -87.3 143.34 34.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 287' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.15 149.35 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 CA-C-N 119.146 0.731 . . . . 20.0 111.341 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.98 148.18 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.71 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.04 175.19 5.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 113.76 17.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.837 -1.171 . . . . 20.0 107.837 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.64 43.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.47 -0.567 . . . . 20.0 109.47 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.11 156.98 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.632 -1.248 . . . . 20.0 107.632 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.51 168.68 12.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.491 0.662 . . . . 20.0 110.23 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.76 -18.5 21.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.778 -1.101 . . . . 20.0 112.192 165.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.0 20.06 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.003 -0.839 . . . . 20.0 111.003 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.49 144.75 15.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.67 -0.765 . . . . 20.0 112.661 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.6 4.09 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.342 -1.103 . . . . 20.0 110.342 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 298' ' ' THR . . . . . . . . . . . . . 20.2 p -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.022 0.915 . . . . 20.0 111.348 -174.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.228 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.29 74.02 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 111.809 0.3 . . . . 20.0 111.809 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.27 96.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.196 -1.002 . . . . 20.0 112.027 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.21 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.192 -0.603 . . . . 20.0 111.212 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.87 -34.45 56.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.996 -0.681 . . . . 20.0 110.17 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.74 -8.9 19.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.704 1.001 . . . . 20.0 113.704 -167.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 306' ' ' THR . . . . . 0.503 ' OG1' ' OE1' ' K' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.56 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.579 0.704 . . . . 20.0 110.531 171.956 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' K' K ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.83 70.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.267 -0.879 . . . . 20.0 113.323 -161.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.13 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.196 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.74 65.09 1.95 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.842 -0.694 . . . . 20.0 113.346 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.603 0.702 . . . . 20.0 111.158 -163.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 311' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.44 141.71 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 CA-C-N 119.451 0.84 . . . . 20.0 110.024 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.325 -0.852 . . . . 20.0 111.19 -169.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.55 162.58 12.33 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.207 -1.557 . . . . 20.0 109.207 164.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.04 27.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.429 0.633 . . . . 20.0 110.112 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.01 153.22 21.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.22 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 316' ' ' SER . . . . . 0.4 ' N ' ' O ' ' K' ' 259' ' ' ALA . 4.2 m -138.46 133.53 32.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.317 -0.856 . . . . 20.0 109.495 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 317' ' ' VAL . . . . . . . . . . . . . 92.3 t -99.47 108.56 51.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 CA-C-O 122.653 1.022 . . . . 20.0 113.596 -154.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.75 35.53 0.15 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.319 161.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.69 157.59 33.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.704 0.764 . . . . 20.0 110.105 176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.08 166.2 11.65 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.824 -1.547 . . . . 20.0 106.824 160.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.28 113.68 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.161 0.984 . . . . 20.0 108.375 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.42 3.29 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.46 1.281 . . . . 20.0 114.46 -140.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.52 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.647 0.61 . . . . 20.0 112.647 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -101.98 -56.12 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.001 1.482 . . . . 20.0 115.001 -152.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.95 50.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.455 -1.313 . . . . 20.0 107.455 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 327' ' ' GLU . . . . . . . . . . . . . 82.7 mt-10 -142.56 52.86 1.42 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.839 -1.528 . . . . 20.0 109.909 -153.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.07 149.38 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.429 0.633 . . . . 20.0 111.926 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.898 0.856 . . . . 20.0 109.461 175.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.49 119.17 27.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.603 -1.18 . . . . 20.0 108.897 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.12 -32.04 53.9 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.878 0.736 . . . . 20.0 111.511 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.77 73.58 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.297 -0.561 . . . . 20.0 110.233 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.05 -44.91 83.21 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.037 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.34 92.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.501 -0.48 . . . . 20.0 110.435 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -34.64 71.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 118.821 -1.151 . . . . 20.0 110.205 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.07 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.093 -0.643 . . . . 20.0 110.415 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.61 -43.75 80.47 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.726 0.298 . . . . 20.0 110.916 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 338' ' ' VAL . . . . . 0.7 ' O ' ' OG1' ' K' ' 342' ' ' THR . 42.6 t -60.25 -48.96 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.953 0.406 . . . . 20.0 110.23 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' K' ' 343' ' ' LYS . 1.3 mm-40 -54.83 -46.91 74.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.968 0.413 . . . . 20.0 110.764 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -55.17 37.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.36 -0.382 . . . . 20.0 111.441 -176.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.14 -40.4 89.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.213 -0.595 . . . . 20.0 110.78 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 342' ' ' THR . . . . . 0.7 ' OG1' ' O ' ' K' ' 338' ' ' VAL . 1.3 m -56.45 -45.03 81.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.185 0.517 . . . . 20.0 110.447 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' K' ' 339' ' ' GLU . 34.6 mttp -74.17 -37.45 63.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.96 -0.696 . . . . 20.0 110.829 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.45 97.72 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.626 -0.429 . . . . 20.0 111.15 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.05 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.499 -0.48 . . . . 20.0 110.808 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.56 -39.17 91.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 119.732 -0.787 . . . . 20.0 110.588 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.46 4.77 30.13 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.468 -0.893 . . . . 20.0 112.54 -178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.16 -23.7 33.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 119.558 -0.857 . . . . 20.0 110.949 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.39 69.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.734 -0.786 . . . . 20.0 111.265 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -85.79 -18.85 31.79 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 122.12 -0.362 . . . . 20.0 111.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.73 -28.81 66.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.134 0.42 . . . . 20.0 112.134 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' K' K ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.09 -26.62 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.051 1.871 . . . . 20.0 116.051 -169.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' K' K ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.02 1.328 . . . . 20.0 108.423 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.269 1.211 . . . . 20.0 114.269 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 82.19 2.88 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.946 -1.501 . . . . 20.0 106.946 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.95 -34.46 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.183 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -107.0 -23.57 12.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.596 0.962 . . . . 20.0 113.596 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.133 0.973 . . . . 20.0 111.64 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.74 32.39 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 122.256 -0.278 . . . . 20.0 111.232 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.45 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.684 -1.228 . . . . 20.0 107.684 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.12 11.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.276 0.56 . . . . 20.0 110.92 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.68 -31.53 72.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.487 -0.778 . . . . 20.0 111.864 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.18 -45.13 74.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.531 -0.467 . . . . 20.0 111.192 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.15 97.12 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.01 -0.276 . . . . 20.0 111.192 -172.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -30.59 70.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.751 -0.379 . . . . 20.0 111.16 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.4 90.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.683 -0.407 . . . . 20.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.93 91.51 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.641 -0.254 . . . . 20.0 111.536 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.91 -40.04 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 119.547 -0.861 . . . . 20.0 110.696 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.17 6.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.06 -1.056 . . . . 20.0 111.008 -162.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.04 68.1 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.958 -0.697 . . . . 20.0 111.295 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.42 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.521 -0.472 . . . . 20.0 109.817 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 19' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.19 144.76 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 120.251 0.634 . . . . 20.0 112.132 -172.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.17 3.44 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 117.286 1.674 . . . . 20.0 117.286 -159.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.67 119.78 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.175 -1.417 . . . . 20.0 107.175 159.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.21 8.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.452 0.644 . . . . 20.0 110.669 -166.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.99 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.477 -0.783 . . . . 20.0 114.003 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.36 0.17 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.3 1.048 . . . . 20.0 109.602 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.91 -13.18 4.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.94 -1.027 . . . . 20.0 113.425 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' L' ' 28' ' ' GLY . 0.0 OUTLIER -87.99 8.98 23.89 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 119.701 1.137 . . . . 20.0 113.771 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 11.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' L' ' 26' ' ' PHE . . . -53.24 -26.85 30.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.784 1.174 . . . . 20.0 115.982 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tt -59.59 -35.75 61.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.151 0.976 . . . . 20.0 110.659 -178.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.47 61.44 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.897 0.379 . . . . 20.0 110.404 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.18 -40.69 74.34 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.275 -0.421 . . . . 20.0 110.958 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.19 -49.61 82.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.081 0.467 . . . . 20.0 110.346 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.68 86.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 119.744 -0.782 . . . . 20.0 110.298 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.5 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 118.762 -1.175 . . . . 20.0 111.134 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -30.97 71.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.003 0.365 . . . . 20.0 111.111 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.01 -56.71 3.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.16 0.43 . . . . 20.0 112.16 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.48 44.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 116.502 -0.317 . . . . 20.0 111.516 -164.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.38 63.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.936 -0.706 . . . . 20.0 112.212 -162.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.52 63.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 118.958 -1.097 . . . . 20.0 111.683 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.92 22.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.56 152.64 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.547 -0.908 . . . . 20.0 108.547 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.1 -42.65 88.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.227 -0.897 . . . . 20.0 111.464 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.56 158.31 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.509 -0.923 . . . . 20.0 108.509 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.5 147.16 16.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.282 -1.007 . . . . 20.0 108.282 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.523 0.678 . . . . 20.0 110.422 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.06 128.96 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.349 -1.352 . . . . 20.0 107.349 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.807 0.813 . . . . 20.0 108.917 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.55 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.94 -0.704 . . . . 20.0 111.14 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 10.9 9.17 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.661 0.986 . . . . 20.0 113.661 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 119.134 -0.815 . . . . 20.0 114.514 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.07 151.45 35.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.466 1.133 . . . . 20.0 110.217 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.2 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 53' ' ' ILE . . . . . . . . . . . . . 31.2 mm -130.2 115.64 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.9 119.79 36.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.619 -0.511 . . . . 20.0 109.619 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.98 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -173.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.36 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.734 -1.58 . . . . 20.0 106.734 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.55 154.49 20.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 123.47 0.481 . . . . 20.0 109.703 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.38 -161.1 23.71 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.12 105.58 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.904 0.882 . . . . 20.0 109.018 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.59 33.53 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.775 -0.726 . . . . 20.0 114.074 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.79 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 CA-C-O 121.747 0.645 . . . . 20.0 112.081 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.96 111.41 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 20.0 109.196 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.74 137.97 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.779 -0.823 . . . . 20.0 108.779 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.8 124.07 46.31 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.015 0.926 . . . . 20.0 109.022 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.27 45.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.112 -1.07 . . . . 20.0 108.112 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.55 51.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.255 0.347 . . . . 20.0 110.993 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.43 154.6 45.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.902 0.881 . . . . 20.0 108.941 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 68' ' ' HIS . . . . . 0.484 ' NE2' ' OD1' ' L' ' 235' ' ' ASP . 0.0 OUTLIER -105.06 146.49 29.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.949 -0.569 . . . . 20.0 110.479 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.32 5.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.163 -0.926 . . . . 20.0 109.676 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' L' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.658 -0.651 . . . . 20.0 112.448 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.26 144.89 28.41 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.736 0.814 . . . . 20.0 109.131 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 73' ' ' GLY . . . . . . . . . . . . . . . -155.81 -175.66 27.07 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.597 -1.001 . . . . 20.0 110.597 173.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 74' ' ' LEU . . . . . . . . . . . . . 5.0 mt -125.09 161.38 26.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.29 0.567 . . . . 20.0 109.995 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 75' ' ' MET . . . . . . . . . . . . . 10.6 ttm -128.12 131.32 49.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.237 1.015 . . . . 20.0 109.679 -174.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.51 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.837 -0.801 . . . . 20.0 108.837 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.09 -29.32 7.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.055 0.761 . . . . 20.0 113.055 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.44 13.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.099 -1.075 . . . . 20.0 108.099 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.9 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.366 -0.976 . . . . 20.0 108.366 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.34 5.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.82 0.819 . . . . 20.0 109.992 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -27.07 60.37 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.732 -0.787 . . . . 20.0 112.708 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.21 4.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.19 12.85 81.82 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.949 -0.917 . . . . 20.0 115.059 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.81 145.07 34.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.384 1.092 . . . . 20.0 110.202 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.94 142.5 28.11 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.264 -0.88 . . . . 20.0 112.569 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.59 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.79 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.617 0.722 . . . . 20.0 109.527 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.33 15.58 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.012 -0.995 . . . . 20.0 109.756 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.79 160.21 24.59 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.307 0.878 . . . . 20.0 112.72 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 90' ' ' ILE . . . . . . . . . . . . . 9.2 mt -88.81 150.28 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 113.696 -1.593 . . . . 20.0 107.365 165.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.9 47.46 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.272 -0.876 . . . . 20.0 112.151 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.22 21.98 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.204 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.87 152.66 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 118.645 1.222 . . . . 20.0 109.237 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 131.02 22.15 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -7.92 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 120.573 1.24 . . . . 20.0 114.805 -170.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.27 59.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.155 0.889 . . . . 20.0 111.79 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 97' ' ' THR . . . . . . . . . . . . . 44.7 p -89.48 35.54 0.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.598 0.759 . . . . 20.0 112.461 178.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 98' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -43.26 -66.43 0.38 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.923 1.289 . . . . 20.0 113.407 -173.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 99' ' ' ILE . . . . . . . . . . . . . 1.6 tt -173.19 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 100' ' ' ALA . . . . . . . . . . . . . . . -123.94 -19.03 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.635 -1.166 . . . . 20.0 111.255 158.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 101' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' J' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.94 74.52 0.38 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.233 1.568 . . . . 20.0 115.233 150.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' L' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.25 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.325 0.966 . . . . 20.0 109.363 160.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.29 37.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.499 -0.773 . . . . 20.0 109.41 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 105' ' ' VAL . . . . . . . . . . . . . 50.7 t -117.43 110.74 32.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.57 83.08 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.559 -0.291 . . . . 20.0 110.282 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -51.97 -54.23 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.361 0.413 . . . . 20.0 110.308 170.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.51 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.432 -0.951 . . . . 20.0 108.432 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.02 126.28 27.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.914 -1.039 . . . . 20.0 110.48 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.21 75.2 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.899 -0.945 . . . . 20.0 115.291 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.01 15.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.497 1.149 . . . . 20.0 108.62 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.25 141.54 37.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.51 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.683 -0.858 . . . . 20.0 108.683 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.73 149.45 31.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.023 -0.989 . . . . 20.0 110.263 -172.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' L' ' 103' ' ' PHE . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.256 -1.138 . . . . 20.0 110.256 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.78 154.44 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.366 -0.975 . . . . 20.0 108.366 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.319 -0.855 . . . . 20.0 114.606 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 118' ' ' ALA . . . . . . . . . . . . . . . -67.18 -47.99 69.29 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.334 1.235 . . . . 20.0 114.334 -156.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.52 1.055 . . . . 20.0 112.646 -155.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.13 35.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.16 123.82 11.04 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 CA-C-N 120.743 1.301 . . . . 20.0 110.546 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.79 89.89 Favored 'Trans proline' 0 C--O 1.233 0.26 0 CA-C-N 119.147 0.731 . . . . 20.0 110.7 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.13 165.42 7.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 20.0 109.93 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.19 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.177 -1.045 . . . . 20.0 108.177 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.84 19.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.872 0.368 . . . . 20.0 110.713 169.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.91 -43.65 1.5 Allowed Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.948 0.899 . . . . 20.0 113.088 -170.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.92 59.39 Favored 'Trans proline' 0 C--N 1.359 1.114 0 CA-C-N 120.845 1.337 . . . . 20.0 112.008 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.52 30.09 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 111.824 0.305 . . . . 20.0 111.824 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -31.94 69.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.274 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.82 -36.83 62.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 111.936 0.347 . . . . 20.0 111.936 172.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.51 90.97 4.5 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.206 -0.664 . . . . 20.0 109.206 174.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.91 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.115 0.413 . . . . 20.0 112.115 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.61 87.45 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 108.513 -0.921 . . . . 20.0 108.513 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.63 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.64 0.907 . . . . 20.0 112.365 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.64 153.62 42.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.531 -1.213 . . . . 20.0 107.968 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.772 -0.632 . . . . 20.0 112.368 -175.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' L' ' 138' ' ' GLN . 14.2 p30 -55.34 -66.4 0.42 Allowed 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.416 -175.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 138' ' ' GLN . . . . . 0.414 ' N ' ' OD1' ' L' ' 137' ' ' ASP . 3.9 tp-100 174.62 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 103.075 -2.935 . . . . 20.0 103.075 133.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 139' ' ' ILE . . . . . . . . . . . . . 1.2 tp -74.85 168.19 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.068 0.947 . . . . 20.0 108.939 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.9 161.43 18.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.967 0.907 . . . . 20.0 110.464 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 141' ' ' ILE . . . . . . . . . . . . . 30.1 mt -124.65 147.46 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 142' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' L' ' 144' ' ' GLY . 0.5 OUTLIER -119.03 134.74 55.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.647 0.779 . . . . 20.0 109.613 175.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 O-C-N 123.719 0.637 . . . . 20.0 111.817 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 144' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' L' ' 142' ' ' ASP . . . 86.87 -6.61 82.68 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 115.495 0.958 . . . . 20.0 115.495 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.17 144.05 53.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.472 1.136 . . . . 20.0 110.252 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.33 -20.94 33.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.608 0.966 . . . . 20.0 113.608 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.63 40.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.971 0.891 . . . . 20.0 111.468 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.48 80.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 113.943 -1.48 . . . . 20.0 111.243 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.39 -46.99 88.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.863 -0.335 . . . . 20.0 110.943 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.39 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.524 -0.47 . . . . 20.0 110.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.63 84.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.052 -0.659 . . . . 20.0 111.119 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.26 58.51 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.368 -0.933 . . . . 20.0 111.057 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.75 -30.1 66.52 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.761 -0.776 . . . . 20.0 110.62 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.53 -40.65 92.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.657 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.8 6.68 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.606 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 133.52 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.462 1.131 . . . . 20.0 108.547 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.724 -1.213 . . . . 20.0 107.724 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.32 147.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.3 15.72 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.793 -1.723 . . . . 20.0 108.793 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 160' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.43 113.61 17.7 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.651 -1.24 . . . . 20.0 107.651 165.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -19.95 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.739 1.015 . . . . 20.0 113.739 -166.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 162' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.71 155.64 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.626 0.648 . . . . 20.0 111.737 -159.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' L' ' 164' ' ' TRP . 3.5 t -145.34 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.306 1.042 . . . . 20.0 110.445 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' L' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.94 16.69 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.189 0.811 . . . . 20.0 113.189 -160.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.76 61.62 0.97 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.837 -0.539 . . . . 20.0 112.281 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.62 29.59 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.089 -1.204 . . . . 20.0 110.089 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.31 37.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.739 -1.208 . . . . 20.0 107.739 170.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.58 30.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.133 -0.939 . . . . 20.0 110.206 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.38 159.8 35.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.829 0.823 . . . . 20.0 110.02 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.41 117.19 34.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.263 -1.335 . . . . 20.0 109.465 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.65 28.96 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.486 -0.561 . . . . 20.0 109.486 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 172' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' L' ' 175' ' ' ARG . . . 56.86 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.202 -1.559 . . . . 20.0 109.202 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.93 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.802 0.667 . . . . 20.0 112.802 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.73 -0.788 . . . . 20.0 111.211 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 175' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' L' ' 172' ' ' GLY . 6.8 ptt-85 -169.9 121.97 0.69 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.592 0.633 . . . . 20.0 112.633 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.52 169.39 0.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.788 2.435 . . . . 20.0 106.185 157.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.69 145.84 20.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.457 -0.942 . . . . 20.0 108.457 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.407 2.003 . . . . 20.0 116.407 -165.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.752 0.705 . . . . 20.0 112.115 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.9 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 114.393 1.257 . . . . 20.0 114.393 -170.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 181' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -84.64 -66.98 0.83 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.606 0.639 . . . . 20.0 111.766 -162.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.21 127.84 32.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.062 0.934 . . . . 20.0 110.679 -152.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' L' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.76 1.04 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.316 1.447 . . . . 20.0 113.166 174.638 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 184' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.76 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.122 0.963 . . . . 20.0 110.783 157.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 185' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -126.13 -41.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 104.515 -2.402 . . . . 20.0 104.515 149.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 186' ' ' ALA . . . . . 0.724 ' O ' ' OG1' ' L' ' 189' ' ' THR . . . -50.06 -43.05 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.364 -0.835 . . . . 20.0 111.536 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.9 -36.01 76.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.225 -0.99 . . . . 20.0 110.115 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 188' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -63.86 -38.65 91.86 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.479 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 189' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' L' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.02 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.85 172.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.29 -50.57 63.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.897 0.379 . . . . 20.0 110.477 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.14 -43.14 96.15 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.959 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.5 84.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.984 -0.686 . . . . 20.0 110.315 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.61 -44.73 97.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.045 0.45 . . . . 20.0 110.114 177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.29 75.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.17 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.58 -38.19 70.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.79 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.66 -26.17 41.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 20.0 112.52 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.61 122.79 27.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.299 -0.63 . . . . 20.0 109.299 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.273 0.358 . . . . 20.0 110.122 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.11 105.35 17.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.735 -0.469 . . . . 20.0 109.735 -172.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.29 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.679 . . . . 20.0 109.165 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.75 -14.56 59.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.047 -0.661 . . . . 20.0 111.386 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.68 30.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.919 -0.771 . . . . 20.0 108.919 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 203' ' ' ASP . . . . . 0.619 ' OD1' ' N ' ' L' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.99 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 -174.468 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.98 151.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 205' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.87 106.63 9.03 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.017 -0.735 . . . . 20.0 109.017 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.37 31.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.752 -0.832 . . . . 20.0 108.752 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 207' ' ' VAL . . . . . . . . . . . . . 34.1 m -119.92 150.18 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.867 -0.79 . . . . 20.0 108.867 174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.83 5.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.84 159.93 19.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 20.0 111.121 -165.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.76 166.44 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 114.644 -1.162 . . . . 20.0 108.21 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.13 29.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.762 -1.108 . . . . 20.0 111.541 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.94 -49.59 13.84 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.412 -0.515 . . . . 20.0 110.952 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.35 64.75 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.212 -0.595 . . . . 20.0 111.483 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.22 121.11 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.536 -0.913 . . . . 20.0 108.536 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.99 6.19 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.67 -1.253 . . . . 20.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 216' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -47.05 -25.52 0.85 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.464 0.912 . . . . 20.0 113.464 -179.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.337 0.495 . . . . 20.0 112.337 173.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.56 40.79 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.686 -1.245 . . . . 20.0 112.004 168.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 219' ' ' ALA . . . . . 0.461 ' O ' ' OG ' ' L' ' 222' ' ' SER . . . -65.27 -37.03 85.93 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 122.28 -0.541 . . . . 20.0 111.335 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 220' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -52.77 -36.66 58.43 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.172 0.434 . . . . 20.0 112.172 -174.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 221' ' ' THR . . . . . . . . . . . . . 74.7 p -58.5 -45.82 87.95 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 120.055 -0.658 . . . . 20.0 110.82 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 222' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' L' ' 219' ' ' ALA . 2.1 p -58.04 -35.77 71.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.78 -0.368 . . . . 20.0 111.438 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.06 68.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.587 0.588 . . . . 20.0 112.587 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.12 -33.45 75.8 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.832 -165.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.69 74.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 118.894 -1.622 . . . . 20.0 112.117 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.98 -45.59 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 112.011 0.374 . . . . 20.0 112.011 -158.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 227' ' ' GLU . . . . . 0.496 ' OE1' ' OG1' ' L' ' 306' ' ' THR . 3.0 pt-20 -56.4 -46.77 99.77 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 118.185 2.661 . . . . 20.0 118.185 -158.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.75 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.2 0 N-CA-C 115.966 1.487 . . . . 20.0 115.966 -134.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.72 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.409 . . . . 20.0 113.4 162.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.091 -0.643 . . . . 20.0 111.734 167.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.51 16.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.925 -0.655 . . . . 20.0 112.266 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.76 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.555 -0.823 . . . . 20.0 108.791 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.04 23.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.178 0.513 . . . . 20.0 110.385 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 234' ' ' ILE . . . . . . . . . . . . . 51.8 mt -133.18 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.56 -1.274 . . . . 20.0 107.56 172.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 235' ' ' ASP . . . . . 0.484 ' OD1' ' NE2' ' L' ' 68' ' ' HIS . 25.5 t0 -135.17 173.25 11.93 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.963 -1.495 . . . . 20.0 106.963 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.38 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.704 0.764 . . . . 20.0 111.452 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 237' ' ' THR . . . . . . . . . . . . . 9.1 t -165.6 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.364 -1.347 . . . . 20.0 107.364 164.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 238' ' ' ILE . . . . . . . . . . . . . 17.9 mm -145.5 151.87 14.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -161.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.2 9.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 158.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.05 18.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.35 36.18 22.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.969 1.308 . . . . 20.0 112.477 158.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.181 -2.155 . . . . 20.0 105.181 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.99 165.59 11.96 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 CA-C-N 120.842 1.336 . . . . 20.0 112.361 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.28 45.02 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.061 -0.972 . . . . 20.0 114.908 -173.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.15 164.52 22.93 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 118.611 1.206 . . . . 20.0 110.653 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.97 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.804 0.668 . . . . 20.0 111.995 171.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.77 59.56 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.036 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.34 -18.59 63.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.833 -0.747 . . . . 20.0 112.878 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 249' ' ' LYS . . . . . 0.729 ' O ' ' OG1' ' L' ' 252' ' ' THR . 16.9 mttt -98.81 -15.13 19.38 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.233 0.827 . . . . 20.0 113.233 170.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.86 88.99 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.338 -0.545 . . . . 20.0 111.342 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -21.02 25.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 119.119 -1.032 . . . . 20.0 111.89 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 252' ' ' THR . . . . . 0.729 ' OG1' ' O ' ' L' ' 249' ' ' LYS . 39.7 p -57.07 -31.88 65.68 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.485 0.584 . . . . 20.0 111.35 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 253' ' ' HIS . . . . . . . . . . . . . 16.6 t-80 -162.37 132.08 4.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.373 0.606 . . . . 20.0 110.421 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.27 3.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 20.0 112.302 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.86 5.85 Favored Glycine 0 CA--C 1.504 -0.63 0 C-N-CA 126.151 1.834 . . . . 20.0 111.571 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.21 10.18 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.26 3.42 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 122.677 1.154 . . . . 20.0 113.333 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.13 6.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 259' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' L' ' 316' ' ' SER . . . -126.48 120.36 29.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.181 -0.918 . . . . 20.0 109.417 -169.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.08 139.95 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.736 -1.209 . . . . 20.0 107.736 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 261' ' ' LYS . . . . . . . . . . . . . 1.9 mtmm -98.84 122.61 42.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.25 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.384 0.611 . . . . 20.0 109.643 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.16 -169.97 2.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.249 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.25 21.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.854 -0.612 . . . . 20.0 110.296 163.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.2 11.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.65 0.981 . . . . 20.0 113.65 -165.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.414 -0.587 . . . . 20.0 109.414 -163.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.25 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.107 -1.812 . . . . 20.0 106.107 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 269' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.37 137.11 56.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.25 0.548 . . . . 20.0 111.34 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 270' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.1 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.591 0 CA-C-N 115.107 -0.951 . . . . 20.0 108.691 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 271' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.42 -20.03 48.62 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 N-CA-C 114.823 1.047 . . . . 20.0 114.823 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.98 74.69 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.193 -0.603 . . . . 20.0 110.576 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.38 77.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.15 0.5 . . . . 20.0 110.105 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.18 -52.49 60.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.806 0.336 . . . . 20.0 110.674 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.9 70.8 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.824 -0.751 . . . . 20.0 110.554 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 276' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -68.48 -47.98 65.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.129 -0.628 . . . . 20.0 111.002 179.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.68 89.7 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.756 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.61 -48.02 78.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.61 -0.436 . . . . 20.0 110.117 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.79 -40.44 88.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.849 -0.34 . . . . 20.0 110.733 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.28 -44.96 78.0 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.251 -0.579 . . . . 20.0 111.126 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.66 72.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.023 -0.671 . . . . 20.0 111.081 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.47 -31.8 65.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.113 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.79 -37.69 73.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.019 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.6 15.47 29.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.306 0.854 . . . . 20.0 113.306 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.73 32.17 13.83 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.713 0.768 . . . . 20.0 111.572 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.37 34.42 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.324 -0.991 . . . . 20.0 108.324 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.18 149.39 13.44 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 119.182 0.743 . . . . 20.0 111.36 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.13 23.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.63 -0.714 . . . . 20.0 109.705 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.11 5.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.693 -1.225 . . . . 20.0 107.693 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.898 -1.149 . . . . 20.0 107.898 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.69 43.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.471 -0.566 . . . . 20.0 109.471 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.05 157.1 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.672 -1.232 . . . . 20.0 107.672 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.48 0.657 . . . . 20.0 110.294 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.56 21.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.874 -1.057 . . . . 20.0 112.162 165.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.011 -0.836 . . . . 20.0 111.011 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 296' ' ' GLY . . . . . . . . . . . . . . . 101.5 144.81 15.6 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.671 -0.764 . . . . 20.0 112.661 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.89 119.58 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.334 -1.106 . . . . 20.0 110.334 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 298' ' ' THR . . . . . . . . . . . . . 20.3 p -110.25 172.92 6.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.995 0.902 . . . . 20.0 111.414 -174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.9 -33.69 76.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.403 -1.271 . . . . 20.0 111.229 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.3 74.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.789 0.292 . . . . 20.0 111.789 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.21 96.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.221 -0.99 . . . . 20.0 112.042 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 302' ' ' ALA . . . . . . . . . . . . . . . -68.3 -26.89 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.162 -0.615 . . . . 20.0 111.189 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.46 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.023 -0.671 . . . . 20.0 110.146 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.24 60.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.92 19.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.687 0.995 . . . . 20.0 113.687 -167.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 306' ' ' THR . . . . . 0.496 ' OG1' ' OE1' ' L' ' 227' ' ' GLU . 0.5 OUTLIER -58.31 157.56 8.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.649 0.738 . . . . 20.0 110.519 171.937 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' L' L ' 307' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -61.69 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.258 -0.883 . . . . 20.0 113.299 -161.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.15 66.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.709 -0.796 . . . . 20.0 111.233 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.821 -0.705 . . . . 20.0 113.307 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.64 52.41 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 117.619 0.709 . . . . 20.0 111.079 -163.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.53 141.65 8.94 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 CA-C-N 119.456 0.841 . . . . 20.0 110.04 168.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.45 135.84 32.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.365 -0.834 . . . . 20.0 111.195 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.144 -1.583 . . . . 20.0 109.144 164.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.42 136.06 27.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.445 0.64 . . . . 20.0 110.052 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.06 153.27 21.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.621 -1.172 . . . . 20.0 109.212 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 316' ' ' SER . . . . . 0.402 ' N ' ' O ' ' L' ' 259' ' ' ALA . 4.2 m -138.47 133.51 32.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 20.0 109.48 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 317' ' ' VAL . . . . . . . . . . . . . 92.1 t -99.47 108.62 51.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 107.227 -1.397 . . . . 20.0 107.227 177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.727 0 CA-C-O 122.625 1.011 . . . . 20.0 113.606 -154.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 319' ' ' ALA . . . . . . . . . . . . . . . 79.84 35.46 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.57 -1.65 . . . . 20.0 115.277 161.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 320' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.61 157.58 33.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.71 0.766 . . . . 20.0 110.119 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 321' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -113.06 166.13 11.71 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.18 113.67 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.156 0.982 . . . . 20.0 108.401 -163.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.38 3.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 324' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.54 -60.01 4.53 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.611 0.597 . . . . 20.0 112.611 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 325' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -101.97 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.075 1.509 . . . . 20.0 115.075 -152.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.58 150.95 50.78 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.485 -1.302 . . . . 20.0 107.485 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 327' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -142.55 52.81 1.42 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.846 -1.525 . . . . 20.0 109.943 -153.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.07 149.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.411 0.624 . . . . 20.0 111.969 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 329' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -139.43 179.41 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.877 0.846 . . . . 20.0 109.419 175.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.22 27.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.802 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.06 -32.1 53.58 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.847 0.717 . . . . 20.0 111.497 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.67 -44.76 73.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.289 -0.564 . . . . 20.0 110.211 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.9 83.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.727 -0.389 . . . . 20.0 111.068 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.22 91.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 120.415 -0.514 . . . . 20.0 110.522 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.65 71.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 118.791 -1.164 . . . . 20.0 110.181 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.033 -0.667 . . . . 20.0 110.421 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.57 -43.83 80.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.761 0.315 . . . . 20.0 110.938 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' L' ' 342' ' ' THR . 42.6 t -60.2 -48.93 86.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 120.962 0.411 . . . . 20.0 110.276 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 339' ' ' GLU . . . . . 0.783 ' OE1' ' NZ ' ' L' ' 343' ' ' LYS . 1.3 mm-40 -54.87 -46.85 74.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.996 0.427 . . . . 20.0 110.778 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -55.12 38.09 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.37 -0.377 . . . . 20.0 111.454 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 341' ' ' MET . . . . . . . . . . . . . 31.9 tpp -60.2 -40.36 89.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.778 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' L' ' 338' ' ' VAL . 1.3 m -56.45 -45.04 81.03 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.101 0.476 . . . . 20.0 110.423 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 343' ' ' LYS . . . . . 0.783 ' NZ ' ' OE1' ' L' ' 339' ' ' GLU . 34.7 mttp -74.12 -37.48 64.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.806 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.554 -0.459 . . . . 20.0 111.126 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 345' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.01 -50.41 74.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.524 -0.471 . . . . 20.0 110.827 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.0 90.88 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 119.682 -0.807 . . . . 20.0 110.625 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 347' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -84.53 4.77 30.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.475 -0.89 . . . . 20.0 112.538 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 348' ' ' ILE . . . . . . . . . . . . . 1.3 tt -65.23 -23.63 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 119.525 -0.87 . . . . 20.0 110.93 179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.77 -27.33 69.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.814 -0.755 . . . . 20.0 111.241 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.73 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.085 -0.385 . . . . 20.0 111.512 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 351' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -28.84 66.13 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.118 0.414 . . . . 20.0 112.118 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.03 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 116.032 1.864 . . . . 20.0 116.032 -169.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' L' L ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.983 1.313 . . . . 20.0 108.408 -174.659 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' C' C 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' D' D 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' E' E 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' F' F 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' G' G 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' H' H 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' I' I 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' J' J 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' K' K 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' L' L 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 114.229 1.196 . . . . 20.0 114.229 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 82.24 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.88 -1.526 . . . . 20.0 106.88 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.94 -34.53 66.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.942 -1.026 . . . . 20.0 110.16 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.53 12.3 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.48 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.155 0.982 . . . . 20.0 111.59 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -38.69 32.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.766 0.257 . . . . 20.0 111.226 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.51 37.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.613 -1.254 . . . . 20.0 107.613 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.96 112.14 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 20.0 110.928 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.66 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.5 -0.773 . . . . 20.0 111.882 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.13 -45.19 74.29 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.486 -0.486 . . . . 20.0 111.206 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.11 97.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 121.036 -0.265 . . . . 20.0 111.163 -172.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.742 -0.383 . . . . 20.0 111.172 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.42 90.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.642 -0.423 . . . . 20.0 110.513 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.04 -42.89 91.35 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.667 -0.242 . . . . 20.0 111.555 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.95 -40.03 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 119.515 -0.874 . . . . 20.0 110.67 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.06 -32.11 6.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 119.009 -1.076 . . . . 20.0 111.027 -162.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 68.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.311 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.42 70.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.493 -0.483 . . . . 20.0 109.765 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.13 144.78 9.57 Favored 'Trans proline' 0 C--N 1.33 -0.412 0 C-N-CA 120.249 0.633 . . . . 20.0 112.119 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.98 38.27 3.39 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 117.284 1.674 . . . . 20.0 117.284 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.78 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 159.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.05 171.21 8.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.396 0.617 . . . . 20.0 110.707 -166.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.049 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.307 1.051 . . . . 20.0 109.563 172.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.97 -13.11 3.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.882 -1.054 . . . . 20.0 113.438 169.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -88.02 9.08 23.62 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 119.714 1.143 . . . . 20.0 113.746 178.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.71 11.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.426 1.639 . . . . 20.0 115.426 -154.09 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -53.18 -26.84 29.72 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 116.023 1.169 . . . . 20.0 116.023 -172.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' A' ' 184' ' ' ARG . 1.1 tt -59.62 -35.76 61.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 118.088 0.944 . . . . 20.0 110.655 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.44 61.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.873 0.368 . . . . 20.0 110.369 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.25 -40.64 74.47 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.348 -0.387 . . . . 20.0 110.938 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.6 82.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.043 0.449 . . . . 20.0 110.305 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.23 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 119.692 -0.803 . . . . 20.0 110.336 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.78 -29.42 20.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 118.731 -1.188 . . . . 20.0 111.176 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -62.59 -30.91 71.68 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.816 -0.354 . . . . 20.0 111.101 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.92 -56.78 3.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.196 0.443 . . . . 20.0 112.196 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.4 44.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.461 -0.336 . . . . 20.0 111.514 -164.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -26.38 63.67 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.943 -0.703 . . . . 20.0 112.229 -162.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.55 63.05 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 118.926 -1.11 . . . . 20.0 111.716 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.86 -6.94 22.94 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.534 0.939 . . . . 20.0 113.534 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.5 152.68 22.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.53 -0.915 . . . . 20.0 108.53 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.17 -42.57 88.76 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 20.0 111.468 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.32 35.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.554 -0.906 . . . . 20.0 108.554 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.22 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.17 159.26 44.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.5 0.667 . . . . 20.0 110.469 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.07 128.93 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -176.15 5.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.806 0.812 . . . . 20.0 108.904 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 309' ' ' GLY . 6.0 mmtm -74.61 -34.52 62.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.089 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.23 10.83 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.636 0.976 . . . . 20.0 113.636 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.59 83.41 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.104 -0.831 . . . . 20.0 114.498 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.51 35.87 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.463 1.132 . . . . 20.0 110.212 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.36 140.23 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.172 -1.418 . . . . 20.0 107.172 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.697 HD13 HG12 ' A' ' 207' ' ' VAL . 31.3 mm -130.22 115.62 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.332 -1.359 . . . . 20.0 107.332 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.76 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.663 -0.495 . . . . 20.0 109.663 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 99.96 8.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.599 -0.889 . . . . 20.0 108.599 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.57 145.38 31.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.792 -1.559 . . . . 20.0 106.792 163.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.54 154.48 20.32 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.459 0.474 . . . . 20.0 109.723 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.07 23.66 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.146 -0.781 . . . . 20.0 111.146 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.11 105.59 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.946 0.898 . . . . 20.0 109.049 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.54 33.52 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.082 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.77 165.27 32.67 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 CA-C-O 121.784 0.66 . . . . 20.0 112.066 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -92.03 111.38 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.932 -1.031 . . . . 20.0 109.249 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.71 137.97 30.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.715 -0.846 . . . . 20.0 108.715 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.84 124.04 46.19 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.023 0.929 . . . . 20.0 108.994 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.28 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 108.116 -1.068 . . . . 20.0 108.116 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.57 124.65 51.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.57 45.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.91 0.884 . . . . 20.0 108.947 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' NE2' ' OD1' ' A' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.46 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 20.0 110.57 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 11.9 t0 -97.41 68.01 2.14 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.65 -0.657 . . . . 20.0 112.461 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.88 28.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.196 -1.038 . . . . 20.0 108.196 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.717 0.807 . . . . 20.0 109.164 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 74' ' ' LEU . . . -155.91 -175.76 27.28 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.594 -1.002 . . . . 20.0 110.594 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 73' ' ' GLY . 5.0 mt -125.01 161.49 26.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.339 0.59 . . . . 20.0 109.981 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 160' ' ' THR . 10.6 ttm -128.14 131.29 48.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.985 -1.007 . . . . 20.0 109.721 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.03 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.897 -0.779 . . . . 20.0 108.897 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.05 -29.31 7.04 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.106 0.78 . . . . 20.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.04 174.45 13.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.139 -1.06 . . . . 20.0 108.139 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.05 108.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.317 -0.994 . . . . 20.0 108.317 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.75 166.31 5.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.838 0.828 . . . . 20.0 109.971 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -27.11 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.716 -0.794 . . . . 20.0 112.725 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.54 9.18 4.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.364 0.876 . . . . 20.0 113.364 -177.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.72 81.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 118.95 -0.917 . . . . 20.0 115.067 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.78 145.02 34.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.331 1.065 . . . . 20.0 110.244 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.54 27.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.245 -0.889 . . . . 20.0 112.568 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.45 174.61 6.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.83 -1.174 . . . . 20.0 107.83 158.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.75 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.649 0.737 . . . . 20.0 109.482 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.2 129.4 15.7 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.026 -0.988 . . . . 20.0 109.812 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -79.88 160.25 24.33 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-O 122.26 0.858 . . . . 20.0 112.701 -171.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 160' ' ' THR . 9.2 mt -88.79 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 113.708 -1.587 . . . . 20.0 107.359 165.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.89 47.57 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.231 -0.895 . . . . 20.0 112.161 -168.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.223 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.92 152.65 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.644 1.222 . . . . 20.0 109.25 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.66 130.95 22.21 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 108.467 -0.938 . . . . 20.0 108.467 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.1 -7.96 13.06 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 CA-C-N 120.59 1.246 . . . . 20.0 114.778 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.16 59.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.188 0.903 . . . . 20.0 111.786 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.594 HG21 ' OG ' ' A' ' 324' ' ' SER . 44.7 p -89.52 35.51 0.82 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.626 0.77 . . . . 20.0 112.424 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -43.24 -66.46 0.37 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.963 1.305 . . . . 20.0 113.423 -173.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.68 ' H ' HD12 ' A' ' 98' ' ' LEU . 1.6 tt -173.17 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 109.04 -0.726 . . . . 20.0 109.04 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' C' ' 100' ' ' ALA . . . -123.86 -19.02 5.83 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.533 1.133 . . . . 20.0 111.254 158.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' C' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.65 2.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.464 HH12 ' HB3' ' C' ' 167' ' ' ARG . 0.0 OUTLIER 55.84 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 115.247 1.573 . . . . 20.0 115.247 150.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.26 36.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.249 0.932 . . . . 20.0 109.411 160.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.31 37.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.56 -0.745 . . . . 20.0 109.375 -173.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.57 HG22 ' CG1' ' A' ' 162' ' ' ILE . 50.3 t -117.46 110.78 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.172 -1.047 . . . . 20.0 108.172 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.04 6.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.23 -0.285 . . . . 20.0 110.23 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.2 mt -51.95 -54.19 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 123.34 0.4 . . . . 20.0 110.351 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.54 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.446 -0.946 . . . . 20.0 108.446 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.475 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.2 11.22 75.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.894 -0.948 . . . . 20.0 115.322 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.0 15.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.47 1.135 . . . . 20.0 108.609 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.5 37.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.52 43.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.652 -0.87 . . . . 20.0 108.652 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.72 149.41 31.17 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.993 -1.003 . . . . 20.0 110.305 -172.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' PHE . . . -147.94 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.322 -1.111 . . . . 20.0 110.322 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 m -128.7 154.46 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.34 -0.985 . . . . 20.0 108.34 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.31 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.308 -0.86 . . . . 20.0 114.56 -168.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . 0.485 ' O ' HD13 ' A' ' 98' ' ' LEU . . . -67.19 -47.94 69.42 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.399 1.259 . . . . 20.0 114.399 -156.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.15 11.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.518 1.054 . . . . 20.0 112.649 -155.369 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.13 35.48 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 102.63 -3.1 . . . . 20.0 102.63 159.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 CA-C-N 120.733 1.298 . . . . 20.0 110.553 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.276 0 CA-C-N 119.223 0.758 . . . . 20.0 110.65 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.799 0.809 . . . . 20.0 109.974 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.162 -1.051 . . . . 20.0 108.162 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.77 19.5 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.791 -0.363 . . . . 20.0 110.722 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.84 -43.63 1.52 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.948 0.899 . . . . 20.0 113.119 -170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -24.89 59.03 Favored 'Trans proline' 0 C--N 1.358 1.073 0 CA-C-N 120.855 1.341 . . . . 20.0 111.968 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.5 -26.55 30.1 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.823 0.305 . . . . 20.0 111.823 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.93 69.16 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.724 -0.791 . . . . 20.0 110.256 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 111.892 0.33 . . . . 20.0 111.892 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -78.48 90.96 4.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.229 -0.656 . . . . 20.0 109.229 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.122 0.415 . . . . 20.0 112.122 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.53 87.27 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 108.507 -0.923 . . . . 20.0 108.507 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.76 153.61 75.36 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 119.629 0.903 . . . . 20.0 112.384 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.66 42.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.544 -1.207 . . . . 20.0 107.98 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -12.19 59.95 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 118.794 -0.622 . . . . 20.0 112.362 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 138' ' ' GLN . 14.1 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.888 -0.577 . . . . 20.0 111.354 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 139' ' ' ILE . 3.9 tp-100 174.68 174.12 0.2 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 103.13 -2.915 . . . . 20.0 103.13 133.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ILE . . . . . 0.421 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 1.2 tp -74.85 168.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.107 0.963 . . . . 20.0 108.978 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.4 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.993 0.917 . . . . 20.0 110.509 177.353 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.416 HD13 HD13 ' A' ' 162' ' ' ILE . 30.2 mt -124.64 147.49 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.607 -0.886 . . . . 20.0 108.607 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -119.09 134.72 55.03 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.662 0.785 . . . . 20.0 109.636 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.91 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 O-C-N 123.679 0.612 . . . . 20.0 111.777 166.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 142' ' ' ASP . . . 86.82 -6.49 82.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 115.486 0.954 . . . . 20.0 115.486 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.49 1.145 . . . . 20.0 110.263 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.83 33.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.42 162.62 40.21 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.976 0.893 . . . . 20.0 111.412 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.47 80.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.263 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.42 -47.03 87.87 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.827 -0.349 . . . . 20.0 110.91 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.33 -35.24 76.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.54 -0.464 . . . . 20.0 110.807 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.58 84.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.032 -0.667 . . . . 20.0 111.141 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.34 58.52 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.346 -0.941 . . . . 20.0 110.999 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.63 -30.11 66.65 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.797 -0.761 . . . . 20.0 110.665 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.57 -40.6 92.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.57 -0.452 . . . . 20.0 111.659 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.79 6.71 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 118.936 -0.925 . . . . 20.0 114.652 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.68 133.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.454 1.127 . . . . 20.0 108.548 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.92 9.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.746 -1.205 . . . . 20.0 107.746 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.3 147.32 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.628 -1.249 . . . . 20.0 107.628 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.823 -1.711 . . . . 20.0 108.823 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -79.46 113.61 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 165.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -19.97 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 113.759 1.022 . . . . 20.0 113.759 -166.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ILE . . . . . 0.57 ' CG1' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -111.7 155.63 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 121.662 -0.649 . . . . 20.0 111.772 -159.2 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 164' ' ' TRP . 3.5 t -145.33 -166.39 2.42 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.308 1.043 . . . . 20.0 110.423 171.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' TRP . . . . . 0.542 ' N ' ' OG1' ' A' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.85 16.74 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.211 0.819 . . . . 20.0 113.211 -160.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' O ' ' NE2' ' C' ' 101' ' ' GLN . 7.5 t70 63.66 61.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.224 0.535 . . . . 20.0 112.317 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.84 158.63 29.63 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB3' HH12 ' C' ' 102' ' ' ARG . 0.0 OUTLIER -142.41 148.35 37.67 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.725 -1.213 . . . . 20.0 107.725 170.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.58 30.38 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.069 -0.968 . . . . 20.0 110.263 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.944 0.878 . . . . 20.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.2 34.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.216 -1.356 . . . . 20.0 109.465 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 151.6 29.1 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.509 -0.552 . . . . 20.0 109.509 168.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 175' ' ' ARG . . . 57.01 68.64 1.59 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.95 4.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.75 0.648 . . . . 20.0 112.75 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -63.02 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.736 -0.786 . . . . 20.0 111.206 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.9 ptt-85 -169.84 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.587 0.631 . . . . 20.0 112.655 172.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.842 2.457 . . . . 20.0 106.263 157.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.7 145.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.23 -64.39 1.17 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.32 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.776 0.716 . . . . 20.0 112.144 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.75 36.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PHE . . . . . 0.758 ' HB3' ' HB3' ' A' ' 327' ' ' GLU . 3.1 t80 -84.62 -66.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.594 0.634 . . . . 20.0 111.8 -162.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.38 127.88 32.91 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.123 0.963 . . . . 20.0 110.665 -152.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.73 1.04 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.339 1.456 . . . . 20.0 113.166 174.659 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.88 1.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.171 0.986 . . . . 20.0 110.819 157.126 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 104.475 -2.417 . . . . 20.0 104.475 149.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.725 ' O ' ' OG1' ' A' ' 189' ' ' THR . . . -50.09 -43.02 51.3 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.32 -0.855 . . . . 20.0 111.502 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.86 -36.09 76.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.33 -0.948 . . . . 20.0 110.118 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.87 -38.57 91.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.12 -1.032 . . . . 20.0 110.546 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' THR . . . . . 0.725 ' OG1' ' O ' ' A' ' 186' ' ' ALA . 25.2 p -59.16 -48.57 81.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.82 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.35 -50.53 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.875 0.369 . . . . 20.0 110.467 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.18 96.18 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.95 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.88 -36.51 84.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.954 -0.699 . . . . 20.0 110.37 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 189' ' ' THR . 11.6 t -60.57 -44.82 97.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.06 0.457 . . . . 20.0 110.082 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.33 75.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.222 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.55 -38.16 71.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.876 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.68 -26.18 41.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.55 0.574 . . . . 20.0 112.55 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.54 122.79 27.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.3 -0.63 . . . . 20.0 109.3 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.43 -57.05 2.33 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.288 0.367 . . . . 20.0 110.113 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.36 17.49 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.691 -0.485 . . . . 20.0 109.691 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.24 4.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.189 -0.671 . . . . 20.0 109.189 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.74 -14.57 59.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.036 -0.666 . . . . 20.0 111.349 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.66 30.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.912 -0.773 . . . . 20.0 108.912 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' A' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.96 16.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -174.5 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.54 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -170.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.92 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.046 -0.724 . . . . 20.0 109.046 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.87 125.37 31.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' VAL . . . . . 0.697 HG12 HD13 ' A' ' 53' ' ' ILE . 34.0 m -119.92 150.16 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.887 -0.783 . . . . 20.0 108.887 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.32 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.86 159.95 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.882 0.849 . . . . 20.0 111.113 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.43 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.22 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.19 29.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.478 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.51 13.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.966 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -20.4 64.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.272 -0.571 . . . . 20.0 111.442 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 89.1 t -131.15 121.13 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.09 60.95 6.21 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 119.65 -1.262 . . . . 20.0 111.406 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -47.05 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.474 0.916 . . . . 20.0 113.474 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.51 -4.52 2.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.7 -40.48 40.92 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 119.7 -1.238 . . . . 20.0 112.001 168.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' A' ' 222' ' ' SER . . . -65.28 -37.06 86.02 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.287 -0.537 . . . . 20.0 111.361 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.409 ' HB2' ' HB1' ' A' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.7 57.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.173 0.434 . . . . 20.0 112.173 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 76.0 p -58.48 -45.85 87.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.054 -0.658 . . . . 20.0 110.83 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 219' ' ' ALA . 2.1 p -58.01 -35.82 71.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 20.0 111.378 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.462 ' HB2' ' HD2' ' E' ' 307' ' ' LYS . 78.9 t80 -64.12 -33.43 75.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.853 -165.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.72 74.95 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 118.965 -1.588 . . . . 20.0 112.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.03 -45.63 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 112.007 0.373 . . . . 20.0 112.007 -158.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLU . . . . . 0.456 ' OE1' ' OG1' ' A' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.63 99.79 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 118.204 2.668 . . . . 20.0 118.204 -158.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.96 143.71 2.98 Favored 'Trans proline' 0 C--O 1.232 0.209 0 N-CA-C 116.005 1.502 . . . . 20.0 116.005 -134.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.18 -4.77 0.77 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.231 1.412 . . . . 20.0 113.403 162.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.25 11.48 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.124 -0.63 . . . . 20.0 111.808 167.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.5 16.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.91 -0.662 . . . . 20.0 112.285 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.77 170.73 15.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.77 -0.826 . . . . 20.0 108.77 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.03 23.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.201 0.524 . . . . 20.0 110.39 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ILE . . . . . 0.48 HD11 ' CE ' ' A' ' 341' ' ' MET . 51.6 mt -133.18 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.568 -1.271 . . . . 20.0 107.568 172.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 68' ' ' HIS . 25.4 t0 -135.16 173.21 11.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.983 -1.488 . . . . 20.0 106.983 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.692 0.758 . . . . 20.0 111.432 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.444 HG21 ' HA3' ' A' ' 296' ' ' GLY . 9.1 t -165.62 122.79 1.46 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.342 -1.355 . . . . 20.0 107.342 164.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 237' ' ' THR . 17.9 mm -145.53 151.87 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -161.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.24 9.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.862 -1.533 . . . . 20.0 106.862 158.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.5 110.02 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.989 0.737 . . . . 20.0 112.989 -155.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.33 36.19 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.936 1.295 . . . . 20.0 112.472 158.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.45 78.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 105.118 -2.178 . . . . 20.0 105.118 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 CA-C-N 120.825 1.33 . . . . 20.0 112.348 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.23 45.22 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.048 -0.978 . . . . 20.0 114.922 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.16 164.51 22.98 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.638 1.219 . . . . 20.0 110.632 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.01 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.328 -0.543 0 CA-C-O 121.904 0.71 . . . . 20.0 111.962 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.718 -1.128 . . . . 20.0 112.035 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.33 -18.67 63.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.821 -0.751 . . . . 20.0 112.846 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.718 ' O ' ' OG1' ' A' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.252 0.834 . . . . 20.0 113.252 170.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -37.76 88.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.279 -0.569 . . . . 20.0 111.349 -172.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -20.94 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.092 -1.043 . . . . 20.0 111.937 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.718 ' OG1' ' O ' ' A' ' 249' ' ' LYS . 39.5 p -57.17 -31.85 65.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.462 0.574 . . . . 20.0 111.329 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.391 0.615 . . . . 20.0 110.363 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.3 3.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.979 -1.009 . . . . 20.0 112.305 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.3 35.97 5.83 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 126.165 1.84 . . . . 20.0 111.542 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.21 10.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.655 -0.868 . . . . 20.0 108.655 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.27 3.34 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 122.667 1.148 . . . . 20.0 113.348 169.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.569 -0.9 . . . . 20.0 108.569 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 316' ' ' SER . . . -126.4 120.35 29.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.128 -0.942 . . . . 20.0 109.422 -169.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.02 139.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LYS . . . . . 0.76 ' HE3' HG21 ' A' ' 298' ' ' THR . 1.9 mtmm -98.85 122.64 42.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.75 -40.29 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 20.0 109.612 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.402 0.62 . . . . 20.0 109.343 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.07 -169.95 2.85 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.784 -1.098 . . . . 20.0 108.209 165.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.97 -56.27 21.5 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.782 -0.645 . . . . 20.0 110.262 163.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.15 11.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.667 0.988 . . . . 20.0 113.667 -165.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.83 143.66 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -163.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.21 103.98 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.172 -1.788 . . . . 20.0 106.172 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.1 56.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.286 0.565 . . . . 20.0 111.317 -171.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.11 109.71 2.01 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.166 -0.924 . . . . 20.0 108.681 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -67.5 -19.96 48.24 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 N-CA-C 114.845 1.056 . . . . 20.0 114.845 -160.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.65 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.168 -0.613 . . . . 20.0 110.587 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.54 -48.38 77.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.14 0.495 . . . . 20.0 110.136 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.16 -52.47 60.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.823 0.344 . . . . 20.0 110.723 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.43 -31.93 70.88 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.881 -0.728 . . . . 20.0 110.493 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' TRP . . . . . 0.495 ' HH2' ' HB3' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -68.45 -47.99 65.72 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.013 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.72 89.78 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.982 -0.687 . . . . 20.0 110.752 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.63 -47.9 78.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.518 -0.473 . . . . 20.0 110.123 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.84 -40.4 88.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.877 -0.329 . . . . 20.0 110.741 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.112 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.06 -31.73 73.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.004 -0.678 . . . . 20.0 111.02 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.77 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.141 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.88 -37.63 73.06 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.88 -0.728 . . . . 20.0 110.98 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.63 15.48 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.8 32.14 13.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.705 0.764 . . . . 20.0 111.546 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.28 143.42 34.47 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.338 -0.986 . . . . 20.0 108.338 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.19 149.34 13.42 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 CA-C-N 119.195 0.748 . . . . 20.0 111.389 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.02 148.11 23.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.679 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.98 175.1 5.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.735 -1.209 . . . . 20.0 107.735 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.69 113.73 17.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.864 -1.162 . . . . 20.0 107.864 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.69 43.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.06 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.68 12.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.46 0.648 . . . . 20.0 110.281 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.77 -18.53 21.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.83 -1.077 . . . . 20.0 112.186 165.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.963 -0.855 . . . . 20.0 110.963 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 237' ' ' THR . . . 101.56 144.81 15.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.652 -0.774 . . . . 20.0 112.674 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.337 -1.105 . . . . 20.0 110.337 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' THR . . . . . 0.76 HG21 ' HE3' ' A' ' 261' ' ' LYS . 20.4 p -110.21 172.94 6.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.015 0.912 . . . . 20.0 111.411 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.379 -1.282 . . . . 20.0 111.261 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.33 74.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 111.768 0.285 . . . . 20.0 111.768 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.12 96.89 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.173 -1.013 . . . . 20.0 112.083 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 220' ' ' ARG . . . -68.31 -26.87 65.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.21 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.95 -34.43 55.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.115 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.15 60.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.315 0.857 . . . . 20.0 113.315 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' J' ' 217' ' ' ARG . 4.1 mp -103.77 -8.93 19.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.724 1.009 . . . . 20.0 113.724 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' THR . . . . . 0.456 ' OG1' ' OE1' ' A' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.619 0.723 . . . . 20.0 110.557 171.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.474 ' HD2' ' HB2' ' J' ' 224' ' ' PHE . 21.5 mmtt -61.68 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.235 -0.893 . . . . 20.0 113.324 -161.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.85 -25.25 66.33 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.79 65.1 1.94 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.829 -0.701 . . . . 20.0 113.311 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.21 139.57 52.62 Favored Pre-proline 0 C--O 1.239 0.505 0 CA-C-N 117.585 0.692 . . . . 20.0 111.161 -163.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.5 141.69 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 CA-C-N 119.509 0.86 . . . . 20.0 110.046 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.7 m -140.46 135.87 32.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.311 -0.859 . . . . 20.0 111.202 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.66 162.57 12.34 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 109.164 -1.575 . . . . 20.0 109.164 164.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.0 27.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 20.0 110.089 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.27 21.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.594 -1.184 . . . . 20.0 109.254 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' ALA . 4.2 m -138.47 133.5 32.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.32 -0.855 . . . . 20.0 109.5 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 185' ' ' ILE . 92.1 t -99.44 108.59 51.23 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 107.254 -1.387 . . . . 20.0 107.254 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.34 -168.95 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.618 1.007 . . . . 20.0 113.608 -154.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 253' ' ' HIS . . . 79.72 35.54 0.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 113.554 -1.657 . . . . 20.0 115.308 161.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.59 33.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.751 0.786 . . . . 20.0 110.044 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 321' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 320' ' ' ARG . 3.3 m-85 -113.1 166.14 11.71 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.809 -1.552 . . . . 20.0 106.809 160.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.21 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.15 0.98 . . . . 20.0 108.423 -163.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.54 -7.49 3.28 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.433 1.271 . . . . 20.0 114.433 -140.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 324' ' ' SER . . . . . 0.594 ' OG ' HG21 ' A' ' 97' ' ' THR . 0.1 OUTLIER -59.47 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.651 0.611 . . . . 20.0 112.651 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 35.1 p-10 -102.01 -56.15 2.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.996 1.48 . . . . 20.0 114.996 -152.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.96 50.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.433 -1.321 . . . . 20.0 107.433 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 181' ' ' PHE . 82.8 mt-10 -142.56 52.8 1.42 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.812 -1.54 . . . . 20.0 109.964 -153.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.05 149.41 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.393 0.616 . . . . 20.0 111.961 -171.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.886 0.851 . . . . 20.0 109.472 175.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.12 27.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.605 -1.18 . . . . 20.0 108.884 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.11 -32.03 53.83 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.825 0.703 . . . . 20.0 111.514 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ARG . . . . . 0.439 ' NH2' ' OE2' ' C' ' 146' ' ' GLU . 10.3 mtm180 -68.6 -44.81 73.52 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.345 -0.542 . . . . 20.0 110.253 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.94 -45.05 83.25 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.777 -0.369 . . . . 20.0 111.049 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.57 -41.3 92.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.464 -0.495 . . . . 20.0 110.518 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -34.68 71.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 118.831 -1.148 . . . . 20.0 110.119 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.39 93.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.038 -0.665 . . . . 20.0 110.446 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.52 -43.84 80.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.74 0.305 . . . . 20.0 110.903 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' VAL . . . . . 0.703 ' O ' ' OG1' ' A' ' 342' ' ' THR . 42.6 t -60.15 -48.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.994 0.426 . . . . 20.0 110.248 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' GLU . . . . . 0.782 ' OE1' ' NZ ' ' A' ' 343' ' ' LYS . 1.3 mm-40 -54.89 -46.86 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.967 0.413 . . . . 20.0 110.771 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -55.15 37.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 20.0 111.403 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' MET . . . . . 0.48 ' CE ' HD11 ' A' ' 234' ' ' ILE . 31.9 tpp -60.21 -40.32 89.68 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.203 -0.599 . . . . 20.0 110.785 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' A' ' 338' ' ' VAL . 1.3 m -56.53 -44.96 81.33 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.121 0.486 . . . . 20.0 110.411 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' LYS . . . . . 0.782 ' NZ ' ' OE1' ' A' ' 339' ' ' GLU . 34.6 mttp -74.24 -37.47 63.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.961 -0.696 . . . . 20.0 110.76 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.53 97.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.538 -0.465 . . . . 20.0 111.1 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 348' ' ' ILE . 1.0 OUTLIER -58.99 -50.4 74.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.555 -0.458 . . . . 20.0 110.782 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.06 90.93 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.7 -0.8 . . . . 20.0 110.594 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' ASN . . . . . 0.495 ' HB3' ' HH2' ' A' ' 276' ' ' TRP . 5.0 m-20 -84.47 4.77 30.2 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.446 -0.901 . . . . 20.0 112.568 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 345' ' ' LEU . 1.3 tt -65.2 -23.67 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 119.574 -0.85 . . . . 20.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.83 -27.27 69.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.786 -0.765 . . . . 20.0 111.235 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -85.94 -18.83 31.6 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.058 -0.401 . . . . 20.0 111.467 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 351' ' ' LEU . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.131 0.419 . . . . 20.0 112.131 -173.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.026 1.862 . . . . 20.0 116.026 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 124.99 1.316 . . . . 20.0 108.381 -174.706 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 114.257 1.206 . . . . 20.0 114.257 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.07 82.22 2.92 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 106.878 -1.527 . . . . 20.0 106.878 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.93 -34.52 66.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 114.904 -1.044 . . . . 20.0 110.198 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -107.0 -23.53 12.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.61 0.967 . . . . 20.0 113.61 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.24 19.89 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.147 0.979 . . . . 20.0 111.623 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.71 32.45 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 122.275 -0.266 . . . . 20.0 111.24 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.43 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.655 -1.239 . . . . 20.0 107.655 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.87 112.21 12.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.309 0.576 . . . . 20.0 110.943 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.468 -0.787 . . . . 20.0 111.83 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.08 -45.23 74.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.251 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -43.1 97.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 121.049 -0.26 . . . . 20.0 111.195 -172.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.85 -30.59 70.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.786 -0.366 . . . . 20.0 111.167 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.4 90.78 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.639 -0.424 . . . . 20.0 110.498 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.03 -42.99 91.54 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.676 -0.238 . . . . 20.0 111.476 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.87 -40.1 26.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.532 -0.867 . . . . 20.0 110.661 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 119.042 -1.063 . . . . 20.0 111.001 -162.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -26.01 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.966 -0.693 . . . . 20.0 111.293 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.42 70.56 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.801 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -85.18 144.73 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.459 0 CA-C-O 121.709 0.629 . . . . 20.0 112.145 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.83 38.23 3.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 117.277 1.671 . . . . 20.0 117.277 -159.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.2 8.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 20.0 110.713 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.032 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.41 0.18 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.28 1.038 . . . . 20.0 109.568 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.87 -13.2 3.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.891 -1.049 . . . . 20.0 113.465 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' B' ' 28' ' ' GLY . 0.0 OUTLIER -87.92 8.97 23.73 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.712 1.142 . . . . 20.0 113.806 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.66 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.433 1.642 . . . . 20.0 115.433 -154.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 26' ' ' PHE . . . -53.07 -26.99 29.42 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 119.775 1.171 . . . . 20.0 116.023 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ILE . . . . . 0.539 HD13 ' NH1' ' B' ' 184' ' ' ARG . 1.1 tt -59.57 -35.75 61.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 118.06 0.93 . . . . 20.0 110.643 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.36 -52.4 61.73 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.895 0.379 . . . . 20.0 110.403 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.58 74.42 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.33 -0.395 . . . . 20.0 110.984 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.3 -49.54 82.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.039 0.447 . . . . 20.0 110.338 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.21 -39.74 86.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.709 -0.797 . . . . 20.0 110.309 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.47 20.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 118.72 -1.192 . . . . 20.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.53 -30.95 71.67 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.0 0.364 . . . . 20.0 111.08 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.68 3.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.184 0.438 . . . . 20.0 112.184 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.34 -28.43 44.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.492 -0.322 . . . . 20.0 111.53 -164.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.34 -26.41 63.74 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.97 -0.692 . . . . 20.0 112.244 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.1 -23.56 63.07 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 118.914 -1.114 . . . . 20.0 111.726 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.94 22.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.479 0.918 . . . . 20.0 113.479 -176.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.57 152.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.08 -42.65 89.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.168 -0.924 . . . . 20.0 111.474 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.3 35.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.548 -0.908 . . . . 20.0 108.548 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.46 147.21 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.12 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.518 0.675 . . . . 20.0 110.443 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.06 129.02 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.351 -1.351 . . . . 20.0 107.351 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.12 5.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.811 0.815 . . . . 20.0 108.857 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.51 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.133 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.24 10.86 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.631 0.975 . . . . 20.0 113.631 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.67 83.35 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 119.124 -0.82 . . . . 20.0 114.458 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.44 35.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.457 1.128 . . . . 20.0 110.239 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.37 140.27 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ILE . . . . . 0.694 HD13 HG12 ' B' ' 207' ' ' VAL . 31.3 mm -130.28 115.67 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 -174.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.677 -0.49 . . . . 20.0 109.677 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.93 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.6 -0.889 . . . . 20.0 108.6 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 145.37 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.745 -1.576 . . . . 20.0 106.745 163.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.52 20.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.492 0.495 . . . . 20.0 109.74 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.62 10.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.829 0.852 . . . . 20.0 108.978 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.53 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.093 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.76 165.22 32.81 Favored 'Trans proline' 0 C--N 1.331 -0.378 0 CA-C-O 121.76 0.65 . . . . 20.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.92 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.995 -1.002 . . . . 20.0 109.255 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.74 137.96 30.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.777 -0.824 . . . . 20.0 108.777 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.09 46.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.083 0.953 . . . . 20.0 109.026 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -116.28 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.075 -1.083 . . . . 20.0 108.075 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.63 124.65 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.329 0.393 . . . . 20.0 110.968 -168.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.5 154.59 45.97 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.887 0.875 . . . . 20.0 108.925 167.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' B' ' 235' ' ' ASP . 0.0 OUTLIER -105.03 146.46 29.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.99 -0.55 . . . . 20.0 110.534 177.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.188 -0.915 . . . . 20.0 109.711 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.645 -0.66 . . . . 20.0 112.445 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.93 28.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.234 -1.025 . . . . 20.0 108.234 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.8 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.778 0.831 . . . . 20.0 109.127 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . 0.461 ' C ' HD23 ' B' ' 74' ' ' LEU . . . -155.79 -175.7 27.09 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.576 -1.01 . . . . 20.0 110.576 173.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.461 HD23 ' C ' ' B' ' 73' ' ' GLY . 5.1 mt -125.06 161.45 26.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.356 0.598 . . . . 20.0 109.954 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' MET . . . . . 0.53 ' HB2' HG23 ' B' ' 160' ' ' THR . 10.6 ttm -128.09 131.39 49.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 20.0 109.709 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.54 137.08 23.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.862 -0.792 . . . . 20.0 108.862 168.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.1 -29.26 7.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.102 0.778 . . . . 20.0 113.102 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.06 174.42 13.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.132 -1.062 . . . . 20.0 108.132 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.6 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.832 0.825 . . . . 20.0 109.998 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.02 60.32 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.705 -0.798 . . . . 20.0 112.687 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.53 9.12 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.317 0.858 . . . . 20.0 113.317 -177.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.8 81.74 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 118.99 -0.894 . . . . 20.0 115.079 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.83 145.04 34.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.335 1.067 . . . . 20.0 110.218 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.5 28.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.235 -0.893 . . . . 20.0 112.604 -172.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.883 -1.154 . . . . 20.0 107.883 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.76 163.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.654 0.74 . . . . 20.0 109.433 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.29 129.31 15.56 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 114.997 -1.002 . . . . 20.0 109.828 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.77 160.24 24.67 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.268 0.862 . . . . 20.0 112.721 -171.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ILE . . . . . 0.481 HD11 HG21 ' B' ' 160' ' ' THR . 9.2 mt -88.77 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 113.711 -1.586 . . . . 20.0 107.364 165.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.02 140.97 47.51 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.258 -0.883 . . . . 20.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.19 22.2 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 118.938 -0.923 . . . . 20.0 115.252 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.82 152.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 118.639 1.219 . . . . 20.0 109.258 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.92 22.25 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 108.473 -0.936 . . . . 20.0 108.473 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.04 -7.95 13.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 CA-C-N 120.575 1.241 . . . . 20.0 114.83 -170.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.2 -15.34 59.75 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.149 0.886 . . . . 20.0 111.781 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.6 HG21 ' OG ' ' B' ' 324' ' ' SER . 44.7 p -89.38 35.48 0.81 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.666 0.786 . . . . 20.0 112.458 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.681 HD12 ' H ' ' B' ' 99' ' ' ILE . 0.5 OUTLIER -43.28 -66.41 0.38 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.985 1.314 . . . . 20.0 113.395 -173.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ILE . . . . . 0.681 ' H ' HD12 ' B' ' 98' ' ' LEU . 1.6 tt -173.21 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 174.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' H ' ' D' ' 100' ' ' ALA . . . -123.95 -19.04 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.628 -1.169 . . . . 20.0 111.242 158.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' GLN . . . . . 0.406 ' HB3' HH21 ' B' ' 102' ' ' ARG . 0.0 OUTLIER -169.31 141.65 2.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.665 -0.865 . . . . 20.0 108.665 176.711 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' D' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.53 0.38 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 115.242 1.571 . . . . 20.0 115.242 150.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 103' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' B' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.23 36.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.236 0.925 . . . . 20.0 109.442 160.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.79 140.23 37.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.571 -0.741 . . . . 20.0 109.404 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 105' ' ' VAL . . . . . 0.568 HG22 ' CG1' ' B' ' 162' ' ' ILE . 50.4 t -117.38 110.78 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.242 -1.021 . . . . 20.0 108.242 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.56 83.05 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.255 -0.276 . . . . 20.0 110.255 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -51.91 -54.18 14.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.378 0.424 . . . . 20.0 110.377 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.63 177.48 10.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.388 -0.967 . . . . 20.0 108.388 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.34 27.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.891 -1.05 . . . . 20.0 110.463 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.28 74.98 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 118.83 -0.984 . . . . 20.0 115.308 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.05 113.97 15.81 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.508 1.154 . . . . 20.0 108.592 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.26 141.51 37.8 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.658 -0.867 . . . . 20.0 108.658 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.68 149.4 31.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.992 -1.004 . . . . 20.0 110.32 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 103' ' ' PHE . . . -147.95 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.288 -1.125 . . . . 20.0 110.288 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.4 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.363 -0.977 . . . . 20.0 108.363 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.321 -0.854 . . . . 20.0 114.565 -168.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' ALA . . . . . 0.497 ' O ' HD13 ' B' ' 98' ' ' LEU . . . -67.18 -47.98 69.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 114.326 1.232 . . . . 20.0 114.326 -156.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.58 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.549 1.068 . . . . 20.0 112.706 -155.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.12 35.51 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 102.616 -3.105 . . . . 20.0 102.616 159.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.85 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 120.677 1.278 . . . . 20.0 110.548 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.79 149.73 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 CA-C-N 119.209 0.753 . . . . 20.0 110.692 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.03 165.4 7.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.832 . . . . 20.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.138 -1.06 . . . . 20.0 108.138 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.88 19.78 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.818 0.342 . . . . 20.0 110.764 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.01 -43.6 1.47 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.93 0.892 . . . . 20.0 113.074 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.02 -24.92 59.41 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.879 1.35 . . . . 20.0 111.998 170.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.51 30.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 111.807 0.299 . . . . 20.0 111.807 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.98 69.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.251 168.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.96 62.73 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.953 0.353 . . . . 20.0 111.953 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.41 90.85 4.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.262 -0.644 . . . . 20.0 109.262 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.41 7.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.125 0.417 . . . . 20.0 112.125 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.21 142.58 87.36 Favored Pre-proline 0 N--CA 1.444 -0.728 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.82 153.64 75.12 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 CA-C-N 119.646 0.909 . . . . 20.0 112.329 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.69 153.66 42.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.481 -1.236 . . . . 20.0 107.935 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.27 59.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.85 -0.595 . . . . 20.0 112.405 -175.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 138' ' ' GLN . 14.2 p30 -55.3 -66.39 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.91 -0.567 . . . . 20.0 111.409 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 138' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' B' ' 139' ' ' ILE . 3.9 tp-100 174.66 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.079 -2.934 . . . . 20.0 103.079 133.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 139' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' B' ' 138' ' ' GLN . 1.2 tp -74.86 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.124 0.97 . . . . 20.0 108.918 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' B' ' 139' ' ' ILE . 0.3 OUTLIER -114.84 161.47 18.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.947 0.899 . . . . 20.0 110.536 177.35 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 141' ' ' ILE . . . . . 0.406 HD13 HD13 ' B' ' 162' ' ' ILE . 30.5 mt -124.67 147.46 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' B' ' 144' ' ' GLY . 0.5 OUTLIER -119.06 134.81 54.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.578 0.751 . . . . 20.0 109.577 175.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.83 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 123.663 0.602 . . . . 20.0 111.818 166.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' B' ' 142' ' ' ASP . . . 86.89 -6.62 82.72 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.11 144.0 54.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.476 1.138 . . . . 20.0 110.353 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 146' ' ' GLU . . . . . 0.4 ' OE2' ' NH2' ' D' ' 332' ' ' ARG . 94.2 mt-10 -83.32 -20.9 33.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.624 0.972 . . . . 20.0 113.624 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.61 40.2 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.982 0.896 . . . . 20.0 111.403 -173.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.4 -41.46 80.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.867 -1.515 . . . . 20.0 111.26 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.48 -46.98 88.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.83 -0.348 . . . . 20.0 110.905 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.33 -35.19 76.71 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.472 -0.491 . . . . 20.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.61 84.28 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.122 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.35 58.49 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.388 -0.925 . . . . 20.0 111.009 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.11 66.61 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 119.782 -0.767 . . . . 20.0 110.61 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.57 -40.67 92.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.569 -0.452 . . . . 20.0 111.614 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.75 6.69 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 118.952 -0.915 . . . . 20.0 114.606 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.68 133.56 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 118.447 1.124 . . . . 20.0 108.567 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.747 -1.205 . . . . 20.0 107.747 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.65 -1.241 . . . . 20.0 107.65 174.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.36 169.34 15.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 108.81 -1.716 . . . . 20.0 108.81 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 160' ' ' THR . . . . . 0.53 HG23 ' HB2' ' B' ' 75' ' ' MET . 0.2 OUTLIER -79.41 113.59 17.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.656 -1.238 . . . . 20.0 107.656 165.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 113.713 1.005 . . . . 20.0 113.713 -166.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 162' ' ' ILE . . . . . 0.568 ' CG1' HG22 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -111.64 155.63 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.691 -0.631 . . . . 20.0 111.79 -159.189 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 163' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 164' ' ' TRP . 3.5 t -145.34 -166.32 2.4 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.272 1.029 . . . . 20.0 110.465 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 164' ' ' TRP . . . . . 0.555 ' N ' ' OG1' ' B' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.91 16.7 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 113.221 0.823 . . . . 20.0 113.221 -160.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.68 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.227 0.536 . . . . 20.0 112.268 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.94 158.61 29.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.133 -1.187 . . . . 20.0 110.133 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 167' ' ' ARG . . . . . 0.482 ' HB3' HH12 ' D' ' 102' ' ' ARG . 0.0 OUTLIER -142.4 148.31 37.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 170.664 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.58 30.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.068 -0.969 . . . . 20.0 110.216 -167.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -129.41 159.75 35.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.913 0.863 . . . . 20.0 110.002 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.2 34.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 20.0 109.471 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.64 28.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.528 -0.545 . . . . 20.0 109.528 168.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 172' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' B' ' 175' ' ' ARG . . . 56.89 68.72 1.55 Allowed Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -170.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.92 4.25 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.785 0.661 . . . . 20.0 112.785 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.17 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.69 -0.804 . . . . 20.0 111.208 157.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 175' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' B' ' 172' ' ' GLY . 6.8 ptt-85 -169.82 122.01 0.7 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.632 0.651 . . . . 20.0 112.605 172.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.89 2.476 . . . . 20.0 106.278 157.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.69 145.81 20.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.458 -0.942 . . . . 20.0 108.458 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.16 -64.51 1.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.415 2.006 . . . . 20.0 116.415 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 118.715 0.689 . . . . 20.0 112.125 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.92 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.359 1.244 . . . . 20.0 114.359 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 181' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' B' ' 327' ' ' GLU . 3.2 t80 -84.68 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.641 0.655 . . . . 20.0 111.723 -162.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.29 127.83 32.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.085 0.945 . . . . 20.0 110.655 -152.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 183' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' B' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.74 1.04 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.353 1.461 . . . . 20.0 113.157 174.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 184' ' ' ARG . . . . . 0.539 ' NH1' HD13 ' B' ' 29' ' ' ILE . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 122.212 1.006 . . . . 20.0 110.809 157.16 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 185' ' ' ILE . . . . . 0.446 HG12 HG11 ' B' ' 317' ' ' VAL . 1.0 OUTLIER -126.15 -41.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 104.468 -2.419 . . . . 20.0 104.468 149.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 186' ' ' ALA . . . . . 0.703 ' O ' ' OG1' ' B' ' 189' ' ' THR . . . -50.18 -42.93 52.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.401 -0.818 . . . . 20.0 111.488 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.092 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.66 91.93 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.151 -1.02 . . . . 20.0 110.539 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 189' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' B' ' 186' ' ' ALA . 25.2 p -59.09 -48.58 81.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.458 -0.897 . . . . 20.0 110.84 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.55 64.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.966 0.412 . . . . 20.0 110.504 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.17 96.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.069 -0.652 . . . . 20.0 110.918 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.56 84.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.951 -0.7 . . . . 20.0 110.34 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 193' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 189' ' ' THR . 11.5 t -60.56 -44.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 20.0 110.074 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.31 75.48 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.19 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.61 -38.2 70.85 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.878 -0.729 . . . . 20.0 110.777 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.61 -26.16 41.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.76 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.258 -0.645 . . . . 20.0 109.258 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.08 2.32 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.277 0.361 . . . . 20.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.39 17.52 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.0 91.28 4.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.221 -0.659 . . . . 20.0 109.221 -174.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.55 59.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.034 -0.667 . . . . 20.0 111.312 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.69 30.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.914 -0.772 . . . . 20.0 108.914 172.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 203' ' ' ASP . . . . . 0.643 ' N ' ' OD1' ' B' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.02 16.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.487 -0.931 . . . . 20.0 108.487 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.59 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.593 -0.891 . . . . 20.0 108.593 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.96 106.58 8.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 20.0 109.009 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.88 125.4 31.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.774 -0.825 . . . . 20.0 108.774 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 207' ' ' VAL . . . . . 0.694 HG12 HD13 ' B' ' 53' ' ' ILE . 34.1 m -119.96 150.17 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.38 98.78 5.17 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.4 -1.333 . . . . 20.0 107.4 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 34.5 p -85.85 159.96 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.889 0.852 . . . . 20.0 111.129 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.82 166.41 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.19 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.22 29.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.743 -1.117 . . . . 20.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.0 -49.51 13.92 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.387 -0.525 . . . . 20.0 110.974 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -20.42 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.461 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.16 121.09 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.582 -0.895 . . . . 20.0 108.582 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.93 6.26 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.71 -1.233 . . . . 20.0 111.473 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 216' ' ' LEU . . . . . 0.427 ' H ' HD23 ' B' ' 216' ' ' LEU . 0.5 OUTLIER -47.01 -25.51 0.82 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.458 0.91 . . . . 20.0 113.458 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 217' ' ' ARG . . . . . 0.442 ' HB3' ' HG ' ' H' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.52 2.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.358 0.503 . . . . 20.0 112.358 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.53 40.82 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.715 -1.231 . . . . 20.0 112.003 168.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' B' ' 222' ' ' SER . . . -65.27 -37.07 86.04 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 122.247 -0.561 . . . . 20.0 111.37 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 220' ' ' ARG . . . . . 0.411 ' HB2' ' HB1' ' B' ' 302' ' ' ALA . 16.6 ttm180 -52.68 -36.73 57.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 75.8 p -58.4 -45.84 87.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.034 -0.666 . . . . 20.0 110.886 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 219' ' ' ALA . 2.1 p -58.0 -35.79 71.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.741 -0.384 . . . . 20.0 111.462 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.63 -49.95 69.3 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.605 0.594 . . . . 20.0 112.605 -169.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 224' ' ' PHE . . . . . 0.421 ' HB2' ' HD2' ' H' ' 307' ' ' LYS . 79.1 t80 -64.19 -33.45 75.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.78 -0.768 . . . . 20.0 111.771 -165.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.68 74.92 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.953 -1.594 . . . . 20.0 112.12 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.01 -45.58 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.004 0.372 . . . . 20.0 112.004 -158.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 227' ' ' GLU . . . . . 0.437 ' OE1' ' OG1' ' B' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 118.223 2.675 . . . . 20.0 118.223 -158.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -43.89 143.67 2.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 N-CA-C 115.964 1.486 . . . . 20.0 115.964 -134.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.18 -4.78 0.77 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.205 1.402 . . . . 20.0 113.405 162.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.86 171.25 11.5 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.043 -0.663 . . . . 20.0 111.749 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.52 151.42 16.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.943 -0.646 . . . . 20.0 112.323 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.66 170.76 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.785 0.834 . . . . 20.0 108.825 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.06 23.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 20.0 110.403 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 234' ' ' ILE . . . . . 0.495 HD11 ' CE ' ' B' ' 341' ' ' MET . 51.8 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' B' ' 68' ' ' HIS . 25.6 t0 -135.17 173.22 11.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.945 -1.502 . . . . 20.0 106.945 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.624 0.726 . . . . 20.0 111.441 -172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 237' ' ' THR . . . . . 0.446 HG21 ' HA3' ' B' ' 296' ' ' GLY . 9.2 t -165.62 122.71 1.45 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.353 -1.351 . . . . 20.0 107.353 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 237' ' ' THR . 18.0 mm -145.49 151.92 14.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -161.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.869 -1.53 . . . . 20.0 106.869 158.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.04 18.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.985 0.735 . . . . 20.0 112.985 -155.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.32 36.13 22.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.92 1.288 . . . . 20.0 112.528 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.91 128.44 79.05 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 105.173 -2.158 . . . . 20.0 105.173 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.06 165.56 12.14 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 120.889 1.353 . . . . 20.0 112.408 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.31 45.22 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.126 -0.943 . . . . 20.0 114.952 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.13 164.49 23.08 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 118.59 1.195 . . . . 20.0 110.702 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.96 -172.65 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.586 0 CA-C-O 121.858 0.691 . . . . 20.0 111.94 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.85 59.56 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.026 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.3 -18.68 63.11 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.838 -0.745 . . . . 20.0 112.865 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 249' ' ' LYS . . . . . 0.723 ' O ' ' OG1' ' B' ' 252' ' ' THR . 16.9 mttt -98.78 -15.16 19.4 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.238 0.829 . . . . 20.0 113.238 170.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.82 88.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.364 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 119.076 -1.05 . . . . 20.0 111.898 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 252' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' B' ' 249' ' ' LYS . 39.2 p -57.14 -31.83 65.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.473 0.579 . . . . 20.0 111.325 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 253' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' B' ' 319' ' ' ALA . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.303 0.573 . . . . 20.0 110.434 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.45 -1.3 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.987 -1.006 . . . . 20.0 112.275 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 126.204 1.859 . . . . 20.0 111.573 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.38 129.23 10.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.05 174.25 3.35 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-O 122.712 1.173 . . . . 20.0 113.307 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 259' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' B' ' 316' ' ' SER . . . -126.42 120.35 29.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.135 -0.939 . . . . 20.0 109.427 -169.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.0 139.95 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 261' ' ' LYS . . . . . 0.769 ' HE3' HG21 ' B' ' 298' ' ' THR . 1.9 mtmm -98.86 122.65 42.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.001 -0.741 . . . . 20.0 109.001 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.8 -40.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.862 -0.608 . . . . 20.0 109.598 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.57 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.337 -0.616 . . . . 20.0 109.337 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.97 2.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.817 -1.083 . . . . 20.0 108.231 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.798 -0.637 . . . . 20.0 110.261 163.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.1 11.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.82 143.63 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.427 -0.583 . . . . 20.0 109.427 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 104.03 14.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.14 -1.8 . . . . 20.0 106.14 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.39 137.08 56.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.288 0.566 . . . . 20.0 111.305 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.65 1.97 Allowed Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.154 -0.93 . . . . 20.0 108.656 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 271' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -67.41 -20.07 48.63 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.851 1.058 . . . . 20.0 114.851 -160.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.591 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.36 77.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.073 0.463 . . . . 20.0 110.104 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.19 -52.52 59.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 120.823 0.344 . . . . 20.0 110.663 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.36 -31.9 70.77 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.825 -0.75 . . . . 20.0 110.569 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 276' ' ' TRP . . . . . 0.486 ' HH2' ' HB3' ' B' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -47.98 65.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.094 -0.642 . . . . 20.0 110.976 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.75 89.88 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.039 -0.664 . . . . 20.0 110.736 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.57 -48.01 78.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.578 -0.449 . . . . 20.0 110.111 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.75 -40.52 88.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.884 -0.326 . . . . 20.0 110.71 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.23 -45.03 78.0 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.303 -0.559 . . . . 20.0 111.077 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.71 73.0 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.052 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.36 -31.85 65.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.176 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.71 73.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.872 -0.731 . . . . 20.0 111.008 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 284' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -102.56 15.44 29.26 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.33 0.863 . . . . 20.0 113.33 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.85 32.13 13.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.734 0.778 . . . . 20.0 111.555 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.29 143.41 34.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.288 -1.004 . . . . 20.0 108.288 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.21 149.37 13.4 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.164 0.737 . . . . 20.0 111.357 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.12 23.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.639 -0.71 . . . . 20.0 109.702 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.99 175.13 5.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.63 113.73 17.11 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.892 -1.151 . . . . 20.0 107.892 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.65 43.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.577 . . . . 20.0 109.441 -172.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.08 157.03 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.688 -1.226 . . . . 20.0 107.688 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.67 12.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.458 0.647 . . . . 20.0 110.292 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.73 -18.55 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.157 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.964 -0.854 . . . . 20.0 110.964 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 296' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' B' ' 237' ' ' THR . . . 101.5 144.73 15.5 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.648 -0.776 . . . . 20.0 112.689 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.346 -1.101 . . . . 20.0 110.346 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 298' ' ' THR . . . . . 0.769 HG21 ' HE3' ' B' ' 261' ' ' LYS . 20.4 p -110.22 172.88 6.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.086 0.946 . . . . 20.0 111.367 -174.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.89 -33.72 76.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.388 -1.278 . . . . 20.0 111.229 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.35 74.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 111.83 0.308 . . . . 20.0 111.83 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.14 96.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.167 -1.016 . . . . 20.0 112.103 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 220' ' ' ARG . . . -68.33 -26.9 65.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.165 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.85 -34.51 56.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.154 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -14.08 59.9 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.287 0.847 . . . . 20.0 113.287 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 305' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' L' ' 217' ' ' ARG . 4.1 mp -103.78 -8.9 19.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.662 0.986 . . . . 20.0 113.662 -167.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' B' ' 227' ' ' GLU . 0.5 OUTLIER -58.36 157.62 8.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 20.0 110.556 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.79 -29.86 70.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.304 -0.862 . . . . 20.0 113.313 -161.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.2 66.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.76 65.16 1.94 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.869 -0.681 . . . . 20.0 113.332 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.3 139.61 52.29 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 117.582 0.691 . . . . 20.0 111.104 -163.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 CA-C-N 119.476 0.849 . . . . 20.0 110.025 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.46 135.78 32.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.355 -0.839 . . . . 20.0 111.239 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.6 12.32 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.144 -1.582 . . . . 20.0 109.144 164.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.01 27.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.463 0.649 . . . . 20.0 110.033 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -103.98 153.22 21.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.617 -1.174 . . . . 20.0 109.231 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 316' ' ' SER . . . . . 0.411 ' N ' ' O ' ' B' ' 259' ' ' ALA . 4.2 m -138.49 133.55 32.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.286 -0.87 . . . . 20.0 109.474 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 317' ' ' VAL . . . . . 0.446 HG11 HG12 ' B' ' 185' ' ' ILE . 92.1 t -99.47 108.65 51.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.218 -1.401 . . . . 20.0 107.218 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.652 1.022 . . . . 20.0 113.603 -154.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' B' ' 253' ' ' HIS . . . 79.88 35.4 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.594 -1.639 . . . . 20.0 115.269 160.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 321' ' ' TYR . 0.4 OUTLIER -75.59 157.59 33.61 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.71 0.767 . . . . 20.0 110.118 176.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 321' ' ' TYR . . . . . 0.426 ' O ' ' HG3' ' B' ' 320' ' ' ARG . 3.3 m-85 -113.11 166.19 11.66 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.811 -1.552 . . . . 20.0 106.811 160.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.2 113.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.137 0.975 . . . . 20.0 108.447 -163.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.6 -7.39 3.27 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' SER . . . . . 0.6 ' OG ' HG21 ' B' ' 97' ' ' THR . 0.1 OUTLIER -59.46 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.69 0.626 . . . . 20.0 112.69 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 325' ' ' ASN . . . . . 0.433 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 35.0 p-10 -102.0 -56.16 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.006 1.484 . . . . 20.0 115.006 -152.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.97 50.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.454 -1.313 . . . . 20.0 107.454 174.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 327' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' B' ' 181' ' ' PHE . 82.8 mt-10 -142.59 52.85 1.42 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.856 -1.52 . . . . 20.0 109.926 -153.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.04 149.41 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.412 0.625 . . . . 20.0 111.925 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' B' ' 181' ' ' PHE . 0.3 OUTLIER -139.38 179.42 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.904 0.859 . . . . 20.0 109.465 175.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.16 27.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.636 -1.166 . . . . 20.0 108.868 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.09 -32.07 53.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.885 0.741 . . . . 20.0 111.495 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.59 -44.84 73.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.337 -0.545 . . . . 20.0 110.192 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.88 83.38 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.057 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.73 -41.24 91.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 120.397 -0.521 . . . . 20.0 110.456 -173.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -34.7 71.59 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.888 -1.125 . . . . 20.0 110.115 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.04 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.422 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.84 80.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.826 0.346 . . . . 20.0 110.937 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 338' ' ' VAL . . . . . 0.691 ' O ' ' OG1' ' B' ' 342' ' ' THR . 42.7 t -60.16 -48.94 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.014 0.435 . . . . 20.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLU . . . . . 0.777 ' OE1' ' NZ ' ' B' ' 343' ' ' LYS . 1.3 mm-40 -54.86 -46.96 74.76 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.982 0.42 . . . . 20.0 110.752 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.14 37.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.375 -0.375 . . . . 20.0 111.452 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 341' ' ' MET . . . . . 0.495 ' CE ' HD11 ' B' ' 234' ' ' ILE . 31.9 tpp -60.15 -40.33 89.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.199 -0.6 . . . . 20.0 110.813 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 342' ' ' THR . . . . . 0.691 ' OG1' ' O ' ' B' ' 338' ' ' VAL . 1.3 m -56.51 -45.03 81.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.15 0.5 . . . . 20.0 110.398 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 343' ' ' LYS . . . . . 0.777 ' NZ ' ' OE1' ' B' ' 339' ' ' GLU . 34.6 mttp -74.14 -37.49 64.04 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.779 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.577 -0.449 . . . . 20.0 111.122 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' B' ' 348' ' ' ILE . 1.0 OUTLIER -58.98 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.829 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.706 -0.797 . . . . 20.0 110.587 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 347' ' ' ASN . . . . . 0.486 ' HB3' ' HH2' ' B' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.8 30.26 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.42 -0.912 . . . . 20.0 112.479 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 345' ' ' LEU . 1.3 tt -65.21 -23.62 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 119.118 0.872 . . . . 20.0 110.936 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.43 69.19 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.785 -0.766 . . . . 20.0 111.245 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.81 -18.85 31.74 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.111 -0.368 . . . . 20.0 111.485 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' LEU . . . . . 0.443 ' O ' HD12 ' B' ' 351' ' ' LEU . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.122 0.416 . . . . 20.0 112.122 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.03 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.057 1.873 . . . . 20.0 116.057 -169.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 124.933 1.293 . . . . 20.0 108.405 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 114.277 1.214 . . . . 20.0 114.277 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.14 82.23 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.898 -1.519 . . . . 20.0 106.898 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.92 -34.46 66.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 114.869 -1.06 . . . . 20.0 110.222 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.07 -23.48 12.3 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.586 0.958 . . . . 20.0 113.586 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.33 30.37 20.07 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.155 0.982 . . . . 20.0 111.667 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -38.64 32.07 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.115 -0.234 . . . . 20.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.12 117.41 37.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.678 -1.23 . . . . 20.0 107.678 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.2 12.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.386 0.612 . . . . 20.0 110.915 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.55 72.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.821 . . . . 20.0 111.869 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.14 -45.18 74.31 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.548 -0.461 . . . . 20.0 111.21 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -43.12 97.11 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.026 -0.27 . . . . 20.0 111.182 -172.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.6 70.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.766 -0.374 . . . . 20.0 111.155 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.37 90.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.588 -0.445 . . . . 20.0 110.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.92 91.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.632 -0.258 . . . . 20.0 111.524 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.94 -40.06 26.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.505 -0.878 . . . . 20.0 110.7 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.053 -1.059 . . . . 20.0 110.996 -162.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -25.99 68.04 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.948 -0.701 . . . . 20.0 111.298 174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.4 70.61 Favored Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 120.518 -0.473 . . . . 20.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -85.13 144.74 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 120.29 0.66 . . . . 20.0 112.151 -172.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.26 3.4 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 117.269 1.668 . . . . 20.0 117.269 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.71 119.81 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.14 -1.429 . . . . 20.0 107.14 159.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 171.18 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.375 0.607 . . . . 20.0 110.708 -166.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.02 -33.35 2.9 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.487 -0.779 . . . . 20.0 114.026 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.35 0.17 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.291 1.043 . . . . 20.0 109.588 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.93 -13.16 3.99 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.913 -1.04 . . . . 20.0 113.467 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 26' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' C' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 9.07 23.56 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.643 1.11 . . . . 20.0 113.748 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 11.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.42 1.637 . . . . 20.0 115.42 -154.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 28' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' C' ' 26' ' ' PHE . . . -53.2 -26.85 29.94 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 116.009 1.164 . . . . 20.0 116.009 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 29' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' C' ' 184' ' ' ARG . 1.1 tt -59.57 -35.83 61.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 118.095 0.948 . . . . 20.0 110.64 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.24 -52.48 61.22 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.875 0.369 . . . . 20.0 110.442 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.57 74.45 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.328 -0.396 . . . . 20.0 111.007 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.23 -49.64 82.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.048 0.451 . . . . 20.0 110.304 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.22 -39.75 86.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 119.737 -0.785 . . . . 20.0 110.261 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.67 -29.5 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 118.757 -1.177 . . . . 20.0 111.191 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.55 -30.92 71.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.804 -0.358 . . . . 20.0 111.147 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.93 -56.77 3.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.192 0.441 . . . . 20.0 112.192 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.49 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.473 -0.331 . . . . 20.0 111.525 -164.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -26.36 63.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.929 -0.708 . . . . 20.0 112.235 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.49 63.03 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 118.875 -1.13 . . . . 20.0 111.708 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.88 22.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.57 152.67 22.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.59 88.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.195 -0.911 . . . . 20.0 111.441 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.63 158.3 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -173.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.51 147.18 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.25 44.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.467 0.651 . . . . 20.0 110.441 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.1 128.99 74.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.341 -1.355 . . . . 20.0 107.341 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 -176.15 5.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.837 0.827 . . . . 20.0 108.881 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.55 -34.63 62.99 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.099 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.81 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.706 1.002 . . . . 20.0 113.706 -171.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.6 83.42 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 119.134 -0.814 . . . . 20.0 114.521 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.47 35.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.427 1.114 . . . . 20.0 110.235 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 53' ' ' ILE . . . . . 0.715 HD13 HG12 ' C' ' 207' ' ' VAL . 31.4 mm -130.29 115.6 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.304 -1.369 . . . . 20.0 107.304 -174.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.73 36.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.654 -0.499 . . . . 20.0 109.654 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.95 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.613 -0.884 . . . . 20.0 108.613 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.65 145.35 31.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 163.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.46 20.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.675 -0.491 . . . . 20.0 109.675 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.08 23.7 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.099 -0.8 . . . . 20.0 111.099 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.14 105.59 10.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.931 0.893 . . . . 20.0 109.003 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.769 -0.729 . . . . 20.0 114.105 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.27 32.65 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.769 0.654 . . . . 20.0 112.105 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.99 111.34 22.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.007 -0.997 . . . . 20.0 109.271 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 137.92 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.756 -0.831 . . . . 20.0 108.756 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.73 124.08 46.41 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.023 0.929 . . . . 20.0 109.032 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.32 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.071 -1.085 . . . . 20.0 108.071 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.58 51.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.285 0.366 . . . . 20.0 110.993 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.61 45.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.896 0.879 . . . . 20.0 108.924 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 68' ' ' HIS . . . . . 0.494 ' NE2' ' OD1' ' C' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.38 29.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 20.0 110.556 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.85 21.34 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.756 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 70' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' C' ' 183' ' ' ASP . 12.0 t0 -97.44 68.03 2.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.601 -0.687 . . . . 20.0 112.388 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.34 144.87 28.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.713 0.805 . . . . 20.0 109.128 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 73' ' ' GLY . . . . . 0.469 ' C ' HD23 ' C' ' 74' ' ' LEU . . . -155.85 -175.68 27.13 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.59 -1.004 . . . . 20.0 110.59 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 74' ' ' LEU . . . . . 0.469 HD23 ' C ' ' C' ' 73' ' ' GLY . 5.0 mt -125.03 161.44 26.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.262 0.553 . . . . 20.0 110.008 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 75' ' ' MET . . . . . 0.526 ' HB2' HG23 ' C' ' 160' ' ' THR . 10.6 ttm -128.11 131.32 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.273 1.029 . . . . 20.0 109.713 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.56 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 108.815 -0.809 . . . . 20.0 108.815 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.08 -29.39 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.058 0.762 . . . . 20.0 113.058 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.121 -1.066 . . . . 20.0 108.121 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.346 -0.983 . . . . 20.0 108.346 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.77 166.36 5.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.838 0.828 . . . . 20.0 109.958 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -26.99 60.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.645 -0.822 . . . . 20.0 112.724 -169.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.56 9.12 4.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -177.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.78 81.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 118.974 -0.903 . . . . 20.0 115.125 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.8 145.04 34.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.337 1.069 . . . . 20.0 110.227 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.46 28.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.236 -0.893 . . . . 20.0 112.617 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.39 174.56 6.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.69 163.8 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.676 0.75 . . . . 20.0 109.463 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.35 15.62 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.811 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.83 160.2 24.49 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 CA-C-O 122.267 0.861 . . . . 20.0 112.742 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 90' ' ' ILE . . . . . 0.496 HD11 HG21 ' C' ' 160' ' ' THR . 9.3 mt -88.7 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 113.78 -1.554 . . . . 20.0 107.425 165.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.96 140.92 47.48 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 20.0 112.168 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.85 -24.08 22.39 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-O 118.965 -0.908 . . . . 20.0 115.244 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.89 152.62 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.613 1.206 . . . . 20.0 109.214 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.73 130.99 22.18 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 108.412 -0.959 . . . . 20.0 108.412 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.05 -8.03 13.11 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.562 1.236 . . . . 20.0 114.846 -170.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.18 -15.26 59.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.162 0.892 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 97' ' ' THR . . . . . 0.586 HG21 ' OG ' ' C' ' 324' ' ' SER . 44.7 p -89.48 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.666 0.786 . . . . 20.0 112.399 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' C' ' 99' ' ' ILE . 0.5 OUTLIER -43.28 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.991 1.317 . . . . 20.0 113.363 -173.001 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' C' ' 98' ' ' LEU . 1.6 tt -173.23 156.04 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.036 -0.727 . . . . 20.0 109.036 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 100' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 100' ' ' ALA . . . -123.85 -19.0 5.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.648 -1.16 . . . . 20.0 111.303 158.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 101' ' ' GLN . . . . . 0.406 ' C ' HD11 ' C' ' 99' ' ' ILE . 0.0 OUTLIER -169.41 141.67 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.672 -0.862 . . . . 20.0 108.672 176.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 102' ' ' ARG . . . . . 0.452 HH12 ' HB3' ' A' ' 167' ' ' ARG . 0.0 OUTLIER 55.85 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.234 1.568 . . . . 20.0 115.234 150.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 103' ' ' PHE . . . . . 0.589 ' O ' ' N ' ' C' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.22 36.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.3 37.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.553 -0.749 . . . . 20.0 109.397 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 105' ' ' VAL . . . . . 0.581 HG22 ' CG1' ' C' ' 162' ' ' ILE . 50.2 t -117.45 110.72 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.213 -1.032 . . . . 20.0 108.213 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.53 83.03 6.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.58 -0.282 . . . . 20.0 110.304 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.95 -54.17 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 123.331 0.394 . . . . 20.0 110.357 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.49 10.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.433 -0.951 . . . . 20.0 108.433 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.3 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.887 -1.051 . . . . 20.0 110.478 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.18 11.28 75.13 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.908 -0.94 . . . . 20.0 115.335 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.06 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.455 1.128 . . . . 20.0 108.586 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.3 141.55 37.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.352 -0.61 . . . . 20.0 109.352 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.67 142.55 43.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.679 -0.86 . . . . 20.0 108.679 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.77 149.45 31.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.002 -0.999 . . . . 20.0 110.295 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 115' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' C' ' 103' ' ' PHE . . . -147.94 157.77 27.46 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.301 -1.119 . . . . 20.0 110.301 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.338 -0.846 . . . . 20.0 114.597 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 118' ' ' ALA . . . . . 0.486 ' O ' HD13 ' C' ' 98' ' ' LEU . . . -67.17 -47.99 69.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.344 1.239 . . . . 20.0 114.344 -156.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.56 1.073 . . . . 20.0 112.69 -155.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.14 35.57 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.653 -3.092 . . . . 20.0 102.653 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.11 123.82 11.06 Favored 'Trans proline' 0 C--N 1.327 -0.563 0 CA-C-N 120.765 1.309 . . . . 20.0 110.585 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.84 149.79 89.88 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 CA-C-N 119.2 0.75 . . . . 20.0 110.673 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.33 7.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.818 0.818 . . . . 20.0 109.941 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.91 3.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.153 -1.054 . . . . 20.0 108.153 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.81 19.52 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.783 -0.367 . . . . 20.0 110.701 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.93 -43.65 1.49 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.938 0.895 . . . . 20.0 113.053 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.92 59.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 120.872 1.347 . . . . 20.0 111.998 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.51 30.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 111.8 0.296 . . . . 20.0 111.8 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -32.01 69.18 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.203 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.83 62.59 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 111.949 0.351 . . . . 20.0 111.949 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.55 90.92 4.53 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.187 -0.672 . . . . 20.0 109.187 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.29 7.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.112 0.412 . . . . 20.0 112.112 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.14 142.5 87.44 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.533 -0.914 . . . . 20.0 108.533 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.71 153.62 75.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 119.639 0.907 . . . . 20.0 112.391 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.61 42.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.516 -1.22 . . . . 20.0 107.964 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -12.24 59.95 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.784 -0.627 . . . . 20.0 112.369 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 137' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' C' ' 138' ' ' GLN . 14.0 p30 -55.37 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.387 0 CA-C-O 118.939 -0.553 . . . . 20.0 111.375 -175.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 138' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' C' ' 139' ' ' ILE . 3.9 tp-100 174.64 174.1 0.2 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 103.125 -2.917 . . . . 20.0 103.125 133.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 139' ' ' ILE . . . . . 0.415 ' H ' ' HG3' ' C' ' 138' ' ' GLN . 1.2 tp -74.85 168.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.102 0.961 . . . . 20.0 108.947 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 140' ' ' PHE . . . . . 0.404 ' H ' HG13 ' C' ' 139' ' ' ILE . 0.3 OUTLIER -114.87 161.44 18.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.951 0.9 . . . . 20.0 110.511 177.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 141' ' ' ILE . . . . . 0.402 HD13 HD13 ' C' ' 162' ' ' ILE . 30.0 mt -124.66 147.45 29.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.602 -0.888 . . . . 20.0 108.602 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 142' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' C' ' 144' ' ' GLY . 0.5 OUTLIER -119.01 134.75 55.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.655 0.782 . . . . 20.0 109.608 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.93 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.943 -0.571 . . . . 20.0 111.817 166.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 144' ' ' GLY . . . . . 0.547 ' N ' ' OD1' ' C' ' 142' ' ' ASP . . . 86.81 -6.6 82.58 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 115.498 0.959 . . . . 20.0 115.498 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.02 54.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.493 1.146 . . . . 20.0 110.273 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 146' ' ' GLU . . . . . 0.439 ' OE2' ' NH2' ' A' ' 332' ' ' ARG . 94.2 mt-10 -83.44 -20.87 33.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.561 0.949 . . . . 20.0 113.561 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.39 162.65 40.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.939 0.876 . . . . 20.0 111.44 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.37 -41.5 80.3 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 113.892 -1.504 . . . . 20.0 111.268 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.4 -46.97 88.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.0 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.4 -35.14 76.67 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.554 -0.459 . . . . 20.0 110.799 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.61 84.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.08 -0.648 . . . . 20.0 111.077 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.32 58.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.355 -0.938 . . . . 20.0 111.013 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.12 66.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.63 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.61 92.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.554 -0.458 . . . . 20.0 111.63 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.71 6.71 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 118.915 -0.936 . . . . 20.0 114.588 -172.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.72 133.51 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.485 1.142 . . . . 20.0 108.56 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.9 9.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.32 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.37 169.36 15.76 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.833 -1.707 . . . . 20.0 108.833 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 160' ' ' THR . . . . . 0.526 HG23 ' HB2' ' C' ' 75' ' ' MET . 0.2 OUTLIER -79.5 113.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.622 -1.251 . . . . 20.0 107.622 165.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.68 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 113.711 1.004 . . . . 20.0 113.711 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 162' ' ' ILE . . . . . 0.581 ' CG1' HG22 ' C' ' 105' ' ' VAL . 0.5 OUTLIER -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.67 -0.644 . . . . 20.0 111.76 -159.218 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 163' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' C' ' 164' ' ' TRP . 3.5 t -145.38 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.263 1.025 . . . . 20.0 110.458 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 164' ' ' TRP . . . . . 0.551 ' N ' ' OG1' ' C' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.93 16.74 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.213 0.82 . . . . 20.0 113.213 -160.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 165' ' ' ASP . . . . . 0.429 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 7.5 t70 63.69 61.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.848 -0.533 . . . . 20.0 112.323 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.91 158.63 29.54 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.071 -1.212 . . . . 20.0 110.071 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 167' ' ' ARG . . . . . 0.464 ' HB3' HH12 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.39 148.35 37.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.677 -1.231 . . . . 20.0 107.677 170.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.58 30.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.107 -0.952 . . . . 20.0 110.208 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.39 159.76 35.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.905 0.86 . . . . 20.0 109.954 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.197 -1.365 . . . . 20.0 109.484 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.59 29.01 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.51 -0.552 . . . . 20.0 109.51 168.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 172' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' C' ' 175' ' ' ARG . . . 56.92 68.71 1.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.754 0.649 . . . . 20.0 112.754 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.99 1.29 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.719 -0.792 . . . . 20.0 111.254 157.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 175' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' C' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.583 0.629 . . . . 20.0 112.653 172.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.54 169.43 0.35 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.839 2.456 . . . . 20.0 106.244 157.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 46.0 t -144.7 145.78 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.13 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 116.445 2.017 . . . . 20.0 116.445 -166.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 22.25 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.746 0.703 . . . . 20.0 112.157 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.68 36.65 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.396 1.258 . . . . 20.0 114.396 -170.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 181' ' ' PHE . . . . . 0.736 ' HB3' ' HB3' ' C' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.602 0.637 . . . . 20.0 111.806 -162.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.26 127.8 32.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.021 0.915 . . . . 20.0 110.711 -152.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 183' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' C' ' 70' ' ' ASP . 0.6 OUTLIER 69.93 -6.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.371 1.468 . . . . 20.0 113.161 174.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 184' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.16 0.981 . . . . 20.0 110.776 157.115 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 185' ' ' ILE . . . . . 0.436 HG12 HG11 ' C' ' 317' ' ' VAL . 1.0 OUTLIER -126.1 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 186' ' ' ALA . . . . . 0.722 ' O ' ' OG1' ' C' ' 189' ' ' THR . . . -50.18 -42.88 51.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.334 -0.848 . . . . 20.0 111.565 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.89 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 119.288 -0.965 . . . . 20.0 110.102 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.84 -38.59 91.67 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.126 -1.03 . . . . 20.0 110.51 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 189' ' ' THR . . . . . 0.722 ' OG1' ' O ' ' C' ' 186' ' ' ALA . 25.2 p -59.14 -48.54 81.23 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.853 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.36 -50.58 64.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 20.0 110.458 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.21 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.106 -0.638 . . . . 20.0 110.953 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.92 -36.53 84.24 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.93 -0.708 . . . . 20.0 110.287 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 193' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 189' ' ' THR . 11.6 t -60.53 -44.85 97.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.053 0.454 . . . . 20.0 110.113 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.39 75.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.27 -0.572 . . . . 20.0 111.206 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.57 -38.16 70.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.895 -0.722 . . . . 20.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.64 -26.15 41.19 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.619 0.6 . . . . 20.0 112.619 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.55 122.82 27.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.317 -0.623 . . . . 20.0 109.317 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 198' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -112.49 -56.99 2.34 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.292 0.37 . . . . 20.0 110.146 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.23 105.37 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.32 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.81 -14.5 59.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.015 -0.674 . . . . 20.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.67 30.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 203' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' C' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.0 16.3 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.482 -0.933 . . . . 20.0 108.482 -174.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.583 -0.895 . . . . 20.0 108.583 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 205' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -128.94 106.66 9.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.016 -0.735 . . . . 20.0 109.016 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.32 31.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.745 -0.835 . . . . 20.0 108.745 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 207' ' ' VAL . . . . . 0.715 HG12 HD13 ' C' ' 53' ' ' ILE . 34.0 m -119.9 150.18 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.852 -0.796 . . . . 20.0 108.852 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.84 5.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.401 -1.333 . . . . 20.0 107.401 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.87 159.97 19.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.845 0.831 . . . . 20.0 111.131 -165.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.74 166.44 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 114.626 -1.17 . . . . 20.0 108.255 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.64 40.16 29.44 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.808 -1.087 . . . . 20.0 111.508 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.03 -49.53 13.83 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.357 -0.537 . . . . 20.0 110.922 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.42 64.76 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.227 -0.589 . . . . 20.0 111.491 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 214' ' ' VAL . . . . . . . . . . . . . 88.6 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.529 -0.915 . . . . 20.0 108.529 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.98 6.2 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.697 -1.24 . . . . 20.0 111.432 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 216' ' ' LEU . . . . . 0.428 ' H ' HD23 ' C' ' 216' ' ' LEU . 0.5 OUTLIER -46.99 -25.61 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.428 0.899 . . . . 20.0 113.428 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 217' ' ' ARG . . . . . 0.429 ' HB3' ' HG ' ' F' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.49 2.84 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.57 40.92 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.765 -1.207 . . . . 20.0 111.945 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 219' ' ' ALA . . . . . 0.444 ' O ' ' OG ' ' C' ' 222' ' ' SER . . . -65.28 -37.0 85.81 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.248 -0.56 . . . . 20.0 111.406 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 220' ' ' ARG . . . . . 0.4 ' HB2' ' HB1' ' C' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.72 57.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.42 -45.87 87.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.045 -0.662 . . . . 20.0 110.854 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 222' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' C' ' 219' ' ' ALA . 2.1 p -58.01 -35.78 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.759 -0.376 . . . . 20.0 111.439 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.97 69.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.545 0.572 . . . . 20.0 112.545 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 224' ' ' PHE . . . . . 0.455 ' HB2' ' HD2' ' F' ' 307' ' ' LYS . 78.9 t80 -64.22 -33.36 75.62 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.82 -0.752 . . . . 20.0 111.855 -165.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.75 74.93 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.964 -1.588 . . . . 20.0 112.109 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -127.01 -45.61 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 111.987 0.365 . . . . 20.0 111.987 -158.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 227' ' ' GLU . . . . . 0.451 ' OE1' ' OG1' ' C' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.69 99.78 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.88 143.75 2.86 Favored 'Trans proline' 0 N--CA 1.472 0.206 0 N-CA-C 115.99 1.496 . . . . 20.0 115.99 -134.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.76 0.78 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.208 1.403 . . . . 20.0 113.362 162.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.21 11.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.081 -0.648 . . . . 20.0 111.767 167.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.49 151.5 16.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.267 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.73 170.69 15.61 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.786 0.834 . . . . 20.0 108.809 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.63 149.05 23.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.139 0.495 . . . . 20.0 110.378 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 234' ' ' ILE . . . . . 0.492 HD11 ' CE ' ' C' ' 341' ' ' MET . 51.6 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 20.0 107.527 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 235' ' ' ASP . . . . . 0.494 ' OD1' ' NE2' ' C' ' 68' ' ' HIS . 25.5 t0 -135.18 173.26 11.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.918 -1.512 . . . . 20.0 106.918 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.23 149.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.687 0.756 . . . . 20.0 111.417 -172.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 237' ' ' THR . . . . . 0.454 HG21 ' HA3' ' C' ' 296' ' ' GLY . 9.2 t -165.59 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 238' ' ' ILE . . . . . 0.414 HD13 ' O ' ' C' ' 237' ' ' THR . 17.9 mm -145.5 151.88 14.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.238 -1.023 . . . . 20.0 108.238 -161.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.24 9.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.842 -1.54 . . . . 20.0 106.842 158.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.03 18.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.39 36.13 22.21 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.926 1.29 . . . . 20.0 112.482 158.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.99 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 105.158 -2.164 . . . . 20.0 105.158 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.01 165.54 12.07 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 CA-C-N 120.838 1.335 . . . . 20.0 112.372 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.38 45.41 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.056 -0.975 . . . . 20.0 114.885 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.12 164.49 23.1 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.588 1.194 . . . . 20.0 110.678 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 246' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.92 -172.63 0.72 Allowed 'Trans proline' 0 C--N 1.327 -0.558 0 CA-C-O 121.877 0.699 . . . . 20.0 111.978 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.737 -1.12 . . . . 20.0 112.065 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.72 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.855 -0.738 . . . . 20.0 112.84 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 249' ' ' LYS . . . . . 0.713 ' O ' ' OG1' ' C' ' 252' ' ' THR . 16.9 mttt -98.79 -15.09 19.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.221 0.822 . . . . 20.0 113.221 170.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.81 88.78 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.26 -0.576 . . . . 20.0 111.392 -172.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.6 -21.04 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.186 -1.006 . . . . 20.0 111.87 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 252' ' ' THR . . . . . 0.713 ' OG1' ' O ' ' C' ' 249' ' ' LYS . 39.7 p -57.11 -31.85 65.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.486 0.585 . . . . 20.0 111.375 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 253' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' C' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.07 4.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.353 0.597 . . . . 20.0 110.369 176.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.015 -0.993 . . . . 20.0 112.34 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.94 5.83 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.216 1.865 . . . . 20.0 111.55 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.37 129.23 10.2 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.08 174.24 3.37 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 122.667 1.149 . . . . 20.0 113.333 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 258' ' ' THR . . . . . . . . . . . . . 6.1 t -98.75 175.03 6.11 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 259' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' C' ' 316' ' ' SER . . . -126.36 120.3 29.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.159 -0.928 . . . . 20.0 109.404 -169.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 85.2 mt -98.0 139.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.813 -1.18 . . . . 20.0 107.813 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 261' ' ' LYS . . . . . 0.753 ' HE3' HG21 ' C' ' 298' ' ' THR . 1.9 mtmm -98.83 122.65 42.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.78 -40.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.353 0.597 . . . . 20.0 109.645 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.426 0.632 . . . . 20.0 109.378 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.14 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.831 -1.077 . . . . 20.0 108.194 165.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.3 21.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.79 -0.641 . . . . 20.0 110.265 163.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.88 -46.18 11.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.644 0.979 . . . . 20.0 113.644 -165.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.66 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.386 -0.598 . . . . 20.0 109.386 -163.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.146 -1.798 . . . . 20.0 106.146 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 269' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.39 137.12 56.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 20.0 111.303 -171.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -58.05 109.63 1.95 Allowed Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.144 -0.934 . . . . 20.0 108.708 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.46 -20.01 48.42 Favored 'Trans proline' 0 CA--C 1.513 -0.549 0 N-CA-C 114.8 1.038 . . . . 20.0 114.8 -160.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.95 74.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.167 -0.613 . . . . 20.0 110.578 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.66 -48.3 77.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.085 0.469 . . . . 20.0 110.063 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 274' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.25 -52.43 60.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 120.815 0.34 . . . . 20.0 110.685 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.4 -31.9 70.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 276' ' ' TRP . . . . . 0.487 ' HH2' ' HB3' ' C' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.92 65.77 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.098 -0.641 . . . . 20.0 110.999 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.15 -38.66 89.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.718 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.66 -47.98 78.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.608 -0.437 . . . . 20.0 110.067 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.78 -40.44 88.3 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.821 -0.352 . . . . 20.0 110.726 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.35 -44.9 77.88 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.235 -0.586 . . . . 20.0 111.073 -172.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.7 72.99 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.02 -0.672 . . . . 20.0 110.992 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.8 65.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.998 -0.681 . . . . 20.0 111.113 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.65 73.19 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 119.866 -0.734 . . . . 20.0 110.973 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.51 29.08 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.32 0.859 . . . . 20.0 113.32 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.12 13.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.702 0.763 . . . . 20.0 111.57 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.32 143.36 34.29 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.272 -1.01 . . . . 20.0 108.272 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.1 149.37 13.56 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 119.173 0.74 . . . . 20.0 111.369 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.17 23.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.613 -0.721 . . . . 20.0 109.7 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.09 5.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.899 -1.148 . . . . 20.0 107.899 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.62 43.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.49 -0.559 . . . . 20.0 109.49 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.67 -1.234 . . . . 20.0 107.67 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.56 168.7 12.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.533 0.682 . . . . 20.0 110.262 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.79 -18.5 21.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.798 -1.092 . . . . 20.0 112.146 165.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.07 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.983 -0.847 . . . . 20.0 110.983 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 296' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' C' ' 237' ' ' THR . . . 101.48 144.79 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 114.657 -0.772 . . . . 20.0 112.642 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.64 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.313 -1.115 . . . . 20.0 110.313 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 298' ' ' THR . . . . . 0.753 HG21 ' HE3' ' C' ' 261' ' ' LYS . 20.2 p -110.3 172.86 6.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.047 0.927 . . . . 20.0 111.345 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.68 76.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.226 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.31 74.05 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 111.76 0.281 . . . . 20.0 111.76 -171.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.16 96.88 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.2 -1.0 . . . . 20.0 112.044 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 302' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 220' ' ' ARG . . . -68.37 -26.85 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.204 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -14.06 59.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 305' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' K' ' 217' ' ' ARG . 4.1 mp -103.75 -8.92 19.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.758 1.022 . . . . 20.0 113.758 -167.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 306' ' ' THR . . . . . 0.451 ' OG1' ' OE1' ' C' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.58 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.709 . . . . 20.0 110.566 171.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 307' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' K' ' 224' ' ' PHE . 21.5 mmtt -61.66 -29.94 70.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.267 -0.878 . . . . 20.0 113.33 -161.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.23 66.29 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.7 -0.8 . . . . 20.0 111.2 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.81 65.13 1.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.853 -0.689 . . . . 20.0 113.315 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.32 139.65 52.23 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 117.599 0.7 . . . . 20.0 111.106 -163.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 311' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.547 0 CA-C-N 119.43 0.832 . . . . 20.0 110.045 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.47 135.81 32.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.326 -0.852 . . . . 20.0 111.175 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.17 -1.572 . . . . 20.0 109.17 164.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.02 27.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.486 0.66 . . . . 20.0 110.045 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.0 153.26 21.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.578 -1.192 . . . . 20.0 109.209 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 316' ' ' SER . . . . . 0.407 ' N ' ' O ' ' C' ' 259' ' ' ALA . 4.1 m -138.47 133.55 32.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.419 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 317' ' ' VAL . . . . . 0.436 HG11 HG12 ' C' ' 185' ' ' ILE . 92.3 t -99.45 108.57 51.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.32 -168.98 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 CA-C-O 122.667 1.028 . . . . 20.0 113.582 -154.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 319' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' C' ' 253' ' ' HIS . . . 79.87 35.4 0.15 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.589 -1.641 . . . . 20.0 115.256 161.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 320' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' C' ' 321' ' ' TYR . 0.4 OUTLIER -75.58 157.57 33.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.689 0.757 . . . . 20.0 110.101 176.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 321' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.19 11.65 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.828 -1.545 . . . . 20.0 106.828 160.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.23 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.18 0.992 . . . . 20.0 108.429 -163.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.52 -7.4 3.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.48 1.289 . . . . 20.0 114.48 -140.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 324' ' ' SER . . . . . 0.586 ' OG ' HG21 ' C' ' 97' ' ' THR . 0.1 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.641 0.608 . . . . 20.0 112.641 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 325' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 35.0 p-10 -102.02 -56.09 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.033 1.494 . . . . 20.0 115.033 -152.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.97 50.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.462 -1.311 . . . . 20.0 107.462 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 327' ' ' GLU . . . . . 0.736 ' HB3' ' HB3' ' C' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.862 -1.517 . . . . 20.0 109.941 -153.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.05 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.432 0.634 . . . . 20.0 111.954 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 329' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' C' ' 181' ' ' PHE . 0.3 OUTLIER -139.38 179.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.917 0.865 . . . . 20.0 109.463 175.668 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.51 119.18 27.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.839 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.16 -32.03 54.24 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.84 0.713 . . . . 20.0 111.479 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.76 73.51 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.263 -0.575 . . . . 20.0 110.202 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.06 -44.89 83.23 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.044 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.69 -41.28 92.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.446 -0.502 . . . . 20.0 110.467 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.67 71.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 118.803 -1.159 . . . . 20.0 110.164 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.39 93.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.473 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.53 -43.85 80.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.78 0.324 . . . . 20.0 110.922 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 338' ' ' VAL . . . . . 0.685 ' O ' ' OG1' ' C' ' 342' ' ' THR . 42.5 t -60.19 -48.93 86.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.977 0.417 . . . . 20.0 110.25 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 339' ' ' GLU . . . . . 0.786 ' OE1' ' NZ ' ' C' ' 343' ' ' LYS . 1.3 mm-40 -54.84 -46.97 74.7 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.988 0.423 . . . . 20.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.325 -0.398 . . . . 20.0 111.412 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 341' ' ' MET . . . . . 0.492 ' CE ' HD11 ' C' ' 234' ' ' ILE . 31.9 tpp -60.1 -40.38 89.44 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.211 -0.595 . . . . 20.0 110.814 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 342' ' ' THR . . . . . 0.685 ' OG1' ' O ' ' C' ' 338' ' ' VAL . 1.3 m -56.43 -45.03 80.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.081 0.467 . . . . 20.0 110.422 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 343' ' ' LYS . . . . . 0.786 ' NZ ' ' OE1' ' C' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.46 63.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.926 -0.71 . . . . 20.0 110.761 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.52 97.81 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.585 -0.446 . . . . 20.0 111.082 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 345' ' ' LEU . . . . . 0.424 ' O ' HG22 ' C' ' 348' ' ' ILE . 1.0 OUTLIER -58.95 -50.48 73.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.77 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.7 -39.01 90.79 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 119.708 -0.797 . . . . 20.0 110.563 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 347' ' ' ASN . . . . . 0.487 ' HB3' ' HH2' ' C' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.83 30.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.408 -0.917 . . . . 20.0 112.525 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 348' ' ' ILE . . . . . 0.424 HG22 ' O ' ' C' ' 345' ' ' LEU . 1.3 tt -65.2 -23.71 33.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 119.141 0.882 . . . . 20.0 110.911 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' C' C ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.799 -0.761 . . . . 20.0 111.248 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.92 -18.76 31.81 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.152 -0.343 . . . . 20.0 111.495 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 351' ' ' LEU . . . . . 0.437 HD12 ' O ' ' C' ' 351' ' ' LEU . 0.1 OUTLIER -69.79 -28.74 65.99 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.146 0.425 . . . . 20.0 112.146 -173.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.069 1.877 . . . . 20.0 116.069 -169.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' C' C ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 125.011 1.325 . . . . 20.0 108.393 -174.678 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 114.239 1.2 . . . . 20.0 114.239 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.22 2.93 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.897 -1.52 . . . . 20.0 106.897 -170.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.91 -34.53 66.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.177 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 113.583 0.957 . . . . 20.0 113.583 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.31 19.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.125 0.97 . . . . 20.0 111.608 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.69 32.09 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 117.782 0.265 . . . . 20.0 111.176 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.41 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.656 -1.239 . . . . 20.0 107.656 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.93 112.18 12.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.371 0.605 . . . . 20.0 110.885 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.67 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.457 -0.792 . . . . 20.0 111.892 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.19 -45.11 74.28 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.471 -0.492 . . . . 20.0 111.212 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.05 97.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 121.019 -0.273 . . . . 20.0 111.209 -172.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.54 70.96 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.699 -0.401 . . . . 20.0 111.174 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -46.4 90.81 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.643 -0.423 . . . . 20.0 110.521 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.0 -42.92 91.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.713 -0.222 . . . . 20.0 111.552 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.96 -40.07 26.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 119.5 -0.88 . . . . 20.0 110.653 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.01 -32.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.006 -162.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.05 68.11 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.987 -0.685 . . . . 20.0 111.265 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.37 70.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 120.553 -0.459 . . . . 20.0 109.794 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.12 144.69 9.54 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 120.271 0.647 . . . . 20.0 112.194 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.26 3.4 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 117.274 1.669 . . . . 20.0 117.274 -159.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 107.141 -1.429 . . . . 20.0 107.141 159.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.06 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.619 . . . . 20.0 110.684 -166.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.35 2.88 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.505 -0.771 . . . . 20.0 114.035 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.307 1.051 . . . . 20.0 109.531 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -58.01 -13.03 3.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.852 -1.067 . . . . 20.0 113.481 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' D' ' 28' ' ' GLY . 0.0 OUTLIER -88.04 9.03 23.85 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.711 1.141 . . . . 20.0 113.741 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.32 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.413 1.634 . . . . 20.0 115.413 -154.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' D' ' 26' ' ' PHE . . . -53.15 -26.87 29.61 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 119.813 1.188 . . . . 20.0 115.994 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 29' ' ' ILE . . . . . 0.534 HD13 ' NH1' ' D' ' 184' ' ' ARG . 1.1 tt -59.66 -35.78 61.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.079 0.94 . . . . 20.0 110.595 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.23 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.929 0.395 . . . . 20.0 110.453 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.59 74.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.294 -0.412 . . . . 20.0 110.975 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.3 -49.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.055 0.455 . . . . 20.0 110.276 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.72 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 119.696 -0.802 . . . . 20.0 110.298 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.7 -29.58 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 118.8 -1.16 . . . . 20.0 111.096 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.45 -30.9 71.58 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.989 0.358 . . . . 20.0 111.179 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 -56.73 3.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.111 0.412 . . . . 20.0 112.111 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.42 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.543 -0.298 . . . . 20.0 111.521 -164.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.37 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.888 -0.725 . . . . 20.0 112.263 -162.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.08 -23.49 63.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 118.874 -1.13 . . . . 20.0 111.757 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.92 -6.91 22.92 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.496 0.924 . . . . 20.0 113.496 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 22.7 t -119.55 152.59 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.559 -0.904 . . . . 20.0 108.559 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.13 -42.62 88.89 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.205 -0.907 . . . . 20.0 111.425 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.59 158.31 35.34 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.514 -0.921 . . . . 20.0 108.514 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.47 147.19 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.261 -1.014 . . . . 20.0 108.261 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.16 159.31 44.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.508 0.67 . . . . 20.0 110.417 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.13 129.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.16 5.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.785 0.803 . . . . 20.0 108.926 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.54 62.88 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.904 -0.718 . . . . 20.0 111.12 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.79 9.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.696 0.999 . . . . 20.0 113.696 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.63 83.38 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-O 119.162 -0.799 . . . . 20.0 114.516 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.49 35.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.473 1.136 . . . . 20.0 110.218 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.28 33.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.131 -1.433 . . . . 20.0 107.131 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 53' ' ' ILE . . . . . 0.713 HD13 HG12 ' D' ' 207' ' ' VAL . 31.2 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.301 -1.37 . . . . 20.0 107.301 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.78 36.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.624 -0.51 . . . . 20.0 109.624 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.93 8.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.638 -0.875 . . . . 20.0 108.638 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.59 145.4 31.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.723 -1.584 . . . . 20.0 106.723 163.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.59 154.43 20.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.676 -0.49 . . . . 20.0 109.676 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.09 23.68 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.883 0.873 . . . . 20.0 108.98 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.57 33.53 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.715 -0.755 . . . . 20.0 114.03 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.72 165.22 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.763 0.651 . . . . 20.0 112.071 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.98 111.39 22.92 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.0 -1.0 . . . . 20.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.72 137.9 30.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.752 -0.833 . . . . 20.0 108.752 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.74 124.05 46.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.074 0.95 . . . . 20.0 109.003 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.25 114.33 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.108 -1.071 . . . . 20.0 108.108 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.61 51.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.245 0.341 . . . . 20.0 110.918 -168.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.873 0.869 . . . . 20.0 108.916 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' D' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.967 -0.56 . . . . 20.0 110.541 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.197 -0.911 . . . . 20.0 109.696 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' D' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.64 -0.663 . . . . 20.0 112.455 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.91 28.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.185 -1.043 . . . . 20.0 108.185 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.78 148.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.73 0.812 . . . . 20.0 109.14 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 73' ' ' GLY . . . . . 0.47 ' C ' HD23 ' D' ' 74' ' ' LEU . . . -155.83 -175.71 27.15 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.588 -1.005 . . . . 20.0 110.588 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 74' ' ' LEU . . . . . 0.47 HD23 ' C ' ' D' ' 73' ' ' GLY . 5.0 mt -124.99 161.45 26.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 20.0 109.992 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 75' ' ' MET . . . . . 0.525 ' HB2' HG23 ' D' ' 160' ' ' THR . 10.6 ttm -128.15 131.37 48.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.006 -0.997 . . . . 20.0 109.67 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.866 -0.791 . . . . 20.0 108.866 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.03 -29.34 7.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.1 0.778 . . . . 20.0 113.1 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 32.6 mm -127.07 108.96 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.322 -0.992 . . . . 20.0 108.322 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.789 0.804 . . . . 20.0 110.002 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -27.11 60.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.687 -0.805 . . . . 20.0 112.745 -169.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 9.14 4.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.346 0.869 . . . . 20.0 113.346 -177.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.75 81.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 118.906 -0.941 . . . . 20.0 115.027 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.78 145.04 34.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.409 1.105 . . . . 20.0 110.23 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.48 28.05 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.246 -0.888 . . . . 20.0 112.61 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.63 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.856 -1.164 . . . . 20.0 107.856 158.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.82 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.681 0.753 . . . . 20.0 109.46 -170.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.24 129.35 15.63 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.992 -1.004 . . . . 20.0 109.814 171.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.84 160.22 24.45 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-O 122.289 0.871 . . . . 20.0 112.765 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 90' ' ' ILE . . . . . 0.479 HD11 HG21 ' D' ' 160' ' ' THR . 9.2 mt -88.78 150.29 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.739 -1.573 . . . . 20.0 107.396 165.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.97 140.91 47.51 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.281 -0.872 . . . . 20.0 112.122 -168.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.86 -24.12 22.29 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 118.931 -0.927 . . . . 20.0 115.206 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.64 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 118.671 1.235 . . . . 20.0 109.275 -169.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 108.387 -0.968 . . . . 20.0 108.387 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 95' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.09 -7.95 13.07 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 CA-C-N 120.557 1.235 . . . . 20.0 114.854 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.21 -15.24 59.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.151 0.887 . . . . 20.0 111.844 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 97' ' ' THR . . . . . 0.587 HG21 ' OG ' ' D' ' 324' ' ' SER . 44.8 p -89.48 35.49 0.82 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.648 0.779 . . . . 20.0 112.421 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' D' ' 99' ' ' ILE . 0.5 OUTLIER -43.21 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.983 1.313 . . . . 20.0 113.386 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' D' ' 98' ' ' LEU . 1.6 tt -173.21 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 100' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' B' ' 100' ' ' ALA . . . -123.92 -19.09 5.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.668 -1.151 . . . . 20.0 111.288 158.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 101' ' ' GLN . . . . . 0.412 ' C ' HD11 ' D' ' 99' ' ' ILE . 0.0 OUTLIER -169.34 141.62 2.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 102' ' ' ARG . . . . . 0.482 HH12 ' HB3' ' B' ' 167' ' ' ARG . 0.0 OUTLIER 55.95 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.204 1.557 . . . . 20.0 115.204 150.521 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 103' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' D' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.24 36.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 119.276 0.944 . . . . 20.0 109.367 160.399 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.32 37.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.474 -0.784 . . . . 20.0 109.367 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 105' ' ' VAL . . . . . 0.579 HG22 ' CG1' ' D' ' 162' ' ' ILE . 50.6 t -117.41 110.71 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.236 -1.024 . . . . 20.0 108.236 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.06 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.206 -0.294 . . . . 20.0 110.206 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -52.0 -54.18 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.322 0.389 . . . . 20.0 110.338 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.5 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.423 -0.954 . . . . 20.0 108.423 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.09 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.458 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.19 11.18 75.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 118.888 -0.951 . . . . 20.0 115.35 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -128.97 114.0 15.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.465 1.132 . . . . 20.0 108.575 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.28 141.55 37.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.392 -0.595 . . . . 20.0 109.392 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.64 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.699 -0.852 . . . . 20.0 108.699 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.65 149.39 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.008 -0.996 . . . . 20.0 110.296 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 115' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' D' ' 103' ' ' PHE . . . -147.92 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.323 -1.111 . . . . 20.0 110.323 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.38 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.385 -0.968 . . . . 20.0 108.385 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.25 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.317 -0.856 . . . . 20.0 114.584 -168.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 118' ' ' ALA . . . . . 0.486 ' O ' HD13 ' D' ' 98' ' ' LEU . . . -67.19 -47.91 69.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.374 1.25 . . . . 20.0 114.374 -156.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.541 1.064 . . . . 20.0 112.695 -155.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.14 35.36 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 102.634 -3.098 . . . . 20.0 102.634 159.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.8 11.03 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 CA-C-N 120.744 1.302 . . . . 20.0 110.554 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 122' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 149.8 89.87 Favored 'Trans proline' 0 CA--C 1.519 -0.228 0 CA-C-N 119.164 0.737 . . . . 20.0 110.677 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.1 165.39 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.852 0.834 . . . . 20.0 109.948 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.18 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 20.0 108.182 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.97 160.84 19.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.793 -0.363 . . . . 20.0 110.724 169.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.68 1.5 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.978 0.911 . . . . 20.0 113.079 -170.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.01 -24.91 59.49 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.826 1.331 . . . . 20.0 112.011 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.59 30.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.776 0.287 . . . . 20.0 111.776 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -31.98 69.03 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.28 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.85 62.56 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 111.947 0.351 . . . . 20.0 111.947 172.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.49 90.97 4.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.216 -0.661 . . . . 20.0 109.216 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.17 14.32 7.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.095 0.406 . . . . 20.0 112.095 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.54 87.36 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.61 75.29 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 CA-C-N 119.641 0.908 . . . . 20.0 112.363 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.58 153.61 42.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.956 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -12.31 59.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.863 -0.589 . . . . 20.0 112.43 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' D' ' 138' ' ' GLN . 14.2 p30 -55.29 -66.39 0.42 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.909 -0.567 . . . . 20.0 111.408 -175.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 138' ' ' GLN . . . . . 0.419 ' N ' ' OD1' ' D' ' 137' ' ' ASP . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 103.091 -2.929 . . . . 20.0 103.091 133.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 139' ' ' ILE . . . . . 0.416 ' H ' ' HG3' ' D' ' 138' ' ' GLN . 1.2 tp -74.88 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.128 0.971 . . . . 20.0 108.938 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.81 161.5 18.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.943 0.897 . . . . 20.0 110.508 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 141' ' ' ILE . . . . . 0.419 HD13 HD13 ' D' ' 162' ' ' ILE . 30.3 mt -124.68 147.45 29.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' D' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.77 55.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.646 0.778 . . . . 20.0 109.6 175.137 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.18 7.82 6.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.875 -0.602 . . . . 20.0 111.759 166.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' D' ' 142' ' ' ASP . . . 86.91 -6.57 82.87 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 115.484 0.953 . . . . 20.0 115.484 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.12 144.01 54.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.444 1.122 . . . . 20.0 110.312 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.34 -20.97 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.577 0.954 . . . . 20.0 113.577 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.66 40.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.967 0.889 . . . . 20.0 111.377 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.52 80.52 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.845 -1.525 . . . . 20.0 111.232 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.38 -46.99 87.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.797 -0.361 . . . . 20.0 110.983 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -61.34 -35.14 76.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.828 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.81 -40.58 83.85 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.056 -0.658 . . . . 20.0 111.095 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.31 58.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.344 -0.942 . . . . 20.0 111.058 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.69 -30.07 66.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 119.757 -0.777 . . . . 20.0 110.638 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.62 -40.57 92.35 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.511 -0.476 . . . . 20.0 111.67 171.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.73 6.71 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.596 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.71 133.49 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 118.469 1.135 . . . . 20.0 108.565 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.86 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.27 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.691 -1.226 . . . . 20.0 107.691 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.39 169.29 15.7 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.786 -1.726 . . . . 20.0 108.786 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 160' ' ' THR . . . . . 0.525 HG23 ' HB2' ' D' ' 75' ' ' MET . 0.2 OUTLIER -79.35 113.52 17.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.62 -20.02 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 113.732 1.012 . . . . 20.0 113.732 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 162' ' ' ILE . . . . . 0.579 ' CG1' HG22 ' D' ' 105' ' ' VAL . 0.5 OUTLIER -111.69 155.64 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.701 -0.624 . . . . 20.0 111.734 -159.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' D' ' 164' ' ' TRP . 3.5 t -145.33 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.287 1.035 . . . . 20.0 110.476 171.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' D' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.93 16.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.237 0.828 . . . . 20.0 113.237 -160.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.72 61.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 20.0 112.298 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.122 -1.191 . . . . 20.0 110.122 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 167' ' ' ARG . . . . . 0.434 ' HB3' HH12 ' B' ' 102' ' ' ARG . 0.0 OUTLIER -142.4 148.27 37.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.709 -1.219 . . . . 20.0 107.709 170.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.65 30.5 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.131 -0.941 . . . . 20.0 110.208 -167.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.46 159.78 35.22 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.899 0.857 . . . . 20.0 109.973 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.33 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.247 -1.342 . . . . 20.0 109.515 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.62 29.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.538 -0.542 . . . . 20.0 109.538 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' D' ' 175' ' ' ARG . . . 56.95 68.68 1.58 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.217 -1.553 . . . . 20.0 109.217 -171.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.93 4.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.781 0.659 . . . . 20.0 112.781 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.0 1.29 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.731 -0.788 . . . . 20.0 111.178 157.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' D' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.95 0.7 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.653 0.66 . . . . 20.0 112.663 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.855 2.462 . . . . 20.0 106.222 157.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 177' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.68 145.76 20.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.493 -0.928 . . . . 20.0 108.493 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.11 -64.47 1.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 116.437 2.014 . . . . 20.0 116.437 -166.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 20.0 112.115 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.68 36.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.398 1.258 . . . . 20.0 114.398 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 181' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' D' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.96 0.83 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.607 0.64 . . . . 20.0 111.766 -162.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.29 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 122.092 0.949 . . . . 20.0 110.685 -152.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' D' ' 70' ' ' ASP . 0.6 OUTLIER 69.89 -6.63 1.04 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.326 1.451 . . . . 20.0 113.193 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 184' ' ' ARG . . . . . 0.534 ' NH1' HD13 ' D' ' 29' ' ' ILE . 0.0 OUTLIER -153.87 83.88 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.213 1.006 . . . . 20.0 110.82 157.108 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 185' ' ' ILE . . . . . 0.438 HG12 HG11 ' D' ' 317' ' ' VAL . 1.0 OUTLIER -126.08 -41.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.496 -2.409 . . . . 20.0 104.496 149.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 186' ' ' ALA . . . . . 0.721 ' O ' ' OG1' ' D' ' 189' ' ' THR . . . -50.13 -42.95 51.53 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.349 -0.841 . . . . 20.0 111.54 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.92 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 119.283 -0.967 . . . . 20.0 110.122 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.82 -38.66 91.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.146 -1.022 . . . . 20.0 110.477 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 189' ' ' THR . . . . . 0.721 ' OG1' ' O ' ' D' ' 186' ' ' ALA . 25.2 p -59.13 -48.61 80.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.453 -0.899 . . . . 20.0 110.831 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.24 -50.56 63.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.941 0.401 . . . . 20.0 110.503 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.21 95.99 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.106 -0.637 . . . . 20.0 110.898 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.59 84.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 120.022 -0.671 . . . . 20.0 110.291 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.52 -44.83 97.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.061 0.458 . . . . 20.0 110.085 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.34 75.53 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.174 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.56 -38.24 71.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.919 -0.712 . . . . 20.0 110.794 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.63 -26.15 41.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.588 0.588 . . . . 20.0 112.588 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.77 27.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.301 -0.629 . . . . 20.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.42 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.293 0.371 . . . . 20.0 110.154 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.2 105.42 17.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.727 -0.471 . . . . 20.0 109.727 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.28 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.191 -0.67 . . . . 20.0 109.191 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.48 59.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 119.993 -0.683 . . . . 20.0 111.358 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.87 141.66 30.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.969 -0.752 . . . . 20.0 108.969 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 203' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' D' ' 203' ' ' ASP . 0.0 OUTLIER -78.6 113.03 16.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.489 -0.93 . . . . 20.0 108.489 -174.466 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -103.02 151.6 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.9 106.56 8.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.91 125.35 31.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.75 -0.833 . . . . 20.0 108.75 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 207' ' ' VAL . . . . . 0.713 HG12 HD13 ' D' ' 53' ' ' ILE . 34.0 m -119.91 150.24 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.836 -0.801 . . . . 20.0 108.836 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.42 98.8 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.37 -1.344 . . . . 20.0 107.37 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.86 159.97 19.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.859 0.837 . . . . 20.0 111.115 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.8 166.45 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 114.631 -1.168 . . . . 20.0 108.232 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.18 29.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.839 -1.073 . . . . 20.0 111.462 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.406 -0.518 . . . . 20.0 110.962 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.44 64.76 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.219 -0.592 . . . . 20.0 111.467 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 214' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.13 121.17 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.499 -0.926 . . . . 20.0 108.499 173.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.07 60.94 6.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.684 -1.246 . . . . 20.0 111.405 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 216' ' ' LEU . . . . . 0.436 HD23 ' H ' ' D' ' 216' ' ' LEU . 0.5 OUTLIER -47.04 -25.49 0.84 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.465 0.913 . . . . 20.0 113.465 -179.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.56 -4.53 2.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.313 0.486 . . . . 20.0 112.313 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.52 40.77 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.721 -1.228 . . . . 20.0 112.022 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 219' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' D' ' 222' ' ' SER . . . -65.28 -37.02 85.88 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 122.241 -0.564 . . . . 20.0 111.375 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 220' ' ' ARG . . . . . 0.414 ' HB2' ' HB1' ' D' ' 302' ' ' ALA . 16.6 ttm180 -52.71 -36.77 57.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 112.139 0.422 . . . . 20.0 112.139 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 221' ' ' THR . . . . . . . . . . . . . 75.5 p -58.42 -45.79 87.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 120.001 -0.68 . . . . 20.0 110.867 -173.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 222' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' D' ' 219' ' ' ALA . 2.1 p -58.01 -35.83 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.771 -0.372 . . . . 20.0 111.433 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.61 -50.03 69.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.582 0.586 . . . . 20.0 112.582 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.13 -33.43 75.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.795 -0.762 . . . . 20.0 111.84 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.71 74.95 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.93 -1.605 . . . . 20.0 112.099 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.94 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 112.03 0.382 . . . . 20.0 112.03 -158.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 227' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' D' ' 306' ' ' THR . 3.0 pt-20 -56.42 -46.67 99.78 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 118.187 2.662 . . . . 20.0 118.187 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 C--O 1.232 0.214 0 N-CA-C 115.988 1.495 . . . . 20.0 115.988 -134.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.172 1.389 . . . . 20.0 113.413 162.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.065 -0.654 . . . . 20.0 111.708 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.49 16.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.906 -0.664 . . . . 20.0 112.256 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.7 170.71 15.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.801 0.84 . . . . 20.0 108.83 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.08 23.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.199 0.523 . . . . 20.0 110.406 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 234' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' D' ' 341' ' ' MET . 51.5 mt -133.22 90.39 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.552 -1.277 . . . . 20.0 107.552 172.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' D' ' 68' ' ' HIS . 25.5 t0 -135.11 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.96 -1.496 . . . . 20.0 106.96 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.14 149.4 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.636 0.731 . . . . 20.0 111.414 -172.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 237' ' ' THR . . . . . 0.46 HG21 ' HA3' ' D' ' 296' ' ' GLY . 9.1 t -165.67 122.7 1.44 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 238' ' ' ILE . . . . . 0.421 HD13 ' O ' ' D' ' 237' ' ' THR . 17.9 mm -145.46 151.88 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.268 -1.012 . . . . 20.0 108.268 -161.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.22 9.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.871 -1.529 . . . . 20.0 106.871 159.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.06 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.983 0.734 . . . . 20.0 112.983 -155.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.12 22.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.915 1.286 . . . . 20.0 112.448 158.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 128.4 79.09 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.22 -2.141 . . . . 20.0 105.22 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.55 12.09 Favored 'Trans proline' 0 CA--C 1.516 -0.381 0 CA-C-N 120.871 1.347 . . . . 20.0 112.311 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.38 -5.21 45.46 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.063 -0.971 . . . . 20.0 114.928 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 33.3 p -92.17 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.595 1.197 . . . . 20.0 110.678 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.871 0.696 . . . . 20.0 111.968 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.768 -1.106 . . . . 20.0 112.087 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.83 -0.748 . . . . 20.0 112.862 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 249' ' ' LYS . . . . . 0.715 ' O ' ' OG1' ' D' ' 252' ' ' THR . 16.9 mttt -98.79 -15.14 19.4 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.234 0.828 . . . . 20.0 113.234 170.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.86 88.96 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.299 -0.56 . . . . 20.0 111.368 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.125 -1.03 . . . . 20.0 111.844 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 252' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' D' ' 249' ' ' LYS . 39.2 p -57.12 -31.84 65.72 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.5 0.591 . . . . 20.0 111.347 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 253' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' D' ' 319' ' ' ALA . 16.7 t-80 -162.4 132.08 4.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.316 0.579 . . . . 20.0 110.37 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.32 3.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.279 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.33 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.688 0 C-N-CA 126.162 1.839 . . . . 20.0 111.56 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.22 10.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.12 174.27 3.41 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-O 122.643 1.135 . . . . 20.0 113.366 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.82 175.09 6.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.52 -0.919 . . . . 20.0 108.52 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' D' ' 316' ' ' SER . . . -126.38 120.34 29.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.123 -0.944 . . . . 20.0 109.391 -169.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 260' ' ' ILE . . . . . . . . . . . . . 85.6 mt -98.02 139.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.77 -1.196 . . . . 20.0 107.77 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 261' ' ' LYS . . . . . 0.768 ' HE3' HG21 ' D' ' 298' ' ' THR . 1.9 mtmm -98.81 122.62 42.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.991 -0.744 . . . . 20.0 108.991 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.73 -40.31 10.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.89 -0.595 . . . . 20.0 109.625 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.61 34.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.326 -0.62 . . . . 20.0 109.326 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -170.0 2.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.23 165.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.25 21.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.802 -0.635 . . . . 20.0 110.281 163.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.17 11.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -165.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.66 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 103.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.13 -1.804 . . . . 20.0 106.13 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.07 56.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.552 . . . . 20.0 111.341 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.144 -0.935 . . . . 20.0 108.67 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 271' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -67.45 -20.0 48.48 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 114.865 1.063 . . . . 20.0 114.865 -160.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -43.0 74.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.149 -0.62 . . . . 20.0 110.599 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.57 -48.38 77.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.111 0.481 . . . . 20.0 110.095 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.09 -52.55 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.838 0.351 . . . . 20.0 110.725 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.34 -31.93 70.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.807 -0.757 . . . . 20.0 110.55 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 276' ' ' TRP . . . . . 0.49 ' HH2' ' HB3' ' D' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.96 65.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.012 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.08 -38.69 89.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.765 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -47.94 78.64 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.097 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.47 88.4 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.839 -0.344 . . . . 20.0 110.737 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.95 77.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.291 -0.563 . . . . 20.0 111.053 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.18 -31.63 72.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.009 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.43 -31.78 65.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.04 -0.664 . . . . 20.0 111.127 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.87 -37.67 73.06 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.902 -0.719 . . . . 20.0 110.939 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 284' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -102.6 15.48 29.16 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.367 0.877 . . . . 20.0 113.367 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.78 32.09 13.76 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.744 0.783 . . . . 20.0 111.626 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.28 143.41 34.46 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.331 -0.989 . . . . 20.0 108.331 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 287' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.16 149.35 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 CA-C-N 119.177 0.742 . . . . 20.0 111.345 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.97 148.13 23.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.67 -0.695 . . . . 20.0 109.725 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.96 175.16 5.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.731 -1.211 . . . . 20.0 107.731 168.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.72 113.78 17.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.67 43.75 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 20.0 109.481 -172.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.642 -1.244 . . . . 20.0 107.642 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.71 12.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.56 0.695 . . . . 20.0 110.245 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.74 -18.6 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.827 -1.079 . . . . 20.0 112.181 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.981 -0.847 . . . . 20.0 110.981 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 296' ' ' GLY . . . . . 0.46 ' HA3' HG21 ' D' ' 237' ' ' THR . . . 101.49 144.83 15.64 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.637 -0.781 . . . . 20.0 112.624 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.84 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.359 -1.097 . . . . 20.0 110.359 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 298' ' ' THR . . . . . 0.768 HG21 ' HE3' ' D' ' 261' ' ' LYS . 20.2 p -110.3 172.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.037 0.922 . . . . 20.0 111.371 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.69 76.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.222 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.41 74.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.788 0.292 . . . . 20.0 111.788 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.18 96.84 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.198 -1.001 . . . . 20.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 302' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 220' ' ' ARG . . . -68.34 -26.87 65.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.119 -0.633 . . . . 20.0 111.186 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.127 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -14.2 60.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.368 0.877 . . . . 20.0 113.368 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.75 -8.82 19.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 306' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' D' ' 227' ' ' GLU . 0.5 OUTLIER -58.39 157.56 8.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.55 0.691 . . . . 20.0 110.543 171.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -161.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.89 -25.24 66.3 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.215 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.871 -0.681 . . . . 20.0 113.301 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.25 139.6 52.48 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-N 117.648 0.724 . . . . 20.0 111.14 -163.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.46 141.72 9.06 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 CA-C-N 119.502 0.858 . . . . 20.0 110.031 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.51 135.81 32.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.327 -0.851 . . . . 20.0 111.203 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.61 12.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.155 -1.578 . . . . 20.0 109.155 164.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.05 27.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.465 0.65 . . . . 20.0 110.049 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.04 153.23 21.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.629 -1.168 . . . . 20.0 109.228 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' D' ' 259' ' ' ALA . 4.2 m -138.41 133.57 33.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.311 -0.859 . . . . 20.0 109.453 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 317' ' ' VAL . . . . . 0.438 HG11 HG12 ' D' ' 185' ' ' ILE . 92.2 t -99.51 108.58 51.38 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.242 -1.392 . . . . 20.0 107.242 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.704 0 CA-C-O 122.693 1.039 . . . . 20.0 113.599 -154.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 319' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' D' ' 253' ' ' HIS . . . 79.78 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 113.532 -1.667 . . . . 20.0 115.269 161.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 320' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' D' ' 321' ' ' TYR . 0.4 OUTLIER -75.61 157.62 33.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.709 0.766 . . . . 20.0 110.103 176.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 321' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' D' ' 320' ' ' ARG . 3.3 m-85 -113.18 166.16 11.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.21 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.123 0.969 . . . . 20.0 108.417 -163.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.37 3.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 324' ' ' SER . . . . . 0.587 ' OG ' HG21 ' D' ' 97' ' ' THR . 0.1 OUTLIER -59.49 -59.96 4.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.677 0.621 . . . . 20.0 112.677 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 325' ' ' ASN . . . . . 0.414 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 35.1 p-10 -102.02 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.997 1.48 . . . . 20.0 114.997 -152.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.54 151.01 50.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.445 -1.317 . . . . 20.0 107.445 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 327' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' D' ' 181' ' ' PHE . 82.7 mt-10 -142.59 52.87 1.42 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.806 -1.543 . . . . 20.0 109.904 -153.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 328' ' ' VAL . . . . . . . . . . . . . 53.5 t -51.09 149.38 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.423 0.63 . . . . 20.0 111.932 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 329' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' D' ' 181' ' ' PHE . 0.3 OUTLIER -139.36 179.38 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.884 0.849 . . . . 20.0 109.459 175.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.47 119.17 27.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.589 -1.187 . . . . 20.0 108.871 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.05 -32.11 53.55 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.819 0.699 . . . . 20.0 111.545 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 332' ' ' ARG . . . . . 0.4 ' NH2' ' OE2' ' B' ' 146' ' ' GLU . 10.3 mtm180 -68.59 -44.76 73.66 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.295 -0.562 . . . . 20.0 110.259 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 333' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.97 -45.03 83.21 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.788 -0.365 . . . . 20.0 111.053 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.58 -41.27 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 120.45 -0.5 . . . . 20.0 110.541 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.68 71.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 118.842 -1.143 . . . . 20.0 110.148 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.42 93.2 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.425 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -43.83 80.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.789 0.328 . . . . 20.0 110.951 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' D' ' 342' ' ' THR . 42.6 t -60.23 -48.94 86.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.978 0.418 . . . . 20.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' D' ' 343' ' ' LYS . 1.3 mm-40 -54.85 -46.88 74.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.027 0.441 . . . . 20.0 110.779 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.424 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 341' ' ' MET . . . . . 0.496 ' CE ' HD11 ' D' ' 234' ' ' ILE . 32.0 tpp -60.12 -40.35 89.45 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 120.17 -0.612 . . . . 20.0 110.8 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' D' ' 338' ' ' VAL . 1.3 m -56.49 -45.04 81.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.109 0.48 . . . . 20.0 110.401 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' D' ' 339' ' ' GLU . 34.5 mttp -74.16 -37.47 63.99 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 119.971 -0.691 . . . . 20.0 110.79 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.47 97.73 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.546 -0.461 . . . . 20.0 111.119 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 345' ' ' LEU . . . . . 0.427 ' O ' HG22 ' D' ' 348' ' ' ILE . 1.0 OUTLIER -59.02 -50.42 74.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.549 -0.461 . . . . 20.0 110.781 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.08 90.97 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.693 -0.803 . . . . 20.0 110.583 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 347' ' ' ASN . . . . . 0.49 ' HB3' ' HH2' ' D' ' 276' ' ' TRP . 4.9 m-20 -84.47 4.79 30.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.435 -0.906 . . . . 20.0 112.54 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 348' ' ' ILE . . . . . 0.427 HG22 ' O ' ' D' ' 345' ' ' LEU . 1.3 tt -65.22 -23.68 33.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.098 0.863 . . . . 20.0 110.893 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' D' D ' 349' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -63.71 -27.36 69.16 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.272 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 122.083 -0.386 . . . . 20.0 111.484 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 351' ' ' LEU . . . . . 0.442 ' O ' HD12 ' D' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -173.888 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' D' D ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.037 1.866 . . . . 20.0 116.037 -169.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' D' D ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.997 1.319 . . . . 20.0 108.371 -174.707 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 114.244 1.201 . . . . 20.0 114.244 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 82.22 2.95 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.912 -1.514 . . . . 20.0 106.912 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.7 t -62.93 -34.48 66.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 114.836 -1.075 . . . . 20.0 110.23 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.01 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.569 0.952 . . . . 20.0 113.569 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.5 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.109 0.964 . . . . 20.0 111.644 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -38.72 32.29 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.302 -0.249 . . . . 20.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.08 117.41 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.683 -1.229 . . . . 20.0 107.683 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.88 112.19 12.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 20.0 110.879 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.51 72.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.397 -0.82 . . . . 20.0 111.864 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.21 -45.13 74.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.527 -0.469 . . . . 20.0 111.207 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -43.03 97.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.982 -0.287 . . . . 20.0 111.189 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.58 70.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.755 -0.378 . . . . 20.0 111.178 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.39 90.82 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.628 -0.429 . . . . 20.0 110.504 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -42.91 91.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.735 -0.212 . . . . 20.0 111.53 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.93 -40.09 26.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 119.529 -0.869 . . . . 20.0 110.676 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.05 -32.13 6.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.056 -1.057 . . . . 20.0 111.024 -162.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -25.94 67.99 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.997 -0.681 . . . . 20.0 111.26 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.47 70.35 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 120.5 -0.48 . . . . 20.0 109.797 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.18 144.76 9.5 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 120.259 0.639 . . . . 20.0 112.149 -172.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.28 3.39 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 117.273 1.669 . . . . 20.0 117.273 -159.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.78 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.168 -1.419 . . . . 20.0 107.168 159.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 171.17 8.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 20.0 110.714 -166.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.29 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.515 -0.766 . . . . 20.0 114.048 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.25 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.326 1.06 . . . . 20.0 109.592 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.17 4.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.878 -1.055 . . . . 20.0 113.445 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 26' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' E' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 8.96 23.93 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.652 1.115 . . . . 20.0 113.71 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 11.35 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.401 1.63 . . . . 20.0 115.401 -154.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' E' ' 26' ' ' PHE . . . -53.2 -26.86 29.93 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 119.83 1.196 . . . . 20.0 116.02 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 29' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' E' ' 184' ' ' ARG . 1.1 tt -59.64 -35.73 61.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 118.059 0.929 . . . . 20.0 110.648 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.43 61.53 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.848 0.356 . . . . 20.0 110.424 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.62 74.51 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.298 -0.41 . . . . 20.0 110.939 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.28 -49.58 82.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.036 0.446 . . . . 20.0 110.277 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.73 86.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 119.683 -0.807 . . . . 20.0 110.31 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.73 -29.43 20.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 118.692 -1.203 . . . . 20.0 111.177 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.51 -30.96 71.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.974 0.352 . . . . 20.0 111.1 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.7 3.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.166 0.432 . . . . 20.0 112.166 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.5 45.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.48 -0.327 . . . . 20.0 111.518 -164.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -26.36 63.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.896 -0.721 . . . . 20.0 112.226 -162.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.2 -23.45 62.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 118.84 -1.144 . . . . 20.0 111.71 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.95 22.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.532 0.938 . . . . 20.0 113.532 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.53 152.7 22.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.532 -0.914 . . . . 20.0 108.532 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.16 -42.6 88.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.197 -0.91 . . . . 20.0 111.458 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.65 158.33 35.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.52 147.18 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.536 0.684 . . . . 20.0 110.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 128.99 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.3 -176.14 5.83 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.811 0.815 . . . . 20.0 108.929 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.57 -34.6 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.957 -0.697 . . . . 20.0 111.13 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.16 10.82 9.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -171.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.64 83.37 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 119.096 -0.836 . . . . 20.0 114.446 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.544 1.172 . . . . 20.0 110.205 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.28 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.104 -1.443 . . . . 20.0 107.104 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 53' ' ' ILE . . . . . 0.721 HD13 HG12 ' E' ' 207' ' ' VAL . 31.1 mm -130.21 115.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.33 -1.359 . . . . 20.0 107.33 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.672 -0.492 . . . . 20.0 109.672 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 100.03 8.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.56 145.4 31.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.76 -1.57 . . . . 20.0 106.76 163.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.55 154.48 20.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.711 -0.477 . . . . 20.0 109.711 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.053 -0.819 . . . . 20.0 111.053 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.876 0.87 . . . . 20.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.03 -168.6 33.51 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.742 -0.742 . . . . 20.0 114.08 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.73 165.2 32.84 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 CA-C-O 121.733 0.639 . . . . 20.0 112.085 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.93 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.293 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.7 138.0 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.82 124.05 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.015 0.926 . . . . 20.0 109.001 -175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.3 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.62 124.62 51.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.317 0.386 . . . . 20.0 110.97 -168.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.942 0.897 . . . . 20.0 108.92 167.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' E' ' 235' ' ' ASP . 0.0 OUTLIER -105.07 146.44 29.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.935 -0.575 . . . . 20.0 110.549 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.32 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.239 -0.891 . . . . 20.0 109.735 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' E' ' 183' ' ' ASP . 12.0 t0 -97.35 67.97 2.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.597 -0.689 . . . . 20.0 112.449 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.33 144.93 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.266 -1.013 . . . . 20.0 108.266 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.85 148.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.692 0.797 . . . . 20.0 109.14 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 73' ' ' GLY . . . . . 0.468 ' C ' HD23 ' E' ' 74' ' ' LEU . . . -155.88 -175.69 27.17 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.576 -1.009 . . . . 20.0 110.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 74' ' ' LEU . . . . . 0.468 HD23 ' C ' ' E' ' 73' ' ' GLY . 5.1 mt -125.05 161.46 26.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.364 0.602 . . . . 20.0 109.989 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 75' ' ' MET . . . . . 0.506 ' HB2' HG23 ' E' ' 160' ' ' THR . 10.6 ttm -128.08 131.33 49.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.228 1.011 . . . . 20.0 109.681 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.5 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.11 -29.29 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.08 0.77 . . . . 20.0 113.08 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.48 13.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.104 -1.073 . . . . 20.0 108.104 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 mm -127.03 108.93 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.337 -0.986 . . . . 20.0 108.337 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.31 5.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.782 0.801 . . . . 20.0 109.972 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.05 60.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.698 -0.801 . . . . 20.0 112.733 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.56 9.15 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.354 0.872 . . . . 20.0 113.354 -177.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.75 81.79 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 118.998 -0.89 . . . . 20.0 115.108 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.75 145.03 34.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.341 1.071 . . . . 20.0 110.222 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.08 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.27 -0.877 . . . . 20.0 112.567 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.42 174.69 6.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.841 -1.17 . . . . 20.0 107.841 158.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.8 163.79 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.652 0.739 . . . . 20.0 109.476 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.27 15.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.019 -0.991 . . . . 20.0 109.808 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -79.78 160.17 24.64 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-O 122.32 0.883 . . . . 20.0 112.735 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 90' ' ' ILE . . . . . 0.467 HD11 HG21 ' E' ' 160' ' ' THR . 9.2 mt -88.75 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.72 -1.582 . . . . 20.0 107.367 165.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.89 47.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.243 -0.889 . . . . 20.0 112.171 -168.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.18 22.12 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.231 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.91 152.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 118.649 1.225 . . . . 20.0 109.232 -169.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.69 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 108.435 -0.95 . . . . 20.0 108.435 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.11 -7.91 13.05 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.544 1.23 . . . . 20.0 114.81 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.15 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.212 0.915 . . . . 20.0 111.805 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 97' ' ' THR . . . . . 0.589 HG21 ' OG ' ' E' ' 324' ' ' SER . 44.7 p -89.54 35.52 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.676 0.79 . . . . 20.0 112.394 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 98' ' ' LEU . . . . . 0.676 HD12 ' H ' ' E' ' 99' ' ' ILE . 0.5 OUTLIER -43.32 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.007 1.323 . . . . 20.0 113.344 -172.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 99' ' ' ILE . . . . . 0.676 ' H ' HD12 ' E' ' 98' ' ' LEU . 1.6 tt -173.19 156.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 100' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' G' ' 325' ' ' ASN . . . -123.91 -19.06 5.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.673 -1.148 . . . . 20.0 111.254 158.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 101' ' ' GLN . . . . . 0.411 ' C ' HD11 ' E' ' 99' ' ' ILE . 0.0 OUTLIER -169.38 141.6 2.51 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.671 -0.863 . . . . 20.0 108.671 176.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 102' ' ' ARG . . . . . 0.574 HH12 ' HB3' ' G' ' 167' ' ' ARG . 0.0 OUTLIER 55.96 74.5 0.38 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 115.238 1.569 . . . . 20.0 115.238 150.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' E' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.309 0.959 . . . . 20.0 109.379 160.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.28 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.492 -0.777 . . . . 20.0 109.414 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 105' ' ' VAL . . . . . 0.576 HG22 ' CG1' ' E' ' 162' ' ' ILE . 50.6 t -117.41 110.78 32.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.04 6.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.238 -0.282 . . . . 20.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.2 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 O-C-N 123.378 0.424 . . . . 20.0 110.389 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.57 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.416 -0.957 . . . . 20.0 108.416 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.05 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.945 -1.025 . . . . 20.0 110.498 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.19 75.18 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.337 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.03 114.01 15.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.474 1.137 . . . . 20.0 108.563 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.28 141.52 37.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.362 -0.607 . . . . 20.0 109.362 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.62 142.56 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.71 -0.848 . . . . 20.0 108.71 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 114' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.78 149.48 31.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.991 -1.004 . . . . 20.0 110.269 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' E' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.28 -1.128 . . . . 20.0 110.28 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.76 154.38 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.24 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.582 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 118' ' ' ALA . . . . . 0.497 ' O ' HD13 ' E' ' 98' ' ' LEU . . . -67.18 -47.91 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.371 1.248 . . . . 20.0 114.371 -156.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.13 11.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.538 1.063 . . . . 20.0 112.651 -155.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.1 35.61 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 102.653 -3.091 . . . . 20.0 102.653 159.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 121' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' G' ' 243' ' ' PRO . 9.3 Cg_endo -68.07 123.83 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.545 0 CA-C-N 120.743 1.301 . . . . 20.0 110.599 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.84 149.75 89.97 Favored 'Trans proline' 0 CA--C 1.518 -0.284 0 CA-C-N 119.245 0.766 . . . . 20.0 110.701 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.38 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.814 0.816 . . . . 20.0 109.949 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.11 91.85 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -175.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.82 19.57 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.89 0.376 . . . . 20.0 110.702 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.85 -43.69 1.51 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 123.983 0.913 . . . . 20.0 113.116 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.94 -25.01 59.95 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.823 1.33 . . . . 20.0 112.006 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.54 -26.51 30.06 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 111.803 0.297 . . . . 20.0 111.803 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.94 69.13 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.735 -0.786 . . . . 20.0 110.265 168.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.84 62.47 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 111.921 0.341 . . . . 20.0 111.921 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.52 90.95 4.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.193 -0.669 . . . . 20.0 109.193 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.25 7.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.37 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.531 -0.915 . . . . 20.0 108.531 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.84 153.63 75.11 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 CA-C-N 119.635 0.905 . . . . 20.0 112.343 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.62 42.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.509 -1.223 . . . . 20.0 107.912 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -12.28 59.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 118.829 -0.605 . . . . 20.0 112.4 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' E' ' 138' ' ' GLN . 14.0 p30 -55.4 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-O 118.87 -0.586 . . . . 20.0 111.353 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 138' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' E' ' 139' ' ' ILE . 3.9 tp-100 174.63 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 103.082 -2.933 . . . . 20.0 103.082 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 139' ' ' ILE . . . . . 0.421 ' H ' ' HG3' ' E' ' 138' ' ' GLN . 1.2 tp -74.81 168.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.108 0.963 . . . . 20.0 109.007 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.85 161.44 18.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.91 0.884 . . . . 20.0 110.514 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 141' ' ' ILE . . . . . 0.413 HD13 HD13 ' E' ' 162' ' ' ILE . 30.2 mt -124.61 147.46 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.896 0.879 . . . . 20.0 108.646 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' E' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.72 55.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.638 0.775 . . . . 20.0 109.578 175.172 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.12 7.81 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.683 0.614 . . . . 20.0 111.783 166.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' E' ' 142' ' ' ASP . . . 86.85 -6.51 82.82 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 115.488 0.955 . . . . 20.0 115.488 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.01 53.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.502 1.151 . . . . 20.0 110.323 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.31 -20.95 33.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.62 0.97 . . . . 20.0 113.62 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.65 40.11 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.992 0.901 . . . . 20.0 111.395 -173.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 148' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -57.37 -41.52 80.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.25 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -47.01 87.93 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.811 -0.356 . . . . 20.0 110.945 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.31 -35.18 76.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.509 -0.477 . . . . 20.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.56 84.11 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.142 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.85 -23.28 58.41 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.337 -0.945 . . . . 20.0 110.956 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.74 -30.04 66.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.77 -0.772 . . . . 20.0 110.637 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.59 92.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.564 -0.454 . . . . 20.0 111.666 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.12 -8.8 6.7 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-O 118.898 -0.946 . . . . 20.0 114.594 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.68 133.52 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 118.497 1.149 . . . . 20.0 108.514 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.738 -1.208 . . . . 20.0 107.738 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.702 -1.222 . . . . 20.0 107.702 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.31 15.73 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.778 -1.729 . . . . 20.0 108.778 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 160' ' ' THR . . . . . 0.506 HG23 ' HB2' ' E' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.61 17.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 165.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -19.99 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 113.766 1.024 . . . . 20.0 113.766 -166.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 162' ' ' ILE . . . . . 0.576 ' CG1' HG22 ' E' ' 105' ' ' VAL . 0.5 OUTLIER -111.69 155.6 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 121.674 -0.641 . . . . 20.0 111.81 -159.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' E' ' 164' ' ' TRP . 3.5 t -145.29 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.299 1.04 . . . . 20.0 110.473 171.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' E' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.94 16.7 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 -160.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.71 61.65 0.97 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.221 0.534 . . . . 20.0 112.333 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.56 29.54 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.064 -1.214 . . . . 20.0 110.064 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.32 37.68 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.721 -1.214 . . . . 20.0 107.721 170.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.63 30.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.129 -0.942 . . . . 20.0 110.198 -167.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.46 159.74 35.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.861 0.839 . . . . 20.0 109.982 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.17 34.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.224 -1.353 . . . . 20.0 109.494 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.66 28.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.522 -0.547 . . . . 20.0 109.522 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' E' ' 175' ' ' ARG . . . 56.88 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.187 -1.565 . . . . 20.0 109.187 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.91 4.25 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.813 0.672 . . . . 20.0 112.813 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -63.05 1.27 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 119.743 -0.783 . . . . 20.0 111.237 157.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' E' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.96 0.7 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.583 0.629 . . . . 20.0 112.649 172.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.41 0.35 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.786 2.434 . . . . 20.0 106.213 157.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.66 145.79 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.478 -0.934 . . . . 20.0 108.478 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.13 -64.47 1.16 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 116.446 2.017 . . . . 20.0 116.446 -166.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.86 22.37 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 118.726 0.694 . . . . 20.0 112.124 -171.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.07 -0.7 36.74 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 181' ' ' PHE . . . . . 0.746 ' HB3' ' HB3' ' E' ' 327' ' ' GLU . 3.1 t80 -84.6 -67.05 0.83 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.599 0.636 . . . . 20.0 111.755 -162.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.24 127.78 32.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.078 0.942 . . . . 20.0 110.727 -152.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' E' ' 70' ' ' ASP . 0.6 OUTLIER 69.99 -6.7 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.348 1.459 . . . . 20.0 113.135 174.669 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 184' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' E' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.152 0.977 . . . . 20.0 110.779 157.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 185' ' ' ILE . . . . . 0.439 HG12 HG11 ' E' ' 317' ' ' VAL . 1.0 OUTLIER -126.06 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.5 -2.407 . . . . 20.0 104.5 149.898 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 186' ' ' ALA . . . . . 0.706 ' O ' ' OG1' ' E' ' 189' ' ' THR . . . -50.1 -42.96 51.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.342 -0.844 . . . . 20.0 111.55 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.93 -36.08 76.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.25 -0.98 . . . . 20.0 110.105 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.551 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 189' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' E' ' 186' ' ' ALA . 25.3 p -59.06 -48.66 80.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.491 -0.884 . . . . 20.0 110.862 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.24 -50.6 63.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.946 0.403 . . . . 20.0 110.5 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.17 96.22 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.064 -0.655 . . . . 20.0 110.961 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.56 84.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.014 -0.674 . . . . 20.0 110.284 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 193' ' ' VAL . . . . . 0.415 HG23 ' O ' ' E' ' 189' ' ' THR . 11.8 t -60.49 -44.81 97.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.08 0.467 . . . . 20.0 110.159 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.3 75.46 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.223 -0.591 . . . . 20.0 111.227 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.6 -38.17 70.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.877 -0.729 . . . . 20.0 110.811 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.11 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.555 0.576 . . . . 20.0 112.555 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.55 122.83 27.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.31 -0.626 . . . . 20.0 109.31 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.47 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.294 0.371 . . . . 20.0 110.085 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.18 105.41 17.56 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.689 -0.486 . . . . 20.0 109.689 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.07 91.33 4.27 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.974 -0.691 . . . . 20.0 111.376 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.65 30.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 203' ' ' ASP . . . . . 0.652 ' N ' ' OD1' ' E' ' 203' ' ' ASP . 0.0 OUTLIER -78.59 113.02 16.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.491 -0.929 . . . . 20.0 108.491 -174.49 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.92 106.6 9.0 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.987 -0.745 . . . . 20.0 108.987 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.38 31.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 207' ' ' VAL . . . . . 0.721 HG12 HD13 ' E' ' 53' ' ' ILE . 34.1 m -119.91 150.19 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.77 5.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.432 -1.321 . . . . 20.0 107.432 171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.81 159.98 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.851 0.834 . . . . 20.0 111.106 -165.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.252 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.6 40.19 29.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.83 -1.077 . . . . 20.0 111.492 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.361 -0.536 . . . . 20.0 110.922 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.45 64.8 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.218 -0.593 . . . . 20.0 111.519 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.13 121.18 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.93 6.25 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.435 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 216' ' ' LEU . . . . . 0.425 HD23 ' H ' ' E' ' 216' ' ' LEU . 0.5 OUTLIER -47.04 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.55 2.89 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.349 0.5 . . . . 20.0 112.349 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.5 40.82 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.708 -1.234 . . . . 20.0 112.017 168.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 219' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' E' ' 222' ' ' SER . . . -65.27 -37.06 86.01 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 122.27 -0.547 . . . . 20.0 111.412 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 220' ' ' ARG . . . . . 0.406 ' HB2' ' HB1' ' E' ' 302' ' ' ALA . 16.6 ttm180 -52.67 -36.73 57.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.191 0.441 . . . . 20.0 112.191 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 221' ' ' THR . . . . . . . . . . . . . 74.5 p -58.43 -45.81 87.73 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.991 -0.684 . . . . 20.0 110.838 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 222' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' E' ' 219' ' ' ALA . 2.1 p -58.05 -35.79 71.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.728 -0.389 . . . . 20.0 111.425 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.23 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.548 0.573 . . . . 20.0 112.548 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.14 -33.44 75.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.818 -0.753 . . . . 20.0 111.805 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.71 74.93 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 118.92 -1.609 . . . . 20.0 112.14 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.99 -45.64 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 111.97 0.359 . . . . 20.0 111.97 -158.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 227' ' ' GLU . . . . . 0.453 ' OE1' ' OG1' ' E' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.71 99.78 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 118.21 2.67 . . . . 20.0 118.21 -158.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.94 143.74 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 N-CA-C 115.957 1.483 . . . . 20.0 115.957 -134.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.82 0.77 Allowed 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.219 1.408 . . . . 20.0 113.391 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.17 11.54 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.104 -0.638 . . . . 20.0 111.77 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.47 151.48 16.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 20.0 112.255 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.45 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.78 0.832 . . . . 20.0 108.812 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.06 23.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.487 . . . . 20.0 110.42 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 234' ' ' ILE . . . . . 0.495 HD11 ' CE ' ' E' ' 341' ' ' MET . 51.6 mt -133.19 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.58 -1.267 . . . . 20.0 107.58 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' E' ' 68' ' ' HIS . 25.5 t0 -135.19 173.23 11.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.979 -1.489 . . . . 20.0 106.979 173.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.763 . . . . 20.0 111.411 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 237' ' ' THR . . . . . 0.447 HG21 ' HA3' ' E' ' 296' ' ' GLY . 9.1 t -165.61 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.368 -1.345 . . . . 20.0 107.368 164.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' E' ' 237' ' ' THR . 17.9 mm -145.48 151.93 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.32 105.28 9.71 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.861 -1.533 . . . . 20.0 106.861 159.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.53 110.01 18.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.033 0.753 . . . . 20.0 113.033 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.11 22.17 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.902 1.281 . . . . 20.0 112.5 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.92 128.41 79.09 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 243' ' ' PRO . . . . . 0.564 ' HG3' ' HD1' ' G' ' 84' ' ' PHE . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 120.83 1.332 . . . . 20.0 112.396 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.26 45.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.069 -0.969 . . . . 20.0 114.94 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 245' ' ' THR . . . . . . . . . . . . . 33.5 p -92.18 164.54 22.82 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.616 1.208 . . . . 20.0 110.679 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.0 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-O 121.833 0.68 . . . . 20.0 111.922 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -10.9 59.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.081 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.64 63.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.859 -0.737 . . . . 20.0 112.885 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 249' ' ' LYS . . . . . 0.713 ' O ' ' OG1' ' E' ' 252' ' ' THR . 16.9 mttt -98.85 -15.11 19.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -37.89 89.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.278 -0.569 . . . . 20.0 111.394 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.56 -21.02 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.107 -1.037 . . . . 20.0 111.907 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 252' ' ' THR . . . . . 0.713 ' OG1' ' O ' ' E' ' 249' ' ' LYS . 39.4 p -57.17 -31.82 65.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.46 0.573 . . . . 20.0 111.304 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 253' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' E' ' 319' ' ' ALA . 16.7 t-80 -162.35 132.08 4.52 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.283 0.563 . . . . 20.0 110.427 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 20.0 112.307 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.31 35.92 5.84 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 126.175 1.845 . . . . 20.0 111.57 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.2 10.15 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.619 -0.882 . . . . 20.0 108.619 -167.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.24 3.41 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-O 122.642 1.134 . . . . 20.0 113.305 169.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.76 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.545 -0.909 . . . . 20.0 108.545 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.38 120.33 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.439 -169.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.04 139.9 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.755 -1.202 . . . . 20.0 107.755 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 261' ' ' LYS . . . . . 0.768 ' HE3' HG21 ' E' ' 298' ' ' THR . 1.9 mtmm -98.81 122.64 42.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.97 -0.752 . . . . 20.0 108.97 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.74 -40.31 10.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.838 -0.619 . . . . 20.0 109.6 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.406 0.622 . . . . 20.0 109.329 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.97 2.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.78 -1.1 . . . . 20.0 108.183 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.28 21.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.783 -0.644 . . . . 20.0 110.278 163.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.14 11.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.67 0.989 . . . . 20.0 113.67 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 143.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.02 14.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.155 -1.795 . . . . 20.0 106.155 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.38 137.11 56.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.232 0.539 . . . . 20.0 111.278 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.1 109.64 1.96 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.112 -0.949 . . . . 20.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.41 -20.07 48.66 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 N-CA-C 114.816 1.045 . . . . 20.0 114.816 -160.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.558 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.6 -48.35 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.124 0.488 . . . . 20.0 110.099 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.15 -52.52 59.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.799 0.333 . . . . 20.0 110.698 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.92 70.82 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.814 -0.755 . . . . 20.0 110.56 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 276' ' ' TRP . . . . . 0.491 ' HH2' ' HB3' ' E' ' 347' ' ' ASN . 0.1 OUTLIER -68.46 -47.96 65.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.09 -0.644 . . . . 20.0 110.988 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.0 -38.75 89.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.068 -0.653 . . . . 20.0 110.769 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.61 -47.97 78.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.583 -0.447 . . . . 20.0 110.116 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.48 88.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.876 -0.33 . . . . 20.0 110.719 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.92 77.91 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.079 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.68 72.96 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.995 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.4 -31.82 65.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.124 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.68 73.19 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.884 -0.727 . . . . 20.0 110.972 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.63 15.47 29.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.81 32.08 13.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.75 0.786 . . . . 20.0 111.614 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.25 143.39 34.47 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 20.0 108.304 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.15 149.35 13.49 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 CA-C-N 119.145 0.73 . . . . 20.0 111.333 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.18 23.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.667 -0.697 . . . . 20.0 109.676 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.02 175.12 5.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.67 113.72 17.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 167.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.68 43.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.59 168.72 12.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.469 0.652 . . . . 20.0 110.241 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.73 -18.63 21.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.824 -1.08 . . . . 20.0 112.144 165.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.57 -176.03 20.04 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.97 -0.852 . . . . 20.0 110.97 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 296' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' E' ' 237' ' ' THR . . . 101.51 144.74 15.5 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.62 -0.79 . . . . 20.0 112.66 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.79 119.63 4.11 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.324 -1.11 . . . . 20.0 110.324 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 298' ' ' THR . . . . . 0.768 HG21 ' HE3' ' E' ' 261' ' ' LYS . 20.4 p -110.27 172.86 6.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.013 0.911 . . . . 20.0 111.363 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.87 -33.74 76.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.215 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.34 74.11 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 111.73 0.27 . . . . 20.0 111.73 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.15 96.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.197 -1.001 . . . . 20.0 112.028 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 302' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' E' ' 220' ' ' ARG . . . -68.28 -26.92 65.9 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.187 -0.605 . . . . 20.0 111.236 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 303' ' ' ILE . . . . . . . . . . . . . 13.2 mm -70.88 -34.44 55.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.122 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.21 60.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.311 0.856 . . . . 20.0 113.311 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.87 19.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.697 0.999 . . . . 20.0 113.697 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 306' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' E' ' 227' ' ' GLU . 0.5 OUTLIER -58.37 157.56 8.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.534 0.683 . . . . 20.0 110.572 171.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 307' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.343 0.868 . . . . 20.0 113.343 -161.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.2 66.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.716 -0.794 . . . . 20.0 111.201 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 309' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 77.72 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.831 -0.699 . . . . 20.0 113.367 -171.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.28 139.58 52.36 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.558 0.679 . . . . 20.0 111.131 -163.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.45 141.68 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 CA-C-N 119.482 0.851 . . . . 20.0 110.039 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.48 135.79 32.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.323 -0.853 . . . . 20.0 111.201 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.58 162.6 12.32 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.166 -1.574 . . . . 20.0 109.166 164.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.03 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.464 0.649 . . . . 20.0 110.082 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.04 153.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.62 -1.173 . . . . 20.0 109.258 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.55 32.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.283 -0.871 . . . . 20.0 109.417 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 317' ' ' VAL . . . . . 0.439 HG11 HG12 ' E' ' 185' ' ' ILE . 92.6 t -99.48 108.61 51.45 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.285 -1.376 . . . . 20.0 107.285 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.31 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 CA-C-O 122.626 1.011 . . . . 20.0 113.589 -154.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 319' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' E' ' 253' ' ' HIS . . . 79.84 35.44 0.15 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.604 -1.634 . . . . 20.0 115.282 161.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 320' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' E' ' 321' ' ' TYR . 0.4 OUTLIER -75.57 157.56 33.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.759 0.79 . . . . 20.0 110.119 176.708 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 321' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' E' ' 320' ' ' ARG . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 106.797 -1.557 . . . . 20.0 106.797 160.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.23 113.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.199 1.0 . . . . 20.0 108.379 -163.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.54 -7.44 3.23 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.45 1.278 . . . . 20.0 114.45 -140.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 324' ' ' SER . . . . . 0.589 ' OG ' HG21 ' E' ' 97' ' ' THR . 0.1 OUTLIER -59.54 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.665 0.617 . . . . 20.0 112.665 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 325' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' G' ' 100' ' ' ALA . 35.0 p-10 -102.0 -56.09 2.35 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 115.007 1.484 . . . . 20.0 115.007 -152.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.93 50.78 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.442 -1.318 . . . . 20.0 107.442 174.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 327' ' ' GLU . . . . . 0.746 ' HB3' ' HB3' ' E' ' 181' ' ' PHE . 82.7 mt-10 -142.55 52.84 1.42 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.817 -1.538 . . . . 20.0 109.94 -153.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.06 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.403 0.621 . . . . 20.0 111.939 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 329' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' E' ' 181' ' ' PHE . 0.3 OUTLIER -139.4 179.41 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.919 0.866 . . . . 20.0 109.427 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.18 27.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.818 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.06 -32.1 53.6 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.835 0.71 . . . . 20.0 111.51 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.73 73.56 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.308 -0.557 . . . . 20.0 110.214 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.05 -44.89 83.24 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.779 -0.368 . . . . 20.0 111.064 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.66 -41.27 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 120.435 -0.506 . . . . 20.0 110.496 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 118.837 -1.145 . . . . 20.0 110.152 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.4 -40.42 93.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.459 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.6 -43.81 80.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.76 0.314 . . . . 20.0 110.924 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 338' ' ' VAL . . . . . 0.705 ' O ' ' OG1' ' E' ' 342' ' ' THR . 42.7 t -60.17 -48.95 86.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.034 0.445 . . . . 20.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' E' ' 343' ' ' LYS . 1.3 mm-40 -54.78 -47.02 74.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.99 0.424 . . . . 20.0 110.726 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -55.14 37.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.332 -0.395 . . . . 20.0 111.456 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 341' ' ' MET . . . . . 0.495 ' CE ' HD11 ' E' ' 234' ' ' ILE . 31.9 tpp -60.19 -40.32 89.64 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.216 -0.594 . . . . 20.0 110.783 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 342' ' ' THR . . . . . 0.705 ' OG1' ' O ' ' E' ' 338' ' ' VAL . 1.3 m -56.52 -45.01 81.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.164 0.507 . . . . 20.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' E' ' 339' ' ' GLU . 34.6 mttp -74.23 -37.42 63.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.935 -0.706 . . . . 20.0 110.756 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.59 -0.444 . . . . 20.0 111.128 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 345' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.39 74.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.53 -0.468 . . . . 20.0 110.806 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.71 -39.0 90.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.669 -0.812 . . . . 20.0 110.574 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 347' ' ' ASN . . . . . 0.491 ' HB3' ' HH2' ' E' ' 276' ' ' TRP . 5.0 m-20 -84.51 4.76 30.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.471 -0.892 . . . . 20.0 112.522 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 348' ' ' ILE . . . . . 0.424 HG22 ' O ' ' E' ' 345' ' ' LEU . 1.3 tt -65.13 -23.8 34.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 119.095 0.861 . . . . 20.0 110.877 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' E' E ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.241 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.8 31.77 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 122.153 -0.342 . . . . 20.0 111.453 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 351' ' ' LEU . . . . . 0.443 ' O ' HD12 ' E' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.154 0.428 . . . . 20.0 112.154 -173.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' E' E ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.7 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.028 1.862 . . . . 20.0 116.028 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' E' E ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 124.956 1.302 . . . . 20.0 108.387 -174.683 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.301 1.223 . . . . 20.0 114.301 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.21 2.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.886 -1.524 . . . . 20.0 106.886 -170.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.93 -34.5 66.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.891 -1.049 . . . . 20.0 110.206 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.0 -23.54 12.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.45 30.32 19.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.146 0.978 . . . . 20.0 111.588 -173.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.65 32.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.765 0.257 . . . . 20.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.44 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.644 -1.243 . . . . 20.0 107.644 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.94 112.19 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.579 . . . . 20.0 110.92 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.427 -0.806 . . . . 20.0 111.874 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.16 -45.16 74.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.515 -0.474 . . . . 20.0 111.202 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.08 97.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 121.024 -0.27 . . . . 20.0 111.162 -172.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -30.55 70.95 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.731 -0.388 . . . . 20.0 111.189 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.85 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.633 -0.427 . . . . 20.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -43.0 91.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.651 -0.249 . . . . 20.0 111.484 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.67 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.02 -32.15 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.054 -1.059 . . . . 20.0 111.015 -162.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.93 67.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.289 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.06 160.4 70.72 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.837 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 19' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -85.13 144.72 9.55 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 120.299 0.666 . . . . 20.0 112.202 -172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.2 3.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 117.303 1.681 . . . . 20.0 117.303 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 159.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.1 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.367 0.604 . . . . 20.0 110.697 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.31 2.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.453 -0.794 . . . . 20.0 114.039 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.36 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.358 1.075 . . . . 20.0 109.569 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.93 -13.15 3.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.057 . . . . 20.0 113.437 169.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 26' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' F' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.01 23.8 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.705 1.139 . . . . 20.0 113.733 178.546 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.405 1.631 . . . . 20.0 115.405 -154.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 28' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' F' ' 26' ' ' PHE . . . -53.17 -26.9 29.84 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.783 1.174 . . . . 20.0 116.005 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 29' ' ' ILE . . . . . 0.526 HD13 ' NH1' ' F' ' 184' ' ' ARG . 1.1 tt -59.54 -35.85 61.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.096 0.948 . . . . 20.0 110.597 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -54.31 -52.39 61.64 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.881 0.372 . . . . 20.0 110.412 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.64 74.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.248 -0.433 . . . . 20.0 110.946 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.6 82.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.077 0.465 . . . . 20.0 110.327 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.67 86.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 119.703 -0.799 . . . . 20.0 110.31 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.74 -29.49 20.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 118.75 -1.18 . . . . 20.0 111.149 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.52 -30.93 71.64 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 117.988 0.358 . . . . 20.0 111.143 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.94 -56.79 3.23 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.145 0.424 . . . . 20.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.515 -0.311 . . . . 20.0 111.499 -164.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -26.35 63.65 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.891 -0.724 . . . . 20.0 112.243 -162.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.17 -23.48 62.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.881 -1.127 . . . . 20.0 111.662 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.88 -7.02 22.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.51 152.68 22.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.584 -0.895 . . . . 20.0 108.584 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.11 -42.63 88.99 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.25 -0.886 . . . . 20.0 111.475 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.32 35.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.542 -0.91 . . . . 20.0 108.542 -173.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.56 147.16 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.274 -1.01 . . . . 20.0 108.274 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.15 159.22 44.17 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.473 0.654 . . . . 20.0 110.442 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 129.01 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.31 -176.13 5.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.828 0.823 . . . . 20.0 108.882 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.63 62.97 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.086 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.83 9.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.692 0.997 . . . . 20.0 113.692 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.58 83.44 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 119.125 -0.819 . . . . 20.0 114.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.21 151.49 35.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.473 1.136 . . . . 20.0 110.194 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.25 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.127 -1.434 . . . . 20.0 107.127 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 53' ' ' ILE . . . . . 0.695 HD13 HG12 ' F' ' 207' ' ' VAL . 31.3 mm -130.24 115.61 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.345 -1.354 . . . . 20.0 107.345 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.83 36.57 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.667 -0.494 . . . . 20.0 109.667 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 145.35 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.759 -1.571 . . . . 20.0 106.759 163.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.49 20.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.674 -0.491 . . . . 20.0 109.674 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.43 -161.08 23.71 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.125 -0.79 . . . . 20.0 111.125 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.58 10.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.91 0.884 . . . . 20.0 109.002 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.693 -0.765 . . . . 20.0 114.07 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.74 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.76 0.65 . . . . 20.0 112.067 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -91.98 111.34 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.188 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.7 137.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.776 -0.824 . . . . 20.0 108.776 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.69 124.09 46.51 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.055 0.942 . . . . 20.0 109.072 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.26 114.3 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.082 -1.081 . . . . 20.0 108.082 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.64 51.42 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.274 0.359 . . . . 20.0 110.973 -168.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.57 45.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.914 0.885 . . . . 20.0 108.957 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' F' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.41 29.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.265 0.555 . . . . 20.0 110.58 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 21.26 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.205 -0.907 . . . . 20.0 109.695 -178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 70' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' F' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.667 -0.646 . . . . 20.0 112.45 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.86 28.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.256 -1.016 . . . . 20.0 108.256 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.8 148.84 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.717 0.807 . . . . 20.0 109.154 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 73' ' ' GLY . . . . . 0.465 ' C ' HD23 ' F' ' 74' ' ' LEU . . . -155.83 -175.74 27.18 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.605 -0.998 . . . . 20.0 110.605 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 74' ' ' LEU . . . . . 0.465 HD23 ' C ' ' F' ' 73' ' ' GLY . 5.1 mt -125.05 161.5 26.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.346 0.593 . . . . 20.0 109.954 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 75' ' ' MET . . . . . 0.509 ' HB2' HG23 ' F' ' 160' ' ' THR . 10.6 ttm -128.15 131.28 48.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.205 1.002 . . . . 20.0 109.698 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.06 23.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.892 -0.781 . . . . 20.0 108.892 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.33 7.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.085 0.772 . . . . 20.0 113.085 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.01 174.47 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.11 -1.07 . . . . 20.0 108.11 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.05 108.96 19.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.32 5.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.845 0.831 . . . . 20.0 110.0 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -27.09 60.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.7 -0.8 . . . . 20.0 112.739 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 9.19 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.348 0.87 . . . . 20.0 113.348 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 12.8 81.84 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 119.009 -0.884 . . . . 20.0 115.105 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.8 145.05 34.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.352 1.076 . . . . 20.0 110.228 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.48 28.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.265 -0.879 . . . . 20.0 112.6 -172.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.7 163.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.654 0.74 . . . . 20.0 109.461 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.36 15.66 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.838 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.89 160.21 24.29 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-O 122.27 0.862 . . . . 20.0 112.71 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 90' ' ' ILE . . . . . 0.489 HD11 HG21 ' F' ' 160' ' ' THR . 9.2 mt -88.76 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.726 -1.579 . . . . 20.0 107.377 165.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.04 140.94 47.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.259 -0.882 . . . . 20.0 112.112 -168.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.22 22.02 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.936 -0.924 . . . . 20.0 115.24 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.9 152.66 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 118.648 1.224 . . . . 20.0 109.209 -169.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 130.97 22.19 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.466 -0.938 . . . . 20.0 108.466 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.11 -7.93 13.05 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 CA-C-N 120.543 1.23 . . . . 20.0 114.792 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.29 59.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.19 0.905 . . . . 20.0 111.788 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 97' ' ' THR . . . . . 0.589 HG21 ' OG ' ' F' ' 324' ' ' SER . 44.7 p -89.4 35.49 0.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.632 0.773 . . . . 20.0 112.44 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' F' ' 99' ' ' ILE . 0.5 OUTLIER -43.26 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.017 1.327 . . . . 20.0 113.331 -172.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' F' ' 98' ' ' LEU . 1.6 tt -173.19 156.07 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.965 -0.754 . . . . 20.0 108.965 174.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 100' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' H' ' 100' ' ' ALA . . . -123.93 -18.93 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.666 -1.152 . . . . 20.0 111.289 157.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 101' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' H' ' 165' ' ' ASP . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.691 -0.855 . . . . 20.0 108.691 176.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 102' ' ' ARG . . . . . 0.546 HH12 ' HB3' ' H' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.55 0.38 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.205 1.557 . . . . 20.0 115.205 150.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 103' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' F' ' 115' ' ' GLY . 0.5 OUTLIER -79.33 134.19 36.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 119.278 0.945 . . . . 20.0 109.442 160.368 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.77 140.33 37.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.556 -0.747 . . . . 20.0 109.426 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 105' ' ' VAL . . . . . 0.582 HG22 ' CG1' ' F' ' 162' ' ' ILE . 50.4 t -117.4 110.73 32.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.08 6.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.237 -0.283 . . . . 20.0 110.237 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.95 -54.25 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 123.379 0.424 . . . . 20.0 110.303 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.401 -0.963 . . . . 20.0 108.401 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.13 126.35 27.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.886 -1.052 . . . . 20.0 110.473 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.31 74.99 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 118.854 -0.97 . . . . 20.0 115.33 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.12 113.96 15.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.149 . . . . 20.0 108.556 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.27 141.54 37.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.409 -0.589 . . . . 20.0 109.409 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.68 142.53 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.44 31.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.97 -1.014 . . . . 20.0 110.257 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 115' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' F' ' 103' ' ' PHE . . . -147.95 157.73 27.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.279 -1.128 . . . . 20.0 110.279 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.587 -168.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 118' ' ' ALA . . . . . 0.488 ' O ' HD13 ' F' ' 98' ' ' LEU . . . -67.2 -47.96 69.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.363 1.246 . . . . 20.0 114.363 -156.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.59 121.13 11.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 119.519 1.054 . . . . 20.0 112.65 -155.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.11 35.61 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 102.668 -3.086 . . . . 20.0 102.668 159.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 CA-C-N 120.766 1.309 . . . . 20.0 110.548 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.75 149.74 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.268 0 CA-C-N 119.191 0.747 . . . . 20.0 110.684 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.05 165.36 7.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.8 0.809 . . . . 20.0 109.99 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.17 91.91 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.192 -1.04 . . . . 20.0 108.192 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.79 19.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.761 -0.376 . . . . 20.0 110.704 169.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.88 -43.62 1.51 Allowed Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 123.937 0.895 . . . . 20.0 113.085 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.96 59.32 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 120.843 1.337 . . . . 20.0 111.975 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.47 30.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 111.778 0.288 . . . . 20.0 111.778 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.94 69.18 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.772 -0.771 . . . . 20.0 110.243 168.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.91 62.48 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.887 0.329 . . . . 20.0 111.887 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.45 90.93 4.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.205 -0.665 . . . . 20.0 109.205 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.25 7.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.075 0.398 . . . . 20.0 112.075 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.54 87.52 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.72 153.62 75.46 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 CA-C-N 119.613 0.898 . . . . 20.0 112.384 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.66 42.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.938 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -12.26 59.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 118.837 -0.601 . . . . 20.0 112.382 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' F' ' 138' ' ' GLN . 14.1 p30 -55.32 -66.42 0.42 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.898 -0.572 . . . . 20.0 111.363 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 138' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' F' ' 139' ' ' ILE . 3.9 tp-100 174.65 174.13 0.2 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.121 -2.918 . . . . 20.0 103.121 133.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 139' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' F' ' 138' ' ' GLN . 1.2 tp -74.84 168.1 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.153 0.981 . . . . 20.0 108.94 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.86 161.45 18.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.924 0.89 . . . . 20.0 110.495 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 141' ' ' ILE . . . . . 0.402 HD13 HD13 ' F' ' 162' ' ' ILE . 30.1 mt -124.6 147.48 29.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.575 -0.898 . . . . 20.0 108.575 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 142' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' F' ' 144' ' ' GLY . 0.5 OUTLIER -119.07 134.72 55.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.678 0.791 . . . . 20.0 109.615 175.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.668 0.605 . . . . 20.0 111.777 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 144' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' F' ' 142' ' ' ASP . . . 86.8 -6.47 82.8 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 115.489 0.956 . . . . 20.0 115.489 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.05 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.51 1.155 . . . . 20.0 110.254 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.41 -20.85 33.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.593 0.96 . . . . 20.0 113.593 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.37 162.65 40.12 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.967 0.889 . . . . 20.0 111.46 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.44 -41.5 80.61 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 113.937 -1.483 . . . . 20.0 111.214 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.35 -47.06 87.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.824 -0.351 . . . . 20.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.3 -35.19 76.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.511 -0.476 . . . . 20.0 110.807 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.59 83.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.09 -0.644 . . . . 20.0 111.072 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.31 58.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.377 -0.929 . . . . 20.0 111.03 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.74 -30.09 66.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.587 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.59 -40.55 92.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.516 -0.474 . . . . 20.0 111.705 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.13 -8.74 6.7 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 118.903 -0.943 . . . . 20.0 114.554 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.5 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.494 1.147 . . . . 20.0 108.553 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.99 9.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.707 -1.22 . . . . 20.0 107.707 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.35 147.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.76 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 108.749 -1.74 . . . . 20.0 108.749 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 160' ' ' THR . . . . . 0.509 HG23 ' HB2' ' F' ' 75' ' ' MET . 0.2 OUTLIER -79.38 113.58 17.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.63 -1.248 . . . . 20.0 107.63 165.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.66 -20.02 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -166.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 162' ' ' ILE . . . . . 0.582 ' CG1' HG22 ' F' ' 105' ' ' VAL . 0.5 OUTLIER -111.72 155.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.587 0.631 . . . . 20.0 111.722 -159.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 163' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' F' ' 164' ' ' TRP . 3.5 t -145.34 -166.33 2.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.235 1.014 . . . . 20.0 110.476 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 164' ' ' TRP . . . . . 0.547 ' N ' ' OG1' ' F' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.9 16.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.7 61.72 0.97 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.844 -0.535 . . . . 20.0 112.262 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 148.35 37.69 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.61 30.43 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.109 -0.95 . . . . 20.0 110.23 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.41 159.76 35.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.858 0.837 . . . . 20.0 110.012 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.12 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.254 -1.339 . . . . 20.0 109.52 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.9 151.64 28.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.5 -0.556 . . . . 20.0 109.5 168.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 172' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' F' ' 175' ' ' ARG . . . 56.93 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.219 -1.552 . . . . 20.0 109.219 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.85 4.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.812 0.671 . . . . 20.0 112.812 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -63.03 1.28 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.749 -0.78 . . . . 20.0 111.233 157.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 175' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' F' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.98 0.7 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.56 0.618 . . . . 20.0 112.653 172.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.51 169.36 0.35 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.844 2.458 . . . . 20.0 106.256 157.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.66 145.82 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.494 -0.928 . . . . 20.0 108.494 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.21 -64.43 1.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 116.421 2.008 . . . . 20.0 116.421 -165.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.33 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.772 0.714 . . . . 20.0 112.137 -171.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.65 36.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.388 1.255 . . . . 20.0 114.388 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 181' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' F' ' 327' ' ' GLU . 3.1 t80 -84.71 -66.92 0.84 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.592 0.633 . . . . 20.0 111.75 -162.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.29 127.82 32.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.094 0.949 . . . . 20.0 110.697 -152.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 183' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' F' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.75 1.03 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.329 1.452 . . . . 20.0 113.191 174.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 184' ' ' ARG . . . . . 0.526 ' NH1' HD13 ' F' ' 29' ' ' ILE . 0.0 OUTLIER -153.77 83.88 1.16 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.14 0.972 . . . . 20.0 110.805 157.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 185' ' ' ILE . . . . . 0.446 HG12 HG11 ' F' ' 317' ' ' VAL . 1.0 OUTLIER -126.1 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 186' ' ' ALA . . . . . 0.695 ' O ' ' OG1' ' F' ' 189' ' ' THR . . . -50.09 -42.98 51.17 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.351 -0.84 . . . . 20.0 111.542 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.85 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 119.292 -0.963 . . . . 20.0 110.133 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.68 92.01 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.206 -0.997 . . . . 20.0 110.481 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 189' ' ' THR . . . . . 0.695 ' OG1' ' O ' ' F' ' 186' ' ' ALA . 25.2 p -59.1 -48.58 81.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.437 -0.905 . . . . 20.0 110.861 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.34 -50.55 64.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.955 0.407 . . . . 20.0 110.49 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.17 96.13 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.025 -0.67 . . . . 20.0 110.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.84 -36.6 84.46 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.98 -0.688 . . . . 20.0 110.339 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 193' ' ' VAL . . . . . 0.407 HG23 ' O ' ' F' ' 189' ' ' THR . 11.7 t -60.45 -44.9 97.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.022 0.439 . . . . 20.0 110.103 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.26 75.35 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.234 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.63 -38.12 70.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.809 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.77 -26.09 40.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.557 0.577 . . . . 20.0 112.557 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.56 122.78 27.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.298 -0.63 . . . . 20.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.286 0.366 . . . . 20.0 110.08 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.14 105.38 17.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.3 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.224 -0.658 . . . . 20.0 109.224 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.54 59.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.001 -0.68 . . . . 20.0 111.349 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.957 -0.757 . . . . 20.0 108.957 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' F' ' 203' ' ' ASP . 0.0 OUTLIER -78.64 112.96 16.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 -174.508 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.61 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.577 -0.897 . . . . 20.0 108.577 -170.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.91 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.042 -0.725 . . . . 20.0 109.042 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.4 31.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.727 -0.842 . . . . 20.0 108.727 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 207' ' ' VAL . . . . . 0.695 HG12 HD13 ' F' ' 53' ' ' ILE . 34.0 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 108.884 -0.784 . . . . 20.0 108.884 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.37 98.79 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.39 -1.337 . . . . 20.0 107.39 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.88 159.95 19.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.91 0.862 . . . . 20.0 111.066 -165.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.77 166.45 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.227 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.17 29.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.778 -1.101 . . . . 20.0 111.481 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.96 -49.57 13.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.331 -0.548 . . . . 20.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.43 64.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.495 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 214' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.691 -1.243 . . . . 20.0 111.441 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 216' ' ' LEU . . . . . 0.429 HD23 ' H ' ' F' ' 216' ' ' LEU . 0.5 OUTLIER -47.03 -25.6 0.85 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.999 0.92 . . . . 20.0 113.411 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 217' ' ' ARG . . . . . 0.539 ' HB3' ' HG ' ' K' ' 305' ' ' LEU . 1.3 mpt_? -63.46 -4.53 2.83 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.368 0.507 . . . . 20.0 112.368 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.64 -40.58 40.7 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 119.754 -1.212 . . . . 20.0 111.973 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' F' ' 222' ' ' SER . . . -65.27 -37.05 86.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 122.298 -0.531 . . . . 20.0 111.378 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 220' ' ' ARG . . . . . 0.414 ' HB2' ' HB1' ' F' ' 302' ' ' ALA . 16.6 ttm180 -52.7 -36.75 57.8 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.43 -45.8 87.75 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.856 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' F' ' 219' ' ' ALA . 2.1 p -58.02 -35.8 71.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.81 -0.356 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.7 -49.97 69.41 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.546 0.573 . . . . 20.0 112.546 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 224' ' ' PHE . . . . . 0.482 ' HB2' ' HD2' ' K' ' 307' ' ' LYS . 78.8 t80 -64.12 -33.48 75.88 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.852 -0.739 . . . . 20.0 111.799 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.72 74.92 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 118.906 -1.616 . . . . 20.0 112.112 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.008 0.373 . . . . 20.0 112.008 -158.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 227' ' ' GLU . . . . . 0.463 ' OE1' ' OG1' ' F' ' 306' ' ' THR . 3.0 pt-20 -56.45 -46.69 99.79 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 118.218 2.673 . . . . 20.0 118.218 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.88 143.66 2.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 N-CA-C 115.974 1.49 . . . . 20.0 115.974 -134.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.24 -4.77 0.77 Allowed 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.201 1.4 . . . . 20.0 113.366 162.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.2 11.47 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.124 -0.631 . . . . 20.0 111.793 167.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.45 151.49 16.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.935 -0.65 . . . . 20.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 232' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.814 0.846 . . . . 20.0 108.825 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.01 23.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.173 0.511 . . . . 20.0 110.379 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 234' ' ' ILE . . . . . 0.485 HD11 ' CE ' ' F' ' 341' ' ' MET . 51.6 mt -133.18 90.43 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.55 -1.278 . . . . 20.0 107.55 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' F' ' 68' ' ' HIS . 25.5 t0 -135.12 173.24 11.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.948 -1.501 . . . . 20.0 106.948 173.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.18 149.37 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.656 0.741 . . . . 20.0 111.436 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 237' ' ' THR . . . . . 0.458 HG21 ' HA3' ' F' ' 296' ' ' GLY . 9.1 t -165.63 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.354 -1.35 . . . . 20.0 107.354 164.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' F' ' 237' ' ' THR . 18.0 mm -145.5 151.92 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.254 -1.017 . . . . 20.0 108.254 -161.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.18 9.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.852 -1.536 . . . . 20.0 106.852 159.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.02 18.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.038 0.755 . . . . 20.0 113.038 -155.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.43 36.09 22.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.92 1.288 . . . . 20.0 112.458 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 243' ' ' PRO . . . . . 0.458 ' HG3' ' HD1' ' H' ' 84' ' ' PHE . 16.6 Cg_exo -61.02 165.53 12.12 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 CA-C-N 120.823 1.33 . . . . 20.0 112.383 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.45 -5.29 45.51 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-O 118.856 -0.969 . . . . 20.0 114.909 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.15 164.51 22.96 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 118.606 1.203 . . . . 20.0 110.65 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.92 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.326 -0.612 0 CA-C-O 121.877 0.699 . . . . 20.0 111.943 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.724 -1.125 . . . . 20.0 112.058 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.26 -18.71 63.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.832 -0.747 . . . . 20.0 112.858 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 249' ' ' LYS . . . . . 0.721 ' O ' ' OG1' ' F' ' 252' ' ' THR . 16.9 mttt -98.78 -15.11 19.41 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.88 89.04 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.305 -0.558 . . . . 20.0 111.347 -172.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.62 -20.94 25.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 119.054 -1.058 . . . . 20.0 111.92 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 252' ' ' THR . . . . . 0.721 ' OG1' ' O ' ' F' ' 249' ' ' LYS . 39.3 p -57.16 -31.83 65.8 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.501 0.591 . . . . 20.0 111.299 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 253' ' ' HIS . . . . . 0.549 ' CD2' ' HB2' ' F' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.343 0.592 . . . . 20.0 110.407 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.36 -1.3 3.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.968 -1.014 . . . . 20.0 112.308 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 126.188 1.851 . . . . 20.0 111.582 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.4 129.23 10.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.22 3.31 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-O 122.695 1.164 . . . . 20.0 113.371 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.12 6.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.525 -0.917 . . . . 20.0 108.525 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.43 120.3 29.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.936 . . . . 20.0 109.424 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.0 139.96 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.781 -1.192 . . . . 20.0 107.781 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 261' ' ' LYS . . . . . 0.748 ' HE3' HG21 ' F' ' 298' ' ' THR . 1.9 mtmm -98.83 122.68 42.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.79 -40.33 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.903 -0.589 . . . . 20.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.59 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.319 -0.622 . . . . 20.0 109.319 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.08 -169.92 2.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.792 -1.095 . . . . 20.0 108.231 165.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.03 -56.21 22.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.781 -0.645 . . . . 20.0 110.271 163.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.15 11.56 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 267' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.76 143.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.411 -0.589 . . . . 20.0 109.411 -163.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 268' ' ' ILE . . . . . . . . . . . . . 9.8 mm -121.31 104.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.099 -1.815 . . . . 20.0 106.099 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.3 137.1 56.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 20.0 111.339 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.67 1.98 Allowed Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 20.0 108.66 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 271' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -67.52 -20.0 48.06 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 N-CA-C 114.77 1.027 . . . . 20.0 114.77 -160.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.196 -0.601 . . . . 20.0 110.561 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.61 -48.36 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.108 0.48 . . . . 20.0 110.092 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.13 -52.5 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.831 0.348 . . . . 20.0 110.742 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.33 -31.94 70.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.801 -0.759 . . . . 20.0 110.581 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 276' ' ' TRP . . . . . 0.481 ' HH2' ' HB3' ' F' ' 347' ' ' ASN . 0.1 OUTLIER -68.46 -47.99 65.68 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.944 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.99 -38.76 89.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.024 -0.67 . . . . 20.0 110.765 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.58 -48.04 78.26 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.625 -0.43 . . . . 20.0 110.049 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.83 -40.43 88.44 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.855 -0.338 . . . . 20.0 110.706 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.28 -44.94 78.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.243 -0.583 . . . . 20.0 111.118 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.72 73.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.989 -0.684 . . . . 20.0 111.028 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.37 -31.8 65.9 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.198 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.66 73.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.885 -0.726 . . . . 20.0 111.031 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.58 15.43 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.16 13.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.672 0.748 . . . . 20.0 111.562 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.35 143.41 34.33 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.32 -0.993 . . . . 20.0 108.32 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.21 149.35 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.176 0.741 . . . . 20.0 111.349 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.12 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.625 -0.716 . . . . 20.0 109.679 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.95 175.1 5.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.689 -1.226 . . . . 20.0 107.689 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.65 113.76 17.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.889 -1.152 . . . . 20.0 107.889 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.73 43.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.403 -0.591 . . . . 20.0 109.403 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.02 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.659 -1.238 . . . . 20.0 107.659 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.55 168.67 12.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.484 0.659 . . . . 20.0 110.245 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.78 -18.53 21.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.832 -1.077 . . . . 20.0 112.143 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 296' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' F' ' 237' ' ' THR . . . 101.52 144.76 15.52 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.679 -0.761 . . . . 20.0 112.666 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.335 -1.106 . . . . 20.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 298' ' ' THR . . . . . 0.748 HG21 ' HE3' ' F' ' 261' ' ' LYS . 20.3 p -110.28 172.9 6.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.028 0.918 . . . . 20.0 111.382 -174.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.88 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.378 -1.283 . . . . 20.0 111.236 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.63 -35.31 74.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.764 0.283 . . . . 20.0 111.764 -171.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.16 96.87 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.176 -1.011 . . . . 20.0 112.059 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 302' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' F' ' 220' ' ' ARG . . . -68.31 -26.87 65.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.165 -0.614 . . . . 20.0 111.216 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.92 -34.47 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.144 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.18 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.304 0.853 . . . . 20.0 113.304 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 305' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' C' ' 217' ' ' ARG . 4.1 mp -103.75 -8.9 19.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.699 1.0 . . . . 20.0 113.699 -167.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 306' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' F' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.6 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.564 0.697 . . . . 20.0 110.551 171.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 307' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' C' ' 224' ' ' PHE . 21.6 mmtt -61.78 -29.8 70.38 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 -160.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.15 66.2 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.666 -0.814 . . . . 20.0 111.215 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.875 -0.678 . . . . 20.0 113.299 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 117.593 0.696 . . . . 20.0 111.13 -163.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 311' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -84.46 141.73 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.492 0.854 . . . . 20.0 110.063 168.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.48 135.8 32.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.354 -0.839 . . . . 20.0 111.186 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.63 12.32 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 109.125 -1.59 . . . . 20.0 109.125 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.02 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.452 0.644 . . . . 20.0 110.029 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -103.99 153.19 21.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.593 -1.185 . . . . 20.0 109.228 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.54 32.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.329 -0.851 . . . . 20.0 109.444 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 317' ' ' VAL . . . . . 0.446 HG11 HG12 ' F' ' 185' ' ' ILE . 92.3 t -99.46 108.62 51.47 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-O 122.645 1.019 . . . . 20.0 113.622 -154.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 319' ' ' ALA . . . . . 0.549 ' HB2' ' CD2' ' F' ' 253' ' ' HIS . . . 79.79 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 113.592 -1.64 . . . . 20.0 115.265 161.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 320' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' F' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.56 33.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.712 0.768 . . . . 20.0 110.113 176.743 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 321' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' F' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.17 11.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.814 -1.55 . . . . 20.0 106.814 160.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.22 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.146 0.978 . . . . 20.0 108.426 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.53 -7.41 3.2 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.438 1.273 . . . . 20.0 114.438 -140.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 324' ' ' SER . . . . . 0.589 ' OG ' HG21 ' F' ' 97' ' ' THR . 0.1 OUTLIER -59.57 -59.91 4.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.671 0.619 . . . . 20.0 112.671 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 325' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -101.98 -56.13 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.062 1.504 . . . . 20.0 115.062 -152.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.98 50.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 327' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' F' ' 181' ' ' PHE . 82.8 mt-10 -142.57 52.82 1.42 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.811 -1.541 . . . . 20.0 109.924 -153.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.05 149.4 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.454 0.645 . . . . 20.0 111.934 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 329' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' F' ' 181' ' ' PHE . 0.3 OUTLIER -139.39 179.38 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.901 0.858 . . . . 20.0 109.479 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 119.24 27.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.833 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.13 -32.05 54.02 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.878 0.736 . . . . 20.0 111.528 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.74 73.56 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.326 -0.549 . . . . 20.0 110.223 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 333' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -66.0 -45.01 83.14 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.029 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.41 -0.516 . . . . 20.0 110.506 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.67 71.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 118.838 -1.145 . . . . 20.0 110.128 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.05 -0.66 . . . . 20.0 110.441 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.55 -43.84 80.33 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.713 0.292 . . . . 20.0 110.872 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' F' ' 342' ' ' THR . 42.6 t -60.19 -48.91 86.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.022 0.439 . . . . 20.0 110.278 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 339' ' ' GLU . . . . . 0.779 ' OE1' ' NZ ' ' F' ' 343' ' ' LYS . 1.3 mm-40 -54.93 -46.84 74.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.971 0.415 . . . . 20.0 110.757 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.16 37.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.371 -0.377 . . . . 20.0 111.397 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 341' ' ' MET . . . . . 0.485 ' CE ' HD11 ' F' ' 234' ' ' ILE . 31.8 tpp -60.19 -40.32 89.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.245 -0.582 . . . . 20.0 110.799 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' F' ' 338' ' ' VAL . 1.3 m -56.52 -45.02 81.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.166 0.508 . . . . 20.0 110.402 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 343' ' ' LYS . . . . . 0.779 ' NZ ' ' OE1' ' F' ' 339' ' ' GLU . 34.4 mttp -74.17 -37.48 63.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.999 -0.681 . . . . 20.0 110.764 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.55 97.83 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.109 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 345' ' ' LEU . . . . . 0.414 ' O ' HG22 ' F' ' 348' ' ' ILE . 1.0 OUTLIER -58.97 -50.42 74.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.809 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.69 -39.02 90.83 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.628 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 347' ' ' ASN . . . . . 0.481 ' HB3' ' HH2' ' F' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.83 30.16 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.501 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 348' ' ' ILE . . . . . 0.414 HG22 ' O ' ' F' ' 345' ' ' LEU . 1.3 tt -65.21 -23.68 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.129 0.877 . . . . 20.0 110.908 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' F' F ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.33 69.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.796 -0.762 . . . . 20.0 111.248 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.93 -18.77 31.77 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.102 -0.374 . . . . 20.0 111.487 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 351' ' ' LEU . . . . . 0.448 ' O ' HD12 ' F' ' 351' ' ' LEU . 0.1 OUTLIER -69.76 -28.77 66.05 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -173.901 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' F' F ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.71 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.065 1.876 . . . . 20.0 116.065 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' F' F ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.944 1.298 . . . . 20.0 108.359 -174.696 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.242 1.201 . . . . 20.0 114.242 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.18 2.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 -170.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.88 -34.5 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.89 -1.05 . . . . 20.0 110.215 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.55 12.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.623 0.972 . . . . 20.0 113.623 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.41 30.33 20.01 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.136 0.975 . . . . 20.0 111.62 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -38.66 32.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 117.74 0.246 . . . . 20.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.45 37.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.14 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.375 0.607 . . . . 20.0 110.94 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.65 -31.58 72.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.429 -0.805 . . . . 20.0 111.896 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.12 -45.21 74.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.5 -0.48 . . . . 20.0 111.176 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -43.14 97.3 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.055 -0.258 . . . . 20.0 111.163 -172.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -30.58 70.95 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.736 -0.386 . . . . 20.0 111.181 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.35 91.0 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.541 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.03 -42.97 91.5 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.699 -0.228 . . . . 20.0 111.531 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.9 -40.06 26.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 119.509 -0.876 . . . . 20.0 110.692 -171.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.03 -32.16 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.036 -1.066 . . . . 20.0 111.039 -162.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -25.97 68.02 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.281 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.4 70.65 Favored Pre-proline 0 N--CA 1.448 -0.562 0 C-N-CA 120.506 -0.478 . . . . 20.0 109.825 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.15 144.71 9.52 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.328 0.685 . . . . 20.0 112.163 -172.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 117.285 1.674 . . . . 20.0 117.285 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 20.0 107.117 159.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.374 0.606 . . . . 20.0 110.73 -166.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.36 2.88 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.499 -0.773 . . . . 20.0 114.04 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.23 -178.36 0.17 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.356 1.074 . . . . 20.0 109.551 172.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.92 -13.16 3.98 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.879 -1.055 . . . . 20.0 113.459 169.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' G' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.02 23.77 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.735 1.152 . . . . 20.0 113.71 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.67 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.443 1.645 . . . . 20.0 115.443 -154.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' G' ' 26' ' ' PHE . . . -53.11 -26.97 29.66 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 116.032 1.173 . . . . 20.0 116.032 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' G' ' 184' ' ' ARG . 1.1 tt -59.56 -35.78 61.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 118.078 0.939 . . . . 20.0 110.646 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.26 -52.46 61.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.934 0.397 . . . . 20.0 110.435 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.52 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.295 -0.411 . . . . 20.0 110.933 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.26 -49.57 82.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.024 0.44 . . . . 20.0 110.291 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 119.702 -0.799 . . . . 20.0 110.293 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.48 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 118.681 -1.208 . . . . 20.0 111.162 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -31.01 71.68 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.995 0.362 . . . . 20.0 111.102 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.96 -56.69 3.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.173 0.435 . . . . 20.0 112.173 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.514 -0.312 . . . . 20.0 111.528 -164.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -26.29 63.55 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.899 -0.72 . . . . 20.0 112.191 -162.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.5 63.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 118.922 -1.111 . . . . 20.0 111.71 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.97 22.86 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.492 0.923 . . . . 20.0 113.492 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.55 152.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.04 -42.66 89.25 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.214 -0.903 . . . . 20.0 111.498 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.61 158.3 35.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.541 -0.911 . . . . 20.0 108.541 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.47 147.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.14 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.474 0.654 . . . . 20.0 110.454 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.385 -1.339 . . . . 20.0 107.385 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.13 5.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.786 0.803 . . . . 20.0 108.923 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.61 62.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.913 -0.715 . . . . 20.0 111.155 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.11 10.84 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.691 0.996 . . . . 20.0 113.691 -171.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.7 83.29 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 119.121 -0.822 . . . . 20.0 114.527 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.09 151.48 35.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.43 1.115 . . . . 20.0 110.24 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.161 -1.422 . . . . 20.0 107.161 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 53' ' ' ILE . . . . . 0.703 HD13 HG12 ' G' ' 207' ' ' VAL . 31.3 mm -130.17 115.64 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.359 -1.349 . . . . 20.0 107.359 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.79 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.634 -0.506 . . . . 20.0 109.634 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.99 100.0 8.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.626 -0.879 . . . . 20.0 108.626 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.64 145.37 31.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.77 -1.566 . . . . 20.0 106.77 163.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.56 154.44 20.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.507 0.505 . . . . 20.0 109.726 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.06 23.62 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.104 -0.798 . . . . 20.0 111.104 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.64 10.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.844 0.858 . . . . 20.0 108.977 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.58 33.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.761 -0.733 . . . . 20.0 114.097 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.71 165.21 32.78 Favored 'Trans proline' 0 CA--C 1.517 -0.354 0 CA-C-O 121.751 0.646 . . . . 20.0 112.12 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.95 111.39 22.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.016 -0.993 . . . . 20.0 109.278 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.94 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.726 -0.842 . . . . 20.0 108.726 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.71 124.03 46.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.074 0.949 . . . . 20.0 109.058 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.33 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.081 -1.081 . . . . 20.0 108.081 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.63 51.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.257 0.348 . . . . 20.0 110.954 -168.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.47 154.61 45.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.936 0.894 . . . . 20.0 108.943 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' G' ' 235' ' ' ASP . 0.0 OUTLIER -105.08 146.46 29.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 20.0 110.473 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 21.33 5.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.751 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' G' ' 183' ' ' ASP . 12.0 t0 -97.41 67.96 2.14 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.605 -0.684 . . . . 20.0 112.478 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.24 144.89 28.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.79 148.8 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 123.747 0.819 . . . . 20.0 109.117 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 73' ' ' GLY . . . . . 0.459 ' C ' HD23 ' G' ' 74' ' ' LEU . . . -155.85 -175.67 27.13 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 20.0 110.592 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 74' ' ' LEU . . . . . 0.459 HD23 ' C ' ' G' ' 73' ' ' GLY . 5.0 mt -125.07 161.47 26.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.35 0.595 . . . . 20.0 109.944 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 75' ' ' MET . . . . . 0.505 ' HB2' HG23 ' G' ' 160' ' ' THR . 10.6 ttm -128.15 131.35 48.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.623 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.02 -29.31 7.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.129 0.789 . . . . 20.0 113.129 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.42 13.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.143 -1.058 . . . . 20.0 108.143 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.92 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 166.31 5.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.758 0.79 . . . . 20.0 110.001 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -26.99 60.33 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 119.637 -0.825 . . . . 20.0 112.763 -169.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.58 9.18 4.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.316 0.858 . . . . 20.0 113.316 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.24 12.78 81.82 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 119.018 -0.879 . . . . 20.0 115.099 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 84' ' ' PHE . . . . . 0.564 ' HD1' ' HG3' ' E' ' 243' ' ' PRO . 20.3 m-30 -107.76 145.0 34.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.358 1.079 . . . . 20.0 110.251 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.49 28.03 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.265 -0.88 . . . . 20.0 112.629 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -97.41 174.64 6.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.846 -1.168 . . . . 20.0 107.846 158.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.75 163.81 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.669 0.747 . . . . 20.0 109.5 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.36 15.62 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.03 -0.987 . . . . 20.0 109.78 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.85 160.22 24.42 Favored 'Trans proline' 0 CA--C 1.508 -0.821 0 CA-C-O 122.306 0.877 . . . . 20.0 112.737 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 90' ' ' ILE . . . . . 0.48 HD11 HG21 ' G' ' 160' ' ' THR . 9.2 mt -88.77 150.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 113.694 -1.594 . . . . 20.0 107.419 165.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.99 140.9 47.55 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.314 -0.857 . . . . 20.0 112.18 -168.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.91 -24.19 22.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 118.962 -0.91 . . . . 20.0 115.232 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.86 152.61 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 118.686 1.243 . . . . 20.0 109.26 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 108.405 -0.961 . . . . 20.0 108.405 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.11 -8.0 13.04 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 CA-C-N 120.542 1.229 . . . . 20.0 114.797 -170.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.15 -15.28 59.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.218 0.917 . . . . 20.0 111.815 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 97' ' ' THR . . . . . 0.6 HG21 ' OG ' ' G' ' 324' ' ' SER . 44.7 p -89.45 35.47 0.82 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.606 0.763 . . . . 20.0 112.468 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 98' ' ' LEU . . . . . 0.671 HD12 ' H ' ' G' ' 99' ' ' ILE . 0.5 OUTLIER -43.22 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.961 1.304 . . . . 20.0 113.368 -172.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 99' ' ' ILE . . . . . 0.671 ' H ' HD12 ' G' ' 98' ' ' LEU . 1.6 tt -173.18 156.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 100' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' E' ' 325' ' ' ASN . . . -123.89 -19.07 5.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.675 -1.148 . . . . 20.0 111.21 158.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 101' ' ' GLN . . . . . 0.414 ' HB3' HH21 ' G' ' 102' ' ' ARG . 0.0 OUTLIER -169.39 141.61 2.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 20.0 108.667 176.781 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 102' ' ' ARG . . . . . 0.414 HH21 ' HB3' ' G' ' 101' ' ' GLN . 0.0 OUTLIER 55.93 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 115.2 1.556 . . . . 20.0 115.2 150.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 103' ' ' PHE . . . . . 0.583 ' O ' ' N ' ' G' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.24 36.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.412 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.3 37.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.534 -0.757 . . . . 20.0 109.405 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 105' ' ' VAL . . . . . 0.584 HG22 ' CG1' ' G' ' 162' ' ' ILE . 50.2 t -117.43 110.79 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.17 -1.048 . . . . 20.0 108.17 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.6 83.05 6.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.249 -0.278 . . . . 20.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -52.0 -54.18 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.35 0.406 . . . . 20.0 110.303 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.46 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.406 -0.961 . . . . 20.0 108.406 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.08 126.32 27.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.95 -1.023 . . . . 20.0 110.476 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 11.27 75.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-O 118.913 -0.937 . . . . 20.0 115.333 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.04 114.04 15.89 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.491 1.145 . . . . 20.0 108.587 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.31 141.57 37.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.36 -0.607 . . . . 20.0 109.36 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.684 -0.858 . . . . 20.0 108.684 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.67 149.43 31.25 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.026 -0.988 . . . . 20.0 110.309 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 115' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' G' ' 103' ' ' PHE . . . -147.92 157.79 27.47 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.314 -1.114 . . . . 20.0 110.314 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.73 154.41 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.29 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.336 -0.847 . . . . 20.0 114.554 -168.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 118' ' ' ALA . . . . . 0.499 ' O ' HD13 ' G' ' 98' ' ' LEU . . . -67.2 -47.97 69.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.342 1.238 . . . . 20.0 114.342 -156.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.525 1.057 . . . . 20.0 112.665 -155.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 136.14 35.5 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 102.627 -3.101 . . . . 20.0 102.627 159.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.15 123.79 11.02 Favored 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 120.728 1.296 . . . . 20.0 110.597 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.78 149.79 89.94 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 CA-C-N 119.242 0.765 . . . . 20.0 110.693 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.35 7.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.8 0.81 . . . . 20.0 109.974 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.197 -1.038 . . . . 20.0 108.197 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.94 160.86 19.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.801 -0.36 . . . . 20.0 110.716 169.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.03 -43.55 1.47 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 123.932 0.893 . . . . 20.0 113.061 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -25.01 59.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 CA-C-N 120.885 1.352 . . . . 20.0 111.968 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.53 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 111.798 0.295 . . . . 20.0 111.798 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -31.94 69.15 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 119.767 -0.773 . . . . 20.0 110.24 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.87 62.6 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.937 0.347 . . . . 20.0 111.937 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -78.5 90.96 4.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.181 -0.674 . . . . 20.0 109.181 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.3 7.98 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.099 0.407 . . . . 20.0 112.099 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.36 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 153.62 75.4 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-N 119.659 0.914 . . . . 20.0 112.383 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.62 42.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.541 -1.208 . . . . 20.0 107.962 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 118.797 -0.62 . . . . 20.0 112.386 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' G' ' 138' ' ' GLN . 14.3 p30 -55.33 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-O 118.954 -0.546 . . . . 20.0 111.4 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 138' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' G' ' 139' ' ' ILE . 3.9 tp-100 174.58 174.05 0.2 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.101 -2.926 . . . . 20.0 103.101 133.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 139' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' G' ' 138' ' ' GLN . 1.2 tp -74.77 168.05 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.166 0.986 . . . . 20.0 108.981 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' G' ' 139' ' ' ILE . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.96 0.904 . . . . 20.0 110.539 177.332 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 141' ' ' ILE . . . . . 0.42 HD13 HD13 ' G' ' 162' ' ' ILE . 30.1 mt -124.67 147.44 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.622 -0.881 . . . . 20.0 108.622 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' G' ' 144' ' ' GLY . 0.5 OUTLIER -119.04 134.79 54.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.593 0.757 . . . . 20.0 109.591 175.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 123.67 0.606 . . . . 20.0 111.842 166.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' G' ' 142' ' ' ASP . . . 86.87 -6.59 82.72 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 115.496 0.959 . . . . 20.0 115.496 172.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.476 1.138 . . . . 20.0 110.297 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.9 33.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.588 0.959 . . . . 20.0 113.588 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.32 162.65 40.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.978 0.894 . . . . 20.0 111.415 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.53 80.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.881 -1.508 . . . . 20.0 111.241 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.33 -46.99 87.97 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.81 -0.356 . . . . 20.0 110.983 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.38 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.489 -0.484 . . . . 20.0 110.795 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.6 84.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.033 -0.667 . . . . 20.0 111.127 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.78 -23.3 58.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.408 -0.917 . . . . 20.0 110.994 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.8 -30.04 66.39 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.714 -0.795 . . . . 20.0 110.613 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.62 92.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.522 -0.471 . . . . 20.0 111.69 171.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.76 6.69 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.603 -172.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.67 133.49 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 118.419 1.11 . . . . 20.0 108.574 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.84 175.91 9.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.745 -1.206 . . . . 20.0 107.745 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.34 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.34 169.29 15.67 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.771 -1.732 . . . . 20.0 108.771 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 160' ' ' THR . . . . . 0.505 HG23 ' HB2' ' G' ' 75' ' ' MET . 0.2 OUTLIER -79.35 113.61 17.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.69 -1.226 . . . . 20.0 107.69 165.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -20.02 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 113.702 1.001 . . . . 20.0 113.702 -166.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 162' ' ' ILE . . . . . 0.584 ' CG1' HG22 ' G' ' 105' ' ' VAL . 0.5 OUTLIER -111.65 155.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.669 -0.644 . . . . 20.0 111.805 -159.225 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 163' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' G' ' 164' ' ' TRP . 3.5 t -145.29 -166.31 2.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.3 1.04 . . . . 20.0 110.449 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 164' ' ' TRP . . . . . 0.548 ' N ' ' OG1' ' G' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.96 16.72 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.213 0.819 . . . . 20.0 113.213 -160.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.69 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.219 0.533 . . . . 20.0 112.299 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.9 158.61 29.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.092 -1.203 . . . . 20.0 110.092 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 167' ' ' ARG . . . . . 0.574 ' HB3' HH12 ' E' ' 102' ' ' ARG . 0.0 OUTLIER -142.41 148.3 37.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.704 -1.221 . . . . 20.0 107.704 170.637 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.64 30.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.102 -0.954 . . . . 20.0 110.149 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.48 159.79 35.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.891 0.853 . . . . 20.0 109.963 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.23 34.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.191 -1.368 . . . . 20.0 109.508 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.59 29.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.502 -0.555 . . . . 20.0 109.502 168.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 172' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' G' ' 175' ' ' ARG . . . 56.9 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.54 -21.87 4.28 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.748 0.647 . . . . 20.0 112.748 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -63.0 1.29 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.764 -0.775 . . . . 20.0 111.179 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 175' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' G' ' 172' ' ' GLY . 6.8 ptt-85 -169.85 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.626 0.648 . . . . 20.0 112.651 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.37 0.35 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.833 2.453 . . . . 20.0 106.245 157.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.65 145.8 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.458 -0.941 . . . . 20.0 108.458 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.16 -64.49 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 116.435 2.013 . . . . 20.0 116.435 -166.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.31 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.707 0.685 . . . . 20.0 112.089 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.66 36.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 181' ' ' PHE . . . . . 0.753 ' HB3' ' HB3' ' G' ' 327' ' ' GLU . 3.1 t80 -84.65 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.626 0.648 . . . . 20.0 111.727 -162.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.26 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.059 0.933 . . . . 20.0 110.694 -152.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' G' ' 70' ' ' ASP . 0.6 OUTLIER 69.92 -6.69 1.03 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.361 1.464 . . . . 20.0 113.161 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' G' ' 29' ' ' ILE . 0.0 OUTLIER -153.78 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.176 0.989 . . . . 20.0 110.799 157.098 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 185' ' ' ILE . . . . . 0.423 HG12 HG11 ' G' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.477 -2.416 . . . . 20.0 104.477 149.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' G' ' 189' ' ' THR . . . -50.12 -42.95 51.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.377 -0.829 . . . . 20.0 111.524 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.91 -36.07 76.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.263 -0.975 . . . . 20.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.86 -38.6 91.71 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 119.163 -1.015 . . . . 20.0 110.488 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' G' ' 186' ' ' ALA . 25.3 p -59.11 -48.61 80.99 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.513 -0.875 . . . . 20.0 110.827 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.55 64.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.92 0.39 . . . . 20.0 110.498 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.22 96.05 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 120.091 -0.644 . . . . 20.0 110.923 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.81 -36.6 84.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.011 -0.676 . . . . 20.0 110.303 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 193' ' ' VAL . . . . . 0.409 HG23 ' O ' ' G' ' 189' ' ' THR . 11.6 t -60.53 -44.82 97.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.027 0.441 . . . . 20.0 110.114 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.31 75.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.209 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.16 70.91 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.767 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.13 40.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 20.0 112.544 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.83 27.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.275 -0.639 . . . . 20.0 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.45 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.27 0.357 . . . . 20.0 110.132 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.33 17.46 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.27 4.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.187 -0.671 . . . . 20.0 109.187 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.78 -14.56 59.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.344 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.78 141.71 30.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.92 -0.77 . . . . 20.0 108.92 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 203' ' ' ASP . . . . . 0.644 ' OD1' ' N ' ' G' ' 203' ' ' ASP . 0.0 OUTLIER -78.61 112.96 16.23 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 -174.525 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.96 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.95 106.6 9.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 20.0 109.021 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 206' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -82.94 125.39 31.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.685 -0.858 . . . . 20.0 108.685 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 207' ' ' VAL . . . . . 0.703 HG12 HD13 ' G' ' 53' ' ' ILE . 34.1 m -119.96 150.17 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.845 -0.798 . . . . 20.0 108.845 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.76 5.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.436 -1.32 . . . . 20.0 107.436 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.85 159.98 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.935 0.874 . . . . 20.0 111.102 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.48 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.621 -1.172 . . . . 20.0 108.222 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.55 40.22 29.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.801 -1.09 . . . . 20.0 111.524 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.53 13.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.418 -0.513 . . . . 20.0 110.95 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -20.43 64.77 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.228 -0.589 . . . . 20.0 111.458 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.19 121.14 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.06 60.96 6.21 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.663 -1.256 . . . . 20.0 111.419 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 216' ' ' LEU . . . . . 0.423 HD23 ' H ' ' G' ' 216' ' ' LEU . 0.5 OUTLIER -47.08 -25.48 0.86 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.486 0.921 . . . . 20.0 113.486 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 217' ' ' ARG . . . . . 0.461 ' HD3' HD21 ' I' ' 305' ' ' LEU . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.324 0.49 . . . . 20.0 112.324 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.56 40.92 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.769 -1.205 . . . . 20.0 111.967 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 219' ' ' ALA . . . . . 0.465 ' O ' ' OG ' ' G' ' 222' ' ' SER . . . -65.29 -37.02 85.86 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.275 -0.544 . . . . 20.0 111.352 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 220' ' ' ARG . . . . . 0.405 ' HB2' ' HB1' ' G' ' 302' ' ' ALA . 16.6 ttm180 -52.78 -36.68 58.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 112.161 0.43 . . . . 20.0 112.161 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 221' ' ' THR . . . . . . . . . . . . . 75.0 p -58.46 -45.77 87.93 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 119.989 -0.684 . . . . 20.0 110.871 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 222' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' G' ' 219' ' ' ALA . 2.1 p -58.06 -35.81 71.89 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.775 -0.37 . . . . 20.0 111.408 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.95 69.4 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.573 0.583 . . . . 20.0 112.573 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 224' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -64.21 -33.4 75.73 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.809 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.71 74.88 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.949 -1.596 . . . . 20.0 112.133 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.03 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 112.0 0.37 . . . . 20.0 112.0 -158.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 227' ' ' GLU . . . . . 0.457 ' OE1' ' OG1' ' G' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.68 99.78 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 118.225 2.676 . . . . 20.0 118.225 -158.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.74 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.198 0 N-CA-C 115.95 1.481 . . . . 20.0 115.95 -134.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.15 -4.76 0.78 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.23 1.412 . . . . 20.0 113.397 162.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.27 11.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.766 167.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.55 151.46 16.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.884 -0.674 . . . . 20.0 112.258 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.563 -0.819 . . . . 20.0 108.824 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.61 149.05 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.147 0.499 . . . . 20.0 110.409 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' G' ' 341' ' ' MET . 51.7 mt -133.2 90.41 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.586 -1.264 . . . . 20.0 107.586 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' G' ' 68' ' ' HIS . 25.5 t0 -135.2 173.24 11.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.949 -1.5 . . . . 20.0 106.949 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.628 0.727 . . . . 20.0 111.426 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 237' ' ' THR . . . . . 0.449 HG21 ' HA3' ' G' ' 296' ' ' GLY . 9.1 t -165.61 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.324 -1.361 . . . . 20.0 107.324 164.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 238' ' ' ILE . . . . . 0.421 HD13 ' O ' ' G' ' 237' ' ' THR . 17.9 mm -145.48 151.94 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 -161.243 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.881 -1.526 . . . . 20.0 106.881 159.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.41 110.03 18.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.01 0.744 . . . . 20.0 113.01 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.14 22.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.97 1.308 . . . . 20.0 112.434 158.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.38 79.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 105.182 -2.155 . . . . 20.0 105.182 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 243' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' E' ' 121' ' ' PRO . 16.6 Cg_exo -60.98 165.56 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 CA-C-N 120.812 1.326 . . . . 20.0 112.385 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.26 45.41 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.912 -0.938 . . . . 20.0 114.926 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.19 164.55 22.74 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 118.572 1.186 . . . . 20.0 110.619 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.67 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-O 121.83 0.679 . . . . 20.0 111.944 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.84 59.56 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.736 -1.12 . . . . 20.0 112.067 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.72 63.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.854 -0.738 . . . . 20.0 112.872 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 249' ' ' LYS . . . . . 0.724 ' O ' ' OG1' ' G' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.83 88.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.297 -0.561 . . . . 20.0 111.345 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 251' ' ' VAL . . . . . . . . . . . . . 10.6 m -68.64 -21.0 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.855 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 252' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' G' ' 249' ' ' LYS . 39.6 p -57.09 -31.86 65.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.537 0.608 . . . . 20.0 111.383 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 253' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' G' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.328 0.585 . . . . 20.0 110.411 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.37 -1.31 3.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.973 -1.012 . . . . 20.0 112.325 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.29 35.96 5.83 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 126.155 1.836 . . . . 20.0 111.57 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.19 10.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.662 -0.866 . . . . 20.0 108.662 -167.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.11 174.29 3.41 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-O 122.706 1.17 . . . . 20.0 113.309 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.07 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.42 120.3 29.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 20.0 109.441 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 260' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.93 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.831 -1.174 . . . . 20.0 107.831 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 261' ' ' LYS . . . . . 0.759 ' HE3' HG21 ' G' ' 298' ' ' THR . 1.9 mtmm -98.85 122.59 42.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.014 -0.735 . . . . 20.0 109.014 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.76 -40.27 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.873 -0.603 . . . . 20.0 109.647 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.59 34.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.428 0.632 . . . . 20.0 109.363 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.13 -169.92 2.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.77 -1.105 . . . . 20.0 108.235 165.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.06 -56.15 22.96 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.829 -0.623 . . . . 20.0 110.272 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -46.11 11.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.659 0.985 . . . . 20.0 113.659 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.419 -0.586 . . . . 20.0 109.419 -163.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.128 -1.805 . . . . 20.0 106.128 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.08 56.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.279 0.561 . . . . 20.0 111.313 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.0 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.669 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 271' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.56 -19.96 47.88 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 N-CA-C 114.834 1.052 . . . . 20.0 114.834 -160.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -42.96 74.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.177 -0.609 . . . . 20.0 110.587 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.59 -48.36 77.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.1 0.476 . . . . 20.0 110.119 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.16 -52.5 60.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.822 0.344 . . . . 20.0 110.723 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.38 -31.88 70.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.528 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 276' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' G' ' 347' ' ' ASN . 0.1 OUTLIER -68.53 -47.96 65.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.97 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.69 89.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.004 -0.679 . . . . 20.0 110.757 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.6 -48.0 78.39 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.594 -0.442 . . . . 20.0 110.098 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.46 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.926 -0.31 . . . . 20.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.3 -44.96 77.92 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.257 -0.577 . . . . 20.0 111.072 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.64 72.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.022 -0.671 . . . . 20.0 111.052 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.45 -31.76 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.976 -0.69 . . . . 20.0 111.144 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.63 73.12 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.89 -0.724 . . . . 20.0 110.974 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.5 29.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.334 0.864 . . . . 20.0 113.334 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.77 32.14 13.75 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.717 0.77 . . . . 20.0 111.588 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.3 143.41 34.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.347 -0.983 . . . . 20.0 108.347 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.17 149.38 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.187 0.746 . . . . 20.0 111.353 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.04 148.08 23.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.648 -0.705 . . . . 20.0 109.728 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.97 175.11 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.75 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.851 -1.166 . . . . 20.0 107.851 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.67 43.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.04 25.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.73 12.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.517 0.675 . . . . 20.0 110.28 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.54 21.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.805 -1.089 . . . . 20.0 112.1 165.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.02 20.09 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.993 -0.843 . . . . 20.0 110.993 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 296' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' G' ' 237' ' ' THR . . . 101.5 144.77 15.55 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.685 -0.758 . . . . 20.0 112.684 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.321 -1.112 . . . . 20.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 298' ' ' THR . . . . . 0.759 HG21 ' HE3' ' G' ' 261' ' ' LYS . 20.5 p -110.26 172.83 6.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.002 0.906 . . . . 20.0 111.384 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.81 -33.71 76.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.358 -1.292 . . . . 20.0 111.274 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.36 74.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 -171.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.11 96.81 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.184 -1.007 . . . . 20.0 112.072 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 302' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' G' ' 220' ' ' ARG . . . -68.32 -26.94 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.199 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.83 -34.52 56.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.051 -0.66 . . . . 20.0 110.139 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.297 0.851 . . . . 20.0 113.297 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.74 -8.94 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.717 1.006 . . . . 20.0 113.717 -167.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 306' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' G' ' 227' ' ' GLU . 0.5 OUTLIER -58.27 157.54 8.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.547 0.689 . . . . 20.0 110.596 171.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.75 -29.85 70.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.314 -0.857 . . . . 20.0 113.309 -160.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.21 66.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.708 -0.797 . . . . 20.0 111.217 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.83 65.08 1.94 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.814 -0.708 . . . . 20.0 113.308 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 310' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.22 139.58 52.56 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 117.626 0.713 . . . . 20.0 111.158 -163.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 311' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -84.47 141.73 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.448 0.838 . . . . 20.0 110.038 168.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.316 -0.856 . . . . 20.0 111.214 -169.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.63 162.57 12.33 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.129 -1.589 . . . . 20.0 109.129 164.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 135.99 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -0.647 . . . . 20.0 110.073 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.28 21.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.618 -1.174 . . . . 20.0 109.252 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.47 133.53 32.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.275 -0.875 . . . . 20.0 109.434 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 317' ' ' VAL . . . . . 0.423 HG11 HG12 ' G' ' 185' ' ' ILE . 91.8 t -99.5 108.58 51.34 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.237 -1.394 . . . . 20.0 107.237 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -83.25 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 CA-C-O 122.653 1.022 . . . . 20.0 113.644 -155.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' G' ' 253' ' ' HIS . . . 79.76 35.49 0.15 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 113.562 -1.654 . . . . 20.0 115.304 161.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 320' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' G' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.62 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.714 0.769 . . . . 20.0 110.112 176.751 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 321' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' G' ' 320' ' ' ARG . 3.3 m-85 -113.1 166.19 11.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.23 113.58 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.169 0.988 . . . . 20.0 108.441 -163.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 323' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.49 -7.42 3.14 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.49 1.293 . . . . 20.0 114.49 -140.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 324' ' ' SER . . . . . 0.6 ' OG ' HG21 ' G' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.99 4.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.652 0.612 . . . . 20.0 112.652 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 325' ' ' ASN . . . . . 0.459 ' HB2' ' HA ' ' E' ' 100' ' ' ALA . 35.1 p-10 -101.99 -56.13 2.34 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 115.031 1.493 . . . . 20.0 115.031 -152.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.94 50.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.42 -1.326 . . . . 20.0 107.42 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 327' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' G' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.78 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.848 -1.524 . . . . 20.0 109.957 -153.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.0 149.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.431 0.634 . . . . 20.0 111.943 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 329' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' G' ' 181' ' ' PHE . 0.3 OUTLIER -139.34 179.4 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.937 0.875 . . . . 20.0 109.464 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.604 -1.18 . . . . 20.0 108.903 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.08 -32.01 53.49 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.864 0.727 . . . . 20.0 111.505 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.82 73.39 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.353 -0.539 . . . . 20.0 110.205 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.0 -44.95 83.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.769 -0.372 . . . . 20.0 111.069 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.474 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -34.6 71.28 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 118.785 -1.166 . . . . 20.0 110.12 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.073 -0.651 . . . . 20.0 110.438 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.51 -43.89 80.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.737 0.303 . . . . 20.0 110.912 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' G' ' 342' ' ' THR . 42.6 t -60.17 -48.95 86.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 120.958 0.409 . . . . 20.0 110.231 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' G' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.93 74.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.015 0.436 . . . . 20.0 110.752 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.2 37.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.322 -0.399 . . . . 20.0 111.424 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' G' ' 234' ' ' ILE . 31.9 tpp -60.15 -40.29 89.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.218 -0.593 . . . . 20.0 110.87 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' G' ' 338' ' ' VAL . 1.3 m -56.52 -45.03 81.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.132 0.491 . . . . 20.0 110.392 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' G' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.44 63.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 119.925 -0.71 . . . . 20.0 110.767 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.48 97.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.58 -0.448 . . . . 20.0 111.135 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' G' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.41 74.18 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.563 -0.455 . . . . 20.0 110.766 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.11 91.15 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.686 -0.806 . . . . 20.0 110.631 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 347' ' ' ASN . . . . . 0.483 ' HB3' ' HH2' ' G' ' 276' ' ' TRP . 5.0 m-20 -84.44 4.78 30.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.444 -0.902 . . . . 20.0 112.48 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' G' ' 345' ' ' LEU . 1.3 tt -65.24 -23.66 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 20.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' G' G ' 349' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -63.69 -27.41 69.2 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.277 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.7 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.111 -0.368 . . . . 20.0 111.468 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 351' ' ' LEU . . . . . 0.447 ' O ' HD12 ' G' ' 351' ' ' LEU . 0.1 OUTLIER -69.71 -28.82 66.15 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.892 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' G' G ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.06 -26.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.01 1.856 . . . . 20.0 116.01 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' G' G ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 20.0 108.406 -174.663 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 114.267 1.21 . . . . 20.0 114.267 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.24 2.93 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -62.96 -34.49 66.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.86 -1.064 . . . . 20.0 110.185 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.02 -23.59 12.27 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.568 0.951 . . . . 20.0 113.568 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.3 19.96 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.129 0.971 . . . . 20.0 111.623 -173.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.72 32.42 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 122.303 -0.248 . . . . 20.0 111.251 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.43 37.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.15 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 20.0 110.915 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.69 -31.52 72.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.448 -0.796 . . . . 20.0 111.861 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.19 -45.11 74.33 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.477 -0.489 . . . . 20.0 111.244 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.12 97.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 121.05 -0.26 . . . . 20.0 111.17 -172.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.53 70.96 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.7 -0.4 . . . . 20.0 111.174 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.32 91.18 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.514 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.09 -42.92 91.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.686 -0.234 . . . . 20.0 111.499 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.06 26.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.512 -0.875 . . . . 20.0 110.716 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.1 -32.12 6.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 119.047 -1.061 . . . . 20.0 111.0 -162.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.97 68.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.946 -0.702 . . . . 20.0 111.256 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.43 70.33 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.572 -0.451 . . . . 20.0 109.794 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -85.21 144.76 9.47 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 CA-C-O 121.718 0.632 . . . . 20.0 112.17 -172.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.21 3.42 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 117.272 1.669 . . . . 20.0 117.272 -159.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.122 -1.436 . . . . 20.0 107.122 159.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.23 8.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.41 0.624 . . . . 20.0 110.668 -166.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.472 -0.786 . . . . 20.0 114.019 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.295 1.045 . . . . 20.0 109.584 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.16 4.03 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.86 -1.064 . . . . 20.0 113.417 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' H' ' 28' ' ' GLY . 0.0 OUTLIER -87.93 8.99 23.65 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.702 1.137 . . . . 20.0 113.773 178.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.386 1.624 . . . . 20.0 115.386 -154.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' H' ' 26' ' ' PHE . . . -53.09 -26.91 29.3 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 116.052 1.181 . . . . 20.0 116.052 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 29' ' ' ILE . . . . . 0.524 HD13 ' NH1' ' H' ' 184' ' ' ARG . 1.1 tt -59.64 -35.76 61.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 118.039 0.92 . . . . 20.0 110.604 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.4 61.61 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.886 0.374 . . . . 20.0 110.425 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.3 -40.6 74.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.309 -0.405 . . . . 20.0 110.967 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.57 82.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.034 0.445 . . . . 20.0 110.357 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.7 86.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 119.711 -0.795 . . . . 20.0 110.273 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.76 -29.46 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 118.736 -1.186 . . . . 20.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.5 -30.98 71.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.036 0.38 . . . . 20.0 111.124 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -86.94 -56.8 3.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.24 -28.43 44.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.481 -0.327 . . . . 20.0 111.536 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.39 63.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.946 -0.702 . . . . 20.0 112.207 -162.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.54 63.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 118.876 -1.13 . . . . 20.0 111.704 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.88 -6.87 23.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.68 22.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.57 88.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.115 -0.948 . . . . 20.0 111.462 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.27 35.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.572 -0.899 . . . . 20.0 108.572 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.49 147.2 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.224 -1.028 . . . . 20.0 108.224 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.15 159.28 44.11 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.513 0.673 . . . . 20.0 110.46 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 46' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.13 128.99 74.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -176.11 5.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.834 0.826 . . . . 20.0 108.882 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.56 62.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.906 -0.718 . . . . 20.0 111.122 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.83 9.26 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.61 83.4 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.113 -0.826 . . . . 20.0 114.462 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.19 151.53 35.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.494 1.147 . . . . 20.0 110.199 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.27 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 53' ' ' ILE . . . . . 0.715 HD13 HG12 ' H' ' 207' ' ' VAL . 31.3 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.314 -1.365 . . . . 20.0 107.314 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.81 36.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.647 -0.501 . . . . 20.0 109.647 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.91 99.97 8.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.646 -0.872 . . . . 20.0 108.646 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.6 145.39 31.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.781 -1.563 . . . . 20.0 106.781 163.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.57 154.5 20.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.68 -0.489 . . . . 20.0 109.68 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.1 23.71 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.076 -0.809 . . . . 20.0 111.076 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.19 105.56 10.35 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.915 0.886 . . . . 20.0 109.043 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.56 33.52 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.724 -0.751 . . . . 20.0 114.048 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.347 0 CA-C-O 121.767 0.653 . . . . 20.0 112.06 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.95 111.37 22.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.033 -0.985 . . . . 20.0 109.242 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.98 30.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.76 -0.83 . . . . 20.0 108.76 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.79 124.07 46.33 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.015 0.926 . . . . 20.0 109.009 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 65' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.27 114.26 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.094 -1.076 . . . . 20.0 108.094 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.55 124.6 51.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.256 0.347 . . . . 20.0 111.0 -168.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.58 45.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.935 0.894 . . . . 20.0 108.965 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 68' ' ' HIS . . . . . 0.485 ' NE2' ' OD1' ' H' ' 235' ' ' ASP . 0.0 OUTLIER -104.99 146.44 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 20.0 110.537 177.403 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 21.36 5.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.23 -0.895 . . . . 20.0 109.657 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' H' ' 183' ' ' ASP . 12.0 t0 -97.44 68.01 2.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 121.582 -0.699 . . . . 20.0 112.421 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 144.83 28.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.73 148.82 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.729 0.812 . . . . 20.0 109.176 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 73' ' ' GLY . . . . . 0.471 ' C ' HD23 ' H' ' 74' ' ' LEU . . . -155.85 -175.72 27.17 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.611 -0.996 . . . . 20.0 110.611 173.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 74' ' ' LEU . . . . . 0.471 HD23 ' C ' ' H' ' 73' ' ' GLY . 5.0 mt -125.01 161.43 26.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.309 0.576 . . . . 20.0 110.0 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 75' ' ' MET . . . . . 0.516 ' HB2' HG23 ' H' ' 160' ' ' THR . 10.5 ttm -128.11 131.4 49.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.004 -0.998 . . . . 20.0 109.705 -174.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.55 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.858 -0.793 . . . . 20.0 108.858 168.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.07 -29.34 7.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.072 0.767 . . . . 20.0 113.072 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.42 13.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.0 108.96 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.28 5.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.827 0.822 . . . . 20.0 110.007 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -27.01 60.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.661 -0.816 . . . . 20.0 112.732 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.52 9.16 4.23 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.332 0.864 . . . . 20.0 113.332 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.79 81.76 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 118.973 -0.904 . . . . 20.0 115.067 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 84' ' ' PHE . . . . . 0.458 ' HD1' ' HG3' ' F' ' 243' ' ' PRO . 20.3 m-30 -107.78 145.02 34.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.372 1.086 . . . . 20.0 110.221 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.29 -0.868 . . . . 20.0 112.602 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.61 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.825 -1.176 . . . . 20.0 107.825 158.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.79 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.598 0.713 . . . . 20.0 109.492 -170.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.23 129.31 15.63 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 115.009 -0.996 . . . . 20.0 109.808 171.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.84 160.2 24.44 Favored 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-O 122.275 0.864 . . . . 20.0 112.749 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 90' ' ' ILE . . . . . 0.493 HD11 HG21 ' H' ' 160' ' ' THR . 9.3 mt -88.72 150.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 113.722 -1.581 . . . . 20.0 107.441 165.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.05 141.0 47.5 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.288 -0.869 . . . . 20.0 112.131 -168.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.16 22.26 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.235 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.672 1.236 . . . . 20.0 109.233 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.91 22.27 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 108.464 -0.939 . . . . 20.0 108.464 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.03 -7.96 13.13 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 CA-C-N 120.598 1.249 . . . . 20.0 114.839 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.19 59.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.201 0.909 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 97' ' ' THR . . . . . 0.598 HG21 ' OG ' ' H' ' 324' ' ' SER . 44.8 p -89.48 35.5 0.82 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.657 0.783 . . . . 20.0 112.462 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 98' ' ' LEU . . . . . 0.671 HD12 ' H ' ' H' ' 99' ' ' ILE . 0.5 OUTLIER -43.25 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.017 1.327 . . . . 20.0 113.364 -173.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 99' ' ' ILE . . . . . 0.671 ' H ' HD12 ' H' ' 98' ' ' LEU . 1.6 tt -173.14 156.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.002 -0.74 . . . . 20.0 109.002 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' F' ' 100' ' ' ALA . . . -123.94 -19.0 5.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.702 -1.135 . . . . 20.0 111.262 158.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 101' ' ' GLN . . . . . 0.413 ' C ' HD11 ' H' ' 99' ' ' ILE . 0.0 OUTLIER -169.37 141.66 2.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.659 -0.867 . . . . 20.0 108.659 176.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.9 74.54 0.38 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.258 1.577 . . . . 20.0 115.258 150.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 103' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' H' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.281 0.946 . . . . 20.0 109.417 160.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.34 37.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 20.0 109.392 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 105' ' ' VAL . . . . . 0.576 HG22 ' CG1' ' H' ' 162' ' ' ILE . 50.3 t -117.49 110.74 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.175 -1.046 . . . . 20.0 108.175 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.54 83.02 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.245 -0.28 . . . . 20.0 110.245 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 107' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.92 -54.22 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 123.334 0.396 . . . . 20.0 110.353 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.403 -0.962 . . . . 20.0 108.403 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.12 126.34 27.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.915 -1.039 . . . . 20.0 110.447 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.25 75.21 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 118.896 -0.946 . . . . 20.0 115.319 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.01 113.99 15.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.483 1.142 . . . . 20.0 108.565 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.3 141.55 37.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.334 -0.617 . . . . 20.0 109.334 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.66 142.49 43.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.69 149.46 31.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.971 -1.013 . . . . 20.0 110.264 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 115' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' H' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.3 -1.12 . . . . 20.0 110.3 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.74 154.39 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.357 -0.979 . . . . 20.0 108.357 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.328 -0.851 . . . . 20.0 114.604 -168.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' H' ' 98' ' ' LEU . . . -67.15 -48.01 69.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -156.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 121.15 11.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.526 1.057 . . . . 20.0 112.707 -155.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.52 136.13 35.44 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 102.632 -3.099 . . . . 20.0 102.632 159.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.84 11.09 Favored 'Trans proline' 0 C--O 1.239 0.527 0 CA-C-N 120.737 1.299 . . . . 20.0 110.561 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.82 149.81 89.86 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 CA-C-N 119.228 0.76 . . . . 20.0 110.725 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 20.0 109.971 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.194 -1.039 . . . . 20.0 108.194 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.78 19.51 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.779 -0.368 . . . . 20.0 110.708 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.87 -43.66 1.51 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.943 0.897 . . . . 20.0 113.091 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.96 -24.96 59.81 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.849 1.339 . . . . 20.0 112.03 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.57 -26.49 30.01 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 111.753 0.279 . . . . 20.0 111.753 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.97 69.15 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 119.817 -0.753 . . . . 20.0 110.231 168.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.89 62.58 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.943 0.349 . . . . 20.0 111.943 172.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.51 90.94 4.5 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.132 0.419 . . . . 20.0 112.132 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.56 87.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 108.502 -0.925 . . . . 20.0 108.502 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.59 75.37 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 CA-C-N 119.647 0.91 . . . . 20.0 112.357 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.6 42.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.494 -1.23 . . . . 20.0 107.957 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -12.19 59.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 118.839 -0.6 . . . . 20.0 112.423 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' H' ' 138' ' ' GLN . 14.1 p30 -55.41 -66.35 0.43 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.355 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 138' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' H' ' 139' ' ' ILE . 3.9 tp-100 174.62 174.11 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.108 -2.923 . . . . 20.0 103.108 133.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 139' ' ' ILE . . . . . 0.412 ' H ' ' HG3' ' H' ' 138' ' ' GLN . 1.2 tp -74.83 168.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.151 0.98 . . . . 20.0 108.976 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 140' ' ' PHE . . . . . 0.4 ' H ' HG13 ' H' ' 139' ' ' ILE . 0.3 OUTLIER -114.8 161.47 18.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.958 0.903 . . . . 20.0 110.533 177.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 141' ' ' ILE . . . . . 0.417 HD13 HD13 ' H' ' 162' ' ' ILE . 30.1 mt -124.67 147.5 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 142' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' H' ' 144' ' ' GLY . 0.5 OUTLIER -119.15 134.74 55.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.633 0.773 . . . . 20.0 109.561 175.196 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.15 7.83 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.88 -0.6 . . . . 20.0 111.795 166.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 144' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' H' ' 142' ' ' ASP . . . 86.89 -6.58 82.79 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 115.467 0.947 . . . . 20.0 115.467 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.16 144.04 53.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.486 1.143 . . . . 20.0 110.314 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.88 33.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.562 0.949 . . . . 20.0 113.562 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.38 162.65 40.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.007 0.908 . . . . 20.0 111.406 -173.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.49 80.5 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.862 -1.517 . . . . 20.0 111.245 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.38 -47.05 87.76 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.788 -0.365 . . . . 20.0 110.941 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.32 -35.19 76.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.523 -0.471 . . . . 20.0 110.834 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.58 84.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.03 -0.668 . . . . 20.0 111.105 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.35 58.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.394 -0.922 . . . . 20.0 110.971 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.78 -29.99 66.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.765 -0.774 . . . . 20.0 110.609 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.56 92.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.567 -0.453 . . . . 20.0 111.701 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.76 6.71 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.901 -0.944 . . . . 20.0 114.589 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 118.462 1.131 . . . . 20.0 108.544 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.99 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.756 -1.202 . . . . 20.0 107.756 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.33 147.26 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.47 169.33 15.78 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.776 -1.729 . . . . 20.0 108.776 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 160' ' ' THR . . . . . 0.516 HG23 ' HB2' ' H' ' 75' ' ' MET . 0.2 OUTLIER -79.42 113.58 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 165.585 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.65 -20.07 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 113.736 1.013 . . . . 20.0 113.736 -166.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 162' ' ' ILE . . . . . 0.576 ' CG1' HG22 ' H' ' 105' ' ' VAL . 0.5 OUTLIER -111.66 155.62 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.708 -0.62 . . . . 20.0 111.757 -159.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' H' ' 164' ' ' TRP . 3.5 t -145.3 -166.35 2.41 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.331 1.052 . . . . 20.0 110.492 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' H' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.87 16.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.23 0.826 . . . . 20.0 113.23 -160.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 165' ' ' ASP . . . . . 0.428 ' O ' ' NE2' ' F' ' 101' ' ' GLN . 7.5 t70 63.63 61.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 20.0 112.291 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.88 158.63 29.58 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.113 -1.195 . . . . 20.0 110.113 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 167' ' ' ARG . . . . . 0.546 ' HB3' HH12 ' F' ' 102' ' ' ARG . 0.0 OUTLIER -142.42 148.36 37.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 170.559 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.04 117.64 30.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.128 -0.942 . . . . 20.0 110.168 -167.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.45 159.8 35.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.882 0.848 . . . . 20.0 110.011 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.38 117.21 34.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.294 -1.321 . . . . 20.0 109.491 -173.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.57 29.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.493 -0.558 . . . . 20.0 109.493 168.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' H' ' 175' ' ' ARG . . . 56.96 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.89 4.26 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.823 0.675 . . . . 20.0 112.823 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.01 1.29 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.202 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' H' ' 172' ' ' GLY . 6.8 ptt-85 -169.78 121.94 0.7 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.635 0.652 . . . . 20.0 112.663 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.829 2.452 . . . . 20.0 106.218 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.68 145.76 20.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.492 -0.929 . . . . 20.0 108.492 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.47 1.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 116.395 1.998 . . . . 20.0 116.395 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.752 0.706 . . . . 20.0 112.076 -170.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.73 37.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 181' ' ' PHE . . . . . 0.74 ' HB3' ' HB3' ' H' ' 327' ' ' GLU . 3.1 t80 -84.58 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.601 0.637 . . . . 20.0 111.778 -162.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.26 127.84 32.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.06 0.933 . . . . 20.0 110.711 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' H' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.301 1.44 . . . . 20.0 113.181 174.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 184' ' ' ARG . . . . . 0.524 ' NH1' HD13 ' H' ' 29' ' ' ILE . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.183 0.992 . . . . 20.0 110.805 157.135 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 185' ' ' ILE . . . . . 0.438 HG12 HG11 ' H' ' 317' ' ' VAL . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.517 -2.401 . . . . 20.0 104.517 149.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 186' ' ' ALA . . . . . 0.722 ' O ' ' OG1' ' H' ' 189' ' ' THR . . . -50.12 -42.98 51.57 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.306 -0.861 . . . . 20.0 111.511 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -35.99 76.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.129 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.86 -38.64 91.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.131 -1.027 . . . . 20.0 110.486 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 189' ' ' THR . . . . . 0.722 ' OG1' ' O ' ' H' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.489 -0.885 . . . . 20.0 110.824 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.25 -50.55 63.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 20.0 110.553 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.12 96.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.052 -0.659 . . . . 20.0 110.958 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.52 84.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.945 -0.702 . . . . 20.0 110.317 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 193' ' ' VAL . . . . . 0.402 HG23 ' O ' ' H' ' 189' ' ' THR . 11.5 t -60.59 -44.75 97.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.035 0.445 . . . . 20.0 110.14 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.26 75.37 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.243 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.64 -38.18 70.75 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.757 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.65 -26.16 41.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.56 122.8 27.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.265 -0.643 . . . . 20.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.1 2.32 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.286 0.366 . . . . 20.0 110.119 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.34 17.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.729 -0.471 . . . . 20.0 109.729 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.3 4.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.161 -0.681 . . . . 20.0 109.161 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.8 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.965 -0.694 . . . . 20.0 111.344 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.84 141.72 30.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.91 -0.774 . . . . 20.0 108.91 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 203' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' H' ' 203' ' ' ASP . 0.0 OUTLIER -78.65 112.97 16.29 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.456 -0.942 . . . . 20.0 108.456 -174.47 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.53 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.578 -0.897 . . . . 20.0 108.578 -170.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 205' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -128.88 106.64 9.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.009 -0.737 . . . . 20.0 109.009 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.88 125.37 31.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 207' ' ' VAL . . . . . 0.715 HG12 HD13 ' H' ' 53' ' ' ILE . 34.1 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.77 5.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.437 -1.32 . . . . 20.0 107.437 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.77 159.94 19.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.879 0.847 . . . . 20.0 111.15 -165.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.83 166.46 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.217 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.17 29.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.485 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.52 13.96 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.388 -0.525 . . . . 20.0 111.007 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -20.41 64.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.215 -0.594 . . . . 20.0 111.46 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.12 121.17 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.564 -0.902 . . . . 20.0 108.564 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.672 -1.251 . . . . 20.0 111.423 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 216' ' ' LEU . . . . . 0.418 HD23 ' H ' ' H' ' 216' ' ' LEU . 0.5 OUTLIER -47.0 -25.59 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.473 0.916 . . . . 20.0 113.473 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.48 -4.52 2.85 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.32 0.489 . . . . 20.0 112.32 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.69 -40.53 41.0 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 119.728 -1.225 . . . . 20.0 111.979 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 219' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' H' ' 222' ' ' SER . . . -65.25 -37.05 86.03 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.29 -0.535 . . . . 20.0 111.365 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 220' ' ' ARG . . . . . 0.42 ' HB2' ' HB1' ' H' ' 302' ' ' ALA . 16.6 ttm180 -52.75 -36.66 58.23 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.184 0.439 . . . . 20.0 112.184 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.43 -45.83 87.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.883 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 222' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' H' ' 219' ' ' ALA . 2.1 p -58.0 -35.85 71.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.405 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.66 -49.93 69.41 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.21 -33.39 75.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.842 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.72 74.98 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 118.962 -1.589 . . . . 20.0 112.102 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 226' ' ' ILE . . . . . . . . . . . . . 25.0 mm -126.97 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.033 0.383 . . . . 20.0 112.033 -158.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 227' ' ' GLU . . . . . 0.484 ' OE1' ' OG1' ' H' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 118.182 2.66 . . . . 20.0 118.182 -158.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 228' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -43.86 143.65 2.89 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 N-CA-C 115.982 1.493 . . . . 20.0 115.982 -134.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.17 -4.68 0.77 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.254 1.422 . . . . 20.0 113.389 162.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.24 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.116 -0.634 . . . . 20.0 111.784 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.43 16.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.919 -0.658 . . . . 20.0 112.289 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.44 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.777 0.831 . . . . 20.0 108.812 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.68 149.1 23.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.201 0.524 . . . . 20.0 110.348 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 234' ' ' ILE . . . . . 0.493 HD11 ' CE ' ' H' ' 341' ' ' MET . 51.6 mt -133.24 90.46 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.503 -1.295 . . . . 20.0 107.503 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 235' ' ' ASP . . . . . 0.485 ' OD1' ' NE2' ' H' ' 68' ' ' HIS . 25.6 t0 -135.21 173.19 11.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.905 -1.517 . . . . 20.0 106.905 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.13 149.41 14.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.674 0.749 . . . . 20.0 111.424 -173.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 237' ' ' THR . . . . . 0.453 HG21 ' HA3' ' H' ' 296' ' ' GLY . 9.2 t -165.62 122.69 1.45 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 164.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 238' ' ' ILE . . . . . 0.419 HD13 ' O ' ' H' ' 237' ' ' THR . 18.0 mm -145.44 151.93 14.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 -161.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.23 9.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.846 -1.539 . . . . 20.0 106.846 159.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.0 18.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.032 0.752 . . . . 20.0 113.032 -155.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.35 36.11 22.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.896 1.278 . . . . 20.0 112.504 158.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.95 128.46 78.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 105.167 -2.16 . . . . 20.0 105.167 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.57 12.08 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 120.816 1.327 . . . . 20.0 112.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.47 -5.38 45.0 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.097 -0.956 . . . . 20.0 114.92 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.13 164.54 22.91 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 118.618 1.209 . . . . 20.0 110.664 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.05 -172.66 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.593 0 CA-C-O 121.825 0.677 . . . . 20.0 111.949 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.88 59.56 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.765 -1.107 . . . . 20.0 112.003 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.68 63.13 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.908 -0.717 . . . . 20.0 112.847 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 249' ' ' LYS . . . . . 0.701 ' O ' ' OG1' ' H' ' 252' ' ' THR . 16.9 mttt -98.73 -15.24 19.41 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 170.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.84 88.88 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.337 -0.545 . . . . 20.0 111.328 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.62 -20.96 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.038 -1.065 . . . . 20.0 111.896 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 252' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' H' ' 249' ' ' LYS . 39.4 p -57.14 -31.85 65.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.497 0.59 . . . . 20.0 111.339 173.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 253' ' ' HIS . . . . . 0.547 ' CD2' ' HB2' ' H' ' 319' ' ' ALA . 16.7 t-80 -162.37 132.04 4.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.313 0.578 . . . . 20.0 110.448 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.4 -1.24 3.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.001 -1.0 . . . . 20.0 112.289 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 126.134 1.826 . . . . 20.0 111.515 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.24 10.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -167.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.25 3.33 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-O 122.695 1.164 . . . . 20.0 113.354 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.11 6.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' H' ' 316' ' ' SER . . . -126.44 120.3 29.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.104 -0.953 . . . . 20.0 109.381 -169.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 260' ' ' ILE . . . . . . . . . . . . . 85.4 mt -98.01 139.98 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.787 -1.19 . . . . 20.0 107.787 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 261' ' ' LYS . . . . . 0.767 ' HE3' HG21 ' H' ' 298' ' ' THR . 1.9 mtmm -98.91 122.64 42.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.71 -40.32 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.844 -0.616 . . . . 20.0 109.653 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.55 147.56 34.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.433 0.635 . . . . 20.0 109.324 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.9 2.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.748 -1.114 . . . . 20.0 108.248 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.0 -56.27 21.56 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.827 -0.624 . . . . 20.0 110.272 163.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.14 11.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -165.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.66 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.158 -1.793 . . . . 20.0 106.158 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.08 56.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.207 0.527 . . . . 20.0 111.303 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.73 2.02 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.162 -0.926 . . . . 20.0 108.673 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.54 -19.98 47.95 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 N-CA-C 114.798 1.038 . . . . 20.0 114.798 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -43.03 74.71 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.587 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.5 -48.37 77.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.111 0.481 . . . . 20.0 110.121 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.2 -52.51 59.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.798 0.332 . . . . 20.0 110.657 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.35 -31.92 70.78 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 20.0 110.568 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 276' ' ' TRP . . . . . 0.498 ' HH2' ' HB3' ' H' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -47.96 65.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.061 -0.655 . . . . 20.0 110.983 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.05 -38.74 89.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.73 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.59 -47.94 78.46 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.561 -0.456 . . . . 20.0 110.143 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.86 -40.42 88.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.828 -0.349 . . . . 20.0 110.68 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.92 78.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.281 -0.568 . . . . 20.0 111.141 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.67 72.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.001 -0.679 . . . . 20.0 111.021 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.86 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.035 -0.666 . . . . 20.0 111.141 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.69 73.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.872 -0.731 . . . . 20.0 110.989 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.58 15.48 29.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.362 0.875 . . . . 20.0 113.362 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.78 32.14 13.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.709 0.766 . . . . 20.0 111.574 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.39 34.46 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.305 -0.998 . . . . 20.0 108.305 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.17 149.31 13.44 Favored 'Trans proline' 0 CA--C 1.517 -0.375 0 CA-C-N 119.167 0.738 . . . . 20.0 111.409 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.99 148.19 23.46 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.652 -0.704 . . . . 20.0 109.687 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.15 5.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.69 113.71 17.04 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.877 -1.157 . . . . 20.0 107.877 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.03 157.05 25.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.505 0.669 . . . . 20.0 110.261 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.58 21.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.176 165.055 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.0 20.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 296' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' H' ' 237' ' ' THR . . . 101.45 144.74 15.55 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.666 -0.767 . . . . 20.0 112.704 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.57 4.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.338 -1.105 . . . . 20.0 110.338 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 298' ' ' THR . . . . . 0.767 HG21 ' HE3' ' H' ' 261' ' ' LYS . 20.2 p -110.28 172.88 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.038 0.923 . . . . 20.0 111.374 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.69 76.61 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.346 -1.297 . . . . 20.0 111.281 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.3 74.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 111.815 0.302 . . . . 20.0 111.815 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.21 96.85 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.192 -1.004 . . . . 20.0 112.058 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 302' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' H' ' 220' ' ' ARG . . . -68.28 -26.9 65.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.201 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.48 56.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.119 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -14.17 60.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.341 0.867 . . . . 20.0 113.341 -174.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 305' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' B' ' 217' ' ' ARG . 4.1 mp -103.76 -8.89 19.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -167.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 306' ' ' THR . . . . . 0.484 ' OG1' ' OE1' ' H' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.54 8.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.523 0.677 . . . . 20.0 110.558 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 307' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' B' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.82 70.35 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -161.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.93 -25.23 66.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.183 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.06 1.95 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.805 -0.712 . . . . 20.0 113.317 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.21 139.61 52.61 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 117.598 0.699 . . . . 20.0 111.128 -163.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 311' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -84.49 141.67 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.568 0 CA-C-N 119.51 0.861 . . . . 20.0 110.041 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.43 135.81 32.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.314 -0.857 . . . . 20.0 111.212 -169.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.55 12.34 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.183 -1.567 . . . . 20.0 109.183 164.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.39 136.07 27.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.9 -0.65 . . . . 20.0 110.087 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -104.04 153.2 21.15 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.246 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' H' ' 259' ' ' ALA . 4.2 m -138.46 133.54 32.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.258 -0.883 . . . . 20.0 109.452 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 317' ' ' VAL . . . . . 0.438 HG11 HG12 ' H' ' 185' ' ' ILE . 92.6 t -99.43 108.58 51.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.276 -1.379 . . . . 20.0 107.276 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.96 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.642 1.018 . . . . 20.0 113.593 -154.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 319' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' H' ' 253' ' ' HIS . . . 79.73 35.52 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.537 -1.665 . . . . 20.0 115.313 161.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 320' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' H' ' 321' ' ' TYR . 0.4 OUTLIER -75.64 157.55 33.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.733 0.778 . . . . 20.0 110.091 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 321' ' ' TYR . . . . . 0.43 ' O ' ' HG3' ' H' ' 320' ' ' ARG . 3.3 m-85 -113.08 166.13 11.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.825 -1.546 . . . . 20.0 106.825 160.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.14 113.61 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.156 0.982 . . . . 20.0 108.462 -163.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.53 -7.42 3.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.442 1.275 . . . . 20.0 114.442 -140.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 324' ' ' SER . . . . . 0.598 ' OG ' HG21 ' H' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.682 0.623 . . . . 20.0 112.682 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 325' ' ' ASN . . . . . 0.443 ' HB2' ' HA ' ' F' ' 100' ' ' ALA . 35.1 p-10 -101.98 -56.23 2.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 114.963 1.468 . . . . 20.0 114.963 -152.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 151.02 50.82 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 327' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' H' ' 181' ' ' PHE . 82.7 mt-10 -142.62 52.82 1.41 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.834 -1.53 . . . . 20.0 109.911 -153.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.06 149.43 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.392 0.615 . . . . 20.0 111.981 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 329' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' H' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.927 0.87 . . . . 20.0 109.462 175.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.57 119.16 27.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.617 -1.174 . . . . 20.0 108.87 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.0 -32.12 53.15 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.793 0.683 . . . . 20.0 111.519 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.8 73.52 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.324 -0.55 . . . . 20.0 110.202 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.02 -44.95 83.24 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.761 -0.376 . . . . 20.0 111.025 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.26 92.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.44 -0.504 . . . . 20.0 110.55 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 118.853 -1.139 . . . . 20.0 110.112 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.37 93.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.072 -0.651 . . . . 20.0 110.458 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.81 80.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.698 0.285 . . . . 20.0 110.889 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 338' ' ' VAL . . . . . 0.704 ' O ' ' OG1' ' H' ' 342' ' ' THR . 42.5 t -60.16 -49.05 85.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.02 0.438 . . . . 20.0 110.221 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 339' ' ' GLU . . . . . 0.782 ' OE1' ' NZ ' ' H' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.92 74.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.951 0.405 . . . . 20.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -55.13 38.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.355 -0.384 . . . . 20.0 111.414 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 341' ' ' MET . . . . . 0.493 ' CE ' HD11 ' H' ' 234' ' ' ILE . 31.9 tpp -60.2 -40.34 89.71 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.2 -0.6 . . . . 20.0 110.828 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 342' ' ' THR . . . . . 0.704 ' OG1' ' O ' ' H' ' 338' ' ' VAL . 1.3 m -56.47 -45.03 81.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.136 0.493 . . . . 20.0 110.437 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 343' ' ' LYS . . . . . 0.782 ' NZ ' ' OE1' ' H' ' 339' ' ' GLU . 34.6 mttp -74.16 -37.45 63.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 119.937 -0.705 . . . . 20.0 110.821 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.49 97.73 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.589 -0.444 . . . . 20.0 111.128 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 345' ' ' LEU . . . . . 0.42 ' O ' HG22 ' H' ' 348' ' ' ILE . 1.0 OUTLIER -59.04 -50.45 74.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.613 -0.435 . . . . 20.0 110.769 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.65 -39.12 91.07 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.725 -0.79 . . . . 20.0 110.554 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 347' ' ' ASN . . . . . 0.498 ' HB3' ' HH2' ' H' ' 276' ' ' TRP . 4.9 m-20 -84.46 4.8 30.04 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.449 -0.9 . . . . 20.0 112.56 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 348' ' ' ILE . . . . . 0.42 HG22 ' O ' ' H' ' 345' ' ' LEU . 1.3 tt -65.22 -23.64 33.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.918 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' H' H ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.82 -27.28 69.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.775 -0.77 . . . . 20.0 111.238 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.89 -18.79 31.79 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 122.077 -0.389 . . . . 20.0 111.484 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 351' ' ' LEU . . . . . 0.431 ' O ' HD12 ' H' ' 351' ' ' LEU . 0.1 OUTLIER -69.81 -28.75 65.98 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.142 0.423 . . . . 20.0 112.142 -173.873 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' H' H ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.15 -26.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.016 1.858 . . . . 20.0 116.016 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' H' H ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.977 1.311 . . . . 20.0 108.402 -174.69 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 114.25 1.204 . . . . 20.0 114.25 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.27 2.91 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.902 -1.518 . . . . 20.0 106.902 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -63.03 -34.45 66.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.895 -1.048 . . . . 20.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.96 -23.56 12.3 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 113.653 0.983 . . . . 20.0 113.653 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.111 0.965 . . . . 20.0 111.65 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.78 32.34 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.758 0.254 . . . . 20.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.05 117.46 37.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.15 12.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.324 0.583 . . . . 20.0 110.958 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.65 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.45 -0.795 . . . . 20.0 111.888 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.15 -45.2 74.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.236 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.04 97.39 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 121.06 -0.256 . . . . 20.0 111.196 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -30.65 71.0 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.79 -0.364 . . . . 20.0 111.158 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -46.44 90.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.616 -0.434 . . . . 20.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -58.96 -42.97 91.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.648 -0.251 . . . . 20.0 111.564 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.03 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 119.492 -0.883 . . . . 20.0 110.713 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 119.007 -1.077 . . . . 20.0 110.966 -162.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -25.98 68.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.945 -0.702 . . . . 20.0 111.284 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.41 70.56 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 120.522 -0.471 . . . . 20.0 109.83 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 19' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -85.09 144.7 9.59 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 C-N-CA 120.32 0.68 . . . . 20.0 112.216 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.91 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 117.309 1.684 . . . . 20.0 117.309 -159.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.14 -1.43 . . . . 20.0 107.14 159.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.15 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 20.0 110.696 -166.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.29 2.89 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.478 -0.783 . . . . 20.0 113.988 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.42 0.17 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.312 1.053 . . . . 20.0 109.567 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.14 3.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.888 -1.051 . . . . 20.0 113.434 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' I' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.02 23.69 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.738 1.153 . . . . 20.0 113.732 178.535 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 11.34 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.419 1.637 . . . . 20.0 115.419 -154.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' I' ' 26' ' ' PHE . . . -53.13 -26.93 29.63 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.752 1.16 . . . . 20.0 115.996 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 29' ' ' ILE . . . . . 0.529 HD13 ' NH1' ' I' ' 184' ' ' ARG . 1.1 tt -59.57 -35.81 61.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 118.062 0.931 . . . . 20.0 110.618 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.22 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.951 0.405 . . . . 20.0 110.428 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.299 -0.41 . . . . 20.0 110.945 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.25 -49.58 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 20.0 110.288 -174.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.71 86.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.711 -0.796 . . . . 20.0 110.32 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.72 -29.5 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 118.735 -1.186 . . . . 20.0 111.134 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.44 -31.03 71.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.996 0.362 . . . . 20.0 111.131 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.96 -56.68 3.27 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.174 0.435 . . . . 20.0 112.174 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.46 44.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.53 -0.305 . . . . 20.0 111.539 -164.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -26.37 63.69 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.922 -0.711 . . . . 20.0 112.254 -162.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.14 -23.48 63.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 118.879 -1.128 . . . . 20.0 111.735 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.9 -6.93 22.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.493 0.923 . . . . 20.0 113.493 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.61 152.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -66.08 -42.59 89.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.16 -0.927 . . . . 20.0 111.529 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.64 158.28 35.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.519 -0.919 . . . . 20.0 108.519 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.21 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.208 -1.034 . . . . 20.0 108.208 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.19 159.21 44.18 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.527 0.68 . . . . 20.0 110.429 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.03 129.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.358 -1.349 . . . . 20.0 107.358 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.09 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.784 0.802 . . . . 20.0 108.893 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.59 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.923 -0.711 . . . . 20.0 111.105 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.86 9.16 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-O 119.151 -0.805 . . . . 20.0 114.51 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.47 35.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.481 1.141 . . . . 20.0 110.221 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.33 140.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.187 -1.412 . . . . 20.0 107.187 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 53' ' ' ILE . . . . . 0.709 HD13 HG12 ' I' ' 207' ' ' VAL . 31.1 mm -130.22 115.65 33.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.296 -1.372 . . . . 20.0 107.296 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.79 36.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.668 -0.493 . . . . 20.0 109.668 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.97 99.97 8.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.615 -0.883 . . . . 20.0 108.615 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.53 145.37 31.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.804 -1.554 . . . . 20.0 106.804 163.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.522 0.514 . . . . 20.0 109.667 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.41 -161.09 23.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.117 -0.793 . . . . 20.0 111.117 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.66 10.45 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.88 0.872 . . . . 20.0 108.997 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.53 33.49 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.075 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.78 165.24 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.763 0.651 . . . . 20.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.94 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.973 -1.012 . . . . 20.0 109.231 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 63' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.73 137.88 30.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.784 -0.821 . . . . 20.0 108.784 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.7 124.1 46.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.039 0.936 . . . . 20.0 109.049 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.27 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.07 -1.085 . . . . 20.0 108.07 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.53 124.58 51.39 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.295 0.372 . . . . 20.0 111.015 -168.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.9 0.88 . . . . 20.0 108.925 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 68' ' ' HIS . . . . . 0.49 ' NE2' ' OD1' ' I' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 20.0 110.52 177.415 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.16 -0.927 . . . . 20.0 109.705 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' I' ' 183' ' ' ASP . 12.0 t0 -97.42 68.04 2.14 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.622 -0.673 . . . . 20.0 112.434 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.88 28.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.77 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.758 0.823 . . . . 20.0 109.123 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 73' ' ' GLY . . . . . 0.467 ' C ' HD23 ' I' ' 74' ' ' LEU . . . -155.79 -175.72 27.12 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.553 -1.019 . . . . 20.0 110.553 173.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 74' ' ' LEU . . . . . 0.467 HD23 ' C ' ' I' ' 73' ' ' GLY . 5.1 mt -125.03 161.45 26.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.33 0.586 . . . . 20.0 109.989 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 75' ' ' MET . . . . . 0.513 ' HB2' HG23 ' I' ' 160' ' ' THR . 10.6 ttm -128.12 131.35 49.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.227 1.011 . . . . 20.0 109.696 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.49 137.11 23.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.38 7.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.091 0.774 . . . . 20.0 113.091 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.98 174.45 13.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.127 -1.064 . . . . 20.0 108.127 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.06 108.9 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.72 166.28 5.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.806 0.812 . . . . 20.0 109.999 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -27.02 60.33 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.632 -0.827 . . . . 20.0 112.72 -169.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.47 9.11 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.36 0.874 . . . . 20.0 113.36 -177.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.83 81.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 118.944 -0.92 . . . . 20.0 115.062 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 84' ' ' PHE . . . . . 0.503 ' HD1' ' HG3' ' K' ' 243' ' ' PRO . 20.2 m-30 -107.83 145.02 34.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.351 1.075 . . . . 20.0 110.208 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.86 142.5 28.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.588 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.6 6.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.855 -1.165 . . . . 20.0 107.855 158.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.84 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.64 0.733 . . . . 20.0 109.478 -170.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 129.27 15.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.772 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.79 160.24 24.61 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 CA-C-O 122.31 0.879 . . . . 20.0 112.734 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 90' ' ' ILE . . . . . 0.488 HD11 HG21 ' I' ' 160' ' ' THR . 9.2 mt -88.81 150.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 113.703 -1.59 . . . . 20.0 107.373 165.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.09 140.94 47.56 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.114 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.2 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 118.96 -0.911 . . . . 20.0 115.216 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.88 152.63 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.67 1.235 . . . . 20.0 109.227 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.68 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.42 -0.955 . . . . 20.0 108.42 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.14 -7.98 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 CA-C-N 120.626 1.259 . . . . 20.0 114.78 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.22 -15.18 59.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.207 0.912 . . . . 20.0 111.83 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 97' ' ' THR . . . . . 0.591 HG21 ' OG ' ' I' ' 324' ' ' SER . 44.7 p -89.51 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.668 0.787 . . . . 20.0 112.406 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 98' ' ' LEU . . . . . 0.678 HD12 ' H ' ' I' ' 99' ' ' ILE . 0.5 OUTLIER -43.25 -66.41 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.973 1.309 . . . . 20.0 113.429 -173.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 99' ' ' ILE . . . . . 0.678 ' H ' HD12 ' I' ' 98' ' ' LEU . 1.6 tt -173.24 156.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.043 -0.725 . . . . 20.0 109.043 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 100' ' ' ALA . . . . . 0.49 ' HB3' ' H ' ' K' ' 100' ' ' ALA . . . -123.91 -19.0 5.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.642 -1.163 . . . . 20.0 111.275 158.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 101' ' ' GLN . . . . . 0.412 ' HB3' HH21 ' I' ' 102' ' ' ARG . 0.0 OUTLIER -169.34 141.7 2.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.666 -0.864 . . . . 20.0 108.666 176.69 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 102' ' ' ARG . . . . . 0.412 HH21 ' HB3' ' I' ' 101' ' ' GLN . 0.0 OUTLIER 55.87 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 115.239 1.57 . . . . 20.0 115.239 150.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' I' ' 115' ' ' GLY . 0.5 OUTLIER -79.39 134.23 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.298 0.954 . . . . 20.0 109.369 160.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.75 140.27 37.25 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.492 -0.776 . . . . 20.0 109.425 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 105' ' ' VAL . . . . . 0.58 HG22 ' CG1' ' I' ' 162' ' ' ILE . 50.2 t -117.43 110.74 32.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.56 83.07 6.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.2 -0.296 . . . . 20.0 110.2 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.94 -54.24 14.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 O-C-N 123.373 0.42 . . . . 20.0 110.321 170.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.55 10.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.11 126.3 27.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 20.0 110.458 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-O 118.842 -0.977 . . . . 20.0 115.326 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.07 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.464 1.132 . . . . 20.0 108.524 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.29 141.56 37.76 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.69 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.39 31.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.287 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' I' ' 103' ' ' PHE . . . -147.9 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.307 -1.117 . . . . 20.0 110.307 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.75 154.43 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.374 -0.973 . . . . 20.0 108.374 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.27 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.331 -0.85 . . . . 20.0 114.559 -168.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' I' ' 98' ' ' LEU . . . -67.16 -47.95 69.46 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -156.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.13 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.513 1.051 . . . . 20.0 112.694 -155.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.16 35.45 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.8 11.05 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 120.749 1.303 . . . . 20.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.77 149.75 90.04 Favored 'Trans proline' 0 C--O 1.233 0.27 0 CA-C-N 119.209 0.753 . . . . 20.0 110.731 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.11 165.37 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.811 0.815 . . . . 20.0 109.984 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.235 -1.024 . . . . 20.0 108.235 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.88 19.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.861 0.362 . . . . 20.0 110.715 169.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.73 1.5 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.001 0.921 . . . . 20.0 113.068 -170.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -24.86 59.6 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 120.849 1.339 . . . . 20.0 112.015 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 -26.53 30.0 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 111.799 0.296 . . . . 20.0 111.799 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.97 69.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.821 -0.751 . . . . 20.0 110.206 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.97 62.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.913 0.338 . . . . 20.0 111.913 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.44 90.93 4.46 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.199 -0.667 . . . . 20.0 109.199 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.33 7.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.16 142.57 87.45 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.56 75.49 Favored 'Trans proline' 0 C--N 1.326 -0.605 0 CA-C-N 119.661 0.915 . . . . 20.0 112.387 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.64 42.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.561 -1.199 . . . . 20.0 107.943 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 118.826 -0.607 . . . . 20.0 112.382 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' I' ' 138' ' ' GLN . 14.0 p30 -55.42 -66.34 0.43 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.927 -0.558 . . . . 20.0 111.392 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 138' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' I' ' 139' ' ' ILE . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 103.124 -2.917 . . . . 20.0 103.124 133.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 139' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' I' ' 138' ' ' GLN . 1.2 tp -74.85 168.07 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.138 0.975 . . . . 20.0 108.952 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.47 18.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.956 0.902 . . . . 20.0 110.455 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 141' ' ' ILE . . . . . 0.421 HD13 HD13 ' I' ' 162' ' ' ILE . 30.2 mt -124.63 147.51 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.606 -0.887 . . . . 20.0 108.606 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' I' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.79 54.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 20.0 109.618 175.117 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.22 7.87 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 123.701 0.626 . . . . 20.0 111.781 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' I' ' 142' ' ' ASP . . . 86.83 -6.55 82.73 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 115.504 0.962 . . . . 20.0 115.504 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.0 54.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.462 1.131 . . . . 20.0 110.305 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.36 -20.9 33.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.558 0.947 . . . . 20.0 113.558 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.41 162.63 40.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.994 0.902 . . . . 20.0 111.4 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.42 -41.48 80.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.832 -1.531 . . . . 20.0 111.278 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.34 -47.02 87.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.818 -0.353 . . . . 20.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.38 -35.14 76.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.487 -0.485 . . . . 20.0 110.806 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.64 84.24 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.107 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.77 -23.27 58.5 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.359 -0.936 . . . . 20.0 111.008 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.77 -30.02 66.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.78 -0.768 . . . . 20.0 110.622 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.6 -40.55 92.23 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.545 -0.462 . . . . 20.0 111.676 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.75 6.71 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.566 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.78 133.52 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 118.485 1.143 . . . . 20.0 108.565 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.85 175.95 9.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.737 -1.209 . . . . 20.0 107.737 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.22 147.29 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.733 -1.747 . . . . 20.0 108.733 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 160' ' ' THR . . . . . 0.513 HG23 ' HB2' ' I' ' 75' ' ' MET . 0.2 OUTLIER -79.39 113.59 17.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 165.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.7 -20.03 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 162' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' I' ' 105' ' ' VAL . 0.5 OUTLIER -111.68 155.61 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 121.64 -0.663 . . . . 20.0 111.776 -159.147 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 163' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' I' ' 164' ' ' TRP . 3.5 t -145.31 -166.29 2.39 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.279 1.032 . . . . 20.0 110.514 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 164' ' ' TRP . . . . . 0.561 ' N ' ' OG1' ' I' ' 163' ' ' THR . 2.5 t-105 -100.82 -17.92 16.67 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.228 0.825 . . . . 20.0 113.228 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 165' ' ' ASP . . . . . 0.45 ' O ' ' NE2' ' K' ' 101' ' ' GLN . 7.5 t70 63.72 61.71 0.97 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.827 -0.545 . . . . 20.0 112.284 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.93 158.62 29.52 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.134 -1.186 . . . . 20.0 110.134 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 167' ' ' ARG . . . . . 0.582 ' HB3' HH12 ' K' ' 102' ' ' ARG . 0.0 OUTLIER -142.43 148.32 37.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.722 -1.214 . . . . 20.0 107.722 170.618 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.63 30.47 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.145 -0.934 . . . . 20.0 110.191 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -129.42 159.76 35.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.896 0.855 . . . . 20.0 109.986 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.4 117.15 34.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.268 -1.333 . . . . 20.0 109.508 -173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.88 151.61 28.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.521 -0.548 . . . . 20.0 109.521 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' I' ' 175' ' ' ARG . . . 56.97 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.215 -1.554 . . . . 20.0 109.215 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.773 0.657 . . . . 20.0 112.773 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.703 -0.799 . . . . 20.0 111.236 157.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' I' ' 172' ' ' GLY . 6.8 ptt-85 -169.8 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.609 0.64 . . . . 20.0 112.634 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.49 169.4 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 127.836 2.454 . . . . 20.0 106.213 157.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.7 145.82 20.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.418 -0.956 . . . . 20.0 108.418 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.17 -64.44 1.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.736 0.698 . . . . 20.0 112.094 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.15 -0.65 36.9 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 181' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' I' ' 327' ' ' GLU . 3.2 t80 -84.67 -66.93 0.84 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.606 0.639 . . . . 20.0 111.768 -162.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.24 127.86 32.84 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.069 0.938 . . . . 20.0 110.715 -152.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' I' ' 70' ' ' ASP . 0.6 OUTLIER 69.94 -6.73 1.03 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.374 1.47 . . . . 20.0 113.199 174.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 184' ' ' ARG . . . . . 0.529 ' NH1' HD13 ' I' ' 29' ' ' ILE . 0.0 OUTLIER -153.78 83.87 1.16 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.155 0.978 . . . . 20.0 110.805 157.144 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 185' ' ' ILE . . . . . 0.439 HG12 HG11 ' I' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.524 -2.399 . . . . 20.0 104.524 149.912 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 186' ' ' ALA . . . . . 0.723 ' O ' ' OG1' ' I' ' 189' ' ' THR . . . -50.2 -42.88 52.18 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.336 -0.847 . . . . 20.0 111.536 173.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.05 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.096 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.84 -38.62 91.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.173 -1.011 . . . . 20.0 110.471 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 189' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' I' ' 186' ' ' ALA . 25.2 p -59.14 -48.56 81.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.456 -0.898 . . . . 20.0 110.886 172.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.59 63.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.954 0.407 . . . . 20.0 110.53 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.03 -43.21 96.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.058 -0.657 . . . . 20.0 111.0 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.85 -36.56 84.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 119.955 -0.698 . . . . 20.0 110.329 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 193' ' ' VAL . . . . . 0.407 HG23 ' O ' ' I' ' 189' ' ' THR . 11.5 t -60.55 -44.82 97.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.081 0.467 . . . . 20.0 110.104 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.36 75.59 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.28 -0.568 . . . . 20.0 111.171 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.14 70.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.854 -0.738 . . . . 20.0 110.799 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.15 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.538 0.57 . . . . 20.0 112.538 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.75 27.4 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.349 -0.612 . . . . 20.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.38 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.323 0.389 . . . . 20.0 110.135 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.37 17.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.7 -0.482 . . . . 20.0 109.7 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.26 4.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.18 -0.674 . . . . 20.0 109.18 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.5 59.92 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.985 -0.686 . . . . 20.0 111.378 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.67 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.894 -0.78 . . . . 20.0 108.894 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 203' ' ' ASP . . . . . 0.657 ' N ' ' OD1' ' I' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.05 16.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.451 -0.944 . . . . 20.0 108.451 -174.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.53 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.557 -0.905 . . . . 20.0 108.557 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.89 106.67 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.004 -0.739 . . . . 20.0 109.004 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -83.0 125.42 31.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.709 -0.849 . . . . 20.0 108.709 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 207' ' ' VAL . . . . . 0.709 HG12 HD13 ' I' ' 53' ' ' ILE . 34.1 m -119.92 150.22 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.848 -0.797 . . . . 20.0 108.848 174.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.8 5.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.87 159.98 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.872 0.844 . . . . 20.0 111.075 -165.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.44 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.648 -1.16 . . . . 20.0 108.236 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.16 29.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.502 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.84 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.347 -0.541 . . . . 20.0 110.928 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -20.36 64.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.468 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 214' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.11 121.11 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.12 60.9 6.26 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.397 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 216' ' ' LEU . . . . . 0.437 HD23 ' H ' ' I' ' 216' ' ' LEU . 0.5 OUTLIER -47.03 -25.53 0.84 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.501 0.926 . . . . 20.0 113.501 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.5 2.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.347 0.499 . . . . 20.0 112.347 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.58 40.89 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 119.739 -1.22 . . . . 20.0 111.969 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 219' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' I' ' 222' ' ' SER . . . -65.26 -36.97 85.76 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.307 -0.525 . . . . 20.0 111.41 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 220' ' ' ARG . . . . . 0.403 ' HB2' ' HB1' ' I' ' 302' ' ' ALA . 16.5 ttm180 -52.76 -36.75 58.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 221' ' ' THR . . . . . . . . . . . . . 74.9 p -58.4 -45.79 87.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.866 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 222' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' I' ' 219' ' ' ALA . 2.1 p -58.04 -35.81 71.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.8 -0.36 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.97 69.3 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.56 0.578 . . . . 20.0 112.56 -169.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 224' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.23 -33.36 75.63 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 20.0 111.804 -165.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.99 -16.72 75.0 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.091 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.97 -45.67 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 111.985 0.365 . . . . 20.0 111.985 -158.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 227' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' I' ' 306' ' ' THR . 3.0 pt-20 -56.36 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 228' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -43.86 143.73 2.85 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.977 1.491 . . . . 20.0 115.977 -134.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.12 -4.73 0.78 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.283 1.433 . . . . 20.0 113.382 162.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.105 -0.638 . . . . 20.0 111.774 167.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.46 151.46 16.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.928 -0.653 . . . . 20.0 112.266 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.72 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.817 0.847 . . . . 20.0 108.797 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.65 149.03 23.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.438 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' I' ' 341' ' ' MET . 51.6 mt -133.15 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 235' ' ' ASP . . . . . 0.49 ' OD1' ' NE2' ' I' ' 68' ' ' HIS . 25.4 t0 -135.16 173.25 11.93 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.981 -1.488 . . . . 20.0 106.981 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.636 0.732 . . . . 20.0 111.447 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 237' ' ' THR . . . . . 0.459 HG21 ' HA3' ' I' ' 296' ' ' GLY . 9.2 t -165.64 122.68 1.45 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.356 -1.35 . . . . 20.0 107.356 164.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 238' ' ' ILE . . . . . 0.41 HD13 ' O ' ' I' ' 237' ' ' THR . 18.0 mm -145.48 151.85 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.249 -1.019 . . . . 20.0 108.249 -161.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.19 105.2 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 158.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.47 110.01 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.37 36.18 22.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.959 1.304 . . . . 20.0 112.463 158.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.97 128.45 78.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.16 -2.163 . . . . 20.0 105.16 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.57 12.05 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 120.857 1.342 . . . . 20.0 112.369 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.28 44.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.081 -0.963 . . . . 20.0 114.904 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 245' ' ' THR . . . . . . . . . . . . . 33.6 p -92.09 164.56 22.89 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 118.643 1.221 . . . . 20.0 110.724 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.05 -172.61 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.569 0 CA-C-O 121.893 0.706 . . . . 20.0 111.925 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.725 -1.125 . . . . 20.0 111.992 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 248' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -70.22 -18.71 63.17 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.824 -0.751 . . . . 20.0 112.882 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 249' ' ' LYS . . . . . 0.714 ' O ' ' OG1' ' I' ' 252' ' ' THR . 16.9 mttt -98.76 -15.13 19.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.87 89.02 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.306 -0.558 . . . . 20.0 111.337 -172.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.087 -1.045 . . . . 20.0 111.88 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 252' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' I' ' 249' ' ' LYS . 39.5 p -57.11 -31.85 65.71 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.467 0.576 . . . . 20.0 111.352 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 253' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' I' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.317 0.58 . . . . 20.0 110.382 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.39 -1.31 3.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.974 -1.012 . . . . 20.0 112.306 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.37 35.9 5.83 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 126.151 1.834 . . . . 20.0 111.566 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.22 10.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 -167.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.15 174.23 3.42 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-O 122.695 1.164 . . . . 20.0 113.307 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.79 175.16 6.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' I' ' 316' ' ' SER . . . -126.4 120.3 29.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.122 -0.944 . . . . 20.0 109.399 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.01 139.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 261' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' I' ' 298' ' ' THR . 1.9 mtmm -98.89 122.59 42.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.971 -0.751 . . . . 20.0 108.971 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.22 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.876 -0.602 . . . . 20.0 109.647 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.63 147.52 34.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.35 -0.611 . . . . 20.0 109.35 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.94 2.85 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.804 -1.089 . . . . 20.0 108.243 165.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.822 -0.626 . . . . 20.0 110.261 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -46.17 11.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -165.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.77 143.67 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 20.0 109.373 -163.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.28 104.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.117 -1.808 . . . . 20.0 106.117 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 269' ' ' CYS . . . . . . . . . . . . . 69.5 m -66.29 137.02 56.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.214 0.53 . . . . 20.0 111.379 -171.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.03 109.66 1.97 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.211 -0.904 . . . . 20.0 108.72 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.47 -19.98 48.4 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.832 1.051 . . . . 20.0 114.832 -160.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -43.01 74.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.11 -0.636 . . . . 20.0 110.579 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 273' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.55 -48.33 77.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.098 0.475 . . . . 20.0 110.123 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.21 -52.47 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 120.82 0.343 . . . . 20.0 110.674 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.38 -31.92 70.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.509 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 276' ' ' TRP . . . . . 0.493 ' HH2' ' HB3' ' I' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -48.0 65.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.01 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.01 -38.73 89.73 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.046 -0.662 . . . . 20.0 110.759 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -48.0 78.5 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.624 -0.431 . . . . 20.0 110.037 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.45 88.36 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.701 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.31 -44.91 78.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.292 -0.563 . . . . 20.0 111.109 -172.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.008 -0.677 . . . . 20.0 111.032 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.48 -31.76 65.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.118 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.73 73.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.898 -0.721 . . . . 20.0 110.976 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.55 15.42 29.3 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.324 0.861 . . . . 20.0 113.324 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.82 32.16 13.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.733 0.778 . . . . 20.0 111.586 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.33 143.41 34.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.3 -1.0 . . . . 20.0 108.3 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 287' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.21 149.33 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 119.193 0.747 . . . . 20.0 111.346 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 148.14 23.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.636 -0.711 . . . . 20.0 109.689 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.94 175.13 5.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.71 -1.219 . . . . 20.0 107.71 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.63 113.78 17.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.882 -1.155 . . . . 20.0 107.882 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.65 43.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.447 -0.575 . . . . 20.0 109.447 -172.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.02 157.03 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.68 -1.23 . . . . 20.0 107.68 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.72 12.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.517 0.675 . . . . 20.0 110.282 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.81 -18.53 21.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.814 -1.085 . . . . 20.0 112.117 165.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.6 -176.01 20.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.99 -0.844 . . . . 20.0 110.99 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 296' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' I' ' 237' ' ' THR . . . 101.47 144.79 15.6 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.638 -0.781 . . . . 20.0 112.691 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.51 4.06 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.36 -1.096 . . . . 20.0 110.36 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 298' ' ' THR . . . . . 0.763 HG21 ' HE3' ' I' ' 261' ' ' LYS . 20.4 p -110.23 172.92 6.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.004 0.907 . . . . 20.0 111.397 -174.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.95 -33.63 76.49 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.37 -1.286 . . . . 20.0 111.264 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 -35.4 74.19 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 111.777 0.288 . . . . 20.0 111.777 -171.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.22 96.85 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.211 -0.995 . . . . 20.0 112.032 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 302' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' I' ' 220' ' ' ARG . . . -68.2 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.193 -0.603 . . . . 20.0 111.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.84 -34.49 56.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 120.044 -0.662 . . . . 20.0 110.171 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.23 60.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.309 0.855 . . . . 20.0 113.309 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 305' ' ' LEU . . . . . 0.461 HD21 ' HD3' ' G' ' 217' ' ' ARG . 4.1 mp -103.74 -8.93 19.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -167.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 306' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' I' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.708 . . . . 20.0 110.572 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.62 -29.92 70.36 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.378 0.881 . . . . 20.0 113.378 -161.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.17 66.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.664 -0.814 . . . . 20.0 111.236 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.701 . . . . 20.0 113.332 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 310' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.37 139.61 52.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.571 0.686 . . . . 20.0 111.105 -163.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.47 141.71 9.04 Favored 'Trans proline' 0 CA--C 1.513 -0.538 0 CA-C-N 119.453 0.84 . . . . 20.0 110.058 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.47 135.79 32.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.31 -0.859 . . . . 20.0 111.212 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.56 12.34 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 109.161 -1.576 . . . . 20.0 109.161 164.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.06 27.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.465 0.65 . . . . 20.0 110.066 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.05 153.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.622 -1.172 . . . . 20.0 109.211 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' I' ' 259' ' ' ALA . 4.2 m -138.46 133.51 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.256 -0.884 . . . . 20.0 109.459 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 317' ' ' VAL . . . . . 0.439 HG11 HG12 ' I' ' 185' ' ' ILE . 92.4 t -99.46 108.56 51.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.245 -1.391 . . . . 20.0 107.245 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.638 1.016 . . . . 20.0 113.614 -154.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 319' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' I' ' 253' ' ' HIS . . . 79.8 35.44 0.15 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.29 161.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 320' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' I' ' 321' ' ' TYR . 0.4 OUTLIER -75.59 157.62 33.56 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.712 0.768 . . . . 20.0 110.082 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 321' ' ' TYR . . . . . 0.432 ' O ' ' HG3' ' I' ' 320' ' ' ARG . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.805 -1.554 . . . . 20.0 106.805 160.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.23 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.196 0.999 . . . . 20.0 108.383 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.56 -7.41 3.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 324' ' ' SER . . . . . 0.591 ' OG ' HG21 ' I' ' 97' ' ' THR . 0.1 OUTLIER -59.5 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.642 0.608 . . . . 20.0 112.642 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 325' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' K' ' 100' ' ' ALA . 35.1 p-10 -102.03 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.017 1.488 . . . . 20.0 115.017 -152.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.97 50.79 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.447 -1.316 . . . . 20.0 107.447 174.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 327' ' ' GLU . . . . . 0.733 ' HB3' ' HB3' ' I' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.81 1.42 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.849 -1.523 . . . . 20.0 109.932 -153.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.09 149.44 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.429 0.633 . . . . 20.0 111.919 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 329' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' I' ' 181' ' ' PHE . 0.3 OUTLIER -139.37 179.44 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.909 0.862 . . . . 20.0 109.463 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.56 119.19 27.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.614 -1.175 . . . . 20.0 108.85 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.12 -32.07 53.98 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.821 0.7 . . . . 20.0 111.449 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 332' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -68.66 -44.77 73.38 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.167 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.04 -44.9 83.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.074 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.64 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.497 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.836 -1.146 . . . . 20.0 110.096 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.413 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.55 -43.83 80.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.79 0.329 . . . . 20.0 110.917 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 338' ' ' VAL . . . . . 0.699 ' O ' ' OG1' ' I' ' 342' ' ' THR . 42.5 t -60.24 -48.91 86.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.956 0.407 . . . . 20.0 110.23 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' I' ' 343' ' ' LYS . 1.3 mm-40 -54.81 -46.96 74.59 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.028 0.442 . . . . 20.0 110.738 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -55.16 37.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.363 -0.38 . . . . 20.0 111.414 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' I' ' 234' ' ' ILE . 31.9 tpp -60.14 -40.34 89.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.864 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 342' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' I' ' 338' ' ' VAL . 1.3 m -56.57 -44.93 81.48 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.112 0.482 . . . . 20.0 110.42 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' I' ' 339' ' ' GLU . 34.6 mttp -74.21 -37.5 63.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 119.967 -0.693 . . . . 20.0 110.726 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.582 -0.447 . . . . 20.0 111.142 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 345' ' ' LEU . . . . . 0.419 ' O ' HG22 ' I' ' 348' ' ' ILE . 1.0 OUTLIER -59.02 -50.44 74.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.577 -0.449 . . . . 20.0 110.801 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.03 90.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.668 -0.813 . . . . 20.0 110.619 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 347' ' ' ASN . . . . . 0.493 ' HB3' ' HH2' ' I' ' 276' ' ' TRP . 5.0 m-20 -84.54 4.84 30.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 348' ' ' ILE . . . . . 0.419 HG22 ' O ' ' I' ' 345' ' ' LEU . 1.3 tt -65.22 -23.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.539 -0.864 . . . . 20.0 110.883 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' I' I ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.76 -27.37 69.15 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.756 -0.778 . . . . 20.0 111.211 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.84 -18.8 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.159 -0.338 . . . . 20.0 111.493 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 351' ' ' LEU . . . . . 0.439 ' O ' HD12 ' I' ' 351' ' ' LEU . 0.1 OUTLIER -69.81 -28.75 65.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.129 0.418 . . . . 20.0 112.129 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' I' I ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.13 -26.66 0.1 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.038 1.866 . . . . 20.0 116.038 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' I' I ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.007 1.323 . . . . 20.0 108.401 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 114.293 1.22 . . . . 20.0 114.293 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.13 2.91 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.934 -1.506 . . . . 20.0 106.934 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.87 -34.52 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.917 -1.038 . . . . 20.0 110.223 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.99 -23.52 12.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.44 30.27 19.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.123 0.969 . . . . 20.0 111.621 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -38.71 32.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.785 0.266 . . . . 20.0 111.207 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.09 117.45 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.667 -1.234 . . . . 20.0 107.667 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.21 12.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 20.0 110.919 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.76 -31.49 72.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.448 -0.797 . . . . 20.0 111.884 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.12 -45.21 74.27 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.553 -0.459 . . . . 20.0 111.233 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -43.13 97.29 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.985 -0.286 . . . . 20.0 111.18 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.5 70.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.719 -0.392 . . . . 20.0 111.184 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.41 90.71 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.02 -42.95 91.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.639 -0.255 . . . . 20.0 111.545 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.08 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.518 -0.873 . . . . 20.0 110.645 -171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 119.03 -1.068 . . . . 20.0 111.029 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -26.0 68.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 119.937 -0.705 . . . . 20.0 111.291 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.95 160.39 70.2 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 120.489 -0.484 . . . . 20.0 109.822 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 19' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.11 144.77 9.58 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.287 0.658 . . . . 20.0 112.158 -172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.97 38.23 3.41 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 117.248 1.659 . . . . 20.0 117.248 -159.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.83 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 159.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.23 8.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.333 0.587 . . . . 20.0 110.721 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.91 -33.25 2.88 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.525 -0.762 . . . . 20.0 114.051 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.34 0.17 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.305 1.05 . . . . 20.0 109.515 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.14 4.0 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.836 -1.075 . . . . 20.0 113.438 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 26' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' J' ' 28' ' ' GLY . 0.0 OUTLIER -88.05 9.06 23.78 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 119.699 1.136 . . . . 20.0 113.705 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.27 0.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' J' ' 26' ' ' PHE . . . -53.08 -26.94 29.31 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 116.025 1.17 . . . . 20.0 116.025 -172.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 29' ' ' ILE . . . . . 0.529 HD13 ' NH1' ' J' ' 184' ' ' ARG . 1.1 tt -59.58 -35.79 61.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 118.079 0.939 . . . . 20.0 110.621 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.29 -52.46 61.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.902 0.382 . . . . 20.0 110.396 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.6 74.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.287 -0.415 . . . . 20.0 110.963 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.26 -49.55 82.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.031 0.443 . . . . 20.0 110.287 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.27 -39.71 86.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.729 -0.788 . . . . 20.0 110.304 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.78 -29.48 20.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 118.724 -1.19 . . . . 20.0 111.09 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.47 -30.97 71.64 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.979 0.354 . . . . 20.0 111.144 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.94 -56.69 3.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.243 0.46 . . . . 20.0 112.243 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.33 -28.44 44.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.447 -0.342 . . . . 20.0 111.521 -164.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.44 63.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.911 -0.716 . . . . 20.0 112.202 -162.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.05 -23.52 63.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 118.914 -1.115 . . . . 20.0 111.744 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.9 -6.92 22.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.62 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.544 -0.91 . . . . 20.0 108.544 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.6 88.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.175 -0.92 . . . . 20.0 111.467 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.3 35.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.524 -0.917 . . . . 20.0 108.524 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.16 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.233 -1.025 . . . . 20.0 108.233 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.13 159.26 44.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.438 0.637 . . . . 20.0 110.466 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.399 -1.334 . . . . 20.0 107.399 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -176.16 5.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.789 0.804 . . . . 20.0 108.929 177.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.57 62.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.908 -0.717 . . . . 20.0 111.145 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.89 9.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.718 1.007 . . . . 20.0 113.718 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.51 -6.7 83.31 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.138 -0.812 . . . . 20.0 114.483 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.47 35.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.433 1.117 . . . . 20.0 110.245 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.42 140.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 53' ' ' ILE . . . . . 0.71 HD13 HG12 ' J' ' 207' ' ' VAL . 31.2 mm -130.23 115.62 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.91 119.85 36.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.639 -0.504 . . . . 20.0 109.639 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 100.0 8.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.565 -0.902 . . . . 20.0 108.565 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.742 -1.577 . . . . 20.0 106.742 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.525 0.516 . . . . 20.0 109.667 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.13 23.82 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.13 -0.788 . . . . 20.0 111.13 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.08 105.62 10.44 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.892 0.877 . . . . 20.0 109.039 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.04 -168.52 33.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.064 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.77 165.2 32.89 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.78 0.658 . . . . 20.0 112.08 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 62' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -91.94 111.37 22.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.001 -0.999 . . . . 20.0 109.207 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.69 137.92 30.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.773 -0.825 . . . . 20.0 108.773 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.08 46.36 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.038 0.935 . . . . 20.0 109.034 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.31 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.57 51.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 123.285 0.366 . . . . 20.0 110.977 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.857 0.863 . . . . 20.0 108.942 167.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' J' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.45 29.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.963 -0.562 . . . . 20.0 110.523 177.46 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.27 5.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.257 -0.883 . . . . 20.0 109.702 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' J' ' 183' ' ' ASP . 12.1 t0 -97.42 68.01 2.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.649 -0.657 . . . . 20.0 112.439 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.85 28.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.743 0.817 . . . . 20.0 109.133 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 73' ' ' GLY . . . . . 0.47 ' C ' HD23 ' J' ' 74' ' ' LEU . . . -155.82 -175.72 27.14 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.591 -1.004 . . . . 20.0 110.591 173.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 74' ' ' LEU . . . . . 0.47 HD23 ' C ' ' J' ' 73' ' ' GLY . 5.0 mt -125.01 161.48 26.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.295 0.569 . . . . 20.0 110.038 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 75' ' ' MET . . . . . 0.526 ' HB2' HG23 ' J' ' 160' ' ' THR . 10.6 ttm -128.12 131.34 49.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.208 1.003 . . . . 20.0 109.711 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.49 137.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.85 -0.796 . . . . 20.0 108.85 168.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.15 -29.33 7.0 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.09 0.774 . . . . 20.0 113.09 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.46 13.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.118 -1.068 . . . . 20.0 108.118 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.96 19.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.369 -0.974 . . . . 20.0 108.369 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 166.29 5.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.798 0.808 . . . . 20.0 109.986 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.08 60.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 119.724 -0.79 . . . . 20.0 112.691 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.5 9.16 4.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.356 0.873 . . . . 20.0 113.356 -177.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.69 81.9 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.006 -0.886 . . . . 20.0 115.106 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 84' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -107.72 145.01 34.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.379 1.09 . . . . 20.0 110.262 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.85 142.48 28.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.305 -0.862 . . . . 20.0 112.571 -172.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.46 174.66 6.56 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.85 -1.167 . . . . 20.0 107.85 158.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.77 163.79 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.606 0.717 . . . . 20.0 109.47 -170.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.26 129.31 15.59 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.804 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.85 160.24 24.41 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 CA-C-O 122.358 0.899 . . . . 20.0 112.693 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 90' ' ' ILE . . . . . 0.491 HD11 HG21 ' J' ' 160' ' ' THR . 9.3 mt -88.76 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.716 -1.584 . . . . 20.0 107.376 165.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.91 47.55 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.263 -0.881 . . . . 20.0 112.172 -168.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.19 22.06 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.983 -0.898 . . . . 20.0 115.219 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.78 152.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.659 1.229 . . . . 20.0 109.27 -169.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.99 22.19 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.431 -0.952 . . . . 20.0 108.431 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.1 -7.89 13.07 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 CA-C-N 120.574 1.241 . . . . 20.0 114.822 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.28 -15.2 59.69 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.192 0.905 . . . . 20.0 111.792 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 97' ' ' THR . . . . . 0.581 HG21 ' OG ' ' J' ' 324' ' ' SER . 44.8 p -89.53 35.55 0.82 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.62 0.768 . . . . 20.0 112.422 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 98' ' ' LEU . . . . . 0.677 HD12 ' H ' ' J' ' 99' ' ' ILE . 0.5 OUTLIER -43.21 -66.5 0.37 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.984 1.314 . . . . 20.0 113.389 -173.07 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 99' ' ' ILE . . . . . 0.677 ' H ' HD12 ' J' ' 98' ' ' LEU . 1.6 tt -173.14 156.11 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.98 -0.748 . . . . 20.0 108.98 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' L' ' 325' ' ' ASN . . . -123.96 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 20.0 111.253 157.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 101' ' ' GLN . . . . . 0.411 ' HB3' HH21 ' J' ' 102' ' ' ARG . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 102' ' ' ARG . . . . . 0.457 HH12 ' HB3' ' L' ' 167' ' ' ARG . 0.0 OUTLIER 55.93 74.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.22 1.563 . . . . 20.0 115.22 150.551 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 103' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' J' ' 115' ' ' GLY . 0.5 OUTLIER -79.31 134.21 36.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.257 0.935 . . . . 20.0 109.415 160.406 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.81 140.35 37.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.502 -0.772 . . . . 20.0 109.378 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 105' ' ' VAL . . . . . 0.58 HG22 ' CG1' ' J' ' 162' ' ' ILE . 50.7 t -117.42 110.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 106' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.63 83.09 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.209 -0.293 . . . . 20.0 110.209 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.26 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 O-C-N 123.327 0.392 . . . . 20.0 110.278 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.53 177.5 10.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.437 -0.949 . . . . 20.0 108.437 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.03 126.29 27.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.93 -1.032 . . . . 20.0 110.505 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.23 75.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.88 -0.956 . . . . 20.0 115.328 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.0 114.01 15.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.489 1.144 . . . . 20.0 108.565 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.53 37.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.346 -0.612 . . . . 20.0 109.346 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.57 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.698 -0.853 . . . . 20.0 108.698 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.7 149.45 31.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 115' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' J' ' 103' ' ' PHE . . . -147.95 157.76 27.46 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.336 -1.106 . . . . 20.0 110.336 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.42 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.371 -0.974 . . . . 20.0 108.371 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.324 -0.853 . . . . 20.0 114.552 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 118' ' ' ALA . . . . . 0.496 ' O ' HD13 ' J' ' 98' ' ' LEU . . . -67.18 -47.9 69.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.405 1.261 . . . . 20.0 114.405 -156.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.17 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.515 1.052 . . . . 20.0 112.646 -155.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.13 35.38 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 102.602 -3.11 . . . . 20.0 102.602 159.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.79 11.02 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 120.711 1.29 . . . . 20.0 110.596 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.78 149.8 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.279 0 CA-C-N 119.199 0.75 . . . . 20.0 110.663 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.08 165.38 7.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.831 0.824 . . . . 20.0 109.945 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.82 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.191 -1.04 . . . . 20.0 108.191 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.79 19.69 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.826 -0.35 . . . . 20.0 110.765 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.83 -43.77 1.52 Allowed Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 124.03 0.932 . . . . 20.0 113.06 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.98 -24.91 59.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 120.861 1.343 . . . . 20.0 112.012 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 128' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -83.53 -26.51 30.07 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.795 0.294 . . . . 20.0 111.795 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -32.02 69.16 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 119.847 -0.741 . . . . 20.0 110.247 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 130' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' L' ' 136' ' ' TRP . 10.8 tpt180 -74.71 -36.91 62.71 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.969 0.359 . . . . 20.0 111.969 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 131' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' L' ' 131' ' ' LYS . 35.1 mttt -78.47 90.97 4.48 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.235 -0.654 . . . . 20.0 109.235 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.21 14.34 7.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.088 0.403 . . . . 20.0 112.088 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.25 142.57 87.22 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 108.495 -0.928 . . . . 20.0 108.495 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.73 153.67 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.621 0.9 . . . . 20.0 112.334 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.61 42.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.561 -1.2 . . . . 20.0 107.898 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 136' ' ' TRP . . . . . 0.412 ' HB3' HH22 ' L' ' 130' ' ' ARG . 0.0 OUTLIER -77.62 -12.3 59.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.838 -0.601 . . . . 20.0 112.374 -175.246 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' J' ' 138' ' ' GLN . 14.1 p30 -55.35 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.918 -0.563 . . . . 20.0 111.378 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 138' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' J' ' 139' ' ' ILE . 3.9 tp-100 174.69 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 103.087 -2.931 . . . . 20.0 103.087 133.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 139' ' ' ILE . . . . . 0.426 ' H ' ' HG3' ' J' ' 138' ' ' GLN . 1.2 tp -74.84 168.14 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.097 0.959 . . . . 20.0 108.964 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.5 18.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.962 0.905 . . . . 20.0 110.507 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 141' ' ' ILE . . . . . 0.42 HD13 HD13 ' J' ' 162' ' ' ILE . 30.1 mt -124.69 147.47 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 142' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' J' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.75 55.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.631 0.773 . . . . 20.0 109.609 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.8 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.669 0.606 . . . . 20.0 111.816 166.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 144' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' J' ' 142' ' ' ASP . . . 86.89 -6.61 82.73 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.05 143.93 54.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.469 1.134 . . . . 20.0 110.323 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.24 -20.99 33.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 113.63 0.974 . . . . 20.0 113.63 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.66 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.987 0.898 . . . . 20.0 111.395 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.39 -41.53 80.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.847 -1.524 . . . . 20.0 111.207 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.4 -47.02 87.9 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.834 -0.346 . . . . 20.0 110.981 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.29 -35.18 76.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.509 -0.476 . . . . 20.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.56 83.94 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.066 -0.654 . . . . 20.0 111.086 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.36 58.49 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.445 -0.902 . . . . 20.0 110.984 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.05 66.49 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.747 -0.781 . . . . 20.0 110.661 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.63 92.26 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.662 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.07 -8.64 6.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.965 -0.908 . . . . 20.0 114.651 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.76 133.52 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 118.452 1.126 . . . . 20.0 108.545 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.94 9.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.72 -1.215 . . . . 20.0 107.72 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.31 15.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 108.853 -1.699 . . . . 20.0 108.853 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 160' ' ' THR . . . . . 0.526 HG23 ' HB2' ' J' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.58 17.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -20.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 113.72 1.008 . . . . 20.0 113.72 -166.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 162' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' J' ' 105' ' ' VAL . 0.5 OUTLIER -111.67 155.64 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.66 -0.65 . . . . 20.0 111.744 -159.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 163' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' J' ' 164' ' ' TRP . 3.5 t -145.36 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.286 1.034 . . . . 20.0 110.421 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 164' ' ' TRP . . . . . 0.552 ' N ' ' OG1' ' J' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.89 16.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.207 0.817 . . . . 20.0 113.207 -160.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 165' ' ' ASP . . . . . 0.425 ' O ' ' NE2' ' L' ' 101' ' ' GLN . 7.5 t70 63.68 61.73 0.97 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.214 0.531 . . . . 20.0 112.261 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.92 158.62 29.53 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.05 -1.22 . . . . 20.0 110.05 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 167' ' ' ARG . . . . . 0.509 ' HB3' HH12 ' L' ' 102' ' ' ARG . 0.0 OUTLIER -142.44 148.33 37.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 170.566 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.61 30.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.06 -0.973 . . . . 20.0 110.199 -167.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.858 0.837 . . . . 20.0 110.024 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.45 117.23 34.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.258 -1.337 . . . . 20.0 109.476 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.58 29.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.53 -0.545 . . . . 20.0 109.53 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' J' ' 175' ' ' ARG . . . 56.93 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.194 -1.562 . . . . 20.0 109.194 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.88 4.22 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.811 0.671 . . . . 20.0 112.811 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.97 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.681 -0.808 . . . . 20.0 111.215 157.378 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 175' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' J' ' 172' ' ' GLY . 6.8 ptt-85 -169.86 121.94 0.69 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.595 0.634 . . . . 20.0 112.621 172.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.845 2.458 . . . . 20.0 106.234 157.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 177' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.71 145.76 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.438 -0.949 . . . . 20.0 108.438 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.08 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 116.467 2.025 . . . . 20.0 116.467 -166.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.707 0.685 . . . . 20.0 112.117 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.05 -0.73 36.83 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.369 1.248 . . . . 20.0 114.369 -170.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 181' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' J' ' 327' ' ' GLU . 3.1 t80 -84.7 -66.93 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.6 0.636 . . . . 20.0 111.717 -162.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.27 127.84 32.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.058 0.932 . . . . 20.0 110.697 -152.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' J' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.48 . . . . 20.0 113.149 174.653 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 184' ' ' ARG . . . . . 0.529 ' NH1' HD13 ' J' ' 29' ' ' ILE . 0.0 OUTLIER -153.74 83.83 1.16 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.152 0.977 . . . . 20.0 110.801 157.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 185' ' ' ILE . . . . . 0.43 HG12 HG11 ' J' ' 317' ' ' VAL . 1.0 OUTLIER -126.03 -41.14 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.518 -2.401 . . . . 20.0 104.518 149.9 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' J' ' 189' ' ' THR . . . -50.08 -42.97 51.12 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.324 -0.853 . . . . 20.0 111.504 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.12 76.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 119.254 -0.979 . . . . 20.0 110.084 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.159 -1.017 . . . . 20.0 110.492 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' J' ' 186' ' ' ALA . 25.4 p -59.12 -48.63 80.91 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.843 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.26 -50.54 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.897 0.38 . . . . 20.0 110.494 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.1 -43.13 96.28 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.987 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.96 -36.54 84.32 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.995 -0.682 . . . . 20.0 110.256 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 193' ' ' VAL . . . . . 0.412 HG23 ' O ' ' J' ' 189' ' ' THR . 11.6 t -60.53 -44.83 97.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.05 0.453 . . . . 20.0 110.091 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.37 75.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.234 -0.586 . . . . 20.0 111.187 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.53 -38.21 71.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.859 -0.737 . . . . 20.0 110.812 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.67 -26.13 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.556 0.576 . . . . 20.0 112.556 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.56 122.82 27.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.303 -0.628 . . . . 20.0 109.303 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.275 0.359 . . . . 20.0 110.133 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.41 17.56 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.72 -0.474 . . . . 20.0 109.72 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.03 91.32 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.188 -0.671 . . . . 20.0 109.188 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.55 59.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.034 -0.666 . . . . 20.0 111.343 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.961 -0.755 . . . . 20.0 108.961 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 203' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' J' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.04 16.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 -174.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.99 151.6 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.91 106.56 8.98 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.038 -0.727 . . . . 20.0 109.038 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.89 125.37 31.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.757 -0.831 . . . . 20.0 108.757 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 207' ' ' VAL . . . . . 0.71 HG12 HD13 ' J' ' 53' ' ' ILE . 34.0 m -119.9 150.21 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.873 -0.788 . . . . 20.0 108.873 174.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.414 -1.328 . . . . 20.0 107.414 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.86 160.0 19.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.912 0.863 . . . . 20.0 111.1 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.87 166.43 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 114.635 -1.166 . . . . 20.0 108.213 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.18 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.472 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.53 13.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.333 -0.547 . . . . 20.0 110.999 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -20.41 64.81 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.542 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 214' ' ' VAL . . . . . . . . . . . . . 88.4 t -131.14 121.13 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.58 -0.896 . . . . 20.0 108.58 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.97 6.22 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.686 -1.245 . . . . 20.0 111.453 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 216' ' ' LEU . . . . . 0.431 ' H ' HD23 ' J' ' 216' ' ' LEU . 0.5 OUTLIER -47.02 -25.57 0.84 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.461 0.911 . . . . 20.0 113.461 -179.123 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 217' ' ' ARG . . . . . 0.459 ' HB3' ' HG ' ' A' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.46 2.83 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.382 0.512 . . . . 20.0 112.382 173.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.53 40.92 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 119.736 -1.221 . . . . 20.0 112.024 168.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 219' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' J' ' 222' ' ' SER . . . -65.24 -37.1 86.18 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.25 -0.559 . . . . 20.0 111.341 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 220' ' ' ARG . . . . . 0.42 ' HB2' ' HB1' ' J' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.72 58.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.157 0.429 . . . . 20.0 112.157 -174.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.47 -45.79 87.93 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.056 -0.658 . . . . 20.0 110.862 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 222' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' J' ' 219' ' ' ALA . 2.1 p -58.08 -35.74 71.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.724 -0.39 . . . . 20.0 111.44 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.98 69.33 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.558 0.577 . . . . 20.0 112.558 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 224' ' ' PHE . . . . . 0.474 ' HB2' ' HD2' ' A' ' 307' ' ' LYS . 79.0 t80 -64.11 -33.45 75.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.802 -0.759 . . . . 20.0 111.833 -165.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.72 74.94 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 118.95 -1.595 . . . . 20.0 112.124 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.57 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 111.999 0.37 . . . . 20.0 111.999 -158.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 227' ' ' GLU . . . . . 0.481 ' OE1' ' OG1' ' J' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 118.214 2.672 . . . . 20.0 118.214 -158.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.989 1.496 . . . . 20.0 115.989 -134.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.277 1.431 . . . . 20.0 113.376 162.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.85 171.27 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.079 -0.649 . . . . 20.0 111.793 167.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.44 16.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.95 -0.643 . . . . 20.0 112.311 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.72 170.76 15.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.768 -0.827 . . . . 20.0 108.768 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.05 23.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.124 -0.489 . . . . 20.0 110.393 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 234' ' ' ILE . . . . . 0.482 HD11 ' CE ' ' J' ' 341' ' ' MET . 51.7 mt -133.22 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.492 -1.299 . . . . 20.0 107.492 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' J' ' 68' ' ' HIS . 25.5 t0 -135.21 173.23 11.95 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.93 -1.507 . . . . 20.0 106.93 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.42 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.672 0.749 . . . . 20.0 111.394 -172.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 237' ' ' THR . . . . . 0.453 HG21 ' HA3' ' J' ' 296' ' ' GLY . 9.2 t -165.66 122.69 1.44 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.315 -1.365 . . . . 20.0 107.315 164.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 238' ' ' ILE . . . . . 0.42 HD13 ' O ' ' J' ' 237' ' ' THR . 17.9 mm -145.48 151.91 14.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.2 9.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.831 -1.544 . . . . 20.0 106.831 159.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 109.98 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.057 0.762 . . . . 20.0 113.057 -155.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.37 36.19 22.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.0 1.32 . . . . 20.0 112.459 158.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.96 128.4 79.01 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.152 -2.166 . . . . 20.0 105.152 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.96 165.54 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 CA-C-N 120.834 1.334 . . . . 20.0 112.373 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.32 45.0 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.046 -0.979 . . . . 20.0 114.939 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.609 1.205 . . . . 20.0 110.663 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.66 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.592 0 CA-C-O 121.841 0.684 . . . . 20.0 111.957 171.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.037 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.7 63.12 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 119.862 -0.735 . . . . 20.0 112.868 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 249' ' ' LYS . . . . . 0.712 ' O ' ' OG1' ' J' ' 252' ' ' THR . 16.9 mttt -98.7 -15.26 19.44 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.247 0.832 . . . . 20.0 113.247 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -37.86 88.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.277 -0.569 . . . . 20.0 111.382 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.59 -21.03 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.122 -1.031 . . . . 20.0 111.859 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 252' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' J' ' 249' ' ' LYS . 39.4 p -57.12 -31.87 65.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.485 0.584 . . . . 20.0 111.307 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 253' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' J' ' 319' ' ' ALA . 16.6 t-80 -162.33 132.09 4.54 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.317 0.58 . . . . 20.0 110.374 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.3 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.038 -0.983 . . . . 20.0 112.308 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 35.94 5.84 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 126.133 1.825 . . . . 20.0 111.583 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.28 10.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.618 -0.882 . . . . 20.0 108.618 -167.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.22 3.32 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-O 122.706 1.17 . . . . 20.0 113.316 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.1 6.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.543 -0.91 . . . . 20.0 108.543 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.37 120.32 29.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.175 -0.92 . . . . 20.0 109.45 -169.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.97 140.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.819 -1.178 . . . . 20.0 107.819 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 261' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' J' ' 298' ' ' THR . 1.9 mtmm -98.88 122.58 42.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.978 -0.749 . . . . 20.0 108.978 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.27 10.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 20.0 109.6 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.64 147.58 34.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.434 0.635 . . . . 20.0 109.324 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.764 -1.107 . . . . 20.0 108.197 165.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.22 22.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.766 -0.652 . . . . 20.0 110.257 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.21 11.51 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.619 0.97 . . . . 20.0 113.619 -165.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.8 143.68 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.391 -0.596 . . . . 20.0 109.391 -163.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.131 -1.803 . . . . 20.0 106.131 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.41 137.06 56.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 20.0 111.314 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.97 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 115.165 -0.925 . . . . 20.0 108.695 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.53 -19.96 48.02 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 N-CA-C 114.819 1.046 . . . . 20.0 114.819 -160.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -42.97 74.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.117 -0.633 . . . . 20.0 110.585 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.57 -48.36 77.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.103 0.478 . . . . 20.0 110.083 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.17 -52.44 60.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.833 0.349 . . . . 20.0 110.7 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.45 -31.85 70.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.823 -0.751 . . . . 20.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 276' ' ' TRP . . . . . 0.481 ' HH2' ' HB3' ' J' ' 347' ' ' ASN . 0.1 OUTLIER -68.53 -47.94 65.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.097 -0.641 . . . . 20.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.76 89.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.991 -0.683 . . . . 20.0 110.746 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.56 -47.99 78.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.113 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.81 -40.44 88.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.873 -0.331 . . . . 20.0 110.712 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.063 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.018 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.81 65.85 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.147 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.67 73.28 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.849 -0.741 . . . . 20.0 111.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.58 15.4 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.325 0.861 . . . . 20.0 113.325 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.2 13.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.732 0.777 . . . . 20.0 111.564 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.31 143.36 34.32 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.341 -0.985 . . . . 20.0 108.341 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.15 149.39 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.161 0.736 . . . . 20.0 111.37 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.19 23.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.599 0.714 . . . . 20.0 109.657 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.05 175.1 5.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.74 17.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.856 -1.165 . . . . 20.0 107.856 168.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.463 -0.569 . . . . 20.0 109.463 -172.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.01 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.7 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.473 0.654 . . . . 20.0 110.31 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.49 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.816 -1.084 . . . . 20.0 112.166 165.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.01 20.08 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.982 -0.847 . . . . 20.0 110.982 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 296' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' J' ' 237' ' ' THR . . . 101.47 144.82 15.63 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.653 -0.773 . . . . 20.0 112.664 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.33 -1.108 . . . . 20.0 110.33 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 298' ' ' THR . . . . . 0.766 HG21 ' HE3' ' J' ' 261' ' ' LYS . 20.3 p -110.31 172.87 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.011 0.91 . . . . 20.0 111.357 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.75 76.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.397 -1.274 . . . . 20.0 111.229 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.37 74.08 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.784 0.29 . . . . 20.0 111.784 -171.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.2 96.9 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.234 -0.984 . . . . 20.0 111.994 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 302' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' J' ' 220' ' ' ARG . . . -68.3 -26.88 65.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.44 55.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 119.997 -0.681 . . . . 20.0 110.179 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.17 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.283 0.846 . . . . 20.0 113.283 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.71 -8.91 19.52 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.761 1.023 . . . . 20.0 113.761 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 306' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' J' ' 227' ' ' GLU . 0.5 OUTLIER -58.34 157.6 8.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.609 0.719 . . . . 20.0 110.537 171.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.88 70.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.215 -0.902 . . . . 20.0 113.357 -161.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.84 -25.24 66.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.693 -0.803 . . . . 20.0 111.238 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.19 1.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.857 -0.687 . . . . 20.0 113.311 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 310' ' ' VAL . . . . . . . . . . . . . 20.4 t -80.35 139.64 52.09 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.593 0.697 . . . . 20.0 111.092 -163.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.49 141.75 9.03 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 CA-C-N 119.479 0.85 . . . . 20.0 110.011 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.55 135.82 32.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.302 -0.863 . . . . 20.0 111.192 -169.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.57 12.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.189 -1.564 . . . . 20.0 109.189 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.02 27.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.455 0.645 . . . . 20.0 110.112 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.05 153.22 21.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.648 -1.16 . . . . 20.0 109.203 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.42 133.53 32.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.455 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 317' ' ' VAL . . . . . 0.43 HG11 HG12 ' J' ' 185' ' ' ILE . 92.4 t -99.43 108.57 51.13 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.262 -1.384 . . . . 20.0 107.262 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.3 -169.03 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-O 122.652 1.022 . . . . 20.0 113.624 -154.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 319' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' J' ' 253' ' ' HIS . . . 79.86 35.45 0.15 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.565 -1.652 . . . . 20.0 115.271 161.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 320' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' J' ' 321' ' ' TYR . 0.4 OUTLIER -75.65 157.57 33.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.709 0.766 . . . . 20.0 110.12 176.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 321' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' J' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.17 11.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.779 -1.563 . . . . 20.0 106.779 160.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.2 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.113 0.965 . . . . 20.0 108.446 -163.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.39 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.488 1.292 . . . . 20.0 114.488 -140.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 324' ' ' SER . . . . . 0.581 ' OG ' HG21 ' J' ' 97' ' ' THR . 0.1 OUTLIER -59.48 -60.06 4.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.618 0.599 . . . . 20.0 112.618 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 325' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' L' ' 100' ' ' ALA . 35.2 p-10 -101.94 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.01 1.485 . . . . 20.0 115.01 -152.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.97 50.8 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.451 -1.314 . . . . 20.0 107.451 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 327' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' J' ' 181' ' ' PHE . 82.7 mt-10 -142.6 52.88 1.41 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.826 -1.534 . . . . 20.0 109.905 -153.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.08 149.41 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.395 0.617 . . . . 20.0 111.951 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 329' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' J' ' 181' ' ' PHE . 0.3 OUTLIER -139.41 179.42 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.929 0.871 . . . . 20.0 109.419 175.692 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.17 27.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.597 -1.183 . . . . 20.0 108.853 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.13 -32.07 54.11 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.839 0.712 . . . . 20.0 111.442 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.76 73.48 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.319 -0.552 . . . . 20.0 110.198 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -65.98 -44.97 83.31 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.784 -0.366 . . . . 20.0 111.066 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.31 92.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 120.452 -0.499 . . . . 20.0 110.491 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.69 71.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 118.859 -1.137 . . . . 20.0 110.155 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.46 93.35 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.085 -0.646 . . . . 20.0 110.425 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.51 -43.84 80.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.751 0.31 . . . . 20.0 110.903 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 338' ' ' VAL . . . . . 0.691 ' O ' ' OG1' ' J' ' 342' ' ' THR . 42.7 t -60.17 -48.98 85.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 120.99 0.424 . . . . 20.0 110.279 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' J' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.91 74.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.934 0.397 . . . . 20.0 110.765 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -55.13 38.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.367 -0.379 . . . . 20.0 111.436 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 341' ' ' MET . . . . . 0.482 ' CE ' HD11 ' J' ' 234' ' ' ILE . 31.9 tpp -60.21 -40.3 89.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.811 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 342' ' ' THR . . . . . 0.691 ' OG1' ' O ' ' J' ' 338' ' ' VAL . 1.3 m -56.49 -44.99 81.21 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.122 0.487 . . . . 20.0 110.438 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' J' ' 339' ' ' GLU . 34.6 mttp -74.2 -37.49 63.89 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.968 -0.693 . . . . 20.0 110.795 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.5 97.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.595 -0.442 . . . . 20.0 111.095 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 345' ' ' LEU . . . . . 0.415 ' O ' HG22 ' J' ' 348' ' ' ILE . 1.0 OUTLIER -59.03 -50.42 74.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.56 -0.456 . . . . 20.0 110.775 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.09 91.13 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.704 -0.798 . . . . 20.0 110.605 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 347' ' ' ASN . . . . . 0.481 ' HB3' ' HH2' ' J' ' 276' ' ' TRP . 5.0 m-20 -84.49 4.79 30.21 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.457 -0.897 . . . . 20.0 112.485 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 348' ' ' ILE . . . . . 0.415 HG22 ' O ' ' J' ' 345' ' ' LEU . 1.3 tt -65.23 -23.65 33.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 119.111 0.869 . . . . 20.0 110.902 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' J' J ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.3 69.09 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.263 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.9 -18.81 31.71 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.082 -0.387 . . . . 20.0 111.49 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 351' ' ' LEU . . . . . 0.433 ' O ' HD12 ' J' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.78 66.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' J' J ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.044 1.868 . . . . 20.0 116.044 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' J' J ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.999 1.319 . . . . 20.0 108.385 -174.671 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 114.282 1.216 . . . . 20.0 114.282 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.08 82.23 2.92 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.916 -1.512 . . . . 20.0 106.916 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -62.87 -34.56 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.862 -1.063 . . . . 20.0 110.222 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -106.97 -23.59 12.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.564 0.95 . . . . 20.0 113.564 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.49 30.28 19.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.093 0.957 . . . . 20.0 111.615 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.75 32.37 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.725 0.238 . . . . 20.0 111.237 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.07 117.44 37.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.673 -1.232 . . . . 20.0 107.673 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.97 112.16 12.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.365 0.602 . . . . 20.0 110.899 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.489 -0.778 . . . . 20.0 111.902 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 10' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.13 -45.26 74.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.557 -0.457 . . . . 20.0 111.217 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -43.11 97.34 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 121.007 -0.277 . . . . 20.0 111.165 -172.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.802 -0.359 . . . . 20.0 111.2 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.569 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.02 -42.94 91.39 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.659 -0.246 . . . . 20.0 111.531 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.9 -40.08 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 119.516 -0.874 . . . . 20.0 110.7 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 119.0 -1.08 . . . . 20.0 111.009 -162.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 67.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.907 -0.717 . . . . 20.0 111.306 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.38 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 120.533 -0.467 . . . . 20.0 109.798 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.13 144.68 9.53 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 120.32 0.68 . . . . 20.0 112.155 -172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.19 3.43 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.312 1.685 . . . . 20.0 117.312 -159.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.72 119.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 159.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.391 0.615 . . . . 20.0 110.683 -166.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.28 2.88 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.488 -0.778 . . . . 20.0 114.043 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.28 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 20.0 109.561 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.95 -13.18 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.865 -1.061 . . . . 20.0 113.455 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 26' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' K' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.04 23.6 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.713 1.142 . . . . 20.0 113.717 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 11.36 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.422 1.638 . . . . 20.0 115.422 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' K' ' 26' ' ' PHE . . . -53.2 -26.82 29.82 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.793 1.179 . . . . 20.0 116.021 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 29' ' ' ILE . . . . . 0.53 HD13 ' NH1' ' K' ' 184' ' ' ARG . 1.1 tt -59.61 -35.86 61.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 118.088 0.944 . . . . 20.0 110.63 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.21 -52.43 61.29 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.935 0.398 . . . . 20.0 110.466 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.62 74.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.284 -0.416 . . . . 20.0 110.944 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.59 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.088 0.47 . . . . 20.0 110.358 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.71 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.286 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.68 -29.53 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 118.776 -1.17 . . . . 20.0 111.144 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.46 -31.01 71.67 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.995 0.361 . . . . 20.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.89 -56.77 3.24 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.189 0.441 . . . . 20.0 112.189 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.44 44.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.487 -0.324 . . . . 20.0 111.526 -164.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.4 63.72 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.858 -0.737 . . . . 20.0 112.255 -162.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.06 -23.49 63.1 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 118.861 -1.135 . . . . 20.0 111.75 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.89 -6.99 22.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.49 152.64 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.61 88.88 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.201 -0.908 . . . . 20.0 111.48 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.31 35.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.539 -0.911 . . . . 20.0 108.539 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.18 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.248 -1.019 . . . . 20.0 108.248 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.27 44.11 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.46 0.648 . . . . 20.0 110.46 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.12 128.97 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.371 -1.344 . . . . 20.0 107.371 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.874 0.845 . . . . 20.0 108.858 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.63 -34.56 62.8 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.098 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.14 10.87 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.671 0.989 . . . . 20.0 113.671 -171.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.63 83.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.112 -0.827 . . . . 20.0 114.481 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.475 1.137 . . . . 20.0 110.237 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.4 140.23 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 53' ' ' ILE . . . . . 0.721 HD13 HG12 ' K' ' 207' ' ' VAL . 31.3 mm -130.17 115.68 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.312 -1.366 . . . . 20.0 107.312 -174.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.76 36.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.656 -0.498 . . . . 20.0 109.656 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.92 100.0 8.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.774 -1.565 . . . . 20.0 106.774 163.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.5 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.661 -0.496 . . . . 20.0 109.661 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.07 23.72 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.58 10.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.846 0.858 . . . . 20.0 108.996 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.55 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.763 -0.732 . . . . 20.0 114.064 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.8 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.769 0.654 . . . . 20.0 112.066 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.93 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.286 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.73 137.96 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.766 -0.827 . . . . 20.0 108.766 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.76 124.04 46.3 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.066 0.946 . . . . 20.0 109.028 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 65' ' ' ILE . . . . . . . . . . . . . 29.1 mm -116.22 114.29 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.107 -1.072 . . . . 20.0 108.107 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.6 51.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.65 45.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.873 0.869 . . . . 20.0 108.908 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' K' ' 235' ' ' ASP . 0.0 OUTLIER -105.05 146.44 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.947 -0.569 . . . . 20.0 110.575 177.394 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 21.42 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.247 -0.888 . . . . 20.0 109.73 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 70' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' K' ' 183' ' ' ASP . 12.0 t0 -97.39 67.97 2.14 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.618 -0.676 . . . . 20.0 112.442 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.3 144.87 28.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.245 -1.02 . . . . 20.0 108.245 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.684 0.793 . . . . 20.0 109.13 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 73' ' ' GLY . . . . . 0.461 ' C ' HD23 ' K' ' 74' ' ' LEU . . . -155.87 -175.7 27.18 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.544 -1.022 . . . . 20.0 110.544 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 74' ' ' LEU . . . . . 0.461 HD23 ' C ' ' K' ' 73' ' ' GLY . 5.0 mt -125.03 161.48 26.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.296 0.57 . . . . 20.0 109.957 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' K' ' 160' ' ' THR . 10.6 ttm -128.16 131.33 48.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.22 1.008 . . . . 20.0 109.67 -174.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.48 137.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 168.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.13 -29.33 7.01 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.061 0.763 . . . . 20.0 113.061 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.46 13.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.155 -1.054 . . . . 20.0 108.155 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.347 -0.982 . . . . 20.0 108.347 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.78 166.32 5.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.818 0.818 . . . . 20.0 109.948 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.01 60.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.714 -0.794 . . . . 20.0 112.724 -169.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.57 9.21 4.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.349 0.87 . . . . 20.0 113.349 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.71 81.86 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.125 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.76 145.05 34.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.328 1.064 . . . . 20.0 110.23 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.5 28.05 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.586 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.37 174.59 6.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.902 -1.148 . . . . 20.0 107.902 158.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.67 163.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.664 0.745 . . . . 20.0 109.479 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.36 15.6 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.785 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.82 160.16 24.52 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.29 0.871 . . . . 20.0 112.727 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 90' ' ' ILE . . . . . 0.493 HD11 HG21 ' K' ' 160' ' ' THR . 9.3 mt -88.73 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 113.756 -1.565 . . . . 20.0 107.418 165.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.92 140.93 47.41 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.16 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 118.993 -0.893 . . . . 20.0 115.215 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.93 152.7 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.631 1.215 . . . . 20.0 109.241 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.94 22.24 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.07 -7.96 13.09 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 CA-C-N 120.568 1.239 . . . . 20.0 114.805 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.26 59.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.177 0.898 . . . . 20.0 111.783 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 97' ' ' THR . . . . . 0.583 HG21 ' OG ' ' K' ' 324' ' ' SER . 44.8 p -89.39 35.46 0.81 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.661 0.784 . . . . 20.0 112.429 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 98' ' ' LEU . . . . . 0.677 HD12 ' H ' ' K' ' 99' ' ' ILE . 0.5 OUTLIER -43.2 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.954 1.302 . . . . 20.0 113.397 -173.015 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 99' ' ' ILE . . . . . 0.677 ' H ' HD12 ' K' ' 98' ' ' LEU . 1.6 tt -173.2 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 100' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' I' ' 100' ' ' ALA . . . -123.97 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.644 -1.162 . . . . 20.0 111.215 158.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 101' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' I' ' 165' ' ' ASP . 0.0 OUTLIER -169.42 141.61 2.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 102' ' ' ARG . . . . . 0.582 HH12 ' HB3' ' I' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.61 0.37 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.211 1.559 . . . . 20.0 115.211 150.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' K' ' 115' ' ' GLY . 0.5 OUTLIER -79.41 134.26 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.298 0.954 . . . . 20.0 109.371 160.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.29 37.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.481 -0.781 . . . . 20.0 109.436 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 105' ' ' VAL . . . . . 0.581 HG22 ' CG1' ' K' ' 162' ' ' ILE . 50.6 t -117.4 110.75 32.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.242 -1.022 . . . . 20.0 108.242 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.12 6.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.246 -0.279 . . . . 20.0 110.246 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -52.01 -54.2 14.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 O-C-N 123.372 0.42 . . . . 20.0 110.32 170.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.58 177.51 10.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.428 -0.953 . . . . 20.0 108.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.12 126.38 27.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.481 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.24 75.05 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.898 -0.945 . . . . 20.0 115.347 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.04 114.07 15.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.438 1.119 . . . . 20.0 108.555 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.33 141.49 37.68 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.341 -0.615 . . . . 20.0 109.341 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.5 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 108.704 -0.851 . . . . 20.0 108.704 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.67 149.44 31.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' K' ' 103' ' ' PHE . . . -147.92 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.277 -1.129 . . . . 20.0 110.277 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.77 154.38 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.372 -0.974 . . . . 20.0 108.372 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.26 1.75 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.395 -0.82 . . . . 20.0 114.584 -168.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' K' ' 98' ' ' LEU . . . -67.24 -47.99 69.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.291 1.219 . . . . 20.0 114.291 -156.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 121.17 11.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.564 1.075 . . . . 20.0 112.684 -155.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.19 35.48 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 102.607 -3.108 . . . . 20.0 102.607 159.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.21 123.83 11.03 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 CA-C-N 120.766 1.309 . . . . 20.0 110.57 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.81 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 CA-C-N 119.193 0.747 . . . . 20.0 110.691 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.38 7.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.822 0.82 . . . . 20.0 109.94 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.9 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.184 -1.043 . . . . 20.0 108.184 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.93 160.83 19.61 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.784 -0.367 . . . . 20.0 110.757 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.92 -43.66 1.5 Allowed Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.961 0.905 . . . . 20.0 113.081 -170.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.96 59.51 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.839 1.335 . . . . 20.0 111.995 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.46 -26.55 30.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 111.817 0.303 . . . . 20.0 111.817 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.9 69.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.733 -0.787 . . . . 20.0 110.226 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.914 0.339 . . . . 20.0 111.914 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.5 91.01 4.5 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.24 14.34 7.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.065 0.394 . . . . 20.0 112.065 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.13 142.52 87.48 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 108.563 -0.903 . . . . 20.0 108.563 172.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.72 153.59 75.5 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 CA-C-N 119.664 0.916 . . . . 20.0 112.381 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.6 153.65 42.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.554 -1.203 . . . . 20.0 107.935 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 118.77 -0.633 . . . . 20.0 112.347 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' K' ' 138' ' ' GLN . 14.0 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.913 -0.565 . . . . 20.0 111.349 -175.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 138' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' K' ' 137' ' ' ASP . 3.9 tp-100 174.64 174.13 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.138 -2.912 . . . . 20.0 103.138 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 139' ' ' ILE . . . . . 0.412 ' H ' ' HG3' ' K' ' 138' ' ' GLN . 1.2 tp -74.86 168.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.181 0.992 . . . . 20.0 108.937 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' K' ' 139' ' ' ILE . 0.3 OUTLIER -114.81 161.45 18.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.007 0.923 . . . . 20.0 110.508 177.345 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 141' ' ' ILE . . . . . 0.4 HD13 HD13 ' K' ' 162' ' ' ILE . 30.4 mt -124.64 147.5 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' K' ' 144' ' ' GLY . 0.5 OUTLIER -119.12 134.76 55.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 20.0 109.582 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.82 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 115.888 -0.596 . . . . 20.0 111.814 166.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' K' ' 142' ' ' ASP . . . 86.89 -6.57 82.81 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 115.447 0.939 . . . . 20.0 115.447 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 144.01 54.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.498 1.149 . . . . 20.0 110.322 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.32 -20.92 33.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.593 0.961 . . . . 20.0 113.593 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.36 162.61 40.2 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.996 0.903 . . . . 20.0 111.44 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.49 80.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.896 -1.502 . . . . 20.0 111.256 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -46.96 88.15 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.96 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.41 -35.2 76.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.485 -0.486 . . . . 20.0 110.787 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.6 84.29 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.112 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.33 58.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.357 -0.937 . . . . 20.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.0 66.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.751 -0.779 . . . . 20.0 110.68 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.62 92.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.65 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.15 -8.73 6.69 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-O 118.914 -0.937 . . . . 20.0 114.559 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 156' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 133.54 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 118.496 1.148 . . . . 20.0 108.565 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.35 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.706 -1.22 . . . . 20.0 107.706 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.3 15.7 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.783 -1.727 . . . . 20.0 108.783 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' K' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.55 17.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.696 -1.224 . . . . 20.0 107.696 165.575 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.63 -19.98 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.784 1.031 . . . . 20.0 113.784 -166.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 162' ' ' ILE . . . . . 0.581 ' CG1' HG22 ' K' ' 105' ' ' VAL . 0.5 OUTLIER -111.72 155.67 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.696 -0.627 . . . . 20.0 111.75 -159.217 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 163' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' K' ' 164' ' ' TRP . 3.5 t -145.35 -166.31 2.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.233 1.013 . . . . 20.0 110.446 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 164' ' ' TRP . . . . . 0.559 ' N ' ' OG1' ' K' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.87 16.73 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 -160.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.67 61.69 0.98 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.215 0.531 . . . . 20.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.6 29.56 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.121 -1.192 . . . . 20.0 110.121 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.31 37.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.726 -1.213 . . . . 20.0 107.726 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.65 30.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.147 -0.933 . . . . 20.0 110.176 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.49 159.77 35.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 20.0 109.949 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.4 117.23 34.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.225 -1.352 . . . . 20.0 109.482 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.58 29.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.479 -0.563 . . . . 20.0 109.479 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 172' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' K' ' 175' ' ' ARG . . . 56.88 68.75 1.54 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.96 4.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.761 0.652 . . . . 20.0 112.761 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -62.95 1.32 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.684 -0.806 . . . . 20.0 111.215 157.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 175' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' K' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.92 0.7 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.623 0.647 . . . . 20.0 112.669 172.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.835 2.454 . . . . 20.0 106.265 157.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.68 145.78 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.436 -0.949 . . . . 20.0 108.436 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.15 -64.41 1.17 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 116.47 2.026 . . . . 20.0 116.47 -166.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 118.741 0.7 . . . . 20.0 112.113 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.65 36.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 181' ' ' PHE . . . . . 0.763 ' HB3' ' HB3' ' K' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.595 0.634 . . . . 20.0 111.754 -162.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.3 127.8 32.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.111 0.958 . . . . 20.0 110.692 -152.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 183' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' K' ' 70' ' ' ASP . 0.6 OUTLIER 69.98 -6.67 1.05 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.375 1.47 . . . . 20.0 113.148 174.688 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 184' ' ' ARG . . . . . 0.53 ' NH1' HD13 ' K' ' 29' ' ' ILE . 0.0 OUTLIER -153.84 83.89 1.16 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.187 0.994 . . . . 20.0 110.779 157.15 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 185' ' ' ILE . . . . . 0.437 HG12 HG11 ' K' ' 317' ' ' VAL . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 104.499 -2.408 . . . . 20.0 104.499 149.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 186' ' ' ALA . . . . . 0.712 ' O ' ' OG1' ' K' ' 189' ' ' THR . . . -50.13 -42.93 51.54 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.338 -0.846 . . . . 20.0 111.532 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.1 76.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.094 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 188' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.75 -38.71 92.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.181 -1.007 . . . . 20.0 110.489 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 189' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 186' ' ' ALA . 25.3 p -59.1 -48.56 81.14 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.446 -0.902 . . . . 20.0 110.86 172.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.56 64.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.961 0.41 . . . . 20.0 110.476 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.072 -0.651 . . . . 20.0 111.007 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.87 -36.59 84.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.988 -0.685 . . . . 20.0 110.314 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 193' ' ' VAL . . . . . 0.414 HG23 ' O ' ' K' ' 189' ' ' THR . 11.6 t -60.55 -44.85 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 120.992 0.425 . . . . 20.0 110.078 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.26 75.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.67 -38.1 70.7 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.866 -0.733 . . . . 20.0 110.778 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.18 40.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.529 0.566 . . . . 20.0 112.529 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.53 122.79 27.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.342 -0.614 . . . . 20.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.11 2.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.239 0.337 . . . . 20.0 110.131 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.15 105.4 17.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.721 -0.474 . . . . 20.0 109.721 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.31 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.237 -0.653 . . . . 20.0 109.237 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 201' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -76.73 -14.61 59.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.041 -0.663 . . . . 20.0 111.38 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.72 30.5 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.876 -0.787 . . . . 20.0 108.876 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 203' ' ' ASP . . . . . 0.653 ' N ' ' OD1' ' K' ' 203' ' ' ASP . 0.0 OUTLIER -78.62 112.99 16.27 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.95 151.55 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 108.577 -0.898 . . . . 20.0 108.577 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.87 106.61 9.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.013 -0.736 . . . . 20.0 109.013 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.94 125.35 31.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.764 -0.828 . . . . 20.0 108.764 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 207' ' ' VAL . . . . . 0.721 HG12 HD13 ' K' ' 53' ' ' ILE . 34.0 m -119.9 150.17 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.811 -0.811 . . . . 20.0 108.811 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.84 159.98 19.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.942 0.877 . . . . 20.0 111.08 -165.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.81 166.46 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 114.609 -1.178 . . . . 20.0 108.236 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.2 29.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.813 -1.085 . . . . 20.0 111.504 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.81 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.351 -0.54 . . . . 20.0 110.926 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.41 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.236 -0.586 . . . . 20.0 111.48 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 214' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.1 121.17 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.536 -0.912 . . . . 20.0 108.536 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.01 60.95 6.24 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.696 -1.24 . . . . 20.0 111.421 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 216' ' ' LEU . . . . . 0.428 HD23 ' H ' ' K' ' 216' ' ' LEU . 0.5 OUTLIER -46.99 -25.6 0.83 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.469 0.914 . . . . 20.0 113.469 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 217' ' ' ARG . . . . . 0.465 ' HB3' ' HG ' ' C' ' 305' ' ' LEU . 1.3 mpt_? -63.47 -4.5 2.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.333 0.494 . . . . 20.0 112.333 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 119.695 -1.241 . . . . 20.0 112.003 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 219' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' K' ' 222' ' ' SER . . . -65.28 -37.04 85.94 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.279 -0.542 . . . . 20.0 111.391 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 220' ' ' ARG . . . . . 0.415 ' HB2' ' HB1' ' K' ' 302' ' ' ALA . 16.6 ttm180 -52.74 -36.72 58.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.171 0.434 . . . . 20.0 112.171 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 221' ' ' THR . . . . . . . . . . . . . 75.3 p -58.38 -45.84 87.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.856 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 222' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' K' ' 219' ' ' ALA . 2.1 p -58.07 -35.77 71.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.433 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.08 68.85 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.559 0.577 . . . . 20.0 112.559 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 224' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' C' ' 307' ' ' LYS . 79.1 t80 -64.16 -33.43 75.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.79 -0.764 . . . . 20.0 111.799 -165.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.73 74.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.122 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -127.0 -45.6 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 112.044 0.387 . . . . 20.0 112.044 -158.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 227' ' ' GLU . . . . . 0.418 ' OE1' ' OG1' ' K' ' 306' ' ' THR . 3.0 pt-20 -56.46 -46.61 99.79 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 118.229 2.678 . . . . 20.0 118.229 -158.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.87 143.7 2.87 Favored 'Trans proline' 0 N--CA 1.472 0.21 0 N-CA-C 116.016 1.506 . . . . 20.0 116.016 -134.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.16 -4.74 0.78 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.252 1.421 . . . . 20.0 113.353 162.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.083 -0.647 . . . . 20.0 111.77 167.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.47 16.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.69 15.62 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.827 0.851 . . . . 20.0 108.806 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.1 23.4 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.177 0.513 . . . . 20.0 110.391 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 234' ' ' ILE . . . . . 0.488 HD11 ' CE ' ' K' ' 341' ' ' MET . 51.6 mt -133.21 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.512 -1.292 . . . . 20.0 107.512 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' K' ' 68' ' ' HIS . 25.4 t0 -135.18 173.2 11.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.996 -1.483 . . . . 20.0 106.996 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.41 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.64 0.733 . . . . 20.0 111.407 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 237' ' ' THR . . . . . 0.446 HG21 ' HA3' ' K' ' 296' ' ' GLY . 9.2 t -165.61 122.7 1.46 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.379 -1.341 . . . . 20.0 107.379 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 238' ' ' ILE . . . . . 0.403 HD13 ' O ' ' K' ' 237' ' ' THR . 17.9 mm -145.5 151.86 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.267 -1.012 . . . . 20.0 108.267 -161.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.18 9.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.889 -1.522 . . . . 20.0 106.889 158.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.42 109.95 18.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.067 0.766 . . . . 20.0 113.067 -155.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.14 22.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.947 1.299 . . . . 20.0 112.461 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 105.13 -2.174 . . . . 20.0 105.13 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 243' ' ' PRO . . . . . 0.503 ' HG3' ' HD1' ' I' ' 84' ' ' PHE . 16.6 Cg_exo -60.98 165.54 12.03 Favored 'Trans proline' 0 CA--C 1.517 -0.37 0 CA-C-N 120.837 1.335 . . . . 20.0 112.408 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.42 -5.28 45.29 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.093 -0.958 . . . . 20.0 114.914 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.54 22.83 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 118.593 1.197 . . . . 20.0 110.665 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.589 0 CA-C-O 121.835 0.681 . . . . 20.0 111.969 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.85 59.57 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.726 -1.125 . . . . 20.0 112.06 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.82 -0.752 . . . . 20.0 112.912 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 249' ' ' LYS . . . . . 0.712 ' O ' ' OG1' ' K' ' 252' ' ' THR . 16.9 mttt -98.76 -15.17 19.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.234 0.827 . . . . 20.0 113.234 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.256 -0.578 . . . . 20.0 111.324 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.106 -1.038 . . . . 20.0 111.872 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 252' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 249' ' ' LYS . 39.5 p -57.12 -31.84 65.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.538 0.608 . . . . 20.0 111.366 173.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 253' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' K' ' 319' ' ' ALA . 16.7 t-80 -162.37 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.349 0.595 . . . . 20.0 110.395 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.31 3.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.287 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 36.0 5.82 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.223 1.868 . . . . 20.0 111.563 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.44 129.19 10.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.14 174.25 3.43 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-O 122.71 1.172 . . . . 20.0 113.309 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 259' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' K' ' 316' ' ' SER . . . -126.42 120.3 29.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.15 -0.932 . . . . 20.0 109.425 -169.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.96 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.8 -1.185 . . . . 20.0 107.8 175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 261' ' ' LYS . . . . . 0.773 ' HE3' HG21 ' K' ' 298' ' ' THR . 1.9 mtmm -98.85 122.62 42.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.81 -40.25 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.893 -0.594 . . . . 20.0 109.593 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.63 34.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.316 -0.624 . . . . 20.0 109.316 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.93 2.86 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.738 -1.119 . . . . 20.0 108.26 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.24 21.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.625 . . . . 20.0 110.262 163.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -46.22 11.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 113.669 0.989 . . . . 20.0 113.669 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.69 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.0 14.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.139 -1.8 . . . . 20.0 106.139 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.37 137.1 56.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.309 0.576 . . . . 20.0 111.3 -171.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.01 109.64 1.95 Allowed Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.687 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.4 -20.09 48.69 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 N-CA-C 114.837 1.053 . . . . 20.0 114.837 -160.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.96 74.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.183 -0.607 . . . . 20.0 110.557 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.59 -48.4 77.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.098 0.475 . . . . 20.0 110.074 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 274' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.19 -52.44 60.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.823 0.344 . . . . 20.0 110.709 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.43 -31.87 70.82 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.832 -0.747 . . . . 20.0 110.525 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 276' ' ' TRP . . . . . 0.497 ' HH2' ' HB3' ' K' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.97 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.088 -0.645 . . . . 20.0 110.991 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.1 -38.66 89.73 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.978 -0.689 . . . . 20.0 110.726 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.6 -47.99 78.41 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.631 -0.427 . . . . 20.0 110.084 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.44 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.9 -0.32 . . . . 20.0 110.7 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.9 77.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.261 -0.575 . . . . 20.0 111.098 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.71 73.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.062 -0.655 . . . . 20.0 111.003 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.83 65.86 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.133 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.86 -37.66 73.1 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 119.874 -0.73 . . . . 20.0 110.963 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.6 15.51 29.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.359 0.874 . . . . 20.0 113.359 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.17 13.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.736 0.779 . . . . 20.0 111.59 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 286' ' ' ILE . . . . . . . . . . . . . 23.7 mm -87.3 143.34 34.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 287' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.15 149.35 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 CA-C-N 119.146 0.731 . . . . 20.0 111.341 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.98 148.18 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.71 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.04 175.19 5.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 113.76 17.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.837 -1.171 . . . . 20.0 107.837 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.64 43.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.47 -0.567 . . . . 20.0 109.47 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.11 156.98 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.632 -1.248 . . . . 20.0 107.632 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.51 168.68 12.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.491 0.662 . . . . 20.0 110.23 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.76 -18.5 21.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.778 -1.101 . . . . 20.0 112.192 165.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.0 20.06 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.003 -0.839 . . . . 20.0 111.003 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 296' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' K' ' 237' ' ' THR . . . 101.49 144.75 15.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.67 -0.765 . . . . 20.0 112.661 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.6 4.09 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.342 -1.103 . . . . 20.0 110.342 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 298' ' ' THR . . . . . 0.773 HG21 ' HE3' ' K' ' 261' ' ' LYS . 20.2 p -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.022 0.915 . . . . 20.0 111.348 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.228 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.29 74.02 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 111.809 0.3 . . . . 20.0 111.809 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.27 96.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.196 -1.002 . . . . 20.0 112.027 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 302' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' K' ' 220' ' ' ARG . . . -68.21 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.192 -0.603 . . . . 20.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.87 -34.45 56.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.996 -0.681 . . . . 20.0 110.17 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 305' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' F' ' 217' ' ' ARG . 4.1 mp -103.74 -8.9 19.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.704 1.001 . . . . 20.0 113.704 -167.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 306' ' ' THR . . . . . 0.418 ' OG1' ' OE1' ' K' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.56 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.579 0.704 . . . . 20.0 110.531 171.956 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 307' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' F' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.83 70.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.267 -0.879 . . . . 20.0 113.323 -161.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.13 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.196 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.74 65.09 1.95 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.842 -0.694 . . . . 20.0 113.346 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.603 0.702 . . . . 20.0 111.158 -163.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 311' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.44 141.71 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 CA-C-N 119.451 0.84 . . . . 20.0 110.024 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.325 -0.852 . . . . 20.0 111.19 -169.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.55 162.58 12.33 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.207 -1.557 . . . . 20.0 109.207 164.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.04 27.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.429 0.633 . . . . 20.0 110.112 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.01 153.22 21.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.22 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 316' ' ' SER . . . . . 0.4 ' N ' ' O ' ' K' ' 259' ' ' ALA . 4.2 m -138.46 133.53 32.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.317 -0.856 . . . . 20.0 109.495 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 317' ' ' VAL . . . . . 0.437 HG11 HG12 ' K' ' 185' ' ' ILE . 92.3 t -99.47 108.56 51.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 CA-C-O 122.653 1.022 . . . . 20.0 113.596 -154.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 319' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' K' ' 253' ' ' HIS . . . 79.75 35.53 0.15 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.319 161.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 320' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' K' ' 321' ' ' TYR . 0.4 OUTLIER -75.69 157.59 33.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.704 0.764 . . . . 20.0 110.105 176.746 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 321' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' K' ' 320' ' ' ARG . 3.3 m-85 -113.08 166.2 11.65 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.824 -1.547 . . . . 20.0 106.824 160.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.28 113.68 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.161 0.984 . . . . 20.0 108.375 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.42 3.29 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.46 1.281 . . . . 20.0 114.46 -140.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 324' ' ' SER . . . . . 0.583 ' OG ' HG21 ' K' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.647 0.61 . . . . 20.0 112.647 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -101.98 -56.12 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.001 1.482 . . . . 20.0 115.001 -152.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.95 50.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.455 -1.313 . . . . 20.0 107.455 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 327' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' K' ' 181' ' ' PHE . 82.7 mt-10 -142.56 52.86 1.42 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.839 -1.528 . . . . 20.0 109.909 -153.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.07 149.38 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.429 0.633 . . . . 20.0 111.926 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 329' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' K' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.898 0.856 . . . . 20.0 109.461 175.644 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.49 119.17 27.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.603 -1.18 . . . . 20.0 108.897 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.12 -32.04 53.9 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.878 0.736 . . . . 20.0 111.511 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.77 73.58 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.297 -0.561 . . . . 20.0 110.233 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.05 -44.91 83.21 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.037 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.34 92.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.501 -0.48 . . . . 20.0 110.435 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -34.64 71.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 118.821 -1.151 . . . . 20.0 110.205 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.07 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.093 -0.643 . . . . 20.0 110.415 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.61 -43.75 80.47 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.726 0.298 . . . . 20.0 110.916 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' K' ' 342' ' ' THR . 42.6 t -60.25 -48.96 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.953 0.406 . . . . 20.0 110.23 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' K' ' 343' ' ' LYS . 1.3 mm-40 -54.83 -46.91 74.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.968 0.413 . . . . 20.0 110.764 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -55.17 37.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.36 -0.382 . . . . 20.0 111.441 -176.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 341' ' ' MET . . . . . 0.488 ' CE ' HD11 ' K' ' 234' ' ' ILE . 31.9 tpp -60.14 -40.4 89.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.213 -0.595 . . . . 20.0 110.78 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' K' ' 338' ' ' VAL . 1.3 m -56.45 -45.03 81.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.185 0.517 . . . . 20.0 110.447 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' K' ' 339' ' ' GLU . 34.6 mttp -74.17 -37.45 63.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.96 -0.696 . . . . 20.0 110.829 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.45 97.72 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.626 -0.429 . . . . 20.0 111.15 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 345' ' ' LEU . . . . . 0.418 ' O ' HG22 ' K' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.499 -0.48 . . . . 20.0 110.808 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.56 -39.17 91.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 119.732 -0.787 . . . . 20.0 110.588 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 347' ' ' ASN . . . . . 0.497 ' HB3' ' HH2' ' K' ' 276' ' ' TRP . 5.0 m-20 -84.46 4.77 30.13 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.468 -0.893 . . . . 20.0 112.54 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 348' ' ' ILE . . . . . 0.418 HG22 ' O ' ' K' ' 345' ' ' LEU . 1.3 tt -65.16 -23.7 33.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 119.558 -0.857 . . . . 20.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' K' K ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.39 69.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.734 -0.786 . . . . 20.0 111.265 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -85.79 -18.85 31.79 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 122.12 -0.362 . . . . 20.0 111.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 351' ' ' LEU . . . . . 0.432 ' O ' HD12 ' K' ' 351' ' ' LEU . 0.1 OUTLIER -69.73 -28.81 66.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.134 0.42 . . . . 20.0 112.134 -173.87 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' K' K ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.09 -26.62 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.051 1.871 . . . . 20.0 116.051 -169.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' K' K ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.02 1.328 . . . . 20.0 108.423 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.269 1.211 . . . . 20.0 114.269 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 82.19 2.88 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.946 -1.501 . . . . 20.0 106.946 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.95 -34.46 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.183 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -107.0 -23.57 12.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.596 0.962 . . . . 20.0 113.596 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.133 0.973 . . . . 20.0 111.64 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.74 32.39 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 122.256 -0.278 . . . . 20.0 111.232 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.45 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.684 -1.228 . . . . 20.0 107.684 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.12 11.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.276 0.56 . . . . 20.0 110.92 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.68 -31.53 72.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.487 -0.778 . . . . 20.0 111.864 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.18 -45.13 74.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.531 -0.467 . . . . 20.0 111.192 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.15 97.12 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.01 -0.276 . . . . 20.0 111.192 -172.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -30.59 70.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.751 -0.379 . . . . 20.0 111.16 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.4 90.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.683 -0.407 . . . . 20.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.93 91.51 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.641 -0.254 . . . . 20.0 111.536 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.91 -40.04 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 119.547 -0.861 . . . . 20.0 110.696 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.17 6.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.06 -1.056 . . . . 20.0 111.008 -162.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.04 68.1 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.958 -0.697 . . . . 20.0 111.295 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.42 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.521 -0.472 . . . . 20.0 109.817 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 19' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.19 144.76 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 120.251 0.634 . . . . 20.0 112.132 -172.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.17 3.44 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 117.286 1.674 . . . . 20.0 117.286 -159.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.67 119.78 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.175 -1.417 . . . . 20.0 107.175 159.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.21 8.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.452 0.644 . . . . 20.0 110.669 -166.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.99 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.477 -0.783 . . . . 20.0 114.003 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.36 0.17 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.3 1.048 . . . . 20.0 109.602 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.91 -13.18 4.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.94 -1.027 . . . . 20.0 113.425 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' L' ' 28' ' ' GLY . 0.0 OUTLIER -87.99 8.98 23.89 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 119.701 1.137 . . . . 20.0 113.771 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 11.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' L' ' 26' ' ' PHE . . . -53.24 -26.85 30.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.784 1.174 . . . . 20.0 115.982 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' L' ' 184' ' ' ARG . 1.1 tt -59.59 -35.75 61.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.151 0.976 . . . . 20.0 110.659 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.47 61.44 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.897 0.379 . . . . 20.0 110.404 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.18 -40.69 74.34 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.275 -0.421 . . . . 20.0 110.958 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.19 -49.61 82.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.081 0.467 . . . . 20.0 110.346 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.68 86.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 119.744 -0.782 . . . . 20.0 110.298 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.5 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 118.762 -1.175 . . . . 20.0 111.134 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -30.97 71.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.003 0.365 . . . . 20.0 111.111 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.01 -56.71 3.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.16 0.43 . . . . 20.0 112.16 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.48 44.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 116.502 -0.317 . . . . 20.0 111.516 -164.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.38 63.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.936 -0.706 . . . . 20.0 112.212 -162.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.52 63.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 118.958 -1.097 . . . . 20.0 111.683 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.92 22.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.56 152.64 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.547 -0.908 . . . . 20.0 108.547 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.1 -42.65 88.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.227 -0.897 . . . . 20.0 111.464 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.56 158.31 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.509 -0.923 . . . . 20.0 108.509 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.5 147.16 16.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.282 -1.007 . . . . 20.0 108.282 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.523 0.678 . . . . 20.0 110.422 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.06 128.96 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.349 -1.352 . . . . 20.0 107.349 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.807 0.813 . . . . 20.0 108.917 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.55 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.94 -0.704 . . . . 20.0 111.14 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 10.9 9.17 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.661 0.986 . . . . 20.0 113.661 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 119.134 -0.815 . . . . 20.0 114.514 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.07 151.45 35.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.466 1.133 . . . . 20.0 110.217 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.2 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 53' ' ' ILE . . . . . 0.711 HD13 HG12 ' L' ' 207' ' ' VAL . 31.2 mm -130.2 115.64 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.9 119.79 36.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.619 -0.511 . . . . 20.0 109.619 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.98 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -173.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.36 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.734 -1.58 . . . . 20.0 106.734 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.55 154.49 20.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 123.47 0.481 . . . . 20.0 109.703 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.38 -161.1 23.71 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.12 105.58 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.904 0.882 . . . . 20.0 109.018 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.59 33.53 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.775 -0.726 . . . . 20.0 114.074 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.79 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 CA-C-O 121.747 0.645 . . . . 20.0 112.081 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.96 111.41 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 20.0 109.196 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.74 137.97 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.779 -0.823 . . . . 20.0 108.779 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.8 124.07 46.31 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.015 0.926 . . . . 20.0 109.022 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.27 45.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.112 -1.07 . . . . 20.0 108.112 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.55 51.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.255 0.347 . . . . 20.0 110.993 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.43 154.6 45.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.902 0.881 . . . . 20.0 108.941 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 68' ' ' HIS . . . . . 0.484 ' NE2' ' OD1' ' L' ' 235' ' ' ASP . 0.0 OUTLIER -105.06 146.49 29.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.949 -0.569 . . . . 20.0 110.479 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.32 5.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.163 -0.926 . . . . 20.0 109.676 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' L' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.658 -0.651 . . . . 20.0 112.448 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.26 144.89 28.41 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.736 0.814 . . . . 20.0 109.131 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 73' ' ' GLY . . . . . 0.471 ' C ' HD23 ' L' ' 74' ' ' LEU . . . -155.81 -175.66 27.07 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.597 -1.001 . . . . 20.0 110.597 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 74' ' ' LEU . . . . . 0.471 HD23 ' C ' ' L' ' 73' ' ' GLY . 5.0 mt -125.09 161.38 26.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.29 0.567 . . . . 20.0 109.995 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' L' ' 160' ' ' THR . 10.6 ttm -128.12 131.32 49.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.237 1.015 . . . . 20.0 109.679 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.51 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.837 -0.801 . . . . 20.0 108.837 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.09 -29.32 7.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.055 0.761 . . . . 20.0 113.055 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.44 13.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.099 -1.075 . . . . 20.0 108.099 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.9 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.366 -0.976 . . . . 20.0 108.366 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.34 5.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.82 0.819 . . . . 20.0 109.992 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -27.07 60.37 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.732 -0.787 . . . . 20.0 112.708 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -78.56 9.21 4.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -177.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.19 12.85 81.82 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.949 -0.917 . . . . 20.0 115.059 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.81 145.07 34.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.384 1.092 . . . . 20.0 110.202 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.94 142.5 28.11 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.264 -0.88 . . . . 20.0 112.569 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.59 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.79 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.617 0.722 . . . . 20.0 109.527 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.33 15.58 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.012 -0.995 . . . . 20.0 109.756 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.79 160.21 24.59 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.307 0.878 . . . . 20.0 112.72 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 90' ' ' ILE . . . . . 0.49 HD11 HG21 ' L' ' 160' ' ' THR . 9.2 mt -88.81 150.28 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 113.696 -1.593 . . . . 20.0 107.365 165.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.9 47.46 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.272 -0.876 . . . . 20.0 112.151 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.22 21.98 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.204 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.87 152.66 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 118.645 1.222 . . . . 20.0 109.237 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 131.02 22.15 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -7.92 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 120.573 1.24 . . . . 20.0 114.805 -170.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.27 59.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.155 0.889 . . . . 20.0 111.79 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 97' ' ' THR . . . . . 0.594 HG21 ' OG ' ' L' ' 324' ' ' SER . 44.7 p -89.48 35.54 0.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.598 0.759 . . . . 20.0 112.461 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 98' ' ' LEU . . . . . 0.679 HD12 ' H ' ' L' ' 99' ' ' ILE . 0.5 OUTLIER -43.26 -66.43 0.38 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.923 1.289 . . . . 20.0 113.407 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 99' ' ' ILE . . . . . 0.679 ' H ' HD12 ' L' ' 98' ' ' LEU . 1.6 tt -173.19 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 100' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' J' ' 325' ' ' ASN . . . -123.94 -19.03 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.635 -1.166 . . . . 20.0 111.255 158.039 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 101' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' J' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 102' ' ' ARG . . . . . 0.509 HH12 ' HB3' ' J' ' 167' ' ' ARG . 0.0 OUTLIER 55.94 74.52 0.38 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.233 1.568 . . . . 20.0 115.233 150.539 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' L' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.25 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.325 0.966 . . . . 20.0 109.363 160.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.29 37.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.499 -0.773 . . . . 20.0 109.41 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 105' ' ' VAL . . . . . 0.584 HG22 ' CG1' ' L' ' 162' ' ' ILE . 50.7 t -117.43 110.74 32.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.57 83.08 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.559 -0.291 . . . . 20.0 110.282 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -51.97 -54.23 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.361 0.413 . . . . 20.0 110.308 170.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.51 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.432 -0.951 . . . . 20.0 108.432 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.02 126.28 27.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.914 -1.039 . . . . 20.0 110.48 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.21 75.2 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.899 -0.945 . . . . 20.0 115.291 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.01 15.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.497 1.149 . . . . 20.0 108.62 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.25 141.54 37.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.51 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.683 -0.858 . . . . 20.0 108.683 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.73 149.45 31.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.023 -0.989 . . . . 20.0 110.263 -172.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' L' ' 103' ' ' PHE . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.256 -1.138 . . . . 20.0 110.256 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.78 154.44 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.366 -0.975 . . . . 20.0 108.366 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.319 -0.855 . . . . 20.0 114.606 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 118' ' ' ALA . . . . . 0.498 ' O ' HD13 ' L' ' 98' ' ' LEU . . . -67.18 -47.99 69.29 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.334 1.235 . . . . 20.0 114.334 -156.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.52 1.055 . . . . 20.0 112.646 -155.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.13 35.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.16 123.82 11.04 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 CA-C-N 120.743 1.301 . . . . 20.0 110.546 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.79 89.89 Favored 'Trans proline' 0 C--O 1.233 0.26 0 CA-C-N 119.147 0.731 . . . . 20.0 110.7 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.13 165.42 7.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 20.0 109.93 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.19 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.177 -1.045 . . . . 20.0 108.177 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.84 19.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.872 0.368 . . . . 20.0 110.713 169.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.91 -43.65 1.5 Allowed Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.948 0.899 . . . . 20.0 113.088 -170.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.92 59.39 Favored 'Trans proline' 0 C--N 1.359 1.114 0 CA-C-N 120.845 1.337 . . . . 20.0 112.008 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.52 30.09 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 111.824 0.305 . . . . 20.0 111.824 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -31.94 69.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.274 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 130' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' J' ' 136' ' ' TRP . 10.8 tpt180 -74.82 -36.83 62.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 111.936 0.347 . . . . 20.0 111.936 172.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 131' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' J' ' 131' ' ' LYS . 35.1 mttt -78.51 90.97 4.5 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.206 -0.664 . . . . 20.0 109.206 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.91 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.115 0.413 . . . . 20.0 112.115 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.61 87.45 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 108.513 -0.921 . . . . 20.0 108.513 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.63 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.64 0.907 . . . . 20.0 112.365 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.64 153.62 42.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.531 -1.213 . . . . 20.0 107.968 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 136' ' ' TRP . . . . . 0.409 ' HB3' HH22 ' J' ' 130' ' ' ARG . 0.0 OUTLIER -77.65 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.772 -0.632 . . . . 20.0 112.368 -175.254 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' L' ' 138' ' ' GLN . 14.2 p30 -55.34 -66.4 0.42 Allowed 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.416 -175.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 138' ' ' GLN . . . . . 0.414 ' N ' ' OD1' ' L' ' 137' ' ' ASP . 3.9 tp-100 174.62 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 103.075 -2.935 . . . . 20.0 103.075 133.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 139' ' ' ILE . . . . . 0.408 ' H ' ' HG3' ' L' ' 138' ' ' GLN . 1.2 tp -74.85 168.19 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.068 0.947 . . . . 20.0 108.939 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.9 161.43 18.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.967 0.907 . . . . 20.0 110.464 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 141' ' ' ILE . . . . . 0.407 HD13 HD13 ' L' ' 162' ' ' ILE . 30.1 mt -124.65 147.46 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 142' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' L' ' 144' ' ' GLY . 0.5 OUTLIER -119.03 134.74 55.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.647 0.779 . . . . 20.0 109.613 175.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 O-C-N 123.719 0.637 . . . . 20.0 111.817 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 144' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' L' ' 142' ' ' ASP . . . 86.87 -6.61 82.68 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 115.495 0.958 . . . . 20.0 115.495 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.17 144.05 53.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.472 1.136 . . . . 20.0 110.252 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.33 -20.94 33.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.608 0.966 . . . . 20.0 113.608 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.63 40.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.971 0.891 . . . . 20.0 111.468 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.48 80.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 113.943 -1.48 . . . . 20.0 111.243 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.39 -46.99 88.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.863 -0.335 . . . . 20.0 110.943 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.39 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.524 -0.47 . . . . 20.0 110.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.63 84.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.052 -0.659 . . . . 20.0 111.119 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.26 58.51 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.368 -0.933 . . . . 20.0 111.057 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.75 -30.1 66.52 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.761 -0.776 . . . . 20.0 110.62 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.53 -40.65 92.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.657 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.8 6.68 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.606 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 133.52 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.462 1.131 . . . . 20.0 108.547 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.724 -1.213 . . . . 20.0 107.724 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.32 147.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.3 15.72 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.793 -1.723 . . . . 20.0 108.793 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' L' ' 75' ' ' MET . 0.2 OUTLIER -79.43 113.61 17.7 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.651 -1.24 . . . . 20.0 107.651 165.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -19.95 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.739 1.015 . . . . 20.0 113.739 -166.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 162' ' ' ILE . . . . . 0.584 ' CG1' HG22 ' L' ' 105' ' ' VAL . 0.5 OUTLIER -111.71 155.64 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.626 0.648 . . . . 20.0 111.737 -159.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' L' ' 164' ' ' TRP . 3.5 t -145.34 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.306 1.042 . . . . 20.0 110.445 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' L' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.94 16.69 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.189 0.811 . . . . 20.0 113.189 -160.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.76 61.62 0.97 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.837 -0.539 . . . . 20.0 112.281 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.62 29.59 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.089 -1.204 . . . . 20.0 110.089 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 167' ' ' ARG . . . . . 0.457 ' HB3' HH12 ' J' ' 102' ' ' ARG . 0.0 OUTLIER -142.38 148.31 37.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.739 -1.208 . . . . 20.0 107.739 170.569 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.58 30.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.133 -0.939 . . . . 20.0 110.206 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.38 159.8 35.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.829 0.823 . . . . 20.0 110.02 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.41 117.19 34.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.263 -1.335 . . . . 20.0 109.465 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.65 28.96 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.486 -0.561 . . . . 20.0 109.486 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 172' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' L' ' 175' ' ' ARG . . . 56.86 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.202 -1.559 . . . . 20.0 109.202 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.93 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.802 0.667 . . . . 20.0 112.802 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.73 -0.788 . . . . 20.0 111.211 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 175' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' L' ' 172' ' ' GLY . 6.8 ptt-85 -169.9 121.97 0.69 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.592 0.633 . . . . 20.0 112.633 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.52 169.39 0.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.788 2.435 . . . . 20.0 106.185 157.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.69 145.84 20.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.457 -0.942 . . . . 20.0 108.457 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.407 2.003 . . . . 20.0 116.407 -165.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.752 0.705 . . . . 20.0 112.115 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.9 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 114.393 1.257 . . . . 20.0 114.393 -170.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 181' ' ' PHE . . . . . 0.739 ' HB3' ' HB3' ' L' ' 327' ' ' GLU . 3.2 t80 -84.64 -66.98 0.83 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.606 0.639 . . . . 20.0 111.766 -162.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.21 127.84 32.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.062 0.934 . . . . 20.0 110.679 -152.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' L' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.76 1.04 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.316 1.447 . . . . 20.0 113.166 174.638 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' L' ' 29' ' ' ILE . 0.0 OUTLIER -153.76 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.122 0.963 . . . . 20.0 110.783 157.175 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 185' ' ' ILE . . . . . 0.435 HG12 HG11 ' L' ' 317' ' ' VAL . 1.0 OUTLIER -126.13 -41.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 104.515 -2.402 . . . . 20.0 104.515 149.886 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 186' ' ' ALA . . . . . 0.724 ' O ' ' OG1' ' L' ' 189' ' ' THR . . . -50.06 -43.05 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.364 -0.835 . . . . 20.0 111.536 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.9 -36.01 76.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.225 -0.99 . . . . 20.0 110.115 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 188' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -63.86 -38.65 91.86 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.479 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 189' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' L' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.02 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.85 172.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.29 -50.57 63.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.897 0.379 . . . . 20.0 110.477 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.14 -43.14 96.15 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.959 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.5 84.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.984 -0.686 . . . . 20.0 110.315 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 193' ' ' VAL . . . . . 0.414 HG23 ' O ' ' L' ' 189' ' ' THR . 11.5 t -60.61 -44.73 97.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.045 0.45 . . . . 20.0 110.114 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.29 75.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.17 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.58 -38.19 70.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.79 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.66 -26.17 41.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 20.0 112.52 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.61 122.79 27.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.299 -0.63 . . . . 20.0 109.299 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.273 0.358 . . . . 20.0 110.122 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.11 105.35 17.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.735 -0.469 . . . . 20.0 109.735 -172.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.29 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.679 . . . . 20.0 109.165 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.75 -14.56 59.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.047 -0.661 . . . . 20.0 111.386 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.68 30.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.919 -0.771 . . . . 20.0 108.919 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 203' ' ' ASP . . . . . 0.619 ' OD1' ' N ' ' L' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.99 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 -174.468 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.98 151.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 205' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.87 106.63 9.03 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.017 -0.735 . . . . 20.0 109.017 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.37 31.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.752 -0.832 . . . . 20.0 108.752 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 207' ' ' VAL . . . . . 0.711 HG12 HD13 ' L' ' 53' ' ' ILE . 34.1 m -119.92 150.18 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.867 -0.79 . . . . 20.0 108.867 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.83 5.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.84 159.93 19.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 20.0 111.121 -165.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.76 166.44 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 114.644 -1.162 . . . . 20.0 108.21 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.13 29.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.762 -1.108 . . . . 20.0 111.541 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.94 -49.59 13.84 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.412 -0.515 . . . . 20.0 110.952 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.35 64.75 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.212 -0.595 . . . . 20.0 111.483 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.22 121.11 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.536 -0.913 . . . . 20.0 108.536 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.99 6.19 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.67 -1.253 . . . . 20.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 216' ' ' LEU . . . . . 0.438 HD23 ' H ' ' L' ' 216' ' ' LEU . 0.5 OUTLIER -47.05 -25.52 0.85 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.464 0.912 . . . . 20.0 113.464 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 217' ' ' ARG . . . . . 0.46 ' HB3' ' HG ' ' B' ' 305' ' ' LEU . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.337 0.495 . . . . 20.0 112.337 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.56 40.79 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.686 -1.245 . . . . 20.0 112.004 168.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 219' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' L' ' 222' ' ' SER . . . -65.27 -37.03 85.93 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 122.28 -0.541 . . . . 20.0 111.335 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 220' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' L' ' 302' ' ' ALA . 16.6 ttm180 -52.77 -36.66 58.43 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.172 0.434 . . . . 20.0 112.172 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 221' ' ' THR . . . . . . . . . . . . . 74.7 p -58.5 -45.82 87.95 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 120.055 -0.658 . . . . 20.0 110.82 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 222' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' L' ' 219' ' ' ALA . 2.1 p -58.04 -35.77 71.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.78 -0.368 . . . . 20.0 111.438 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.06 68.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.587 0.588 . . . . 20.0 112.587 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.12 -33.45 75.8 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.832 -165.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.69 74.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 118.894 -1.622 . . . . 20.0 112.117 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.98 -45.59 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 112.011 0.374 . . . . 20.0 112.011 -158.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.4 -46.77 99.77 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 118.185 2.661 . . . . 20.0 118.185 -158.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.75 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.2 0 N-CA-C 115.966 1.487 . . . . 20.0 115.966 -134.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.72 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.409 . . . . 20.0 113.4 162.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.091 -0.643 . . . . 20.0 111.734 167.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.51 16.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.925 -0.655 . . . . 20.0 112.266 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.76 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.555 -0.823 . . . . 20.0 108.791 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.04 23.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.178 0.513 . . . . 20.0 110.385 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' L' ' 341' ' ' MET . 51.8 mt -133.18 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.56 -1.274 . . . . 20.0 107.56 172.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 235' ' ' ASP . . . . . 0.484 ' OD1' ' NE2' ' L' ' 68' ' ' HIS . 25.5 t0 -135.17 173.25 11.93 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.963 -1.495 . . . . 20.0 106.963 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.38 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.704 0.764 . . . . 20.0 111.452 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 237' ' ' THR . . . . . 0.46 HG21 ' HA3' ' L' ' 296' ' ' GLY . 9.1 t -165.6 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.364 -1.347 . . . . 20.0 107.364 164.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 238' ' ' ILE . . . . . 0.413 HD13 ' O ' ' L' ' 237' ' ' THR . 17.9 mm -145.5 151.87 14.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -161.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.2 9.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 158.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.05 18.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.35 36.18 22.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.969 1.308 . . . . 20.0 112.477 158.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.181 -2.155 . . . . 20.0 105.181 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.99 165.59 11.96 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 CA-C-N 120.842 1.336 . . . . 20.0 112.361 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.28 45.02 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.061 -0.972 . . . . 20.0 114.908 -173.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.15 164.52 22.93 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 118.611 1.206 . . . . 20.0 110.653 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.97 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.804 0.668 . . . . 20.0 111.995 171.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.77 59.56 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.036 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.34 -18.59 63.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.833 -0.747 . . . . 20.0 112.878 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 249' ' ' LYS . . . . . 0.728 ' O ' ' OG1' ' L' ' 252' ' ' THR . 16.9 mttt -98.81 -15.13 19.38 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.233 0.827 . . . . 20.0 113.233 170.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.86 88.99 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.338 -0.545 . . . . 20.0 111.342 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -21.02 25.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 119.119 -1.032 . . . . 20.0 111.89 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 252' ' ' THR . . . . . 0.728 ' OG1' ' O ' ' L' ' 249' ' ' LYS . 39.7 p -57.07 -31.88 65.68 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.485 0.584 . . . . 20.0 111.35 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 253' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' L' ' 319' ' ' ALA . 16.6 t-80 -162.37 132.08 4.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.373 0.606 . . . . 20.0 110.421 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.27 3.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 20.0 112.302 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.86 5.85 Favored Glycine 0 CA--C 1.504 -0.63 0 C-N-CA 126.151 1.834 . . . . 20.0 111.571 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.21 10.18 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.26 3.42 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 122.677 1.154 . . . . 20.0 113.333 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.13 6.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 259' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' L' ' 316' ' ' SER . . . -126.48 120.36 29.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.181 -0.918 . . . . 20.0 109.417 -169.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.08 139.95 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.736 -1.209 . . . . 20.0 107.736 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 261' ' ' LYS . . . . . 0.74 ' HE3' HG21 ' L' ' 298' ' ' THR . 1.9 mtmm -98.84 122.61 42.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.25 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.384 0.611 . . . . 20.0 109.643 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.16 -169.97 2.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.249 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.25 21.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.854 -0.612 . . . . 20.0 110.296 163.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.2 11.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.65 0.981 . . . . 20.0 113.65 -165.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.414 -0.587 . . . . 20.0 109.414 -163.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.25 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.107 -1.812 . . . . 20.0 106.107 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 269' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.37 137.11 56.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.25 0.548 . . . . 20.0 111.34 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 270' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.1 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.591 0 CA-C-N 115.107 -0.951 . . . . 20.0 108.691 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 271' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.42 -20.03 48.62 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 N-CA-C 114.823 1.047 . . . . 20.0 114.823 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.98 74.69 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.193 -0.603 . . . . 20.0 110.576 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.38 77.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.15 0.5 . . . . 20.0 110.105 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.18 -52.49 60.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.806 0.336 . . . . 20.0 110.674 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.9 70.8 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.824 -0.751 . . . . 20.0 110.554 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 276' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' L' ' 347' ' ' ASN . 0.1 OUTLIER -68.48 -47.98 65.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.129 -0.628 . . . . 20.0 111.002 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.68 89.7 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.756 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.61 -48.02 78.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.61 -0.436 . . . . 20.0 110.117 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.79 -40.44 88.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.849 -0.34 . . . . 20.0 110.733 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.28 -44.96 78.0 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.251 -0.579 . . . . 20.0 111.126 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.66 72.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.023 -0.671 . . . . 20.0 111.081 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.47 -31.8 65.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.113 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.79 -37.69 73.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.019 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.6 15.47 29.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.306 0.854 . . . . 20.0 113.306 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.73 32.17 13.83 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.713 0.768 . . . . 20.0 111.572 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.37 34.42 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.324 -0.991 . . . . 20.0 108.324 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.18 149.39 13.44 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 119.182 0.743 . . . . 20.0 111.36 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.13 23.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.63 -0.714 . . . . 20.0 109.705 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.11 5.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.693 -1.225 . . . . 20.0 107.693 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.898 -1.149 . . . . 20.0 107.898 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.69 43.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.471 -0.566 . . . . 20.0 109.471 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.05 157.1 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.672 -1.232 . . . . 20.0 107.672 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.48 0.657 . . . . 20.0 110.294 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.56 21.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.874 -1.057 . . . . 20.0 112.162 165.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.011 -0.836 . . . . 20.0 111.011 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 296' ' ' GLY . . . . . 0.46 ' HA3' HG21 ' L' ' 237' ' ' THR . . . 101.5 144.81 15.6 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.671 -0.764 . . . . 20.0 112.661 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.89 119.58 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.334 -1.106 . . . . 20.0 110.334 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 298' ' ' THR . . . . . 0.74 HG21 ' HE3' ' L' ' 261' ' ' LYS . 20.3 p -110.25 172.92 6.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.995 0.902 . . . . 20.0 111.414 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.9 -33.69 76.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.403 -1.271 . . . . 20.0 111.229 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.3 74.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.789 0.292 . . . . 20.0 111.789 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.21 96.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.221 -0.99 . . . . 20.0 112.042 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 302' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' L' ' 220' ' ' ARG . . . -68.3 -26.89 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.162 -0.615 . . . . 20.0 111.189 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.46 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.023 -0.671 . . . . 20.0 110.146 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.24 60.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.92 19.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.687 0.995 . . . . 20.0 113.687 -167.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 306' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.31 157.56 8.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.649 0.738 . . . . 20.0 110.519 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 307' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -61.69 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.258 -0.883 . . . . 20.0 113.299 -161.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.15 66.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.709 -0.796 . . . . 20.0 111.233 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.821 -0.705 . . . . 20.0 113.307 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.64 52.41 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 117.619 0.709 . . . . 20.0 111.079 -163.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.53 141.65 8.94 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 CA-C-N 119.456 0.841 . . . . 20.0 110.04 168.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.45 135.84 32.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.365 -0.834 . . . . 20.0 111.195 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.144 -1.583 . . . . 20.0 109.144 164.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.42 136.06 27.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.445 0.64 . . . . 20.0 110.052 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.06 153.27 21.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.621 -1.172 . . . . 20.0 109.212 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 316' ' ' SER . . . . . 0.402 ' N ' ' O ' ' L' ' 259' ' ' ALA . 4.2 m -138.47 133.51 32.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 20.0 109.48 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 317' ' ' VAL . . . . . 0.435 HG11 HG12 ' L' ' 185' ' ' ILE . 92.1 t -99.47 108.62 51.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 107.227 -1.397 . . . . 20.0 107.227 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.727 0 CA-C-O 122.625 1.011 . . . . 20.0 113.606 -154.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' L' ' 253' ' ' HIS . . . 79.84 35.46 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.57 -1.65 . . . . 20.0 115.277 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 320' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' L' ' 321' ' ' TYR . 0.4 OUTLIER -75.61 157.58 33.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.71 0.766 . . . . 20.0 110.119 176.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 321' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' L' ' 320' ' ' ARG . 3.3 m-85 -113.06 166.13 11.71 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.18 113.67 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.156 0.982 . . . . 20.0 108.401 -163.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.38 3.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 324' ' ' SER . . . . . 0.594 ' OG ' HG21 ' L' ' 97' ' ' THR . 0.1 OUTLIER -59.54 -60.01 4.53 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.611 0.597 . . . . 20.0 112.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 325' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' J' ' 100' ' ' ALA . 35.2 p-10 -101.97 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.075 1.509 . . . . 20.0 115.075 -152.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.58 150.95 50.78 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.485 -1.302 . . . . 20.0 107.485 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 327' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' L' ' 181' ' ' PHE . 82.8 mt-10 -142.55 52.81 1.42 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.846 -1.525 . . . . 20.0 109.943 -153.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.07 149.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.411 0.624 . . . . 20.0 111.969 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 329' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' L' ' 181' ' ' PHE . 0.3 OUTLIER -139.43 179.41 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.877 0.846 . . . . 20.0 109.419 175.677 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.22 27.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.802 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.06 -32.1 53.58 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.847 0.717 . . . . 20.0 111.497 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.67 -44.76 73.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.289 -0.564 . . . . 20.0 110.211 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.9 83.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.727 -0.389 . . . . 20.0 111.068 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.22 91.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 120.415 -0.514 . . . . 20.0 110.522 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.65 71.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 118.791 -1.164 . . . . 20.0 110.181 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.033 -0.667 . . . . 20.0 110.421 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.57 -43.83 80.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.761 0.315 . . . . 20.0 110.938 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' L' ' 342' ' ' THR . 42.6 t -60.2 -48.93 86.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 120.962 0.411 . . . . 20.0 110.276 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 339' ' ' GLU . . . . . 0.783 ' OE1' ' NZ ' ' L' ' 343' ' ' LYS . 1.3 mm-40 -54.87 -46.85 74.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.996 0.427 . . . . 20.0 110.778 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -55.12 38.09 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.37 -0.377 . . . . 20.0 111.454 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' L' ' 234' ' ' ILE . 31.9 tpp -60.2 -40.36 89.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.778 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' L' ' 338' ' ' VAL . 1.3 m -56.45 -45.04 81.03 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.101 0.476 . . . . 20.0 110.423 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 343' ' ' LYS . . . . . 0.783 ' NZ ' ' OE1' ' L' ' 339' ' ' GLU . 34.7 mttp -74.12 -37.48 64.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.806 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.554 -0.459 . . . . 20.0 111.126 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 345' ' ' LEU . . . . . 0.427 ' O ' HG22 ' L' ' 348' ' ' ILE . 1.0 OUTLIER -59.01 -50.41 74.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.524 -0.471 . . . . 20.0 110.827 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.0 90.88 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 119.682 -0.807 . . . . 20.0 110.625 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 347' ' ' ASN . . . . . 0.488 ' HB3' ' HH2' ' L' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.77 30.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.475 -0.89 . . . . 20.0 112.538 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 348' ' ' ILE . . . . . 0.427 HG22 ' O ' ' L' ' 345' ' ' LEU . 1.3 tt -65.23 -23.63 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 119.525 -0.87 . . . . 20.0 110.93 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' L' L ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.77 -27.33 69.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.814 -0.755 . . . . 20.0 111.241 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.73 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.085 -0.385 . . . . 20.0 111.512 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 351' ' ' LEU . . . . . 0.439 ' O ' HD12 ' L' ' 351' ' ' LEU . 0.1 OUTLIER -69.74 -28.84 66.13 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.118 0.414 . . . . 20.0 112.118 -173.881 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.03 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 116.032 1.864 . . . . 20.0 116.032 -169.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' L' L ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.983 1.313 . . . . 20.0 108.408 -174.659 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' C' C 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' D' D 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' E' E 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' F' F 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' G' G 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' H' H 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' I' I 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' J' J 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' K' K 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' L' L 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.501 2.084 0 N-CA-C 114.229 1.196 . . . . 20.0 114.229 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.1 82.24 2.94 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.88 -1.526 . . . . 20.0 106.88 -170.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.94 -34.53 66.76 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 114.942 -1.026 . . . . 20.0 110.16 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.53 12.3 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.48 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.525 0 C-N-CA 124.155 0.982 . . . . 20.0 111.59 -173.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.81 -38.69 32.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.766 0.257 . . . . 20.0 111.226 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.51 37.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 N-CA-C 107.613 -1.254 . . . . 20.0 107.613 -178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.96 112.14 12.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.343 0.592 . . . . 20.0 110.928 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.66 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.5 -0.773 . . . . 20.0 111.882 -177.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.13 -45.19 74.29 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.486 -0.486 . . . . 20.0 111.206 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.11 97.2 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 121.036 -0.265 . . . . 20.0 111.163 -172.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.742 -0.383 . . . . 20.0 111.172 -178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.42 90.66 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.642 -0.423 . . . . 20.0 110.513 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.04 -42.89 91.35 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 116.667 -0.242 . . . . 20.0 111.555 -174.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.95 -40.03 26.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 119.515 -0.874 . . . . 20.0 110.67 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.06 -32.11 6.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 119.009 -1.076 . . . . 20.0 111.027 -162.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 68.0 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.311 174.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.42 70.67 Favored Pre-proline 0 N--CA 1.448 -0.549 0 C-N-CA 120.493 -0.483 . . . . 20.0 109.765 -175.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.13 144.78 9.57 Favored 'Trans proline' 0 C--N 1.33 -0.412 0 C-N-CA 120.249 0.633 . . . . 20.0 112.119 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.98 38.27 3.39 Favored Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 117.284 1.674 . . . . 20.0 117.284 -159.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.78 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 159.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.05 171.21 8.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.396 0.617 . . . . 20.0 110.707 -166.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.049 -177.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.413 0 CA-C-O 122.307 1.051 . . . . 20.0 109.563 172.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.97 -13.11 3.96 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 114.882 -1.054 . . . . 20.0 113.438 169.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' O ' ' N ' ' A' ' 28' ' ' GLY . 0.0 OUTLIER -88.02 9.08 23.62 Favored 'General case' 0 C--N 1.345 0.412 0 CA-C-N 119.714 1.143 . . . . 20.0 113.746 178.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.71 11.37 0.05 Allowed 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 115.426 1.639 . . . . 20.0 115.426 -154.09 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 26' ' ' PHE . . . -53.18 -26.84 29.72 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 116.023 1.169 . . . . 20.0 116.023 -172.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' A' ' 184' ' ' ARG . 1.1 tt -59.62 -35.76 61.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 118.088 0.944 . . . . 20.0 110.655 -178.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.44 61.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.873 0.368 . . . . 20.0 110.369 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.25 -40.64 74.47 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.348 -0.387 . . . . 20.0 110.938 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.6 82.38 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 CA-C-O 121.043 0.449 . . . . 20.0 110.305 -174.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.23 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 119.692 -0.803 . . . . 20.0 110.336 -175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.78 -29.42 20.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 C-N-CA 118.731 -1.188 . . . . 20.0 111.176 179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 60.5 tt0 -62.59 -30.91 71.68 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.816 -0.354 . . . . 20.0 111.101 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.92 -56.78 3.24 Favored 'General case' 0 C--O 1.237 0.417 0 N-CA-C 112.196 0.443 . . . . 20.0 112.196 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.4 44.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-N 116.461 -0.336 . . . . 20.0 111.514 -164.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.4 -26.38 63.67 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.943 -0.703 . . . . 20.0 112.229 -162.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.55 63.05 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 118.926 -1.11 . . . . 20.0 111.716 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.86 -6.94 22.94 Favored 'General case' 0 C--O 1.234 0.28 0 N-CA-C 113.534 0.939 . . . . 20.0 113.534 -176.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.5 152.68 22.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.171 0 N-CA-C 108.53 -0.915 . . . . 20.0 108.53 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.17 -42.57 88.76 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.17 -0.923 . . . . 20.0 111.468 -175.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.32 35.31 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.554 -0.906 . . . . 20.0 108.554 -173.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.22 16.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 -174.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.17 159.26 44.13 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.5 0.667 . . . . 20.0 110.469 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.4 t -117.07 128.93 74.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.25 -176.15 5.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 121.806 0.812 . . . . 20.0 108.904 177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' E' ' 309' ' ' GLY . 6.0 mmtm -74.61 -34.52 62.85 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.089 -176.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.23 10.83 9.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.636 0.976 . . . . 20.0 113.636 -171.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.59 83.41 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.104 -0.831 . . . . 20.0 114.498 -176.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.51 35.87 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.463 1.132 . . . . 20.0 110.212 173.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.36 140.23 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.172 -1.418 . . . . 20.0 107.172 176.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.697 HD13 HG12 ' A' ' 207' ' ' VAL . 31.3 mm -130.22 115.62 33.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.332 -1.359 . . . . 20.0 107.332 -174.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.76 36.38 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.663 -0.495 . . . . 20.0 109.663 174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 99.96 8.04 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.599 -0.889 . . . . 20.0 108.599 -173.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.57 145.38 31.8 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 106.792 -1.559 . . . . 20.0 106.792 163.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.54 154.48 20.32 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.459 0.474 . . . . 20.0 109.723 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.07 23.66 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 111.146 -0.781 . . . . 20.0 111.146 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.11 105.59 10.41 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.946 0.898 . . . . 20.0 109.049 178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.54 33.52 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.082 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.77 165.27 32.67 Favored 'Trans proline' 0 C--N 1.331 -0.36 0 CA-C-O 121.784 0.66 . . . . 20.0 112.066 179.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -92.03 111.38 22.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 114.932 -1.031 . . . . 20.0 109.249 -176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.71 137.97 30.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 N-CA-C 108.715 -0.846 . . . . 20.0 108.715 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.84 124.04 46.19 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 124.023 0.929 . . . . 20.0 108.994 -175.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.28 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 N-CA-C 108.116 -1.068 . . . . 20.0 108.116 -176.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.57 124.65 51.53 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.57 45.99 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.91 0.884 . . . . 20.0 108.947 167.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' NE2' ' OD1' ' A' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.46 29.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 20.0 110.57 177.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.743 -178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' A' ' 183' ' ' ASP . 11.9 t0 -97.41 68.01 2.14 Favored 'General case' 0 CA--C 1.516 -0.33 0 O-C-N 121.65 -0.657 . . . . 20.0 112.461 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.88 28.79 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.196 -1.038 . . . . 20.0 108.196 178.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 C-N-CA 123.717 0.807 . . . . 20.0 109.164 -178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.467 ' C ' HD23 ' A' ' 74' ' ' LEU . . . -155.91 -175.76 27.28 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 110.594 -1.002 . . . . 20.0 110.594 173.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . 0.467 HD23 ' C ' ' A' ' 73' ' ' GLY . 5.0 mt -125.01 161.49 26.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.339 0.59 . . . . 20.0 109.981 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' A' ' 160' ' ' THR . 10.6 ttm -128.14 131.29 48.97 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-N 114.985 -1.007 . . . . 20.0 109.721 -174.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.03 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.897 -0.779 . . . . 20.0 108.897 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.05 -29.31 7.04 Favored 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 113.106 0.78 . . . . 20.0 113.106 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.04 174.45 13.72 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.139 -1.06 . . . . 20.0 108.139 178.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.05 108.98 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.317 -0.994 . . . . 20.0 108.317 -175.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.75 166.31 5.63 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-O 121.838 0.828 . . . . 20.0 109.971 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.52 -27.11 60.39 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.716 -0.794 . . . . 20.0 112.725 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.54 9.18 4.22 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.364 0.876 . . . . 20.0 113.364 -177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.72 81.76 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-O 118.95 -0.917 . . . . 20.0 115.067 -178.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.78 145.02 34.11 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 118.331 1.065 . . . . 20.0 110.244 178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.54 27.99 Favored 'General case' 0 CA--C 1.518 -0.273 0 CA-C-N 115.245 -0.889 . . . . 20.0 112.568 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.45 174.61 6.59 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 107.83 -1.174 . . . . 20.0 107.83 158.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.75 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.649 0.737 . . . . 20.0 109.482 -170.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.2 129.4 15.7 Favored Pre-proline 0 N--CA 1.448 -0.527 0 CA-C-N 115.026 -0.988 . . . . 20.0 109.812 171.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -79.88 160.25 24.33 Favored 'Trans proline' 0 N--CA 1.455 -0.792 0 CA-C-O 122.26 0.858 . . . . 20.0 112.701 -171.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.473 HD11 HG21 ' A' ' 160' ' ' THR . 9.2 mt -88.79 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 CA-C-N 113.708 -1.587 . . . . 20.0 107.359 165.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.89 47.57 Favored Glycine 0 N--CA 1.449 -0.465 0 CA-C-N 115.231 -0.895 . . . . 20.0 112.161 -168.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.223 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.92 152.65 4.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 118.644 1.222 . . . . 20.0 109.25 -169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.66 130.95 22.21 Favored Pre-proline 0 C--O 1.24 0.56 0 N-CA-C 108.467 -0.938 . . . . 20.0 108.467 173.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.1 -7.96 13.06 Favored 'Trans proline' 0 CA--C 1.515 -0.464 0 CA-C-N 120.59 1.246 . . . . 20.0 114.778 -170.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.16 59.59 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 119.188 0.903 . . . . 20.0 111.786 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.594 HG21 ' OG ' ' A' ' 324' ' ' SER . 44.7 p -89.52 35.51 0.82 Allowed 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.626 0.77 . . . . 20.0 112.424 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.68 HD12 ' H ' ' A' ' 99' ' ' ILE . 0.5 OUTLIER -43.24 -66.46 0.37 Allowed 'General case' 0 CA--C 1.519 -0.219 0 C-N-CA 124.963 1.305 . . . . 20.0 113.423 -173.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.68 ' H ' HD12 ' A' ' 98' ' ' LEU . 1.6 tt -173.17 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.382 0 N-CA-C 109.04 -0.726 . . . . 20.0 109.04 174.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' C' ' 100' ' ' ALA . . . -123.86 -19.02 5.83 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 124.533 1.133 . . . . 20.0 111.254 158.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.429 ' NE2' ' O ' ' C' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.65 2.52 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.464 HH12 ' HB3' ' C' ' 167' ' ' ARG . 0.0 OUTLIER 55.84 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 115.247 1.573 . . . . 20.0 115.247 150.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . 0.57 ' O ' ' N ' ' A' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.26 36.63 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 119.249 0.932 . . . . 20.0 109.411 160.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.31 37.27 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 115.56 -0.745 . . . . 20.0 109.375 -173.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.57 HG22 ' CG1' ' A' ' 162' ' ' ILE . 50.3 t -117.46 110.78 32.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 N-CA-C 108.172 -1.047 . . . . 20.0 108.172 -178.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.04 6.29 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 110.23 -0.285 . . . . 20.0 110.23 179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 27.2 mt -51.95 -54.19 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.299 0 O-C-N 123.34 0.4 . . . . 20.0 110.351 170.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.54 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.446 -0.946 . . . . 20.0 108.446 178.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.475 -177.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.2 11.22 75.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-O 118.894 -0.948 . . . . 20.0 115.322 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.0 15.87 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 118.47 1.135 . . . . 20.0 108.609 177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.5 37.76 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -178.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.52 43.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.652 -0.87 . . . . 20.0 108.652 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.72 149.41 31.17 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.993 -1.003 . . . . 20.0 110.305 -172.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.57 ' N ' ' O ' ' A' ' 103' ' ' PHE . . . -147.94 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 110.322 -1.111 . . . . 20.0 110.322 -176.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 m -128.7 154.46 39.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.34 -0.985 . . . . 20.0 108.34 -177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.31 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.308 -0.86 . . . . 20.0 114.56 -168.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . 0.485 ' O ' HD13 ' A' ' 98' ' ' LEU . . . -67.19 -47.94 69.42 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.399 1.259 . . . . 20.0 114.399 -156.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.15 11.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 119.518 1.054 . . . . 20.0 112.649 -155.369 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.13 35.48 Favored Pre-proline 0 C--O 1.24 0.558 0 N-CA-C 102.63 -3.1 . . . . 20.0 102.63 159.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.529 0 CA-C-N 120.733 1.298 . . . . 20.0 110.553 -178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.276 0 CA-C-N 119.223 0.758 . . . . 20.0 110.65 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.799 0.809 . . . . 20.0 109.974 -178.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.94 3.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.162 -1.051 . . . . 20.0 108.162 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.77 19.5 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.791 -0.363 . . . . 20.0 110.722 169.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.84 -43.63 1.52 Allowed Pre-proline 0 C--O 1.237 0.421 0 C-N-CA 123.948 0.899 . . . . 20.0 113.119 -170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.08 -24.89 59.03 Favored 'Trans proline' 0 C--N 1.358 1.073 0 CA-C-N 120.855 1.341 . . . . 20.0 111.968 170.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.5 -26.55 30.1 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 111.823 0.305 . . . . 20.0 111.823 -177.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.93 69.16 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 119.724 -0.791 . . . . 20.0 110.256 168.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.576 0 N-CA-C 111.892 0.33 . . . . 20.0 111.892 172.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 35.0 mttt -78.48 90.96 4.49 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 109.229 -0.656 . . . . 20.0 109.229 174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.122 0.415 . . . . 20.0 112.122 175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.22 142.53 87.27 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 108.507 -0.923 . . . . 20.0 108.507 172.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.76 153.61 75.36 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 CA-C-N 119.629 0.903 . . . . 20.0 112.384 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.66 42.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.544 -1.207 . . . . 20.0 107.98 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.74 -12.19 59.95 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-O 118.794 -0.622 . . . . 20.0 112.362 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' A' ' 138' ' ' GLN . 14.1 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.888 -0.577 . . . . 20.0 111.354 -175.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' A' ' 139' ' ' ILE . 3.9 tp-100 174.68 174.12 0.2 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 103.13 -2.915 . . . . 20.0 103.13 133.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ILE . . . . . 0.421 ' H ' ' HG3' ' A' ' 138' ' ' GLN . 1.2 tp -74.85 168.12 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 124.107 0.963 . . . . 20.0 108.978 -179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.4 ' H ' HG13 ' A' ' 139' ' ' ILE . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.993 0.917 . . . . 20.0 110.509 177.353 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.416 HD13 HD13 ' A' ' 162' ' ' ILE . 30.2 mt -124.64 147.49 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 108.607 -0.886 . . . . 20.0 108.607 -177.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.553 ' OD1' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -119.09 134.72 55.03 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 123.662 0.785 . . . . 20.0 109.636 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.91 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 O-C-N 123.679 0.612 . . . . 20.0 111.777 166.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.553 ' N ' ' OD1' ' A' ' 142' ' ' ASP . . . 86.82 -6.49 82.81 Favored Glycine 0 N--CA 1.44 -1.051 0 N-CA-C 115.486 0.954 . . . . 20.0 115.486 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.94 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 118.49 1.145 . . . . 20.0 110.263 176.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.83 33.51 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.42 162.62 40.21 Favored 'General case' 0 CA--C 1.516 -0.332 0 CA-C-O 121.976 0.893 . . . . 20.0 111.412 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.47 80.47 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.263 177.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.42 -47.03 87.87 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.827 -0.349 . . . . 20.0 110.91 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.33 -35.24 76.85 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.54 -0.464 . . . . 20.0 110.807 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.58 84.26 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 120.032 -0.667 . . . . 20.0 111.141 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.34 58.52 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.346 -0.941 . . . . 20.0 110.999 -178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.63 -30.11 66.65 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.797 -0.761 . . . . 20.0 110.665 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.57 -40.6 92.24 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 120.57 -0.452 . . . . 20.0 111.659 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.79 6.71 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-O 118.936 -0.925 . . . . 20.0 114.652 -172.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.68 133.53 29.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 118.454 1.127 . . . . 20.0 108.548 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.92 9.34 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 107.746 -1.205 . . . . 20.0 107.746 174.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.3 147.32 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 N-CA-C 107.628 -1.249 . . . . 20.0 107.628 174.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 108.823 -1.711 . . . . 20.0 108.823 -176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' A' ' 75' ' ' MET . 0.2 OUTLIER -79.46 113.61 17.74 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 165.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -19.97 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 N-CA-C 113.759 1.022 . . . . 20.0 113.759 -166.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ILE . . . . . 0.57 ' CG1' HG22 ' A' ' 105' ' ' VAL . 0.5 OUTLIER -111.7 155.63 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 O-C-N 121.662 -0.649 . . . . 20.0 111.772 -159.2 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 164' ' ' TRP . 3.5 t -145.33 -166.39 2.42 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 124.308 1.043 . . . . 20.0 110.423 171.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' TRP . . . . . 0.542 ' N ' ' OG1' ' A' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.85 16.74 Favored 'General case' 0 C--O 1.235 0.308 0 N-CA-C 113.211 0.819 . . . . 20.0 113.211 -160.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ASP . . . . . 0.403 ' O ' ' NE2' ' C' ' 101' ' ' GLN . 7.5 t70 63.66 61.67 0.98 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.224 0.535 . . . . 20.0 112.317 -177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.84 158.63 29.63 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ARG . . . . . 0.452 ' HB3' HH12 ' C' ' 102' ' ' ARG . 0.0 OUTLIER -142.41 148.35 37.67 Favored 'General case' 0 CA--C 1.509 -0.613 0 N-CA-C 107.725 -1.213 . . . . 20.0 107.725 170.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.58 30.38 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.069 -0.968 . . . . 20.0 110.263 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.944 0.878 . . . . 20.0 109.973 177.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.2 34.22 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.216 -1.356 . . . . 20.0 109.465 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.0 151.6 29.1 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.509 -0.552 . . . . 20.0 109.509 168.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLY . . . . . 0.597 ' O ' ' N ' ' A' ' 175' ' ' ARG . . . 57.01 68.64 1.59 Allowed Glycine 0 N--CA 1.442 -0.913 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.95 4.27 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 112.75 0.648 . . . . 20.0 112.75 -174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.09 -63.02 1.28 Allowed 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.736 -0.786 . . . . 20.0 111.206 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.597 ' N ' ' O ' ' A' ' 172' ' ' GLY . 6.9 ptt-85 -169.84 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.1 0 CA-C-N 118.587 0.631 . . . . 20.0 112.655 172.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.41 0.35 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.842 2.457 . . . . 20.0 106.263 157.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.7 145.78 20.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.23 -64.39 1.17 Allowed 'General case' 0 N--CA 1.464 0.229 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.32 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 118.776 0.716 . . . . 20.0 112.144 -171.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.03 -0.75 36.82 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -170.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PHE . . . . . 0.758 ' HB3' ' HB3' ' A' ' 327' ' ' GLU . 3.1 t80 -84.62 -66.91 0.84 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 118.594 0.634 . . . . 20.0 111.8 -162.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.38 127.88 32.91 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 122.123 0.963 . . . . 20.0 110.665 -152.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' A' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.73 1.04 Allowed 'General case' 0 C--O 1.234 0.251 0 C-N-CA 125.339 1.456 . . . . 20.0 113.166 174.659 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.88 1.16 Allowed 'General case' 0 N--CA 1.446 -0.649 0 CA-C-O 122.171 0.986 . . . . 20.0 110.819 157.126 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . 0.44 HG12 HG11 ' A' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 104.475 -2.417 . . . . 20.0 104.475 149.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.725 ' O ' ' OG1' ' A' ' 189' ' ' THR . . . -50.09 -43.02 51.3 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 115.32 -0.855 . . . . 20.0 111.502 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.86 -36.09 76.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.33 -0.948 . . . . 20.0 110.118 -178.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.87 -38.57 91.59 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 119.12 -1.032 . . . . 20.0 110.546 177.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' THR . . . . . 0.725 ' OG1' ' O ' ' A' ' 186' ' ' ALA . 25.2 p -59.16 -48.57 81.12 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.82 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.35 -50.53 64.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 CA-C-O 120.875 0.369 . . . . 20.0 110.467 178.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.18 96.18 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.95 -178.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.88 -36.51 84.16 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.954 -0.699 . . . . 20.0 110.37 177.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.417 HG23 ' O ' ' A' ' 189' ' ' THR . 11.6 t -60.57 -44.82 97.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 CA-C-O 121.06 0.457 . . . . 20.0 110.082 177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.06 -33.33 75.51 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.222 -176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -71.55 -38.16 71.02 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.876 175.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.68 -26.18 41.05 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.55 0.574 . . . . 20.0 112.55 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.54 122.79 27.47 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.3 -0.63 . . . . 20.0 109.3 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.43 -57.05 2.33 Favored 'General case' 0 C--O 1.234 0.267 0 O-C-N 123.288 0.367 . . . . 20.0 110.113 176.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.36 17.49 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 109.691 -0.485 . . . . 20.0 109.691 -172.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.24 4.23 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.189 -0.671 . . . . 20.0 109.189 -174.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.74 -14.57 59.93 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 120.036 -0.666 . . . . 20.0 111.349 176.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.66 30.45 Favored 'General case' 0 N--CA 1.451 -0.396 0 N-CA-C 108.912 -0.773 . . . . 20.0 108.912 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' A' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.96 16.19 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -174.5 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.54 6.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -170.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.92 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.046 -0.724 . . . . 20.0 109.046 173.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.87 125.37 31.28 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' VAL . . . . . 0.697 HG12 HD13 ' A' ' 53' ' ' ILE . 34.0 m -119.92 150.16 22.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.887 -0.783 . . . . 20.0 108.887 174.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.32 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.86 159.95 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.882 0.849 . . . . 20.0 111.113 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.43 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.22 179.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.19 29.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.478 -179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.51 13.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.966 176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.33 -20.4 64.73 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.272 -0.571 . . . . 20.0 111.442 -173.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' VAL . . . . . . . . . . . . . 89.1 t -131.15 121.13 48.53 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.41 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.09 60.95 6.21 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 119.65 -1.262 . . . . 20.0 111.406 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -47.05 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 113.474 0.916 . . . . 20.0 113.474 -179.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.51 -4.52 2.89 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.7 -40.48 40.92 Favored Glycine 0 C--N 1.338 0.641 0 C-N-CA 119.7 -1.238 . . . . 20.0 112.001 168.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' A' ' 222' ' ' SER . . . -65.28 -37.06 86.02 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.287 -0.537 . . . . 20.0 111.361 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.409 ' HB2' ' HB1' ' A' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.7 57.98 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 112.173 0.434 . . . . 20.0 112.173 -174.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' THR . . . . . . . . . . . . . 76.0 p -58.48 -45.85 87.85 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.054 -0.658 . . . . 20.0 110.83 -173.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 219' ' ' ALA . 2.1 p -58.01 -35.82 71.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.789 -0.365 . . . . 20.0 111.378 175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.24 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.462 ' HB2' ' HD2' ' E' ' 307' ' ' LYS . 78.9 t80 -64.12 -33.43 75.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.853 -165.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.72 74.95 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 118.965 -1.588 . . . . 20.0 112.109 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.03 -45.63 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 112.007 0.373 . . . . 20.0 112.007 -158.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLU . . . . . 0.456 ' OE1' ' OG1' ' A' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.63 99.79 Favored Pre-proline 0 C--O 1.237 0.405 0 N-CA-C 118.204 2.668 . . . . 20.0 118.204 -158.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_exo -43.96 143.71 2.98 Favored 'Trans proline' 0 C--O 1.232 0.209 0 N-CA-C 116.005 1.502 . . . . 20.0 116.005 -134.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.18 -4.77 0.77 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 125.231 1.412 . . . . 20.0 113.403 162.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.25 11.48 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 120.124 -0.63 . . . . 20.0 111.808 167.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.5 16.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.91 -0.662 . . . . 20.0 112.285 -175.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.77 170.73 15.54 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 108.77 -0.826 . . . . 20.0 108.77 178.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.03 23.31 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.201 0.524 . . . . 20.0 110.39 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ILE . . . . . 0.48 HD11 ' CE ' ' A' ' 341' ' ' MET . 51.6 mt -133.18 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 107.568 -1.271 . . . . 20.0 107.568 172.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.492 ' OD1' ' NE2' ' A' ' 68' ' ' HIS . 25.4 t0 -135.16 173.21 11.97 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.983 -1.488 . . . . 20.0 106.983 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.692 0.758 . . . . 20.0 111.432 -172.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.444 HG21 ' HA3' ' A' ' 296' ' ' GLY . 9.1 t -165.62 122.79 1.46 Allowed 'General case' 0 C--O 1.233 0.221 0 N-CA-C 107.342 -1.355 . . . . 20.0 107.342 164.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 237' ' ' THR . 17.9 mm -145.53 151.87 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -161.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.24 9.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 106.862 -1.533 . . . . 20.0 106.862 158.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.5 110.02 18.66 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 112.989 0.737 . . . . 20.0 112.989 -155.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.33 36.19 22.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.936 1.295 . . . . 20.0 112.472 158.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.45 78.84 Favored Pre-proline 0 C--N 1.322 -0.613 0 N-CA-C 105.118 -2.178 . . . . 20.0 105.118 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.517 -0.364 0 CA-C-N 120.825 1.33 . . . . 20.0 112.348 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.37 -5.23 45.22 Favored Glycine 0 N--CA 1.442 -0.928 0 CA-C-N 115.048 -0.978 . . . . 20.0 114.922 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.16 164.51 22.98 Favored Pre-proline 0 N--CA 1.453 -0.321 0 CA-C-N 118.638 1.219 . . . . 20.0 110.632 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.01 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.328 -0.543 0 CA-C-O 121.904 0.71 . . . . 20.0 111.962 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 114.718 -1.128 . . . . 20.0 112.035 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.33 -18.67 63.09 Favored 'General case' 0 CA--C 1.518 -0.283 0 C-N-CA 119.821 -0.751 . . . . 20.0 112.846 -171.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.718 ' O ' ' OG1' ' A' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.252 0.834 . . . . 20.0 113.252 170.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.18 -37.76 88.62 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 120.279 -0.569 . . . . 20.0 111.349 -172.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -20.94 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.092 -1.043 . . . . 20.0 111.937 -178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.718 ' OG1' ' O ' ' A' ' 249' ' ' LYS . 39.5 p -57.17 -31.85 65.82 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 118.462 0.574 . . . . 20.0 111.329 173.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' A' ' 319' ' ' ALA . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.391 0.615 . . . . 20.0 110.363 176.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.3 3.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 114.979 -1.009 . . . . 20.0 112.305 175.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.3 35.97 5.83 Favored Glycine 0 CA--C 1.504 -0.614 0 C-N-CA 126.165 1.84 . . . . 20.0 111.542 -177.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.21 10.15 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.655 -0.868 . . . . 20.0 108.655 -167.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.27 3.34 Favored Glycine 0 N--CA 1.437 -1.275 0 CA-C-O 122.667 1.148 . . . . 20.0 113.348 169.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.569 -0.9 . . . . 20.0 108.569 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 316' ' ' SER . . . -126.4 120.35 29.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.128 -0.942 . . . . 20.0 109.422 -169.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.02 139.91 19.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 175.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LYS . . . . . 0.76 ' HE3' HG21 ' A' ' 298' ' ' THR . 1.9 mtmm -98.85 122.64 42.35 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.75 -40.29 10.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 115.865 -0.607 . . . . 20.0 109.612 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 121.402 0.62 . . . . 20.0 109.343 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.07 -169.95 2.85 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.784 -1.098 . . . . 20.0 108.209 165.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.97 -56.27 21.5 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 115.782 -0.645 . . . . 20.0 110.262 163.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.15 11.57 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 113.667 0.988 . . . . 20.0 113.667 -165.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.83 143.66 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -163.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.21 103.98 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 106.172 -1.788 . . . . 20.0 106.172 171.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.1 56.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.286 0.565 . . . . 20.0 111.317 -171.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.11 109.71 2.01 Favored Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.166 -0.924 . . . . 20.0 108.681 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -67.5 -19.96 48.24 Favored 'Trans proline' 0 CA--C 1.513 -0.57 0 N-CA-C 114.845 1.056 . . . . 20.0 114.845 -160.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.65 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.168 -0.613 . . . . 20.0 110.587 176.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.54 -48.38 77.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.14 0.495 . . . . 20.0 110.136 175.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.16 -52.47 60.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.823 0.344 . . . . 20.0 110.723 -176.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.43 -31.93 70.88 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 119.881 -0.728 . . . . 20.0 110.493 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' TRP . . . . . 0.495 ' HH2' ' HB3' ' A' ' 347' ' ' ASN . 0.1 OUTLIER -68.45 -47.99 65.72 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.013 179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.72 89.78 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.982 -0.687 . . . . 20.0 110.752 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.63 -47.9 78.69 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 120.518 -0.473 . . . . 20.0 110.123 173.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.84 -40.4 88.41 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.877 -0.329 . . . . 20.0 110.741 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.112 -172.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.06 -31.73 73.02 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.004 -0.678 . . . . 20.0 111.02 -175.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.77 65.79 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.141 178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.88 -37.63 73.06 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.88 -0.728 . . . . 20.0 110.98 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.63 15.48 29.16 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.8 32.14 13.69 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 121.705 0.764 . . . . 20.0 111.546 173.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.28 143.42 34.47 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.338 -0.986 . . . . 20.0 108.338 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.19 149.34 13.42 Favored 'Trans proline' 0 CA--C 1.516 -0.401 0 CA-C-N 119.195 0.748 . . . . 20.0 111.389 175.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.02 148.11 23.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.679 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.98 175.1 5.61 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 107.735 -1.209 . . . . 20.0 107.735 168.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.69 113.73 17.07 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.864 -1.162 . . . . 20.0 107.864 168.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.69 43.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.06 25.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 173.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.68 12.28 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.46 0.648 . . . . 20.0 110.281 175.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.77 -18.53 21.16 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.83 -1.077 . . . . 20.0 112.186 165.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 N--CA 1.448 -0.533 0 N-CA-C 110.963 -0.855 . . . . 20.0 110.963 -176.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 237' ' ' THR . . . 101.56 144.81 15.56 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 114.652 -0.774 . . . . 20.0 112.674 -178.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.393 0 N-CA-C 110.337 -1.105 . . . . 20.0 110.337 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' THR . . . . . 0.76 HG21 ' HE3' ' A' ' 261' ' ' LYS . 20.4 p -110.21 172.94 6.57 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 122.015 0.912 . . . . 20.0 111.411 -174.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.64 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 114.379 -1.282 . . . . 20.0 111.261 176.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.33 74.1 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 111.768 0.285 . . . . 20.0 111.768 -171.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.12 96.89 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.173 -1.013 . . . . 20.0 112.083 -178.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ALA . . . . . 0.409 ' HB1' ' HB2' ' A' ' 220' ' ' ARG . . . -68.31 -26.87 65.84 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.21 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.95 -34.43 55.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.115 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.15 60.02 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 113.315 0.857 . . . . 20.0 113.315 -174.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' J' ' 217' ' ' ARG . 4.1 mp -103.77 -8.93 19.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 113.724 1.009 . . . . 20.0 113.724 -167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' THR . . . . . 0.456 ' OG1' ' OE1' ' A' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.47 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.619 0.723 . . . . 20.0 110.557 171.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.474 ' HD2' ' HB2' ' J' ' 224' ' ' PHE . 21.5 mmtt -61.68 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.235 -0.893 . . . . 20.0 113.324 -161.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.85 -25.25 66.33 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.79 65.1 1.94 Allowed Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.829 -0.701 . . . . 20.0 113.311 -171.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.21 139.57 52.62 Favored Pre-proline 0 C--O 1.239 0.505 0 CA-C-N 117.585 0.692 . . . . 20.0 111.161 -163.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.5 141.69 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 CA-C-N 119.509 0.86 . . . . 20.0 110.046 168.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 25.7 m -140.46 135.87 32.42 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 115.311 -0.859 . . . . 20.0 111.202 -169.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.66 162.57 12.34 Favored Glycine 0 N--CA 1.441 -0.995 0 N-CA-C 109.164 -1.575 . . . . 20.0 109.164 164.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.0 27.3 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.45 0.643 . . . . 20.0 110.089 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.27 21.03 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 114.594 -1.184 . . . . 20.0 109.254 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' ALA . 4.2 m -138.47 133.5 32.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.32 -0.855 . . . . 20.0 109.5 -178.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.44 HG11 HG12 ' A' ' 185' ' ' ILE . 92.1 t -99.44 108.59 51.23 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 107.254 -1.387 . . . . 20.0 107.254 177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.34 -168.95 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.618 1.007 . . . . 20.0 113.608 -154.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' A' ' 253' ' ' HIS . . . 79.72 35.54 0.15 Allowed 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 113.554 -1.657 . . . . 20.0 115.308 161.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' A' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.59 33.49 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.751 0.786 . . . . 20.0 110.044 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' A' ' 320' ' ' ARG . 3.3 m-85 -113.1 166.14 11.71 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 106.809 -1.552 . . . . 20.0 106.809 160.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.21 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.15 0.98 . . . . 20.0 108.423 -163.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.54 -7.49 3.28 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 114.433 1.271 . . . . 20.0 114.433 -140.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' SER . . . . . 0.594 ' OG ' HG21 ' A' ' 97' ' ' THR . 0.1 OUTLIER -59.47 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.651 0.611 . . . . 20.0 112.651 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' C' ' 100' ' ' ALA . 35.1 p-10 -102.01 -56.15 2.33 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 114.996 1.48 . . . . 20.0 114.996 -152.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.96 50.8 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.433 -1.321 . . . . 20.0 107.433 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLU . . . . . 0.758 ' HB3' ' HB3' ' A' ' 181' ' ' PHE . 82.8 mt-10 -142.56 52.8 1.42 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 113.812 -1.54 . . . . 20.0 109.964 -153.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.05 149.41 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 121.393 0.616 . . . . 20.0 111.961 -171.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' A' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.43 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.253 0 CA-C-O 121.886 0.851 . . . . 20.0 109.472 175.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.12 27.33 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.605 -1.18 . . . . 20.0 108.884 178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.11 -32.03 53.83 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 123.825 0.703 . . . . 20.0 111.514 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ARG . . . . . 0.439 ' NH2' ' OE2' ' C' ' 146' ' ' GLU . 10.3 mtm180 -68.6 -44.81 73.52 Favored 'General case' 0 C--O 1.237 0.436 0 C-N-CA 120.345 -0.542 . . . . 20.0 110.253 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -65.94 -45.05 83.25 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 120.777 -0.369 . . . . 20.0 111.049 -172.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.57 -41.3 92.17 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.464 -0.495 . . . . 20.0 110.518 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -34.68 71.44 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 118.831 -1.148 . . . . 20.0 110.119 178.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.46 -40.39 93.14 Favored 'General case' 0 CA--C 1.515 -0.372 0 C-N-CA 120.038 -0.665 . . . . 20.0 110.446 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.52 -43.84 80.21 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-O 120.74 0.305 . . . . 20.0 110.903 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' VAL . . . . . 0.703 ' O ' ' OG1' ' A' ' 342' ' ' THR . 42.6 t -60.15 -48.97 85.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 120.994 0.426 . . . . 20.0 110.248 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' GLU . . . . . 0.782 ' OE1' ' NZ ' ' A' ' 343' ' ' LYS . 1.3 mm-40 -54.89 -46.86 74.85 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.967 0.413 . . . . 20.0 110.771 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.85 -55.15 37.71 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.359 -0.382 . . . . 20.0 111.403 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' MET . . . . . 0.48 ' CE ' HD11 ' A' ' 234' ' ' ILE . 31.9 tpp -60.21 -40.32 89.68 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.203 -0.599 . . . . 20.0 110.785 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' A' ' 338' ' ' VAL . 1.3 m -56.53 -44.96 81.33 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 121.121 0.486 . . . . 20.0 110.411 -177.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' LYS . . . . . 0.782 ' NZ ' ' OE1' ' A' ' 339' ' ' GLU . 34.6 mttp -74.24 -37.47 63.78 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.961 -0.696 . . . . 20.0 110.76 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.53 97.73 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 120.538 -0.465 . . . . 20.0 111.1 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' A' ' 348' ' ' ILE . 1.0 OUTLIER -58.99 -50.4 74.24 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 120.555 -0.458 . . . . 20.0 110.782 -179.011 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.06 90.93 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.7 -0.8 . . . . 20.0 110.594 -178.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' ASN . . . . . 0.495 ' HB3' ' HH2' ' A' ' 276' ' ' TRP . 5.0 m-20 -84.47 4.77 30.2 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 119.446 -0.901 . . . . 20.0 112.568 -178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 345' ' ' LEU . 1.3 tt -65.2 -23.67 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 119.574 -0.85 . . . . 20.0 110.886 179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.83 -27.27 69.06 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.786 -0.765 . . . . 20.0 111.235 -175.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' GLU . . . . . . . . . . . . . 35.7 tp10 -85.94 -18.83 31.6 Favored 'General case' 0 C--O 1.234 0.275 0 O-C-N 122.058 -0.401 . . . . 20.0 111.467 177.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 351' ' ' LEU . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.131 0.419 . . . . 20.0 112.131 -173.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 116.026 1.862 . . . . 20.0 116.026 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.79 0 C-N-CA 124.99 1.316 . . . . 20.0 108.381 -174.706 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.106 0 N-CA-C 114.257 1.206 . . . . 20.0 114.257 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.07 82.22 2.92 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 106.878 -1.527 . . . . 20.0 106.878 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . . . . . . . . . 35.0 t -62.93 -34.52 66.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-N 114.904 -1.044 . . . . 20.0 110.198 178.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -107.0 -23.53 12.3 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.61 0.967 . . . . 20.0 113.61 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.24 19.89 Favored 'General case' 0 C--O 1.239 0.507 0 C-N-CA 124.147 0.979 . . . . 20.0 111.623 -173.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.71 32.45 Favored 'General case' 0 C--O 1.236 0.389 0 O-C-N 122.275 -0.266 . . . . 20.0 111.24 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.43 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 107.655 -1.239 . . . . 20.0 107.655 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.87 112.21 12.03 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.309 0.576 . . . . 20.0 110.943 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.74 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 115.468 -0.787 . . . . 20.0 111.83 -177.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.08 -45.23 74.39 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.251 178.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.8 -43.1 97.27 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 121.049 -0.26 . . . . 20.0 111.195 -172.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.85 -30.59 70.95 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.786 -0.366 . . . . 20.0 111.167 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.4 90.78 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.639 -0.424 . . . . 20.0 110.498 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.03 -42.99 91.54 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 116.676 -0.238 . . . . 20.0 111.476 -174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.87 -40.1 26.71 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.532 -0.867 . . . . 20.0 110.661 -171.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 C-N-CA 119.042 -1.063 . . . . 20.0 111.001 -162.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -26.01 68.04 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.966 -0.693 . . . . 20.0 111.293 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.42 70.56 Favored Pre-proline 0 N--CA 1.447 -0.584 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.801 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -85.18 144.73 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.459 0 CA-C-O 121.709 0.629 . . . . 20.0 112.145 -172.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.83 38.23 3.41 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 117.277 1.671 . . . . 20.0 117.277 -159.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.8 2.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.118 -1.438 . . . . 20.0 107.118 159.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.2 8.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.356 0.598 . . . . 20.0 110.713 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.678 0 CA-C-N 115.494 -0.775 . . . . 20.0 114.032 -177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.41 0.18 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.28 1.038 . . . . 20.0 109.568 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.87 -13.2 3.98 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 114.891 -1.049 . . . . 20.0 113.465 169.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' B' ' 28' ' ' GLY . 0.0 OUTLIER -87.92 8.97 23.73 Favored 'General case' 0 C--N 1.344 0.367 0 CA-C-N 119.712 1.142 . . . . 20.0 113.806 178.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.66 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 115.433 1.642 . . . . 20.0 115.433 -154.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' B' ' 26' ' ' PHE . . . -53.07 -26.99 29.42 Favored Glycine 0 C--N 1.342 0.894 0 CA-C-N 119.775 1.171 . . . . 20.0 116.023 -172.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ILE . . . . . 0.539 HD13 ' NH1' ' B' ' 184' ' ' ARG . 1.1 tt -59.57 -35.75 61.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 118.06 0.93 . . . . 20.0 110.643 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.36 -52.4 61.73 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-O 120.895 0.379 . . . . 20.0 110.403 178.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.58 74.42 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.33 -0.395 . . . . 20.0 110.984 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.3 -49.54 82.54 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.039 0.447 . . . . 20.0 110.338 -174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' VAL . . . . . . . . . . . . . 53.7 t -64.21 -39.74 86.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.709 -0.797 . . . . 20.0 110.309 -175.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.47 20.4 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 C-N-CA 118.72 -1.192 . . . . 20.0 111.129 179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.53 -30.95 71.67 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.0 0.364 . . . . 20.0 111.08 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.68 3.28 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.184 0.438 . . . . 20.0 112.184 177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.34 -28.43 44.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 CA-C-N 116.492 -0.322 . . . . 20.0 111.53 -164.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.34 -26.41 63.74 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.97 -0.692 . . . . 20.0 112.244 -162.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.1 -23.56 63.07 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 118.914 -1.114 . . . . 20.0 111.726 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.94 22.94 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.479 0.918 . . . . 20.0 113.479 -176.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.57 152.63 22.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -176.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.08 -42.65 89.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.168 -0.924 . . . . 20.0 111.474 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.3 35.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.548 -0.908 . . . . 20.0 108.548 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.46 147.21 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.12 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.518 0.675 . . . . 20.0 110.443 -178.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.06 129.02 74.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.351 -1.351 . . . . 20.0 107.351 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.12 5.83 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.811 0.815 . . . . 20.0 108.857 177.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.51 62.84 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 119.921 -0.712 . . . . 20.0 111.133 -176.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.24 10.86 9.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.631 0.975 . . . . 20.0 113.631 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.53 -6.67 83.35 Favored Glycine 0 N--CA 1.445 -0.753 0 CA-C-O 119.124 -0.82 . . . . 20.0 114.458 -176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.44 35.68 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 118.457 1.128 . . . . 20.0 110.239 173.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.37 140.27 32.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ILE . . . . . 0.694 HD13 HG12 ' B' ' 207' ' ' VAL . 31.3 mm -130.28 115.67 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 -174.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.677 -0.49 . . . . 20.0 109.677 174.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.93 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.6 -0.889 . . . . 20.0 108.6 -173.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 145.37 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 106.745 -1.576 . . . . 20.0 106.745 163.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.52 20.26 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 123.492 0.495 . . . . 20.0 109.74 -175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.62 10.41 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.829 0.852 . . . . 20.0 108.978 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.53 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.093 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.76 165.22 32.81 Favored 'Trans proline' 0 C--N 1.331 -0.378 0 CA-C-O 121.76 0.65 . . . . 20.0 112.082 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.92 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.995 -1.002 . . . . 20.0 109.255 -176.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' VAL . . . . . . . . . . . . . 45.3 t -103.74 137.96 30.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.777 -0.824 . . . . 20.0 108.777 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.09 46.37 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 124.083 0.953 . . . . 20.0 109.026 -175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 29.5 mm -116.28 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.075 -1.083 . . . . 20.0 108.075 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.63 124.65 51.47 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 123.329 0.393 . . . . 20.0 110.968 -168.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.5 154.59 45.97 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.887 0.875 . . . . 20.0 108.925 167.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' B' ' 235' ' ' ASP . 0.0 OUTLIER -105.03 146.46 29.05 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.99 -0.55 . . . . 20.0 110.534 177.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.188 -0.915 . . . . 20.0 109.711 -178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' B' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.645 -0.66 . . . . 20.0 112.445 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.32 144.93 28.59 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.234 -1.025 . . . . 20.0 108.234 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.8 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 C-N-CA 123.778 0.831 . . . . 20.0 109.127 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . 0.461 ' C ' HD23 ' B' ' 74' ' ' LEU . . . -155.79 -175.7 27.09 Favored Glycine 0 N--CA 1.445 -0.74 0 N-CA-C 110.576 -1.01 . . . . 20.0 110.576 173.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.461 HD23 ' C ' ' B' ' 73' ' ' GLY . 5.1 mt -125.06 161.45 26.74 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.356 0.598 . . . . 20.0 109.954 178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' MET . . . . . 0.53 ' HB2' HG23 ' B' ' 160' ' ' THR . 10.6 ttm -128.09 131.39 49.05 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 114.977 -1.01 . . . . 20.0 109.709 -174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.54 137.08 23.83 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 108.862 -0.792 . . . . 20.0 108.862 168.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.1 -29.26 7.04 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 113.102 0.778 . . . . 20.0 113.102 178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.06 174.42 13.75 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.132 -1.062 . . . . 20.0 108.132 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.6 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.832 0.825 . . . . 20.0 109.998 173.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.02 60.32 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 119.705 -0.798 . . . . 20.0 112.687 -169.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.53 9.12 4.27 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.317 0.858 . . . . 20.0 113.317 -177.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.8 81.74 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-O 118.99 -0.894 . . . . 20.0 115.079 -178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.83 145.04 34.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 118.335 1.067 . . . . 20.0 110.218 178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.5 28.02 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.235 -0.893 . . . . 20.0 112.604 -172.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.883 -1.154 . . . . 20.0 107.883 158.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.76 163.85 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-O 121.654 0.74 . . . . 20.0 109.433 -170.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.29 129.31 15.56 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 114.997 -1.002 . . . . 20.0 109.828 171.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.77 160.24 24.67 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.268 0.862 . . . . 20.0 112.721 -171.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ILE . . . . . 0.481 HD11 HG21 ' B' ' 160' ' ' THR . 9.2 mt -88.77 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 CA-C-N 113.711 -1.586 . . . . 20.0 107.364 165.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.02 140.97 47.51 Favored Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.258 -0.883 . . . . 20.0 112.148 -168.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.19 22.2 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-O 118.938 -0.923 . . . . 20.0 115.252 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.82 152.62 4.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 118.639 1.219 . . . . 20.0 109.258 -169.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.92 22.25 Favored Pre-proline 0 C--O 1.239 0.55 0 N-CA-C 108.473 -0.936 . . . . 20.0 108.473 173.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.04 -7.95 13.12 Favored 'Trans proline' 0 CA--C 1.515 -0.441 0 CA-C-N 120.575 1.241 . . . . 20.0 114.83 -170.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.2 -15.34 59.75 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 119.149 0.886 . . . . 20.0 111.781 174.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.6 HG21 ' OG ' ' B' ' 324' ' ' SER . 44.7 p -89.38 35.48 0.81 Allowed 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.666 0.786 . . . . 20.0 112.458 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.681 HD12 ' H ' ' B' ' 99' ' ' ILE . 0.5 OUTLIER -43.28 -66.41 0.38 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 124.985 1.314 . . . . 20.0 113.395 -173.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ILE . . . . . 0.681 ' H ' HD12 ' B' ' 98' ' ' LEU . 1.6 tt -173.21 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.346 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 174.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ALA . . . . . 0.443 ' HB3' ' H ' ' D' ' 100' ' ' ALA . . . -123.95 -19.04 5.78 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.628 -1.169 . . . . 20.0 111.242 158.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' GLN . . . . . 0.406 ' HB3' HH21 ' B' ' 102' ' ' ARG . 0.0 OUTLIER -169.31 141.65 2.55 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.665 -0.865 . . . . 20.0 108.665 176.711 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ARG . . . . . 0.434 HH12 ' HB3' ' D' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.53 0.38 Allowed 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 115.242 1.571 . . . . 20.0 115.242 150.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' PHE . . . . . 0.576 ' O ' ' N ' ' B' ' 115' ' ' GLY . 0.5 OUTLIER -79.29 134.23 36.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 119.236 0.925 . . . . 20.0 109.442 160.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.79 140.23 37.34 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-N 115.571 -0.741 . . . . 20.0 109.404 -173.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' VAL . . . . . 0.568 HG22 ' CG1' ' B' ' 162' ' ' ILE . 50.4 t -117.38 110.78 32.21 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.242 -1.021 . . . . 20.0 108.242 -179.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.56 83.05 6.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.255 -0.276 . . . . 20.0 110.255 179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -51.91 -54.18 14.5 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 O-C-N 123.378 0.424 . . . . 20.0 110.377 170.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.63 177.48 10.62 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.388 -0.967 . . . . 20.0 108.388 178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.34 27.3 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.891 -1.05 . . . . 20.0 110.463 -177.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.28 74.98 Favored Glycine 0 N--CA 1.445 -0.708 0 CA-C-O 118.83 -0.984 . . . . 20.0 115.308 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.05 113.97 15.81 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.508 1.154 . . . . 20.0 108.592 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.26 141.51 37.8 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 N-CA-C 108.658 -0.867 . . . . 20.0 108.658 172.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.68 149.4 31.24 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.992 -1.004 . . . . 20.0 110.32 -172.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . 0.576 ' N ' ' O ' ' B' ' 103' ' ' PHE . . . -147.95 157.74 27.45 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.288 -1.125 . . . . 20.0 110.288 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.4 39.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 108.363 -0.977 . . . . 20.0 108.363 -177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.22 1.75 Allowed Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.321 -0.854 . . . . 20.0 114.565 -168.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' ALA . . . . . 0.497 ' O ' HD13 ' B' ' 98' ' ' LEU . . . -67.18 -47.98 69.33 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 114.326 1.232 . . . . 20.0 114.326 -156.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.58 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 119.549 1.068 . . . . 20.0 112.706 -155.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.12 35.51 Favored Pre-proline 0 C--O 1.24 0.557 0 N-CA-C 102.616 -3.105 . . . . 20.0 102.616 159.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.85 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.527 0 CA-C-N 120.677 1.278 . . . . 20.0 110.548 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.79 149.73 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 CA-C-N 119.209 0.753 . . . . 20.0 110.692 177.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.03 165.4 7.02 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.846 0.832 . . . . 20.0 109.947 -178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.2 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 108.138 -1.06 . . . . 20.0 108.138 -175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.88 19.78 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 120.818 0.342 . . . . 20.0 110.764 169.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.01 -43.6 1.47 Allowed Pre-proline 0 C--O 1.237 0.419 0 C-N-CA 123.93 0.892 . . . . 20.0 113.074 -170.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 127' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -65.02 -24.92 59.41 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.879 1.35 . . . . 20.0 111.998 170.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.51 30.12 Favored 'General case' 0 C--O 1.237 0.418 0 N-CA-C 111.807 0.299 . . . . 20.0 111.807 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.98 69.16 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.251 168.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.96 62.73 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.953 0.353 . . . . 20.0 111.953 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.41 90.85 4.44 Favored 'General case' 0 CA--C 1.513 -0.463 0 N-CA-C 109.262 -0.644 . . . . 20.0 109.262 174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.41 7.7 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.125 0.417 . . . . 20.0 112.125 175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.21 142.58 87.36 Favored Pre-proline 0 N--CA 1.444 -0.728 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.82 153.64 75.12 Favored 'Trans proline' 0 C--N 1.327 -0.567 0 CA-C-N 119.646 0.909 . . . . 20.0 112.329 177.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.69 153.66 42.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.481 -1.236 . . . . 20.0 107.935 177.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.27 59.95 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 118.85 -0.595 . . . . 20.0 112.405 -175.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' B' ' 138' ' ' GLN . 14.2 p30 -55.3 -66.39 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.91 -0.567 . . . . 20.0 111.409 -175.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 138' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' B' ' 139' ' ' ILE . 3.9 tp-100 174.66 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.079 -2.934 . . . . 20.0 103.079 133.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 139' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' B' ' 138' ' ' GLN . 1.2 tp -74.86 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.495 0 C-N-CA 124.124 0.97 . . . . 20.0 108.918 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' B' ' 139' ' ' ILE . 0.3 OUTLIER -114.84 161.47 18.18 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.947 0.899 . . . . 20.0 110.536 177.35 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 141' ' ' ILE . . . . . 0.406 HD13 HD13 ' B' ' 162' ' ' ILE . 30.5 mt -124.67 147.46 29.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' B' ' 144' ' ' GLY . 0.5 OUTLIER -119.06 134.81 54.97 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.578 0.751 . . . . 20.0 109.577 175.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.83 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 O-C-N 123.663 0.602 . . . . 20.0 111.818 166.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' B' ' 142' ' ' ASP . . . 86.89 -6.62 82.72 Favored Glycine 0 N--CA 1.441 -0.992 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.11 144.0 54.01 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.476 1.138 . . . . 20.0 110.353 176.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 146' ' ' GLU . . . . . 0.4 ' OE2' ' NH2' ' D' ' 332' ' ' ARG . 94.2 mt-10 -83.32 -20.9 33.51 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 113.624 0.972 . . . . 20.0 113.624 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.61 40.2 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.982 0.896 . . . . 20.0 111.403 -173.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.4 -41.46 80.35 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 113.867 -1.515 . . . . 20.0 111.26 177.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.48 -46.98 88.13 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.83 -0.348 . . . . 20.0 110.905 -179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.33 -35.19 76.71 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.472 -0.491 . . . . 20.0 110.826 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.71 -40.61 84.28 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.122 -175.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.35 58.49 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.388 -0.925 . . . . 20.0 111.009 -178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.11 66.61 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 119.782 -0.767 . . . . 20.0 110.61 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.57 -40.67 92.54 Favored 'General case' 0 CA--C 1.514 -0.417 0 C-N-CA 120.569 -0.452 . . . . 20.0 111.614 171.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.75 6.69 Favored Glycine 0 N--CA 1.445 -0.766 0 CA-C-O 118.952 -0.915 . . . . 20.0 114.606 -172.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 156' ' ' VAL . . . . . . . . . . . . . 75.1 t -63.68 133.56 29.28 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 118.447 1.124 . . . . 20.0 108.567 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 107.747 -1.205 . . . . 20.0 107.747 174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 N-CA-C 107.65 -1.241 . . . . 20.0 107.65 174.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.36 169.34 15.74 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 108.81 -1.716 . . . . 20.0 108.81 -176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 160' ' ' THR . . . . . 0.53 HG23 ' HB2' ' B' ' 75' ' ' MET . 0.2 OUTLIER -79.41 113.59 17.67 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.656 -1.238 . . . . 20.0 107.656 165.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.69 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.346 0 N-CA-C 113.713 1.005 . . . . 20.0 113.713 -166.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 162' ' ' ILE . . . . . 0.568 ' CG1' HG22 ' B' ' 105' ' ' VAL . 0.5 OUTLIER -111.64 155.63 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.437 0 O-C-N 121.691 -0.631 . . . . 20.0 111.79 -159.189 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 163' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' B' ' 164' ' ' TRP . 3.5 t -145.34 -166.32 2.4 Favored 'General case' 0 C--O 1.233 0.201 0 C-N-CA 124.272 1.029 . . . . 20.0 110.465 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 164' ' ' TRP . . . . . 0.555 ' N ' ' OG1' ' B' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.91 16.7 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 113.221 0.823 . . . . 20.0 113.221 -160.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.68 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.227 0.536 . . . . 20.0 112.268 -177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.94 158.61 29.5 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.133 -1.187 . . . . 20.0 110.133 172.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 167' ' ' ARG . . . . . 0.482 ' HB3' HH12 ' D' ' 102' ' ' ARG . 0.0 OUTLIER -142.4 148.31 37.63 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 170.664 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.58 30.38 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.068 -0.969 . . . . 20.0 110.216 -167.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 169' ' ' GLU . . . . . . . . . . . . . 36.5 mm-40 -129.41 159.75 35.26 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 121.913 0.863 . . . . 20.0 110.002 177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.2 34.22 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.203 -1.362 . . . . 20.0 109.471 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.64 28.96 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 109.528 -0.545 . . . . 20.0 109.528 168.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 172' ' ' GLY . . . . . 0.6 ' O ' ' N ' ' B' ' 175' ' ' ARG . . . 56.89 68.72 1.55 Allowed Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -170.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.92 4.25 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 112.785 0.661 . . . . 20.0 112.785 -174.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.17 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.69 -0.804 . . . . 20.0 111.208 157.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 175' ' ' ARG . . . . . 0.6 ' N ' ' O ' ' B' ' 172' ' ' GLY . 6.8 ptt-85 -169.82 122.01 0.7 Allowed 'General case' 0 C--O 1.231 0.108 0 CA-C-N 118.632 0.651 . . . . 20.0 112.605 172.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.39 0.35 Allowed 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 127.89 2.476 . . . . 20.0 106.278 157.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.69 145.81 20.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 108.458 -0.942 . . . . 20.0 108.458 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.16 -64.51 1.15 Allowed 'General case' 0 N--CA 1.464 0.225 0 N-CA-C 116.415 2.006 . . . . 20.0 116.415 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 118.715 0.689 . . . . 20.0 112.125 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.92 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.359 1.244 . . . . 20.0 114.359 -170.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 181' ' ' PHE . . . . . 0.747 ' HB3' ' HB3' ' B' ' 327' ' ' GLU . 3.2 t80 -84.68 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 118.641 0.655 . . . . 20.0 111.723 -162.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.29 127.83 32.83 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 122.085 0.945 . . . . 20.0 110.655 -152.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 183' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' B' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.74 1.04 Allowed 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.353 1.461 . . . . 20.0 113.157 174.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 184' ' ' ARG . . . . . 0.539 ' NH1' HD13 ' B' ' 29' ' ' ILE . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 122.212 1.006 . . . . 20.0 110.809 157.16 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 185' ' ' ILE . . . . . 0.446 HG12 HG11 ' B' ' 317' ' ' VAL . 1.0 OUTLIER -126.15 -41.06 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 104.468 -2.419 . . . . 20.0 104.468 149.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 186' ' ' ALA . . . . . 0.703 ' O ' ' OG1' ' B' ' 189' ' ' THR . . . -50.18 -42.93 52.1 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.401 -0.818 . . . . 20.0 111.488 173.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.092 -178.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.66 91.93 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.151 -1.02 . . . . 20.0 110.539 177.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 189' ' ' THR . . . . . 0.703 ' OG1' ' O ' ' B' ' 186' ' ' ALA . 25.2 p -59.09 -48.58 81.07 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 119.458 -0.897 . . . . 20.0 110.84 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.55 64.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 CA-C-O 120.966 0.412 . . . . 20.0 110.504 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.17 96.02 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.069 -0.652 . . . . 20.0 110.918 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.56 84.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.951 -0.7 . . . . 20.0 110.34 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 193' ' ' VAL . . . . . 0.401 HG23 ' O ' ' B' ' 189' ' ' THR . 11.5 t -60.56 -44.83 97.52 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-O 121.017 0.437 . . . . 20.0 110.074 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.31 75.48 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.19 -176.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.61 -38.2 70.85 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.878 -0.729 . . . . 20.0 110.777 175.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.61 -26.16 41.27 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.76 27.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.258 -0.645 . . . . 20.0 109.258 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.08 2.32 Favored 'General case' 0 C--O 1.234 0.246 0 O-C-N 123.277 0.361 . . . . 20.0 110.11 176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.39 17.52 Favored 'General case' 0 C--O 1.237 0.396 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.0 91.28 4.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.221 -0.659 . . . . 20.0 109.221 -174.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.55 59.92 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 120.034 -0.667 . . . . 20.0 111.312 176.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.69 30.46 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 108.914 -0.772 . . . . 20.0 108.914 172.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 203' ' ' ASP . . . . . 0.643 ' N ' ' OD1' ' B' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.02 16.35 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.487 -0.931 . . . . 20.0 108.487 -174.492 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.59 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.394 0 N-CA-C 108.593 -0.891 . . . . 20.0 108.593 -170.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.96 106.58 8.99 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.009 -0.738 . . . . 20.0 109.009 173.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.88 125.4 31.3 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 108.774 -0.825 . . . . 20.0 108.774 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 207' ' ' VAL . . . . . 0.694 HG12 HD13 ' B' ' 53' ' ' ILE . 34.1 m -119.96 150.17 22.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.328 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.38 98.78 5.17 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.4 -1.333 . . . . 20.0 107.4 171.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 209' ' ' THR . . . . . . . . . . . . . 34.5 p -85.85 159.96 19.57 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.889 0.852 . . . . 20.0 111.129 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.82 166.41 13.21 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.406 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.19 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.22 29.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.743 -1.117 . . . . 20.0 111.515 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.0 -49.51 13.92 Favored 'General case' 0 CA--C 1.516 -0.353 0 C-N-CA 120.387 -0.525 . . . . 20.0 110.974 176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -20.42 64.74 Favored 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.461 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.16 121.09 48.4 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.582 -0.895 . . . . 20.0 108.582 173.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.93 6.26 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 119.71 -1.233 . . . . 20.0 111.473 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 216' ' ' LEU . . . . . 0.427 ' H ' HD23 ' B' ' 216' ' ' LEU . 0.5 OUTLIER -47.01 -25.51 0.82 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.458 0.91 . . . . 20.0 113.458 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 217' ' ' ARG . . . . . 0.442 ' HB3' ' HG ' ' H' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.52 2.86 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.358 0.503 . . . . 20.0 112.358 173.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.53 40.82 Favored Glycine 0 C--N 1.338 0.64 0 C-N-CA 119.715 -1.231 . . . . 20.0 112.003 168.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' B' ' 222' ' ' SER . . . -65.27 -37.07 86.04 Favored 'General case' 0 C--O 1.237 0.424 0 O-C-N 122.247 -0.561 . . . . 20.0 111.37 179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 220' ' ' ARG . . . . . 0.411 ' HB2' ' HB1' ' B' ' 302' ' ' ALA . 16.6 ttm180 -52.68 -36.73 57.66 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 221' ' ' THR . . . . . . . . . . . . . 75.8 p -58.4 -45.84 87.58 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.034 -0.666 . . . . 20.0 110.886 -173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' B' ' 219' ' ' ALA . 2.1 p -58.0 -35.79 71.75 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.741 -0.384 . . . . 20.0 111.462 175.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.63 -49.95 69.3 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 112.605 0.594 . . . . 20.0 112.605 -169.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 224' ' ' PHE . . . . . 0.421 ' HB2' ' HD2' ' H' ' 307' ' ' LYS . 79.1 t80 -64.19 -33.45 75.83 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.78 -0.768 . . . . 20.0 111.771 -165.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.68 74.92 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.953 -1.594 . . . . 20.0 112.12 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.01 -45.58 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 112.004 0.372 . . . . 20.0 112.004 -158.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 227' ' ' GLU . . . . . 0.437 ' OE1' ' OG1' ' B' ' 306' ' ' THR . 3.0 pt-20 -56.47 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.418 0 N-CA-C 118.223 2.675 . . . . 20.0 118.223 -158.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 228' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_exo -43.89 143.67 2.91 Favored 'Trans proline' 0 C--O 1.232 0.198 0 N-CA-C 115.964 1.486 . . . . 20.0 115.964 -134.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.18 -4.78 0.77 Allowed 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 125.205 1.402 . . . . 20.0 113.405 162.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.86 171.25 11.5 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.043 -0.663 . . . . 20.0 111.749 167.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.52 151.42 16.26 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.943 -0.646 . . . . 20.0 112.323 -175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.66 170.76 15.46 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 123.785 0.834 . . . . 20.0 108.825 178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.06 23.38 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.137 0.494 . . . . 20.0 110.403 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 234' ' ' ILE . . . . . 0.495 HD11 ' CE ' ' B' ' 341' ' ' MET . 51.8 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' B' ' 68' ' ' HIS . 25.6 t0 -135.17 173.22 11.96 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.945 -1.502 . . . . 20.0 106.945 173.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-O 121.624 0.726 . . . . 20.0 111.441 -172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 237' ' ' THR . . . . . 0.446 HG21 ' HA3' ' B' ' 296' ' ' GLY . 9.2 t -165.62 122.71 1.45 Allowed 'General case' 0 C--O 1.233 0.196 0 N-CA-C 107.353 -1.351 . . . . 20.0 107.353 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' B' ' 237' ' ' THR . 18.0 mm -145.49 151.92 14.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -161.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 106.869 -1.53 . . . . 20.0 106.869 158.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.04 18.71 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.985 0.735 . . . . 20.0 112.985 -155.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.32 36.13 22.05 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.92 1.288 . . . . 20.0 112.528 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.91 128.44 79.05 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 105.173 -2.158 . . . . 20.0 105.173 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.06 165.56 12.14 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 120.889 1.353 . . . . 20.0 112.408 -178.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.43 -5.31 45.22 Favored Glycine 0 N--CA 1.441 -0.998 0 CA-C-N 115.126 -0.943 . . . . 20.0 114.952 -173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.13 164.49 23.08 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 118.59 1.195 . . . . 20.0 110.702 177.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.96 -172.65 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.586 0 CA-C-O 121.858 0.691 . . . . 20.0 111.94 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.85 59.56 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.026 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.3 -18.68 63.11 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 119.838 -0.745 . . . . 20.0 112.865 -171.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 249' ' ' LYS . . . . . 0.723 ' O ' ' OG1' ' B' ' 252' ' ' THR . 16.9 mttt -98.78 -15.16 19.4 Favored 'General case' 0 CA--C 1.513 -0.465 0 N-CA-C 113.238 0.829 . . . . 20.0 113.238 170.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.82 88.84 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.364 -172.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.57 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 119.076 -1.05 . . . . 20.0 111.898 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 252' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' B' ' 249' ' ' LYS . 39.2 p -57.14 -31.83 65.76 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.473 0.579 . . . . 20.0 111.325 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 253' ' ' HIS . . . . . 0.551 ' CD2' ' HB2' ' B' ' 319' ' ' ALA . 16.6 t-80 -162.4 132.1 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.303 0.573 . . . . 20.0 110.434 176.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.45 -1.3 3.93 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.987 -1.006 . . . . 20.0 112.275 175.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.692 0 C-N-CA 126.204 1.859 . . . . 20.0 111.573 -177.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.38 129.23 10.2 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.05 174.25 3.35 Favored Glycine 0 N--CA 1.437 -1.251 0 CA-C-O 122.712 1.173 . . . . 20.0 113.307 169.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.08 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 259' ' ' ALA . . . . . 0.411 ' O ' ' N ' ' B' ' 316' ' ' SER . . . -126.42 120.35 29.57 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.135 -0.939 . . . . 20.0 109.427 -169.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -98.0 139.95 19.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 261' ' ' LYS . . . . . 0.769 ' HE3' HG21 ' B' ' 298' ' ' THR . 1.9 mtmm -98.86 122.65 42.37 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.001 -0.741 . . . . 20.0 109.001 -177.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 262' ' ' ILE . . . . . . . . . . . . . 13.7 mt -95.8 -40.21 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 CA-C-N 115.862 -0.608 . . . . 20.0 109.598 173.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.57 34.59 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.337 -0.616 . . . . 20.0 109.337 -174.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.97 2.87 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 114.817 -1.083 . . . . 20.0 108.231 165.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.62 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 115.798 -0.637 . . . . 20.0 110.261 163.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.1 11.62 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.82 143.63 25.32 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.427 -0.583 . . . . 20.0 109.427 -163.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 104.03 14.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 106.14 -1.8 . . . . 20.0 106.14 171.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.39 137.08 56.62 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.288 0.566 . . . . 20.0 111.305 -171.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.65 1.97 Allowed Pre-proline 0 C--O 1.24 0.586 0 CA-C-N 115.154 -0.93 . . . . 20.0 108.656 177.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 271' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -67.41 -20.07 48.63 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.851 1.058 . . . . 20.0 114.851 -160.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.235 0.342 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.591 176.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.36 77.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-O 121.073 0.463 . . . . 20.0 110.104 175.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.19 -52.52 59.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-O 120.823 0.344 . . . . 20.0 110.663 -176.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.36 -31.9 70.77 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.825 -0.75 . . . . 20.0 110.569 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 276' ' ' TRP . . . . . 0.486 ' HH2' ' HB3' ' B' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -47.98 65.67 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.094 -0.642 . . . . 20.0 110.976 179.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.04 -38.75 89.88 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.039 -0.664 . . . . 20.0 110.736 177.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.57 -48.01 78.28 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.578 -0.449 . . . . 20.0 110.111 173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.75 -40.52 88.39 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.884 -0.326 . . . . 20.0 110.71 175.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.23 -45.03 78.0 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.303 -0.559 . . . . 20.0 111.077 -172.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.71 73.0 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.052 -175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.36 -31.85 65.96 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.176 178.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.71 73.28 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.872 -0.731 . . . . 20.0 111.008 -175.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 284' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -102.56 15.44 29.26 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 113.33 0.863 . . . . 20.0 113.33 178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.85 32.13 13.55 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.734 0.778 . . . . 20.0 111.555 173.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.29 143.41 34.43 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 108.288 -1.004 . . . . 20.0 108.288 -178.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.21 149.37 13.4 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.164 0.737 . . . . 20.0 111.357 175.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.12 23.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 115.639 -0.71 . . . . 20.0 109.702 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.99 175.13 5.6 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.63 113.73 17.11 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 107.892 -1.151 . . . . 20.0 107.892 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.65 43.77 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.441 -0.577 . . . . 20.0 109.441 -172.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.08 157.03 25.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 107.688 -1.226 . . . . 20.0 107.688 173.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.67 12.29 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.458 0.647 . . . . 20.0 110.292 176.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.73 -18.55 21.18 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.157 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.59 -176.04 20.06 Favored Glycine 0 C--N 1.335 0.474 0 N-CA-C 110.964 -0.854 . . . . 20.0 110.964 -176.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 296' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' B' ' 237' ' ' THR . . . 101.5 144.73 15.5 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 114.648 -0.776 . . . . 20.0 112.689 -178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.346 -1.101 . . . . 20.0 110.346 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 298' ' ' THR . . . . . 0.769 HG21 ' HE3' ' B' ' 261' ' ' LYS . 20.4 p -110.22 172.88 6.6 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 122.086 0.946 . . . . 20.0 111.367 -174.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.89 -33.72 76.7 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 114.388 -1.278 . . . . 20.0 111.229 176.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.35 74.02 Favored 'General case' 0 C--O 1.235 0.322 0 N-CA-C 111.83 0.308 . . . . 20.0 111.83 -171.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.14 96.85 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.167 -1.016 . . . . 20.0 112.103 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' ALA . . . . . 0.411 ' HB1' ' HB2' ' B' ' 220' ' ' ARG . . . -68.33 -26.9 65.85 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.165 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.85 -34.51 56.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.154 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.27 -14.08 59.9 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.287 0.847 . . . . 20.0 113.287 -174.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' LEU . . . . . 0.46 ' HG ' ' HB3' ' L' ' 217' ' ' ARG . 4.1 mp -103.78 -8.9 19.47 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.662 0.986 . . . . 20.0 113.662 -167.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' THR . . . . . 0.437 ' OG1' ' OE1' ' B' ' 227' ' ' GLU . 0.5 OUTLIER -58.36 157.62 8.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.597 0.713 . . . . 20.0 110.556 171.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.79 -29.86 70.43 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.304 -0.862 . . . . 20.0 113.313 -161.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.2 66.29 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 119.715 -0.794 . . . . 20.0 111.221 -178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.76 65.16 1.94 Allowed Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.869 -0.681 . . . . 20.0 113.332 -171.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.3 139.61 52.29 Favored Pre-proline 0 C--O 1.238 0.469 0 CA-C-N 117.582 0.691 . . . . 20.0 111.104 -163.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.533 0 CA-C-N 119.476 0.849 . . . . 20.0 110.025 168.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.46 135.78 32.33 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.355 -0.839 . . . . 20.0 111.239 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.6 12.32 Favored Glycine 0 N--CA 1.442 -0.952 0 N-CA-C 109.144 -1.582 . . . . 20.0 109.144 164.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.44 136.01 27.31 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.463 0.649 . . . . 20.0 110.033 -176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -103.98 153.22 21.08 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 114.617 -1.174 . . . . 20.0 109.231 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' SER . . . . . 0.411 ' N ' ' O ' ' B' ' 259' ' ' ALA . 4.2 m -138.49 133.55 32.82 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.286 -0.87 . . . . 20.0 109.474 -178.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' VAL . . . . . 0.446 HG11 HG12 ' B' ' 185' ' ' ILE . 92.1 t -99.47 108.65 51.62 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.218 -1.401 . . . . 20.0 107.218 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.715 0 CA-C-O 122.652 1.022 . . . . 20.0 113.603 -154.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.551 ' HB2' ' CD2' ' B' ' 253' ' ' HIS . . . 79.88 35.4 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.594 -1.639 . . . . 20.0 115.269 160.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 321' ' ' TYR . 0.4 OUTLIER -75.59 157.59 33.61 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.71 0.767 . . . . 20.0 110.118 176.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' TYR . . . . . 0.426 ' O ' ' HG3' ' B' ' 320' ' ' ARG . 3.3 m-85 -113.11 166.19 11.66 Favored 'General case' 0 CA--C 1.516 -0.356 0 N-CA-C 106.811 -1.552 . . . . 20.0 106.811 160.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.2 113.64 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 124.137 0.975 . . . . 20.0 108.447 -163.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.6 -7.39 3.27 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' SER . . . . . 0.6 ' OG ' HG21 ' B' ' 97' ' ' THR . 0.1 OUTLIER -59.46 -59.97 4.6 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.69 0.626 . . . . 20.0 112.69 179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' ASN . . . . . 0.433 ' HB2' ' HA ' ' D' ' 100' ' ' ALA . 35.0 p-10 -102.0 -56.16 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.006 1.484 . . . . 20.0 115.006 -152.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.97 50.79 Favored 'General case' 0 CA--C 1.508 -0.65 0 N-CA-C 107.454 -1.313 . . . . 20.0 107.454 174.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' GLU . . . . . 0.747 ' HB3' ' HB3' ' B' ' 181' ' ' PHE . 82.8 mt-10 -142.59 52.85 1.42 Allowed 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 113.856 -1.52 . . . . 20.0 109.926 -153.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' VAL . . . . . . . . . . . . . 53.1 t -51.04 149.41 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 CA-C-O 121.412 0.625 . . . . 20.0 111.925 -171.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' VAL . . . . . 0.422 HG13 ' HB2' ' B' ' 181' ' ' PHE . 0.3 OUTLIER -139.38 179.42 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.904 0.859 . . . . 20.0 109.465 175.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.16 27.43 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.636 -1.166 . . . . 20.0 108.868 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.09 -32.07 53.74 Favored 'General case' 0 C--O 1.235 0.332 0 O-C-N 123.885 0.741 . . . . 20.0 111.495 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.59 -44.84 73.49 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 120.337 -0.545 . . . . 20.0 110.192 -176.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.88 83.38 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.057 -172.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.73 -41.24 91.92 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 120.397 -0.521 . . . . 20.0 110.456 -173.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.01 -34.7 71.59 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.888 -1.125 . . . . 20.0 110.115 178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.04 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.422 176.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.84 80.48 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.826 0.346 . . . . 20.0 110.937 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' VAL . . . . . 0.691 ' O ' ' OG1' ' B' ' 342' ' ' THR . 42.7 t -60.16 -48.94 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 121.014 0.435 . . . . 20.0 110.305 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLU . . . . . 0.777 ' OE1' ' NZ ' ' B' ' 343' ' ' LYS . 1.3 mm-40 -54.86 -46.96 74.76 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.982 0.42 . . . . 20.0 110.752 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.14 37.97 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-N 116.375 -0.375 . . . . 20.0 111.452 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' MET . . . . . 0.495 ' CE ' HD11 ' B' ' 234' ' ' ILE . 31.9 tpp -60.15 -40.33 89.48 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.199 -0.6 . . . . 20.0 110.813 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' THR . . . . . 0.691 ' OG1' ' O ' ' B' ' 338' ' ' VAL . 1.3 m -56.51 -45.03 81.26 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 121.15 0.5 . . . . 20.0 110.398 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' LYS . . . . . 0.777 ' NZ ' ' OE1' ' B' ' 339' ' ' GLU . 34.6 mttp -74.14 -37.49 64.04 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.779 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.81 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.577 -0.449 . . . . 20.0 111.122 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' B' ' 348' ' ' ILE . 1.0 OUTLIER -58.98 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.829 -179.077 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.63 -39.09 91.08 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 119.706 -0.797 . . . . 20.0 110.587 -178.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' ASN . . . . . 0.486 ' HB3' ' HH2' ' B' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.8 30.26 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.42 -0.912 . . . . 20.0 112.479 -178.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' B' ' 345' ' ' LEU . 1.3 tt -65.21 -23.62 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 119.118 0.872 . . . . 20.0 110.936 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.43 69.19 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.785 -0.766 . . . . 20.0 111.245 -175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.81 -18.85 31.74 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 122.111 -0.368 . . . . 20.0 111.485 177.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' LEU . . . . . 0.443 ' O ' HD12 ' B' ' 351' ' ' LEU . 0.1 OUTLIER -69.75 -28.77 66.06 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.122 0.416 . . . . 20.0 112.122 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.03 -26.74 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.057 1.873 . . . . 20.0 116.057 -169.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 124.933 1.293 . . . . 20.0 108.405 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.049 0 N-CA-C 114.277 1.214 . . . . 20.0 114.277 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.14 82.23 2.96 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 106.898 -1.519 . . . . 20.0 106.898 -170.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.92 -34.46 66.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-N 114.869 -1.06 . . . . 20.0 110.222 178.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.07 -23.48 12.3 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 113.586 0.958 . . . . 20.0 113.586 -179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.33 30.37 20.07 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 124.155 0.982 . . . . 20.0 111.667 -173.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.91 -38.64 32.07 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 121.115 -0.234 . . . . 20.0 111.179 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.12 117.41 37.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.678 -1.23 . . . . 20.0 107.678 -178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.2 12.09 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.386 0.612 . . . . 20.0 110.915 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.55 72.76 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.395 -0.821 . . . . 20.0 111.869 -177.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.14 -45.18 74.31 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.548 -0.461 . . . . 20.0 111.21 178.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.84 -43.12 97.11 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 121.026 -0.27 . . . . 20.0 111.182 -172.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.6 70.95 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.766 -0.374 . . . . 20.0 111.155 -178.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.37 90.93 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.588 -0.445 . . . . 20.0 110.523 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.92 91.48 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 116.632 -0.258 . . . . 20.0 111.524 -174.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.94 -40.06 26.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.505 -0.878 . . . . 20.0 110.7 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 119.053 -1.059 . . . . 20.0 110.996 -162.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.07 -25.99 68.04 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 119.948 -0.701 . . . . 20.0 111.298 174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.4 70.61 Favored Pre-proline 0 N--CA 1.448 -0.567 0 C-N-CA 120.518 -0.473 . . . . 20.0 109.822 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 19' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -85.13 144.74 9.55 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 120.29 0.66 . . . . 20.0 112.151 -172.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.26 3.4 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 117.269 1.668 . . . . 20.0 117.269 -159.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.71 119.81 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.14 -1.429 . . . . 20.0 107.14 159.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.12 171.18 8.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.375 0.607 . . . . 20.0 110.708 -166.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 23' ' ' GLY . . . . . . . . . . . . . . . 83.02 -33.35 2.9 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.487 -0.779 . . . . 20.0 114.026 -177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.35 0.17 Allowed 'General case' 0 N--CA 1.45 -0.439 0 CA-C-O 122.291 1.043 . . . . 20.0 109.588 172.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.93 -13.16 3.99 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 114.913 -1.04 . . . . 20.0 113.467 169.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 26' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' C' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 9.07 23.56 Favored 'General case' 0 C--N 1.346 0.434 0 CA-C-N 119.643 1.11 . . . . 20.0 113.748 178.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.69 11.38 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.42 1.637 . . . . 20.0 115.42 -154.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 28' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' C' ' 26' ' ' PHE . . . -53.2 -26.85 29.94 Favored Glycine 0 C--N 1.343 0.947 0 N-CA-C 116.009 1.164 . . . . 20.0 116.009 -172.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 29' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' C' ' 184' ' ' ARG . 1.1 tt -59.57 -35.83 61.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 CA-C-N 118.095 0.948 . . . . 20.0 110.64 -178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.24 -52.48 61.22 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 120.875 0.369 . . . . 20.0 110.442 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.57 74.45 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 116.328 -0.396 . . . . 20.0 111.007 177.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.23 -49.64 82.27 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.048 0.451 . . . . 20.0 110.304 -174.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.22 -39.75 86.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 119.737 -0.785 . . . . 20.0 110.261 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.67 -29.5 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 118.757 -1.177 . . . . 20.0 111.191 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.55 -30.92 71.66 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.804 -0.358 . . . . 20.0 111.147 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.93 -56.77 3.24 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 112.192 0.441 . . . . 20.0 112.192 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.49 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-N 116.473 -0.331 . . . . 20.0 111.525 -164.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.38 -26.36 63.68 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 119.929 -0.708 . . . . 20.0 112.235 -162.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.49 63.03 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 118.875 -1.13 . . . . 20.0 111.708 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.88 22.97 Favored 'General case' 0 C--O 1.234 0.252 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 41' ' ' VAL . . . . . . . . . . . . . 23.1 t -119.57 152.67 22.15 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.59 88.83 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.195 -0.911 . . . . 20.0 111.441 -175.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.63 158.3 35.24 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -173.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.51 147.18 16.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.25 44.12 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.467 0.651 . . . . 20.0 110.441 -178.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.1 128.99 74.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 107.341 -1.355 . . . . 20.0 107.341 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.26 -176.15 5.83 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.837 0.827 . . . . 20.0 108.881 177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.55 -34.63 62.99 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.099 -176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.81 9.28 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.706 1.002 . . . . 20.0 113.706 -171.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.6 83.42 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-O 119.134 -0.814 . . . . 20.0 114.521 -176.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.47 35.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.427 1.114 . . . . 20.0 110.235 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.32 32.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 53' ' ' ILE . . . . . 0.715 HD13 HG12 ' C' ' 207' ' ' VAL . 31.4 mm -130.29 115.6 32.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 107.304 -1.369 . . . . 20.0 107.304 -174.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.88 119.73 36.27 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.654 -0.499 . . . . 20.0 109.654 174.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.95 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.613 -0.884 . . . . 20.0 108.613 -173.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.65 145.35 31.7 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 163.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.46 20.33 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.675 -0.491 . . . . 20.0 109.675 -175.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.08 23.7 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 111.099 -0.8 . . . . 20.0 111.099 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.14 105.59 10.39 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 123.931 0.893 . . . . 20.0 109.003 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.52 Favored Glycine 0 N--CA 1.442 -0.907 0 C-N-CA 120.769 -0.729 . . . . 20.0 114.105 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.27 32.65 Favored 'Trans proline' 0 C--N 1.332 -0.338 0 CA-C-O 121.769 0.654 . . . . 20.0 112.105 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.99 111.34 22.84 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.007 -0.997 . . . . 20.0 109.271 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 63' ' ' VAL . . . . . . . . . . . . . 45.6 t -103.72 137.92 30.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 108.756 -0.831 . . . . 20.0 108.756 -179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.73 124.08 46.41 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.023 0.929 . . . . 20.0 109.032 -175.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.22 114.32 45.75 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.071 -1.085 . . . . 20.0 108.071 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.58 51.34 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.285 0.366 . . . . 20.0 110.993 -168.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.51 154.61 45.95 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 123.896 0.879 . . . . 20.0 108.924 167.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 68' ' ' HIS . . . . . 0.494 ' NE2' ' OD1' ' C' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.38 29.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.962 -0.563 . . . . 20.0 110.556 177.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.85 21.34 5.9 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.229 -0.896 . . . . 20.0 109.756 -178.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 70' ' ' ASP . . . . . 0.542 ' N ' ' OD1' ' C' ' 183' ' ' ASP . 12.0 t0 -97.44 68.03 2.13 Favored 'General case' 0 CA--C 1.517 -0.326 0 O-C-N 121.601 -0.687 . . . . 20.0 112.388 178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.34 144.87 28.89 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.279 -1.008 . . . . 20.0 108.279 178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 C-N-CA 123.713 0.805 . . . . 20.0 109.128 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 73' ' ' GLY . . . . . 0.469 ' C ' HD23 ' C' ' 74' ' ' LEU . . . -155.85 -175.68 27.13 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.59 -1.004 . . . . 20.0 110.59 173.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 74' ' ' LEU . . . . . 0.469 HD23 ' C ' ' C' ' 73' ' ' GLY . 5.0 mt -125.03 161.44 26.73 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-O 121.262 0.553 . . . . 20.0 110.008 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 75' ' ' MET . . . . . 0.526 ' HB2' HG23 ' C' ' 160' ' ' THR . 10.6 ttm -128.11 131.32 49.01 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 124.273 1.029 . . . . 20.0 109.713 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.56 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 108.815 -0.809 . . . . 20.0 108.815 168.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.08 -29.39 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 N-CA-C 113.058 0.762 . . . . 20.0 113.058 178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.121 -1.066 . . . . 20.0 108.121 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.06 108.93 19.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 108.346 -0.983 . . . . 20.0 108.346 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.77 166.36 5.6 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.838 0.828 . . . . 20.0 109.958 173.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -26.99 60.3 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 119.645 -0.822 . . . . 20.0 112.724 -169.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.12 4.29 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.78 81.78 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 118.974 -0.903 . . . . 20.0 115.125 -178.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.8 145.04 34.14 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 118.337 1.069 . . . . 20.0 110.227 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.46 28.08 Favored 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.236 -0.893 . . . . 20.0 112.617 -172.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.39 174.56 6.63 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.69 163.8 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.358 0 CA-C-O 121.676 0.75 . . . . 20.0 109.463 -170.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.35 15.62 Favored Pre-proline 0 N--CA 1.448 -0.552 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.811 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.83 160.2 24.49 Favored 'Trans proline' 0 CA--C 1.507 -0.851 0 CA-C-O 122.267 0.861 . . . . 20.0 112.742 -171.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 90' ' ' ILE . . . . . 0.496 HD11 HG21 ' C' ' 160' ' ' THR . 9.3 mt -88.7 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-N 113.78 -1.554 . . . . 20.0 107.425 165.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.96 140.92 47.48 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.282 -0.872 . . . . 20.0 112.168 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.85 -24.08 22.39 Favored Glycine 0 N--CA 1.441 -1.024 0 CA-C-O 118.965 -0.908 . . . . 20.0 115.244 176.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.89 152.62 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 118.613 1.206 . . . . 20.0 109.214 -169.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.73 130.99 22.18 Favored Pre-proline 0 C--O 1.239 0.514 0 N-CA-C 108.412 -0.959 . . . . 20.0 108.412 173.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.05 -8.03 13.11 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.562 1.236 . . . . 20.0 114.846 -170.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.18 -15.26 59.5 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 119.162 0.892 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 97' ' ' THR . . . . . 0.586 HG21 ' OG ' ' C' ' 324' ' ' SER . 44.7 p -89.48 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 123.666 0.786 . . . . 20.0 112.399 178.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' C' ' 99' ' ' ILE . 0.5 OUTLIER -43.28 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.188 0 C-N-CA 124.991 1.317 . . . . 20.0 113.363 -173.001 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' C' ' 98' ' ' LEU . 1.6 tt -173.23 156.04 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.376 0 N-CA-C 109.036 -0.727 . . . . 20.0 109.036 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 100' ' ' ALA . . . . . 0.477 ' HB3' ' H ' ' A' ' 100' ' ' ALA . . . -123.85 -19.0 5.84 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.648 -1.16 . . . . 20.0 111.303 158.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 101' ' ' GLN . . . . . 0.406 ' C ' HD11 ' C' ' 99' ' ' ILE . 0.0 OUTLIER -169.41 141.67 2.5 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.672 -0.862 . . . . 20.0 108.672 176.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 102' ' ' ARG . . . . . 0.452 HH12 ' HB3' ' A' ' 167' ' ' ARG . 0.0 OUTLIER 55.85 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 115.234 1.568 . . . . 20.0 115.234 150.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 103' ' ' PHE . . . . . 0.589 ' O ' ' N ' ' C' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.22 36.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.3 37.29 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.553 -0.749 . . . . 20.0 109.397 -173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 105' ' ' VAL . . . . . 0.581 HG22 ' CG1' ' C' ' 162' ' ' ILE . 50.2 t -117.45 110.72 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.213 -1.032 . . . . 20.0 108.213 -178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.53 83.03 6.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.58 -0.282 . . . . 20.0 110.304 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.95 -54.17 14.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 O-C-N 123.331 0.394 . . . . 20.0 110.357 170.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.49 10.59 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.433 -0.951 . . . . 20.0 108.433 178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.08 126.3 27.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.887 -1.051 . . . . 20.0 110.478 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.18 11.28 75.13 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.908 -0.94 . . . . 20.0 115.335 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.06 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 118.455 1.128 . . . . 20.0 108.586 177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.3 141.55 37.73 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 109.352 -0.61 . . . . 20.0 109.352 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.67 142.55 43.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 N-CA-C 108.679 -0.86 . . . . 20.0 108.679 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.77 149.45 31.09 Favored 'General case' 0 N--CA 1.444 -0.74 0 CA-C-N 115.002 -0.999 . . . . 20.0 110.295 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 115' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' C' ' 103' ' ' PHE . . . -147.94 157.77 27.46 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.301 -1.119 . . . . 20.0 110.301 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.57 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.377 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 -177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 115.338 -0.846 . . . . 20.0 114.597 -168.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 118' ' ' ALA . . . . . 0.486 ' O ' HD13 ' C' ' 98' ' ' LEU . . . -67.17 -47.99 69.33 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 114.344 1.239 . . . . 20.0 114.344 -156.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.56 1.073 . . . . 20.0 112.69 -155.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.14 35.57 Favored Pre-proline 0 C--O 1.24 0.603 0 N-CA-C 102.653 -3.092 . . . . 20.0 102.653 159.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 121' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -68.11 123.82 11.06 Favored 'Trans proline' 0 C--N 1.327 -0.563 0 CA-C-N 120.765 1.309 . . . . 20.0 110.585 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.84 149.79 89.88 Favored 'Trans proline' 0 CA--C 1.519 -0.269 0 CA-C-N 119.2 0.75 . . . . 20.0 110.673 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.33 7.22 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.818 0.818 . . . . 20.0 109.941 -178.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.91 3.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.153 -1.054 . . . . 20.0 108.153 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.81 19.52 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.783 -0.367 . . . . 20.0 110.701 169.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.93 -43.65 1.49 Allowed Pre-proline 0 C--O 1.237 0.415 0 C-N-CA 123.938 0.895 . . . . 20.0 113.053 -170.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.92 59.59 Favored 'Trans proline' 0 C--N 1.359 1.117 0 CA-C-N 120.872 1.347 . . . . 20.0 111.998 170.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.51 30.04 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 111.8 0.296 . . . . 20.0 111.8 -177.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -32.01 69.18 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.203 168.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.83 62.59 Favored 'General case' 0 C--O 1.239 0.542 0 N-CA-C 111.949 0.351 . . . . 20.0 111.949 172.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.55 90.92 4.53 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.187 -0.672 . . . . 20.0 109.187 174.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.29 7.91 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.112 0.412 . . . . 20.0 112.112 175.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.14 142.5 87.44 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.533 -0.914 . . . . 20.0 108.533 172.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.71 153.62 75.48 Favored 'Trans proline' 0 N--CA 1.458 -0.583 0 CA-C-N 119.639 0.907 . . . . 20.0 112.391 177.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.61 42.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.516 -1.22 . . . . 20.0 107.964 177.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.65 -12.24 59.95 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 118.784 -0.627 . . . . 20.0 112.369 -175.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 137' ' ' ASP . . . . . 0.411 ' OD1' ' N ' ' C' ' 138' ' ' GLN . 14.0 p30 -55.37 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.387 0 CA-C-O 118.939 -0.553 . . . . 20.0 111.375 -175.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 138' ' ' GLN . . . . . 0.415 ' HG3' ' H ' ' C' ' 139' ' ' ILE . 3.9 tp-100 174.64 174.1 0.2 Allowed 'General case' 0 C--O 1.235 0.34 0 N-CA-C 103.125 -2.917 . . . . 20.0 103.125 133.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 139' ' ' ILE . . . . . 0.415 ' H ' ' HG3' ' C' ' 138' ' ' GLN . 1.2 tp -74.85 168.17 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 124.102 0.961 . . . . 20.0 108.947 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 140' ' ' PHE . . . . . 0.404 ' H ' HG13 ' C' ' 139' ' ' ILE . 0.3 OUTLIER -114.87 161.44 18.24 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 123.951 0.9 . . . . 20.0 110.511 177.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 141' ' ' ILE . . . . . 0.402 HD13 HD13 ' C' ' 162' ' ' ILE . 30.0 mt -124.66 147.45 29.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 N-CA-C 108.602 -0.888 . . . . 20.0 108.602 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 142' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' C' ' 144' ' ' GLY . 0.5 OUTLIER -119.01 134.75 55.0 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.655 0.782 . . . . 20.0 109.608 175.151 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.19 7.93 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 115.943 -0.571 . . . . 20.0 111.817 166.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 144' ' ' GLY . . . . . 0.547 ' N ' ' OD1' ' C' ' 142' ' ' ASP . . . 86.81 -6.6 82.58 Favored Glycine 0 N--CA 1.441 -1.028 0 N-CA-C 115.498 0.959 . . . . 20.0 115.498 172.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.02 54.06 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 118.493 1.146 . . . . 20.0 110.273 176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 146' ' ' GLU . . . . . 0.439 ' OE2' ' NH2' ' A' ' 332' ' ' ARG . 94.2 mt-10 -83.44 -20.87 33.3 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 113.561 0.949 . . . . 20.0 113.561 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.39 162.65 40.14 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.939 0.876 . . . . 20.0 111.44 -173.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.37 -41.5 80.3 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 113.892 -1.504 . . . . 20.0 111.268 177.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.4 -46.97 88.07 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.0 -179.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.4 -35.14 76.67 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 120.554 -0.459 . . . . 20.0 110.799 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.77 -40.61 84.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 120.08 -0.648 . . . . 20.0 111.077 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.32 58.49 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.355 -0.938 . . . . 20.0 111.013 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.67 -30.12 66.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.63 177.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.61 92.35 Favored 'General case' 0 CA--C 1.514 -0.434 0 C-N-CA 120.554 -0.458 . . . . 20.0 111.63 171.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.71 6.71 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-O 118.915 -0.936 . . . . 20.0 114.588 -172.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.72 133.51 29.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 118.485 1.142 . . . . 20.0 108.56 178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.9 9.35 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.28 147.32 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.37 169.36 15.76 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.833 -1.707 . . . . 20.0 108.833 -176.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 160' ' ' THR . . . . . 0.526 HG23 ' HB2' ' C' ' 75' ' ' MET . 0.2 OUTLIER -79.5 113.61 17.78 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 107.622 -1.251 . . . . 20.0 107.622 165.679 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.68 -20.01 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 113.711 1.004 . . . . 20.0 113.711 -166.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 162' ' ' ILE . . . . . 0.581 ' CG1' HG22 ' C' ' 105' ' ' VAL . 0.5 OUTLIER -111.64 155.68 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 O-C-N 121.67 -0.644 . . . . 20.0 111.76 -159.218 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 163' ' ' THR . . . . . 0.551 ' OG1' ' N ' ' C' ' 164' ' ' TRP . 3.5 t -145.38 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.263 1.025 . . . . 20.0 110.458 171.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 164' ' ' TRP . . . . . 0.551 ' N ' ' OG1' ' C' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.93 16.74 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.213 0.82 . . . . 20.0 113.213 -160.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 165' ' ' ASP . . . . . 0.429 ' O ' ' NE2' ' A' ' 101' ' ' GLN . 7.5 t70 63.69 61.68 0.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.848 -0.533 . . . . 20.0 112.323 -177.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.91 158.63 29.54 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.071 -1.212 . . . . 20.0 110.071 172.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 167' ' ' ARG . . . . . 0.464 ' HB3' HH12 ' A' ' 102' ' ' ARG . 0.0 OUTLIER -142.39 148.35 37.72 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.677 -1.231 . . . . 20.0 107.677 170.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.58 30.39 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.107 -0.952 . . . . 20.0 110.208 -167.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.39 159.76 35.21 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-O 121.905 0.86 . . . . 20.0 109.954 177.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.197 -1.365 . . . . 20.0 109.484 -173.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.59 29.01 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 109.51 -0.552 . . . . 20.0 109.51 168.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 172' ' ' GLY . . . . . 0.598 ' O ' ' N ' ' C' ' 175' ' ' ARG . . . 56.92 68.71 1.56 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 112.754 0.649 . . . . 20.0 112.754 -174.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.99 1.29 Allowed 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.719 -0.792 . . . . 20.0 111.254 157.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 175' ' ' ARG . . . . . 0.598 ' N ' ' O ' ' C' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 118.583 0.629 . . . . 20.0 112.653 172.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.54 169.43 0.35 Allowed 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 127.839 2.456 . . . . 20.0 106.244 157.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 177' ' ' VAL . . . . . . . . . . . . . 46.0 t -144.7 145.78 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.13 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 116.445 2.017 . . . . 20.0 116.445 -166.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.78 22.25 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 118.746 0.703 . . . . 20.0 112.157 -171.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.06 -0.68 36.65 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 114.396 1.258 . . . . 20.0 114.396 -170.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 181' ' ' PHE . . . . . 0.736 ' HB3' ' HB3' ' C' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.94 0.84 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 118.602 0.637 . . . . 20.0 111.806 -162.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.26 127.8 32.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 CA-C-O 122.021 0.915 . . . . 20.0 110.711 -152.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 183' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' C' ' 70' ' ' ASP . 0.6 OUTLIER 69.93 -6.68 1.04 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.371 1.468 . . . . 20.0 113.161 174.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 184' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' C' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 122.16 0.981 . . . . 20.0 110.776 157.115 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 185' ' ' ILE . . . . . 0.436 HG12 HG11 ' C' ' 317' ' ' VAL . 1.0 OUTLIER -126.1 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 186' ' ' ALA . . . . . 0.722 ' O ' ' OG1' ' C' ' 189' ' ' THR . . . -50.18 -42.88 51.93 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.334 -0.848 . . . . 20.0 111.565 173.293 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.89 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 C-N-CA 119.288 -0.965 . . . . 20.0 110.102 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.84 -38.59 91.67 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 119.126 -1.03 . . . . 20.0 110.51 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 189' ' ' THR . . . . . 0.722 ' OG1' ' O ' ' C' ' 186' ' ' ALA . 25.2 p -59.14 -48.54 81.23 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 119.447 -0.901 . . . . 20.0 110.853 172.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.36 -50.58 64.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.913 0.387 . . . . 20.0 110.458 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.21 Favored 'General case' 0 C--O 1.237 0.395 0 C-N-CA 120.106 -0.638 . . . . 20.0 110.953 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.92 -36.53 84.24 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.93 -0.708 . . . . 20.0 110.287 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 193' ' ' VAL . . . . . 0.413 HG23 ' O ' ' C' ' 189' ' ' THR . 11.6 t -60.53 -44.85 97.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 CA-C-O 121.053 0.454 . . . . 20.0 110.113 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.04 -33.39 75.65 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.27 -0.572 . . . . 20.0 111.206 -176.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.57 -38.16 70.99 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 119.895 -0.722 . . . . 20.0 110.802 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.64 -26.15 41.19 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.619 0.6 . . . . 20.0 112.619 -175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.55 122.82 27.51 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.317 -0.623 . . . . 20.0 109.317 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 198' ' ' LYS . . . . . . . . . . . . . 24.8 mmtt -112.49 -56.99 2.34 Favored 'General case' 0 C--O 1.234 0.256 0 O-C-N 123.292 0.37 . . . . 20.0 110.146 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.23 105.37 17.51 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.32 4.26 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 -173.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.81 -14.5 59.9 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 120.015 -0.674 . . . . 20.0 111.348 176.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.67 30.48 Favored 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 172.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 203' ' ' ASP . . . . . 0.629 ' N ' ' OD1' ' C' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.0 16.3 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 108.482 -0.933 . . . . 20.0 108.482 -174.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 108.583 -0.895 . . . . 20.0 108.583 -170.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 205' ' ' TYR . . . . . . . . . . . . . 62.9 m-85 -128.94 106.66 9.04 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.016 -0.735 . . . . 20.0 109.016 173.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.32 31.27 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.745 -0.835 . . . . 20.0 108.745 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 207' ' ' VAL . . . . . 0.715 HG12 HD13 ' C' ' 53' ' ' ILE . 34.0 m -119.9 150.18 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.334 0 N-CA-C 108.852 -0.796 . . . . 20.0 108.852 174.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.84 5.2 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 107.401 -1.333 . . . . 20.0 107.401 171.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.87 159.97 19.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.845 0.831 . . . . 20.0 111.131 -165.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.74 166.44 13.1 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 CA-C-N 114.626 -1.17 . . . . 20.0 108.255 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.64 40.16 29.44 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 114.808 -1.087 . . . . 20.0 111.508 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.03 -49.53 13.83 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.357 -0.537 . . . . 20.0 110.922 176.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.42 64.76 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.227 -0.589 . . . . 20.0 111.491 -173.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 214' ' ' VAL . . . . . . . . . . . . . 88.6 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.402 0 N-CA-C 108.529 -0.915 . . . . 20.0 108.529 173.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.02 60.98 6.2 Favored Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 119.697 -1.24 . . . . 20.0 111.432 -174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 216' ' ' LEU . . . . . 0.428 ' H ' HD23 ' C' ' 216' ' ' LEU . 0.5 OUTLIER -46.99 -25.61 0.83 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.428 0.899 . . . . 20.0 113.428 -179.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 217' ' ' ARG . . . . . 0.429 ' HB3' ' HG ' ' F' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.49 2.84 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.342 0.497 . . . . 20.0 112.342 173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.57 40.92 Favored Glycine 0 C--N 1.337 0.632 0 C-N-CA 119.765 -1.207 . . . . 20.0 111.945 168.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 219' ' ' ALA . . . . . 0.444 ' O ' ' OG ' ' C' ' 222' ' ' SER . . . -65.28 -37.0 85.81 Favored 'General case' 0 C--O 1.237 0.398 0 O-C-N 122.248 -0.56 . . . . 20.0 111.406 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 220' ' ' ARG . . . . . 0.4 ' HB2' ' HB1' ' C' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.72 57.99 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 112.201 0.445 . . . . 20.0 112.201 -174.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.42 -45.87 87.59 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 120.045 -0.662 . . . . 20.0 110.854 -173.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 222' ' ' SER . . . . . 0.444 ' OG ' ' O ' ' C' ' 219' ' ' ALA . 2.1 p -58.01 -35.78 71.74 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.759 -0.376 . . . . 20.0 111.439 175.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.97 69.34 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 112.545 0.572 . . . . 20.0 112.545 -169.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 224' ' ' PHE . . . . . 0.455 ' HB2' ' HD2' ' F' ' 307' ' ' LYS . 78.9 t80 -64.22 -33.36 75.62 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 119.82 -0.752 . . . . 20.0 111.855 -165.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.75 74.93 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.964 -1.588 . . . . 20.0 112.109 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -127.01 -45.61 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 111.987 0.365 . . . . 20.0 111.987 -158.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 227' ' ' GLU . . . . . 0.451 ' OE1' ' OG1' ' C' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.69 99.78 Favored Pre-proline 0 C--O 1.236 0.342 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.88 143.75 2.86 Favored 'Trans proline' 0 N--CA 1.472 0.206 0 N-CA-C 115.99 1.496 . . . . 20.0 115.99 -134.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.76 0.78 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 125.208 1.403 . . . . 20.0 113.362 162.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.21 11.48 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 120.081 -0.648 . . . . 20.0 111.767 167.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.49 151.5 16.49 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.267 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.73 170.69 15.61 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 123.786 0.834 . . . . 20.0 108.809 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.63 149.05 23.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.139 0.495 . . . . 20.0 110.378 177.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 234' ' ' ILE . . . . . 0.492 HD11 ' CE ' ' C' ' 341' ' ' MET . 51.6 mt -133.2 90.43 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 107.527 -1.286 . . . . 20.0 107.527 172.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 235' ' ' ASP . . . . . 0.494 ' OD1' ' NE2' ' C' ' 68' ' ' HIS . 25.5 t0 -135.18 173.26 11.91 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 106.918 -1.512 . . . . 20.0 106.918 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.23 149.34 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.687 0.756 . . . . 20.0 111.417 -172.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 237' ' ' THR . . . . . 0.454 HG21 ' HA3' ' C' ' 296' ' ' GLY . 9.2 t -165.59 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 238' ' ' ILE . . . . . 0.414 HD13 ' O ' ' C' ' 237' ' ' THR . 17.9 mm -145.5 151.88 14.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 N-CA-C 108.238 -1.023 . . . . 20.0 108.238 -161.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.24 9.68 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 106.842 -1.54 . . . . 20.0 106.842 158.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.03 18.71 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.39 36.13 22.21 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.926 1.29 . . . . 20.0 112.482 158.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.99 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.618 0 N-CA-C 105.158 -2.164 . . . . 20.0 105.158 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.01 165.54 12.07 Favored 'Trans proline' 0 CA--C 1.517 -0.363 0 CA-C-N 120.838 1.335 . . . . 20.0 112.372 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.51 -5.38 45.41 Favored Glycine 0 N--CA 1.442 -0.943 0 CA-C-N 115.056 -0.975 . . . . 20.0 114.885 -173.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.12 164.49 23.1 Favored Pre-proline 0 N--CA 1.453 -0.306 0 CA-C-N 118.588 1.194 . . . . 20.0 110.678 177.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 246' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -70.92 -172.63 0.72 Allowed 'Trans proline' 0 C--N 1.327 -0.558 0 CA-C-O 121.877 0.699 . . . . 20.0 111.978 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.17 -10.84 59.57 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 114.737 -1.12 . . . . 20.0 112.065 179.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.72 63.12 Favored 'General case' 0 CA--C 1.518 -0.267 0 C-N-CA 119.855 -0.738 . . . . 20.0 112.84 -171.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 249' ' ' LYS . . . . . 0.713 ' O ' ' OG1' ' C' ' 252' ' ' THR . 16.9 mttt -98.79 -15.09 19.41 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 113.221 0.822 . . . . 20.0 113.221 170.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.81 88.78 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 120.26 -0.576 . . . . 20.0 111.392 -172.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.6 -21.04 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.186 -1.006 . . . . 20.0 111.87 -178.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 252' ' ' THR . . . . . 0.713 ' OG1' ' O ' ' C' ' 249' ' ' LYS . 39.7 p -57.11 -31.85 65.72 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 118.486 0.585 . . . . 20.0 111.375 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 253' ' ' HIS . . . . . 0.546 ' CD2' ' HB2' ' C' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.07 4.5 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.353 0.597 . . . . 20.0 110.369 176.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.015 -0.993 . . . . 20.0 112.34 175.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.94 5.83 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.216 1.865 . . . . 20.0 111.55 -177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.37 129.23 10.2 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -167.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.08 174.24 3.37 Favored Glycine 0 N--CA 1.437 -1.245 0 CA-C-O 122.667 1.149 . . . . 20.0 113.333 169.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 258' ' ' THR . . . . . . . . . . . . . 6.1 t -98.75 175.03 6.11 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 -177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 259' ' ' ALA . . . . . 0.407 ' O ' ' N ' ' C' ' 316' ' ' SER . . . -126.36 120.3 29.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.159 -0.928 . . . . 20.0 109.404 -169.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 260' ' ' ILE . . . . . . . . . . . . . 85.2 mt -98.0 139.94 19.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 107.813 -1.18 . . . . 20.0 107.813 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 261' ' ' LYS . . . . . 0.753 ' HE3' HG21 ' C' ' 298' ' ' THR . 1.9 mtmm -98.83 122.65 42.34 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.78 -40.27 10.62 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.354 0 CA-C-O 121.353 0.597 . . . . 20.0 109.645 173.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.426 0.632 . . . . 20.0 109.378 -174.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.14 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.815 0 CA-C-N 114.831 -1.077 . . . . 20.0 108.194 165.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.3 21.22 Favored 'General case' 0 CA--C 1.515 -0.369 0 CA-C-N 115.79 -0.641 . . . . 20.0 110.265 163.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.88 -46.18 11.55 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 113.644 0.979 . . . . 20.0 113.644 -165.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.66 25.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 109.386 -0.598 . . . . 20.0 109.386 -163.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 106.146 -1.798 . . . . 20.0 106.146 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 269' ' ' CYS . . . . . . . . . . . . . 69.2 m -66.39 137.12 56.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 20.0 111.303 -171.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -58.05 109.63 1.95 Allowed Pre-proline 0 C--O 1.24 0.589 0 CA-C-N 115.144 -0.934 . . . . 20.0 108.708 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 271' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.46 -20.01 48.42 Favored 'Trans proline' 0 CA--C 1.513 -0.549 0 N-CA-C 114.8 1.038 . . . . 20.0 114.8 -160.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.95 74.54 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 120.167 -0.613 . . . . 20.0 110.578 176.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.66 -48.3 77.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-O 121.085 0.469 . . . . 20.0 110.063 175.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 274' ' ' VAL . . . . . . . . . . . . . 13.0 t -59.25 -52.43 60.88 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-O 120.815 0.34 . . . . 20.0 110.685 -176.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.4 -31.9 70.82 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 119.83 -0.748 . . . . 20.0 110.519 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 276' ' ' TRP . . . . . 0.487 ' HH2' ' HB3' ' C' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.92 65.77 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.098 -0.641 . . . . 20.0 110.999 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.15 -38.66 89.87 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.718 177.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.66 -47.98 78.59 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.608 -0.437 . . . . 20.0 110.067 173.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.78 -40.44 88.3 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.821 -0.352 . . . . 20.0 110.726 175.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.35 -44.9 77.88 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 120.235 -0.586 . . . . 20.0 111.073 -172.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.7 72.99 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.02 -0.672 . . . . 20.0 110.992 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.8 65.82 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.998 -0.681 . . . . 20.0 111.113 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.65 73.19 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 119.866 -0.734 . . . . 20.0 110.973 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.51 29.08 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 113.32 0.859 . . . . 20.0 113.32 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.12 13.7 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 121.702 0.763 . . . . 20.0 111.57 173.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.32 143.36 34.29 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.272 -1.01 . . . . 20.0 108.272 -178.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 287' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -83.1 149.37 13.56 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 119.173 0.74 . . . . 20.0 111.369 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.17 23.35 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.613 -0.721 . . . . 20.0 109.7 -179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.09 5.62 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 107.899 -1.148 . . . . 20.0 107.899 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.62 43.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.49 -0.559 . . . . 20.0 109.49 -172.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.05 25.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 107.67 -1.234 . . . . 20.0 107.67 173.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.56 168.7 12.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.533 0.682 . . . . 20.0 110.262 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.79 -18.5 21.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.798 -1.092 . . . . 20.0 112.146 165.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.07 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.983 -0.847 . . . . 20.0 110.983 -176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 296' ' ' GLY . . . . . 0.454 ' HA3' HG21 ' C' ' 237' ' ' THR . . . 101.48 144.79 15.59 Favored Glycine 0 N--CA 1.449 -0.473 0 CA-C-N 114.657 -0.772 . . . . 20.0 112.642 -179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.64 4.1 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 110.313 -1.115 . . . . 20.0 110.313 179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 298' ' ' THR . . . . . 0.753 HG21 ' HE3' ' C' ' 261' ' ' LYS . 20.2 p -110.3 172.86 6.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 122.047 0.927 . . . . 20.0 111.345 -174.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.68 76.61 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.226 176.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.31 74.05 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 111.76 0.281 . . . . 20.0 111.76 -171.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.16 96.88 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.2 -1.0 . . . . 20.0 112.044 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 302' ' ' ALA . . . . . 0.4 ' HB1' ' HB2' ' C' ' 220' ' ' ARG . . . -68.37 -26.85 65.78 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.204 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.379 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -14.06 59.94 Favored 'General case' 0 C--O 1.235 0.301 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 305' ' ' LEU . . . . . 0.465 ' HG ' ' HB3' ' K' ' 217' ' ' ARG . 4.1 mp -103.75 -8.92 19.47 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 113.758 1.022 . . . . 20.0 113.758 -167.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 306' ' ' THR . . . . . 0.451 ' OG1' ' OE1' ' C' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.58 8.39 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.709 . . . . 20.0 110.566 171.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 307' ' ' LYS . . . . . 0.435 ' HD2' ' HB2' ' K' ' 224' ' ' PHE . 21.5 mmtt -61.66 -29.94 70.4 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.267 -0.878 . . . . 20.0 113.33 -161.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.23 66.29 Favored 'General case' 0 C--O 1.236 0.386 0 C-N-CA 119.7 -0.8 . . . . 20.0 111.2 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.81 65.13 1.94 Allowed Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.853 -0.689 . . . . 20.0 113.315 -171.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.32 139.65 52.23 Favored Pre-proline 0 C--O 1.238 0.486 0 CA-C-N 117.599 0.7 . . . . 20.0 111.106 -163.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 311' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -84.48 141.69 9.02 Favored 'Trans proline' 0 CA--C 1.513 -0.547 0 CA-C-N 119.43 0.832 . . . . 20.0 110.045 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.47 135.81 32.34 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 115.326 -0.852 . . . . 20.0 111.175 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.441 -0.973 0 N-CA-C 109.17 -1.572 . . . . 20.0 109.17 164.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.49 136.02 27.23 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 121.486 0.66 . . . . 20.0 110.045 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.0 153.26 21.05 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 114.578 -1.192 . . . . 20.0 109.209 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 316' ' ' SER . . . . . 0.407 ' N ' ' O ' ' C' ' 259' ' ' ALA . 4.1 m -138.47 133.55 32.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.419 -178.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 317' ' ' VAL . . . . . 0.436 HG11 HG12 ' C' ' 185' ' ' ILE . 92.3 t -99.45 108.57 51.18 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.32 -168.98 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.716 0 CA-C-O 122.667 1.028 . . . . 20.0 113.582 -154.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 319' ' ' ALA . . . . . 0.546 ' HB2' ' CD2' ' C' ' 253' ' ' HIS . . . 79.87 35.4 0.15 Allowed 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 113.589 -1.641 . . . . 20.0 115.256 161.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 320' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' C' ' 321' ' ' TYR . 0.4 OUTLIER -75.58 157.57 33.65 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-O 121.689 0.757 . . . . 20.0 110.101 176.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 321' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' C' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.19 11.65 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 106.828 -1.545 . . . . 20.0 106.828 160.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.23 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.403 0 C-N-CA 124.18 0.992 . . . . 20.0 108.429 -163.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.52 -7.4 3.16 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.48 1.289 . . . . 20.0 114.48 -140.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 324' ' ' SER . . . . . 0.586 ' OG ' HG21 ' C' ' 97' ' ' THR . 0.1 OUTLIER -59.56 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 112.641 0.608 . . . . 20.0 112.641 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 325' ' ' ASN . . . . . 0.43 ' HB2' ' HA ' ' A' ' 100' ' ' ALA . 35.0 p-10 -102.02 -56.09 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 115.033 1.494 . . . . 20.0 115.033 -152.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.6 150.97 50.76 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.462 -1.311 . . . . 20.0 107.462 174.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 327' ' ' GLU . . . . . 0.736 ' HB3' ' HB3' ' C' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.79 1.42 Allowed 'General case' 0 N--CA 1.439 -0.986 0 CA-C-N 113.862 -1.517 . . . . 20.0 109.941 -153.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.05 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 CA-C-O 121.432 0.634 . . . . 20.0 111.954 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 329' ' ' VAL . . . . . 0.429 HG13 ' HB2' ' C' ' 181' ' ' PHE . 0.3 OUTLIER -139.38 179.41 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.276 0 CA-C-O 121.917 0.865 . . . . 20.0 109.463 175.668 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.51 119.18 27.49 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.839 178.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.16 -32.03 54.24 Favored 'General case' 0 C--O 1.235 0.321 0 O-C-N 123.84 0.713 . . . . 20.0 111.479 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.76 73.51 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 120.263 -0.575 . . . . 20.0 110.202 -176.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.06 -44.89 83.23 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.044 -172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.69 -41.28 92.06 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 120.446 -0.502 . . . . 20.0 110.467 -173.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.67 71.52 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 118.803 -1.159 . . . . 20.0 110.164 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.39 93.25 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.473 176.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.53 -43.85 80.24 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-O 120.78 0.324 . . . . 20.0 110.922 176.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 338' ' ' VAL . . . . . 0.685 ' O ' ' OG1' ' C' ' 342' ' ' THR . 42.5 t -60.19 -48.93 86.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 CA-C-O 120.977 0.417 . . . . 20.0 110.25 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 339' ' ' GLU . . . . . 0.786 ' OE1' ' NZ ' ' C' ' 343' ' ' LYS . 1.3 mm-40 -54.84 -46.97 74.7 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-O 120.988 0.423 . . . . 20.0 110.718 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 116.325 -0.398 . . . . 20.0 111.412 -176.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 341' ' ' MET . . . . . 0.492 ' CE ' HD11 ' C' ' 234' ' ' ILE . 31.9 tpp -60.1 -40.38 89.44 Favored 'General case' 0 C--O 1.238 0.455 0 C-N-CA 120.211 -0.595 . . . . 20.0 110.814 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 342' ' ' THR . . . . . 0.685 ' OG1' ' O ' ' C' ' 338' ' ' VAL . 1.3 m -56.43 -45.03 80.95 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.081 0.467 . . . . 20.0 110.422 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 343' ' ' LYS . . . . . 0.786 ' NZ ' ' OE1' ' C' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.46 63.85 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 119.926 -0.71 . . . . 20.0 110.761 -178.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.52 97.81 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.585 -0.446 . . . . 20.0 111.082 -179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 345' ' ' LEU . . . . . 0.424 ' O ' HG22 ' C' ' 348' ' ' ILE . 1.0 OUTLIER -58.95 -50.48 73.89 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.77 -179.013 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.7 -39.01 90.79 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 119.708 -0.797 . . . . 20.0 110.563 -178.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 347' ' ' ASN . . . . . 0.487 ' HB3' ' HH2' ' C' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.83 30.17 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 119.408 -0.917 . . . . 20.0 112.525 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 348' ' ' ILE . . . . . 0.424 HG22 ' O ' ' C' ' 345' ' ' LEU . 1.3 tt -65.2 -23.71 33.73 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-N 119.141 0.882 . . . . 20.0 110.911 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' C' C ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 119.799 -0.761 . . . . 20.0 111.248 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.92 -18.76 31.81 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 122.152 -0.343 . . . . 20.0 111.495 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 351' ' ' LEU . . . . . 0.437 HD12 ' O ' ' C' ' 351' ' ' LEU . 0.1 OUTLIER -69.79 -28.74 65.99 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 112.146 0.425 . . . . 20.0 112.146 -173.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' C' C ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.069 1.877 . . . . 20.0 116.069 -169.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' C' C ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.796 0 C-N-CA 125.011 1.325 . . . . 20.0 108.393 -174.678 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.105 0 N-CA-C 114.239 1.2 . . . . 20.0 114.239 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.22 2.93 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 106.897 -1.52 . . . . 20.0 106.897 -170.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.91 -34.53 66.66 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.177 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 113.583 0.957 . . . . 20.0 113.583 -179.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.31 19.96 Favored 'General case' 0 C--O 1.239 0.511 0 C-N-CA 124.125 0.97 . . . . 20.0 111.608 -173.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.69 32.09 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 117.782 0.265 . . . . 20.0 111.176 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.1 117.41 37.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.656 -1.239 . . . . 20.0 107.656 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.93 112.18 12.07 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.371 0.605 . . . . 20.0 110.885 -174.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.67 -31.56 72.77 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.457 -0.792 . . . . 20.0 111.892 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.19 -45.11 74.28 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.471 -0.492 . . . . 20.0 111.212 178.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.05 97.29 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 121.019 -0.273 . . . . 20.0 111.209 -172.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.54 70.96 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 120.699 -0.401 . . . . 20.0 111.174 -178.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.91 -46.4 90.81 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 120.643 -0.423 . . . . 20.0 110.521 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.0 -42.92 91.24 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 116.713 -0.222 . . . . 20.0 111.552 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.96 -40.07 26.29 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 C-N-CA 119.5 -0.88 . . . . 20.0 110.653 -171.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.01 -32.19 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.006 -162.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.05 68.11 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 119.987 -0.685 . . . . 20.0 111.265 174.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.37 70.82 Favored Pre-proline 0 N--CA 1.448 -0.531 0 C-N-CA 120.553 -0.459 . . . . 20.0 109.794 -175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.12 144.69 9.54 Favored 'Trans proline' 0 C--N 1.33 -0.439 0 C-N-CA 120.271 0.647 . . . . 20.0 112.194 -172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.26 3.4 Favored Glycine 0 N--CA 1.445 -0.736 0 N-CA-C 117.274 1.669 . . . . 20.0 117.274 -159.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.84 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 107.141 -1.429 . . . . 20.0 107.141 159.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.06 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.399 0.619 . . . . 20.0 110.684 -166.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.96 -33.35 2.88 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.505 -0.771 . . . . 20.0 114.035 -177.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 N--CA 1.451 -0.404 0 CA-C-O 122.307 1.051 . . . . 20.0 109.531 172.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -58.01 -13.03 3.88 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 114.852 -1.067 . . . . 20.0 113.481 169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' D' ' 28' ' ' GLY . 0.0 OUTLIER -88.04 9.03 23.85 Favored 'General case' 0 C--N 1.346 0.429 0 CA-C-N 119.711 1.141 . . . . 20.0 113.741 178.511 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.32 0.05 Allowed 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 115.413 1.634 . . . . 20.0 115.413 -154.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' D' ' 26' ' ' PHE . . . -53.15 -26.87 29.61 Favored Glycine 0 C--N 1.342 0.868 0 CA-C-N 119.813 1.188 . . . . 20.0 115.994 -172.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 29' ' ' ILE . . . . . 0.534 HD13 ' NH1' ' D' ' 184' ' ' ARG . 1.1 tt -59.66 -35.78 61.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 CA-C-N 118.079 0.94 . . . . 20.0 110.595 -178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.23 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.929 0.395 . . . . 20.0 110.453 178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.59 74.51 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.294 -0.412 . . . . 20.0 110.975 177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.3 -49.59 82.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.437 0 CA-C-O 121.055 0.455 . . . . 20.0 110.276 -174.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.72 86.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 C-N-CA 119.696 -0.802 . . . . 20.0 110.298 -175.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.7 -29.58 20.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 C-N-CA 118.8 -1.16 . . . . 20.0 111.096 179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.45 -30.9 71.58 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 117.989 0.358 . . . . 20.0 111.179 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.05 -56.73 3.25 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 112.111 0.412 . . . . 20.0 112.111 177.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.42 44.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-N 116.543 -0.298 . . . . 20.0 111.521 -164.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.37 63.67 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 119.888 -0.725 . . . . 20.0 112.263 -162.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.08 -23.49 63.08 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 118.874 -1.13 . . . . 20.0 111.757 -177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.92 -6.91 22.92 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 113.496 0.924 . . . . 20.0 113.496 -176.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 41' ' ' VAL . . . . . . . . . . . . . 22.7 t -119.55 152.59 22.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 108.559 -0.904 . . . . 20.0 108.559 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 42' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -66.13 -42.62 88.89 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 115.205 -0.907 . . . . 20.0 111.425 -175.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.59 158.31 35.34 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.514 -0.921 . . . . 20.0 108.514 -173.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.47 147.19 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 108.261 -1.014 . . . . 20.0 108.261 -174.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.16 159.31 44.07 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.508 0.67 . . . . 20.0 110.417 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 46' ' ' VAL . . . . . . . . . . . . . 62.0 t -117.13 129.0 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.16 5.84 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-O 121.785 0.803 . . . . 20.0 108.926 177.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.54 62.88 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 119.904 -0.718 . . . . 20.0 111.12 -176.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.79 9.32 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.696 0.999 . . . . 20.0 113.696 -171.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.63 83.38 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-O 119.162 -0.799 . . . . 20.0 114.516 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.17 151.49 35.77 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 118.473 1.136 . . . . 20.0 110.218 173.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.28 33.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 107.131 -1.433 . . . . 20.0 107.131 176.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 53' ' ' ILE . . . . . 0.713 HD13 HG12 ' D' ' 207' ' ' VAL . 31.2 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.301 -1.37 . . . . 20.0 107.301 -174.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.78 36.41 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.624 -0.51 . . . . 20.0 109.624 174.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.93 8.04 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.638 -0.875 . . . . 20.0 108.638 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.59 145.4 31.76 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.723 -1.584 . . . . 20.0 106.723 163.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.59 154.43 20.42 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.676 -0.49 . . . . 20.0 109.676 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.37 -161.09 23.68 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.279 0 C-N-CA 123.883 0.873 . . . . 20.0 108.98 179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.57 33.53 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.715 -0.755 . . . . 20.0 114.03 179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.72 165.22 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.37 0 CA-C-O 121.763 0.651 . . . . 20.0 112.071 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.98 111.39 22.92 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.0 -1.0 . . . . 20.0 109.216 -176.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 63' ' ' VAL . . . . . . . . . . . . . 45.5 t -103.72 137.9 30.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.395 0 N-CA-C 108.752 -0.833 . . . . 20.0 108.752 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.74 124.05 46.35 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 124.074 0.95 . . . . 20.0 109.003 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.25 114.33 45.78 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 N-CA-C 108.108 -1.071 . . . . 20.0 108.108 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.61 51.36 Favored 'General case' 0 C--N 1.327 -0.385 0 O-C-N 123.245 0.341 . . . . 20.0 110.918 -168.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 123.873 0.869 . . . . 20.0 108.916 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' D' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 N--CA 1.453 -0.32 0 CA-C-N 115.967 -0.56 . . . . 20.0 110.541 177.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.33 5.87 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.197 -0.911 . . . . 20.0 109.696 -178.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 70' ' ' ASP . . . . . 0.547 ' N ' ' OD1' ' D' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.64 -0.663 . . . . 20.0 112.455 178.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.91 28.42 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.185 -1.043 . . . . 20.0 108.185 178.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.78 148.81 6.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 C-N-CA 123.73 0.812 . . . . 20.0 109.14 -178.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 73' ' ' GLY . . . . . 0.47 ' C ' HD23 ' D' ' 74' ' ' LEU . . . -155.83 -175.71 27.15 Favored Glycine 0 N--CA 1.445 -0.757 0 N-CA-C 110.588 -1.005 . . . . 20.0 110.588 173.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 74' ' ' LEU . . . . . 0.47 HD23 ' C ' ' D' ' 73' ' ' GLY . 5.0 mt -124.99 161.45 26.68 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 121.36 0.6 . . . . 20.0 109.992 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 75' ' ' MET . . . . . 0.525 ' HB2' HG23 ' D' ' 160' ' ' THR . 10.6 ttm -128.15 131.37 48.95 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 115.006 -0.997 . . . . 20.0 109.67 -174.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.866 -0.791 . . . . 20.0 108.866 168.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.03 -29.34 7.04 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.1 0.778 . . . . 20.0 113.1 178.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.44 13.76 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 79' ' ' ILE . . . . . . . . . . . . . 32.6 mm -127.07 108.96 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 N-CA-C 108.322 -0.992 . . . . 20.0 108.322 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 166.3 5.59 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-O 121.789 0.804 . . . . 20.0 110.002 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.48 -27.11 60.43 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.687 -0.805 . . . . 20.0 112.745 -169.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.14 4.24 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 113.346 0.869 . . . . 20.0 113.346 -177.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.32 12.75 81.72 Favored Glycine 0 N--CA 1.444 -0.823 0 CA-C-O 118.906 -0.941 . . . . 20.0 115.027 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.78 145.04 34.09 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 118.409 1.105 . . . . 20.0 110.23 178.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.48 28.05 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 115.246 -0.888 . . . . 20.0 112.61 -172.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.63 6.59 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.856 -1.164 . . . . 20.0 107.856 158.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.82 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.681 0.753 . . . . 20.0 109.46 -170.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.24 129.35 15.63 Favored Pre-proline 0 N--CA 1.448 -0.533 0 CA-C-N 114.992 -1.004 . . . . 20.0 109.814 171.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 89' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -79.84 160.22 24.45 Favored 'Trans proline' 0 CA--C 1.508 -0.818 0 CA-C-O 122.289 0.871 . . . . 20.0 112.765 -171.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 90' ' ' ILE . . . . . 0.479 HD11 HG21 ' D' ' 160' ' ' THR . 9.2 mt -88.78 150.29 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 CA-C-N 113.739 -1.573 . . . . 20.0 107.396 165.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.97 140.91 47.51 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.281 -0.872 . . . . 20.0 112.122 -168.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.86 -24.12 22.29 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-O 118.931 -0.927 . . . . 20.0 115.206 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.64 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 118.671 1.235 . . . . 20.0 109.275 -169.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.531 0 N-CA-C 108.387 -0.968 . . . . 20.0 108.387 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 95' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -81.09 -7.95 13.07 Favored 'Trans proline' 0 CA--C 1.515 -0.473 0 CA-C-N 120.557 1.235 . . . . 20.0 114.854 -170.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.21 -15.24 59.56 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 119.151 0.887 . . . . 20.0 111.844 174.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 97' ' ' THR . . . . . 0.587 HG21 ' OG ' ' D' ' 324' ' ' SER . 44.8 p -89.48 35.49 0.82 Allowed 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.648 0.779 . . . . 20.0 112.421 178.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' D' ' 99' ' ' ILE . 0.5 OUTLIER -43.21 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.206 0 C-N-CA 124.983 1.313 . . . . 20.0 113.386 -173.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' D' ' 98' ' ' LEU . 1.6 tt -173.21 156.08 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.372 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 100' ' ' ALA . . . . . 0.443 ' H ' ' HB3' ' B' ' 100' ' ' ALA . . . -123.92 -19.09 5.79 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.668 -1.151 . . . . 20.0 111.288 158.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 101' ' ' GLN . . . . . 0.412 ' C ' HD11 ' D' ' 99' ' ' ILE . 0.0 OUTLIER -169.34 141.62 2.53 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 108.673 -0.862 . . . . 20.0 108.673 176.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 102' ' ' ARG . . . . . 0.482 HH12 ' HB3' ' B' ' 167' ' ' ARG . 0.0 OUTLIER 55.95 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.204 1.557 . . . . 20.0 115.204 150.521 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 103' ' ' PHE . . . . . 0.585 ' O ' ' N ' ' D' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.24 36.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 119.276 0.944 . . . . 20.0 109.367 160.399 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.83 140.32 37.25 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.474 -0.784 . . . . 20.0 109.367 -173.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 105' ' ' VAL . . . . . 0.579 HG22 ' CG1' ' D' ' 162' ' ' ILE . 50.6 t -117.41 110.71 31.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.236 -1.024 . . . . 20.0 108.236 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.06 6.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 110.206 -0.294 . . . . 20.0 110.206 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -52.0 -54.18 14.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 O-C-N 123.322 0.389 . . . . 20.0 110.338 170.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.5 10.58 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.423 -0.954 . . . . 20.0 108.423 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.09 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.458 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.19 11.18 75.08 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 118.888 -0.951 . . . . 20.0 115.35 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -128.97 114.0 15.89 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.465 1.132 . . . . 20.0 108.575 177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.28 141.55 37.77 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.392 -0.595 . . . . 20.0 109.392 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.64 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 108.699 -0.852 . . . . 20.0 108.699 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.65 149.39 31.29 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.008 -0.996 . . . . 20.0 110.296 -172.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 115' ' ' GLY . . . . . 0.585 ' N ' ' O ' ' D' ' 103' ' ' PHE . . . -147.92 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.323 -1.111 . . . . 20.0 110.323 -176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.38 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.385 -0.968 . . . . 20.0 108.385 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.25 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.317 -0.856 . . . . 20.0 114.584 -168.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 118' ' ' ALA . . . . . 0.486 ' O ' HD13 ' D' ' 98' ' ' LEU . . . -67.19 -47.91 69.5 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 114.374 1.25 . . . . 20.0 114.374 -156.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.78 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 119.541 1.064 . . . . 20.0 112.695 -155.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.14 35.36 Favored Pre-proline 0 C--O 1.24 0.596 0 N-CA-C 102.634 -3.098 . . . . 20.0 102.634 159.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.12 123.8 11.03 Favored 'Trans proline' 0 C--N 1.327 -0.573 0 CA-C-N 120.744 1.302 . . . . 20.0 110.554 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 122' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -63.83 149.8 89.87 Favored 'Trans proline' 0 CA--C 1.519 -0.228 0 CA-C-N 119.164 0.737 . . . . 20.0 110.677 177.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.1 165.39 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.852 0.834 . . . . 20.0 109.948 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.18 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.182 -1.044 . . . . 20.0 108.182 -175.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.97 160.84 19.52 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 120.793 -0.363 . . . . 20.0 110.724 169.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.68 1.5 Allowed Pre-proline 0 C--O 1.237 0.398 0 C-N-CA 123.978 0.911 . . . . 20.0 113.079 -170.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.01 -24.91 59.49 Favored 'Trans proline' 0 C--N 1.359 1.122 0 CA-C-N 120.826 1.331 . . . . 20.0 112.011 170.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.59 30.04 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 111.776 0.287 . . . . 20.0 111.776 -177.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.86 -31.98 69.03 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 119.748 -0.781 . . . . 20.0 110.28 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.85 62.56 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 111.947 0.351 . . . . 20.0 111.947 172.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.49 90.97 4.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.216 -0.661 . . . . 20.0 109.216 174.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.17 14.32 7.9 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.095 0.406 . . . . 20.0 112.095 175.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.54 87.36 Favored Pre-proline 0 N--CA 1.446 -0.665 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.61 75.29 Favored 'Trans proline' 0 C--N 1.326 -0.614 0 CA-C-N 119.641 0.908 . . . . 20.0 112.363 177.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.58 153.61 42.6 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.956 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -12.31 59.95 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 118.863 -0.589 . . . . 20.0 112.43 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' D' ' 138' ' ' GLN . 14.2 p30 -55.29 -66.39 0.42 Allowed 'General case' 0 C--N 1.344 0.369 0 CA-C-O 118.909 -0.567 . . . . 20.0 111.408 -175.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 138' ' ' GLN . . . . . 0.419 ' N ' ' OD1' ' D' ' 137' ' ' ASP . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.335 0 N-CA-C 103.091 -2.929 . . . . 20.0 103.091 133.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 139' ' ' ILE . . . . . 0.416 ' H ' ' HG3' ' D' ' 138' ' ' GLN . 1.2 tp -74.88 168.14 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 C-N-CA 124.128 0.971 . . . . 20.0 108.938 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.81 161.5 18.12 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 123.943 0.897 . . . . 20.0 110.508 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 141' ' ' ILE . . . . . 0.419 HD13 HD13 ' D' ' 162' ' ' ILE . 30.3 mt -124.68 147.45 29.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' D' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.77 55.0 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.646 0.778 . . . . 20.0 109.6 175.137 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.18 7.82 6.69 Favored 'Isoleucine or valine' 0 C--O 1.239 0.53 0 CA-C-N 115.875 -0.602 . . . . 20.0 111.759 166.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' D' ' 142' ' ' ASP . . . 86.91 -6.57 82.87 Favored Glycine 0 N--CA 1.441 -0.994 0 N-CA-C 115.484 0.953 . . . . 20.0 115.484 172.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.12 144.01 54.0 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 118.444 1.122 . . . . 20.0 110.312 176.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.34 -20.97 33.34 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 113.577 0.954 . . . . 20.0 113.577 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.66 40.09 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 121.967 0.889 . . . . 20.0 111.377 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.52 80.52 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 113.845 -1.525 . . . . 20.0 111.232 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.38 -46.99 87.99 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.797 -0.361 . . . . 20.0 110.983 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 150' ' ' GLU . . . . . . . . . . . . . 42.7 tp10 -61.34 -35.14 76.61 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 120.568 -0.453 . . . . 20.0 110.828 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.81 -40.58 83.85 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 120.056 -0.658 . . . . 20.0 111.095 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.31 58.5 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.344 -0.942 . . . . 20.0 111.058 -178.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.69 -30.07 66.54 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 119.757 -0.777 . . . . 20.0 110.638 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.62 -40.57 92.35 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 120.511 -0.476 . . . . 20.0 111.67 171.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.73 6.71 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.596 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.71 133.49 29.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 118.469 1.135 . . . . 20.0 108.565 178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.86 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.27 11.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 107.691 -1.226 . . . . 20.0 107.691 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.39 169.29 15.7 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 108.786 -1.726 . . . . 20.0 108.786 -176.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 160' ' ' THR . . . . . 0.525 HG23 ' HB2' ' D' ' 75' ' ' MET . 0.2 OUTLIER -79.35 113.52 17.56 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.62 -20.02 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 113.732 1.012 . . . . 20.0 113.732 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 162' ' ' ILE . . . . . 0.579 ' CG1' HG22 ' D' ' 105' ' ' VAL . 0.5 OUTLIER -111.69 155.64 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.46 0 O-C-N 121.701 -0.624 . . . . 20.0 111.734 -159.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' D' ' 164' ' ' TRP . 3.5 t -145.33 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.287 1.035 . . . . 20.0 110.476 171.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' D' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.93 16.7 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 113.237 0.828 . . . . 20.0 113.237 -160.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.72 61.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.238 0.542 . . . . 20.0 112.298 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.122 -1.191 . . . . 20.0 110.122 172.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 167' ' ' ARG . . . . . 0.434 ' HB3' HH12 ' B' ' 102' ' ' ARG . 0.0 OUTLIER -142.4 148.27 37.57 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 107.709 -1.219 . . . . 20.0 107.709 170.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.65 30.5 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.131 -0.941 . . . . 20.0 110.208 -167.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.46 159.78 35.22 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.899 0.857 . . . . 20.0 109.973 177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.33 117.21 34.24 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.247 -1.342 . . . . 20.0 109.515 -173.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.62 29.01 Favored 'General case' 0 CA--C 1.515 -0.38 0 N-CA-C 109.538 -0.542 . . . . 20.0 109.538 168.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' D' ' 175' ' ' ARG . . . 56.95 68.68 1.58 Allowed Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 109.217 -1.553 . . . . 20.0 109.217 -171.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.93 4.26 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 112.781 0.659 . . . . 20.0 112.781 -174.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.0 1.29 Allowed 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.731 -0.788 . . . . 20.0 111.178 157.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' D' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.95 0.7 Allowed 'General case' 0 C--O 1.232 0.144 0 CA-C-N 118.653 0.66 . . . . 20.0 112.663 172.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 127.855 2.462 . . . . 20.0 106.222 157.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 177' ' ' VAL . . . . . . . . . . . . . 45.6 t -144.68 145.76 20.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 N-CA-C 108.493 -0.928 . . . . 20.0 108.493 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.11 -64.47 1.15 Allowed 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 116.437 2.014 . . . . 20.0 116.437 -166.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 118.742 0.701 . . . . 20.0 112.115 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.68 36.77 Favored 'General case' 0 C--O 1.234 0.242 0 N-CA-C 114.398 1.258 . . . . 20.0 114.398 -170.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 181' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' D' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.96 0.83 Allowed 'General case' 0 C--O 1.237 0.406 0 CA-C-N 118.607 0.64 . . . . 20.0 111.766 -162.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.29 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.632 0 CA-C-O 122.092 0.949 . . . . 20.0 110.685 -152.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 183' ' ' ASP . . . . . 0.547 ' OD1' ' N ' ' D' ' 70' ' ' ASP . 0.6 OUTLIER 69.89 -6.63 1.04 Allowed 'General case' 0 C--O 1.233 0.227 0 C-N-CA 125.326 1.451 . . . . 20.0 113.193 174.704 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 184' ' ' ARG . . . . . 0.534 ' NH1' HD13 ' D' ' 29' ' ' ILE . 0.0 OUTLIER -153.87 83.88 1.15 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 122.213 1.006 . . . . 20.0 110.82 157.108 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 185' ' ' ILE . . . . . 0.438 HG12 HG11 ' D' ' 317' ' ' VAL . 1.0 OUTLIER -126.08 -41.13 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 104.496 -2.409 . . . . 20.0 104.496 149.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 186' ' ' ALA . . . . . 0.721 ' O ' ' OG1' ' D' ' 189' ' ' THR . . . -50.13 -42.95 51.53 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.349 -0.841 . . . . 20.0 111.54 173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.92 -36.07 76.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 119.283 -0.967 . . . . 20.0 110.122 -178.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.82 -38.66 91.92 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 119.146 -1.022 . . . . 20.0 110.477 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 189' ' ' THR . . . . . 0.721 ' OG1' ' O ' ' D' ' 186' ' ' ALA . 25.2 p -59.13 -48.61 80.98 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.453 -0.899 . . . . 20.0 110.831 172.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.24 -50.56 63.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 CA-C-O 120.941 0.401 . . . . 20.0 110.503 178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.21 95.99 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.106 -0.637 . . . . 20.0 110.898 -178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.85 -36.59 84.41 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 120.022 -0.671 . . . . 20.0 110.291 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 193' ' ' VAL . . . . . . . . . . . . . 11.5 t -60.52 -44.83 97.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-O 121.061 0.458 . . . . 20.0 110.085 177.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.34 75.53 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.174 -176.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.56 -38.24 71.01 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.919 -0.712 . . . . 20.0 110.794 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.63 -26.15 41.23 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.588 0.588 . . . . 20.0 112.588 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.77 27.44 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.301 -0.629 . . . . 20.0 109.301 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.42 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 123.293 0.371 . . . . 20.0 110.154 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 199' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.2 105.42 17.56 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.727 -0.471 . . . . 20.0 109.727 -172.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.28 4.25 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.191 -0.67 . . . . 20.0 109.191 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.48 59.92 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 119.993 -0.683 . . . . 20.0 111.358 176.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.87 141.66 30.42 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.969 -0.752 . . . . 20.0 108.969 172.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 203' ' ' ASP . . . . . 0.642 ' N ' ' OD1' ' D' ' 203' ' ' ASP . 0.0 OUTLIER -78.6 113.03 16.29 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.489 -0.93 . . . . 20.0 108.489 -174.466 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -103.02 151.6 6.14 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.398 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.9 106.56 8.99 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.05 -0.722 . . . . 20.0 109.05 173.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.91 125.35 31.26 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.75 -0.833 . . . . 20.0 108.75 177.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 207' ' ' VAL . . . . . 0.713 HG12 HD13 ' D' ' 53' ' ' ILE . 34.0 m -119.91 150.24 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.836 -0.801 . . . . 20.0 108.836 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.42 98.8 5.17 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 107.37 -1.344 . . . . 20.0 107.37 171.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.86 159.97 19.56 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.859 0.837 . . . . 20.0 111.115 -165.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.8 166.45 13.16 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 114.631 -1.168 . . . . 20.0 108.232 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.18 29.46 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.839 -1.073 . . . . 20.0 111.462 -179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.86 Favored 'General case' 0 CA--C 1.516 -0.36 0 C-N-CA 120.406 -0.518 . . . . 20.0 110.962 176.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.44 64.76 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.219 -0.592 . . . . 20.0 111.467 -173.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 214' ' ' VAL . . . . . . . . . . . . . 90.7 t -131.13 121.17 48.67 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.42 0 N-CA-C 108.499 -0.926 . . . . 20.0 108.499 173.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.07 60.94 6.23 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 119.684 -1.246 . . . . 20.0 111.405 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 216' ' ' LEU . . . . . 0.436 HD23 ' H ' ' D' ' 216' ' ' LEU . 0.5 OUTLIER -47.04 -25.49 0.84 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 113.465 0.913 . . . . 20.0 113.465 -179.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.56 -4.53 2.95 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 112.313 0.486 . . . . 20.0 112.313 173.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.52 40.77 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 119.721 -1.228 . . . . 20.0 112.022 168.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 219' ' ' ALA . . . . . 0.459 ' O ' ' OG ' ' D' ' 222' ' ' SER . . . -65.28 -37.02 85.88 Favored 'General case' 0 C--O 1.236 0.379 0 O-C-N 122.241 -0.564 . . . . 20.0 111.375 179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 220' ' ' ARG . . . . . 0.414 ' HB2' ' HB1' ' D' ' 302' ' ' ALA . 16.6 ttm180 -52.71 -36.77 57.94 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 112.139 0.422 . . . . 20.0 112.139 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 221' ' ' THR . . . . . . . . . . . . . 75.5 p -58.42 -45.79 87.74 Favored 'General case' 0 C--O 1.238 0.489 0 C-N-CA 120.001 -0.68 . . . . 20.0 110.867 -173.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 222' ' ' SER . . . . . 0.459 ' OG ' ' O ' ' D' ' 219' ' ' ALA . 2.1 p -58.01 -35.83 71.82 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.771 -0.372 . . . . 20.0 111.433 175.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.61 -50.03 69.05 Favored 'General case' 0 CA--C 1.517 -0.29 0 N-CA-C 112.582 0.586 . . . . 20.0 112.582 -169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.13 -33.43 75.76 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.795 -0.762 . . . . 20.0 111.84 -165.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.97 -16.71 74.95 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 118.93 -1.605 . . . . 20.0 112.099 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.94 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.251 0 N-CA-C 112.03 0.382 . . . . 20.0 112.03 -158.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 227' ' ' GLU . . . . . 0.487 ' OE1' ' OG1' ' D' ' 306' ' ' THR . 3.0 pt-20 -56.42 -46.67 99.78 Favored Pre-proline 0 C--O 1.236 0.388 0 N-CA-C 118.187 2.662 . . . . 20.0 118.187 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 228' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 C--O 1.232 0.214 0 N-CA-C 115.988 1.495 . . . . 20.0 115.988 -134.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.223 -0.325 0 C-N-CA 125.172 1.389 . . . . 20.0 113.413 162.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 120.065 -0.654 . . . . 20.0 111.708 167.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.49 16.44 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.906 -0.664 . . . . 20.0 112.256 -175.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.7 170.71 15.56 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 123.801 0.84 . . . . 20.0 108.83 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.64 149.08 23.41 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.199 0.523 . . . . 20.0 110.406 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 234' ' ' ILE . . . . . 0.496 HD11 ' CE ' ' D' ' 341' ' ' MET . 51.5 mt -133.22 90.39 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 107.552 -1.277 . . . . 20.0 107.552 172.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' D' ' 68' ' ' HIS . 25.5 t0 -135.11 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 106.96 -1.496 . . . . 20.0 106.96 173.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.14 149.4 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.636 0.731 . . . . 20.0 111.414 -172.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 237' ' ' THR . . . . . 0.46 HG21 ' HA3' ' D' ' 296' ' ' GLY . 9.1 t -165.67 122.7 1.44 Allowed 'General case' 0 C--O 1.234 0.241 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 164.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 238' ' ' ILE . . . . . 0.421 HD13 ' O ' ' D' ' 237' ' ' THR . 17.9 mm -145.46 151.88 14.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 108.268 -1.012 . . . . 20.0 108.268 -161.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.22 9.67 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.871 -1.529 . . . . 20.0 106.871 159.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.06 18.75 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 112.983 0.734 . . . . 20.0 112.983 -155.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.12 22.11 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.915 1.286 . . . . 20.0 112.448 158.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.93 128.4 79.09 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 105.22 -2.141 . . . . 20.0 105.22 -177.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.55 12.09 Favored 'Trans proline' 0 CA--C 1.516 -0.381 0 CA-C-N 120.871 1.347 . . . . 20.0 112.311 -178.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.38 -5.21 45.46 Favored Glycine 0 N--CA 1.441 -1.002 0 CA-C-N 115.063 -0.971 . . . . 20.0 114.928 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 245' ' ' THR . . . . . . . . . . . . . 33.3 p -92.17 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.595 1.197 . . . . 20.0 110.678 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.871 0.696 . . . . 20.0 111.968 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 114.768 -1.106 . . . . 20.0 112.087 179.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.28 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.83 -0.748 . . . . 20.0 112.862 -171.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 249' ' ' LYS . . . . . 0.715 ' O ' ' OG1' ' D' ' 252' ' ' THR . 16.9 mttt -98.79 -15.14 19.4 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.234 0.828 . . . . 20.0 113.234 170.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.86 88.96 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 120.299 -0.56 . . . . 20.0 111.368 -172.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.64 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.125 -1.03 . . . . 20.0 111.844 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 252' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' D' ' 249' ' ' LYS . 39.2 p -57.12 -31.84 65.72 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.5 0.591 . . . . 20.0 111.347 173.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 253' ' ' HIS . . . . . 0.536 ' CD2' ' HB2' ' D' ' 319' ' ' ALA . 16.7 t-80 -162.4 132.08 4.49 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.316 0.579 . . . . 20.0 110.37 176.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.32 3.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.279 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.33 35.93 5.83 Favored Glycine 0 CA--C 1.503 -0.688 0 C-N-CA 126.162 1.839 . . . . 20.0 111.56 -177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.22 10.16 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.12 174.27 3.41 Favored Glycine 0 N--CA 1.437 -1.259 0 CA-C-O 122.643 1.135 . . . . 20.0 113.366 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.82 175.09 6.08 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.52 -0.919 . . . . 20.0 108.52 -177.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' D' ' 316' ' ' SER . . . -126.38 120.34 29.6 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.123 -0.944 . . . . 20.0 109.391 -169.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 260' ' ' ILE . . . . . . . . . . . . . 85.6 mt -98.02 139.95 19.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.77 -1.196 . . . . 20.0 107.77 175.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 261' ' ' LYS . . . . . 0.768 ' HE3' HG21 ' D' ' 298' ' ' THR . 1.9 mtmm -98.81 122.62 42.28 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 108.991 -0.744 . . . . 20.0 108.991 -177.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.73 -40.31 10.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 CA-C-N 115.89 -0.595 . . . . 20.0 109.625 173.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.61 34.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.326 -0.62 . . . . 20.0 109.326 -174.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -170.0 2.87 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.23 165.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.96 -56.25 21.7 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.802 -0.635 . . . . 20.0 110.281 163.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.17 11.57 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -165.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.66 25.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 103.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 106.13 -1.804 . . . . 20.0 106.13 171.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.07 56.66 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.26 0.552 . . . . 20.0 111.341 -171.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.04 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.557 0 CA-C-N 115.144 -0.935 . . . . 20.0 108.67 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 271' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -67.45 -20.0 48.48 Favored 'Trans proline' 0 CA--C 1.512 -0.589 0 N-CA-C 114.865 1.063 . . . . 20.0 114.865 -160.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -43.0 74.55 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.149 -0.62 . . . . 20.0 110.599 176.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.57 -48.38 77.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 CA-C-O 121.111 0.481 . . . . 20.0 110.095 175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.09 -52.55 59.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 CA-C-O 120.838 0.351 . . . . 20.0 110.725 -176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.34 -31.93 70.78 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.807 -0.757 . . . . 20.0 110.55 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 276' ' ' TRP . . . . . 0.49 ' HH2' ' HB3' ' D' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.96 65.66 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 120.098 -0.641 . . . . 20.0 111.012 179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.08 -38.69 89.78 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.765 177.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -47.94 78.64 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.573 -0.451 . . . . 20.0 110.097 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.47 88.4 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.839 -0.344 . . . . 20.0 110.737 175.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.95 77.95 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.291 -0.563 . . . . 20.0 111.053 -172.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.18 -31.63 72.9 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 120.007 -0.677 . . . . 20.0 111.009 -175.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.43 -31.78 65.77 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.04 -0.664 . . . . 20.0 111.127 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.87 -37.67 73.06 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.902 -0.719 . . . . 20.0 110.939 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 284' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 -102.6 15.48 29.16 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.367 0.877 . . . . 20.0 113.367 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.78 32.09 13.76 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.744 0.783 . . . . 20.0 111.626 173.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.28 143.41 34.46 Favored Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 108.331 -0.989 . . . . 20.0 108.331 -178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 287' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -83.16 149.35 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.395 0 CA-C-N 119.177 0.742 . . . . 20.0 111.345 175.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.97 148.13 23.44 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.67 -0.695 . . . . 20.0 109.725 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.96 175.16 5.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 107.731 -1.211 . . . . 20.0 107.731 168.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.72 113.78 17.12 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.828 -1.175 . . . . 20.0 107.828 167.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.67 43.75 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.481 -0.563 . . . . 20.0 109.481 -172.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.03 25.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 N-CA-C 107.642 -1.244 . . . . 20.0 107.642 173.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.71 12.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.56 0.695 . . . . 20.0 110.245 175.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.74 -18.6 21.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 114.827 -1.079 . . . . 20.0 112.181 165.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 110.981 -0.847 . . . . 20.0 110.981 -176.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 296' ' ' GLY . . . . . 0.46 ' HA3' HG21 ' D' ' 237' ' ' THR . . . 101.49 144.83 15.64 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 114.637 -0.781 . . . . 20.0 112.624 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.84 119.53 4.07 Favored Glycine 0 N--CA 1.45 -0.378 0 N-CA-C 110.359 -1.097 . . . . 20.0 110.359 179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 298' ' ' THR . . . . . 0.768 HG21 ' HE3' ' D' ' 261' ' ' LYS . 20.2 p -110.3 172.91 6.58 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-O 122.037 0.922 . . . . 20.0 111.371 -174.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.92 -33.69 76.63 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.374 -1.285 . . . . 20.0 111.222 176.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.49 -35.41 74.07 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 111.788 0.292 . . . . 20.0 111.788 -171.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.18 96.84 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.198 -1.001 . . . . 20.0 112.002 -178.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 302' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' D' ' 220' ' ' ARG . . . -68.34 -26.87 65.82 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.119 -0.633 . . . . 20.0 111.186 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.44 55.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 120.003 -0.679 . . . . 20.0 110.127 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.21 -14.2 60.09 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 113.368 0.877 . . . . 20.0 113.368 -174.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.75 -8.82 19.55 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -167.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 306' ' ' THR . . . . . 0.487 ' OG1' ' OE1' ' D' ' 227' ' ' GLU . 0.5 OUTLIER -58.39 157.56 8.56 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.55 0.691 . . . . 20.0 110.543 171.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -161.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.89 -25.24 66.3 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.215 -178.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.871 -0.681 . . . . 20.0 113.301 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.25 139.6 52.48 Favored Pre-proline 0 C--O 1.239 0.508 0 CA-C-N 117.648 0.724 . . . . 20.0 111.14 -163.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.46 141.72 9.06 Favored 'Trans proline' 0 CA--C 1.512 -0.576 0 CA-C-N 119.502 0.858 . . . . 20.0 110.031 168.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.51 135.81 32.29 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.327 -0.851 . . . . 20.0 111.203 -169.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.61 12.32 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.155 -1.578 . . . . 20.0 109.155 164.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.05 27.32 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.465 0.65 . . . . 20.0 110.049 -176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.04 153.23 21.11 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 114.629 -1.168 . . . . 20.0 109.228 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' D' ' 259' ' ' ALA . 4.2 m -138.41 133.57 33.01 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.311 -0.859 . . . . 20.0 109.453 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 317' ' ' VAL . . . . . 0.438 HG11 HG12 ' D' ' 185' ' ' ILE . 92.2 t -99.51 108.58 51.38 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.242 -1.392 . . . . 20.0 107.242 177.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.704 0 CA-C-O 122.693 1.039 . . . . 20.0 113.599 -154.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 319' ' ' ALA . . . . . 0.536 ' HB2' ' CD2' ' D' ' 253' ' ' HIS . . . 79.78 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.313 0 CA-C-N 113.532 -1.667 . . . . 20.0 115.269 161.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 320' ' ' ARG . . . . . 0.418 ' HG3' ' O ' ' D' ' 321' ' ' TYR . 0.4 OUTLIER -75.61 157.62 33.54 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.709 0.766 . . . . 20.0 110.103 176.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 321' ' ' TYR . . . . . 0.418 ' O ' ' HG3' ' D' ' 320' ' ' ARG . 3.3 m-85 -113.18 166.16 11.71 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.21 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 124.123 0.969 . . . . 20.0 108.417 -163.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.37 3.24 Favored 'General case' 0 N--CA 1.468 0.458 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 324' ' ' SER . . . . . 0.587 ' OG ' HG21 ' D' ' 97' ' ' THR . 0.1 OUTLIER -59.49 -59.96 4.61 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.677 0.621 . . . . 20.0 112.677 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 325' ' ' ASN . . . . . 0.414 ' HB2' ' HA ' ' B' ' 100' ' ' ALA . 35.1 p-10 -102.02 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 114.997 1.48 . . . . 20.0 114.997 -152.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.54 151.01 50.82 Favored 'General case' 0 CA--C 1.51 -0.595 0 N-CA-C 107.445 -1.317 . . . . 20.0 107.445 174.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 327' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' D' ' 181' ' ' PHE . 82.7 mt-10 -142.59 52.87 1.42 Allowed 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 113.806 -1.543 . . . . 20.0 109.904 -153.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 328' ' ' VAL . . . . . . . . . . . . . 53.5 t -51.09 149.38 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.358 0 CA-C-O 121.423 0.63 . . . . 20.0 111.932 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 329' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' D' ' 181' ' ' PHE . 0.3 OUTLIER -139.36 179.38 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.884 0.849 . . . . 20.0 109.459 175.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.47 119.17 27.49 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 114.589 -1.187 . . . . 20.0 108.871 178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.05 -32.11 53.55 Favored 'General case' 0 C--O 1.235 0.314 0 O-C-N 123.819 0.699 . . . . 20.0 111.545 179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 332' ' ' ARG . . . . . 0.4 ' NH2' ' OE2' ' B' ' 146' ' ' GLU . 10.3 mtm180 -68.59 -44.76 73.66 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.295 -0.562 . . . . 20.0 110.259 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 333' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -65.97 -45.03 83.21 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.788 -0.365 . . . . 20.0 111.053 -172.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.58 -41.27 92.08 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 C-N-CA 120.45 -0.5 . . . . 20.0 110.541 -173.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.68 71.49 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 118.842 -1.143 . . . . 20.0 110.148 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.42 93.2 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.425 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.5 -43.83 80.12 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-O 120.789 0.328 . . . . 20.0 110.951 176.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' D' ' 342' ' ' THR . 42.6 t -60.23 -48.94 86.11 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 CA-C-O 120.978 0.418 . . . . 20.0 110.246 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' D' ' 343' ' ' LYS . 1.3 mm-40 -54.85 -46.88 74.72 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.027 0.441 . . . . 20.0 110.779 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.8 -55.23 36.82 Favored 'General case' 0 C--O 1.237 0.409 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.424 -176.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 341' ' ' MET . . . . . 0.496 ' CE ' HD11 ' D' ' 234' ' ' ILE . 32.0 tpp -60.12 -40.35 89.45 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 120.17 -0.612 . . . . 20.0 110.8 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' D' ' 338' ' ' VAL . 1.3 m -56.49 -45.04 81.17 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.109 0.48 . . . . 20.0 110.401 -177.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' D' ' 339' ' ' GLU . 34.5 mttp -74.16 -37.47 63.99 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 119.971 -0.691 . . . . 20.0 110.79 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.47 97.73 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.546 -0.461 . . . . 20.0 111.119 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 345' ' ' LEU . . . . . 0.427 ' O ' HG22 ' D' ' 348' ' ' ILE . 1.0 OUTLIER -59.02 -50.42 74.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 120.549 -0.461 . . . . 20.0 110.781 -179.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.67 -39.08 90.97 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.693 -0.803 . . . . 20.0 110.583 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 347' ' ' ASN . . . . . 0.49 ' HB3' ' HH2' ' D' ' 276' ' ' TRP . 4.9 m-20 -84.47 4.79 30.09 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 119.435 -0.906 . . . . 20.0 112.54 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 348' ' ' ILE . . . . . 0.427 HG22 ' O ' ' D' ' 345' ' ' LEU . 1.3 tt -65.22 -23.68 33.64 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 CA-C-N 119.098 0.863 . . . . 20.0 110.893 179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' D' D ' 349' ' ' HIS . . . . . . . . . . . . . 33.3 p-80 -63.71 -27.36 69.16 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.272 -175.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 122.083 -0.386 . . . . 20.0 111.484 177.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 351' ' ' LEU . . . . . 0.442 ' O ' HD12 ' D' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -173.888 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' D' D ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 116.037 1.866 . . . . 20.0 116.037 -169.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' D' D ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.815 0 C-N-CA 124.997 1.319 . . . . 20.0 108.371 -174.707 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.069 0 N-CA-C 114.244 1.201 . . . . 20.0 114.244 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.13 82.22 2.95 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 106.912 -1.514 . . . . 20.0 106.912 -170.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 3' ' ' VAL . . . . . . . . . . . . . 34.7 t -62.93 -34.48 66.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 114.836 -1.075 . . . . 20.0 110.23 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.01 -23.58 12.28 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 113.569 0.952 . . . . 20.0 113.569 -179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.5 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.109 0.964 . . . . 20.0 111.644 -173.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.83 -38.72 32.29 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.302 -0.249 . . . . 20.0 111.232 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.08 117.41 37.17 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 107.683 -1.229 . . . . 20.0 107.683 -178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.88 112.19 12.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.35 0.595 . . . . 20.0 110.879 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.51 72.7 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.397 -0.82 . . . . 20.0 111.864 -177.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.21 -45.13 74.17 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.527 -0.469 . . . . 20.0 111.207 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -43.03 97.26 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 120.982 -0.287 . . . . 20.0 111.189 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.58 70.97 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.755 -0.378 . . . . 20.0 111.178 -178.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.39 90.82 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.628 -0.429 . . . . 20.0 110.504 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -42.91 91.38 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-N 116.735 -0.212 . . . . 20.0 111.53 -174.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 m -77.93 -40.09 26.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 C-N-CA 119.529 -0.869 . . . . 20.0 110.676 -171.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.05 -32.13 6.76 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.056 -1.057 . . . . 20.0 111.024 -162.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.12 -25.94 67.99 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.997 -0.681 . . . . 20.0 111.26 174.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.07 160.47 70.35 Favored Pre-proline 0 N--CA 1.448 -0.558 0 C-N-CA 120.5 -0.48 . . . . 20.0 109.797 -175.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 19' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -85.18 144.76 9.5 Favored 'Trans proline' 0 C--N 1.33 -0.411 0 C-N-CA 120.259 0.639 . . . . 20.0 112.149 -172.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.28 3.39 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 117.273 1.669 . . . . 20.0 117.273 -159.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.78 2.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.168 -1.419 . . . . 20.0 107.168 159.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.02 171.17 8.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.349 0.595 . . . . 20.0 110.714 -166.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.93 -33.29 2.88 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.515 -0.766 . . . . 20.0 114.048 -177.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.25 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 122.326 1.06 . . . . 20.0 109.592 172.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.17 4.02 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 114.878 -1.055 . . . . 20.0 113.445 169.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 26' ' ' PHE . . . . . 0.499 ' O ' ' N ' ' E' ' 28' ' ' GLY . 0.0 OUTLIER -87.98 8.96 23.93 Favored 'General case' 0 C--N 1.346 0.417 0 CA-C-N 119.652 1.115 . . . . 20.0 113.71 178.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.62 11.35 0.05 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 115.401 1.63 . . . . 20.0 115.401 -154.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 28' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' E' ' 26' ' ' PHE . . . -53.2 -26.86 29.93 Favored Glycine 0 C--N 1.342 0.885 0 CA-C-N 119.83 1.196 . . . . 20.0 116.02 -172.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 29' ' ' ILE . . . . . 0.533 HD13 ' NH1' ' E' ' 184' ' ' ARG . 1.1 tt -59.64 -35.73 61.26 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-N 118.059 0.929 . . . . 20.0 110.648 -178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.43 61.53 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 120.848 0.356 . . . . 20.0 110.424 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.62 74.51 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.298 -0.41 . . . . 20.0 110.939 177.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 32' ' ' VAL . . . . . . . . . . . . . 11.1 t -63.28 -49.58 82.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.036 0.446 . . . . 20.0 110.277 -174.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.22 -39.73 86.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 119.683 -0.807 . . . . 20.0 110.31 -175.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.73 -29.43 20.39 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 118.692 -1.203 . . . . 20.0 111.177 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.51 -30.96 71.66 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.974 0.352 . . . . 20.0 111.1 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.98 -56.7 3.27 Favored 'General case' 0 C--O 1.236 0.393 0 N-CA-C 112.166 0.432 . . . . 20.0 112.166 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.27 -28.5 45.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 CA-C-N 116.48 -0.327 . . . . 20.0 111.518 -164.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.33 -26.36 63.72 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.896 -0.721 . . . . 20.0 112.226 -162.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.2 -23.45 62.95 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 118.84 -1.144 . . . . 20.0 111.71 -177.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.87 -6.95 22.92 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.532 0.938 . . . . 20.0 113.532 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.53 152.7 22.09 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 N-CA-C 108.532 -0.914 . . . . 20.0 108.532 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.16 -42.6 88.79 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 115.197 -0.91 . . . . 20.0 111.458 -175.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.65 158.33 35.26 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.522 -0.918 . . . . 20.0 108.522 -173.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.52 147.18 16.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.536 0.684 . . . . 20.0 110.458 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 128.99 74.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.3 -176.14 5.83 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.811 0.815 . . . . 20.0 108.929 177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.57 -34.6 62.95 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 119.957 -0.697 . . . . 20.0 111.13 -176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.16 10.82 9.28 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -171.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.64 83.37 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-O 119.096 -0.836 . . . . 20.0 114.446 -176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.91 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.544 1.172 . . . . 20.0 110.205 173.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.28 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 107.104 -1.443 . . . . 20.0 107.104 176.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 53' ' ' ILE . . . . . 0.721 HD13 HG12 ' E' ' 207' ' ' VAL . 31.1 mm -130.21 115.65 33.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 107.33 -1.359 . . . . 20.0 107.33 -174.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.92 119.75 36.32 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.672 -0.492 . . . . 20.0 109.672 174.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 100.03 8.11 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.56 145.4 31.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.76 -1.57 . . . . 20.0 106.76 163.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.55 154.48 20.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.711 -0.477 . . . . 20.0 109.711 -175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.44 -161.11 23.76 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.053 -0.819 . . . . 20.0 111.053 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.61 10.41 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 123.876 0.87 . . . . 20.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.03 -168.6 33.51 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.742 -0.742 . . . . 20.0 114.08 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.73 165.2 32.84 Favored 'Trans proline' 0 C--N 1.331 -0.388 0 CA-C-O 121.733 0.639 . . . . 20.0 112.085 179.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.93 111.34 22.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.293 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.7 138.0 29.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 N-CA-C 108.767 -0.827 . . . . 20.0 108.767 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.82 124.05 46.25 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 124.015 0.926 . . . . 20.0 109.001 -175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.3 45.68 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.311 0 N-CA-C 108.113 -1.069 . . . . 20.0 108.113 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.62 124.62 51.4 Favored 'General case' 0 CA--C 1.515 -0.401 0 O-C-N 123.317 0.386 . . . . 20.0 110.97 -168.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.88 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 123.942 0.897 . . . . 20.0 108.92 167.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' E' ' 235' ' ' ASP . 0.0 OUTLIER -105.07 146.44 29.12 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.935 -0.575 . . . . 20.0 110.549 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.32 5.86 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.239 -0.891 . . . . 20.0 109.735 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' E' ' 183' ' ' ASP . 12.0 t0 -97.35 67.97 2.16 Favored 'General case' 0 CA--C 1.516 -0.332 0 O-C-N 121.597 -0.689 . . . . 20.0 112.449 177.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.33 144.93 28.63 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.266 -1.013 . . . . 20.0 108.266 178.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.85 148.85 6.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 C-N-CA 123.692 0.797 . . . . 20.0 109.14 -178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 73' ' ' GLY . . . . . 0.468 ' C ' HD23 ' E' ' 74' ' ' LEU . . . -155.88 -175.69 27.17 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 110.576 -1.009 . . . . 20.0 110.576 173.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 74' ' ' LEU . . . . . 0.468 HD23 ' C ' ' E' ' 73' ' ' GLY . 5.1 mt -125.05 161.46 26.71 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.364 0.602 . . . . 20.0 109.989 178.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 75' ' ' MET . . . . . 0.506 ' HB2' HG23 ' E' ' 160' ' ' THR . 10.6 ttm -128.08 131.33 49.07 Favored 'General case' 0 CA--C 1.517 -0.294 0 C-N-CA 124.228 1.011 . . . . 20.0 109.681 -174.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.5 137.04 23.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.11 -29.29 7.03 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 113.08 0.77 . . . . 20.0 113.08 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.48 13.72 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.104 -1.073 . . . . 20.0 108.104 178.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 79' ' ' ILE . . . . . . . . . . . . . 32.3 mm -127.03 108.93 19.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 108.337 -0.986 . . . . 20.0 108.337 -175.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.31 5.66 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.782 0.801 . . . . 20.0 109.972 173.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.05 60.38 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 119.698 -0.801 . . . . 20.0 112.733 -169.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.15 4.27 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.354 0.872 . . . . 20.0 113.354 -177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.28 12.75 81.79 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-O 118.998 -0.89 . . . . 20.0 115.108 -178.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.75 145.03 34.06 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 118.341 1.071 . . . . 20.0 110.222 178.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.08 Favored 'General case' 0 CA--C 1.518 -0.268 0 CA-C-N 115.27 -0.877 . . . . 20.0 112.567 -172.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.42 174.69 6.55 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.841 -1.17 . . . . 20.0 107.841 158.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.8 163.79 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 CA-C-O 121.652 0.739 . . . . 20.0 109.476 -170.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.27 15.62 Favored Pre-proline 0 N--CA 1.449 -0.524 0 CA-C-N 115.019 -0.991 . . . . 20.0 109.808 171.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 89' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -79.78 160.17 24.64 Favored 'Trans proline' 0 CA--C 1.508 -0.82 0 CA-C-O 122.32 0.883 . . . . 20.0 112.735 -171.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 90' ' ' ILE . . . . . 0.467 HD11 HG21 ' E' ' 160' ' ' THR . 9.2 mt -88.75 150.27 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.72 -1.582 . . . . 20.0 107.367 165.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.89 47.46 Favored Glycine 0 N--CA 1.449 -0.493 0 CA-C-N 115.243 -0.889 . . . . 20.0 112.171 -168.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.18 22.12 Favored Glycine 0 N--CA 1.441 -1.025 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.231 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.91 152.62 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 118.649 1.225 . . . . 20.0 109.232 -169.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.69 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.559 0 N-CA-C 108.435 -0.95 . . . . 20.0 108.435 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 95' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.11 -7.91 13.05 Favored 'Trans proline' 0 CA--C 1.514 -0.516 0 CA-C-N 120.544 1.23 . . . . 20.0 114.81 -170.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.15 59.52 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.212 0.915 . . . . 20.0 111.805 174.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 97' ' ' THR . . . . . 0.589 HG21 ' OG ' ' E' ' 324' ' ' SER . 44.7 p -89.54 35.52 0.82 Allowed 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.676 0.79 . . . . 20.0 112.394 178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 98' ' ' LEU . . . . . 0.676 HD12 ' H ' ' E' ' 99' ' ' ILE . 0.5 OUTLIER -43.32 -66.44 0.38 Allowed 'General case' 0 C--O 1.233 0.21 0 C-N-CA 125.007 1.323 . . . . 20.0 113.344 -172.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 99' ' ' ILE . . . . . 0.676 ' H ' HD12 ' E' ' 98' ' ' LEU . 1.6 tt -173.19 156.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 100' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' G' ' 325' ' ' ASN . . . -123.91 -19.06 5.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.673 -1.148 . . . . 20.0 111.254 158.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 101' ' ' GLN . . . . . 0.411 ' C ' HD11 ' E' ' 99' ' ' ILE . 0.0 OUTLIER -169.38 141.6 2.51 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.671 -0.863 . . . . 20.0 108.671 176.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 102' ' ' ARG . . . . . 0.574 HH12 ' HB3' ' G' ' 167' ' ' ARG . 0.0 OUTLIER 55.96 74.5 0.38 Allowed 'General case' 0 N--CA 1.455 -0.181 0 N-CA-C 115.238 1.569 . . . . 20.0 115.238 150.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' E' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 119.309 0.959 . . . . 20.0 109.379 160.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.28 37.26 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.492 -0.777 . . . . 20.0 109.414 -173.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 105' ' ' VAL . . . . . 0.576 HG22 ' CG1' ' E' ' 162' ' ' ILE . 50.6 t -117.41 110.78 32.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 108.227 -1.027 . . . . 20.0 108.227 -178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.55 83.04 6.31 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 110.238 -0.282 . . . . 20.0 110.238 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.2 14.61 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 O-C-N 123.378 0.424 . . . . 20.0 110.389 170.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 108' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -152.57 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.416 -0.957 . . . . 20.0 108.416 178.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.05 126.32 27.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.945 -1.025 . . . . 20.0 110.498 -177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.19 75.18 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.337 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.03 114.01 15.86 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 118.474 1.137 . . . . 20.0 108.563 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.28 141.52 37.77 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 109.362 -0.607 . . . . 20.0 109.362 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.62 142.56 43.59 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 N-CA-C 108.71 -0.848 . . . . 20.0 108.71 172.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 114' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -79.78 149.48 31.07 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.991 -1.004 . . . . 20.0 110.269 -172.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' E' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 110.28 -1.128 . . . . 20.0 110.28 -176.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.76 154.38 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.24 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.791 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.582 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 118' ' ' ALA . . . . . 0.497 ' O ' HD13 ' E' ' 98' ' ' LEU . . . -67.18 -47.91 69.54 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 114.371 1.248 . . . . 20.0 114.371 -156.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.13 11.74 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 119.538 1.063 . . . . 20.0 112.651 -155.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.1 35.61 Favored Pre-proline 0 C--O 1.24 0.569 0 N-CA-C 102.653 -3.091 . . . . 20.0 102.653 159.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 121' ' ' PRO . . . . . 0.419 ' HG3' ' O ' ' G' ' 243' ' ' PRO . 9.3 Cg_endo -68.07 123.83 11.09 Favored 'Trans proline' 0 C--N 1.328 -0.545 0 CA-C-N 120.743 1.301 . . . . 20.0 110.599 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.84 149.75 89.97 Favored 'Trans proline' 0 CA--C 1.518 -0.284 0 CA-C-N 119.245 0.766 . . . . 20.0 110.701 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.38 7.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.814 0.816 . . . . 20.0 109.949 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.11 91.85 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 108.259 -1.015 . . . . 20.0 108.259 -175.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.82 19.57 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-O 120.89 0.376 . . . . 20.0 110.702 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.85 -43.69 1.51 Allowed Pre-proline 0 C--O 1.237 0.407 0 C-N-CA 123.983 0.913 . . . . 20.0 113.116 -170.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.94 -25.01 59.95 Favored 'Trans proline' 0 C--N 1.359 1.11 0 CA-C-N 120.823 1.33 . . . . 20.0 112.006 170.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.54 -26.51 30.06 Favored 'General case' 0 C--O 1.237 0.4 0 N-CA-C 111.803 0.297 . . . . 20.0 111.803 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.94 69.13 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 119.735 -0.786 . . . . 20.0 110.265 168.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.84 62.47 Favored 'General case' 0 C--O 1.24 0.577 0 N-CA-C 111.921 0.341 . . . . 20.0 111.921 172.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.52 90.95 4.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 109.193 -0.669 . . . . 20.0 109.193 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.25 7.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.37 Favored Pre-proline 0 N--CA 1.445 -0.701 0 N-CA-C 108.531 -0.915 . . . . 20.0 108.531 172.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 134' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -67.84 153.63 75.11 Favored 'Trans proline' 0 C--N 1.326 -0.626 0 CA-C-N 119.635 0.905 . . . . 20.0 112.343 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.62 42.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.509 -1.223 . . . . 20.0 107.912 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.6 -12.28 59.95 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 118.829 -0.605 . . . . 20.0 112.4 -175.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' E' ' 138' ' ' GLN . 14.0 p30 -55.4 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.372 0 CA-C-O 118.87 -0.586 . . . . 20.0 111.353 -175.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 138' ' ' GLN . . . . . 0.421 ' HG3' ' H ' ' E' ' 139' ' ' ILE . 3.9 tp-100 174.63 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.3 0 N-CA-C 103.082 -2.933 . . . . 20.0 103.082 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 139' ' ' ILE . . . . . 0.421 ' H ' ' HG3' ' E' ' 138' ' ' GLN . 1.2 tp -74.81 168.13 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 124.108 0.963 . . . . 20.0 109.007 -179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.85 161.44 18.22 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.91 0.884 . . . . 20.0 110.514 177.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 141' ' ' ILE . . . . . 0.413 HD13 HD13 ' E' ' 162' ' ' ILE . 30.2 mt -124.61 147.46 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 C-N-CA 123.896 0.879 . . . . 20.0 108.646 -177.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 142' ' ' ASP . . . . . 0.568 ' OD1' ' N ' ' E' ' 144' ' ' GLY . 0.5 OUTLIER -119.08 134.72 55.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.638 0.775 . . . . 20.0 109.578 175.172 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.12 7.81 6.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 123.683 0.614 . . . . 20.0 111.783 166.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 144' ' ' GLY . . . . . 0.568 ' N ' ' OD1' ' E' ' 142' ' ' ASP . . . 86.85 -6.51 82.82 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 115.488 0.955 . . . . 20.0 115.488 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.13 144.01 53.97 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 118.502 1.151 . . . . 20.0 110.323 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.31 -20.95 33.43 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 113.62 0.97 . . . . 20.0 113.62 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.65 40.11 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-O 121.992 0.901 . . . . 20.0 111.395 -173.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 148' ' ' LYS . . . . . . . . . . . . . 27.6 tttt -57.37 -41.52 80.32 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 113.878 -1.51 . . . . 20.0 111.25 177.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -47.01 87.93 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.811 -0.356 . . . . 20.0 110.945 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.31 -35.18 76.65 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.509 -0.477 . . . . 20.0 110.859 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.75 -40.56 84.11 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 120.039 -0.664 . . . . 20.0 111.142 -175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.85 -23.28 58.41 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.337 -0.945 . . . . 20.0 110.956 -178.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.74 -30.04 66.46 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.77 -0.772 . . . . 20.0 110.637 177.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.58 -40.59 92.27 Favored 'General case' 0 CA--C 1.514 -0.441 0 C-N-CA 120.564 -0.454 . . . . 20.0 111.666 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.12 -8.8 6.7 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-O 118.898 -0.946 . . . . 20.0 114.594 -172.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.68 133.52 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 118.497 1.149 . . . . 20.0 108.514 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.738 -1.208 . . . . 20.0 107.738 174.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 107.702 -1.222 . . . . 20.0 107.702 174.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.31 15.73 Favored Glycine 0 N--CA 1.448 -0.521 0 N-CA-C 108.778 -1.729 . . . . 20.0 108.778 -176.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 160' ' ' THR . . . . . 0.506 HG23 ' HB2' ' E' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.61 17.72 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 165.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -19.99 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.323 0 N-CA-C 113.766 1.024 . . . . 20.0 113.766 -166.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 162' ' ' ILE . . . . . 0.576 ' CG1' HG22 ' E' ' 105' ' ' VAL . 0.5 OUTLIER -111.69 155.6 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 O-C-N 121.674 -0.641 . . . . 20.0 111.81 -159.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 163' ' ' THR . . . . . 0.558 ' OG1' ' N ' ' E' ' 164' ' ' TRP . 3.5 t -145.29 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 124.299 1.04 . . . . 20.0 110.473 171.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 164' ' ' TRP . . . . . 0.558 ' N ' ' OG1' ' E' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.94 16.7 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 -160.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.71 61.65 0.97 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.221 0.534 . . . . 20.0 112.333 -177.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.56 29.54 Favored Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 110.064 -1.214 . . . . 20.0 110.064 172.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.32 37.68 Favored 'General case' 0 CA--C 1.51 -0.589 0 N-CA-C 107.721 -1.214 . . . . 20.0 107.721 170.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.96 117.63 30.46 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.129 -0.942 . . . . 20.0 110.198 -167.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.46 159.74 35.33 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.861 0.839 . . . . 20.0 109.982 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.32 117.17 34.17 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 114.224 -1.353 . . . . 20.0 109.494 -173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.66 28.95 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.522 -0.547 . . . . 20.0 109.522 168.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' E' ' 175' ' ' ARG . . . 56.88 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 109.187 -1.565 . . . . 20.0 109.187 -171.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.91 4.25 Favored 'General case' 0 C--O 1.235 0.296 0 N-CA-C 112.813 0.672 . . . . 20.0 112.813 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.06 -63.05 1.27 Allowed 'General case' 0 C--O 1.235 0.304 0 C-N-CA 119.743 -0.783 . . . . 20.0 111.237 157.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' E' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.96 0.7 Allowed 'General case' 0 C--O 1.231 0.104 0 CA-C-N 118.583 0.629 . . . . 20.0 112.649 172.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.41 0.35 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 127.786 2.434 . . . . 20.0 106.213 157.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.66 145.79 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 108.478 -0.934 . . . . 20.0 108.478 177.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.13 -64.47 1.16 Allowed 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 116.446 2.017 . . . . 20.0 116.446 -166.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.86 22.37 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 118.726 0.694 . . . . 20.0 112.124 -171.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.07 -0.7 36.74 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -170.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 181' ' ' PHE . . . . . 0.746 ' HB3' ' HB3' ' E' ' 327' ' ' GLU . 3.1 t80 -84.6 -67.05 0.83 Allowed 'General case' 0 C--O 1.237 0.412 0 CA-C-N 118.599 0.636 . . . . 20.0 111.755 -162.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.24 127.78 32.76 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.078 0.942 . . . . 20.0 110.727 -152.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' E' ' 70' ' ' ASP . 0.6 OUTLIER 69.99 -6.7 1.04 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.348 1.459 . . . . 20.0 113.135 174.669 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 184' ' ' ARG . . . . . 0.533 ' NH1' HD13 ' E' ' 29' ' ' ILE . 0.0 OUTLIER -153.8 83.91 1.16 Allowed 'General case' 0 N--CA 1.446 -0.668 0 CA-C-O 122.152 0.977 . . . . 20.0 110.779 157.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 185' ' ' ILE . . . . . 0.439 HG12 HG11 ' E' ' 317' ' ' VAL . 1.0 OUTLIER -126.06 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.5 -2.407 . . . . 20.0 104.5 149.898 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 186' ' ' ALA . . . . . 0.706 ' O ' ' OG1' ' E' ' 189' ' ' THR . . . -50.1 -42.96 51.28 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.342 -0.844 . . . . 20.0 111.55 173.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.93 -36.08 76.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.25 -0.98 . . . . 20.0 110.105 -178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.551 177.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 189' ' ' THR . . . . . 0.706 ' OG1' ' O ' ' E' ' 186' ' ' ALA . 25.3 p -59.06 -48.66 80.81 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 119.491 -0.884 . . . . 20.0 110.862 171.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.24 -50.6 63.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.35 0 CA-C-O 120.946 0.403 . . . . 20.0 110.5 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.17 96.22 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.064 -0.655 . . . . 20.0 110.961 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.56 84.34 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.014 -0.674 . . . . 20.0 110.284 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 193' ' ' VAL . . . . . 0.415 HG23 ' O ' ' E' ' 189' ' ' THR . 11.8 t -60.49 -44.81 97.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.08 0.467 . . . . 20.0 110.159 177.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.1 -33.3 75.46 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.223 -0.591 . . . . 20.0 111.227 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.6 -38.17 70.88 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.877 -0.729 . . . . 20.0 110.811 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.11 41.01 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.555 0.576 . . . . 20.0 112.555 -175.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.55 122.83 27.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.31 -0.626 . . . . 20.0 109.31 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.47 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.292 0 O-C-N 123.294 0.371 . . . . 20.0 110.085 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 199' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -98.18 105.41 17.56 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 109.689 -0.486 . . . . 20.0 109.689 -172.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.07 91.33 4.27 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 119.974 -0.691 . . . . 20.0 111.376 176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.65 30.47 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 172.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 203' ' ' ASP . . . . . 0.652 ' N ' ' OD1' ' E' ' 203' ' ' ASP . 0.0 OUTLIER -78.59 113.02 16.26 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 108.491 -0.929 . . . . 20.0 108.491 -174.49 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.59 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 108.567 -0.901 . . . . 20.0 108.567 -170.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.92 106.6 9.0 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.987 -0.745 . . . . 20.0 108.987 173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.38 31.31 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 207' ' ' VAL . . . . . 0.721 HG12 HD13 ' E' ' 53' ' ' ILE . 34.1 m -119.91 150.19 22.53 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.825 -0.806 . . . . 20.0 108.825 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.77 5.17 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.432 -1.321 . . . . 20.0 107.432 171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.81 159.98 19.59 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.851 0.834 . . . . 20.0 111.106 -165.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.46 13.13 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.436 0 CA-C-N 114.618 -1.173 . . . . 20.0 108.252 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.6 40.19 29.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.83 -1.077 . . . . 20.0 111.492 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.82 Favored 'General case' 0 CA--C 1.516 -0.362 0 C-N-CA 120.361 -0.536 . . . . 20.0 110.922 176.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.45 64.8 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.218 -0.593 . . . . 20.0 111.519 -173.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.13 121.18 48.68 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.442 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.93 6.25 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.435 -174.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 216' ' ' LEU . . . . . 0.425 HD23 ' H ' ' E' ' 216' ' ' LEU . 0.5 OUTLIER -47.04 -25.51 0.84 Allowed 'General case' 0 C--O 1.235 0.314 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -179.107 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.55 2.89 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.349 0.5 . . . . 20.0 112.349 173.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.5 40.82 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.708 -1.234 . . . . 20.0 112.017 168.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 219' ' ' ALA . . . . . 0.445 ' O ' ' OG ' ' E' ' 222' ' ' SER . . . -65.27 -37.06 86.01 Favored 'General case' 0 C--O 1.237 0.404 0 O-C-N 122.27 -0.547 . . . . 20.0 111.412 179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 220' ' ' ARG . . . . . 0.406 ' HB2' ' HB1' ' E' ' 302' ' ' ALA . 16.6 ttm180 -52.67 -36.73 57.53 Favored 'General case' 0 CA--C 1.516 -0.362 0 N-CA-C 112.191 0.441 . . . . 20.0 112.191 -174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 221' ' ' THR . . . . . . . . . . . . . 74.5 p -58.43 -45.81 87.73 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 119.991 -0.684 . . . . 20.0 110.838 -173.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 222' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' E' ' 219' ' ' ALA . 2.1 p -58.05 -35.79 71.84 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 120.728 -0.389 . . . . 20.0 111.425 175.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.99 69.23 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.548 0.573 . . . . 20.0 112.548 -169.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.14 -33.44 75.78 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.818 -0.753 . . . . 20.0 111.805 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.71 74.93 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 118.92 -1.609 . . . . 20.0 112.14 179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.99 -45.64 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 111.97 0.359 . . . . 20.0 111.97 -158.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 227' ' ' GLU . . . . . 0.453 ' OE1' ' OG1' ' E' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.71 99.78 Favored Pre-proline 0 C--O 1.236 0.385 0 N-CA-C 118.21 2.67 . . . . 20.0 118.21 -158.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 228' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -43.94 143.74 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.174 0 N-CA-C 115.957 1.483 . . . . 20.0 115.957 -134.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.82 0.77 Allowed 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 125.219 1.408 . . . . 20.0 113.391 162.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.17 11.54 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 120.104 -0.638 . . . . 20.0 111.77 167.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.47 151.48 16.45 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.897 -0.668 . . . . 20.0 112.255 -175.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.45 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 123.78 0.832 . . . . 20.0 108.812 178.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.06 23.35 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.124 0.487 . . . . 20.0 110.42 177.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 234' ' ' ILE . . . . . 0.495 HD11 ' CE ' ' E' ' 341' ' ' MET . 51.6 mt -133.19 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.368 0 N-CA-C 107.58 -1.267 . . . . 20.0 107.58 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' E' ' 68' ' ' HIS . 25.5 t0 -135.19 173.23 11.96 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.979 -1.489 . . . . 20.0 106.979 173.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.39 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.701 0.763 . . . . 20.0 111.411 -172.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 237' ' ' THR . . . . . 0.447 HG21 ' HA3' ' E' ' 296' ' ' GLY . 9.1 t -165.61 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.368 -1.345 . . . . 20.0 107.368 164.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' E' ' 237' ' ' THR . 17.9 mm -145.48 151.93 14.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.209 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.32 105.28 9.71 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 106.861 -1.533 . . . . 20.0 106.861 159.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.53 110.01 18.63 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 113.033 0.753 . . . . 20.0 113.033 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.11 22.17 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.902 1.281 . . . . 20.0 112.5 158.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.92 128.41 79.09 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 243' ' ' PRO . . . . . 0.564 ' HG3' ' HD1' ' G' ' 84' ' ' PHE . 16.6 Cg_exo -61.02 165.56 12.06 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 120.83 1.332 . . . . 20.0 112.396 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.26 45.15 Favored Glycine 0 N--CA 1.442 -0.917 0 CA-C-N 115.069 -0.969 . . . . 20.0 114.94 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 245' ' ' THR . . . . . . . . . . . . . 33.5 p -92.18 164.54 22.82 Favored Pre-proline 0 N--CA 1.453 -0.316 0 CA-C-N 118.616 1.208 . . . . 20.0 110.679 177.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.0 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.601 0 CA-C-O 121.833 0.68 . . . . 20.0 111.922 171.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.11 -10.9 59.59 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.081 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.64 63.13 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 119.859 -0.737 . . . . 20.0 112.885 -171.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 249' ' ' LYS . . . . . 0.713 ' O ' ' OG1' ' E' ' 252' ' ' THR . 16.9 mttt -98.85 -15.11 19.34 Favored 'General case' 0 CA--C 1.513 -0.448 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -37.89 89.07 Favored 'General case' 0 C--O 1.232 0.135 0 C-N-CA 120.278 -0.569 . . . . 20.0 111.394 -172.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.56 -21.02 25.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.107 -1.037 . . . . 20.0 111.907 -178.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 252' ' ' THR . . . . . 0.713 ' OG1' ' O ' ' E' ' 249' ' ' LYS . 39.4 p -57.17 -31.82 65.78 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.46 0.573 . . . . 20.0 111.304 173.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 253' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' E' ' 319' ' ' ALA . 16.7 t-80 -162.35 132.08 4.52 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.283 0.563 . . . . 20.0 110.427 176.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.38 -1.33 3.96 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.024 -0.989 . . . . 20.0 112.307 175.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.31 35.92 5.84 Favored Glycine 0 CA--C 1.504 -0.651 0 C-N-CA 126.175 1.845 . . . . 20.0 111.57 -177.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.2 10.15 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 108.619 -0.882 . . . . 20.0 108.619 -167.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.24 3.41 Favored Glycine 0 N--CA 1.437 -1.237 0 CA-C-O 122.642 1.134 . . . . 20.0 113.305 169.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.76 175.09 6.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.545 -0.909 . . . . 20.0 108.545 -177.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.38 120.33 29.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.439 -169.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.04 139.9 19.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 107.755 -1.202 . . . . 20.0 107.755 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 261' ' ' LYS . . . . . 0.768 ' HE3' HG21 ' E' ' 298' ' ' THR . 1.9 mtmm -98.81 122.64 42.31 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.97 -0.752 . . . . 20.0 108.97 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.74 -40.31 10.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-N 115.838 -0.619 . . . . 20.0 109.6 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-O 121.406 0.622 . . . . 20.0 109.329 -174.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.97 2.86 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-N 114.78 -1.1 . . . . 20.0 108.183 165.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.28 21.42 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.783 -0.644 . . . . 20.0 110.278 163.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.14 11.56 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.67 0.989 . . . . 20.0 113.67 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.75 143.65 25.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.02 14.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 106.155 -1.795 . . . . 20.0 106.155 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.38 137.11 56.65 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.232 0.539 . . . . 20.0 111.278 -171.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.1 109.64 1.96 Allowed Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 115.112 -0.949 . . . . 20.0 108.688 177.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.41 -20.07 48.66 Favored 'Trans proline' 0 CA--C 1.512 -0.58 0 N-CA-C 114.816 1.045 . . . . 20.0 114.816 -160.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.96 74.66 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.558 176.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.6 -48.35 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 CA-C-O 121.124 0.488 . . . . 20.0 110.099 175.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.15 -52.52 59.82 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-O 120.799 0.333 . . . . 20.0 110.698 -176.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.92 70.82 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.814 -0.755 . . . . 20.0 110.56 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 276' ' ' TRP . . . . . 0.491 ' HH2' ' HB3' ' E' ' 347' ' ' ASN . 0.1 OUTLIER -68.46 -47.96 65.76 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.09 -0.644 . . . . 20.0 110.988 179.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.0 -38.75 89.81 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 120.068 -0.653 . . . . 20.0 110.769 177.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.61 -47.97 78.48 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.583 -0.447 . . . . 20.0 110.116 173.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.48 88.44 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.876 -0.33 . . . . 20.0 110.719 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.92 77.91 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 120.286 -0.566 . . . . 20.0 111.079 -172.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.16 -31.68 72.96 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.017 -0.673 . . . . 20.0 110.995 -175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.4 -31.82 65.85 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.124 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.83 -37.68 73.19 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 119.884 -0.727 . . . . 20.0 110.972 -175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.63 15.47 29.2 Favored 'General case' 0 C--O 1.234 0.281 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.81 32.08 13.69 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 121.75 0.786 . . . . 20.0 111.614 173.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.25 143.39 34.47 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 108.304 -0.998 . . . . 20.0 108.304 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.15 149.35 13.49 Favored 'Trans proline' 0 CA--C 1.516 -0.379 0 CA-C-N 119.145 0.73 . . . . 20.0 111.333 175.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.06 148.18 23.35 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.667 -0.697 . . . . 20.0 109.676 -179.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.02 175.12 5.61 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 168.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.67 113.72 17.07 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.906 -1.146 . . . . 20.0 107.906 167.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.68 43.74 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.07 25.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 173.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.59 168.72 12.25 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.469 0.652 . . . . 20.0 110.241 176.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.73 -18.63 21.09 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 114.824 -1.08 . . . . 20.0 112.144 165.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.57 -176.03 20.04 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 110.97 -0.852 . . . . 20.0 110.97 -176.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 296' ' ' GLY . . . . . 0.447 ' HA3' HG21 ' E' ' 237' ' ' THR . . . 101.51 144.74 15.5 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.62 -0.79 . . . . 20.0 112.66 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.79 119.63 4.11 Favored Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.324 -1.11 . . . . 20.0 110.324 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 298' ' ' THR . . . . . 0.768 HG21 ' HE3' ' E' ' 261' ' ' LYS . 20.4 p -110.27 172.86 6.61 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 122.013 0.911 . . . . 20.0 111.363 -174.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.87 -33.74 76.72 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.215 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.34 74.11 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 111.73 0.27 . . . . 20.0 111.73 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.42 -41.15 96.9 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.197 -1.001 . . . . 20.0 112.028 -178.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 302' ' ' ALA . . . . . 0.406 ' HB1' ' HB2' ' E' ' 220' ' ' ARG . . . -68.28 -26.92 65.9 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.187 -0.605 . . . . 20.0 111.236 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 303' ' ' ILE . . . . . . . . . . . . . 13.2 mm -70.88 -34.44 55.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.122 -178.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.21 60.18 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.311 0.856 . . . . 20.0 113.311 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.87 19.53 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.697 0.999 . . . . 20.0 113.697 -167.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 306' ' ' THR . . . . . 0.453 ' OG1' ' OE1' ' E' ' 227' ' ' GLU . 0.5 OUTLIER -58.37 157.56 8.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.534 0.683 . . . . 20.0 110.572 171.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 307' ' ' LYS . . . . . 0.462 ' HD2' ' HB2' ' A' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.86 70.38 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 113.343 0.868 . . . . 20.0 113.343 -161.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.88 -25.2 66.28 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.716 -0.794 . . . . 20.0 111.201 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 309' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 48' ' ' LYS . . . 77.72 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.831 -0.699 . . . . 20.0 113.367 -171.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.28 139.58 52.36 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.558 0.679 . . . . 20.0 111.131 -163.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.45 141.68 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 CA-C-N 119.482 0.851 . . . . 20.0 110.039 168.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.48 135.79 32.31 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 115.323 -0.853 . . . . 20.0 111.201 -169.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.58 162.6 12.32 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 109.166 -1.574 . . . . 20.0 109.166 164.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.03 27.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.464 0.649 . . . . 20.0 110.082 -176.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.04 153.19 21.15 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 114.62 -1.173 . . . . 20.0 109.258 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.55 32.91 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.283 -0.871 . . . . 20.0 109.417 -178.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 317' ' ' VAL . . . . . 0.439 HG11 HG12 ' E' ' 185' ' ' ILE . 92.6 t -99.48 108.61 51.45 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.285 -1.376 . . . . 20.0 107.285 177.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 318' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -83.31 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.325 -0.69 0 CA-C-O 122.626 1.011 . . . . 20.0 113.589 -154.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 319' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' E' ' 253' ' ' HIS . . . 79.84 35.44 0.15 Allowed 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 113.604 -1.634 . . . . 20.0 115.282 161.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 320' ' ' ARG . . . . . 0.422 ' HG3' ' O ' ' E' ' 321' ' ' TYR . 0.4 OUTLIER -75.57 157.56 33.69 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.759 0.79 . . . . 20.0 110.119 176.708 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 321' ' ' TYR . . . . . 0.422 ' O ' ' HG3' ' E' ' 320' ' ' ARG . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 106.797 -1.557 . . . . 20.0 106.797 160.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.23 113.65 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 124.199 1.0 . . . . 20.0 108.379 -163.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.54 -7.44 3.23 Favored 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.45 1.278 . . . . 20.0 114.45 -140.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 324' ' ' SER . . . . . 0.589 ' OG ' HG21 ' E' ' 97' ' ' THR . 0.1 OUTLIER -59.54 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.665 0.617 . . . . 20.0 112.665 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 325' ' ' ASN . . . . . 0.465 ' HB2' ' O ' ' G' ' 100' ' ' ALA . 35.0 p-10 -102.0 -56.09 2.35 Favored 'General case' 0 CA--C 1.514 -0.411 0 N-CA-C 115.007 1.484 . . . . 20.0 115.007 -152.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.56 150.93 50.78 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.442 -1.318 . . . . 20.0 107.442 174.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 327' ' ' GLU . . . . . 0.746 ' HB3' ' HB3' ' E' ' 181' ' ' PHE . 82.7 mt-10 -142.55 52.84 1.42 Allowed 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 113.817 -1.538 . . . . 20.0 109.94 -153.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.06 149.39 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.403 0.621 . . . . 20.0 111.939 -171.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 329' ' ' VAL . . . . . 0.414 HG13 ' HB2' ' E' ' 181' ' ' PHE . 0.3 OUTLIER -139.4 179.41 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 121.919 0.866 . . . . 20.0 109.427 175.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.18 27.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.818 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 331' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -54.06 -32.1 53.6 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.835 0.71 . . . . 20.0 111.51 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.73 73.56 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 120.308 -0.557 . . . . 20.0 110.214 -176.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 333' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -66.05 -44.89 83.24 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.779 -0.368 . . . . 20.0 111.064 -172.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.66 -41.27 92.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 C-N-CA 120.435 -0.506 . . . . 20.0 110.496 -173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 118.837 -1.145 . . . . 20.0 110.152 178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.4 -40.42 93.4 Favored 'General case' 0 C--O 1.237 0.433 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.459 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.6 -43.81 80.48 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.76 0.314 . . . . 20.0 110.924 176.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 338' ' ' VAL . . . . . 0.705 ' O ' ' OG1' ' E' ' 342' ' ' THR . 42.7 t -60.17 -48.95 86.02 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 CA-C-O 121.034 0.445 . . . . 20.0 110.288 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' E' ' 343' ' ' LYS . 1.3 mm-40 -54.78 -47.02 74.46 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 120.99 0.424 . . . . 20.0 110.726 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.76 -55.14 37.94 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-N 116.332 -0.395 . . . . 20.0 111.456 -176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 341' ' ' MET . . . . . 0.495 ' CE ' HD11 ' E' ' 234' ' ' ILE . 31.9 tpp -60.19 -40.32 89.64 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 120.216 -0.594 . . . . 20.0 110.783 -179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 342' ' ' THR . . . . . 0.705 ' OG1' ' O ' ' E' ' 338' ' ' VAL . 1.3 m -56.52 -45.01 81.33 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.164 0.507 . . . . 20.0 110.412 -177.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' E' ' 339' ' ' GLU . 34.6 mttp -74.23 -37.42 63.84 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.935 -0.706 . . . . 20.0 110.756 -178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.59 -0.444 . . . . 20.0 111.128 -179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 345' ' ' LEU . . . . . 0.424 ' O ' HG22 ' E' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.39 74.27 Favored 'General case' 0 CA--C 1.516 -0.328 0 C-N-CA 120.53 -0.468 . . . . 20.0 110.806 -179.04 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.71 -39.0 90.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 119.669 -0.812 . . . . 20.0 110.574 -178.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 347' ' ' ASN . . . . . 0.491 ' HB3' ' HH2' ' E' ' 276' ' ' TRP . 5.0 m-20 -84.51 4.76 30.42 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.471 -0.892 . . . . 20.0 112.522 -178.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 348' ' ' ILE . . . . . 0.424 HG22 ' O ' ' E' ' 345' ' ' LEU . 1.3 tt -65.13 -23.8 34.0 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 119.095 0.861 . . . . 20.0 110.877 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' E' E ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.69 -27.39 69.18 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.241 -175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.8 31.77 Favored 'General case' 0 C--O 1.235 0.293 0 O-C-N 122.153 -0.342 . . . . 20.0 111.453 177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 351' ' ' LEU . . . . . 0.443 ' O ' HD12 ' E' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.75 66.01 Favored 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.154 0.428 . . . . 20.0 112.154 -173.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' E' E ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.04 -26.7 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 116.028 1.862 . . . . 20.0 116.028 -169.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' E' E ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 124.956 1.302 . . . . 20.0 108.387 -174.683 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 1' ' ' MET . . . . . . . . . . . . . 6.7 mmt . . . . . 0 N--CA 1.5 2.044 0 N-CA-C 114.301 1.223 . . . . 20.0 114.301 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.21 2.93 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 106.886 -1.524 . . . . 20.0 106.886 -170.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 3' ' ' VAL . . . . . . . . . . . . . 34.5 t -62.93 -34.5 66.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 114.891 -1.049 . . . . 20.0 110.206 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -107.0 -23.54 12.3 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 113.622 0.971 . . . . 20.0 113.622 -179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.45 30.32 19.99 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 124.146 0.978 . . . . 20.0 111.588 -173.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.89 -38.65 32.17 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 117.765 0.257 . . . . 20.0 111.237 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.44 37.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 107.644 -1.243 . . . . 20.0 107.644 -178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.94 112.19 12.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.317 0.579 . . . . 20.0 110.92 -174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.72 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.427 -0.806 . . . . 20.0 111.874 -177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.16 -45.16 74.25 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 120.515 -0.474 . . . . 20.0 111.202 178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.85 -43.08 97.19 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 121.024 -0.27 . . . . 20.0 111.162 -172.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -30.55 70.95 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.731 -0.388 . . . . 20.0 111.189 -178.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.85 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.633 -0.427 . . . . 20.0 110.575 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.04 -43.0 91.57 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 116.651 -0.249 . . . . 20.0 111.484 -174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.91 -40.09 26.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.368 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.67 -171.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.02 -32.15 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 119.054 -1.059 . . . . 20.0 111.015 -162.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.93 67.99 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 119.956 -0.698 . . . . 20.0 111.289 174.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.06 160.4 70.72 Favored Pre-proline 0 N--CA 1.447 -0.58 0 C-N-CA 120.496 -0.482 . . . . 20.0 109.837 -175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 19' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -85.13 144.72 9.55 Favored 'Trans proline' 0 C--N 1.33 -0.442 0 C-N-CA 120.299 0.666 . . . . 20.0 112.202 -172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.2 3.43 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 117.303 1.681 . . . . 20.0 117.303 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.8 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 107.129 -1.434 . . . . 20.0 107.129 159.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.1 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.367 0.604 . . . . 20.0 110.697 -166.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.31 2.88 Favored Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.453 -0.794 . . . . 20.0 114.039 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.24 -178.36 0.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 122.358 1.075 . . . . 20.0 109.569 172.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.93 -13.15 3.99 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.876 -1.057 . . . . 20.0 113.437 169.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 26' ' ' PHE . . . . . 0.501 ' O ' ' N ' ' F' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.01 23.8 Favored 'General case' 0 C--N 1.346 0.448 0 CA-C-N 119.705 1.139 . . . . 20.0 113.733 178.546 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 115.405 1.631 . . . . 20.0 115.405 -154.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 28' ' ' GLY . . . . . 0.501 ' N ' ' O ' ' F' ' 26' ' ' PHE . . . -53.17 -26.9 29.84 Favored Glycine 0 C--N 1.341 0.854 0 CA-C-N 119.783 1.174 . . . . 20.0 116.005 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 29' ' ' ILE . . . . . 0.526 HD13 ' NH1' ' F' ' 184' ' ' ARG . 1.1 tt -59.54 -35.85 61.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 CA-C-N 118.096 0.948 . . . . 20.0 110.597 -178.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 30' ' ' ARG . . . . . . . . . . . . . 7.5 ttp180 -54.31 -52.39 61.64 Favored 'General case' 0 C--O 1.236 0.357 0 CA-C-O 120.881 0.372 . . . . 20.0 110.412 178.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.64 74.59 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.248 -0.433 . . . . 20.0 110.946 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.6 82.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.077 0.465 . . . . 20.0 110.327 -174.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.67 86.34 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 119.703 -0.799 . . . . 20.0 110.31 -175.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.74 -29.49 20.44 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 118.75 -1.18 . . . . 20.0 111.149 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 35' ' ' GLU . . . . . . . . . . . . . 60.7 tt0 -62.52 -30.93 71.64 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 117.988 0.358 . . . . 20.0 111.143 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -86.94 -56.79 3.23 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 112.145 0.424 . . . . 20.0 112.145 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.515 -0.311 . . . . 20.0 111.499 -164.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.41 -26.35 63.65 Favored 'General case' 0 CA--C 1.517 -0.293 0 C-N-CA 119.891 -0.724 . . . . 20.0 112.243 -162.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 39' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -70.17 -23.48 62.99 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 118.881 -1.127 . . . . 20.0 111.662 -177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.88 -7.02 22.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.51 152.68 22.05 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 N-CA-C 108.584 -0.895 . . . . 20.0 108.584 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.11 -42.63 88.99 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.25 -0.886 . . . . 20.0 111.475 -175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.32 35.34 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.542 -0.91 . . . . 20.0 108.542 -173.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.56 147.16 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 108.274 -1.01 . . . . 20.0 108.274 -174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 45' ' ' LYS . . . . . . . . . . . . . 6.9 mtpt -148.15 159.22 44.17 Favored 'General case' 0 CA--C 1.517 -0.313 0 CA-C-O 121.473 0.654 . . . . 20.0 110.442 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.04 129.01 74.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.36 -1.348 . . . . 20.0 107.36 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.31 -176.13 5.83 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.828 0.823 . . . . 20.0 108.882 177.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.63 62.97 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.086 -176.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.83 9.22 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.692 0.997 . . . . 20.0 113.692 -171.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.58 83.44 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 119.125 -0.819 . . . . 20.0 114.446 -176.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.21 151.49 35.97 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 118.473 1.136 . . . . 20.0 110.194 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.25 33.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 107.127 -1.434 . . . . 20.0 107.127 176.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 53' ' ' ILE . . . . . 0.695 HD13 HG12 ' F' ' 207' ' ' VAL . 31.3 mm -130.24 115.61 33.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 107.345 -1.354 . . . . 20.0 107.345 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.83 36.57 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.667 -0.494 . . . . 20.0 109.667 174.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.94 99.98 8.08 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 145.35 31.73 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.759 -1.571 . . . . 20.0 106.759 163.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.51 154.49 20.29 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.674 -0.491 . . . . 20.0 109.674 -175.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.43 -161.08 23.71 Favored Glycine 0 N--CA 1.449 -0.461 0 N-CA-C 111.125 -0.79 . . . . 20.0 111.125 179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.58 10.37 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 123.91 0.884 . . . . 20.0 109.002 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.59 33.53 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.693 -0.765 . . . . 20.0 114.07 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.74 Favored 'Trans proline' 0 C--N 1.331 -0.371 0 CA-C-O 121.76 0.65 . . . . 20.0 112.067 179.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 62' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -91.98 111.34 22.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.188 -176.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.7 137.88 30.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 N-CA-C 108.776 -0.824 . . . . 20.0 108.776 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.69 124.09 46.51 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 124.055 0.942 . . . . 20.0 109.072 -175.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.26 114.3 45.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.082 -1.081 . . . . 20.0 108.082 -176.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.64 51.42 Favored 'General case' 0 CA--C 1.514 -0.404 0 O-C-N 123.274 0.359 . . . . 20.0 110.973 -168.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.57 45.97 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 123.914 0.885 . . . . 20.0 108.957 167.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 68' ' ' HIS . . . . . 0.488 ' NE2' ' OD1' ' F' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.41 29.1 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 121.265 0.555 . . . . 20.0 110.58 177.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.88 21.26 5.89 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.205 -0.907 . . . . 20.0 109.695 -178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 70' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' F' ' 183' ' ' ASP . 11.9 t0 -97.4 67.99 2.14 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.667 -0.646 . . . . 20.0 112.45 178.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.86 28.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.256 -1.016 . . . . 20.0 108.256 178.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.8 148.84 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 123.717 0.807 . . . . 20.0 109.154 -178.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 73' ' ' GLY . . . . . 0.465 ' C ' HD23 ' F' ' 74' ' ' LEU . . . -155.83 -175.74 27.18 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.605 -0.998 . . . . 20.0 110.605 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 74' ' ' LEU . . . . . 0.465 HD23 ' C ' ' F' ' 73' ' ' GLY . 5.1 mt -125.05 161.5 26.63 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.346 0.593 . . . . 20.0 109.954 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 75' ' ' MET . . . . . 0.509 ' HB2' HG23 ' F' ' 160' ' ' THR . 10.6 ttm -128.15 131.28 48.95 Favored 'General case' 0 CA--C 1.518 -0.281 0 C-N-CA 124.205 1.002 . . . . 20.0 109.698 -174.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.44 137.06 23.89 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 108.892 -0.781 . . . . 20.0 108.892 168.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.33 7.02 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 113.085 0.772 . . . . 20.0 113.085 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.01 174.47 13.72 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.11 -1.07 . . . . 20.0 108.11 178.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.05 108.96 19.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.32 5.61 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 121.845 0.831 . . . . 20.0 110.0 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.51 -27.09 60.39 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 119.7 -0.8 . . . . 20.0 112.739 -169.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.19 4.21 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 113.348 0.87 . . . . 20.0 113.348 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.21 12.8 81.84 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 119.009 -0.884 . . . . 20.0 115.105 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.8 145.05 34.12 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.352 1.076 . . . . 20.0 110.228 178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.48 28.08 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.265 -0.879 . . . . 20.0 112.6 -172.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.36 174.61 6.61 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.7 163.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.654 0.74 . . . . 20.0 109.461 -170.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.22 129.36 15.66 Favored Pre-proline 0 N--CA 1.448 -0.561 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.838 171.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.89 160.21 24.29 Favored 'Trans proline' 0 CA--C 1.508 -0.792 0 CA-C-O 122.27 0.862 . . . . 20.0 112.71 -171.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 90' ' ' ILE . . . . . 0.489 HD11 HG21 ' F' ' 160' ' ' THR . 9.2 mt -88.76 150.33 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 CA-C-N 113.726 -1.579 . . . . 20.0 107.377 165.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.04 140.94 47.54 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.259 -0.882 . . . . 20.0 112.112 -168.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.22 22.02 Favored Glycine 0 N--CA 1.441 -0.983 0 CA-C-O 118.936 -0.924 . . . . 20.0 115.24 176.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.9 152.66 4.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 118.648 1.224 . . . . 20.0 109.209 -169.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 130.97 22.19 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 108.466 -0.938 . . . . 20.0 108.466 173.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -81.11 -7.93 13.05 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 CA-C-N 120.543 1.23 . . . . 20.0 114.792 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.29 59.74 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 119.19 0.905 . . . . 20.0 111.788 174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 97' ' ' THR . . . . . 0.589 HG21 ' OG ' ' F' ' 324' ' ' SER . 44.7 p -89.4 35.49 0.82 Allowed 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 123.632 0.773 . . . . 20.0 112.44 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 98' ' ' LEU . . . . . 0.69 HD12 ' H ' ' F' ' 99' ' ' ILE . 0.5 OUTLIER -43.26 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.017 1.327 . . . . 20.0 113.331 -172.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 99' ' ' ILE . . . . . 0.69 ' H ' HD12 ' F' ' 98' ' ' LEU . 1.6 tt -173.19 156.07 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 N-CA-C 108.965 -0.754 . . . . 20.0 108.965 174.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 100' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' H' ' 100' ' ' ALA . . . -123.93 -18.93 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.666 -1.152 . . . . 20.0 111.289 157.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 101' ' ' GLN . . . . . 0.428 ' NE2' ' O ' ' H' ' 165' ' ' ASP . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.691 -0.855 . . . . 20.0 108.691 176.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 102' ' ' ARG . . . . . 0.546 HH12 ' HB3' ' H' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.55 0.38 Allowed 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 115.205 1.557 . . . . 20.0 115.205 150.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 103' ' ' PHE . . . . . 0.584 ' O ' ' N ' ' F' ' 115' ' ' GLY . 0.5 OUTLIER -79.33 134.19 36.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 119.278 0.945 . . . . 20.0 109.442 160.368 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.77 140.33 37.19 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-N 115.556 -0.747 . . . . 20.0 109.426 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 105' ' ' VAL . . . . . 0.582 HG22 ' CG1' ' F' ' 162' ' ' ILE . 50.4 t -117.4 110.73 32.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.08 6.29 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 110.237 -0.283 . . . . 20.0 110.237 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.95 -54.25 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 O-C-N 123.379 0.424 . . . . 20.0 110.303 170.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.56 177.52 10.56 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.401 -0.963 . . . . 20.0 108.401 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.13 126.35 27.33 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.886 -1.052 . . . . 20.0 110.473 -177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.31 74.99 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-O 118.854 -0.97 . . . . 20.0 115.33 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.12 113.96 15.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 118.499 1.149 . . . . 20.0 108.556 177.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.27 141.54 37.8 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 109.409 -0.589 . . . . 20.0 109.409 -178.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.68 142.53 43.65 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 172.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.44 31.16 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.97 -1.014 . . . . 20.0 110.257 -172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 115' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' F' ' 103' ' ' PHE . . . -147.95 157.73 27.45 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.279 -1.128 . . . . 20.0 110.279 -176.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.71 154.41 39.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 -177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.354 -0.839 . . . . 20.0 114.587 -168.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 118' ' ' ALA . . . . . 0.488 ' O ' HD13 ' F' ' 98' ' ' LEU . . . -67.2 -47.96 69.3 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 114.363 1.246 . . . . 20.0 114.363 -156.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.59 121.13 11.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 119.519 1.054 . . . . 20.0 112.65 -155.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.46 136.11 35.61 Favored Pre-proline 0 C--O 1.24 0.578 0 N-CA-C 102.668 -3.086 . . . . 20.0 102.668 159.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.82 11.06 Favored 'Trans proline' 0 C--N 1.328 -0.531 0 CA-C-N 120.766 1.309 . . . . 20.0 110.548 -178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.75 149.74 90.07 Favored 'Trans proline' 0 CA--C 1.519 -0.268 0 CA-C-N 119.191 0.747 . . . . 20.0 110.684 177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 123' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -63.05 165.36 7.09 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.8 0.809 . . . . 20.0 109.99 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.17 91.91 3.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 108.192 -1.04 . . . . 20.0 108.192 -175.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.96 160.79 19.52 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 120.761 -0.376 . . . . 20.0 110.704 169.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.88 -43.62 1.51 Allowed Pre-proline 0 C--O 1.237 0.428 0 C-N-CA 123.937 0.895 . . . . 20.0 113.085 -170.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.96 59.32 Favored 'Trans proline' 0 C--N 1.359 1.106 0 CA-C-N 120.843 1.337 . . . . 20.0 111.975 170.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.55 -26.47 30.08 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 111.778 0.288 . . . . 20.0 111.778 -177.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.94 69.18 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.772 -0.771 . . . . 20.0 110.243 168.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.8 -36.91 62.48 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 111.887 0.329 . . . . 20.0 111.887 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 131' ' ' LYS . . . . . . . . . . . . . 35.3 mttt -78.45 90.93 4.47 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 109.205 -0.665 . . . . 20.0 109.205 174.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.14 14.25 7.98 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 112.075 0.398 . . . . 20.0 112.075 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.12 142.54 87.52 Favored Pre-proline 0 N--CA 1.445 -0.685 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 172.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.72 153.62 75.46 Favored 'Trans proline' 0 C--N 1.327 -0.605 0 CA-C-N 119.613 0.898 . . . . 20.0 112.384 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.66 42.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.539 -1.21 . . . . 20.0 107.938 177.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.69 -12.26 59.95 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 118.837 -0.601 . . . . 20.0 112.382 -175.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' F' ' 138' ' ' GLN . 14.1 p30 -55.32 -66.42 0.42 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.898 -0.572 . . . . 20.0 111.363 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 138' ' ' GLN . . . . . 0.431 ' HG3' ' H ' ' F' ' 139' ' ' ILE . 3.9 tp-100 174.65 174.13 0.2 Allowed 'General case' 0 C--O 1.236 0.378 0 N-CA-C 103.121 -2.918 . . . . 20.0 103.121 133.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 139' ' ' ILE . . . . . 0.431 ' H ' ' HG3' ' F' ' 138' ' ' GLN . 1.2 tp -74.84 168.1 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 C-N-CA 124.153 0.981 . . . . 20.0 108.94 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.86 161.45 18.22 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.924 0.89 . . . . 20.0 110.495 177.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 141' ' ' ILE . . . . . 0.402 HD13 HD13 ' F' ' 162' ' ' ILE . 30.1 mt -124.6 147.48 29.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.575 -0.898 . . . . 20.0 108.575 -177.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 142' ' ' ASP . . . . . 0.549 ' OD1' ' N ' ' F' ' 144' ' ' GLY . 0.5 OUTLIER -119.07 134.72 55.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.678 0.791 . . . . 20.0 109.615 175.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 O-C-N 123.668 0.605 . . . . 20.0 111.777 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 144' ' ' GLY . . . . . 0.549 ' N ' ' OD1' ' F' ' 142' ' ' ASP . . . 86.8 -6.47 82.8 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 115.489 0.956 . . . . 20.0 115.489 172.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.05 53.88 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 118.51 1.155 . . . . 20.0 110.254 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.41 -20.85 33.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 113.593 0.96 . . . . 20.0 113.593 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.37 162.65 40.12 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-O 121.967 0.889 . . . . 20.0 111.46 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.44 -41.5 80.61 Favored 'General case' 0 C--O 1.237 0.424 0 CA-C-N 113.937 -1.483 . . . . 20.0 111.214 177.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.35 -47.06 87.66 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.824 -0.351 . . . . 20.0 110.952 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.3 -35.19 76.67 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.511 -0.476 . . . . 20.0 110.807 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.59 83.92 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 120.09 -0.644 . . . . 20.0 111.072 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.31 58.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.377 -0.929 . . . . 20.0 111.03 -178.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.74 -30.09 66.51 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.799 -0.76 . . . . 20.0 110.587 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.59 -40.55 92.17 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 120.516 -0.474 . . . . 20.0 111.705 171.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.13 -8.74 6.7 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 118.903 -0.943 . . . . 20.0 114.554 -172.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.5 29.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 118.494 1.147 . . . . 20.0 108.553 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.99 9.28 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.707 -1.22 . . . . 20.0 107.707 174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.35 147.29 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.41 169.33 15.76 Favored Glycine 0 N--CA 1.448 -0.501 0 N-CA-C 108.749 -1.74 . . . . 20.0 108.749 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 160' ' ' THR . . . . . 0.509 HG23 ' HB2' ' F' ' 75' ' ' MET . 0.2 OUTLIER -79.38 113.58 17.64 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.63 -1.248 . . . . 20.0 107.63 165.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.66 -20.02 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.34 0 N-CA-C 113.708 1.003 . . . . 20.0 113.708 -166.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 162' ' ' ILE . . . . . 0.582 ' CG1' HG22 ' F' ' 105' ' ' VAL . 0.5 OUTLIER -111.72 155.63 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 CA-C-N 118.587 0.631 . . . . 20.0 111.722 -159.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 163' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' F' ' 164' ' ' TRP . 3.5 t -145.34 -166.33 2.4 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.235 1.014 . . . . 20.0 110.476 171.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 164' ' ' TRP . . . . . 0.547 ' N ' ' OG1' ' F' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.9 16.71 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.7 61.72 0.97 Allowed 'General case' 0 C--O 1.235 0.334 0 O-C-N 121.844 -0.535 . . . . 20.0 112.262 -177.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.62 29.58 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.083 -1.207 . . . . 20.0 110.083 172.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.4 148.35 37.69 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.716 -1.216 . . . . 20.0 107.716 170.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.98 117.61 30.43 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 115.109 -0.95 . . . . 20.0 110.23 -167.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.41 159.76 35.23 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 121.858 0.837 . . . . 20.0 110.012 177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.39 117.12 34.05 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 114.254 -1.339 . . . . 20.0 109.52 -173.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.9 151.64 28.92 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 109.5 -0.556 . . . . 20.0 109.5 168.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 172' ' ' GLY . . . . . 0.585 ' O ' ' N ' ' F' ' 175' ' ' ARG . . . 56.93 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 109.219 -1.552 . . . . 20.0 109.219 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.85 4.23 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 112.812 0.671 . . . . 20.0 112.812 -174.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -63.03 1.28 Allowed 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.749 -0.78 . . . . 20.0 111.233 157.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 175' ' ' ARG . . . . . 0.585 ' N ' ' O ' ' F' ' 172' ' ' GLY . 6.8 ptt-85 -169.81 121.98 0.7 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 118.56 0.618 . . . . 20.0 112.653 172.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.51 169.36 0.35 Allowed 'General case' 0 N--CA 1.465 0.275 0 C-N-CA 127.844 2.458 . . . . 20.0 106.256 157.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.66 145.82 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 N-CA-C 108.494 -0.928 . . . . 20.0 108.494 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.21 -64.43 1.17 Allowed 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 116.421 2.008 . . . . 20.0 116.421 -165.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.33 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-N 118.772 0.714 . . . . 20.0 112.137 -171.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.65 36.6 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 114.388 1.255 . . . . 20.0 114.388 -170.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 181' ' ' PHE . . . . . 0.735 ' HB3' ' HB3' ' F' ' 327' ' ' GLU . 3.1 t80 -84.71 -66.92 0.84 Allowed 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.592 0.633 . . . . 20.0 111.75 -162.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.29 127.82 32.82 Favored 'General case' 0 CA--C 1.509 -0.634 0 CA-C-O 122.094 0.949 . . . . 20.0 110.697 -152.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 183' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' F' ' 70' ' ' ASP . 0.6 OUTLIER 69.97 -6.75 1.03 Allowed 'General case' 0 C--N 1.331 -0.223 0 C-N-CA 125.329 1.452 . . . . 20.0 113.191 174.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 184' ' ' ARG . . . . . 0.526 ' NH1' HD13 ' F' ' 29' ' ' ILE . 0.0 OUTLIER -153.77 83.88 1.16 Allowed 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.14 0.972 . . . . 20.0 110.805 157.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 185' ' ' ILE . . . . . 0.446 HG12 HG11 ' F' ' 317' ' ' VAL . 1.0 OUTLIER -126.1 -41.16 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 104.497 -2.409 . . . . 20.0 104.497 149.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 186' ' ' ALA . . . . . 0.695 ' O ' ' OG1' ' F' ' 189' ' ' THR . . . -50.09 -42.98 51.17 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 115.351 -0.84 . . . . 20.0 111.542 173.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.85 -36.12 76.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 C-N-CA 119.292 -0.963 . . . . 20.0 110.133 -178.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.79 -38.68 92.01 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.206 -0.997 . . . . 20.0 110.481 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 189' ' ' THR . . . . . 0.695 ' OG1' ' O ' ' F' ' 186' ' ' ALA . 25.2 p -59.1 -48.58 81.08 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.437 -0.905 . . . . 20.0 110.861 172.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.34 -50.55 64.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.37 0 CA-C-O 120.955 0.407 . . . . 20.0 110.49 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.12 -43.17 96.13 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.025 -0.67 . . . . 20.0 110.949 -178.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.84 -36.6 84.46 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.98 -0.688 . . . . 20.0 110.339 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 193' ' ' VAL . . . . . 0.407 HG23 ' O ' ' F' ' 189' ' ' THR . 11.7 t -60.45 -44.9 97.29 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 121.022 0.439 . . . . 20.0 110.103 177.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.26 75.35 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.234 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.63 -38.12 70.79 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.809 175.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.77 -26.09 40.78 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.557 0.577 . . . . 20.0 112.557 -175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.56 122.78 27.47 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.298 -0.63 . . . . 20.0 109.298 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 123.286 0.366 . . . . 20.0 110.08 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.14 105.38 17.52 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.701 -0.481 . . . . 20.0 109.701 -172.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.04 91.3 4.25 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.224 -0.658 . . . . 20.0 109.224 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.77 -14.54 59.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 120.001 -0.68 . . . . 20.0 111.349 176.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 108.957 -0.757 . . . . 20.0 108.957 172.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 203' ' ' ASP . . . . . 0.647 ' OD1' ' N ' ' F' ' 203' ' ' ASP . 0.0 OUTLIER -78.64 112.96 16.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 -174.508 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.61 6.11 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.577 -0.897 . . . . 20.0 108.577 -170.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.91 106.59 9.0 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.042 -0.725 . . . . 20.0 109.042 173.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.92 125.4 31.33 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.727 -0.842 . . . . 20.0 108.727 177.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 207' ' ' VAL . . . . . 0.695 HG12 HD13 ' F' ' 53' ' ' ILE . 34.0 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.353 0 N-CA-C 108.884 -0.784 . . . . 20.0 108.884 174.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.37 98.79 5.18 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.39 -1.337 . . . . 20.0 107.39 171.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.88 159.95 19.55 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.91 0.862 . . . . 20.0 111.066 -165.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.77 166.45 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.227 179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.17 29.48 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.778 -1.101 . . . . 20.0 111.481 -179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.96 -49.57 13.85 Favored 'General case' 0 CA--C 1.516 -0.345 0 C-N-CA 120.331 -0.548 . . . . 20.0 110.954 176.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.25 -20.43 64.8 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.253 -0.579 . . . . 20.0 111.495 -173.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 214' ' ' VAL . . . . . . . . . . . . . 89.3 t -131.14 121.12 48.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 173.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.04 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 119.691 -1.243 . . . . 20.0 111.441 -174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 216' ' ' LEU . . . . . 0.429 HD23 ' H ' ' F' ' 216' ' ' LEU . 0.5 OUTLIER -47.03 -25.6 0.85 Allowed 'General case' 0 C--O 1.236 0.344 0 C-N-CA 123.999 0.92 . . . . 20.0 113.411 -179.11 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 217' ' ' ARG . . . . . 0.539 ' HB3' ' HG ' ' K' ' 305' ' ' LEU . 1.3 mpt_? -63.46 -4.53 2.83 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 112.368 0.507 . . . . 20.0 112.368 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.64 -40.58 40.7 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 119.754 -1.212 . . . . 20.0 111.973 168.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 219' ' ' ALA . . . . . 0.46 ' O ' ' OG ' ' F' ' 222' ' ' SER . . . -65.27 -37.05 86.0 Favored 'General case' 0 C--O 1.236 0.391 0 O-C-N 122.298 -0.531 . . . . 20.0 111.378 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 220' ' ' ARG . . . . . 0.414 ' HB2' ' HB1' ' F' ' 302' ' ' ALA . 16.6 ttm180 -52.7 -36.75 57.8 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 -174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.43 -45.8 87.75 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.004 -0.678 . . . . 20.0 110.856 -173.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 222' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' F' ' 219' ' ' ALA . 2.1 p -58.02 -35.8 71.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 120.81 -0.356 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.7 -49.97 69.41 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 112.546 0.573 . . . . 20.0 112.546 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 224' ' ' PHE . . . . . 0.482 ' HB2' ' HD2' ' K' ' 307' ' ' LYS . 78.8 t80 -64.12 -33.48 75.88 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 119.852 -0.739 . . . . 20.0 111.799 -165.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.95 -16.72 74.92 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 118.906 -1.616 . . . . 20.0 112.112 179.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 112.008 0.373 . . . . 20.0 112.008 -158.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 227' ' ' GLU . . . . . 0.463 ' OE1' ' OG1' ' F' ' 306' ' ' THR . 3.0 pt-20 -56.45 -46.69 99.79 Favored Pre-proline 0 C--O 1.236 0.387 0 N-CA-C 118.218 2.673 . . . . 20.0 118.218 -158.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.88 143.66 2.92 Favored 'Trans proline' 0 C--O 1.232 0.187 0 N-CA-C 115.974 1.49 . . . . 20.0 115.974 -134.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.24 -4.77 0.77 Allowed 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 125.201 1.4 . . . . 20.0 113.366 162.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.2 11.47 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 120.124 -0.631 . . . . 20.0 111.793 167.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.45 151.49 16.49 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.935 -0.65 . . . . 20.0 112.291 -175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 232' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 123.814 0.846 . . . . 20.0 108.825 178.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.01 23.29 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 121.173 0.511 . . . . 20.0 110.379 177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 234' ' ' ILE . . . . . 0.485 HD11 ' CE ' ' F' ' 341' ' ' MET . 51.6 mt -133.18 90.43 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.55 -1.278 . . . . 20.0 107.55 172.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 235' ' ' ASP . . . . . 0.488 ' OD1' ' NE2' ' F' ' 68' ' ' HIS . 25.5 t0 -135.12 173.24 11.94 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 106.948 -1.501 . . . . 20.0 106.948 173.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.18 149.37 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.656 0.741 . . . . 20.0 111.436 -172.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 237' ' ' THR . . . . . 0.458 HG21 ' HA3' ' F' ' 296' ' ' GLY . 9.1 t -165.63 122.74 1.46 Allowed 'General case' 0 C--O 1.233 0.214 0 N-CA-C 107.354 -1.35 . . . . 20.0 107.354 164.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 238' ' ' ILE . . . . . 0.422 HD13 ' O ' ' F' ' 237' ' ' THR . 18.0 mm -145.5 151.92 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.227 0 N-CA-C 108.254 -1.017 . . . . 20.0 108.254 -161.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.18 9.64 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 106.852 -1.536 . . . . 20.0 106.852 159.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.46 110.02 18.69 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 113.038 0.755 . . . . 20.0 113.038 -155.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.43 36.09 22.21 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 124.92 1.288 . . . . 20.0 112.458 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.96 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 105.139 -2.171 . . . . 20.0 105.139 -177.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 243' ' ' PRO . . . . . 0.458 ' HG3' ' HD1' ' H' ' 84' ' ' PHE . 16.6 Cg_exo -61.02 165.53 12.12 Favored 'Trans proline' 0 CA--C 1.517 -0.371 0 CA-C-N 120.823 1.33 . . . . 20.0 112.383 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.45 -5.29 45.51 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-O 118.856 -0.969 . . . . 20.0 114.909 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.15 164.51 22.96 Favored Pre-proline 0 N--CA 1.453 -0.319 0 CA-C-N 118.606 1.203 . . . . 20.0 110.65 177.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.92 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.326 -0.612 0 CA-C-O 121.877 0.699 . . . . 20.0 111.943 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.22 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.724 -1.125 . . . . 20.0 112.058 179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.26 -18.71 63.14 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.832 -0.747 . . . . 20.0 112.858 -171.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 249' ' ' LYS . . . . . 0.721 ' O ' ' OG1' ' F' ' 252' ' ' THR . 16.9 mttt -98.78 -15.11 19.41 Favored 'General case' 0 CA--C 1.513 -0.468 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.06 -37.88 89.04 Favored 'General case' 0 C--O 1.232 0.144 0 C-N-CA 120.305 -0.558 . . . . 20.0 111.347 -172.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 251' ' ' VAL . . . . . . . . . . . . . 10.4 m -68.62 -20.94 25.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 119.054 -1.058 . . . . 20.0 111.92 -178.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 252' ' ' THR . . . . . 0.721 ' OG1' ' O ' ' F' ' 249' ' ' LYS . 39.3 p -57.16 -31.83 65.8 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.501 0.591 . . . . 20.0 111.299 173.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 253' ' ' HIS . . . . . 0.549 ' CD2' ' HB2' ' F' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 121.343 0.592 . . . . 20.0 110.407 176.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.36 -1.3 3.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.968 -1.014 . . . . 20.0 112.308 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 126.188 1.851 . . . . 20.0 111.582 -177.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.4 129.23 10.18 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.624 -0.88 . . . . 20.0 108.624 -167.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.22 3.31 Favored Glycine 0 N--CA 1.437 -1.293 0 CA-C-O 122.695 1.164 . . . . 20.0 113.371 169.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.12 6.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.525 -0.917 . . . . 20.0 108.525 -177.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.43 120.3 29.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.142 -0.936 . . . . 20.0 109.424 -169.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.0 139.96 19.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 107.781 -1.192 . . . . 20.0 107.781 175.053 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 261' ' ' LYS . . . . . 0.748 ' HE3' HG21 ' F' ' 298' ' ' THR . 1.9 mtmm -98.83 122.68 42.38 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.79 -40.33 10.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-N 115.903 -0.589 . . . . 20.0 109.564 173.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.59 147.55 34.55 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 109.319 -0.622 . . . . 20.0 109.319 -174.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.08 -169.92 2.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.792 -1.095 . . . . 20.0 108.231 165.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.03 -56.21 22.29 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-N 115.781 -0.645 . . . . 20.0 110.271 163.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.91 -46.15 11.56 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -165.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 267' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -115.76 143.66 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.411 -0.589 . . . . 20.0 109.411 -163.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 268' ' ' ILE . . . . . . . . . . . . . 9.8 mm -121.31 104.04 14.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.099 -1.815 . . . . 20.0 106.099 171.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.3 137.1 56.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.215 0.531 . . . . 20.0 111.339 -171.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.67 1.98 Allowed Pre-proline 0 C--N 1.322 -0.591 0 CA-C-N 115.198 -0.91 . . . . 20.0 108.66 177.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 271' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -67.52 -20.0 48.06 Favored 'Trans proline' 0 CA--C 1.512 -0.599 0 N-CA-C 114.77 1.027 . . . . 20.0 114.77 -160.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.32 -43.02 74.51 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.196 -0.601 . . . . 20.0 110.561 176.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.61 -48.36 77.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-O 121.108 0.48 . . . . 20.0 110.092 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 274' ' ' VAL . . . . . . . . . . . . . 13.5 t -59.13 -52.5 59.96 Favored 'Isoleucine or valine' 0 C--O 1.237 0.397 0 CA-C-O 120.831 0.348 . . . . 20.0 110.742 -176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.33 -31.94 70.77 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.801 -0.759 . . . . 20.0 110.581 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 276' ' ' TRP . . . . . 0.481 ' HH2' ' HB3' ' F' ' 347' ' ' ASN . 0.1 OUTLIER -68.46 -47.99 65.68 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.944 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -61.99 -38.76 89.79 Favored 'General case' 0 CA--C 1.514 -0.426 0 C-N-CA 120.024 -0.67 . . . . 20.0 110.765 177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.58 -48.04 78.26 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.625 -0.43 . . . . 20.0 110.049 173.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.83 -40.43 88.44 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.855 -0.338 . . . . 20.0 110.706 175.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.28 -44.94 78.05 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 120.243 -0.583 . . . . 20.0 111.118 -172.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.72 73.01 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.989 -0.684 . . . . 20.0 111.028 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.37 -31.8 65.9 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 120.067 -0.653 . . . . 20.0 111.198 178.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.66 73.14 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.885 -0.726 . . . . 20.0 111.031 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.58 15.43 29.28 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 113.322 0.86 . . . . 20.0 113.322 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.8 32.16 13.68 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 121.672 0.748 . . . . 20.0 111.562 173.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.35 143.41 34.33 Favored Pre-proline 0 C--N 1.323 -0.58 0 N-CA-C 108.32 -0.993 . . . . 20.0 108.32 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 287' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -83.21 149.35 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.176 0.741 . . . . 20.0 111.349 175.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.12 23.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.625 -0.716 . . . . 20.0 109.679 -179.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.95 175.1 5.61 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 107.689 -1.226 . . . . 20.0 107.689 168.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.65 113.76 17.13 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.889 -1.152 . . . . 20.0 107.889 167.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.73 43.68 Favored 'General case' 0 CA--C 1.514 -0.407 0 N-CA-C 109.403 -0.591 . . . . 20.0 109.403 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.1 157.02 25.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 N-CA-C 107.659 -1.238 . . . . 20.0 107.659 173.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.55 168.67 12.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.484 0.659 . . . . 20.0 110.245 176.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.78 -18.53 21.16 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.832 -1.077 . . . . 20.0 112.143 165.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.01 20.03 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 296' ' ' GLY . . . . . 0.458 ' HA3' HG21 ' F' ' 237' ' ' THR . . . 101.52 144.76 15.52 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 114.679 -0.761 . . . . 20.0 112.666 -179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 110.335 -1.106 . . . . 20.0 110.335 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 298' ' ' THR . . . . . 0.748 HG21 ' HE3' ' F' ' 261' ' ' LYS . 20.3 p -110.28 172.9 6.59 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 122.028 0.918 . . . . 20.0 111.382 -174.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.88 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 114.378 -1.283 . . . . 20.0 111.236 176.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.63 -35.31 74.12 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.764 0.283 . . . . 20.0 111.764 -171.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.39 -41.16 96.87 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.176 -1.011 . . . . 20.0 112.059 -178.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 302' ' ' ALA . . . . . 0.414 ' HB1' ' HB2' ' F' ' 220' ' ' ARG . . . -68.31 -26.87 65.84 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.165 -0.614 . . . . 20.0 111.216 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.92 -34.47 55.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.144 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.18 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.304 0.853 . . . . 20.0 113.304 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 305' ' ' LEU . . . . . 0.429 ' HG ' ' HB3' ' C' ' 217' ' ' ARG . 4.1 mp -103.75 -8.9 19.5 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.699 1.0 . . . . 20.0 113.699 -167.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 306' ' ' THR . . . . . 0.463 ' OG1' ' OE1' ' F' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.6 8.43 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.564 0.697 . . . . 20.0 110.551 171.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 307' ' ' LYS . . . . . 0.455 ' HD2' ' HB2' ' C' ' 224' ' ' PHE . 21.6 mmtt -61.78 -29.8 70.38 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.326 0.861 . . . . 20.0 113.326 -160.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.15 66.2 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.666 -0.814 . . . . 20.0 111.215 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.875 -0.678 . . . . 20.0 113.299 -171.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--O 1.238 0.497 0 CA-C-N 117.593 0.696 . . . . 20.0 111.13 -163.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 311' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -84.46 141.73 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.492 0.854 . . . . 20.0 110.063 168.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.48 135.8 32.31 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.354 -0.839 . . . . 20.0 111.186 -169.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.64 162.63 12.32 Favored Glycine 0 N--CA 1.442 -0.939 0 N-CA-C 109.125 -1.59 . . . . 20.0 109.125 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.46 136.02 27.28 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.452 0.644 . . . . 20.0 110.029 -176.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -103.99 153.19 21.12 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-N 114.593 -1.185 . . . . 20.0 109.228 174.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 316' ' ' SER . . . . . . . . . . . . . 4.1 m -138.45 133.54 32.89 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.329 -0.851 . . . . 20.0 109.444 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 317' ' ' VAL . . . . . 0.446 HG11 HG12 ' F' ' 185' ' ' ILE . 92.3 t -99.46 108.62 51.47 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.253 -1.388 . . . . 20.0 107.253 177.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 318' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -83.32 -168.99 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-O 122.645 1.019 . . . . 20.0 113.622 -154.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 319' ' ' ALA . . . . . 0.549 ' HB2' ' CD2' ' F' ' 253' ' ' HIS . . . 79.79 35.52 0.15 Allowed 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 113.592 -1.64 . . . . 20.0 115.265 161.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 320' ' ' ARG . . . . . 0.424 ' HG3' ' O ' ' F' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.56 33.52 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.712 0.768 . . . . 20.0 110.113 176.743 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 321' ' ' TYR . . . . . 0.424 ' O ' ' HG3' ' F' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.17 11.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 106.814 -1.55 . . . . 20.0 106.814 160.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 322' ' ' ILE . . . . . . . . . . . . . 50.1 mm -49.22 113.62 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.146 0.978 . . . . 20.0 108.426 -163.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.53 -7.41 3.2 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 114.438 1.273 . . . . 20.0 114.438 -140.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 324' ' ' SER . . . . . 0.589 ' OG ' HG21 ' F' ' 97' ' ' THR . 0.1 OUTLIER -59.57 -59.91 4.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.671 0.619 . . . . 20.0 112.671 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 325' ' ' ASN . . . . . . . . . . . . . 35.2 p-10 -101.98 -56.13 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.062 1.504 . . . . 20.0 115.062 -152.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.98 50.75 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 327' ' ' GLU . . . . . 0.735 ' HB3' ' HB3' ' F' ' 181' ' ' PHE . 82.8 mt-10 -142.57 52.82 1.42 Allowed 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 113.811 -1.541 . . . . 20.0 109.924 -153.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.05 149.4 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.454 0.645 . . . . 20.0 111.934 -171.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 329' ' ' VAL . . . . . 0.418 HG13 ' HB2' ' F' ' 181' ' ' PHE . 0.3 OUTLIER -139.39 179.38 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.298 0 CA-C-O 121.901 0.858 . . . . 20.0 109.479 175.648 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.48 119.24 27.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.637 -1.165 . . . . 20.0 108.833 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.13 -32.05 54.02 Favored 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.878 0.736 . . . . 20.0 111.528 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.74 73.56 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 120.326 -0.549 . . . . 20.0 110.223 -176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 333' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -66.0 -45.01 83.14 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.029 -172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 120.41 -0.516 . . . . 20.0 110.506 -173.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.04 -34.67 71.49 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 118.838 -1.145 . . . . 20.0 110.128 178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.05 -0.66 . . . . 20.0 110.441 176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.55 -43.84 80.33 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.713 0.292 . . . . 20.0 110.872 176.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' F' ' 342' ' ' THR . 42.6 t -60.19 -48.91 86.21 Favored 'Isoleucine or valine' 0 C--O 1.237 0.43 0 CA-C-O 121.022 0.439 . . . . 20.0 110.278 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 339' ' ' GLU . . . . . 0.779 ' OE1' ' NZ ' ' F' ' 343' ' ' LYS . 1.3 mm-40 -54.93 -46.84 74.97 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 120.971 0.415 . . . . 20.0 110.757 179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.16 37.65 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 116.371 -0.377 . . . . 20.0 111.397 -176.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 341' ' ' MET . . . . . 0.485 ' CE ' HD11 ' F' ' 234' ' ' ILE . 31.8 tpp -60.19 -40.32 89.61 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.245 -0.582 . . . . 20.0 110.799 -179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' F' ' 338' ' ' VAL . 1.3 m -56.52 -45.02 81.34 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.166 0.508 . . . . 20.0 110.402 -177.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 343' ' ' LYS . . . . . 0.779 ' NZ ' ' OE1' ' F' ' 339' ' ' GLU . 34.4 mttp -74.17 -37.48 63.97 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.999 -0.681 . . . . 20.0 110.764 -178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.8 -42.55 97.83 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.109 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 345' ' ' LEU . . . . . 0.414 ' O ' HG22 ' F' ' 348' ' ' ILE . 1.0 OUTLIER -58.97 -50.42 74.15 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.809 -179.039 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.69 -39.02 90.83 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.628 -178.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 347' ' ' ASN . . . . . 0.481 ' HB3' ' HH2' ' F' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.83 30.16 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.501 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 348' ' ' ILE . . . . . 0.414 HG22 ' O ' ' F' ' 345' ' ' LEU . 1.3 tt -65.21 -23.68 33.65 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 CA-C-N 119.129 0.877 . . . . 20.0 110.908 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' F' F ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.33 69.11 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.796 -0.762 . . . . 20.0 111.248 -175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.93 -18.77 31.77 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.102 -0.374 . . . . 20.0 111.487 177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 351' ' ' LEU . . . . . 0.448 ' O ' HD12 ' F' ' 351' ' ' LEU . 0.1 OUTLIER -69.76 -28.77 66.05 Favored 'General case' 0 C--N 1.332 -0.164 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -173.901 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' F' F ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.07 -26.71 0.1 Allowed 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 116.065 1.876 . . . . 20.0 116.065 -169.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' F' F ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 124.944 1.298 . . . . 20.0 108.359 -174.696 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.242 1.201 . . . . 20.0 114.242 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.18 2.91 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 -170.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.88 -34.5 66.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 CA-C-N 114.89 -1.05 . . . . 20.0 110.215 178.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 4' ' ' ARG . . . . . . . . . . . . . 69.4 mtt180 -106.99 -23.55 12.29 Favored 'General case' 0 C--O 1.238 0.469 0 N-CA-C 113.623 0.972 . . . . 20.0 113.623 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.41 30.33 20.01 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.136 0.975 . . . . 20.0 111.62 -173.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.86 -38.66 32.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 117.74 0.246 . . . . 20.0 111.238 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.11 117.45 37.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.336 0 N-CA-C 107.668 -1.234 . . . . 20.0 107.668 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.14 12.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.375 0.607 . . . . 20.0 110.94 -174.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.65 -31.58 72.79 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 115.429 -0.805 . . . . 20.0 111.896 -177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 10' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -68.12 -45.21 74.28 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.5 -0.48 . . . . 20.0 111.176 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.76 -43.14 97.3 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.055 -0.258 . . . . 20.0 111.163 -172.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.86 -30.58 70.95 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.736 -0.386 . . . . 20.0 111.181 -178.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -46.35 91.0 Favored 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.593 -0.443 . . . . 20.0 110.541 179.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.03 -42.97 91.5 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.699 -0.228 . . . . 20.0 111.531 -174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.9 -40.06 26.52 Favored 'Isoleucine or valine' 0 C--O 1.236 0.348 0 C-N-CA 119.509 -0.876 . . . . 20.0 110.692 -171.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.03 -32.16 6.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.036 -1.066 . . . . 20.0 111.039 -162.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.09 -25.97 68.02 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.967 -0.693 . . . . 20.0 111.281 174.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.04 160.4 70.65 Favored Pre-proline 0 N--CA 1.448 -0.562 0 C-N-CA 120.506 -0.478 . . . . 20.0 109.825 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 19' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -85.15 144.71 9.52 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.328 0.685 . . . . 20.0 112.163 -172.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.9 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 117.285 1.674 . . . . 20.0 117.285 -159.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.76 119.78 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.117 -1.438 . . . . 20.0 107.117 159.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.22 8.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.374 0.606 . . . . 20.0 110.73 -166.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.95 -33.36 2.88 Favored Glycine 0 N--CA 1.447 -0.612 0 CA-C-N 115.499 -0.773 . . . . 20.0 114.04 -177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.23 -178.36 0.17 Allowed 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 122.356 1.074 . . . . 20.0 109.551 172.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.92 -13.16 3.98 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 114.879 -1.055 . . . . 20.0 113.459 169.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' G' ' 28' ' ' GLY . 0.0 OUTLIER -88.0 9.02 23.77 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.735 1.152 . . . . 20.0 113.71 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.67 11.34 0.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 115.443 1.645 . . . . 20.0 115.443 -154.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' G' ' 26' ' ' PHE . . . -53.11 -26.97 29.66 Favored Glycine 0 C--N 1.342 0.913 0 N-CA-C 116.032 1.173 . . . . 20.0 116.032 -172.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' G' ' 184' ' ' ARG . 1.1 tt -59.56 -35.78 61.21 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-N 118.078 0.939 . . . . 20.0 110.646 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.26 -52.46 61.29 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 120.934 0.397 . . . . 20.0 110.435 178.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.52 Favored 'General case' 0 C--O 1.237 0.44 0 CA-C-N 116.295 -0.411 . . . . 20.0 110.933 177.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.26 -49.57 82.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.463 0 CA-C-O 121.024 0.44 . . . . 20.0 110.291 -174.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.26 -39.68 86.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.358 0 C-N-CA 119.702 -0.799 . . . . 20.0 110.293 -175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.48 20.4 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 C-N-CA 118.681 -1.208 . . . . 20.0 111.162 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -31.01 71.68 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 117.995 0.362 . . . . 20.0 111.102 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.96 -56.69 3.27 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 112.173 0.435 . . . . 20.0 112.173 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.29 -28.43 44.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.357 0 CA-C-N 116.514 -0.312 . . . . 20.0 111.528 -164.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.48 -26.29 63.55 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 119.899 -0.72 . . . . 20.0 112.191 -162.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.5 63.02 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 118.922 -1.111 . . . . 20.0 111.71 -177.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.97 22.86 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.492 0.923 . . . . 20.0 113.492 -176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.55 152.6 22.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 N-CA-C 108.537 -0.912 . . . . 20.0 108.537 -176.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 42' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -66.04 -42.66 89.25 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.214 -0.903 . . . . 20.0 111.498 -175.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.61 158.3 35.26 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.541 -0.911 . . . . 20.0 108.541 -173.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.47 147.23 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.14 159.26 44.12 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.474 0.654 . . . . 20.0 110.454 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 46' ' ' VAL . . . . . . . . . . . . . 61.0 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 107.385 -1.339 . . . . 20.0 107.385 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.27 -176.13 5.82 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.786 0.803 . . . . 20.0 108.923 177.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.56 -34.61 62.97 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 119.913 -0.715 . . . . 20.0 111.155 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.11 10.84 9.14 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.691 0.996 . . . . 20.0 113.691 -171.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.46 -6.7 83.29 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-O 119.121 -0.822 . . . . 20.0 114.527 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.09 151.48 35.44 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 118.43 1.115 . . . . 20.0 110.24 173.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.38 140.23 33.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 107.161 -1.422 . . . . 20.0 107.161 176.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 53' ' ' ILE . . . . . 0.703 HD13 HG12 ' G' ' 207' ' ' VAL . 31.3 mm -130.17 115.64 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 107.359 -1.349 . . . . 20.0 107.359 -174.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.79 36.47 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.634 -0.506 . . . . 20.0 109.634 174.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.99 100.0 8.08 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.626 -0.879 . . . . 20.0 108.626 -173.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.64 145.37 31.7 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 106.77 -1.566 . . . . 20.0 106.77 163.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.56 154.44 20.38 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 123.507 0.505 . . . . 20.0 109.726 -175.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.06 23.62 Favored Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.104 -0.798 . . . . 20.0 111.104 179.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.17 105.64 10.43 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.844 0.858 . . . . 20.0 108.977 179.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.58 33.49 Favored Glycine 0 N--CA 1.443 -0.854 0 C-N-CA 120.761 -0.733 . . . . 20.0 114.097 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.71 165.21 32.78 Favored 'Trans proline' 0 CA--C 1.517 -0.354 0 CA-C-O 121.751 0.646 . . . . 20.0 112.12 179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.95 111.39 22.91 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 115.016 -0.993 . . . . 20.0 109.278 -176.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.94 30.3 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 108.726 -0.842 . . . . 20.0 108.726 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.71 124.03 46.32 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 124.074 0.949 . . . . 20.0 109.058 -175.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.33 45.76 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 N-CA-C 108.081 -1.081 . . . . 20.0 108.081 -176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.59 124.63 51.46 Favored 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 123.257 0.348 . . . . 20.0 110.954 -168.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.47 154.61 45.91 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 123.936 0.894 . . . . 20.0 108.943 167.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 68' ' ' HIS . . . . . 0.483 ' NE2' ' OD1' ' G' ' 235' ' ' ASP . 0.0 OUTLIER -105.08 146.46 29.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.922 -0.581 . . . . 20.0 110.473 177.452 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.89 21.33 5.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.148 -0.933 . . . . 20.0 109.751 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' G' ' 183' ' ' ASP . 12.0 t0 -97.41 67.96 2.14 Favored 'General case' 0 CA--C 1.516 -0.343 0 O-C-N 121.605 -0.684 . . . . 20.0 112.478 178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.24 144.89 28.32 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 178.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.79 148.8 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 123.747 0.819 . . . . 20.0 109.117 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 73' ' ' GLY . . . . . 0.459 ' C ' HD23 ' G' ' 74' ' ' LEU . . . -155.85 -175.67 27.13 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.592 -1.003 . . . . 20.0 110.592 173.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 74' ' ' LEU . . . . . 0.459 HD23 ' C ' ' G' ' 73' ' ' GLY . 5.0 mt -125.07 161.47 26.7 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.35 0.595 . . . . 20.0 109.944 178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 75' ' ' MET . . . . . 0.505 ' HB2' HG23 ' G' ' 160' ' ' THR . 10.6 ttm -128.15 131.35 48.95 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.623 -174.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.53 137.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.02 -29.31 7.05 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 113.129 0.789 . . . . 20.0 113.129 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.42 13.79 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.143 -1.058 . . . . 20.0 108.143 178.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.92 19.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 166.31 5.59 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.758 0.79 . . . . 20.0 110.001 173.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -26.99 60.33 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 119.637 -0.825 . . . . 20.0 112.763 -169.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.58 9.18 4.26 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.316 0.858 . . . . 20.0 113.316 -177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.24 12.78 81.82 Favored Glycine 0 N--CA 1.443 -0.876 0 CA-C-O 119.018 -0.879 . . . . 20.0 115.099 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 84' ' ' PHE . . . . . 0.564 ' HD1' ' HG3' ' E' ' 243' ' ' PRO . 20.3 m-30 -107.76 145.0 34.11 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 118.358 1.079 . . . . 20.0 110.251 178.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.83 142.49 28.03 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-N 115.265 -0.88 . . . . 20.0 112.629 -172.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 86' ' ' ARG . . . . . . . . . . . . . 2.8 mmt-85 -97.41 174.64 6.58 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.846 -1.168 . . . . 20.0 107.846 158.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.75 163.81 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 CA-C-O 121.669 0.747 . . . . 20.0 109.5 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.25 129.36 15.62 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.03 -0.987 . . . . 20.0 109.78 171.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 89' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -79.85 160.22 24.42 Favored 'Trans proline' 0 CA--C 1.508 -0.821 0 CA-C-O 122.306 0.877 . . . . 20.0 112.737 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 90' ' ' ILE . . . . . 0.48 HD11 HG21 ' G' ' 160' ' ' THR . 9.2 mt -88.77 150.31 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 CA-C-N 113.694 -1.594 . . . . 20.0 107.419 165.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.99 140.9 47.55 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.314 -0.857 . . . . 20.0 112.18 -168.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.91 -24.19 22.03 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 118.962 -0.91 . . . . 20.0 115.232 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.86 152.61 4.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 118.686 1.243 . . . . 20.0 109.26 -169.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.98 22.19 Favored Pre-proline 0 C--O 1.239 0.537 0 N-CA-C 108.405 -0.961 . . . . 20.0 108.405 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 95' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -81.11 -8.0 13.04 Favored 'Trans proline' 0 CA--C 1.514 -0.499 0 CA-C-N 120.542 1.229 . . . . 20.0 114.797 -170.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.15 -15.28 59.45 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 119.218 0.917 . . . . 20.0 111.815 174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 97' ' ' THR . . . . . 0.6 HG21 ' OG ' ' G' ' 324' ' ' SER . 44.7 p -89.45 35.47 0.82 Allowed 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 123.606 0.763 . . . . 20.0 112.468 178.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 98' ' ' LEU . . . . . 0.671 HD12 ' H ' ' G' ' 99' ' ' ILE . 0.5 OUTLIER -43.22 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.961 1.304 . . . . 20.0 113.368 -172.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 99' ' ' ILE . . . . . 0.671 ' H ' HD12 ' G' ' 98' ' ' LEU . 1.6 tt -173.18 156.09 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.994 -0.743 . . . . 20.0 108.994 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 100' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' E' ' 325' ' ' ASN . . . -123.89 -19.07 5.81 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.675 -1.148 . . . . 20.0 111.21 158.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 101' ' ' GLN . . . . . 0.414 ' HB3' HH21 ' G' ' 102' ' ' ARG . 0.0 OUTLIER -169.39 141.61 2.5 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.667 -0.864 . . . . 20.0 108.667 176.781 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 102' ' ' ARG . . . . . 0.414 HH21 ' HB3' ' G' ' 101' ' ' GLN . 0.0 OUTLIER 55.93 74.56 0.38 Allowed 'General case' 0 N--CA 1.455 -0.186 0 N-CA-C 115.2 1.556 . . . . 20.0 115.2 150.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 103' ' ' PHE . . . . . 0.583 ' O ' ' N ' ' G' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.24 36.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 119.27 0.941 . . . . 20.0 109.386 160.412 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.3 37.26 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 115.534 -0.757 . . . . 20.0 109.405 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 105' ' ' VAL . . . . . 0.584 HG22 ' CG1' ' G' ' 162' ' ' ILE . 50.2 t -117.43 110.79 32.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.17 -1.048 . . . . 20.0 108.17 -178.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.6 83.05 6.28 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.249 -0.278 . . . . 20.0 110.249 179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -52.0 -54.18 14.82 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 O-C-N 123.35 0.406 . . . . 20.0 110.303 170.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.46 10.63 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.406 -0.961 . . . . 20.0 108.406 178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.08 126.32 27.21 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.95 -1.023 . . . . 20.0 110.476 -177.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.16 11.27 75.02 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-O 118.913 -0.937 . . . . 20.0 115.333 -179.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.04 114.04 15.89 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 118.491 1.145 . . . . 20.0 108.587 177.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.31 141.57 37.72 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 109.36 -0.607 . . . . 20.0 109.36 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.47 43.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.684 -0.858 . . . . 20.0 108.684 172.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 114' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -79.67 149.43 31.25 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 115.026 -0.988 . . . . 20.0 110.309 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 115' ' ' GLY . . . . . 0.583 ' N ' ' O ' ' G' ' 103' ' ' PHE . . . -147.92 157.79 27.47 Favored Glycine 0 N--CA 1.447 -0.594 0 N-CA-C 110.314 -1.114 . . . . 20.0 110.314 -176.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.73 154.41 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.381 0 N-CA-C 108.383 -0.969 . . . . 20.0 108.383 -177.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.29 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.336 -0.847 . . . . 20.0 114.554 -168.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 118' ' ' ALA . . . . . 0.499 ' O ' HD13 ' G' ' 98' ' ' LEU . . . -67.2 -47.97 69.29 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 114.342 1.238 . . . . 20.0 114.342 -156.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.15 11.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 119.525 1.057 . . . . 20.0 112.665 -155.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.49 136.14 35.5 Favored Pre-proline 0 C--O 1.24 0.594 0 N-CA-C 102.627 -3.101 . . . . 20.0 102.627 159.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.15 123.79 11.02 Favored 'Trans proline' 0 C--O 1.239 0.531 0 CA-C-N 120.728 1.296 . . . . 20.0 110.597 -178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.78 149.79 89.94 Favored 'Trans proline' 0 CA--C 1.519 -0.265 0 CA-C-N 119.242 0.765 . . . . 20.0 110.693 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.35 7.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.8 0.81 . . . . 20.0 109.974 -178.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.15 91.92 3.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.197 -1.038 . . . . 20.0 108.197 -175.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.94 160.86 19.63 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 120.801 -0.36 . . . . 20.0 110.716 169.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -80.03 -43.55 1.47 Allowed Pre-proline 0 C--O 1.238 0.46 0 C-N-CA 123.932 0.893 . . . . 20.0 113.061 -170.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -25.01 59.38 Favored 'Trans proline' 0 C--N 1.359 1.115 0 CA-C-N 120.885 1.352 . . . . 20.0 111.968 170.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.51 -26.53 30.11 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 111.798 0.295 . . . . 20.0 111.798 -177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.94 -31.94 69.15 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 119.767 -0.773 . . . . 20.0 110.24 168.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.75 -36.87 62.6 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 111.937 0.347 . . . . 20.0 111.937 172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 131' ' ' LYS . . . . . . . . . . . . . 35.2 mttt -78.5 90.96 4.5 Favored 'General case' 0 CA--C 1.513 -0.462 0 N-CA-C 109.181 -0.674 . . . . 20.0 109.181 174.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.3 7.98 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.099 0.407 . . . . 20.0 112.099 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.55 87.36 Favored Pre-proline 0 N--CA 1.445 -0.706 0 N-CA-C 108.528 -0.916 . . . . 20.0 108.528 172.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 134' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.74 153.62 75.4 Favored 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-N 119.659 0.914 . . . . 20.0 112.383 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.67 153.62 42.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 114.541 -1.208 . . . . 20.0 107.962 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.64 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-O 118.797 -0.62 . . . . 20.0 112.386 -175.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 137' ' ' ASP . . . . . 0.41 ' OD1' ' N ' ' G' ' 138' ' ' GLN . 14.3 p30 -55.33 -66.37 0.43 Allowed 'General case' 0 C--N 1.345 0.388 0 CA-C-O 118.954 -0.546 . . . . 20.0 111.4 -175.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 138' ' ' GLN . . . . . 0.418 ' HG3' ' H ' ' G' ' 139' ' ' ILE . 3.9 tp-100 174.58 174.05 0.2 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 103.101 -2.926 . . . . 20.0 103.101 133.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 139' ' ' ILE . . . . . 0.418 ' H ' ' HG3' ' G' ' 138' ' ' GLN . 1.2 tp -74.77 168.05 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 124.166 0.986 . . . . 20.0 108.981 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' G' ' 139' ' ' ILE . 0.3 OUTLIER -114.79 161.45 18.18 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.96 0.904 . . . . 20.0 110.539 177.332 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 141' ' ' ILE . . . . . 0.42 HD13 HD13 ' G' ' 162' ' ' ILE . 30.1 mt -124.67 147.44 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.622 -0.881 . . . . 20.0 108.622 -177.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 142' ' ' ASP . . . . . 0.565 ' OD1' ' N ' ' G' ' 144' ' ' GLY . 0.5 OUTLIER -119.04 134.79 54.98 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.593 0.757 . . . . 20.0 109.591 175.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.85 6.69 Favored 'Isoleucine or valine' 0 C--O 1.237 0.447 0 O-C-N 123.67 0.606 . . . . 20.0 111.842 166.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 144' ' ' GLY . . . . . 0.565 ' N ' ' OD1' ' G' ' 142' ' ' ASP . . . 86.87 -6.59 82.72 Favored Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 115.496 0.959 . . . . 20.0 115.496 172.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.15 144.03 53.95 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.476 1.138 . . . . 20.0 110.297 176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.9 33.36 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 113.588 0.959 . . . . 20.0 113.588 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.32 162.65 40.1 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-O 121.978 0.894 . . . . 20.0 111.415 -173.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.53 80.65 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 113.881 -1.508 . . . . 20.0 111.241 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.33 -46.99 87.97 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.81 -0.356 . . . . 20.0 110.983 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.38 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.489 -0.484 . . . . 20.0 110.795 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.6 84.23 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.033 -0.667 . . . . 20.0 111.127 -175.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.78 -23.3 58.49 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 119.408 -0.917 . . . . 20.0 110.994 -178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.8 -30.04 66.39 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 119.714 -0.795 . . . . 20.0 110.613 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.62 92.22 Favored 'General case' 0 CA--C 1.513 -0.456 0 C-N-CA 120.522 -0.471 . . . . 20.0 111.69 171.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.76 6.69 Favored Glycine 0 N--CA 1.444 -0.772 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.603 -172.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.67 133.49 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 118.419 1.11 . . . . 20.0 108.574 178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.84 175.91 9.34 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 107.745 -1.206 . . . . 20.0 107.745 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.34 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.34 169.29 15.67 Favored Glycine 0 N--CA 1.449 -0.49 0 N-CA-C 108.771 -1.732 . . . . 20.0 108.771 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 160' ' ' THR . . . . . 0.505 HG23 ' HB2' ' G' ' 75' ' ' MET . 0.2 OUTLIER -79.35 113.61 17.62 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 107.69 -1.226 . . . . 20.0 107.69 165.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -20.02 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.348 0 N-CA-C 113.702 1.001 . . . . 20.0 113.702 -166.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 162' ' ' ILE . . . . . 0.584 ' CG1' HG22 ' G' ' 105' ' ' VAL . 0.5 OUTLIER -111.65 155.62 12.96 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 O-C-N 121.669 -0.644 . . . . 20.0 111.805 -159.225 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 163' ' ' THR . . . . . 0.548 ' OG1' ' N ' ' G' ' 164' ' ' TRP . 3.5 t -145.29 -166.31 2.4 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.3 1.04 . . . . 20.0 110.449 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 164' ' ' TRP . . . . . 0.548 ' N ' ' OG1' ' G' ' 163' ' ' THR . 2.5 t-105 -100.72 -17.96 16.72 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 113.213 0.819 . . . . 20.0 113.213 -160.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.69 61.7 0.97 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.219 0.533 . . . . 20.0 112.299 -177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.9 158.61 29.54 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.092 -1.203 . . . . 20.0 110.092 172.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 167' ' ' ARG . . . . . 0.574 ' HB3' HH12 ' E' ' 102' ' ' ARG . 0.0 OUTLIER -142.41 148.3 37.58 Favored 'General case' 0 CA--C 1.509 -0.6 0 N-CA-C 107.704 -1.221 . . . . 20.0 107.704 170.637 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.64 30.47 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.102 -0.954 . . . . 20.0 110.149 -167.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.48 159.79 35.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 121.891 0.853 . . . . 20.0 109.963 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.37 117.23 34.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.191 -1.368 . . . . 20.0 109.508 -173.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.59 29.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.502 -0.555 . . . . 20.0 109.502 168.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 172' ' ' GLY . . . . . 0.592 ' O ' ' N ' ' G' ' 175' ' ' ARG . . . 56.9 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.864 0 N-CA-C 109.208 -1.557 . . . . 20.0 109.208 -171.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.54 -21.87 4.28 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.748 0.647 . . . . 20.0 112.748 -174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -63.0 1.29 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.764 -0.775 . . . . 20.0 111.179 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 175' ' ' ARG . . . . . 0.592 ' N ' ' O ' ' G' ' 172' ' ' GLY . 6.8 ptt-85 -169.85 121.99 0.7 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-N 118.626 0.648 . . . . 20.0 112.651 172.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.5 169.37 0.35 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 127.833 2.453 . . . . 20.0 106.245 157.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.65 145.8 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 108.458 -0.941 . . . . 20.0 108.458 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 178' ' ' SER . . . . . . . . . . . . . 46.7 t -78.16 -64.49 1.15 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 116.435 2.013 . . . . 20.0 116.435 -166.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.79 22.31 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-N 118.707 0.685 . . . . 20.0 112.089 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.09 -0.66 36.69 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 181' ' ' PHE . . . . . 0.753 ' HB3' ' HB3' ' G' ' 327' ' ' GLU . 3.1 t80 -84.65 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.626 0.648 . . . . 20.0 111.727 -162.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 182' ' ' ASP . . . . . . . . . . . . . 33.7 t0 -80.26 127.85 32.85 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-O 122.059 0.933 . . . . 20.0 110.694 -152.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' G' ' 70' ' ' ASP . 0.6 OUTLIER 69.92 -6.69 1.03 Allowed 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.361 1.464 . . . . 20.0 113.161 174.683 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' G' ' 29' ' ' ILE . 0.0 OUTLIER -153.78 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.176 0.989 . . . . 20.0 110.799 157.098 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 185' ' ' ILE . . . . . 0.423 HG12 HG11 ' G' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.1 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 104.477 -2.416 . . . . 20.0 104.477 149.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' G' ' 189' ' ' THR . . . -50.12 -42.95 51.46 Favored 'General case' 0 C--O 1.238 0.457 0 CA-C-N 115.377 -0.829 . . . . 20.0 111.524 173.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.91 -36.07 76.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 C-N-CA 119.263 -0.975 . . . . 20.0 110.109 -178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 188' ' ' TYR . . . . . . . . . . . . . 77.2 t80 -63.86 -38.6 91.71 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 119.163 -1.015 . . . . 20.0 110.488 177.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' G' ' 186' ' ' ALA . 25.3 p -59.11 -48.61 80.99 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 119.513 -0.875 . . . . 20.0 110.827 171.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.55 64.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.92 0.39 . . . . 20.0 110.498 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.09 -43.22 96.05 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 120.091 -0.644 . . . . 20.0 110.923 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.81 -36.6 84.43 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 120.011 -0.676 . . . . 20.0 110.303 177.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 193' ' ' VAL . . . . . 0.409 HG23 ' O ' ' G' ' 189' ' ' THR . 11.6 t -60.53 -44.82 97.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.027 0.441 . . . . 20.0 110.114 177.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.09 -33.31 75.47 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.254 -0.578 . . . . 20.0 111.209 -176.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.16 70.91 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.767 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.13 40.94 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.544 0.572 . . . . 20.0 112.544 -175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.58 122.83 27.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.275 -0.639 . . . . 20.0 109.275 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.45 -57.07 2.33 Favored 'General case' 0 C--O 1.235 0.306 0 O-C-N 123.27 0.357 . . . . 20.0 110.132 176.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.16 105.33 17.46 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 109.715 -0.476 . . . . 20.0 109.715 -172.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.27 4.22 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.187 -0.671 . . . . 20.0 109.187 -174.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.78 -14.56 59.91 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.344 176.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.78 141.71 30.54 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.92 -0.77 . . . . 20.0 108.92 172.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 203' ' ' ASP . . . . . 0.644 ' OD1' ' N ' ' G' ' 203' ' ' ASP . 0.0 OUTLIER -78.61 112.96 16.23 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.527 -0.916 . . . . 20.0 108.527 -174.525 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.96 151.57 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -170.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.95 106.6 9.0 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.021 -0.733 . . . . 20.0 109.021 173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 206' ' ' PHE . . . . . . . . . . . . . 22.1 m-30 -82.94 125.39 31.33 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.685 -0.858 . . . . 20.0 108.685 177.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 207' ' ' VAL . . . . . 0.703 HG12 HD13 ' G' ' 53' ' ' ILE . 34.1 m -119.96 150.17 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.845 -0.798 . . . . 20.0 108.845 174.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.76 5.18 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.436 -1.32 . . . . 20.0 107.436 171.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.85 159.98 19.56 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.935 0.874 . . . . 20.0 111.102 -165.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.79 166.48 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 CA-C-N 114.621 -1.172 . . . . 20.0 108.222 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.55 40.22 29.55 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.801 -1.09 . . . . 20.0 111.524 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.53 13.86 Favored 'General case' 0 CA--C 1.517 -0.327 0 C-N-CA 120.418 -0.513 . . . . 20.0 110.95 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.29 -20.43 64.77 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 120.228 -0.589 . . . . 20.0 111.458 -173.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.19 121.14 48.43 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 173.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.06 60.96 6.21 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 119.663 -1.256 . . . . 20.0 111.419 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 216' ' ' LEU . . . . . 0.423 HD23 ' H ' ' G' ' 216' ' ' LEU . 0.5 OUTLIER -47.08 -25.48 0.86 Allowed 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.486 0.921 . . . . 20.0 113.486 -179.103 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 217' ' ' ARG . . . . . 0.461 ' HD3' HD21 ' I' ' 305' ' ' LEU . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.235 0.328 0 N-CA-C 112.324 0.49 . . . . 20.0 112.324 173.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.67 -40.56 40.92 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 119.769 -1.205 . . . . 20.0 111.967 168.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 219' ' ' ALA . . . . . 0.465 ' O ' ' OG ' ' G' ' 222' ' ' SER . . . -65.29 -37.02 85.86 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 122.275 -0.544 . . . . 20.0 111.352 179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 220' ' ' ARG . . . . . 0.405 ' HB2' ' HB1' ' G' ' 302' ' ' ALA . 16.6 ttm180 -52.78 -36.68 58.49 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 112.161 0.43 . . . . 20.0 112.161 -174.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 221' ' ' THR . . . . . . . . . . . . . 75.0 p -58.46 -45.77 87.93 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 119.989 -0.684 . . . . 20.0 110.871 -173.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 222' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' G' ' 219' ' ' ALA . 2.1 p -58.06 -35.81 71.89 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.775 -0.37 . . . . 20.0 111.408 175.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.67 -49.95 69.4 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.573 0.583 . . . . 20.0 112.573 -169.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 224' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -64.21 -33.4 75.73 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.819 -0.752 . . . . 20.0 111.809 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.71 74.88 Favored Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 118.949 -1.596 . . . . 20.0 112.133 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 226' ' ' ILE . . . . . . . . . . . . . 25.4 mm -127.03 -45.56 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 112.0 0.37 . . . . 20.0 112.0 -158.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 227' ' ' GLU . . . . . 0.457 ' OE1' ' OG1' ' G' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.68 99.78 Favored Pre-proline 0 C--O 1.237 0.41 0 N-CA-C 118.225 2.676 . . . . 20.0 118.225 -158.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.74 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.198 0 N-CA-C 115.95 1.481 . . . . 20.0 115.95 -134.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.15 -4.76 0.78 Allowed 'General case' 0 C--O 1.223 -0.323 0 C-N-CA 125.23 1.412 . . . . 20.0 113.397 162.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.89 171.27 11.43 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.766 167.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.55 151.46 16.32 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.884 -0.674 . . . . 20.0 112.258 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.7 170.73 15.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 114.563 -0.819 . . . . 20.0 108.824 178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.61 149.05 23.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.147 0.499 . . . . 20.0 110.409 177.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' G' ' 341' ' ' MET . 51.7 mt -133.2 90.41 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.364 0 N-CA-C 107.586 -1.264 . . . . 20.0 107.586 172.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 235' ' ' ASP . . . . . 0.483 ' OD1' ' NE2' ' G' ' 68' ' ' HIS . 25.5 t0 -135.2 173.24 11.95 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 106.949 -1.5 . . . . 20.0 106.949 173.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.37 14.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.628 0.727 . . . . 20.0 111.426 -172.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 237' ' ' THR . . . . . 0.449 HG21 ' HA3' ' G' ' 296' ' ' GLY . 9.1 t -165.61 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.324 -1.361 . . . . 20.0 107.324 164.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 238' ' ' ILE . . . . . 0.421 HD13 ' O ' ' G' ' 237' ' ' THR . 17.9 mm -145.48 151.94 14.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.234 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 -161.243 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.31 105.22 9.66 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 106.881 -1.526 . . . . 20.0 106.881 159.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.41 110.03 18.74 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.01 0.744 . . . . 20.0 113.01 -155.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.36 36.14 22.16 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 124.97 1.308 . . . . 20.0 112.434 158.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.38 79.16 Favored Pre-proline 0 C--N 1.321 -0.645 0 N-CA-C 105.182 -2.155 . . . . 20.0 105.182 -177.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 243' ' ' PRO . . . . . 0.419 ' O ' ' HG3' ' E' ' 121' ' ' PRO . 16.6 Cg_exo -60.98 165.56 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.38 0 CA-C-N 120.812 1.326 . . . . 20.0 112.385 -178.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.26 45.41 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.912 -0.938 . . . . 20.0 114.926 -173.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 245' ' ' THR . . . . . . . . . . . . . 33.2 p -92.19 164.55 22.74 Favored Pre-proline 0 N--CA 1.453 -0.298 0 CA-C-N 118.572 1.186 . . . . 20.0 110.619 177.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.67 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.581 0 CA-C-O 121.83 0.679 . . . . 20.0 111.944 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.18 -10.84 59.56 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.736 -1.12 . . . . 20.0 112.067 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.72 63.14 Favored 'General case' 0 CA--C 1.518 -0.282 0 C-N-CA 119.854 -0.738 . . . . 20.0 112.872 -171.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 249' ' ' LYS . . . . . 0.724 ' O ' ' OG1' ' G' ' 252' ' ' THR . 16.9 mttt -98.77 -15.12 19.43 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 113.216 0.821 . . . . 20.0 113.216 170.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.83 88.86 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.297 -0.561 . . . . 20.0 111.345 -172.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 251' ' ' VAL . . . . . . . . . . . . . 10.6 m -68.64 -21.0 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 C-N-CA 119.103 -1.039 . . . . 20.0 111.855 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 252' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' G' ' 249' ' ' LYS . 39.6 p -57.09 -31.86 65.69 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 118.537 0.608 . . . . 20.0 111.383 173.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 253' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' G' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.08 4.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.328 0.585 . . . . 20.0 110.411 176.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.37 -1.31 3.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.973 -1.012 . . . . 20.0 112.325 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.29 35.96 5.83 Favored Glycine 0 CA--C 1.503 -0.677 0 C-N-CA 126.155 1.836 . . . . 20.0 111.57 -177.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.19 10.14 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 108.662 -0.866 . . . . 20.0 108.662 -167.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.11 174.29 3.41 Favored Glycine 0 N--CA 1.437 -1.258 0 CA-C-O 122.706 1.17 . . . . 20.0 113.309 169.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.75 175.07 6.1 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.546 -0.909 . . . . 20.0 108.546 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.42 120.3 29.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 20.0 109.441 -169.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 260' ' ' ILE . . . . . . . . . . . . . 85.1 mt -97.93 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 107.831 -1.174 . . . . 20.0 107.831 175.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 261' ' ' LYS . . . . . 0.759 ' HE3' HG21 ' G' ' 298' ' ' THR . 1.9 mtmm -98.85 122.59 42.29 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.014 -0.735 . . . . 20.0 109.014 -177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.76 -40.27 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.362 0 CA-C-N 115.873 -0.603 . . . . 20.0 109.647 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.58 147.59 34.63 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.428 0.632 . . . . 20.0 109.363 -174.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.13 -169.92 2.85 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 114.77 -1.105 . . . . 20.0 108.235 165.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.06 -56.15 22.96 Favored 'General case' 0 CA--C 1.515 -0.382 0 CA-C-N 115.829 -0.623 . . . . 20.0 110.272 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.98 -46.11 11.53 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.659 0.985 . . . . 20.0 113.659 -165.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.81 143.62 25.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 N-CA-C 109.419 -0.586 . . . . 20.0 109.419 -163.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.24 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 106.128 -1.805 . . . . 20.0 106.128 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.33 137.08 56.66 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.279 0.561 . . . . 20.0 111.313 -171.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.0 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.569 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.669 177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 271' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -67.56 -19.96 47.88 Favored 'Trans proline' 0 CA--C 1.513 -0.553 0 N-CA-C 114.834 1.052 . . . . 20.0 114.834 -160.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.38 -42.96 74.69 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 120.177 -0.609 . . . . 20.0 110.587 176.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.59 -48.36 77.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.363 0 CA-C-O 121.1 0.476 . . . . 20.0 110.119 175.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.16 -52.5 60.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-O 120.822 0.344 . . . . 20.0 110.723 -176.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.38 -31.88 70.76 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.528 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 276' ' ' TRP . . . . . 0.483 ' HH2' ' HB3' ' G' ' 347' ' ' ASN . 0.1 OUTLIER -68.53 -47.96 65.58 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 120.107 -0.637 . . . . 20.0 110.97 179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.69 89.71 Favored 'General case' 0 CA--C 1.515 -0.401 0 C-N-CA 120.004 -0.679 . . . . 20.0 110.757 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.6 -48.0 78.39 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 120.594 -0.442 . . . . 20.0 110.098 173.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.46 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.926 -0.31 . . . . 20.0 110.708 175.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 280' ' ' LEU . . . . . . . . . . . . . 5.5 tp -67.3 -44.96 77.92 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.257 -0.577 . . . . 20.0 111.072 -172.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.64 72.91 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.022 -0.671 . . . . 20.0 111.052 -175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.45 -31.76 65.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 119.976 -0.69 . . . . 20.0 111.144 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.85 -37.63 73.12 Favored 'General case' 0 C--O 1.235 0.33 0 C-N-CA 119.89 -0.724 . . . . 20.0 110.974 -175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 284' ' ' HIS . . . . . . . . . . . . . 79.8 m-70 -102.66 15.5 29.1 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 113.334 0.864 . . . . 20.0 113.334 179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.77 32.14 13.75 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.717 0.77 . . . . 20.0 111.588 173.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.3 143.41 34.42 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 108.347 -0.983 . . . . 20.0 108.347 -178.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.17 149.38 13.46 Favored 'Trans proline' 0 CA--C 1.516 -0.39 0 CA-C-N 119.187 0.746 . . . . 20.0 111.353 175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.04 148.08 23.28 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 115.648 -0.705 . . . . 20.0 109.728 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.97 175.11 5.61 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 168.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.75 17.13 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 107.851 -1.166 . . . . 20.0 107.851 167.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.67 43.76 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.481 -0.562 . . . . 20.0 109.481 -172.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.07 157.04 25.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 107.653 -1.24 . . . . 20.0 107.653 173.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.73 12.21 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.517 0.675 . . . . 20.0 110.28 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.54 21.12 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.805 -1.089 . . . . 20.0 112.1 165.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.02 20.09 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.993 -0.843 . . . . 20.0 110.993 -176.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 296' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' G' ' 237' ' ' THR . . . 101.5 144.77 15.55 Favored Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 114.685 -0.758 . . . . 20.0 112.684 -178.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.54 4.07 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 110.321 -1.112 . . . . 20.0 110.321 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 298' ' ' THR . . . . . 0.759 HG21 ' HE3' ' G' ' 261' ' ' LYS . 20.5 p -110.26 172.83 6.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 122.002 0.906 . . . . 20.0 111.384 -174.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.81 -33.71 76.64 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 114.358 -1.292 . . . . 20.0 111.274 176.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.36 74.15 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 111.786 0.291 . . . . 20.0 111.786 -171.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.37 -41.11 96.81 Favored Glycine 0 C--N 1.332 0.338 0 C-N-CA 120.184 -1.007 . . . . 20.0 112.072 -178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 302' ' ' ALA . . . . . 0.405 ' HB1' ' HB2' ' G' ' 220' ' ' ARG . . . -68.32 -26.94 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.199 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.83 -34.52 56.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 120.051 -0.66 . . . . 20.0 110.139 -178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.23 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.297 0.851 . . . . 20.0 113.297 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.74 -8.94 19.47 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.717 1.006 . . . . 20.0 113.717 -167.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 306' ' ' THR . . . . . 0.457 ' OG1' ' OE1' ' G' ' 227' ' ' GLU . 0.5 OUTLIER -58.27 157.54 8.33 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.547 0.689 . . . . 20.0 110.596 171.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.75 -29.85 70.4 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.314 -0.857 . . . . 20.0 113.309 -160.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.87 -25.21 66.29 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.708 -0.797 . . . . 20.0 111.217 -178.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.83 65.08 1.94 Allowed Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.814 -0.708 . . . . 20.0 113.308 -171.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 310' ' ' VAL . . . . . . . . . . . . . 20.0 t -80.22 139.58 52.56 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 117.626 0.713 . . . . 20.0 111.158 -163.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 311' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -84.47 141.73 9.05 Favored 'Trans proline' 0 CA--C 1.513 -0.567 0 CA-C-N 119.448 0.838 . . . . 20.0 110.038 168.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.26 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.316 -0.856 . . . . 20.0 111.214 -169.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.63 162.57 12.33 Favored Glycine 0 N--CA 1.442 -0.963 0 N-CA-C 109.129 -1.589 . . . . 20.0 109.129 164.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 135.99 27.36 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 114.906 -0.647 . . . . 20.0 110.073 -176.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -103.99 153.28 21.02 Favored 'General case' 0 N--CA 1.447 -0.578 0 CA-C-N 114.618 -1.174 . . . . 20.0 109.252 174.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.47 133.53 32.84 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.275 -0.875 . . . . 20.0 109.434 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 317' ' ' VAL . . . . . 0.423 HG11 HG12 ' G' ' 185' ' ' ILE . 91.8 t -99.5 108.58 51.34 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 107.237 -1.394 . . . . 20.0 107.237 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 318' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -83.25 -168.98 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.755 0 CA-C-O 122.653 1.022 . . . . 20.0 113.644 -155.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' G' ' 253' ' ' HIS . . . 79.76 35.49 0.15 Allowed 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 113.562 -1.654 . . . . 20.0 115.304 161.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 320' ' ' ARG . . . . . 0.428 ' HG3' ' O ' ' G' ' 321' ' ' TYR . 0.4 OUTLIER -75.66 157.62 33.44 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.714 0.769 . . . . 20.0 110.112 176.751 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 321' ' ' TYR . . . . . 0.428 ' O ' ' HG3' ' G' ' 320' ' ' ARG . 3.3 m-85 -113.1 166.19 11.66 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 106.778 -1.564 . . . . 20.0 106.778 160.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.23 113.58 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 124.169 0.988 . . . . 20.0 108.441 -163.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 323' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -61.49 -7.42 3.14 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 114.49 1.293 . . . . 20.0 114.49 -140.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 324' ' ' SER . . . . . 0.6 ' OG ' HG21 ' G' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.99 4.57 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 112.652 0.612 . . . . 20.0 112.652 -180.0 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 325' ' ' ASN . . . . . 0.459 ' HB2' ' HA ' ' E' ' 100' ' ' ALA . 35.1 p-10 -101.99 -56.13 2.34 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 115.031 1.493 . . . . 20.0 115.031 -152.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.94 50.78 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.42 -1.326 . . . . 20.0 107.42 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 327' ' ' GLU . . . . . 0.753 ' HB3' ' HB3' ' G' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.78 1.42 Allowed 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.848 -1.524 . . . . 20.0 109.957 -153.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.0 149.37 0.93 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.373 0 CA-C-O 121.431 0.634 . . . . 20.0 111.943 -171.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 329' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' G' ' 181' ' ' PHE . 0.3 OUTLIER -139.34 179.4 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.937 0.875 . . . . 20.0 109.464 175.647 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.5 119.11 27.31 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 114.604 -1.18 . . . . 20.0 108.903 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.08 -32.01 53.49 Favored 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.864 0.727 . . . . 20.0 111.505 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.63 -44.82 73.39 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 120.353 -0.539 . . . . 20.0 110.205 -176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.0 -44.95 83.3 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.769 -0.372 . . . . 20.0 111.069 -172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.63 -41.29 92.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.474 -173.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.09 -34.6 71.28 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 118.785 -1.166 . . . . 20.0 110.12 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.1 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.073 -0.651 . . . . 20.0 110.438 176.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 337' ' ' THR . . . . . . . . . . . . . 20.3 m -56.51 -43.89 80.19 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 120.737 0.303 . . . . 20.0 110.912 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' G' ' 342' ' ' THR . 42.6 t -60.17 -48.95 86.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 CA-C-O 120.958 0.409 . . . . 20.0 110.231 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' G' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.93 74.63 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-O 121.015 0.436 . . . . 20.0 110.752 179.543 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.83 -55.2 37.17 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 116.322 -0.399 . . . . 20.0 111.424 -176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' G' ' 234' ' ' ILE . 31.9 tpp -60.15 -40.29 89.33 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 120.218 -0.593 . . . . 20.0 110.87 -179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' G' ' 338' ' ' VAL . 1.3 m -56.52 -45.03 81.31 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-O 121.132 0.491 . . . . 20.0 110.392 -177.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' G' ' 339' ' ' GLU . 34.6 mttp -74.22 -37.44 63.84 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 119.925 -0.71 . . . . 20.0 110.767 -178.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.79 -42.48 97.66 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.58 -0.448 . . . . 20.0 111.135 -179.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 345' ' ' LEU . . . . . 0.426 ' O ' HG22 ' G' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.41 74.18 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 120.563 -0.455 . . . . 20.0 110.766 -179.01 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.11 91.15 Favored 'General case' 0 C--O 1.237 0.447 0 C-N-CA 119.686 -0.806 . . . . 20.0 110.631 -178.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 347' ' ' ASN . . . . . 0.483 ' HB3' ' HH2' ' G' ' 276' ' ' TRP . 5.0 m-20 -84.44 4.78 30.05 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.444 -0.902 . . . . 20.0 112.48 -178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 348' ' ' ILE . . . . . 0.426 HG22 ' O ' ' G' ' 345' ' ' LEU . 1.3 tt -65.24 -23.66 33.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-N 119.143 0.883 . . . . 20.0 110.903 179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' G' G ' 349' ' ' HIS . . . . . . . . . . . . . 33.4 p-80 -63.69 -27.41 69.2 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.277 -175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.7 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 122.111 -0.368 . . . . 20.0 111.468 177.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 351' ' ' LEU . . . . . 0.447 ' O ' HD12 ' G' ' 351' ' ' LEU . 0.1 OUTLIER -69.71 -28.82 66.15 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.892 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' G' G ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.06 -26.73 0.1 Allowed 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 116.01 1.856 . . . . 20.0 116.01 -169.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' G' G ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.76 0 C-N-CA 125.014 1.326 . . . . 20.0 108.406 -174.663 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.08 0 N-CA-C 114.267 1.21 . . . . 20.0 114.267 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.09 82.24 2.93 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 -170.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -62.96 -34.49 66.6 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.86 -1.064 . . . . 20.0 110.185 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 4' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -107.02 -23.59 12.27 Favored 'General case' 0 C--O 1.238 0.491 0 N-CA-C 113.568 0.951 . . . . 20.0 113.568 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.3 19.96 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 124.129 0.971 . . . . 20.0 111.623 -173.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.72 32.42 Favored 'General case' 0 C--O 1.236 0.38 0 O-C-N 122.303 -0.248 . . . . 20.0 111.251 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.43 37.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.15 12.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.349 0.595 . . . . 20.0 110.915 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.69 -31.52 72.71 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.448 -0.796 . . . . 20.0 111.861 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 10' ' ' GLU . . . . . . . . . . . . . 69.0 mt-10 -68.19 -45.11 74.33 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 120.477 -0.489 . . . . 20.0 111.244 178.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.12 97.2 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 121.05 -0.26 . . . . 20.0 111.17 -172.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.92 -30.53 70.96 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 120.7 -0.4 . . . . 20.0 111.174 -178.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.94 -46.32 91.18 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.514 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.09 -42.92 91.6 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.686 -0.234 . . . . 20.0 111.499 -174.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.06 26.56 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.512 -0.875 . . . . 20.0 110.716 -171.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.1 -32.12 6.73 Favored 'Isoleucine or valine' 0 C--O 1.235 0.337 0 C-N-CA 119.047 -1.061 . . . . 20.0 111.0 -162.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.97 68.0 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 119.946 -0.702 . . . . 20.0 111.256 174.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.43 70.33 Favored Pre-proline 0 N--CA 1.448 -0.56 0 C-N-CA 120.572 -0.451 . . . . 20.0 109.794 -175.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 19' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -85.21 144.76 9.47 Favored 'Trans proline' 0 C--N 1.33 -0.441 0 CA-C-O 121.718 0.632 . . . . 20.0 112.17 -172.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.92 38.21 3.42 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 117.272 1.669 . . . . 20.0 117.272 -159.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.75 119.82 2.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 107.122 -1.436 . . . . 20.0 107.122 159.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.23 8.87 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.41 0.624 . . . . 20.0 110.668 -166.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.38 2.88 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.472 -0.786 . . . . 20.0 114.019 -177.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.38 0.17 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 122.295 1.045 . . . . 20.0 109.584 172.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.16 4.03 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.86 -1.064 . . . . 20.0 113.417 169.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 26' ' ' PHE . . . . . 0.489 ' O ' ' N ' ' H' ' 28' ' ' GLY . 0.0 OUTLIER -87.93 8.99 23.65 Favored 'General case' 0 C--N 1.345 0.396 0 CA-C-N 119.702 1.137 . . . . 20.0 113.773 178.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.65 11.3 0.05 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 115.386 1.624 . . . . 20.0 115.386 -154.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' H' ' 26' ' ' PHE . . . -53.09 -26.91 29.3 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 116.052 1.181 . . . . 20.0 116.052 -172.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 29' ' ' ILE . . . . . 0.524 HD13 ' NH1' ' H' ' 184' ' ' ARG . 1.1 tt -59.64 -35.76 61.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.417 0 CA-C-N 118.039 0.92 . . . . 20.0 110.604 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.31 -52.4 61.61 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.886 0.374 . . . . 20.0 110.425 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.3 -40.6 74.6 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 116.309 -0.405 . . . . 20.0 110.967 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.27 -49.57 82.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 121.034 0.445 . . . . 20.0 110.357 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.7 86.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 C-N-CA 119.711 -0.795 . . . . 20.0 110.273 -175.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.76 -29.46 20.36 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 C-N-CA 118.736 -1.186 . . . . 20.0 111.121 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.5 -30.98 71.67 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.036 0.38 . . . . 20.0 111.124 179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -86.94 -56.8 3.22 Favored 'General case' 0 C--O 1.237 0.429 0 N-CA-C 112.152 0.427 . . . . 20.0 112.152 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.24 -28.43 44.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 CA-C-N 116.481 -0.327 . . . . 20.0 111.536 -164.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.39 63.68 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 119.946 -0.702 . . . . 20.0 112.207 -162.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.13 -23.54 63.04 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 118.876 -1.13 . . . . 20.0 111.704 -177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.88 -6.87 23.01 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.521 0.934 . . . . 20.0 113.521 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.68 22.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 108.51 -0.922 . . . . 20.0 108.51 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 42' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -66.15 -42.57 88.86 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.115 -0.948 . . . . 20.0 111.462 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.27 35.21 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.572 -0.899 . . . . 20.0 108.572 -173.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.49 147.2 16.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.313 0 N-CA-C 108.224 -1.028 . . . . 20.0 108.224 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.15 159.28 44.11 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-O 121.513 0.673 . . . . 20.0 110.46 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 46' ' ' VAL . . . . . . . . . . . . . 61.8 t -117.13 128.99 74.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 107.35 -1.352 . . . . 20.0 107.35 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.32 -176.11 5.82 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.834 0.826 . . . . 20.0 108.882 177.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.56 62.86 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 119.906 -0.718 . . . . 20.0 111.122 -176.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.83 9.26 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -171.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.61 83.4 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-O 119.113 -0.826 . . . . 20.0 114.462 -176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.19 151.53 35.75 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 118.494 1.147 . . . . 20.0 110.199 173.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.44 140.27 33.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 176.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 53' ' ' ILE . . . . . 0.715 HD13 HG12 ' H' ' 207' ' ' VAL . 31.3 mm -130.21 115.63 33.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.314 -1.365 . . . . 20.0 107.314 -174.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.89 119.81 36.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.647 -0.501 . . . . 20.0 109.647 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.91 99.97 8.08 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.646 -0.872 . . . . 20.0 108.646 -173.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.6 145.39 31.75 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 106.781 -1.563 . . . . 20.0 106.781 163.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.57 154.5 20.3 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.68 -0.489 . . . . 20.0 109.68 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.4 -161.1 23.71 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.076 -0.809 . . . . 20.0 111.076 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.19 105.56 10.35 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 123.915 0.886 . . . . 20.0 109.043 179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.56 33.52 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.724 -0.751 . . . . 20.0 114.048 179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 61' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -70.79 165.25 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.347 0 CA-C-O 121.767 0.653 . . . . 20.0 112.06 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.95 111.37 22.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.033 -0.985 . . . . 20.0 109.242 -176.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.76 137.98 30.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.76 -0.83 . . . . 20.0 108.76 -179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.79 124.07 46.33 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 124.015 0.926 . . . . 20.0 109.009 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 65' ' ' ILE . . . . . . . . . . . . . 29.0 mm -116.27 114.26 45.55 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.333 0 N-CA-C 108.094 -1.076 . . . . 20.0 108.094 -176.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.55 124.6 51.43 Favored 'General case' 0 CA--C 1.515 -0.384 0 O-C-N 123.256 0.347 . . . . 20.0 111.0 -168.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.58 45.92 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 123.935 0.894 . . . . 20.0 108.965 167.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 68' ' ' HIS . . . . . 0.485 ' NE2' ' OD1' ' H' ' 235' ' ' ASP . 0.0 OUTLIER -104.99 146.44 29.04 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.998 -0.546 . . . . 20.0 110.537 177.403 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 21.36 5.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.23 -0.895 . . . . 20.0 109.657 -178.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 70' ' ' ASP . . . . . 0.544 ' N ' ' OD1' ' H' ' 183' ' ' ASP . 12.0 t0 -97.44 68.01 2.13 Favored 'General case' 0 CA--C 1.516 -0.331 0 O-C-N 121.582 -0.699 . . . . 20.0 112.421 178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.31 144.83 28.88 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.73 148.82 6.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 C-N-CA 123.729 0.812 . . . . 20.0 109.176 -178.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 73' ' ' GLY . . . . . 0.471 ' C ' HD23 ' H' ' 74' ' ' LEU . . . -155.85 -175.72 27.17 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.611 -0.996 . . . . 20.0 110.611 173.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 74' ' ' LEU . . . . . 0.471 HD23 ' C ' ' H' ' 73' ' ' GLY . 5.0 mt -125.01 161.43 26.75 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-O 121.309 0.576 . . . . 20.0 110.0 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 75' ' ' MET . . . . . 0.516 ' HB2' HG23 ' H' ' 160' ' ' THR . 10.5 ttm -128.11 131.4 49.03 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.004 -0.998 . . . . 20.0 109.705 -174.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.55 137.08 23.82 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.858 -0.793 . . . . 20.0 108.858 168.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.07 -29.34 7.02 Favored 'General case' 0 CA--C 1.518 -0.274 0 N-CA-C 113.072 0.767 . . . . 20.0 113.072 178.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.02 174.42 13.78 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.0 108.96 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.355 -0.98 . . . . 20.0 108.355 -175.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.77 166.28 5.68 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 121.827 0.822 . . . . 20.0 110.007 173.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.54 -27.01 60.34 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.661 -0.816 . . . . 20.0 112.732 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.52 9.16 4.23 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.332 0.864 . . . . 20.0 113.332 -177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.27 12.79 81.76 Favored Glycine 0 N--CA 1.443 -0.898 0 CA-C-O 118.973 -0.904 . . . . 20.0 115.067 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 84' ' ' PHE . . . . . 0.458 ' HD1' ' HG3' ' F' ' 243' ' ' PRO . 20.3 m-30 -107.78 145.02 34.12 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.372 1.086 . . . . 20.0 110.221 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.84 142.45 28.09 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.29 -0.868 . . . . 20.0 112.602 -172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.61 6.6 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.825 -1.176 . . . . 20.0 107.825 158.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.73 163.79 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-O 121.598 0.713 . . . . 20.0 109.492 -170.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.23 129.31 15.63 Favored Pre-proline 0 N--CA 1.448 -0.548 0 CA-C-N 115.009 -0.996 . . . . 20.0 109.808 171.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.84 160.2 24.44 Favored 'Trans proline' 0 CA--C 1.508 -0.809 0 CA-C-O 122.275 0.864 . . . . 20.0 112.749 -171.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 90' ' ' ILE . . . . . 0.493 HD11 HG21 ' H' ' 160' ' ' THR . 9.3 mt -88.72 150.34 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.632 0 CA-C-N 113.722 -1.581 . . . . 20.0 107.441 165.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.05 141.0 47.5 Favored Glycine 0 N--CA 1.449 -0.479 0 CA-C-N 115.288 -0.869 . . . . 20.0 112.131 -168.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.83 -24.16 22.26 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-O 118.966 -0.908 . . . . 20.0 115.235 176.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.89 152.65 4.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.672 1.236 . . . . 20.0 109.233 -169.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.71 130.91 22.27 Favored Pre-proline 0 C--O 1.24 0.601 0 N-CA-C 108.464 -0.939 . . . . 20.0 108.464 173.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.03 -7.96 13.13 Favored 'Trans proline' 0 CA--C 1.513 -0.528 0 CA-C-N 120.598 1.249 . . . . 20.0 114.839 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.26 -15.19 59.63 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.201 0.909 . . . . 20.0 111.8 174.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 97' ' ' THR . . . . . 0.598 HG21 ' OG ' ' H' ' 324' ' ' SER . 44.8 p -89.48 35.5 0.82 Allowed 'General case' 0 N--CA 1.448 -0.537 0 C-N-CA 123.657 0.783 . . . . 20.0 112.462 178.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 98' ' ' LEU . . . . . 0.671 HD12 ' H ' ' H' ' 99' ' ' ILE . 0.5 OUTLIER -43.25 -66.48 0.37 Allowed 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.017 1.327 . . . . 20.0 113.364 -173.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 99' ' ' ILE . . . . . 0.671 ' H ' HD12 ' H' ' 98' ' ' LEU . 1.6 tt -173.14 156.09 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.349 0 N-CA-C 109.002 -0.74 . . . . 20.0 109.002 174.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 100' ' ' ALA . . . . . 0.467 ' HB3' ' H ' ' F' ' 100' ' ' ALA . . . -123.94 -19.0 5.8 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.702 -1.135 . . . . 20.0 111.262 158.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 101' ' ' GLN . . . . . 0.413 ' C ' HD11 ' H' ' 99' ' ' ILE . 0.0 OUTLIER -169.37 141.66 2.52 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.659 -0.867 . . . . 20.0 108.659 176.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.9 74.54 0.38 Allowed 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 115.258 1.577 . . . . 20.0 115.258 150.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 103' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' H' ' 115' ' ' GLY . 0.5 OUTLIER -79.36 134.23 36.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 119.281 0.946 . . . . 20.0 109.417 160.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.8 140.34 37.2 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 115.475 -0.784 . . . . 20.0 109.392 -173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 105' ' ' VAL . . . . . 0.576 HG22 ' CG1' ' H' ' 162' ' ' ILE . 50.3 t -117.49 110.74 31.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 N-CA-C 108.175 -1.046 . . . . 20.0 108.175 -178.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.54 83.02 6.31 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 110.245 -0.28 . . . . 20.0 110.245 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 107' ' ' ILE . . . . . . . . . . . . . 27.5 mt -51.92 -54.22 14.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 O-C-N 123.334 0.396 . . . . 20.0 110.353 170.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.59 177.48 10.6 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.403 -0.962 . . . . 20.0 108.403 178.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.12 126.34 27.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.915 -1.039 . . . . 20.0 110.447 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.25 75.21 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-O 118.896 -0.946 . . . . 20.0 115.319 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.01 113.99 15.85 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 118.483 1.142 . . . . 20.0 108.565 177.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 112' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -139.3 141.55 37.72 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 109.334 -0.617 . . . . 20.0 109.334 -178.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.66 142.49 43.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.69 149.46 31.21 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 114.971 -1.013 . . . . 20.0 110.264 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 115' ' ' GLY . . . . . 0.578 ' N ' ' O ' ' H' ' 103' ' ' PHE . . . -147.94 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 110.3 -1.12 . . . . 20.0 110.3 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.74 154.39 39.58 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.365 0 N-CA-C 108.357 -0.979 . . . . 20.0 108.357 -177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.812 0 CA-C-N 115.328 -0.851 . . . . 20.0 114.604 -168.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' H' ' 98' ' ' LEU . . . -67.15 -48.01 69.32 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 114.373 1.249 . . . . 20.0 114.373 -156.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.54 121.15 11.8 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 119.526 1.057 . . . . 20.0 112.707 -155.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.52 136.13 35.44 Favored Pre-proline 0 C--O 1.241 0.613 0 N-CA-C 102.632 -3.099 . . . . 20.0 102.632 159.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.84 11.09 Favored 'Trans proline' 0 C--O 1.239 0.527 0 CA-C-N 120.737 1.299 . . . . 20.0 110.561 -178.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.82 149.81 89.86 Favored 'Trans proline' 0 CA--C 1.518 -0.303 0 CA-C-N 119.228 0.76 . . . . 20.0 110.725 177.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.12 165.37 7.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.818 0.818 . . . . 20.0 109.971 -178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.84 3.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 108.194 -1.039 . . . . 20.0 108.194 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.95 160.78 19.51 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.779 -0.368 . . . . 20.0 110.708 169.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.87 -43.66 1.51 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 123.943 0.897 . . . . 20.0 113.091 -170.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -64.96 -24.96 59.81 Favored 'Trans proline' 0 C--N 1.359 1.104 0 CA-C-N 120.849 1.339 . . . . 20.0 112.03 170.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.57 -26.49 30.01 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 111.753 0.279 . . . . 20.0 111.753 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.93 -31.97 69.15 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 119.817 -0.753 . . . . 20.0 110.231 168.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.76 -36.89 62.58 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.943 0.349 . . . . 20.0 111.943 172.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.51 90.94 4.5 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 109.186 -0.672 . . . . 20.0 109.186 174.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.15 14.31 7.88 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.132 0.419 . . . . 20.0 112.132 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.19 142.56 87.38 Favored Pre-proline 0 N--CA 1.446 -0.649 0 N-CA-C 108.502 -0.925 . . . . 20.0 108.502 172.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.78 153.59 75.37 Favored 'Trans proline' 0 C--N 1.326 -0.631 0 CA-C-N 119.647 0.91 . . . . 20.0 112.357 177.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.62 153.6 42.67 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.494 -1.23 . . . . 20.0 107.957 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.66 -12.19 59.94 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-O 118.839 -0.6 . . . . 20.0 112.423 -175.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 137' ' ' ASP . . . . . 0.409 ' OD1' ' N ' ' H' ' 138' ' ' GLN . 14.1 p30 -55.41 -66.35 0.43 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.355 -175.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 138' ' ' GLN . . . . . 0.412 ' HG3' ' H ' ' H' ' 139' ' ' ILE . 3.9 tp-100 174.62 174.11 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 N-CA-C 103.108 -2.923 . . . . 20.0 103.108 133.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 139' ' ' ILE . . . . . 0.412 ' H ' ' HG3' ' H' ' 138' ' ' GLN . 1.2 tp -74.83 168.07 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 C-N-CA 124.151 0.98 . . . . 20.0 108.976 -179.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 140' ' ' PHE . . . . . 0.4 ' H ' HG13 ' H' ' 139' ' ' ILE . 0.3 OUTLIER -114.8 161.47 18.16 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 123.958 0.903 . . . . 20.0 110.533 177.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 141' ' ' ILE . . . . . 0.417 HD13 HD13 ' H' ' 162' ' ' ILE . 30.1 mt -124.67 147.5 29.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -177.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 142' ' ' ASP . . . . . 0.573 ' OD1' ' N ' ' H' ' 144' ' ' GLY . 0.5 OUTLIER -119.15 134.74 55.03 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 123.633 0.773 . . . . 20.0 109.561 175.196 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.15 7.83 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 CA-C-N 115.88 -0.6 . . . . 20.0 111.795 166.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 144' ' ' GLY . . . . . 0.573 ' N ' ' OD1' ' H' ' 142' ' ' ASP . . . 86.89 -6.58 82.79 Favored Glycine 0 N--CA 1.441 -1.016 0 N-CA-C 115.467 0.947 . . . . 20.0 115.467 172.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.16 144.04 53.91 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 118.486 1.143 . . . . 20.0 110.314 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.38 -20.88 33.4 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 113.562 0.949 . . . . 20.0 113.562 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.38 162.65 40.14 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 122.007 0.908 . . . . 20.0 111.406 -173.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.42 -41.49 80.5 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 113.862 -1.517 . . . . 20.0 111.245 177.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.38 -47.05 87.76 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 120.788 -0.365 . . . . 20.0 110.941 -179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.32 -35.19 76.71 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.523 -0.471 . . . . 20.0 110.834 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.73 -40.58 84.18 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.03 -0.668 . . . . 20.0 111.105 -175.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.77 -23.35 58.51 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 119.394 -0.922 . . . . 20.0 110.971 -178.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.78 -29.99 66.34 Favored 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.765 -0.774 . . . . 20.0 110.609 177.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.56 92.25 Favored 'General case' 0 CA--C 1.513 -0.455 0 C-N-CA 120.567 -0.453 . . . . 20.0 111.701 171.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.11 -8.76 6.71 Favored Glycine 0 N--CA 1.444 -0.818 0 CA-C-O 118.901 -0.944 . . . . 20.0 114.589 -172.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 156' ' ' VAL . . . . . . . . . . . . . 74.9 t -63.66 133.48 29.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 118.462 1.131 . . . . 20.0 108.544 178.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.99 9.28 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 107.756 -1.202 . . . . 20.0 107.756 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.33 147.26 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.646 0 N-CA-C 107.694 -1.224 . . . . 20.0 107.694 174.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.47 169.33 15.78 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 108.776 -1.729 . . . . 20.0 108.776 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 160' ' ' THR . . . . . 0.516 HG23 ' HB2' ' H' ' 75' ' ' MET . 0.2 OUTLIER -79.42 113.58 17.67 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 165.585 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.65 -20.07 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 113.736 1.013 . . . . 20.0 113.736 -166.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 162' ' ' ILE . . . . . 0.576 ' CG1' HG22 ' H' ' 105' ' ' VAL . 0.5 OUTLIER -111.66 155.62 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 O-C-N 121.708 -0.62 . . . . 20.0 111.757 -159.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' H' ' 164' ' ' TRP . 3.5 t -145.3 -166.35 2.41 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 124.331 1.052 . . . . 20.0 110.492 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' H' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.87 16.73 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 113.23 0.826 . . . . 20.0 113.23 -160.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 165' ' ' ASP . . . . . 0.428 ' O ' ' NE2' ' F' ' 101' ' ' GLN . 7.5 t70 63.63 61.72 0.98 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.255 0.55 . . . . 20.0 112.291 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.88 158.63 29.58 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.113 -1.195 . . . . 20.0 110.113 172.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 167' ' ' ARG . . . . . 0.546 ' HB3' HH12 ' F' ' 102' ' ' ARG . 0.0 OUTLIER -142.42 148.36 37.68 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 107.714 -1.217 . . . . 20.0 107.714 170.559 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.04 117.64 30.5 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.128 -0.942 . . . . 20.0 110.168 -167.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.45 159.8 35.12 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 121.882 0.848 . . . . 20.0 110.011 177.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.38 117.21 34.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.294 -1.321 . . . . 20.0 109.491 -173.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.95 151.57 29.08 Favored 'General case' 0 CA--C 1.516 -0.337 0 N-CA-C 109.493 -0.558 . . . . 20.0 109.493 168.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 172' ' ' GLY . . . . . 0.599 ' O ' ' N ' ' H' ' 175' ' ' ARG . . . 56.96 68.68 1.57 Allowed Glycine 0 N--CA 1.442 -0.915 0 N-CA-C 109.216 -1.554 . . . . 20.0 109.216 -171.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.51 -21.89 4.26 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 112.823 0.675 . . . . 20.0 112.823 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -63.01 1.29 Allowed 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.202 157.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 175' ' ' ARG . . . . . 0.599 ' N ' ' O ' ' H' ' 172' ' ' GLY . 6.8 ptt-85 -169.78 121.94 0.7 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-N 118.635 0.652 . . . . 20.0 112.663 172.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.45 0.35 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 127.829 2.452 . . . . 20.0 106.218 157.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.68 145.76 20.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 N-CA-C 108.492 -0.929 . . . . 20.0 108.492 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.47 1.16 Allowed 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 116.395 1.998 . . . . 20.0 116.395 -165.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.34 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 118.752 0.706 . . . . 20.0 112.076 -170.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.73 37.13 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 181' ' ' PHE . . . . . 0.74 ' HB3' ' HB3' ' H' ' 327' ' ' GLU . 3.1 t80 -84.58 -67.01 0.83 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 118.601 0.637 . . . . 20.0 111.778 -162.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.26 127.84 32.83 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.06 0.933 . . . . 20.0 110.711 -152.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 183' ' ' ASP . . . . . 0.544 ' OD1' ' N ' ' H' ' 70' ' ' ASP . 0.6 OUTLIER 70.01 -6.75 1.04 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.301 1.44 . . . . 20.0 113.181 174.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 184' ' ' ARG . . . . . 0.524 ' NH1' HD13 ' H' ' 29' ' ' ILE . 0.0 OUTLIER -153.83 83.93 1.16 Allowed 'General case' 0 N--CA 1.446 -0.645 0 CA-C-O 122.183 0.992 . . . . 20.0 110.805 157.135 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 185' ' ' ILE . . . . . 0.438 HG12 HG11 ' H' ' 317' ' ' VAL . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.517 -2.401 . . . . 20.0 104.517 149.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 186' ' ' ALA . . . . . 0.722 ' O ' ' OG1' ' H' ' 189' ' ' THR . . . -50.12 -42.98 51.57 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 115.306 -0.861 . . . . 20.0 111.511 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -35.99 76.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.129 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.86 -38.64 91.86 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.131 -1.027 . . . . 20.0 110.486 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 189' ' ' THR . . . . . 0.722 ' OG1' ' O ' ' H' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.0 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 119.489 -0.885 . . . . 20.0 110.824 172.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.25 -50.55 63.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.974 0.416 . . . . 20.0 110.553 178.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.15 -43.12 96.17 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.052 -0.659 . . . . 20.0 110.958 -178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.52 84.21 Favored 'General case' 0 C--O 1.237 0.412 0 C-N-CA 119.945 -0.702 . . . . 20.0 110.317 177.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 193' ' ' VAL . . . . . 0.402 HG23 ' O ' ' H' ' 189' ' ' THR . 11.5 t -60.59 -44.75 97.46 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 CA-C-O 121.035 0.445 . . . . 20.0 110.14 177.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.12 -33.26 75.37 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.233 -0.587 . . . . 20.0 111.243 -176.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.64 -38.18 70.75 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.882 -0.727 . . . . 20.0 110.757 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.65 -26.16 41.15 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.568 0.581 . . . . 20.0 112.568 -175.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 197' ' ' LEU . . . . . . . . . . . . . 34.2 tp -80.56 122.8 27.5 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.265 -0.643 . . . . 20.0 109.265 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.1 2.32 Favored 'General case' 0 C--O 1.235 0.29 0 O-C-N 123.286 0.366 . . . . 20.0 110.119 176.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.34 17.47 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.729 -0.471 . . . . 20.0 109.729 -172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.3 4.23 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.161 -0.681 . . . . 20.0 109.161 -173.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.8 -14.52 59.91 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.965 -0.694 . . . . 20.0 111.344 176.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.84 141.72 30.49 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.91 -0.774 . . . . 20.0 108.91 172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 203' ' ' ASP . . . . . 0.648 ' OD1' ' N ' ' H' ' 203' ' ' ASP . 0.0 OUTLIER -78.65 112.97 16.29 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.456 -0.942 . . . . 20.0 108.456 -174.47 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.94 151.53 6.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 108.578 -0.897 . . . . 20.0 108.578 -170.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 205' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -128.88 106.64 9.04 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.009 -0.737 . . . . 20.0 109.009 173.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 206' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -82.88 125.37 31.28 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.737 -0.838 . . . . 20.0 108.737 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 207' ' ' VAL . . . . . 0.715 HG12 HD13 ' H' ' 53' ' ' ILE . 34.1 m -119.94 150.18 22.56 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 174.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.3 98.77 5.19 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.437 -1.32 . . . . 20.0 107.437 171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.77 159.94 19.62 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.879 0.847 . . . . 20.0 111.15 -165.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.83 166.46 13.18 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.405 0 CA-C-N 114.642 -1.163 . . . . 20.0 108.217 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.17 29.44 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.485 -179.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.52 13.96 Favored 'General case' 0 CA--C 1.515 -0.366 0 C-N-CA 120.388 -0.525 . . . . 20.0 111.007 176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -20.41 64.73 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 120.215 -0.594 . . . . 20.0 111.46 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 214' ' ' VAL . . . . . . . . . . . . . 88.9 t -131.12 121.17 48.7 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.427 0 N-CA-C 108.564 -0.902 . . . . 20.0 108.564 173.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.96 6.22 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 119.672 -1.251 . . . . 20.0 111.423 -174.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 216' ' ' LEU . . . . . 0.418 HD23 ' H ' ' H' ' 216' ' ' LEU . 0.5 OUTLIER -47.0 -25.59 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 N-CA-C 113.473 0.916 . . . . 20.0 113.473 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.48 -4.52 2.85 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 112.32 0.489 . . . . 20.0 112.32 173.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.69 -40.53 41.0 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 119.728 -1.225 . . . . 20.0 111.979 168.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 219' ' ' ALA . . . . . 0.456 ' O ' ' OG ' ' H' ' 222' ' ' SER . . . -65.25 -37.05 86.03 Favored 'General case' 0 C--O 1.237 0.396 0 O-C-N 122.29 -0.535 . . . . 20.0 111.365 179.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 220' ' ' ARG . . . . . 0.42 ' HB2' ' HB1' ' H' ' 302' ' ' ALA . 16.6 ttm180 -52.75 -36.66 58.23 Favored 'General case' 0 CA--C 1.515 -0.378 0 N-CA-C 112.184 0.439 . . . . 20.0 112.184 -174.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 221' ' ' THR . . . . . . . . . . . . . 75.9 p -58.43 -45.83 87.71 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.883 -173.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 222' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' H' ' 219' ' ' ALA . 2.1 p -58.0 -35.85 71.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.781 -0.368 . . . . 20.0 111.405 175.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.66 -49.93 69.41 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 112.57 0.581 . . . . 20.0 112.57 -169.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 224' ' ' PHE . . . . . . . . . . . . . 79.0 t80 -64.21 -33.39 75.69 Favored 'General case' 0 C--O 1.236 0.374 0 C-N-CA 119.8 -0.76 . . . . 20.0 111.842 -165.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.98 -16.72 74.98 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 118.962 -1.589 . . . . 20.0 112.102 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 226' ' ' ILE . . . . . . . . . . . . . 25.0 mm -126.97 -45.64 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 112.033 0.383 . . . . 20.0 112.033 -158.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 227' ' ' GLU . . . . . 0.484 ' OE1' ' OG1' ' H' ' 306' ' ' THR . 3.0 pt-20 -56.39 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.369 0 N-CA-C 118.182 2.66 . . . . 20.0 118.182 -158.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 228' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -43.86 143.65 2.89 Favored 'Trans proline' 0 N--CA 1.471 0.188 0 N-CA-C 115.982 1.493 . . . . 20.0 115.982 -134.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.17 -4.68 0.77 Allowed 'General case' 0 C--O 1.223 -0.328 0 C-N-CA 125.254 1.422 . . . . 20.0 113.389 162.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.88 171.24 11.47 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 120.116 -0.634 . . . . 20.0 111.784 167.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.43 16.31 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.919 -0.658 . . . . 20.0 112.289 -175.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 232' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -144.66 170.77 15.44 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.777 0.831 . . . . 20.0 108.812 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.68 149.1 23.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.201 0.524 . . . . 20.0 110.348 177.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 234' ' ' ILE . . . . . 0.493 HD11 ' CE ' ' H' ' 341' ' ' MET . 51.6 mt -133.24 90.46 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 107.503 -1.295 . . . . 20.0 107.503 172.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 235' ' ' ASP . . . . . 0.485 ' OD1' ' NE2' ' H' ' 68' ' ' HIS . 25.6 t0 -135.21 173.19 11.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 106.905 -1.517 . . . . 20.0 106.905 173.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.13 149.41 14.53 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 CA-C-O 121.674 0.749 . . . . 20.0 111.424 -173.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 237' ' ' THR . . . . . 0.453 HG21 ' HA3' ' H' ' 296' ' ' GLY . 9.2 t -165.62 122.69 1.45 Allowed 'General case' 0 C--O 1.233 0.211 0 N-CA-C 107.389 -1.338 . . . . 20.0 107.389 164.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 238' ' ' ILE . . . . . 0.419 HD13 ' O ' ' H' ' 237' ' ' THR . 18.0 mm -145.44 151.93 14.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.27 -1.011 . . . . 20.0 108.27 -161.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.28 105.23 9.68 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.846 -1.539 . . . . 20.0 106.846 159.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 110.0 18.67 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 113.032 0.752 . . . . 20.0 113.032 -155.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.35 36.11 22.07 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.896 1.278 . . . . 20.0 112.504 158.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.95 128.46 78.87 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 105.167 -2.16 . . . . 20.0 105.167 -177.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 243' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -61.03 165.57 12.08 Favored 'Trans proline' 0 CA--C 1.516 -0.388 0 CA-C-N 120.816 1.327 . . . . 20.0 112.361 -178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.47 -5.38 45.0 Favored Glycine 0 N--CA 1.441 -0.974 0 CA-C-N 115.097 -0.956 . . . . 20.0 114.92 -173.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.13 164.54 22.91 Favored Pre-proline 0 N--CA 1.452 -0.326 0 CA-C-N 118.618 1.209 . . . . 20.0 110.664 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.05 -172.66 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.593 0 CA-C-O 121.825 0.677 . . . . 20.0 111.949 171.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.88 59.56 Favored 'General case' 0 C--O 1.236 0.389 0 CA-C-N 114.765 -1.107 . . . . 20.0 112.003 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.27 -18.68 63.13 Favored 'General case' 0 CA--C 1.518 -0.271 0 C-N-CA 119.908 -0.717 . . . . 20.0 112.847 -171.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 249' ' ' LYS . . . . . 0.701 ' O ' ' OG1' ' H' ' 252' ' ' THR . 16.9 mttt -98.73 -15.24 19.41 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 170.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.84 88.88 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 120.337 -0.545 . . . . 20.0 111.328 -172.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.62 -20.96 25.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 C-N-CA 119.038 -1.065 . . . . 20.0 111.896 -178.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 252' ' ' THR . . . . . 0.701 ' OG1' ' O ' ' H' ' 249' ' ' LYS . 39.4 p -57.14 -31.85 65.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 118.497 0.59 . . . . 20.0 111.339 173.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 253' ' ' HIS . . . . . 0.547 ' CD2' ' HB2' ' H' ' 319' ' ' ALA . 16.7 t-80 -162.37 132.04 4.5 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 121.313 0.578 . . . . 20.0 110.448 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.4 -1.24 3.95 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.001 -1.0 . . . . 20.0 112.289 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.91 5.84 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 126.134 1.826 . . . . 20.0 111.515 -177.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.41 129.24 10.18 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.61 -0.885 . . . . 20.0 108.61 -167.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.03 174.25 3.33 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-O 122.695 1.164 . . . . 20.0 113.354 169.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.11 6.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -177.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' H' ' 316' ' ' SER . . . -126.44 120.3 29.39 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.104 -0.953 . . . . 20.0 109.381 -169.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 260' ' ' ILE . . . . . . . . . . . . . 85.4 mt -98.01 139.98 19.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.787 -1.19 . . . . 20.0 107.787 175.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 261' ' ' LYS . . . . . 0.767 ' HE3' HG21 ' H' ' 298' ' ' THR . 1.9 mtmm -98.91 122.64 42.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 N-CA-C 108.967 -0.753 . . . . 20.0 108.967 -177.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 262' ' ' ILE . . . . . . . . . . . . . 13.5 mt -95.71 -40.32 10.71 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.367 0 CA-C-N 115.844 -0.616 . . . . 20.0 109.653 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.55 147.56 34.63 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 121.433 0.635 . . . . 20.0 109.324 -174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.9 2.84 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.748 -1.114 . . . . 20.0 108.248 165.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.0 -56.27 21.56 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.827 -0.624 . . . . 20.0 110.272 163.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.14 11.58 Favored 'General case' 0 N--CA 1.447 -0.592 0 N-CA-C 113.648 0.981 . . . . 20.0 113.648 -165.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.66 25.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 N-CA-C 109.431 -0.581 . . . . 20.0 109.431 -163.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.23 103.96 14.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.158 -1.793 . . . . 20.0 106.158 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.32 137.08 56.67 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.207 0.527 . . . . 20.0 111.303 -171.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 270' ' ' HIS . . . . . . . . . . . . . 28.1 t60 -58.07 109.73 2.02 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.162 -0.926 . . . . 20.0 108.673 177.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.54 -19.98 47.95 Favored 'Trans proline' 0 CA--C 1.513 -0.551 0 N-CA-C 114.798 1.038 . . . . 20.0 114.798 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.36 -43.03 74.71 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.192 -0.603 . . . . 20.0 110.587 176.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.5 -48.37 77.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 CA-C-O 121.111 0.481 . . . . 20.0 110.121 175.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.2 -52.51 59.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.446 0 CA-C-O 120.798 0.332 . . . . 20.0 110.657 -176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.35 -31.92 70.78 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.873 -0.731 . . . . 20.0 110.568 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 276' ' ' TRP . . . . . 0.498 ' HH2' ' HB3' ' H' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -47.96 65.72 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.061 -0.655 . . . . 20.0 110.983 179.165 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.05 -38.74 89.92 Favored 'General case' 0 CA--C 1.515 -0.403 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.73 177.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.59 -47.94 78.46 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 120.561 -0.456 . . . . 20.0 110.143 173.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.86 -40.42 88.56 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 120.828 -0.349 . . . . 20.0 110.68 175.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.3 -44.92 78.03 Favored 'General case' 0 CA--C 1.515 -0.371 0 C-N-CA 120.281 -0.568 . . . . 20.0 111.141 -172.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.15 -31.67 72.95 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 120.001 -0.679 . . . . 20.0 111.021 -175.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.41 -31.86 65.87 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.035 -0.666 . . . . 20.0 111.141 178.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.69 73.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 119.872 -0.731 . . . . 20.0 110.989 -175.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.58 15.48 29.13 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 113.362 0.875 . . . . 20.0 113.362 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.78 32.14 13.73 Favored 'General case' 0 N--CA 1.471 0.575 0 CA-C-O 121.709 0.766 . . . . 20.0 111.574 173.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.39 34.46 Favored Pre-proline 0 C--N 1.322 -0.587 0 N-CA-C 108.305 -0.998 . . . . 20.0 108.305 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 287' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.17 149.31 13.44 Favored 'Trans proline' 0 CA--C 1.517 -0.375 0 CA-C-N 119.167 0.738 . . . . 20.0 111.409 175.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.99 148.19 23.46 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 115.652 -0.704 . . . . 20.0 109.687 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.15 5.59 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 107.683 -1.228 . . . . 20.0 107.683 168.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.69 113.71 17.04 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.877 -1.157 . . . . 20.0 107.877 167.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.77 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.452 -0.573 . . . . 20.0 109.452 -172.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.03 157.05 25.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 173.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.33 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.505 0.669 . . . . 20.0 110.261 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.58 21.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.819 -1.082 . . . . 20.0 112.176 165.055 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.58 -176.0 20.02 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.998 -0.841 . . . . 20.0 110.998 -176.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 296' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' H' ' 237' ' ' THR . . . 101.45 144.74 15.55 Favored Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 114.666 -0.767 . . . . 20.0 112.704 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.81 119.57 4.09 Favored Glycine 0 N--CA 1.451 -0.323 0 N-CA-C 110.338 -1.105 . . . . 20.0 110.338 179.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 298' ' ' THR . . . . . 0.767 HG21 ' HE3' ' H' ' 261' ' ' LYS . 20.2 p -110.28 172.88 6.6 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 122.038 0.923 . . . . 20.0 111.374 -174.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.69 76.61 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 114.346 -1.297 . . . . 20.0 111.281 176.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.6 -35.3 74.05 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 111.815 0.302 . . . . 20.0 111.815 -171.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.21 96.85 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 120.192 -1.004 . . . . 20.0 112.058 -178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 302' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' H' ' 220' ' ' ARG . . . -68.28 -26.9 65.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.201 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.48 56.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 120.018 -0.673 . . . . 20.0 110.119 -178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.2 -14.17 60.0 Favored 'General case' 0 CA--C 1.517 -0.293 0 N-CA-C 113.341 0.867 . . . . 20.0 113.341 -174.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 305' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' B' ' 217' ' ' ARG . 4.1 mp -103.76 -8.89 19.49 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -167.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 306' ' ' THR . . . . . 0.484 ' OG1' ' OE1' ' H' ' 227' ' ' GLU . 0.5 OUTLIER -58.32 157.54 8.43 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.523 0.677 . . . . 20.0 110.558 171.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 307' ' ' LYS . . . . . 0.421 ' HD2' ' HB2' ' B' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.82 70.35 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -161.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.93 -25.23 66.26 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 119.698 -0.801 . . . . 20.0 111.183 -178.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.82 65.06 1.95 Allowed Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.805 -0.712 . . . . 20.0 113.317 -171.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 310' ' ' VAL . . . . . . . . . . . . . 20.1 t -80.21 139.61 52.61 Favored Pre-proline 0 C--O 1.238 0.477 0 CA-C-N 117.598 0.699 . . . . 20.0 111.128 -163.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 311' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -84.49 141.67 9.0 Favored 'Trans proline' 0 CA--C 1.513 -0.568 0 CA-C-N 119.51 0.861 . . . . 20.0 110.041 168.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.43 135.81 32.4 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 115.314 -0.857 . . . . 20.0 111.212 -169.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.55 12.34 Favored Glycine 0 N--CA 1.441 -0.974 0 N-CA-C 109.183 -1.567 . . . . 20.0 109.183 164.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.39 136.07 27.44 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.9 -0.65 . . . . 20.0 110.087 -176.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 315' ' ' LEU . . . . . . . . . . . . . 23.3 mt -104.04 153.2 21.15 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.246 174.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' H' ' 259' ' ' ALA . 4.2 m -138.46 133.54 32.87 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.258 -0.883 . . . . 20.0 109.452 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 317' ' ' VAL . . . . . 0.438 HG11 HG12 ' H' ' 185' ' ' ILE . 92.6 t -99.43 108.58 51.17 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 107.276 -1.379 . . . . 20.0 107.276 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -168.96 0.63 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.642 1.018 . . . . 20.0 113.593 -154.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 319' ' ' ALA . . . . . 0.547 ' HB2' ' CD2' ' H' ' 253' ' ' HIS . . . 79.73 35.52 0.15 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 113.537 -1.665 . . . . 20.0 115.313 161.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 320' ' ' ARG . . . . . 0.43 ' HG3' ' O ' ' H' ' 321' ' ' TYR . 0.4 OUTLIER -75.64 157.55 33.58 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-O 121.733 0.778 . . . . 20.0 110.091 176.755 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 321' ' ' TYR . . . . . 0.43 ' O ' ' HG3' ' H' ' 320' ' ' ARG . 3.3 m-85 -113.08 166.13 11.72 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 106.825 -1.546 . . . . 20.0 106.825 160.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.14 113.61 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.407 0 C-N-CA 124.156 0.982 . . . . 20.0 108.462 -163.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.53 -7.42 3.21 Favored 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 114.442 1.275 . . . . 20.0 114.442 -140.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 324' ' ' SER . . . . . 0.598 ' OG ' HG21 ' H' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.94 4.65 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.682 0.623 . . . . 20.0 112.682 -179.974 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 325' ' ' ASN . . . . . 0.443 ' HB2' ' HA ' ' F' ' 100' ' ' ALA . 35.1 p-10 -101.98 -56.23 2.32 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 114.963 1.468 . . . . 20.0 114.963 -152.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 151.02 50.82 Favored 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 107.417 -1.327 . . . . 20.0 107.417 174.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 327' ' ' GLU . . . . . 0.74 ' HB3' ' HB3' ' H' ' 181' ' ' PHE . 82.7 mt-10 -142.62 52.82 1.41 Allowed 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 113.834 -1.53 . . . . 20.0 109.911 -153.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.06 149.43 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.379 0 CA-C-O 121.392 0.615 . . . . 20.0 111.981 -171.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 329' ' ' VAL . . . . . 0.431 HG13 ' HB2' ' H' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-O 121.927 0.87 . . . . 20.0 109.462 175.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.57 119.16 27.37 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 114.617 -1.174 . . . . 20.0 108.87 178.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.0 -32.12 53.15 Favored 'General case' 0 C--O 1.235 0.324 0 O-C-N 123.793 0.683 . . . . 20.0 111.519 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.8 73.52 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 120.324 -0.55 . . . . 20.0 110.202 -176.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.02 -44.95 83.24 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.761 -0.376 . . . . 20.0 111.025 -172.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.26 92.02 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 120.44 -0.504 . . . . 20.0 110.55 -173.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.1 -34.65 71.31 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 118.853 -1.139 . . . . 20.0 110.112 178.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.37 93.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.072 -0.651 . . . . 20.0 110.458 176.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.59 -43.81 80.47 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 120.698 0.285 . . . . 20.0 110.889 176.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 338' ' ' VAL . . . . . 0.704 ' O ' ' OG1' ' H' ' 342' ' ' THR . 42.5 t -60.16 -49.05 85.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 121.02 0.438 . . . . 20.0 110.221 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 339' ' ' GLU . . . . . 0.782 ' OE1' ' NZ ' ' H' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.92 74.61 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.951 0.405 . . . . 20.0 110.774 179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.81 -55.13 38.03 Favored 'General case' 0 C--O 1.237 0.441 0 CA-C-N 116.355 -0.384 . . . . 20.0 111.414 -176.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 341' ' ' MET . . . . . 0.493 ' CE ' HD11 ' H' ' 234' ' ' ILE . 31.9 tpp -60.2 -40.34 89.71 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.2 -0.6 . . . . 20.0 110.828 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 342' ' ' THR . . . . . 0.704 ' OG1' ' O ' ' H' ' 338' ' ' VAL . 1.3 m -56.47 -45.03 81.1 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-O 121.136 0.493 . . . . 20.0 110.437 -177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 343' ' ' LYS . . . . . 0.782 ' NZ ' ' OE1' ' H' ' 339' ' ' GLU . 34.6 mttp -74.16 -37.45 63.99 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 119.937 -0.705 . . . . 20.0 110.821 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.81 -42.49 97.73 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.589 -0.444 . . . . 20.0 111.128 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 345' ' ' LEU . . . . . 0.42 ' O ' HG22 ' H' ' 348' ' ' ILE . 1.0 OUTLIER -59.04 -50.45 74.04 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 120.613 -0.435 . . . . 20.0 110.769 -179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.65 -39.12 91.07 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 119.725 -0.79 . . . . 20.0 110.554 -178.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 347' ' ' ASN . . . . . 0.498 ' HB3' ' HH2' ' H' ' 276' ' ' TRP . 4.9 m-20 -84.46 4.8 30.04 Favored 'General case' 0 C--O 1.236 0.355 0 C-N-CA 119.449 -0.9 . . . . 20.0 112.56 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 348' ' ' ILE . . . . . 0.42 HG22 ' O ' ' H' ' 345' ' ' LEU . 1.3 tt -65.22 -23.64 33.56 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 119.54 -0.864 . . . . 20.0 110.918 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' H' H ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.82 -27.28 69.07 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 119.775 -0.77 . . . . 20.0 111.238 -175.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.89 -18.79 31.79 Favored 'General case' 0 C--O 1.235 0.328 0 O-C-N 122.077 -0.389 . . . . 20.0 111.484 177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 351' ' ' LEU . . . . . 0.431 ' O ' HD12 ' H' ' 351' ' ' LEU . 0.1 OUTLIER -69.81 -28.75 65.98 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.142 0.423 . . . . 20.0 112.142 -173.873 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' H' H ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.15 -26.64 0.1 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 116.016 1.858 . . . . 20.0 116.016 -169.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' H' H ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.813 0 C-N-CA 124.977 1.311 . . . . 20.0 108.402 -174.69 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 114.25 1.204 . . . . 20.0 114.25 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.27 2.91 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 106.902 -1.518 . . . . 20.0 106.902 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 3' ' ' VAL . . . . . . . . . . . . . 35.2 t -63.03 -34.45 66.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 114.895 -1.048 . . . . 20.0 110.161 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.96 -23.56 12.3 Favored 'General case' 0 C--O 1.239 0.508 0 N-CA-C 113.653 0.983 . . . . 20.0 113.653 -179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.46 30.26 19.91 Favored 'General case' 0 C--O 1.239 0.501 0 C-N-CA 124.111 0.965 . . . . 20.0 111.65 -173.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.78 32.34 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.758 0.254 . . . . 20.0 111.239 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.05 117.46 37.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 107.675 -1.232 . . . . 20.0 107.675 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.15 12.02 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-O 121.324 0.583 . . . . 20.0 110.958 -174.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.65 -31.55 72.75 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.45 -0.795 . . . . 20.0 111.888 -177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.15 -45.2 74.19 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.51 -0.476 . . . . 20.0 111.236 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.82 -43.04 97.39 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 121.06 -0.256 . . . . 20.0 111.196 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.87 -30.65 71.0 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.79 -0.364 . . . . 20.0 111.158 -178.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.84 -46.44 90.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 120.616 -0.434 . . . . 20.0 110.555 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -58.96 -42.97 91.16 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.648 -0.251 . . . . 20.0 111.564 -174.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.03 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 119.492 -0.883 . . . . 20.0 110.713 -171.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.12 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 119.007 -1.077 . . . . 20.0 110.966 -162.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.08 -25.98 68.03 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 119.945 -0.702 . . . . 20.0 111.284 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.03 160.41 70.56 Favored Pre-proline 0 N--CA 1.448 -0.55 0 C-N-CA 120.522 -0.471 . . . . 20.0 109.83 -175.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 19' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -85.09 144.7 9.59 Favored 'Trans proline' 0 C--N 1.33 -0.438 0 C-N-CA 120.32 0.68 . . . . 20.0 112.216 -172.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.91 38.28 3.39 Favored Glycine 0 N--CA 1.445 -0.707 0 N-CA-C 117.309 1.684 . . . . 20.0 117.309 -159.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.74 119.84 2.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.14 -1.43 . . . . 20.0 107.14 159.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.15 8.92 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.364 0.602 . . . . 20.0 110.696 -166.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.97 -33.29 2.89 Favored Glycine 0 N--CA 1.447 -0.619 0 CA-C-N 115.478 -0.783 . . . . 20.0 113.988 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.26 -178.42 0.17 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.312 1.053 . . . . 20.0 109.567 172.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.94 -13.14 3.97 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 114.888 -1.051 . . . . 20.0 113.434 169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' I' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.02 23.69 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.738 1.153 . . . . 20.0 113.732 178.535 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.7 11.34 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 115.419 1.637 . . . . 20.0 115.419 -154.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' I' ' 26' ' ' PHE . . . -53.13 -26.93 29.63 Favored Glycine 0 C--N 1.343 0.923 0 CA-C-N 119.752 1.16 . . . . 20.0 115.996 -172.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 29' ' ' ILE . . . . . 0.529 HD13 ' NH1' ' I' ' 184' ' ' ARG . 1.1 tt -59.57 -35.81 61.42 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 CA-C-N 118.062 0.931 . . . . 20.0 110.618 -178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.22 -52.46 61.23 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-O 120.951 0.405 . . . . 20.0 110.428 178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.26 -40.64 74.53 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-N 116.299 -0.41 . . . . 20.0 110.945 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.25 -49.58 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.442 0 CA-C-O 121.046 0.451 . . . . 20.0 110.288 -174.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.25 -39.71 86.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.711 -0.796 . . . . 20.0 110.32 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.72 -29.5 20.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 C-N-CA 118.735 -1.186 . . . . 20.0 111.134 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.44 -31.03 71.68 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 117.996 0.362 . . . . 20.0 111.131 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 36' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -86.96 -56.68 3.27 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 112.174 0.435 . . . . 20.0 112.174 177.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.28 -28.46 44.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 116.53 -0.305 . . . . 20.0 111.539 -164.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.37 -26.37 63.69 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 119.922 -0.711 . . . . 20.0 112.254 -162.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.14 -23.48 63.01 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 118.879 -1.128 . . . . 20.0 111.735 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.9 -6.93 22.92 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 113.493 0.923 . . . . 20.0 113.493 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 41' ' ' VAL . . . . . . . . . . . . . 23.0 t -119.61 152.63 22.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 N-CA-C 108.504 -0.924 . . . . 20.0 108.504 -176.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 42' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -66.08 -42.59 89.18 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.16 -0.927 . . . . 20.0 111.529 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.64 158.28 35.18 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.519 -0.919 . . . . 20.0 108.519 -173.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.21 16.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 N-CA-C 108.208 -1.034 . . . . 20.0 108.208 -174.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.19 159.21 44.18 Favored 'General case' 0 CA--C 1.516 -0.335 0 CA-C-O 121.527 0.68 . . . . 20.0 110.429 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 46' ' ' VAL . . . . . . . . . . . . . 61.3 t -117.03 129.02 74.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.358 -1.349 . . . . 20.0 107.358 179.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.35 -176.09 5.82 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.784 0.802 . . . . 20.0 108.893 177.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.6 -34.59 62.86 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 119.923 -0.711 . . . . 20.0 111.105 -176.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.15 10.86 9.16 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 113.674 0.991 . . . . 20.0 113.674 -171.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.49 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.74 0 CA-C-O 119.151 -0.805 . . . . 20.0 114.51 -176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 51' ' ' ASN . . . . . . . . . . . . . 97.9 m-20 -62.2 151.47 35.96 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 118.481 1.141 . . . . 20.0 110.221 173.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.33 140.26 32.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 107.187 -1.412 . . . . 20.0 107.187 176.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 53' ' ' ILE . . . . . 0.709 HD13 HG12 ' I' ' 207' ' ' VAL . 31.1 mm -130.22 115.65 33.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 107.296 -1.372 . . . . 20.0 107.296 -174.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.79 36.44 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.668 -0.493 . . . . 20.0 109.668 174.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.97 99.97 8.06 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.615 -0.883 . . . . 20.0 108.615 -173.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.53 145.37 31.85 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 106.804 -1.554 . . . . 20.0 106.804 163.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.522 0.514 . . . . 20.0 109.667 -175.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.41 -161.09 23.71 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.117 -0.793 . . . . 20.0 111.117 179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.18 105.66 10.45 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 123.88 0.872 . . . . 20.0 108.997 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.01 -168.53 33.49 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.726 -0.75 . . . . 20.0 114.075 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.78 165.24 32.77 Favored 'Trans proline' 0 C--N 1.331 -0.363 0 CA-C-O 121.763 0.651 . . . . 20.0 112.028 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 62' ' ' LYS . . . . . . . . . . . . . 53.1 mttt -91.94 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.973 -1.012 . . . . 20.0 109.231 -176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 63' ' ' VAL . . . . . . . . . . . . . 45.7 t -103.73 137.88 30.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 108.784 -0.821 . . . . 20.0 108.784 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.7 124.1 46.5 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.039 0.936 . . . . 20.0 109.049 -175.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 65' ' ' ILE . . . . . . . . . . . . . 29.3 mm -116.27 114.27 45.59 Favored 'Isoleucine or valine' 0 C--O 1.235 0.329 0 N-CA-C 108.07 -1.085 . . . . 20.0 108.07 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.53 124.58 51.39 Favored 'General case' 0 C--N 1.327 -0.384 0 O-C-N 123.295 0.372 . . . . 20.0 111.015 -168.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.45 154.61 45.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 123.9 0.88 . . . . 20.0 108.925 167.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 68' ' ' HIS . . . . . 0.49 ' NE2' ' OD1' ' I' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.42 29.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.973 -0.558 . . . . 20.0 110.52 177.415 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.92 21.34 5.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.16 -0.927 . . . . 20.0 109.705 -178.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' I' ' 183' ' ' ASP . 12.0 t0 -97.42 68.04 2.14 Favored 'General case' 0 CA--C 1.516 -0.34 0 O-C-N 121.622 -0.673 . . . . 20.0 112.434 178.011 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.27 144.88 28.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 178.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.77 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 123.758 0.823 . . . . 20.0 109.123 -178.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 73' ' ' GLY . . . . . 0.467 ' C ' HD23 ' I' ' 74' ' ' LEU . . . -155.79 -175.72 27.12 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.553 -1.019 . . . . 20.0 110.553 173.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 74' ' ' LEU . . . . . 0.467 HD23 ' C ' ' I' ' 73' ' ' GLY . 5.1 mt -125.03 161.45 26.72 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 121.33 0.586 . . . . 20.0 109.989 178.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 75' ' ' MET . . . . . 0.513 ' HB2' HG23 ' I' ' 160' ' ' THR . 10.6 ttm -128.12 131.35 49.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 124.227 1.011 . . . . 20.0 109.696 -174.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.49 137.11 23.77 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 108.875 -0.787 . . . . 20.0 108.875 168.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.09 -29.38 7.01 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.091 0.774 . . . . 20.0 113.091 178.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -160.98 174.45 13.77 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.127 -1.064 . . . . 20.0 108.127 178.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.06 108.9 19.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 108.335 -0.987 . . . . 20.0 108.335 -175.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 80' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.72 166.28 5.62 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-O 121.806 0.812 . . . . 20.0 109.999 173.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.55 -27.02 60.33 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 119.632 -0.827 . . . . 20.0 112.72 -169.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.47 9.11 4.24 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 113.36 0.874 . . . . 20.0 113.36 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.83 81.73 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 118.944 -0.92 . . . . 20.0 115.062 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 84' ' ' PHE . . . . . 0.503 ' HD1' ' HG3' ' K' ' 243' ' ' PRO . 20.2 m-30 -107.83 145.02 34.21 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 118.351 1.075 . . . . 20.0 110.208 178.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.86 142.5 28.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.588 -172.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.4 174.6 6.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 107.855 -1.165 . . . . 20.0 107.855 158.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.84 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 CA-C-O 121.64 0.733 . . . . 20.0 109.478 -170.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.32 129.27 15.51 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 114.989 -1.005 . . . . 20.0 109.772 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 89' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -79.79 160.24 24.61 Favored 'Trans proline' 0 CA--C 1.508 -0.814 0 CA-C-O 122.31 0.879 . . . . 20.0 112.734 -171.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 90' ' ' ILE . . . . . 0.488 HD11 HG21 ' I' ' 160' ' ' THR . 9.2 mt -88.81 150.36 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 113.703 -1.59 . . . . 20.0 107.373 165.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.09 140.94 47.56 Favored Glycine 0 N--CA 1.449 -0.448 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.114 -168.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.89 -24.12 22.2 Favored Glycine 0 N--CA 1.441 -0.999 0 CA-C-O 118.96 -0.911 . . . . 20.0 115.216 176.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.88 152.63 4.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 118.67 1.235 . . . . 20.0 109.227 -169.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.68 130.99 22.17 Favored Pre-proline 0 C--O 1.24 0.577 0 N-CA-C 108.42 -0.955 . . . . 20.0 108.42 173.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 95' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -81.14 -7.98 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.511 0 CA-C-N 120.626 1.259 . . . . 20.0 114.78 -170.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.22 -15.18 59.45 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 119.207 0.912 . . . . 20.0 111.83 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 97' ' ' THR . . . . . 0.591 HG21 ' OG ' ' I' ' 324' ' ' SER . 44.7 p -89.51 35.52 0.82 Allowed 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.668 0.787 . . . . 20.0 112.406 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 98' ' ' LEU . . . . . 0.678 HD12 ' H ' ' I' ' 99' ' ' ILE . 0.5 OUTLIER -43.25 -66.41 0.38 Allowed 'General case' 0 CA--C 1.52 -0.191 0 C-N-CA 124.973 1.309 . . . . 20.0 113.429 -173.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 99' ' ' ILE . . . . . 0.678 ' H ' HD12 ' I' ' 98' ' ' LEU . 1.6 tt -173.24 156.03 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.369 0 N-CA-C 109.043 -0.725 . . . . 20.0 109.043 174.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 100' ' ' ALA . . . . . 0.49 ' HB3' ' H ' ' K' ' 100' ' ' ALA . . . -123.91 -19.0 5.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.642 -1.163 . . . . 20.0 111.275 158.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 101' ' ' GLN . . . . . 0.412 ' HB3' HH21 ' I' ' 102' ' ' ARG . 0.0 OUTLIER -169.34 141.7 2.55 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.666 -0.864 . . . . 20.0 108.666 176.69 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 102' ' ' ARG . . . . . 0.412 HH21 ' HB3' ' I' ' 101' ' ' GLN . 0.0 OUTLIER 55.87 74.55 0.38 Allowed 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 115.239 1.57 . . . . 20.0 115.239 150.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' I' ' 115' ' ' GLY . 0.5 OUTLIER -79.39 134.23 36.57 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 119.298 0.954 . . . . 20.0 109.369 160.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.75 140.27 37.25 Favored 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.492 -0.776 . . . . 20.0 109.425 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 105' ' ' VAL . . . . . 0.58 HG22 ' CG1' ' I' ' 162' ' ' ILE . 50.2 t -117.43 110.74 32.04 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 N-CA-C 108.24 -1.022 . . . . 20.0 108.24 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.56 83.07 6.3 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.2 -0.296 . . . . 20.0 110.2 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 107' ' ' ILE . . . . . . . . . . . . . 27.0 mt -51.94 -54.24 14.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 O-C-N 123.373 0.42 . . . . 20.0 110.321 170.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.55 10.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 109' ' ' LYS . . . . . . . . . . . . . 53.8 tttm -59.11 126.3 27.13 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.892 -1.049 . . . . 20.0 110.458 -177.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.25 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-O 118.842 -0.977 . . . . 20.0 115.326 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.07 114.02 15.86 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 118.464 1.132 . . . . 20.0 108.524 177.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.29 141.56 37.76 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.369 -0.604 . . . . 20.0 109.369 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.69 142.53 43.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.669 -0.863 . . . . 20.0 108.669 172.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 114' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -79.73 149.39 31.18 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-N 114.96 -1.018 . . . . 20.0 110.287 -172.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' I' ' 103' ' ' PHE . . . -147.9 157.8 27.47 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 110.307 -1.117 . . . . 20.0 110.307 -176.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.75 154.43 39.64 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 N-CA-C 108.374 -0.973 . . . . 20.0 108.374 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.27 34.18 1.76 Allowed Glycine 0 N--CA 1.444 -0.832 0 CA-C-N 115.331 -0.85 . . . . 20.0 114.559 -168.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' I' ' 98' ' ' LEU . . . -67.16 -47.95 69.46 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.384 1.253 . . . . 20.0 114.384 -156.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.56 121.13 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.513 1.051 . . . . 20.0 112.694 -155.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.5 136.16 35.45 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.09 123.8 11.05 Favored 'Trans proline' 0 C--O 1.239 0.552 0 CA-C-N 120.749 1.303 . . . . 20.0 110.526 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.77 149.75 90.04 Favored 'Trans proline' 0 C--O 1.233 0.27 0 CA-C-N 119.209 0.753 . . . . 20.0 110.731 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.11 165.37 7.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.811 0.815 . . . . 20.0 109.984 -178.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.13 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 N-CA-C 108.235 -1.024 . . . . 20.0 108.235 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.88 19.71 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-O 120.861 0.362 . . . . 20.0 110.715 169.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.9 -43.73 1.5 Allowed Pre-proline 0 C--O 1.236 0.393 0 C-N-CA 124.001 0.921 . . . . 20.0 113.068 -170.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 127' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -65.01 -24.86 59.6 Favored 'Trans proline' 0 C--N 1.359 1.123 0 CA-C-N 120.849 1.339 . . . . 20.0 112.015 170.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.56 -26.53 30.0 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 111.799 0.296 . . . . 20.0 111.799 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.97 69.2 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 119.821 -0.751 . . . . 20.0 110.206 168.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.7 -36.97 62.73 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 111.913 0.338 . . . . 20.0 111.913 172.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.44 90.93 4.46 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 109.199 -0.667 . . . . 20.0 109.199 174.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.19 14.33 7.92 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 112.101 0.408 . . . . 20.0 112.101 175.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.16 142.57 87.45 Favored Pre-proline 0 N--CA 1.444 -0.739 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 172.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.56 75.49 Favored 'Trans proline' 0 C--N 1.326 -0.605 0 CA-C-N 119.661 0.915 . . . . 20.0 112.387 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.65 153.64 42.63 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.561 -1.199 . . . . 20.0 107.943 177.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.67 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 118.826 -0.607 . . . . 20.0 112.382 -175.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' I' ' 138' ' ' GLN . 14.0 p30 -55.42 -66.34 0.43 Allowed 'General case' 0 C--N 1.345 0.382 0 CA-C-O 118.927 -0.558 . . . . 20.0 111.392 -175.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 138' ' ' GLN . . . . . 0.423 ' HG3' ' H ' ' I' ' 139' ' ' ILE . 3.9 tp-100 174.65 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.31 0 N-CA-C 103.124 -2.917 . . . . 20.0 103.124 133.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 139' ' ' ILE . . . . . 0.423 ' H ' ' HG3' ' I' ' 138' ' ' GLN . 1.2 tp -74.85 168.07 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.138 0.975 . . . . 20.0 108.952 -179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.47 18.17 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.956 0.902 . . . . 20.0 110.455 177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 141' ' ' ILE . . . . . 0.421 HD13 HD13 ' I' ' 162' ' ' ILE . 30.2 mt -124.63 147.51 29.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 108.606 -0.887 . . . . 20.0 108.606 -177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' I' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.79 54.98 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.672 0.789 . . . . 20.0 109.618 175.117 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.22 7.87 6.68 Favored 'Isoleucine or valine' 0 C--O 1.238 0.481 0 O-C-N 123.701 0.626 . . . . 20.0 111.781 166.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' I' ' 142' ' ' ASP . . . 86.83 -6.55 82.73 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 115.504 0.962 . . . . 20.0 115.504 172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.08 144.0 54.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 118.462 1.131 . . . . 20.0 110.305 176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.36 -20.9 33.4 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 113.558 0.947 . . . . 20.0 113.558 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.41 162.63 40.2 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.994 0.902 . . . . 20.0 111.4 -173.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.42 -41.48 80.49 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-N 113.832 -1.531 . . . . 20.0 111.278 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 149' ' ' GLU . . . . . . . . . . . . . 78.9 tt0 -60.34 -47.02 87.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.818 -0.353 . . . . 20.0 110.972 -179.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.38 -35.14 76.67 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 120.487 -0.485 . . . . 20.0 110.806 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.64 84.24 Favored 'General case' 0 C--O 1.235 0.297 0 C-N-CA 120.038 -0.665 . . . . 20.0 111.107 -175.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.77 -23.27 58.5 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.359 -0.936 . . . . 20.0 111.008 -178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 153' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -70.77 -30.02 66.4 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.78 -0.768 . . . . 20.0 110.622 177.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 154' ' ' MET . . . . . . . . . . . . . 38.3 mtt -60.6 -40.55 92.23 Favored 'General case' 0 CA--C 1.514 -0.44 0 C-N-CA 120.545 -0.462 . . . . 20.0 111.676 171.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.1 -8.75 6.71 Favored Glycine 0 N--CA 1.445 -0.751 0 CA-C-O 118.935 -0.925 . . . . 20.0 114.566 -172.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 156' ' ' VAL . . . . . . . . . . . . . 75.0 t -63.78 133.52 29.38 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-N 118.485 1.143 . . . . 20.0 108.565 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.85 175.95 9.31 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.737 -1.209 . . . . 20.0 107.737 174.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.22 147.29 11.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 N-CA-C 107.733 -1.21 . . . . 20.0 107.733 174.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.33 15.75 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 108.733 -1.747 . . . . 20.0 108.733 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 160' ' ' THR . . . . . 0.513 HG23 ' HB2' ' I' ' 75' ' ' MET . 0.2 OUTLIER -79.39 113.59 17.65 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.665 -1.235 . . . . 20.0 107.665 165.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.7 -20.03 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -166.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 162' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' I' ' 105' ' ' VAL . 0.5 OUTLIER -111.68 155.61 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 O-C-N 121.64 -0.663 . . . . 20.0 111.776 -159.147 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 163' ' ' THR . . . . . 0.561 ' OG1' ' N ' ' I' ' 164' ' ' TRP . 3.5 t -145.31 -166.29 2.39 Favored 'General case' 0 C--O 1.233 0.233 0 C-N-CA 124.279 1.032 . . . . 20.0 110.514 171.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 164' ' ' TRP . . . . . 0.561 ' N ' ' OG1' ' I' ' 163' ' ' THR . 2.5 t-105 -100.82 -17.92 16.67 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 113.228 0.825 . . . . 20.0 113.228 -160.172 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 165' ' ' ASP . . . . . 0.45 ' O ' ' NE2' ' K' ' 101' ' ' GLN . 7.5 t70 63.72 61.71 0.97 Allowed 'General case' 0 C--O 1.235 0.332 0 O-C-N 121.827 -0.545 . . . . 20.0 112.284 -177.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.93 158.62 29.52 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.134 -1.186 . . . . 20.0 110.134 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 167' ' ' ARG . . . . . 0.582 ' HB3' HH12 ' K' ' 102' ' ' ARG . 0.0 OUTLIER -142.43 148.32 37.59 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 107.722 -1.214 . . . . 20.0 107.722 170.618 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -95.01 117.63 30.47 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.145 -0.934 . . . . 20.0 110.191 -167.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 169' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -129.42 159.76 35.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 121.896 0.855 . . . . 20.0 109.986 177.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.4 117.15 34.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.268 -1.333 . . . . 20.0 109.508 -173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.88 151.61 28.94 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.521 -0.548 . . . . 20.0 109.521 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 172' ' ' GLY . . . . . 0.594 ' O ' ' N ' ' I' ' 175' ' ' ARG . . . 56.97 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 109.215 -1.554 . . . . 20.0 109.215 -171.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.91 4.27 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 112.773 0.657 . . . . 20.0 112.773 -174.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.11 -62.99 1.3 Allowed 'General case' 0 C--O 1.235 0.31 0 C-N-CA 119.703 -0.799 . . . . 20.0 111.236 157.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 175' ' ' ARG . . . . . 0.594 ' N ' ' O ' ' I' ' 172' ' ' GLY . 6.8 ptt-85 -169.8 121.97 0.7 Allowed 'General case' 0 C--O 1.232 0.139 0 CA-C-N 118.609 0.64 . . . . 20.0 112.634 172.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.49 169.4 0.34 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 127.836 2.454 . . . . 20.0 106.213 157.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 177' ' ' VAL . . . . . . . . . . . . . 45.9 t -144.7 145.82 20.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 N-CA-C 108.418 -0.956 . . . . 20.0 108.418 177.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 178' ' ' SER . . . . . . . . . . . . . 46.5 t -78.17 -64.44 1.16 Allowed 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 116.41 2.004 . . . . 20.0 116.41 -165.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.81 22.35 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-N 118.736 0.698 . . . . 20.0 112.094 -171.023 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.15 -0.65 36.9 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 114.362 1.245 . . . . 20.0 114.362 -170.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 181' ' ' PHE . . . . . 0.733 ' HB3' ' HB3' ' I' ' 327' ' ' GLU . 3.2 t80 -84.67 -66.93 0.84 Allowed 'General case' 0 C--O 1.236 0.384 0 CA-C-N 118.606 0.639 . . . . 20.0 111.768 -162.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 182' ' ' ASP . . . . . . . . . . . . . 34.0 t0 -80.24 127.86 32.84 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 122.069 0.938 . . . . 20.0 110.715 -152.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' I' ' 70' ' ' ASP . 0.6 OUTLIER 69.94 -6.73 1.03 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.374 1.47 . . . . 20.0 113.199 174.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 184' ' ' ARG . . . . . 0.529 ' NH1' HD13 ' I' ' 29' ' ' ILE . 0.0 OUTLIER -153.78 83.87 1.16 Allowed 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 122.155 0.978 . . . . 20.0 110.805 157.144 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 185' ' ' ILE . . . . . 0.439 HG12 HG11 ' I' ' 317' ' ' VAL . 1.0 OUTLIER -126.07 -41.12 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 104.524 -2.399 . . . . 20.0 104.524 149.912 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 186' ' ' ALA . . . . . 0.723 ' O ' ' OG1' ' I' ' 189' ' ' THR . . . -50.2 -42.88 52.18 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 115.336 -0.847 . . . . 20.0 111.536 173.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.95 -36.05 76.56 Favored 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 119.247 -0.981 . . . . 20.0 110.096 -178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.84 -38.62 91.77 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 119.173 -1.011 . . . . 20.0 110.471 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 189' ' ' THR . . . . . 0.723 ' OG1' ' O ' ' I' ' 186' ' ' ALA . 25.2 p -59.14 -48.56 81.17 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 119.456 -0.898 . . . . 20.0 110.886 172.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 190' ' ' ILE . . . . . . . . . . . . . 12.9 mt -55.3 -50.59 63.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-O 120.954 0.407 . . . . 20.0 110.53 178.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.03 -43.21 96.28 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 120.058 -0.657 . . . . 20.0 111.0 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 192' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -63.85 -36.56 84.32 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 119.955 -0.698 . . . . 20.0 110.329 177.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 193' ' ' VAL . . . . . 0.407 HG23 ' O ' ' I' ' 189' ' ' THR . 11.5 t -60.55 -44.82 97.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 CA-C-O 121.081 0.467 . . . . 20.0 110.104 177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.07 -33.36 75.59 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.28 -0.568 . . . . 20.0 111.171 -176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.59 -38.14 70.92 Favored 'General case' 0 C--O 1.236 0.367 0 C-N-CA 119.854 -0.738 . . . . 20.0 110.799 175.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.71 -26.15 40.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.538 0.57 . . . . 20.0 112.538 -175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.51 122.75 27.4 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.349 -0.612 . . . . 20.0 109.349 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.38 -57.13 2.32 Favored 'General case' 0 C--O 1.234 0.247 0 O-C-N 123.323 0.389 . . . . 20.0 110.135 176.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.37 17.5 Favored 'General case' 0 C--O 1.235 0.339 0 N-CA-C 109.7 -0.482 . . . . 20.0 109.7 -172.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.05 91.26 4.25 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.18 -0.674 . . . . 20.0 109.18 -173.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.76 -14.5 59.92 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 119.985 -0.686 . . . . 20.0 111.378 176.375 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.85 141.67 30.45 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.894 -0.78 . . . . 20.0 108.894 172.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 203' ' ' ASP . . . . . 0.657 ' N ' ' OD1' ' I' ' 203' ' ' ASP . 0.0 OUTLIER -78.66 113.05 16.37 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.451 -0.944 . . . . 20.0 108.451 -174.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.97 151.53 6.15 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 N-CA-C 108.557 -0.905 . . . . 20.0 108.557 -170.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 205' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -128.89 106.67 9.06 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.004 -0.739 . . . . 20.0 109.004 173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -83.0 125.42 31.41 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.709 -0.849 . . . . 20.0 108.709 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 207' ' ' VAL . . . . . 0.709 HG12 HD13 ' I' ' 53' ' ' ILE . 34.1 m -119.92 150.22 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.352 0 N-CA-C 108.848 -0.797 . . . . 20.0 108.848 174.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.8 5.19 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.412 -1.329 . . . . 20.0 107.412 171.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.87 159.98 19.55 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.872 0.844 . . . . 20.0 111.075 -165.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.78 166.44 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-N 114.648 -1.16 . . . . 20.0 108.236 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.61 40.16 29.47 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 114.786 -1.097 . . . . 20.0 111.502 -179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.98 -49.56 13.84 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 120.347 -0.541 . . . . 20.0 110.928 176.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.35 -20.36 64.71 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.468 -173.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 214' ' ' VAL . . . . . . . . . . . . . 89.0 t -131.11 121.11 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.424 0 N-CA-C 108.589 -0.893 . . . . 20.0 108.589 173.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.12 60.9 6.26 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.682 -1.247 . . . . 20.0 111.397 -174.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 216' ' ' LEU . . . . . 0.437 HD23 ' H ' ' I' ' 216' ' ' LEU . 0.5 OUTLIER -47.03 -25.53 0.84 Allowed 'General case' 0 C--O 1.235 0.318 0 N-CA-C 113.501 0.926 . . . . 20.0 113.501 -179.122 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 217' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -63.49 -4.5 2.85 Favored 'General case' 0 C--O 1.234 0.275 0 N-CA-C 112.347 0.499 . . . . 20.0 112.347 173.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.58 40.89 Favored Glycine 0 C--N 1.337 0.624 0 C-N-CA 119.739 -1.22 . . . . 20.0 111.969 168.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 219' ' ' ALA . . . . . 0.442 ' O ' ' OG ' ' I' ' 222' ' ' SER . . . -65.26 -36.97 85.76 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.307 -0.525 . . . . 20.0 111.41 179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 220' ' ' ARG . . . . . 0.403 ' HB2' ' HB1' ' I' ' 302' ' ' ALA . 16.5 ttm180 -52.76 -36.75 58.44 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 112.156 0.428 . . . . 20.0 112.156 -174.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 221' ' ' THR . . . . . . . . . . . . . 74.9 p -58.4 -45.79 87.67 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.015 -0.674 . . . . 20.0 110.866 -173.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 222' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' I' ' 219' ' ' ALA . 2.1 p -58.04 -35.81 71.84 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.8 -0.36 . . . . 20.0 111.416 175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.65 -49.97 69.3 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 112.56 0.578 . . . . 20.0 112.56 -169.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 224' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.23 -33.36 75.63 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.778 -0.769 . . . . 20.0 111.804 -165.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.99 -16.72 75.0 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.091 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 226' ' ' ILE . . . . . . . . . . . . . 25.3 mm -126.97 -45.67 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.298 0 N-CA-C 111.985 0.365 . . . . 20.0 111.985 -158.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 227' ' ' GLU . . . . . 0.471 ' OE1' ' OG1' ' I' ' 306' ' ' THR . 3.0 pt-20 -56.36 -46.73 99.77 Favored Pre-proline 0 C--O 1.236 0.382 0 N-CA-C 118.241 2.682 . . . . 20.0 118.241 -158.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 228' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_exo -43.86 143.73 2.85 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.977 1.491 . . . . 20.0 115.977 -134.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.12 -4.73 0.78 Allowed 'General case' 0 C--O 1.223 -0.331 0 C-N-CA 125.283 1.433 . . . . 20.0 113.382 162.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.105 -0.638 . . . . 20.0 111.774 167.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.46 151.46 16.41 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.928 -0.653 . . . . 20.0 112.266 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.72 15.56 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 123.817 0.847 . . . . 20.0 108.797 178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.65 149.03 23.34 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.127 -0.488 . . . . 20.0 110.438 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' I' ' 341' ' ' MET . 51.6 mt -133.15 90.44 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.581 -1.266 . . . . 20.0 107.581 172.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 235' ' ' ASP . . . . . 0.49 ' OD1' ' NE2' ' I' ' 68' ' ' HIS . 25.4 t0 -135.16 173.25 11.93 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.981 -1.488 . . . . 20.0 106.981 173.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.15 149.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.636 0.732 . . . . 20.0 111.447 -172.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 237' ' ' THR . . . . . 0.459 HG21 ' HA3' ' I' ' 296' ' ' GLY . 9.2 t -165.64 122.68 1.45 Allowed 'General case' 0 C--O 1.234 0.244 0 N-CA-C 107.356 -1.35 . . . . 20.0 107.356 164.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 238' ' ' ILE . . . . . 0.41 HD13 ' O ' ' I' ' 237' ' ' THR . 18.0 mm -145.48 151.85 14.72 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 108.249 -1.019 . . . . 20.0 108.249 -161.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.19 105.2 9.69 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 106.923 -1.51 . . . . 20.0 106.923 158.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.47 110.01 18.66 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.37 36.18 22.29 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.959 1.304 . . . . 20.0 112.463 158.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.97 128.45 78.86 Favored Pre-proline 0 C--N 1.322 -0.625 0 N-CA-C 105.16 -2.163 . . . . 20.0 105.16 -177.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -61.02 165.57 12.05 Favored 'Trans proline' 0 CA--C 1.516 -0.419 0 CA-C-N 120.857 1.342 . . . . 20.0 112.369 -179.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.36 -5.28 44.86 Favored Glycine 0 N--CA 1.442 -0.922 0 CA-C-N 115.081 -0.963 . . . . 20.0 114.904 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 245' ' ' THR . . . . . . . . . . . . . 33.6 p -92.09 164.56 22.89 Favored Pre-proline 0 N--CA 1.453 -0.325 0 CA-C-N 118.643 1.221 . . . . 20.0 110.724 177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 246' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.05 -172.61 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.569 0 CA-C-O 121.893 0.706 . . . . 20.0 111.925 171.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.85 59.54 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 114.725 -1.125 . . . . 20.0 111.992 179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 248' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 -70.22 -18.71 63.17 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 119.824 -0.751 . . . . 20.0 112.882 -171.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 249' ' ' LYS . . . . . 0.714 ' O ' ' OG1' ' I' ' 252' ' ' THR . 16.9 mttt -98.76 -15.13 19.43 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.229 0.825 . . . . 20.0 113.229 170.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.07 -37.87 89.02 Favored 'General case' 0 C--O 1.232 0.138 0 C-N-CA 120.306 -0.558 . . . . 20.0 111.337 -172.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.63 -20.99 25.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 C-N-CA 119.087 -1.045 . . . . 20.0 111.88 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 252' ' ' THR . . . . . 0.714 ' OG1' ' O ' ' I' ' 249' ' ' LYS . 39.5 p -57.11 -31.85 65.71 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.467 0.576 . . . . 20.0 111.352 173.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 253' ' ' HIS . . . . . 0.548 ' CD2' ' HB2' ' I' ' 319' ' ' ALA . 16.6 t-80 -162.39 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.317 0.58 . . . . 20.0 110.382 176.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.39 -1.31 3.96 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.974 -1.012 . . . . 20.0 112.306 175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.37 35.9 5.83 Favored Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 126.151 1.834 . . . . 20.0 111.566 -177.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.22 10.18 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.67 -0.863 . . . . 20.0 108.67 -167.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.15 174.23 3.42 Favored Glycine 0 N--CA 1.438 -1.222 0 CA-C-O 122.695 1.164 . . . . 20.0 113.307 169.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.79 175.16 6.06 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.538 -0.912 . . . . 20.0 108.538 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 259' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' I' ' 316' ' ' SER . . . -126.4 120.3 29.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.122 -0.944 . . . . 20.0 109.399 -169.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.01 139.98 19.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 107.807 -1.183 . . . . 20.0 107.807 175.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 261' ' ' LYS . . . . . 0.763 ' HE3' HG21 ' I' ' 298' ' ' THR . 1.9 mtmm -98.89 122.59 42.33 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.971 -0.751 . . . . 20.0 108.971 -177.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.22 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.375 0 CA-C-N 115.876 -0.602 . . . . 20.0 109.647 173.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.63 147.52 34.46 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.35 -0.611 . . . . 20.0 109.35 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.11 -169.94 2.85 Favored 'General case' 0 N--CA 1.442 -0.858 0 CA-C-N 114.804 -1.089 . . . . 20.0 108.243 165.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.99 -56.27 21.57 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.822 -0.626 . . . . 20.0 110.261 163.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.86 -46.17 11.58 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 113.703 1.001 . . . . 20.0 113.703 -165.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.77 143.67 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.373 -0.603 . . . . 20.0 109.373 -163.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.28 104.0 14.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 106.117 -1.808 . . . . 20.0 106.117 171.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 269' ' ' CYS . . . . . . . . . . . . . 69.5 m -66.29 137.02 56.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.214 0.53 . . . . 20.0 111.379 -171.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.03 109.66 1.97 Allowed Pre-proline 0 C--N 1.323 -0.57 0 CA-C-N 115.211 -0.904 . . . . 20.0 108.72 177.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.47 -19.98 48.4 Favored 'Trans proline' 0 CA--C 1.513 -0.561 0 N-CA-C 114.832 1.051 . . . . 20.0 114.832 -160.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -43.01 74.63 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.11 -0.636 . . . . 20.0 110.579 176.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 273' ' ' ILE . . . . . . . . . . . . . 72.5 mt -55.55 -48.33 77.54 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-O 121.098 0.475 . . . . 20.0 110.123 175.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 274' ' ' VAL . . . . . . . . . . . . . 13.2 t -59.21 -52.47 60.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-O 120.82 0.343 . . . . 20.0 110.674 -176.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.38 -31.92 70.81 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 119.818 -0.753 . . . . 20.0 110.509 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 276' ' ' TRP . . . . . 0.493 ' HH2' ' HB3' ' I' ' 347' ' ' ASN . 0.1 OUTLIER -68.47 -48.0 65.64 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 120.106 -0.638 . . . . 20.0 111.01 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.01 -38.73 89.73 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 120.046 -0.662 . . . . 20.0 110.759 177.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.64 -48.0 78.5 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.624 -0.431 . . . . 20.0 110.037 174.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.79 -40.45 88.36 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.701 175.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.31 -44.91 78.03 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.292 -0.563 . . . . 20.0 111.109 -172.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.008 -0.677 . . . . 20.0 111.032 -175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 282' ' ' LYS . . . . . . . . . . . . . 38.7 mttt -72.48 -31.76 65.66 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.118 178.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.73 73.29 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 119.898 -0.721 . . . . 20.0 110.976 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.55 15.42 29.3 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 113.324 0.861 . . . . 20.0 113.324 178.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 285' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 63.82 32.16 13.62 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 121.733 0.778 . . . . 20.0 111.586 173.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.33 143.41 34.35 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.3 -1.0 . . . . 20.0 108.3 -178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 287' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -83.21 149.33 13.39 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 CA-C-N 119.193 0.747 . . . . 20.0 111.346 175.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.0 148.14 23.41 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.636 -0.711 . . . . 20.0 109.689 -179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -113.94 175.13 5.6 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.71 -1.219 . . . . 20.0 107.71 168.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.63 113.78 17.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.882 -1.155 . . . . 20.0 107.882 167.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.99 144.65 43.8 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.447 -0.575 . . . . 20.0 109.447 -172.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.02 157.03 25.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 107.68 -1.23 . . . . 20.0 107.68 173.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.53 168.72 12.23 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.517 0.675 . . . . 20.0 110.282 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.81 -18.53 21.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.814 -1.085 . . . . 20.0 112.117 165.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.6 -176.01 20.05 Favored Glycine 0 N--CA 1.449 -0.476 0 N-CA-C 110.99 -0.844 . . . . 20.0 110.99 -176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 296' ' ' GLY . . . . . 0.459 ' HA3' HG21 ' I' ' 237' ' ' THR . . . 101.47 144.79 15.6 Favored Glycine 0 N--CA 1.448 -0.547 0 CA-C-N 114.638 -0.781 . . . . 20.0 112.691 -178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.51 4.06 Favored Glycine 0 N--CA 1.45 -0.37 0 N-CA-C 110.36 -1.096 . . . . 20.0 110.36 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 298' ' ' THR . . . . . 0.763 HG21 ' HE3' ' I' ' 261' ' ' LYS . 20.4 p -110.23 172.92 6.58 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 122.004 0.907 . . . . 20.0 111.397 -174.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.95 -33.63 76.49 Favored 'General case' 0 C--O 1.237 0.407 0 CA-C-N 114.37 -1.286 . . . . 20.0 111.264 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.57 -35.4 74.19 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 111.777 0.288 . . . . 20.0 111.777 -171.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.22 96.85 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.211 -0.995 . . . . 20.0 112.032 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 302' ' ' ALA . . . . . 0.403 ' HB1' ' HB2' ' I' ' 220' ' ' ARG . . . -68.2 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.193 -0.603 . . . . 20.0 111.215 179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.84 -34.49 56.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.384 0 C-N-CA 120.044 -0.662 . . . . 20.0 110.171 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.23 60.14 Favored 'General case' 0 CA--C 1.517 -0.3 0 N-CA-C 113.309 0.855 . . . . 20.0 113.309 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 305' ' ' LEU . . . . . 0.461 HD21 ' HD3' ' G' ' 217' ' ' ARG . 4.1 mp -103.74 -8.93 19.48 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 113.675 0.991 . . . . 20.0 113.675 -167.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 306' ' ' THR . . . . . 0.471 ' OG1' ' OE1' ' I' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.58 8.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.588 0.708 . . . . 20.0 110.572 171.941 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.62 -29.92 70.36 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 113.378 0.881 . . . . 20.0 113.378 -161.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.9 -25.17 66.25 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 119.664 -0.814 . . . . 20.0 111.236 -178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.75 65.2 1.93 Allowed Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.827 -0.701 . . . . 20.0 113.332 -171.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 310' ' ' VAL . . . . . . . . . . . . . 20.3 t -80.37 139.61 52.02 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 117.571 0.686 . . . . 20.0 111.105 -163.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 311' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -84.47 141.71 9.04 Favored 'Trans proline' 0 CA--C 1.513 -0.538 0 CA-C-N 119.453 0.84 . . . . 20.0 110.058 168.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 312' ' ' THR . . . . . . . . . . . . . 25.4 m -140.47 135.79 32.32 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.31 -0.859 . . . . 20.0 111.212 -169.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.61 162.56 12.34 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 109.161 -1.576 . . . . 20.0 109.161 164.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.06 27.43 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 121.465 0.65 . . . . 20.0 110.066 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.05 153.23 21.11 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.622 -1.172 . . . . 20.0 109.211 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 316' ' ' SER . . . . . 0.409 ' N ' ' O ' ' I' ' 259' ' ' ALA . 4.2 m -138.46 133.51 32.84 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.256 -0.884 . . . . 20.0 109.459 -178.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 317' ' ' VAL . . . . . 0.439 HG11 HG12 ' I' ' 185' ' ' ILE . 92.4 t -99.46 108.56 51.18 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 107.245 -1.391 . . . . 20.0 107.245 177.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.27 -169.01 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.722 0 CA-C-O 122.638 1.016 . . . . 20.0 113.614 -154.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 319' ' ' ALA . . . . . 0.548 ' HB2' ' CD2' ' I' ' 253' ' ' HIS . . . 79.8 35.44 0.15 Allowed 'General case' 0 CA--C 1.517 -0.315 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.29 161.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 320' ' ' ARG . . . . . 0.432 ' HG3' ' O ' ' I' ' 321' ' ' TYR . 0.4 OUTLIER -75.59 157.62 33.56 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.712 0.768 . . . . 20.0 110.082 176.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 321' ' ' TYR . . . . . 0.432 ' O ' ' HG3' ' I' ' 320' ' ' ARG . 3.3 m-85 -113.14 166.18 11.68 Favored 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 106.805 -1.554 . . . . 20.0 106.805 160.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.23 113.65 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 124.196 0.999 . . . . 20.0 108.383 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 323' ' ' HIS . . . . . . . . . . . . . 34.6 p-80 -61.56 -7.41 3.23 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 114.463 1.283 . . . . 20.0 114.463 -140.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 324' ' ' SER . . . . . 0.591 ' OG ' HG21 ' I' ' 97' ' ' THR . 0.1 OUTLIER -59.5 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.642 0.608 . . . . 20.0 112.642 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 325' ' ' ASN . . . . . 0.426 ' HB2' ' HA ' ' K' ' 100' ' ' ALA . 35.1 p-10 -102.03 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 115.017 1.488 . . . . 20.0 115.017 -152.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.57 150.97 50.79 Favored 'General case' 0 CA--C 1.509 -0.633 0 N-CA-C 107.447 -1.316 . . . . 20.0 107.447 174.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 327' ' ' GLU . . . . . 0.733 ' HB3' ' HB3' ' I' ' 181' ' ' PHE . 82.7 mt-10 -142.57 52.81 1.42 Allowed 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 113.849 -1.523 . . . . 20.0 109.932 -153.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.09 149.44 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-O 121.429 0.633 . . . . 20.0 111.919 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 329' ' ' VAL . . . . . 0.412 HG13 ' HB2' ' I' ' 181' ' ' PHE . 0.3 OUTLIER -139.37 179.44 2.95 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-O 121.909 0.862 . . . . 20.0 109.463 175.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.56 119.19 27.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.614 -1.175 . . . . 20.0 108.85 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.12 -32.07 53.98 Favored 'General case' 0 C--O 1.235 0.308 0 O-C-N 123.821 0.7 . . . . 20.0 111.449 179.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 332' ' ' ARG . . . . . . . . . . . . . 10.4 mtm180 -68.66 -44.77 73.38 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.334 -0.546 . . . . 20.0 110.167 -175.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.04 -44.9 83.28 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.748 -0.381 . . . . 20.0 111.074 -172.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.64 -41.29 92.1 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 C-N-CA 120.43 -0.508 . . . . 20.0 110.497 -173.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.68 71.46 Favored 'General case' 0 C--O 1.237 0.403 0 C-N-CA 118.836 -1.146 . . . . 20.0 110.096 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.45 -40.4 93.18 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.413 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.55 -43.83 80.32 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-O 120.79 0.329 . . . . 20.0 110.917 176.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 338' ' ' VAL . . . . . 0.699 ' O ' ' OG1' ' I' ' 342' ' ' THR . 42.5 t -60.24 -48.91 86.23 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-O 120.956 0.407 . . . . 20.0 110.23 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 339' ' ' GLU . . . . . 0.79 ' OE1' ' NZ ' ' I' ' 343' ' ' LYS . 1.3 mm-40 -54.81 -46.96 74.59 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-O 121.028 0.442 . . . . 20.0 110.738 179.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.82 -55.16 37.74 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-N 116.363 -0.38 . . . . 20.0 111.414 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' I' ' 234' ' ' ILE . 31.9 tpp -60.14 -40.34 89.46 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.864 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 342' ' ' THR . . . . . 0.699 ' OG1' ' O ' ' I' ' 338' ' ' VAL . 1.3 m -56.57 -44.93 81.48 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.112 0.482 . . . . 20.0 110.42 -177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 343' ' ' LYS . . . . . 0.79 ' NZ ' ' OE1' ' I' ' 339' ' ' GLU . 34.6 mttp -74.21 -37.5 63.86 Favored 'General case' 0 C--O 1.238 0.494 0 C-N-CA 119.967 -0.693 . . . . 20.0 110.726 -178.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.84 -42.45 97.78 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.582 -0.447 . . . . 20.0 111.142 -179.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 345' ' ' LEU . . . . . 0.419 ' O ' HG22 ' I' ' 348' ' ' ILE . 1.0 OUTLIER -59.02 -50.44 74.09 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 120.577 -0.449 . . . . 20.0 110.801 -179.048 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.03 90.92 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 119.668 -0.813 . . . . 20.0 110.619 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 347' ' ' ASN . . . . . 0.493 ' HB3' ' HH2' ' I' ' 276' ' ' TRP . 5.0 m-20 -84.54 4.84 30.14 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.399 -0.92 . . . . 20.0 112.517 -178.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 348' ' ' ILE . . . . . 0.419 HG22 ' O ' ' I' ' 345' ' ' LEU . 1.3 tt -65.22 -23.67 33.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.539 -0.864 . . . . 20.0 110.883 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' I' I ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.76 -27.37 69.15 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.756 -0.778 . . . . 20.0 111.211 -175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.84 -18.8 31.86 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 122.159 -0.338 . . . . 20.0 111.493 177.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 351' ' ' LEU . . . . . 0.439 ' O ' HD12 ' I' ' 351' ' ' LEU . 0.1 OUTLIER -69.81 -28.75 65.97 Favored 'General case' 0 C--O 1.233 0.195 0 N-CA-C 112.129 0.418 . . . . 20.0 112.129 -173.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' I' I ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.13 -26.66 0.1 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 116.038 1.866 . . . . 20.0 116.038 -169.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' I' I ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 125.007 1.323 . . . . 20.0 108.401 -174.719 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 114.293 1.22 . . . . 20.0 114.293 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.06 82.13 2.91 Favored 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 106.934 -1.506 . . . . 20.0 106.934 -170.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 3' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.87 -34.52 66.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 CA-C-N 114.917 -1.038 . . . . 20.0 110.223 178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 4' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 -106.99 -23.52 12.3 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 113.615 0.968 . . . . 20.0 113.615 -179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.44 30.27 19.94 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.123 0.969 . . . . 20.0 111.621 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.84 -38.71 32.24 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 117.785 0.266 . . . . 20.0 111.207 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.09 117.45 37.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 N-CA-C 107.667 -1.234 . . . . 20.0 107.667 -178.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.92 112.21 12.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.285 0.564 . . . . 20.0 110.919 -174.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.76 -31.49 72.68 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 115.448 -0.797 . . . . 20.0 111.884 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.12 -45.21 74.27 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 120.553 -0.459 . . . . 20.0 111.233 178.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.77 -43.13 97.29 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 120.985 -0.286 . . . . 20.0 111.18 -172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.9 -30.5 70.92 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 120.719 -0.392 . . . . 20.0 111.184 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.87 -46.41 90.71 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.551 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.02 -42.95 91.38 Favored 'General case' 0 C--O 1.236 0.363 0 CA-C-N 116.639 -0.255 . . . . 20.0 111.545 -174.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 15' ' ' VAL . . . . . . . . . . . . . 16.3 m -77.89 -40.08 26.59 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 119.518 -0.873 . . . . 20.0 110.645 -171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 119.03 -1.068 . . . . 20.0 111.029 -162.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.1 -26.0 68.02 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 119.937 -0.705 . . . . 20.0 111.291 174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.95 160.39 70.2 Favored Pre-proline 0 N--CA 1.448 -0.537 0 C-N-CA 120.489 -0.484 . . . . 20.0 109.822 -175.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 19' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -85.11 144.77 9.58 Favored 'Trans proline' 0 C--N 1.329 -0.475 0 C-N-CA 120.287 0.658 . . . . 20.0 112.158 -172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.97 38.23 3.41 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 117.248 1.659 . . . . 20.0 117.248 -159.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.77 119.83 2.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 159.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.11 171.23 8.87 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 121.333 0.587 . . . . 20.0 110.721 -166.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.91 -33.25 2.88 Favored Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.525 -0.762 . . . . 20.0 114.051 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.31 -178.34 0.17 Allowed 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.305 1.05 . . . . 20.0 109.515 172.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.96 -13.14 4.0 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 114.836 -1.075 . . . . 20.0 113.438 169.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 26' ' ' PHE . . . . . 0.49 ' O ' ' N ' ' J' ' 28' ' ' GLY . 0.0 OUTLIER -88.05 9.06 23.78 Favored 'General case' 0 C--N 1.345 0.399 0 CA-C-N 119.699 1.136 . . . . 20.0 113.705 178.571 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.64 11.27 0.05 Allowed 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 28' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' J' ' 26' ' ' PHE . . . -53.08 -26.94 29.31 Favored Glycine 0 C--N 1.342 0.901 0 N-CA-C 116.025 1.17 . . . . 20.0 116.025 -172.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 29' ' ' ILE . . . . . 0.529 HD13 ' NH1' ' J' ' 184' ' ' ARG . 1.1 tt -59.58 -35.79 61.35 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 CA-C-N 118.079 0.939 . . . . 20.0 110.621 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.29 -52.46 61.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 120.902 0.382 . . . . 20.0 110.396 178.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.27 -40.6 74.51 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.287 -0.415 . . . . 20.0 110.963 177.115 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -63.26 -49.55 82.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 CA-C-O 121.031 0.443 . . . . 20.0 110.287 -174.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 33' ' ' VAL . . . . . . . . . . . . . 53.9 t -64.27 -39.71 86.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 119.729 -0.788 . . . . 20.0 110.304 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 34' ' ' ILE . . . . . . . . . . . . . 8.3 pt -75.78 -29.48 20.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.364 0 C-N-CA 118.724 -1.19 . . . . 20.0 111.09 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.47 -30.97 71.64 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 117.979 0.354 . . . . 20.0 111.144 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.94 -56.69 3.27 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 112.243 0.46 . . . . 20.0 112.243 177.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.33 -28.44 44.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.447 -0.342 . . . . 20.0 111.521 -164.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.44 63.74 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.911 -0.716 . . . . 20.0 112.202 -162.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.05 -23.52 63.1 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 118.914 -1.115 . . . . 20.0 111.744 -177.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 40' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -101.9 -6.92 22.93 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 113.512 0.93 . . . . 20.0 113.512 -176.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.56 152.62 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.544 -0.91 . . . . 20.0 108.544 -176.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.6 88.93 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 115.175 -0.92 . . . . 20.0 111.467 -175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.62 158.3 35.25 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 108.524 -0.917 . . . . 20.0 108.524 -173.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 44' ' ' VAL . . . . . . . . . . . . . 3.4 p -149.5 147.16 16.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 N-CA-C 108.233 -1.025 . . . . 20.0 108.233 -174.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.13 159.26 44.12 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.438 0.637 . . . . 20.0 110.466 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 46' ' ' VAL . . . . . . . . . . . . . 61.2 t -117.06 128.93 74.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 107.399 -1.334 . . . . 20.0 107.399 179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.24 -176.16 5.84 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.789 0.804 . . . . 20.0 108.929 177.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.59 -34.57 62.9 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.908 -0.717 . . . . 20.0 111.145 -176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.17 10.89 9.12 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 113.718 1.007 . . . . 20.0 113.718 -171.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.51 -6.7 83.31 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-O 119.138 -0.812 . . . . 20.0 114.483 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.11 151.47 35.57 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 118.433 1.117 . . . . 20.0 110.245 173.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.42 140.26 33.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.119 -1.437 . . . . 20.0 107.119 176.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 53' ' ' ILE . . . . . 0.71 HD13 HG12 ' J' ' 207' ' ' VAL . 31.2 mm -130.23 115.62 33.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.91 119.85 36.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.639 -0.504 . . . . 20.0 109.639 174.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -114.0 100.0 8.08 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.565 -0.902 . . . . 20.0 108.565 -173.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.69 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 106.742 -1.577 . . . . 20.0 106.742 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.51 154.51 20.27 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 123.525 0.516 . . . . 20.0 109.667 -175.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.13 23.82 Favored Glycine 0 N--CA 1.45 -0.415 0 N-CA-C 111.13 -0.788 . . . . 20.0 111.13 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.08 105.62 10.44 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.892 0.877 . . . . 20.0 109.039 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.04 -168.52 33.5 Favored Glycine 0 N--CA 1.443 -0.855 0 C-N-CA 120.76 -0.733 . . . . 20.0 114.064 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 61' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -70.77 165.2 32.89 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.78 0.658 . . . . 20.0 112.08 179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 62' ' ' LYS . . . . . . . . . . . . . 53.3 mttt -91.94 111.37 22.89 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.001 -0.999 . . . . 20.0 109.207 -176.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.69 137.92 30.29 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 N-CA-C 108.773 -0.825 . . . . 20.0 108.773 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 64' ' ' MET . . . . . . . . . . . . . 28.0 ttt -118.79 124.08 46.36 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.038 0.935 . . . . 20.0 109.034 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 65' ' ' ILE . . . . . . . . . . . . . 29.4 mm -116.23 114.31 45.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 N-CA-C 108.118 -1.067 . . . . 20.0 108.118 -176.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.64 124.57 51.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 123.285 0.366 . . . . 20.0 110.977 -168.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.61 45.93 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 123.857 0.863 . . . . 20.0 108.942 167.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' J' ' 235' ' ' ASP . 0.0 OUTLIER -105.01 146.45 29.04 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.963 -0.562 . . . . 20.0 110.523 177.46 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.27 5.87 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.257 -0.883 . . . . 20.0 109.702 -178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 70' ' ' ASP . . . . . 0.539 ' N ' ' OD1' ' J' ' 183' ' ' ASP . 12.1 t0 -97.42 68.01 2.14 Favored 'General case' 0 CA--C 1.517 -0.311 0 O-C-N 121.649 -0.657 . . . . 20.0 112.439 178.033 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.28 144.85 28.66 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 108.241 -1.022 . . . . 20.0 108.241 178.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.77 148.81 6.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 123.743 0.817 . . . . 20.0 109.133 -178.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 73' ' ' GLY . . . . . 0.47 ' C ' HD23 ' J' ' 74' ' ' LEU . . . -155.82 -175.72 27.14 Favored Glycine 0 N--CA 1.445 -0.745 0 N-CA-C 110.591 -1.004 . . . . 20.0 110.591 173.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 74' ' ' LEU . . . . . 0.47 HD23 ' C ' ' J' ' 73' ' ' GLY . 5.0 mt -125.01 161.48 26.63 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 121.295 0.569 . . . . 20.0 110.038 178.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 75' ' ' MET . . . . . 0.526 ' HB2' HG23 ' J' ' 160' ' ' THR . 10.6 ttm -128.12 131.34 49.0 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 124.208 1.003 . . . . 20.0 109.711 -174.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.49 137.14 23.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 N-CA-C 108.85 -0.796 . . . . 20.0 108.85 168.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.15 -29.33 7.0 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 113.09 0.774 . . . . 20.0 113.09 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.46 13.72 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.118 -1.068 . . . . 20.0 108.118 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.96 19.59 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.369 -0.974 . . . . 20.0 108.369 -175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 166.29 5.67 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-O 121.798 0.808 . . . . 20.0 109.986 173.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.5 -27.08 60.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 119.724 -0.79 . . . . 20.0 112.691 -169.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.5 9.16 4.21 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.356 0.873 . . . . 20.0 113.356 -177.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.69 81.9 Favored Glycine 0 N--CA 1.443 -0.837 0 CA-C-O 119.006 -0.886 . . . . 20.0 115.106 -178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 84' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -107.72 145.01 34.04 Favored 'General case' 0 N--CA 1.452 -0.373 0 CA-C-N 118.379 1.09 . . . . 20.0 110.262 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 85' ' ' LEU . . . . . . . . . . . . . 7.1 mp -95.85 142.48 28.05 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.305 -0.862 . . . . 20.0 112.571 -172.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.46 174.66 6.56 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.85 -1.167 . . . . 20.0 107.85 158.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.77 163.79 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.398 0 CA-C-O 121.606 0.717 . . . . 20.0 109.47 -170.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.26 129.31 15.59 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-N 114.994 -1.003 . . . . 20.0 109.804 171.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 89' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -79.85 160.24 24.41 Favored 'Trans proline' 0 CA--C 1.507 -0.826 0 CA-C-O 122.358 0.899 . . . . 20.0 112.693 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 90' ' ' ILE . . . . . 0.491 HD11 HG21 ' J' ' 160' ' ' THR . 9.3 mt -88.76 150.3 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 113.716 -1.584 . . . . 20.0 107.376 165.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.0 140.91 47.55 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.263 -0.881 . . . . 20.0 112.172 -168.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.19 22.06 Favored Glycine 0 N--CA 1.441 -1.015 0 CA-C-O 118.983 -0.898 . . . . 20.0 115.219 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 93' ' ' VAL . . . . . . . . . . . . . 5.2 p -78.78 152.62 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 118.659 1.229 . . . . 20.0 109.27 -169.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.99 22.19 Favored Pre-proline 0 C--O 1.24 0.589 0 N-CA-C 108.431 -0.952 . . . . 20.0 108.431 173.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 95' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -81.1 -7.89 13.07 Favored 'Trans proline' 0 CA--C 1.514 -0.486 0 CA-C-N 120.574 1.241 . . . . 20.0 114.822 -170.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.28 -15.2 59.69 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 119.192 0.905 . . . . 20.0 111.792 174.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 97' ' ' THR . . . . . 0.581 HG21 ' OG ' ' J' ' 324' ' ' SER . 44.8 p -89.53 35.55 0.82 Allowed 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 123.62 0.768 . . . . 20.0 112.422 178.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 98' ' ' LEU . . . . . 0.677 HD12 ' H ' ' J' ' 99' ' ' ILE . 0.5 OUTLIER -43.21 -66.5 0.37 Allowed 'General case' 0 CA--C 1.52 -0.196 0 C-N-CA 124.984 1.314 . . . . 20.0 113.389 -173.07 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 99' ' ' ILE . . . . . 0.677 ' H ' HD12 ' J' ' 98' ' ' LEU . 1.6 tt -173.14 156.11 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.98 -0.748 . . . . 20.0 108.98 174.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 100' ' ' ALA . . . . . 0.472 ' HA ' ' HB2' ' L' ' 325' ' ' ASN . . . -123.96 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 20.0 111.253 157.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 101' ' ' GLN . . . . . 0.411 ' HB3' HH21 ' J' ' 102' ' ' ARG . 0.0 OUTLIER -169.38 141.64 2.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 176.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 102' ' ' ARG . . . . . 0.457 HH12 ' HB3' ' L' ' 167' ' ' ARG . 0.0 OUTLIER 55.93 74.52 0.38 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 115.22 1.563 . . . . 20.0 115.22 150.551 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 103' ' ' PHE . . . . . 0.577 ' O ' ' N ' ' J' ' 115' ' ' GLY . 0.5 OUTLIER -79.31 134.21 36.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 119.257 0.935 . . . . 20.0 109.415 160.406 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.81 140.35 37.19 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 115.502 -0.772 . . . . 20.0 109.378 -173.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 105' ' ' VAL . . . . . 0.58 HG22 ' CG1' ' J' ' 162' ' ' ILE . 50.7 t -117.42 110.78 32.18 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 N-CA-C 108.206 -1.035 . . . . 20.0 108.206 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 106' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -89.63 83.09 6.27 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.209 -0.293 . . . . 20.0 110.209 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 107' ' ' ILE . . . . . . . . . . . . . 27.1 mt -51.97 -54.26 14.35 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 O-C-N 123.327 0.392 . . . . 20.0 110.278 170.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.53 177.5 10.57 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 108.437 -0.949 . . . . 20.0 108.437 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.03 126.29 27.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.93 -1.032 . . . . 20.0 110.505 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.23 75.02 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-O 118.88 -0.956 . . . . 20.0 115.328 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 111' ' ' LYS . . . . . . . . . . . . . 57.7 mttt -129.0 114.01 15.89 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.489 1.144 . . . . 20.0 108.565 177.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.29 141.53 37.75 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.346 -0.612 . . . . 20.0 109.346 -178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.57 43.56 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 N-CA-C 108.698 -0.853 . . . . 20.0 108.698 172.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.7 149.45 31.19 Favored 'General case' 0 N--CA 1.445 -0.705 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 115' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' J' ' 103' ' ' PHE . . . -147.95 157.76 27.46 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.336 -1.106 . . . . 20.0 110.336 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.7 154.42 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 N-CA-C 108.371 -0.974 . . . . 20.0 108.371 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.28 34.2 1.75 Allowed Glycine 0 N--CA 1.444 -0.803 0 CA-C-N 115.324 -0.853 . . . . 20.0 114.552 -168.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 118' ' ' ALA . . . . . 0.496 ' O ' HD13 ' J' ' 98' ' ' LEU . . . -67.18 -47.9 69.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 114.405 1.261 . . . . 20.0 114.405 -156.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.61 121.17 11.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 119.515 1.052 . . . . 20.0 112.646 -155.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.55 136.13 35.38 Favored Pre-proline 0 C--O 1.24 0.554 0 N-CA-C 102.602 -3.11 . . . . 20.0 102.602 159.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.13 123.79 11.02 Favored 'Trans proline' 0 C--O 1.238 0.52 0 CA-C-N 120.711 1.29 . . . . 20.0 110.596 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.78 149.8 89.92 Favored 'Trans proline' 0 CA--C 1.518 -0.279 0 CA-C-N 119.199 0.75 . . . . 20.0 110.663 177.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.08 165.38 7.15 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.831 0.824 . . . . 20.0 109.945 -178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.82 3.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 108.191 -1.04 . . . . 20.0 108.191 -175.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.89 160.79 19.69 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.826 -0.35 . . . . 20.0 110.765 169.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 126' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -79.83 -43.77 1.52 Allowed Pre-proline 0 C--O 1.237 0.417 0 C-N-CA 124.03 0.932 . . . . 20.0 113.06 -170.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -64.98 -24.91 59.72 Favored 'Trans proline' 0 C--N 1.359 1.129 0 CA-C-N 120.861 1.343 . . . . 20.0 112.012 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 128' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -83.53 -26.51 30.07 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 111.795 0.294 . . . . 20.0 111.795 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -32.02 69.16 Favored 'General case' 0 C--O 1.241 0.608 0 C-N-CA 119.847 -0.741 . . . . 20.0 110.247 168.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 130' ' ' ARG . . . . . 0.409 HH22 ' HB3' ' L' ' 136' ' ' TRP . 10.8 tpt180 -74.71 -36.91 62.71 Favored 'General case' 0 C--O 1.239 0.544 0 N-CA-C 111.969 0.359 . . . . 20.0 111.969 172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 131' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' L' ' 131' ' ' LYS . 35.1 mttt -78.47 90.97 4.48 Favored 'General case' 0 CA--C 1.512 -0.492 0 N-CA-C 109.235 -0.654 . . . . 20.0 109.235 174.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.21 14.34 7.92 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.088 0.403 . . . . 20.0 112.088 175.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.25 142.57 87.22 Favored Pre-proline 0 N--CA 1.445 -0.688 0 N-CA-C 108.495 -0.928 . . . . 20.0 108.495 172.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.73 153.67 75.27 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 CA-C-N 119.621 0.9 . . . . 20.0 112.334 177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.7 153.61 42.76 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.561 -1.2 . . . . 20.0 107.898 177.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 136' ' ' TRP . . . . . 0.412 ' HB3' HH22 ' L' ' 130' ' ' ARG . 0.0 OUTLIER -77.62 -12.3 59.95 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 118.838 -0.601 . . . . 20.0 112.374 -175.246 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 137' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' J' ' 138' ' ' GLN . 14.1 p30 -55.35 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.401 0 CA-C-O 118.918 -0.563 . . . . 20.0 111.378 -175.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 138' ' ' GLN . . . . . 0.426 ' HG3' ' H ' ' J' ' 139' ' ' ILE . 3.9 tp-100 174.69 174.14 0.2 Allowed 'General case' 0 C--O 1.235 0.332 0 N-CA-C 103.087 -2.931 . . . . 20.0 103.087 133.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 139' ' ' ILE . . . . . 0.426 ' H ' ' HG3' ' J' ' 138' ' ' GLN . 1.2 tp -74.84 168.14 2.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 124.097 0.959 . . . . 20.0 108.964 -179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.83 161.5 18.14 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.962 0.905 . . . . 20.0 110.507 177.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 141' ' ' ILE . . . . . 0.42 HD13 HD13 ' J' ' 162' ' ' ILE . 30.1 mt -124.69 147.47 29.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.573 -0.899 . . . . 20.0 108.573 -177.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 142' ' ' ASP . . . . . 0.564 ' OD1' ' N ' ' J' ' 144' ' ' GLY . 0.5 OUTLIER -119.05 134.75 55.01 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.631 0.773 . . . . 20.0 109.609 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.8 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 O-C-N 123.669 0.606 . . . . 20.0 111.816 166.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 144' ' ' GLY . . . . . 0.564 ' N ' ' OD1' ' J' ' 142' ' ' ASP . . . 86.89 -6.61 82.73 Favored Glycine 0 N--CA 1.441 -1.029 0 N-CA-C 115.476 0.95 . . . . 20.0 115.476 172.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.05 143.93 54.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 118.469 1.134 . . . . 20.0 110.323 176.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.24 -20.99 33.52 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 113.63 0.974 . . . . 20.0 113.63 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.35 162.66 40.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.987 0.898 . . . . 20.0 111.395 -173.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.39 -41.53 80.43 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-N 113.847 -1.524 . . . . 20.0 111.207 177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 149' ' ' GLU . . . . . . . . . . . . . 78.7 tt0 -60.4 -47.02 87.9 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.834 -0.346 . . . . 20.0 110.981 -179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 150' ' ' GLU . . . . . . . . . . . . . 42.8 tp10 -61.29 -35.18 76.62 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 120.509 -0.476 . . . . 20.0 110.851 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.79 -40.56 83.94 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 120.066 -0.654 . . . . 20.0 111.086 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.79 -23.36 58.49 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 119.445 -0.902 . . . . 20.0 110.984 -178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.05 66.49 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 119.747 -0.781 . . . . 20.0 110.661 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.54 -40.63 92.26 Favored 'General case' 0 CA--C 1.513 -0.453 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.662 171.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.07 -8.64 6.73 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-O 118.965 -0.908 . . . . 20.0 114.651 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 156' ' ' VAL . . . . . . . . . . . . . 75.2 t -63.76 133.52 29.36 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.3 0 CA-C-N 118.452 1.126 . . . . 20.0 108.545 178.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.87 175.94 9.32 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.72 -1.215 . . . . 20.0 107.72 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.27 147.29 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 107.657 -1.238 . . . . 20.0 107.657 174.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.31 15.71 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 108.853 -1.699 . . . . 20.0 108.853 -176.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 160' ' ' THR . . . . . 0.526 HG23 ' HB2' ' J' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.58 17.69 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.692 -1.225 . . . . 20.0 107.692 165.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.67 -20.0 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.394 0 N-CA-C 113.72 1.008 . . . . 20.0 113.72 -166.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 162' ' ' ILE . . . . . 0.58 ' CG1' HG22 ' J' ' 105' ' ' VAL . 0.5 OUTLIER -111.67 155.64 12.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 O-C-N 121.66 -0.65 . . . . 20.0 111.744 -159.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 163' ' ' THR . . . . . 0.552 ' OG1' ' N ' ' J' ' 164' ' ' TRP . 3.5 t -145.36 -166.37 2.41 Favored 'General case' 0 C--O 1.233 0.22 0 C-N-CA 124.286 1.034 . . . . 20.0 110.421 171.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 164' ' ' TRP . . . . . 0.552 ' N ' ' OG1' ' J' ' 163' ' ' THR . 2.5 t-105 -100.76 -17.89 16.72 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 113.207 0.817 . . . . 20.0 113.207 -160.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 165' ' ' ASP . . . . . 0.425 ' O ' ' NE2' ' L' ' 101' ' ' GLN . 7.5 t70 63.68 61.73 0.97 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 121.214 0.531 . . . . 20.0 112.261 -177.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.92 158.62 29.53 Favored Glycine 0 N--CA 1.448 -0.551 0 N-CA-C 110.05 -1.22 . . . . 20.0 110.05 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 167' ' ' ARG . . . . . 0.509 ' HB3' HH12 ' L' ' 102' ' ' ARG . 0.0 OUTLIER -142.44 148.33 37.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 170.566 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.93 117.61 30.42 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 115.06 -0.973 . . . . 20.0 110.199 -167.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 169' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -129.4 159.83 34.99 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-O 121.858 0.837 . . . . 20.0 110.024 177.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 170' ' ' ARG . . . . . . . . . . . . . 2.7 mtt-85 -102.45 117.23 34.28 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.258 -1.337 . . . . 20.0 109.476 -173.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.94 151.58 29.05 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.53 -0.545 . . . . 20.0 109.53 168.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 172' ' ' GLY . . . . . 0.595 ' O ' ' N ' ' J' ' 175' ' ' ARG . . . 56.93 68.67 1.58 Allowed Glycine 0 N--CA 1.443 -0.851 0 N-CA-C 109.194 -1.562 . . . . 20.0 109.194 -171.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.48 -21.88 4.22 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 112.811 0.671 . . . . 20.0 112.811 -174.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.97 1.31 Allowed 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.681 -0.808 . . . . 20.0 111.215 157.378 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 175' ' ' ARG . . . . . 0.595 ' N ' ' O ' ' J' ' 172' ' ' GLY . 6.8 ptt-85 -169.86 121.94 0.69 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 118.595 0.634 . . . . 20.0 112.621 172.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.55 169.42 0.35 Allowed 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 127.845 2.458 . . . . 20.0 106.234 157.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 177' ' ' VAL . . . . . . . . . . . . . 46.1 t -144.71 145.76 20.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.438 -0.949 . . . . 20.0 108.438 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.08 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 116.467 2.025 . . . . 20.0 116.467 -166.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 118.707 0.685 . . . . 20.0 112.117 -171.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.05 -0.73 36.83 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 114.369 1.248 . . . . 20.0 114.369 -170.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 181' ' ' PHE . . . . . 0.742 ' HB3' ' HB3' ' J' ' 327' ' ' GLU . 3.1 t80 -84.7 -66.93 0.84 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.6 0.636 . . . . 20.0 111.717 -162.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.27 127.84 32.84 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 122.058 0.932 . . . . 20.0 110.697 -152.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 183' ' ' ASP . . . . . 0.539 ' OD1' ' N ' ' J' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.77 1.03 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.401 1.48 . . . . 20.0 113.149 174.653 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 184' ' ' ARG . . . . . 0.529 ' NH1' HD13 ' J' ' 29' ' ' ILE . 0.0 OUTLIER -153.74 83.83 1.16 Allowed 'General case' 0 N--CA 1.446 -0.63 0 CA-C-O 122.152 0.977 . . . . 20.0 110.801 157.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 185' ' ' ILE . . . . . 0.43 HG12 HG11 ' J' ' 317' ' ' VAL . 1.0 OUTLIER -126.03 -41.14 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 N-CA-C 104.518 -2.401 . . . . 20.0 104.518 149.9 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 186' ' ' ALA . . . . . 0.715 ' O ' ' OG1' ' J' ' 189' ' ' THR . . . -50.08 -42.97 51.12 Favored 'General case' 0 C--O 1.238 0.471 0 CA-C-N 115.324 -0.853 . . . . 20.0 111.504 173.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.12 76.75 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 C-N-CA 119.254 -0.979 . . . . 20.0 110.084 -178.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 188' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -63.8 -38.63 91.82 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 119.159 -1.017 . . . . 20.0 110.492 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 189' ' ' THR . . . . . 0.715 ' OG1' ' O ' ' J' ' 186' ' ' ALA . 25.4 p -59.12 -48.63 80.91 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.843 172.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.26 -50.54 63.85 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 CA-C-O 120.897 0.38 . . . . 20.0 110.494 178.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.1 -43.13 96.28 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.029 -0.668 . . . . 20.0 110.987 -178.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 192' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -63.96 -36.54 84.32 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 119.995 -0.682 . . . . 20.0 110.256 177.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 193' ' ' VAL . . . . . 0.412 HG23 ' O ' ' J' ' 189' ' ' THR . 11.6 t -60.53 -44.83 97.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 CA-C-O 121.05 0.453 . . . . 20.0 110.091 177.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.37 75.6 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 120.234 -0.586 . . . . 20.0 111.187 -176.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.53 -38.21 71.07 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.859 -0.737 . . . . 20.0 110.812 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.67 -26.13 41.1 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.556 0.576 . . . . 20.0 112.556 -175.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 197' ' ' LEU . . . . . . . . . . . . . 34.0 tp -80.56 122.82 27.52 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.303 -0.628 . . . . 20.0 109.303 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 198' ' ' LYS . . . . . . . . . . . . . 24.7 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.249 0 O-C-N 123.275 0.359 . . . . 20.0 110.133 176.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.17 105.41 17.56 Favored 'General case' 0 C--O 1.236 0.382 0 N-CA-C 109.72 -0.474 . . . . 20.0 109.72 -172.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.03 91.32 4.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.188 -0.671 . . . . 20.0 109.188 -174.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.79 -14.55 59.91 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 120.034 -0.666 . . . . 20.0 111.343 176.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.81 141.69 30.5 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 108.961 -0.755 . . . . 20.0 108.961 172.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 203' ' ' ASP . . . . . 0.633 ' N ' ' OD1' ' J' ' 203' ' ' ASP . 0.0 OUTLIER -78.63 113.04 16.32 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.449 -0.945 . . . . 20.0 108.449 -174.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.99 151.6 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.4 0 N-CA-C 108.56 -0.904 . . . . 20.0 108.56 -170.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 205' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -128.91 106.56 8.98 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.038 -0.727 . . . . 20.0 109.038 173.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.89 125.37 31.27 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.757 -0.831 . . . . 20.0 108.757 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 207' ' ' VAL . . . . . 0.71 HG12 HD13 ' J' ' 53' ' ' ILE . 34.0 m -119.9 150.21 22.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.873 -0.788 . . . . 20.0 108.873 174.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.36 98.85 5.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 107.414 -1.328 . . . . 20.0 107.414 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 209' ' ' THR . . . . . . . . . . . . . 34.2 p -85.86 160.0 19.55 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.912 0.863 . . . . 20.0 111.1 -165.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.87 166.43 13.24 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 CA-C-N 114.635 -1.166 . . . . 20.0 108.213 179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.63 40.18 29.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 114.771 -1.104 . . . . 20.0 111.472 -179.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.95 -49.53 13.94 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 120.333 -0.547 . . . . 20.0 110.999 176.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.24 -20.41 64.81 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.154 -0.619 . . . . 20.0 111.542 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 214' ' ' VAL . . . . . . . . . . . . . 88.4 t -131.14 121.13 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 N-CA-C 108.58 -0.896 . . . . 20.0 108.58 173.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.0 60.97 6.22 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 119.686 -1.245 . . . . 20.0 111.453 -174.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 216' ' ' LEU . . . . . 0.431 ' H ' HD23 ' J' ' 216' ' ' LEU . 0.5 OUTLIER -47.02 -25.57 0.84 Allowed 'General case' 0 C--O 1.234 0.257 0 N-CA-C 113.461 0.911 . . . . 20.0 113.461 -179.123 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 217' ' ' ARG . . . . . 0.459 ' HB3' ' HG ' ' A' ' 305' ' ' LEU . 1.3 mpt_? -63.49 -4.46 2.83 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 112.382 0.512 . . . . 20.0 112.382 173.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.53 40.92 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 119.736 -1.221 . . . . 20.0 112.024 168.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 219' ' ' ALA . . . . . 0.453 ' O ' ' OG ' ' J' ' 222' ' ' SER . . . -65.24 -37.1 86.18 Favored 'General case' 0 C--O 1.237 0.41 0 O-C-N 122.25 -0.559 . . . . 20.0 111.341 179.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 220' ' ' ARG . . . . . 0.42 ' HB2' ' HB1' ' J' ' 302' ' ' ALA . 16.6 ttm180 -52.72 -36.72 58.04 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 112.157 0.429 . . . . 20.0 112.157 -174.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 221' ' ' THR . . . . . . . . . . . . . 75.1 p -58.47 -45.79 87.93 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 120.056 -0.658 . . . . 20.0 110.862 -173.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 222' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' J' ' 219' ' ' ALA . 2.1 p -58.08 -35.74 71.83 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.724 -0.39 . . . . 20.0 111.44 175.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.68 -49.98 69.33 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 112.558 0.577 . . . . 20.0 112.558 -169.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 224' ' ' PHE . . . . . 0.474 ' HB2' ' HD2' ' A' ' 307' ' ' LYS . 79.0 t80 -64.11 -33.45 75.8 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 119.802 -0.759 . . . . 20.0 111.833 -165.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.72 74.94 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 118.95 -1.595 . . . . 20.0 112.124 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 226' ' ' ILE . . . . . . . . . . . . . 25.2 mm -127.02 -45.57 1.19 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.271 0 N-CA-C 111.999 0.37 . . . . 20.0 111.999 -158.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 227' ' ' GLU . . . . . 0.481 ' OE1' ' OG1' ' J' ' 306' ' ' THR . 3.0 pt-20 -56.43 -46.67 99.79 Favored Pre-proline 0 C--O 1.237 0.404 0 N-CA-C 118.214 2.672 . . . . 20.0 118.214 -158.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.92 143.7 2.94 Favored 'Trans proline' 0 N--CA 1.471 0.194 0 N-CA-C 115.989 1.496 . . . . 20.0 115.989 -134.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.2 -4.79 0.77 Allowed 'General case' 0 C--O 1.222 -0.364 0 C-N-CA 125.277 1.431 . . . . 20.0 113.376 162.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.85 171.27 11.48 Favored 'General case' 0 C--O 1.235 0.296 0 C-N-CA 120.079 -0.649 . . . . 20.0 111.793 167.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.44 16.31 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.95 -0.643 . . . . 20.0 112.311 -175.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.72 170.76 15.48 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.768 -0.827 . . . . 20.0 108.768 178.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.05 23.34 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 116.124 -0.489 . . . . 20.0 110.393 177.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 234' ' ' ILE . . . . . 0.482 HD11 ' CE ' ' J' ' 341' ' ' MET . 51.7 mt -133.22 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.361 0 N-CA-C 107.492 -1.299 . . . . 20.0 107.492 172.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' J' ' 68' ' ' HIS . 25.5 t0 -135.21 173.23 11.95 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.93 -1.507 . . . . 20.0 106.93 173.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.2 149.42 14.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.672 0.749 . . . . 20.0 111.394 -172.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 237' ' ' THR . . . . . 0.453 HG21 ' HA3' ' J' ' 296' ' ' GLY . 9.2 t -165.66 122.69 1.44 Allowed 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.315 -1.365 . . . . 20.0 107.315 164.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 238' ' ' ILE . . . . . 0.42 HD13 ' O ' ' J' ' 237' ' ' THR . 17.9 mm -145.48 151.91 14.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.249 0 N-CA-C 108.257 -1.016 . . . . 20.0 108.257 -161.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.29 105.2 9.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 106.831 -1.544 . . . . 20.0 106.831 159.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.45 109.98 18.64 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 113.057 0.762 . . . . 20.0 113.057 -155.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.37 36.19 22.32 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.0 1.32 . . . . 20.0 112.459 158.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.96 128.4 79.01 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 105.152 -2.166 . . . . 20.0 105.152 -177.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.96 165.54 11.98 Favored 'Trans proline' 0 CA--C 1.516 -0.403 0 CA-C-N 120.834 1.334 . . . . 20.0 112.373 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.41 -5.32 45.0 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.046 -0.979 . . . . 20.0 114.939 -173.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.56 22.75 Favored Pre-proline 0 N--CA 1.452 -0.331 0 CA-C-N 118.609 1.205 . . . . 20.0 110.663 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.98 -172.66 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.592 0 CA-C-O 121.841 0.684 . . . . 20.0 111.957 171.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.19 -10.83 59.56 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 114.734 -1.121 . . . . 20.0 112.037 179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.7 63.12 Favored 'General case' 0 CA--C 1.517 -0.304 0 C-N-CA 119.862 -0.735 . . . . 20.0 112.868 -171.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 249' ' ' LYS . . . . . 0.712 ' O ' ' OG1' ' J' ' 252' ' ' THR . 16.9 mttt -98.7 -15.26 19.44 Favored 'General case' 0 CA--C 1.514 -0.44 0 N-CA-C 113.247 0.832 . . . . 20.0 113.247 170.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.01 -37.86 88.98 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.277 -0.569 . . . . 20.0 111.382 -172.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.59 -21.03 25.72 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 C-N-CA 119.122 -1.031 . . . . 20.0 111.859 -178.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 252' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' J' ' 249' ' ' LYS . 39.4 p -57.12 -31.87 65.74 Favored 'General case' 0 C--O 1.237 0.416 0 CA-C-N 118.485 0.584 . . . . 20.0 111.307 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 253' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' J' ' 319' ' ' ALA . 16.6 t-80 -162.33 132.09 4.54 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.317 0.58 . . . . 20.0 110.374 176.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.3 3.94 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.038 -0.983 . . . . 20.0 112.308 175.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 35.94 5.84 Favored Glycine 0 CA--C 1.503 -0.66 0 C-N-CA 126.133 1.825 . . . . 20.0 111.583 -177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.42 129.28 10.21 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.618 -0.882 . . . . 20.0 108.618 -167.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.04 174.22 3.32 Favored Glycine 0 N--CA 1.438 -1.225 0 CA-C-O 122.706 1.17 . . . . 20.0 113.316 169.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.1 6.08 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.543 -0.91 . . . . 20.0 108.543 -177.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 259' ' ' ALA . . . . . . . . . . . . . . . -126.37 120.32 29.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.175 -0.92 . . . . 20.0 109.45 -169.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.97 140.0 18.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 107.819 -1.178 . . . . 20.0 107.819 175.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 261' ' ' LYS . . . . . 0.766 ' HE3' HG21 ' J' ' 298' ' ' THR . 1.9 mtmm -98.88 122.58 42.31 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 108.978 -0.749 . . . . 20.0 108.978 -177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.27 10.63 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-O 121.294 0.568 . . . . 20.0 109.6 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.64 147.58 34.53 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-O 121.434 0.635 . . . . 20.0 109.324 -174.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.95 2.86 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-N 114.764 -1.107 . . . . 20.0 108.197 165.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.22 22.14 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.766 -0.652 . . . . 20.0 110.257 163.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.89 -46.21 11.51 Favored 'General case' 0 N--CA 1.448 -0.575 0 N-CA-C 113.619 0.97 . . . . 20.0 113.619 -165.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.8 143.68 25.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 N-CA-C 109.391 -0.596 . . . . 20.0 109.391 -163.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.01 14.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.131 -1.803 . . . . 20.0 106.131 171.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.41 137.06 56.59 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.316 0.579 . . . . 20.0 111.314 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 270' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -57.97 109.67 1.97 Allowed Pre-proline 0 C--O 1.24 0.582 0 CA-C-N 115.165 -0.925 . . . . 20.0 108.695 177.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 271' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -67.53 -19.96 48.02 Favored 'Trans proline' 0 CA--C 1.512 -0.577 0 N-CA-C 114.819 1.046 . . . . 20.0 114.819 -160.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.41 -42.97 74.83 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.117 -0.633 . . . . 20.0 110.585 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 273' ' ' ILE . . . . . . . . . . . . . 72.0 mt -55.57 -48.36 77.55 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 CA-C-O 121.103 0.478 . . . . 20.0 110.083 175.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 274' ' ' VAL . . . . . . . . . . . . . 13.4 t -59.17 -52.44 60.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.386 0 CA-C-O 120.833 0.349 . . . . 20.0 110.7 -176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.45 -31.85 70.83 Favored 'General case' 0 C--O 1.237 0.396 0 C-N-CA 119.823 -0.751 . . . . 20.0 110.522 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 276' ' ' TRP . . . . . 0.481 ' HH2' ' HB3' ' J' ' 347' ' ' ASN . 0.1 OUTLIER -68.53 -47.94 65.6 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.097 -0.641 . . . . 20.0 110.997 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.76 89.98 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 119.991 -0.683 . . . . 20.0 110.746 177.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.56 -47.99 78.29 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 120.569 -0.452 . . . . 20.0 110.113 173.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 279' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -59.81 -40.44 88.39 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.873 -0.331 . . . . 20.0 110.712 175.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.34 -44.95 77.81 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.29 -0.564 . . . . 20.0 111.063 -172.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.1 -31.69 72.97 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.018 -175.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.81 65.85 Favored 'General case' 0 C--O 1.235 0.324 0 C-N-CA 120.005 -0.678 . . . . 20.0 111.147 178.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.8 -37.67 73.28 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.849 -0.741 . . . . 20.0 111.023 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.58 15.4 29.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 113.325 0.861 . . . . 20.0 113.325 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.2 13.74 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.732 0.777 . . . . 20.0 111.564 173.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 286' ' ' ILE . . . . . . . . . . . . . 23.9 mm -87.31 143.36 34.32 Favored Pre-proline 0 C--N 1.322 -0.588 0 N-CA-C 108.341 -0.985 . . . . 20.0 108.341 -178.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 287' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.15 149.39 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.406 0 CA-C-N 119.161 0.736 . . . . 20.0 111.37 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.05 148.19 23.39 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 121.599 0.714 . . . . 20.0 109.657 -179.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.05 175.1 5.62 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 107.666 -1.235 . . . . 20.0 107.666 168.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.64 113.74 17.12 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 107.856 -1.165 . . . . 20.0 107.856 168.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.0 144.68 43.76 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 109.463 -0.569 . . . . 20.0 109.463 -172.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.09 157.01 25.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 107.621 -1.251 . . . . 20.0 107.621 173.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.52 168.7 12.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.473 0.654 . . . . 20.0 110.31 175.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 294' ' ' LEU . . . . . . . . . . . . . 8.6 mt -94.81 -18.49 21.17 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.816 -1.084 . . . . 20.0 112.166 165.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.01 20.08 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 110.982 -0.847 . . . . 20.0 110.982 -176.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 296' ' ' GLY . . . . . 0.453 ' HA3' HG21 ' J' ' 237' ' ' THR . . . 101.47 144.82 15.63 Favored Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 114.653 -0.773 . . . . 20.0 112.664 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.86 119.61 4.09 Favored Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.33 -1.108 . . . . 20.0 110.33 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 298' ' ' THR . . . . . 0.766 HG21 ' HE3' ' J' ' 261' ' ' LYS . 20.3 p -110.31 172.87 6.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 122.011 0.91 . . . . 20.0 111.357 -174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.85 -33.75 76.75 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 114.397 -1.274 . . . . 20.0 111.229 176.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.54 -35.37 74.08 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 111.784 0.29 . . . . 20.0 111.784 -171.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.2 96.9 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.234 -0.984 . . . . 20.0 111.994 -178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 302' ' ' ALA . . . . . 0.42 ' HB1' ' HB2' ' J' ' 220' ' ' ARG . . . -68.3 -26.88 65.86 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 120.172 -0.611 . . . . 20.0 111.226 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.9 -34.44 55.86 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 C-N-CA 119.997 -0.681 . . . . 20.0 110.179 -178.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.25 -14.17 60.07 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 113.283 0.846 . . . . 20.0 113.283 -174.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.71 -8.91 19.52 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 113.761 1.023 . . . . 20.0 113.761 -167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 306' ' ' THR . . . . . 0.481 ' OG1' ' OE1' ' J' ' 227' ' ' GLU . 0.5 OUTLIER -58.34 157.6 8.4 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.609 0.719 . . . . 20.0 110.537 171.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 307' ' ' LYS . . . . . . . . . . . . . 21.5 mmtt -61.71 -29.88 70.39 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.215 -0.902 . . . . 20.0 113.357 -161.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.84 -25.24 66.33 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 119.693 -0.803 . . . . 20.0 111.238 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.19 1.93 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.857 -0.687 . . . . 20.0 113.311 -171.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 310' ' ' VAL . . . . . . . . . . . . . 20.4 t -80.35 139.64 52.09 Favored Pre-proline 0 C--O 1.238 0.474 0 CA-C-N 117.593 0.697 . . . . 20.0 111.092 -163.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 311' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -84.49 141.75 9.03 Favored 'Trans proline' 0 CA--C 1.512 -0.592 0 CA-C-N 119.479 0.85 . . . . 20.0 110.011 168.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 312' ' ' THR . . . . . . . . . . . . . 25.5 m -140.55 135.82 32.22 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.302 -0.863 . . . . 20.0 111.192 -169.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.6 162.57 12.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 109.189 -1.564 . . . . 20.0 109.189 164.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.02 27.38 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-O 121.455 0.645 . . . . 20.0 110.112 -176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.05 153.22 21.13 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.648 -1.16 . . . . 20.0 109.203 174.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 316' ' ' SER . . . . . . . . . . . . . 4.2 m -138.42 133.53 32.95 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.274 -0.875 . . . . 20.0 109.455 -178.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 317' ' ' VAL . . . . . 0.43 HG11 HG12 ' J' ' 185' ' ' ILE . 92.4 t -99.43 108.57 51.13 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 107.262 -1.384 . . . . 20.0 107.262 177.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.3 -169.03 0.64 Allowed 'Trans proline' 0 N--CA 1.456 -0.699 0 CA-C-O 122.652 1.022 . . . . 20.0 113.624 -154.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 319' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' J' ' 253' ' ' HIS . . . 79.86 35.45 0.15 Allowed 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 113.565 -1.652 . . . . 20.0 115.271 161.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 320' ' ' ARG . . . . . 0.421 ' HG3' ' O ' ' J' ' 321' ' ' TYR . 0.4 OUTLIER -75.65 157.57 33.53 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-O 121.709 0.766 . . . . 20.0 110.12 176.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 321' ' ' TYR . . . . . 0.421 ' O ' ' HG3' ' J' ' 320' ' ' ARG . 3.3 m-85 -113.07 166.17 11.68 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 106.779 -1.563 . . . . 20.0 106.779 160.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 322' ' ' ILE . . . . . . . . . . . . . 50.0 mm -49.2 113.66 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 124.113 0.965 . . . . 20.0 108.446 -163.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.39 3.25 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 114.488 1.292 . . . . 20.0 114.488 -140.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 324' ' ' SER . . . . . 0.581 ' OG ' HG21 ' J' ' 97' ' ' THR . 0.1 OUTLIER -59.48 -60.06 4.45 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 112.618 0.599 . . . . 20.0 112.618 179.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 325' ' ' ASN . . . . . 0.485 ' HB2' ' HA ' ' L' ' 100' ' ' ALA . 35.2 p-10 -101.94 -56.17 2.33 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 115.01 1.485 . . . . 20.0 115.01 -152.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.55 150.97 50.8 Favored 'General case' 0 CA--C 1.509 -0.606 0 N-CA-C 107.451 -1.314 . . . . 20.0 107.451 174.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 327' ' ' GLU . . . . . 0.742 ' HB3' ' HB3' ' J' ' 181' ' ' PHE . 82.7 mt-10 -142.6 52.88 1.41 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 113.826 -1.534 . . . . 20.0 109.905 -153.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 328' ' ' VAL . . . . . . . . . . . . . 53.3 t -51.08 149.41 0.95 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.398 0 CA-C-O 121.395 0.617 . . . . 20.0 111.951 -171.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 329' ' ' VAL . . . . . 0.419 HG13 ' HB2' ' J' ' 181' ' ' PHE . 0.3 OUTLIER -139.41 179.42 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.27 0 CA-C-O 121.929 0.871 . . . . 20.0 109.419 175.692 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.17 27.45 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 114.597 -1.183 . . . . 20.0 108.853 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 331' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -54.13 -32.07 54.11 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 123.839 0.712 . . . . 20.0 111.442 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.64 -44.76 73.48 Favored 'General case' 0 C--O 1.238 0.468 0 C-N-CA 120.319 -0.552 . . . . 20.0 110.198 -176.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -65.98 -44.97 83.31 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.784 -0.366 . . . . 20.0 111.066 -172.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 334' ' ' VAL . . . . . . . . . . . . . 7.9 p -63.6 -41.31 92.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 C-N-CA 120.452 -0.499 . . . . 20.0 110.491 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.02 -34.69 71.54 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 118.859 -1.137 . . . . 20.0 110.155 178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.43 -40.46 93.35 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 120.085 -0.646 . . . . 20.0 110.425 176.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 337' ' ' THR . . . . . . . . . . . . . 20.1 m -56.51 -43.84 80.15 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.751 0.31 . . . . 20.0 110.903 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 338' ' ' VAL . . . . . 0.691 ' O ' ' OG1' ' J' ' 342' ' ' THR . 42.7 t -60.17 -48.98 85.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 CA-C-O 120.99 0.424 . . . . 20.0 110.279 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 339' ' ' GLU . . . . . 0.78 ' OE1' ' NZ ' ' J' ' 343' ' ' LYS . 1.3 mm-40 -54.82 -46.91 74.61 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.934 0.397 . . . . 20.0 110.765 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.84 -55.13 38.07 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 116.367 -0.379 . . . . 20.0 111.436 -176.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 341' ' ' MET . . . . . 0.482 ' CE ' HD11 ' J' ' 234' ' ' ILE . 31.9 tpp -60.21 -40.3 89.62 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 120.187 -0.605 . . . . 20.0 110.811 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 342' ' ' THR . . . . . 0.691 ' OG1' ' O ' ' J' ' 338' ' ' VAL . 1.3 m -56.49 -44.99 81.21 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.122 0.487 . . . . 20.0 110.438 -177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 343' ' ' LYS . . . . . 0.78 ' NZ ' ' OE1' ' J' ' 339' ' ' GLU . 34.6 mttp -74.2 -37.49 63.89 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.968 -0.693 . . . . 20.0 110.795 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.78 -42.5 97.66 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 120.595 -0.442 . . . . 20.0 111.095 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 345' ' ' LEU . . . . . 0.415 ' O ' HG22 ' J' ' 348' ' ' ILE . 1.0 OUTLIER -59.03 -50.42 74.16 Favored 'General case' 0 CA--C 1.516 -0.333 0 C-N-CA 120.56 -0.456 . . . . 20.0 110.775 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.62 -39.09 91.13 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 119.704 -0.798 . . . . 20.0 110.605 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 347' ' ' ASN . . . . . 0.481 ' HB3' ' HH2' ' J' ' 276' ' ' TRP . 5.0 m-20 -84.49 4.79 30.21 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 119.457 -0.897 . . . . 20.0 112.485 -178.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 348' ' ' ILE . . . . . 0.415 HG22 ' O ' ' J' ' 345' ' ' LEU . 1.3 tt -65.23 -23.65 33.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 119.111 0.869 . . . . 20.0 110.902 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' J' J ' 349' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -63.78 -27.3 69.09 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.77 -0.772 . . . . 20.0 111.263 -175.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 350' ' ' GLU . . . . . . . . . . . . . 35.9 tp10 -85.9 -18.81 31.71 Favored 'General case' 0 C--O 1.235 0.32 0 O-C-N 122.082 -0.387 . . . . 20.0 111.49 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 351' ' ' LEU . . . . . 0.433 ' O ' HD12 ' J' ' 351' ' ' LEU . 0.1 OUTLIER -69.78 -28.78 66.03 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.126 0.417 . . . . 20.0 112.126 -173.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' J' J ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.05 -26.68 0.1 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 116.044 1.868 . . . . 20.0 116.044 -169.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' J' J ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.999 1.319 . . . . 20.0 108.385 -174.671 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 114.282 1.216 . . . . 20.0 114.282 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.08 82.23 2.92 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 106.916 -1.512 . . . . 20.0 106.916 -170.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 3' ' ' VAL . . . . . . . . . . . . . 34.3 t -62.87 -34.56 66.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.4 0 CA-C-N 114.862 -1.063 . . . . 20.0 110.222 178.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -106.97 -23.59 12.29 Favored 'General case' 0 C--O 1.238 0.464 0 N-CA-C 113.564 0.95 . . . . 20.0 113.564 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.49 30.28 19.93 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.093 0.957 . . . . 20.0 111.615 -173.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.79 -38.75 32.37 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 117.725 0.238 . . . . 20.0 111.237 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.07 117.44 37.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 N-CA-C 107.673 -1.232 . . . . 20.0 107.673 -178.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.97 112.16 12.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.365 0.602 . . . . 20.0 110.899 -174.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 9' ' ' TYR . . . . . . . . . . . . . 91.7 t80 -63.69 -31.5 72.69 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.489 -0.778 . . . . 20.0 111.902 -177.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 10' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 -68.13 -45.26 74.11 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 120.557 -0.457 . . . . 20.0 111.217 178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.78 -43.11 97.34 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 121.007 -0.277 . . . . 20.0 111.165 -172.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.84 -30.61 70.96 Favored 'General case' 0 C--O 1.236 0.345 0 C-N-CA 120.802 -0.359 . . . . 20.0 111.2 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.37 90.86 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 120.604 -0.438 . . . . 20.0 110.569 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 14' ' ' LYS . . . . . . . . . . . . . 28.0 mttt -59.02 -42.94 91.39 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.659 -0.246 . . . . 20.0 111.531 -174.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.9 -40.08 26.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 119.516 -0.874 . . . . 20.0 110.7 -171.104 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.08 -32.1 6.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 119.0 -1.08 . . . . 20.0 111.009 -162.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.11 -25.95 67.99 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 119.907 -0.717 . . . . 20.0 111.306 174.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.38 Favored Pre-proline 0 N--CA 1.448 -0.563 0 C-N-CA 120.533 -0.467 . . . . 20.0 109.798 -175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 19' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -85.13 144.68 9.53 Favored 'Trans proline' 0 C--N 1.33 -0.436 0 C-N-CA 120.32 0.68 . . . . 20.0 112.155 -172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.87 38.19 3.43 Favored Glycine 0 N--CA 1.445 -0.706 0 N-CA-C 117.312 1.685 . . . . 20.0 117.312 -159.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.72 119.85 2.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 N-CA-C 107.113 -1.44 . . . . 20.0 107.113 159.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.09 171.21 8.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.391 0.615 . . . . 20.0 110.683 -166.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.92 -33.28 2.88 Favored Glycine 0 N--CA 1.446 -0.666 0 CA-C-N 115.488 -0.778 . . . . 20.0 114.043 -177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.28 -178.37 0.17 Allowed 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.372 1.082 . . . . 20.0 109.561 172.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 25' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -57.95 -13.18 4.05 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 114.865 -1.061 . . . . 20.0 113.455 169.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 26' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' K' ' 28' ' ' GLY . 0.0 OUTLIER -87.97 9.04 23.6 Favored 'General case' 0 C--N 1.346 0.427 0 CA-C-N 119.713 1.142 . . . . 20.0 113.717 178.522 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.68 11.36 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 115.422 1.638 . . . . 20.0 115.422 -154.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 28' ' ' GLY . . . . . 0.497 ' N ' ' O ' ' K' ' 26' ' ' PHE . . . -53.2 -26.82 29.82 Favored Glycine 0 C--N 1.343 0.926 0 CA-C-N 119.793 1.179 . . . . 20.0 116.021 -172.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 29' ' ' ILE . . . . . 0.53 HD13 ' NH1' ' K' ' 184' ' ' ARG . 1.1 tt -59.61 -35.86 61.88 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 CA-C-N 118.088 0.944 . . . . 20.0 110.63 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.21 -52.43 61.29 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 120.935 0.398 . . . . 20.0 110.466 178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.28 -40.62 74.55 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 116.284 -0.416 . . . . 20.0 110.944 177.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 32' ' ' VAL . . . . . . . . . . . . . 11.3 t -63.22 -49.59 82.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 121.088 0.47 . . . . 20.0 110.358 -174.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.71 86.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 C-N-CA 119.689 -0.804 . . . . 20.0 110.286 -175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.68 -29.53 20.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 C-N-CA 118.776 -1.17 . . . . 20.0 111.144 179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.46 -31.01 71.67 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 117.995 0.361 . . . . 20.0 111.147 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 36' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -86.89 -56.77 3.24 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 112.189 0.441 . . . . 20.0 112.189 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.44 44.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-N 116.487 -0.324 . . . . 20.0 111.526 -164.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.35 -26.4 63.72 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.858 -0.737 . . . . 20.0 112.255 -162.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.06 -23.49 63.1 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 118.861 -1.135 . . . . 20.0 111.75 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.89 -6.99 22.85 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.478 0.918 . . . . 20.0 113.478 -176.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 41' ' ' VAL . . . . . . . . . . . . . 22.9 t -119.49 152.64 22.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.13 -42.61 88.88 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 115.201 -0.908 . . . . 20.0 111.48 -175.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.6 158.31 35.32 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.539 -0.911 . . . . 20.0 108.539 -173.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.48 147.18 16.62 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 N-CA-C 108.248 -1.019 . . . . 20.0 108.248 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.27 44.11 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-O 121.46 0.648 . . . . 20.0 110.46 -178.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 46' ' ' VAL . . . . . . . . . . . . . 61.6 t -117.12 128.97 74.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 107.371 -1.344 . . . . 20.0 107.371 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.874 0.845 . . . . 20.0 108.858 177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.63 -34.56 62.8 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.098 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.14 10.87 9.12 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 113.671 0.989 . . . . 20.0 113.671 -171.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.44 -6.63 83.37 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-O 119.112 -0.827 . . . . 20.0 114.481 -176.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.18 151.47 35.9 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 118.475 1.137 . . . . 20.0 110.237 173.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.4 140.23 33.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.144 -1.428 . . . . 20.0 107.144 176.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 53' ' ' ILE . . . . . 0.721 HD13 HG12 ' K' ' 207' ' ' VAL . 31.3 mm -130.17 115.68 33.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 107.312 -1.366 . . . . 20.0 107.312 -174.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.93 119.76 36.34 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.656 -0.498 . . . . 20.0 109.656 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.92 100.0 8.09 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.611 -0.885 . . . . 20.0 108.611 -173.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.39 31.7 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 106.774 -1.565 . . . . 20.0 106.774 163.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 57' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -105.52 154.5 20.29 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.661 -0.496 . . . . 20.0 109.661 -175.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.47 -161.07 23.72 Favored Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 111.112 -0.795 . . . . 20.0 111.112 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.15 105.58 10.39 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 123.846 0.858 . . . . 20.0 108.996 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.06 -168.55 33.52 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.763 -0.732 . . . . 20.0 114.064 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.8 Favored 'Trans proline' 0 C--N 1.331 -0.364 0 CA-C-O 121.769 0.654 . . . . 20.0 112.066 179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.93 111.35 22.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.984 -1.007 . . . . 20.0 109.286 -176.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 63' ' ' VAL . . . . . . . . . . . . . 45.4 t -103.73 137.96 30.19 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 N-CA-C 108.766 -0.827 . . . . 20.0 108.766 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.76 124.04 46.3 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 124.066 0.946 . . . . 20.0 109.028 -175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 65' ' ' ILE . . . . . . . . . . . . . 29.1 mm -116.22 114.29 45.67 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.107 -1.072 . . . . 20.0 108.107 -176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.6 51.41 Favored 'General case' 0 CA--C 1.514 -0.408 0 O-C-N 123.244 0.34 . . . . 20.0 110.997 -168.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.49 154.65 45.88 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.873 0.869 . . . . 20.0 108.908 167.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 68' ' ' HIS . . . . . 0.493 ' NE2' ' OD1' ' K' ' 235' ' ' ASP . 0.0 OUTLIER -105.05 146.44 29.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.947 -0.569 . . . . 20.0 110.575 177.394 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.94 21.42 5.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.247 -0.888 . . . . 20.0 109.73 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 70' ' ' ASP . . . . . 0.541 ' N ' ' OD1' ' K' ' 183' ' ' ASP . 12.0 t0 -97.39 67.97 2.14 Favored 'General case' 0 CA--C 1.516 -0.356 0 O-C-N 121.618 -0.676 . . . . 20.0 112.442 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.3 144.87 28.73 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.245 -1.02 . . . . 20.0 108.245 178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.76 148.84 6.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 123.684 0.793 . . . . 20.0 109.13 -178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 73' ' ' GLY . . . . . 0.461 ' C ' HD23 ' K' ' 74' ' ' LEU . . . -155.87 -175.7 27.18 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.544 -1.022 . . . . 20.0 110.544 173.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 74' ' ' LEU . . . . . 0.461 HD23 ' C ' ' K' ' 73' ' ' GLY . 5.0 mt -125.03 161.48 26.64 Favored 'General case' 0 N--CA 1.453 -0.321 0 CA-C-O 121.296 0.57 . . . . 20.0 109.957 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' K' ' 160' ' ' THR . 10.6 ttm -128.16 131.33 48.94 Favored 'General case' 0 CA--C 1.517 -0.291 0 C-N-CA 124.22 1.008 . . . . 20.0 109.67 -174.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 76' ' ' VAL . . . . . . . . . . . . . 17.1 m -74.48 137.09 23.81 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.929 0 N-CA-C 108.857 -0.794 . . . . 20.0 108.857 168.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 77' ' ' THR . . . . . . . . . . . . . 5.5 t -114.13 -29.33 7.01 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 113.061 0.763 . . . . 20.0 113.061 178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.0 174.46 13.74 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.155 -1.054 . . . . 20.0 108.155 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 79' ' ' ILE . . . . . . . . . . . . . 32.4 mm -127.04 108.95 19.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.347 -0.982 . . . . 20.0 108.347 -175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 80' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -62.78 166.32 5.65 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.818 0.818 . . . . 20.0 109.948 173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.56 -27.01 60.32 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 119.714 -0.794 . . . . 20.0 112.724 -169.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.57 9.21 4.23 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.349 0.87 . . . . 20.0 113.349 -177.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.26 12.71 81.86 Favored Glycine 0 N--CA 1.444 -0.827 0 CA-C-O 118.987 -0.896 . . . . 20.0 115.125 -178.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 84' ' ' PHE . . . . . . . . . . . . . 20.3 m-30 -107.76 145.05 34.05 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-N 118.328 1.064 . . . . 20.0 110.23 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.88 142.5 28.05 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-N 115.26 -0.882 . . . . 20.0 112.586 -172.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.37 174.59 6.61 Favored 'General case' 0 N--CA 1.449 -0.482 0 N-CA-C 107.902 -1.148 . . . . 20.0 107.902 158.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.67 163.8 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.664 0.745 . . . . 20.0 109.479 -170.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.36 15.6 Favored Pre-proline 0 N--CA 1.448 -0.546 0 CA-C-N 115.005 -0.998 . . . . 20.0 109.785 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.82 160.16 24.52 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.29 0.871 . . . . 20.0 112.727 -171.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 90' ' ' ILE . . . . . 0.493 HD11 HG21 ' K' ' 160' ' ' THR . 9.3 mt -88.73 150.25 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.651 0 CA-C-N 113.756 -1.565 . . . . 20.0 107.418 165.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.92 140.93 47.41 Favored Glycine 0 N--CA 1.449 -0.462 0 CA-C-N 115.269 -0.878 . . . . 20.0 112.16 -168.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.88 -24.12 22.23 Favored Glycine 0 N--CA 1.441 -0.997 0 CA-C-O 118.993 -0.893 . . . . 20.0 115.215 176.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.93 152.7 4.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 118.631 1.215 . . . . 20.0 109.241 -169.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.76 130.94 22.24 Favored Pre-proline 0 C--O 1.24 0.576 0 N-CA-C 108.41 -0.959 . . . . 20.0 108.41 173.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 95' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -81.07 -7.96 13.09 Favored 'Trans proline' 0 CA--C 1.515 -0.463 0 CA-C-N 120.568 1.239 . . . . 20.0 114.805 -170.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 96' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -64.23 -15.26 59.68 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 119.177 0.898 . . . . 20.0 111.783 174.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 97' ' ' THR . . . . . 0.583 HG21 ' OG ' ' K' ' 324' ' ' SER . 44.8 p -89.39 35.46 0.81 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 123.661 0.784 . . . . 20.0 112.429 178.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 98' ' ' LEU . . . . . 0.677 HD12 ' H ' ' K' ' 99' ' ' ILE . 0.5 OUTLIER -43.2 -66.45 0.37 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 124.954 1.302 . . . . 20.0 113.397 -173.015 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 99' ' ' ILE . . . . . 0.677 ' H ' HD12 ' K' ' 98' ' ' LEU . 1.6 tt -173.2 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.34 0 N-CA-C 108.966 -0.753 . . . . 20.0 108.966 174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 100' ' ' ALA . . . . . 0.49 ' H ' ' HB3' ' I' ' 100' ' ' ALA . . . -123.97 -19.0 5.79 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.644 -1.162 . . . . 20.0 111.215 158.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 101' ' ' GLN . . . . . 0.45 ' NE2' ' O ' ' I' ' 165' ' ' ASP . 0.0 OUTLIER -169.42 141.61 2.49 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.76 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 102' ' ' ARG . . . . . 0.582 HH12 ' HB3' ' I' ' 167' ' ' ARG . 0.0 OUTLIER 55.89 74.61 0.37 Allowed 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 115.211 1.559 . . . . 20.0 115.211 150.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 103' ' ' PHE . . . . . 0.581 ' O ' ' N ' ' K' ' 115' ' ' GLY . 0.5 OUTLIER -79.41 134.26 36.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 119.298 0.954 . . . . 20.0 109.371 160.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 104' ' ' LYS . . . . . . . . . . . . . 13.0 ttpt -102.78 140.29 37.24 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 115.481 -0.781 . . . . 20.0 109.436 -173.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 105' ' ' VAL . . . . . 0.581 HG22 ' CG1' ' K' ' 162' ' ' ILE . 50.6 t -117.4 110.75 32.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.41 0 N-CA-C 108.242 -1.022 . . . . 20.0 108.242 -178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 106' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -89.58 83.12 6.29 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 110.246 -0.279 . . . . 20.0 110.246 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 107' ' ' ILE . . . . . . . . . . . . . 27.4 mt -52.01 -54.2 14.76 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 O-C-N 123.372 0.42 . . . . 20.0 110.32 170.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.58 177.51 10.57 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.428 -0.953 . . . . 20.0 108.428 178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.12 126.38 27.47 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.921 -1.036 . . . . 20.0 110.481 -177.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.17 11.24 75.05 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-O 118.898 -0.945 . . . . 20.0 115.347 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 111' ' ' LYS . . . . . . . . . . . . . 57.8 mttt -129.04 114.07 15.93 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.438 1.119 . . . . 20.0 108.555 177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 112' ' ' PHE . . . . . . . . . . . . . 44.2 p90 -139.33 141.49 37.68 Favored 'General case' 0 N--CA 1.448 -0.564 0 N-CA-C 109.341 -0.615 . . . . 20.0 109.341 -178.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.63 142.5 43.74 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.423 0 N-CA-C 108.704 -0.851 . . . . 20.0 108.704 172.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 114' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -79.67 149.44 31.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 114.974 -1.012 . . . . 20.0 110.296 -172.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 115' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' K' ' 103' ' ' PHE . . . -147.92 157.83 27.48 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.277 -1.129 . . . . 20.0 110.277 -176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 m -128.77 154.38 39.6 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 108.372 -0.974 . . . . 20.0 108.372 -177.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.3 34.26 1.75 Allowed Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.395 -0.82 . . . . 20.0 114.584 -168.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 118' ' ' ALA . . . . . 0.493 ' O ' HD13 ' K' ' 98' ' ' LEU . . . -67.24 -47.99 69.12 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 114.291 1.219 . . . . 20.0 114.291 -156.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.53 121.17 11.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 119.564 1.075 . . . . 20.0 112.684 -155.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.19 35.48 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 102.607 -3.108 . . . . 20.0 102.607 159.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.21 123.83 11.03 Favored 'Trans proline' 0 C--N 1.328 -0.526 0 CA-C-N 120.766 1.309 . . . . 20.0 110.57 -178.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 122' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -63.81 149.78 89.92 Favored 'Trans proline' 0 CA--C 1.519 -0.252 0 CA-C-N 119.193 0.747 . . . . 20.0 110.691 177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.09 165.38 7.15 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.822 0.82 . . . . 20.0 109.94 -178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.16 91.9 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.184 -1.043 . . . . 20.0 108.184 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.93 160.83 19.61 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 120.784 -0.367 . . . . 20.0 110.757 169.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.92 -43.66 1.5 Allowed Pre-proline 0 C--O 1.237 0.431 0 C-N-CA 123.961 0.905 . . . . 20.0 113.081 -170.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.0 -24.96 59.51 Favored 'Trans proline' 0 C--N 1.359 1.098 0 CA-C-N 120.839 1.335 . . . . 20.0 111.995 170.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.46 -26.55 30.19 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 111.817 0.303 . . . . 20.0 111.817 -177.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.96 -31.9 69.14 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 119.733 -0.787 . . . . 20.0 110.226 168.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 130' ' ' ARG . . . . . . . . . . . . . 10.8 tpt180 -74.77 -36.91 62.55 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 111.914 0.339 . . . . 20.0 111.914 172.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 131' ' ' LYS . . . . . . . . . . . . . 35.1 mttt -78.5 91.01 4.5 Favored 'General case' 0 CA--C 1.513 -0.467 0 N-CA-C 109.217 -0.66 . . . . 20.0 109.217 174.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.24 14.34 7.97 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 112.065 0.394 . . . . 20.0 112.065 175.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.13 142.52 87.48 Favored Pre-proline 0 N--CA 1.445 -0.695 0 N-CA-C 108.563 -0.903 . . . . 20.0 108.563 172.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.72 153.59 75.5 Favored 'Trans proline' 0 C--N 1.327 -0.604 0 CA-C-N 119.664 0.916 . . . . 20.0 112.381 177.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.6 153.65 42.53 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.554 -1.203 . . . . 20.0 107.935 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 136' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -77.7 -12.23 59.95 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 118.77 -0.633 . . . . 20.0 112.347 -175.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' K' ' 138' ' ' GLN . 14.0 p30 -55.39 -66.38 0.42 Allowed 'General case' 0 C--N 1.345 0.375 0 CA-C-O 118.913 -0.565 . . . . 20.0 111.349 -175.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 138' ' ' GLN . . . . . 0.413 ' N ' ' OD1' ' K' ' 137' ' ' ASP . 3.9 tp-100 174.64 174.13 0.2 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 103.138 -2.912 . . . . 20.0 103.138 133.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 139' ' ' ILE . . . . . 0.412 ' H ' ' HG3' ' K' ' 138' ' ' GLN . 1.2 tp -74.86 168.08 2.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 C-N-CA 124.181 0.992 . . . . 20.0 108.937 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 140' ' ' PHE . . . . . 0.402 ' H ' HG13 ' K' ' 139' ' ' ILE . 0.3 OUTLIER -114.81 161.45 18.2 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.007 0.923 . . . . 20.0 110.508 177.345 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 141' ' ' ILE . . . . . 0.4 HD13 HD13 ' K' ' 162' ' ' ILE . 30.4 mt -124.64 147.5 29.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 108.627 -0.879 . . . . 20.0 108.627 -177.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 142' ' ' ASP . . . . . 0.571 ' OD1' ' N ' ' K' ' 144' ' ' GLY . 0.5 OUTLIER -119.12 134.76 55.01 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.641 0.776 . . . . 20.0 109.582 175.152 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.13 7.82 6.7 Favored 'Isoleucine or valine' 0 C--O 1.238 0.495 0 CA-C-N 115.888 -0.596 . . . . 20.0 111.814 166.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 144' ' ' GLY . . . . . 0.571 ' N ' ' OD1' ' K' ' 142' ' ' ASP . . . 86.89 -6.57 82.81 Favored Glycine 0 N--CA 1.441 -1.015 0 N-CA-C 115.447 0.939 . . . . 20.0 115.447 172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.1 144.01 54.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 118.498 1.149 . . . . 20.0 110.322 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.32 -20.92 33.46 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 113.593 0.961 . . . . 20.0 113.593 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.36 162.61 40.2 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-O 121.996 0.903 . . . . 20.0 111.44 -173.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 148' ' ' LYS . . . . . . . . . . . . . 27.5 tttt -57.41 -41.49 80.45 Favored 'General case' 0 C--O 1.237 0.412 0 CA-C-N 113.896 -1.502 . . . . 20.0 111.256 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.42 -46.96 88.15 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 120.839 -0.345 . . . . 20.0 110.96 -179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.41 -35.2 76.86 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.485 -0.486 . . . . 20.0 110.787 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.7 -40.6 84.29 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 120.024 -0.67 . . . . 20.0 111.112 -175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 152' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -74.78 -23.33 58.5 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 119.357 -0.937 . . . . 20.0 111.014 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 153' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -70.72 -30.0 66.43 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 119.751 -0.779 . . . . 20.0 110.68 177.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.6 -40.62 92.48 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 120.571 -0.452 . . . . 20.0 111.65 171.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.15 -8.73 6.69 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-O 118.914 -0.937 . . . . 20.0 114.559 -172.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 156' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.71 133.54 29.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 118.496 1.148 . . . . 20.0 108.565 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.89 175.91 9.35 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.669 -1.234 . . . . 20.0 107.669 174.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.26 147.35 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 N-CA-C 107.706 -1.22 . . . . 20.0 107.706 174.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.38 169.3 15.7 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 108.783 -1.727 . . . . 20.0 108.783 -176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' K' ' 75' ' ' MET . 0.2 OUTLIER -79.44 113.55 17.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 107.696 -1.224 . . . . 20.0 107.696 165.575 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.63 -19.98 0.99 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 113.784 1.031 . . . . 20.0 113.784 -166.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 162' ' ' ILE . . . . . 0.581 ' CG1' HG22 ' K' ' 105' ' ' VAL . 0.5 OUTLIER -111.72 155.67 13.02 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 O-C-N 121.696 -0.627 . . . . 20.0 111.75 -159.217 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 163' ' ' THR . . . . . 0.559 ' OG1' ' N ' ' K' ' 164' ' ' TRP . 3.5 t -145.35 -166.31 2.4 Favored 'General case' 0 C--O 1.234 0.248 0 C-N-CA 124.233 1.013 . . . . 20.0 110.446 171.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 164' ' ' TRP . . . . . 0.559 ' N ' ' OG1' ' K' ' 163' ' ' THR . 2.5 t-105 -100.77 -17.87 16.73 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 113.262 0.838 . . . . 20.0 113.262 -160.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.67 61.69 0.98 Allowed 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.215 0.531 . . . . 20.0 112.311 -177.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.87 158.6 29.56 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 110.121 -1.192 . . . . 20.0 110.121 172.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 167' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -142.38 148.31 37.66 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 107.726 -1.213 . . . . 20.0 107.726 170.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.65 30.49 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 115.147 -0.933 . . . . 20.0 110.176 -167.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 169' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -129.49 159.77 35.25 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.9 0.857 . . . . 20.0 109.949 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.4 117.23 34.28 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.225 -1.352 . . . . 20.0 109.482 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.92 151.58 29.02 Favored 'General case' 0 CA--C 1.516 -0.365 0 N-CA-C 109.479 -0.563 . . . . 20.0 109.479 168.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 172' ' ' GLY . . . . . 0.601 ' O ' ' N ' ' K' ' 175' ' ' ARG . . . 56.88 68.75 1.54 Allowed Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 109.192 -1.563 . . . . 20.0 109.192 -171.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.5 -21.96 4.32 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 112.761 0.652 . . . . 20.0 112.761 -174.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.13 -62.95 1.32 Allowed 'General case' 0 C--O 1.235 0.317 0 C-N-CA 119.684 -0.806 . . . . 20.0 111.215 157.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 175' ' ' ARG . . . . . 0.601 ' N ' ' O ' ' K' ' 172' ' ' GLY . 6.8 ptt-85 -169.84 121.92 0.7 Allowed 'General case' 0 C--O 1.231 0.12 0 CA-C-N 118.623 0.647 . . . . 20.0 112.669 172.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 176' ' ' PHE . . . . . . . . . . . . . 1.5 m-30 175.53 169.42 0.35 Allowed 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 127.835 2.454 . . . . 20.0 106.265 157.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 177' ' ' VAL . . . . . . . . . . . . . 45.7 t -144.68 145.78 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 N-CA-C 108.436 -0.949 . . . . 20.0 108.436 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.15 -64.41 1.17 Allowed 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 116.47 2.026 . . . . 20.0 116.47 -166.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.84 22.36 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 CA-C-N 118.741 0.7 . . . . 20.0 112.113 -171.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.13 -0.65 36.82 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 114.376 1.25 . . . . 20.0 114.376 -170.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 181' ' ' PHE . . . . . 0.763 ' HB3' ' HB3' ' K' ' 327' ' ' GLU . 3.1 t80 -84.66 -66.96 0.84 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.595 0.634 . . . . 20.0 111.754 -162.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 182' ' ' ASP . . . . . . . . . . . . . 33.9 t0 -80.3 127.8 32.79 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 122.111 0.958 . . . . 20.0 110.692 -152.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 183' ' ' ASP . . . . . 0.541 ' OD1' ' N ' ' K' ' 70' ' ' ASP . 0.6 OUTLIER 69.98 -6.67 1.05 Allowed 'General case' 0 C--O 1.233 0.229 0 C-N-CA 125.375 1.47 . . . . 20.0 113.148 174.688 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 184' ' ' ARG . . . . . 0.53 ' NH1' HD13 ' K' ' 29' ' ' ILE . 0.0 OUTLIER -153.84 83.89 1.16 Allowed 'General case' 0 N--CA 1.446 -0.628 0 CA-C-O 122.187 0.994 . . . . 20.0 110.779 157.15 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 185' ' ' ILE . . . . . 0.437 HG12 HG11 ' K' ' 317' ' ' VAL . 1.0 OUTLIER -126.11 -41.12 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 104.499 -2.408 . . . . 20.0 104.499 149.913 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 186' ' ' ALA . . . . . 0.712 ' O ' ' OG1' ' K' ' 189' ' ' THR . . . -50.13 -42.93 51.54 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-N 115.338 -0.846 . . . . 20.0 111.532 173.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 187' ' ' VAL . . . . . . . . . . . . . 10.8 m -65.9 -36.1 76.71 Favored 'Isoleucine or valine' 0 C--O 1.238 0.466 0 C-N-CA 119.27 -0.972 . . . . 20.0 110.094 -178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 188' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.75 -38.71 92.11 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 119.181 -1.007 . . . . 20.0 110.489 177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 189' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 186' ' ' ALA . 25.3 p -59.1 -48.56 81.14 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 119.446 -0.902 . . . . 20.0 110.86 172.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.33 -50.56 64.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 120.961 0.41 . . . . 20.0 110.476 178.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.07 -43.18 96.25 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 120.072 -0.651 . . . . 20.0 111.007 -178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.87 -36.59 84.42 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 119.988 -0.685 . . . . 20.0 110.314 177.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 193' ' ' VAL . . . . . 0.414 HG23 ' O ' ' K' ' 189' ' ' THR . 11.6 t -60.55 -44.85 97.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 CA-C-O 120.992 0.425 . . . . 20.0 110.078 177.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.08 -33.26 75.37 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 120.262 -0.575 . . . . 20.0 111.205 -176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.67 -38.1 70.7 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 119.866 -0.733 . . . . 20.0 110.778 175.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.7 -26.18 40.96 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.529 0.566 . . . . 20.0 112.529 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.53 122.79 27.46 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.342 -0.614 . . . . 20.0 109.342 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.43 -57.11 2.32 Favored 'General case' 0 C--O 1.235 0.294 0 O-C-N 123.239 0.337 . . . . 20.0 110.131 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.15 105.4 17.54 Favored 'General case' 0 C--O 1.236 0.381 0 N-CA-C 109.721 -0.474 . . . . 20.0 109.721 -172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.01 91.31 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.237 -0.653 . . . . 20.0 109.237 -174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 201' ' ' LYS . . . . . . . . . . . . . 42.5 tptt -76.73 -14.61 59.93 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.041 -0.663 . . . . 20.0 111.38 176.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.82 141.72 30.5 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 108.876 -0.787 . . . . 20.0 108.876 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 203' ' ' ASP . . . . . 0.653 ' N ' ' OD1' ' K' ' 203' ' ' ASP . 0.0 OUTLIER -78.62 112.99 16.27 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.5 -0.926 . . . . 20.0 108.5 -174.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.95 151.55 6.13 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.389 0 N-CA-C 108.577 -0.898 . . . . 20.0 108.577 -170.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 205' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -128.87 106.61 9.02 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.013 -0.736 . . . . 20.0 109.013 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.94 125.35 31.28 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.764 -0.828 . . . . 20.0 108.764 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 207' ' ' VAL . . . . . 0.721 HG12 HD13 ' K' ' 53' ' ' ILE . 34.0 m -119.9 150.17 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.326 0 N-CA-C 108.811 -0.811 . . . . 20.0 108.811 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.75 5.17 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 209' ' ' THR . . . . . . . . . . . . . 34.3 p -85.84 159.98 19.57 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.942 0.877 . . . . 20.0 111.08 -165.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.81 166.46 13.15 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.433 0 CA-C-N 114.609 -1.178 . . . . 20.0 108.236 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.59 40.2 29.49 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.813 -1.085 . . . . 20.0 111.504 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -78.01 -49.56 13.81 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 120.351 -0.54 . . . . 20.0 110.926 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.41 64.76 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.236 -0.586 . . . . 20.0 111.48 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 214' ' ' VAL . . . . . . . . . . . . . 90.4 t -131.1 121.17 48.73 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.408 0 N-CA-C 108.536 -0.912 . . . . 20.0 108.536 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.01 60.95 6.24 Favored Glycine 0 N--CA 1.445 -0.715 0 C-N-CA 119.696 -1.24 . . . . 20.0 111.421 -174.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 216' ' ' LEU . . . . . 0.428 HD23 ' H ' ' K' ' 216' ' ' LEU . 0.5 OUTLIER -46.99 -25.6 0.83 Allowed 'General case' 0 C--O 1.235 0.321 0 N-CA-C 113.469 0.914 . . . . 20.0 113.469 -179.139 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 217' ' ' ARG . . . . . 0.465 ' HB3' ' HG ' ' C' ' 305' ' ' LEU . 1.3 mpt_? -63.47 -4.5 2.82 Favored 'General case' 0 C--O 1.234 0.257 0 N-CA-C 112.333 0.494 . . . . 20.0 112.333 173.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.68 -40.52 40.92 Favored Glycine 0 C--N 1.337 0.622 0 C-N-CA 119.695 -1.241 . . . . 20.0 112.003 168.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 219' ' ' ALA . . . . . 0.458 ' O ' ' OG ' ' K' ' 222' ' ' SER . . . -65.28 -37.04 85.94 Favored 'General case' 0 C--O 1.237 0.416 0 O-C-N 122.279 -0.542 . . . . 20.0 111.391 179.082 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 220' ' ' ARG . . . . . 0.415 ' HB2' ' HB1' ' K' ' 302' ' ' ALA . 16.6 ttm180 -52.74 -36.72 58.2 Favored 'General case' 0 CA--C 1.515 -0.387 0 N-CA-C 112.171 0.434 . . . . 20.0 112.171 -174.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 221' ' ' THR . . . . . . . . . . . . . 75.3 p -58.38 -45.84 87.52 Favored 'General case' 0 C--O 1.238 0.479 0 C-N-CA 120.075 -0.65 . . . . 20.0 110.856 -173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 222' ' ' SER . . . . . 0.458 ' OG ' ' O ' ' K' ' 219' ' ' ALA . 2.1 p -58.07 -35.77 71.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 120.774 -0.37 . . . . 20.0 111.433 175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.08 68.85 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 112.559 0.577 . . . . 20.0 112.559 -169.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 224' ' ' PHE . . . . . 0.435 ' HB2' ' HD2' ' C' ' 307' ' ' LYS . 79.1 t80 -64.16 -33.43 75.76 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 119.79 -0.764 . . . . 20.0 111.799 -165.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.93 -16.73 74.87 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 118.948 -1.596 . . . . 20.0 112.122 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -127.0 -45.6 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 112.044 0.387 . . . . 20.0 112.044 -158.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 227' ' ' GLU . . . . . 0.418 ' OE1' ' OG1' ' K' ' 306' ' ' THR . 3.0 pt-20 -56.46 -46.61 99.79 Favored Pre-proline 0 C--O 1.237 0.422 0 N-CA-C 118.229 2.678 . . . . 20.0 118.229 -158.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 228' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -43.87 143.7 2.87 Favored 'Trans proline' 0 N--CA 1.472 0.21 0 N-CA-C 116.016 1.506 . . . . 20.0 116.016 -134.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 229' ' ' ASP . . . . . . . . . . . . . 8.6 t70 86.16 -4.74 0.78 Allowed 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 125.252 1.421 . . . . 20.0 113.353 162.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.91 171.25 11.42 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 120.083 -0.647 . . . . 20.0 111.77 167.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.5 151.47 16.39 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.916 -0.659 . . . . 20.0 112.269 -175.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 232' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -144.71 170.69 15.62 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.827 0.851 . . . . 20.0 108.806 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.66 149.1 23.4 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-O 121.177 0.513 . . . . 20.0 110.391 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 234' ' ' ILE . . . . . 0.488 HD11 ' CE ' ' K' ' 341' ' ' MET . 51.6 mt -133.21 90.42 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 107.512 -1.292 . . . . 20.0 107.512 172.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 235' ' ' ASP . . . . . 0.493 ' OD1' ' NE2' ' K' ' 68' ' ' HIS . 25.4 t0 -135.18 173.2 11.98 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.996 -1.483 . . . . 20.0 106.996 173.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.16 149.41 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.64 0.733 . . . . 20.0 111.407 -172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 237' ' ' THR . . . . . 0.446 HG21 ' HA3' ' K' ' 296' ' ' GLY . 9.2 t -165.61 122.7 1.46 Allowed 'General case' 0 C--O 1.234 0.237 0 N-CA-C 107.379 -1.341 . . . . 20.0 107.379 164.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 238' ' ' ILE . . . . . 0.403 HD13 ' O ' ' K' ' 237' ' ' THR . 17.9 mm -145.5 151.86 14.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 108.267 -1.012 . . . . 20.0 108.267 -161.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.18 9.67 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.889 -1.522 . . . . 20.0 106.889 158.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.42 109.95 18.61 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.067 0.766 . . . . 20.0 113.067 -155.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 241' ' ' ASP . . . . . . . . . . . . . 20.5 t0 53.4 36.14 22.28 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.947 1.299 . . . . 20.0 112.461 158.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.94 128.44 78.98 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 105.13 -2.174 . . . . 20.0 105.13 -177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 243' ' ' PRO . . . . . 0.503 ' HG3' ' HD1' ' I' ' 84' ' ' PHE . 16.6 Cg_exo -60.98 165.54 12.03 Favored 'Trans proline' 0 CA--C 1.517 -0.37 0 CA-C-N 120.837 1.335 . . . . 20.0 112.408 -179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.42 -5.28 45.29 Favored Glycine 0 N--CA 1.442 -0.914 0 CA-C-N 115.093 -0.958 . . . . 20.0 114.914 -173.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 245' ' ' THR . . . . . . . . . . . . . 33.4 p -92.16 164.54 22.83 Favored Pre-proline 0 N--CA 1.452 -0.328 0 CA-C-N 118.593 1.197 . . . . 20.0 110.665 177.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.99 -172.64 0.73 Allowed 'Trans proline' 0 C--N 1.327 -0.589 0 CA-C-O 121.835 0.681 . . . . 20.0 111.969 171.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.16 -10.85 59.57 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 114.726 -1.125 . . . . 20.0 112.06 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.29 -18.67 63.12 Favored 'General case' 0 CA--C 1.517 -0.289 0 C-N-CA 119.82 -0.752 . . . . 20.0 112.912 -171.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 249' ' ' LYS . . . . . 0.712 ' O ' ' OG1' ' K' ' 252' ' ' THR . 16.9 mttt -98.76 -15.17 19.41 Favored 'General case' 0 CA--C 1.513 -0.452 0 N-CA-C 113.234 0.827 . . . . 20.0 113.234 170.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.12 -37.8 88.76 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 120.256 -0.578 . . . . 20.0 111.324 -172.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.66 -20.96 25.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.391 0 C-N-CA 119.106 -1.038 . . . . 20.0 111.872 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 252' ' ' THR . . . . . 0.712 ' OG1' ' O ' ' K' ' 249' ' ' LYS . 39.5 p -57.12 -31.84 65.73 Favored 'General case' 0 C--O 1.236 0.394 0 CA-C-N 118.538 0.608 . . . . 20.0 111.366 173.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 253' ' ' HIS . . . . . 0.545 ' CD2' ' HB2' ' K' ' 319' ' ' ALA . 16.7 t-80 -162.37 132.09 4.51 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.349 0.595 . . . . 20.0 110.395 176.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.42 -1.31 3.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.972 -1.013 . . . . 20.0 112.287 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.27 36.0 5.82 Favored Glycine 0 CA--C 1.504 -0.64 0 C-N-CA 126.223 1.868 . . . . 20.0 111.563 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.44 129.19 10.12 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.608 -0.886 . . . . 20.0 108.608 -167.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.14 174.25 3.43 Favored Glycine 0 N--CA 1.437 -1.267 0 CA-C-O 122.71 1.172 . . . . 20.0 113.309 169.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.74 175.12 6.09 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.562 -0.903 . . . . 20.0 108.562 -177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 259' ' ' ALA . . . . . 0.4 ' O ' ' N ' ' K' ' 316' ' ' SER . . . -126.42 120.3 29.42 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.15 -0.932 . . . . 20.0 109.425 -169.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 260' ' ' ILE . . . . . . . . . . . . . 85.3 mt -97.96 139.92 19.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 107.8 -1.185 . . . . 20.0 107.8 175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 261' ' ' LYS . . . . . 0.773 ' HE3' HG21 ' K' ' 298' ' ' THR . 1.9 mtmm -98.85 122.62 42.33 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.941 -0.763 . . . . 20.0 108.941 -177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.81 -40.25 10.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 CA-C-N 115.893 -0.594 . . . . 20.0 109.593 173.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.6 147.63 34.67 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.316 -0.624 . . . . 20.0 109.316 -174.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.15 -169.93 2.86 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.738 -1.119 . . . . 20.0 108.26 165.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -55.02 -56.24 21.91 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.824 -0.625 . . . . 20.0 110.262 163.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.84 -46.22 11.55 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 113.669 0.989 . . . . 20.0 113.669 -165.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.78 143.69 25.14 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.316 0 N-CA-C 109.418 -0.586 . . . . 20.0 109.418 -163.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.26 104.0 14.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 106.139 -1.8 . . . . 20.0 106.139 171.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 269' ' ' CYS . . . . . . . . . . . . . 69.3 m -66.37 137.1 56.64 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.309 0.576 . . . . 20.0 111.3 -171.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 270' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -58.01 109.64 1.95 Allowed Pre-proline 0 C--O 1.24 0.595 0 CA-C-N 115.152 -0.931 . . . . 20.0 108.687 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 271' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -67.4 -20.09 48.69 Favored 'Trans proline' 0 CA--C 1.513 -0.562 0 N-CA-C 114.837 1.053 . . . . 20.0 114.837 -160.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.35 -42.96 74.55 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 120.183 -0.607 . . . . 20.0 110.557 176.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 273' ' ' ILE . . . . . . . . . . . . . 72.2 mt -55.59 -48.4 77.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.098 0.475 . . . . 20.0 110.074 175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 274' ' ' VAL . . . . . . . . . . . . . 13.1 t -59.19 -52.44 60.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 CA-C-O 120.823 0.344 . . . . 20.0 110.709 -176.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 275' ' ' ARG . . . . . . . . . . . . . 10.7 mtm180 -60.43 -31.87 70.82 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.832 -0.747 . . . . 20.0 110.525 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 276' ' ' TRP . . . . . 0.497 ' HH2' ' HB3' ' K' ' 347' ' ' ASN . 0.1 OUTLIER -68.5 -47.97 65.63 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 120.088 -0.645 . . . . 20.0 110.991 179.173 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.1 -38.66 89.73 Favored 'General case' 0 C--O 1.237 0.43 0 C-N-CA 119.978 -0.689 . . . . 20.0 110.726 177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 278' ' ' GLU . . . . . . . . . . . . . 26.3 tt0 -56.6 -47.99 78.41 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 120.631 -0.427 . . . . 20.0 110.084 173.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.81 -40.46 88.44 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.9 -0.32 . . . . 20.0 110.7 175.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.33 -44.9 77.96 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 120.261 -0.575 . . . . 20.0 111.098 -172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.13 -31.71 73.0 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.062 -0.655 . . . . 20.0 111.003 -175.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.4 -31.83 65.86 Favored 'General case' 0 C--O 1.236 0.383 0 C-N-CA 120.055 -0.658 . . . . 20.0 111.133 178.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.86 -37.66 73.1 Favored 'General case' 0 C--O 1.236 0.395 0 C-N-CA 119.874 -0.73 . . . . 20.0 110.963 -175.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 284' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -102.6 15.51 29.07 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 113.359 0.874 . . . . 20.0 113.359 178.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.76 32.17 13.75 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 121.736 0.779 . . . . 20.0 111.59 173.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 286' ' ' ILE . . . . . . . . . . . . . 23.7 mm -87.3 143.34 34.31 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 108.343 -0.984 . . . . 20.0 108.343 -178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 287' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.15 149.35 13.48 Favored 'Trans proline' 0 CA--C 1.516 -0.376 0 CA-C-N 119.146 0.731 . . . . 20.0 111.341 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -155.98 148.18 23.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.651 -0.704 . . . . 20.0 109.71 -179.547 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.04 175.19 5.58 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 107.688 -1.227 . . . . 20.0 107.688 168.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 290' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.7 113.76 17.1 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.837 -1.171 . . . . 20.0 107.837 168.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 144.64 43.8 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.47 -0.567 . . . . 20.0 109.47 -172.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.11 156.98 25.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 N-CA-C 107.632 -1.248 . . . . 20.0 107.632 173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.51 168.68 12.27 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.491 0.662 . . . . 20.0 110.23 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.76 -18.5 21.19 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 114.778 -1.101 . . . . 20.0 112.192 165.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.63 -176.0 20.06 Favored Glycine 0 N--CA 1.448 -0.515 0 N-CA-C 111.003 -0.839 . . . . 20.0 111.003 -176.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 296' ' ' GLY . . . . . 0.446 ' HA3' HG21 ' K' ' 237' ' ' THR . . . 101.49 144.75 15.54 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 114.67 -0.765 . . . . 20.0 112.661 -178.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.83 119.6 4.09 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 110.342 -1.103 . . . . 20.0 110.342 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 298' ' ' THR . . . . . 0.773 HG21 ' HE3' ' K' ' 261' ' ' LYS . 20.2 p -110.28 172.9 6.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 122.022 0.915 . . . . 20.0 111.348 -174.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.91 -33.7 76.65 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 114.387 -1.279 . . . . 20.0 111.228 176.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.29 74.02 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 111.809 0.3 . . . . 20.0 111.809 -171.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.34 -41.27 96.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.196 -1.002 . . . . 20.0 112.027 -178.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 302' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' K' ' 220' ' ' ARG . . . -68.21 -26.96 65.98 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.192 -0.603 . . . . 20.0 111.212 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 303' ' ' ILE . . . . . . . . . . . . . 13.0 mm -70.87 -34.45 56.03 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 119.996 -0.681 . . . . 20.0 110.17 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.24 -14.17 60.05 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 113.338 0.866 . . . . 20.0 113.338 -174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 305' ' ' LEU . . . . . 0.539 ' HG ' ' HB3' ' F' ' 217' ' ' ARG . 4.1 mp -103.74 -8.9 19.51 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 113.704 1.001 . . . . 20.0 113.704 -167.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 306' ' ' THR . . . . . 0.418 ' OG1' ' OE1' ' K' ' 227' ' ' GLU . 0.5 OUTLIER -58.35 157.56 8.49 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.579 0.704 . . . . 20.0 110.531 171.956 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 307' ' ' LYS . . . . . 0.482 ' HD2' ' HB2' ' F' ' 224' ' ' PHE . 21.5 mmtt -61.71 -29.83 70.36 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 115.267 -0.879 . . . . 20.0 113.323 -161.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.95 -25.13 66.19 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 119.721 -0.791 . . . . 20.0 111.196 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.74 65.09 1.95 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.842 -0.694 . . . . 20.0 113.346 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.61 52.39 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 117.603 0.702 . . . . 20.0 111.158 -163.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 311' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -84.44 141.71 9.07 Favored 'Trans proline' 0 CA--C 1.513 -0.542 0 CA-C-N 119.451 0.84 . . . . 20.0 110.024 168.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.5 135.78 32.27 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.325 -0.852 . . . . 20.0 111.19 -169.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.55 162.58 12.33 Favored Glycine 0 N--CA 1.441 -1.024 0 N-CA-C 109.207 -1.557 . . . . 20.0 109.207 164.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.4 136.04 27.41 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-O 121.429 0.633 . . . . 20.0 110.112 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 315' ' ' LEU . . . . . . . . . . . . . 23.4 mt -104.01 153.22 21.1 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 114.666 -1.152 . . . . 20.0 109.22 174.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 316' ' ' SER . . . . . 0.4 ' N ' ' O ' ' K' ' 259' ' ' ALA . 4.2 m -138.46 133.53 32.86 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.317 -0.856 . . . . 20.0 109.495 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 317' ' ' VAL . . . . . 0.437 HG11 HG12 ' K' ' 185' ' ' ILE . 92.3 t -99.47 108.56 51.19 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 107.255 -1.387 . . . . 20.0 107.255 177.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 318' ' ' PRO . . . . . . . . . . . . . 8.6 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.754 0 CA-C-O 122.653 1.022 . . . . 20.0 113.596 -154.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 319' ' ' ALA . . . . . 0.545 ' HB2' ' CD2' ' K' ' 253' ' ' HIS . . . 79.75 35.53 0.15 Allowed 'General case' 0 CA--C 1.516 -0.327 0 CA-C-N 113.539 -1.664 . . . . 20.0 115.319 161.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 320' ' ' ARG . . . . . 0.419 ' HG3' ' O ' ' K' ' 321' ' ' TYR . 0.4 OUTLIER -75.69 157.59 33.44 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.704 0.764 . . . . 20.0 110.105 176.746 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 321' ' ' TYR . . . . . 0.419 ' O ' ' HG3' ' K' ' 320' ' ' ARG . 3.3 m-85 -113.08 166.2 11.65 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.824 -1.547 . . . . 20.0 106.824 160.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 322' ' ' ILE . . . . . . . . . . . . . 50.2 mm -49.28 113.68 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.386 0 C-N-CA 124.161 0.984 . . . . 20.0 108.375 -163.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 323' ' ' HIS . . . . . . . . . . . . . 34.7 p-80 -61.59 -7.42 3.29 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 114.46 1.281 . . . . 20.0 114.46 -140.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 324' ' ' SER . . . . . 0.583 ' OG ' HG21 ' K' ' 97' ' ' THR . 0.1 OUTLIER -59.52 -59.95 4.63 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.647 0.61 . . . . 20.0 112.647 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 325' ' ' ASN . . . . . . . . . . . . . 35.1 p-10 -101.98 -56.12 2.34 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 115.001 1.482 . . . . 20.0 115.001 -152.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.61 150.95 50.75 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 107.455 -1.313 . . . . 20.0 107.455 174.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 327' ' ' GLU . . . . . 0.763 ' HB3' ' HB3' ' K' ' 181' ' ' PHE . 82.7 mt-10 -142.56 52.86 1.42 Allowed 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 113.839 -1.528 . . . . 20.0 109.909 -153.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 328' ' ' VAL . . . . . . . . . . . . . 53.2 t -51.07 149.38 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.429 0.633 . . . . 20.0 111.926 -171.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 329' ' ' VAL . . . . . 0.426 HG13 ' HB2' ' K' ' 181' ' ' PHE . 0.3 OUTLIER -139.35 179.41 2.98 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.283 0 CA-C-O 121.898 0.856 . . . . 20.0 109.461 175.644 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.49 119.17 27.47 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.603 -1.18 . . . . 20.0 108.897 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 331' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -54.12 -32.04 53.9 Favored 'General case' 0 C--O 1.235 0.305 0 O-C-N 123.878 0.736 . . . . 20.0 111.511 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.61 -44.77 73.58 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.297 -0.561 . . . . 20.0 110.233 -176.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 333' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -66.05 -44.91 83.21 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 120.776 -0.37 . . . . 20.0 111.037 -172.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.34 92.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.371 0 C-N-CA 120.501 -0.48 . . . . 20.0 110.435 -173.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -70.99 -34.64 71.57 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 118.821 -1.151 . . . . 20.0 110.205 178.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.41 93.07 Favored 'General case' 0 C--O 1.236 0.382 0 C-N-CA 120.093 -0.643 . . . . 20.0 110.415 176.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.61 -43.75 80.47 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 120.726 0.298 . . . . 20.0 110.916 176.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 338' ' ' VAL . . . . . 0.697 ' O ' ' OG1' ' K' ' 342' ' ' THR . 42.6 t -60.25 -48.96 86.06 Favored 'Isoleucine or valine' 0 C--O 1.238 0.478 0 CA-C-O 120.953 0.406 . . . . 20.0 110.23 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 339' ' ' GLU . . . . . 0.791 ' OE1' ' NZ ' ' K' ' 343' ' ' LYS . 1.3 mm-40 -54.83 -46.91 74.65 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.968 0.413 . . . . 20.0 110.764 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -55.17 37.53 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-N 116.36 -0.382 . . . . 20.0 111.441 -176.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 341' ' ' MET . . . . . 0.488 ' CE ' HD11 ' K' ' 234' ' ' ILE . 31.9 tpp -60.14 -40.4 89.7 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 120.213 -0.595 . . . . 20.0 110.78 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 342' ' ' THR . . . . . 0.697 ' OG1' ' O ' ' K' ' 338' ' ' VAL . 1.3 m -56.45 -45.03 81.03 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.185 0.517 . . . . 20.0 110.447 -177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 343' ' ' LYS . . . . . 0.791 ' NZ ' ' OE1' ' K' ' 339' ' ' GLU . 34.6 mttp -74.17 -37.45 63.98 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 119.96 -0.696 . . . . 20.0 110.829 -178.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.82 -42.45 97.72 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 120.626 -0.429 . . . . 20.0 111.15 -179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 345' ' ' LEU . . . . . 0.418 ' O ' HG22 ' K' ' 348' ' ' ILE . 1.0 OUTLIER -59.05 -50.43 74.1 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.499 -0.48 . . . . 20.0 110.808 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.56 -39.17 91.38 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 119.732 -0.787 . . . . 20.0 110.588 -178.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 347' ' ' ASN . . . . . 0.497 ' HB3' ' HH2' ' K' ' 276' ' ' TRP . 5.0 m-20 -84.46 4.77 30.13 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 119.468 -0.893 . . . . 20.0 112.54 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 348' ' ' ILE . . . . . 0.418 HG22 ' O ' ' K' ' 345' ' ' LEU . 1.3 tt -65.16 -23.7 33.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.381 0 C-N-CA 119.558 -0.857 . . . . 20.0 110.949 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' K' K ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.75 -27.39 69.16 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.734 -0.786 . . . . 20.0 111.265 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 350' ' ' GLU . . . . . . . . . . . . . 36.0 tp10 -85.79 -18.85 31.79 Favored 'General case' 0 C--O 1.235 0.33 0 O-C-N 122.12 -0.362 . . . . 20.0 111.517 177.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 351' ' ' LEU . . . . . 0.432 ' O ' HD12 ' K' ' 351' ' ' LEU . 0.1 OUTLIER -69.73 -28.81 66.12 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 112.134 0.42 . . . . 20.0 112.134 -173.87 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' K' K ' 352' ' ' LYS . . . . . . . . . . . . . 40.2 pttt -42.09 -26.62 0.1 Allowed 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 116.051 1.871 . . . . 20.0 116.051 -169.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' K' K ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.784 0 C-N-CA 125.02 1.328 . . . . 20.0 108.423 -174.662 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 1' ' ' MET . . . . . . . . . . . . . 6.8 mmt . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 114.269 1.211 . . . . 20.0 114.269 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -76.01 82.19 2.88 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.946 -1.501 . . . . 20.0 106.946 -170.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 3' ' ' VAL . . . . . . . . . . . . . 34.8 t -62.95 -34.46 66.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 CA-C-N 114.925 -1.034 . . . . 20.0 110.183 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 4' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -107.0 -23.57 12.28 Favored 'General case' 0 C--O 1.239 0.517 0 N-CA-C 113.596 0.962 . . . . 20.0 113.596 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 5' ' ' ASN . . . . . . . . . . . . . 2.2 m120 59.47 30.24 19.89 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.133 0.973 . . . . 20.0 111.64 -173.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -38.74 32.39 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 122.256 -0.278 . . . . 20.0 111.232 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 7' ' ' VAL . . . . . . . . . . . . . 1.7 p -131.06 117.45 37.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 107.684 -1.228 . . . . 20.0 107.684 -178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 8' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -75.91 112.12 11.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.276 0.56 . . . . 20.0 110.92 -174.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 9' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -63.68 -31.53 72.73 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.487 -0.778 . . . . 20.0 111.864 -177.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 10' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -68.18 -45.13 74.29 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 120.531 -0.467 . . . . 20.0 111.192 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 11' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.81 -43.15 97.12 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 121.01 -0.276 . . . . 20.0 111.192 -172.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 12' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -61.83 -30.59 70.94 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 120.751 -0.379 . . . . 20.0 111.16 -178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 13' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.86 -46.4 90.73 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 120.683 -0.407 . . . . 20.0 110.541 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 14' ' ' LYS . . . . . . . . . . . . . 27.9 mttt -59.06 -42.93 91.51 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.641 -0.254 . . . . 20.0 111.536 -174.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 m -77.91 -40.04 26.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.393 0 C-N-CA 119.547 -0.861 . . . . 20.0 110.696 -171.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 16' ' ' VAL . . . . . . . . . . . . . 2.0 p -86.07 -32.17 6.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 119.06 -1.056 . . . . 20.0 111.008 -162.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -65.02 -26.04 68.1 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 119.958 -0.697 . . . . 20.0 111.295 174.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.01 160.42 70.42 Favored Pre-proline 0 N--CA 1.448 -0.538 0 C-N-CA 120.521 -0.472 . . . . 20.0 109.817 -175.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 19' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -85.19 144.76 9.49 Favored 'Trans proline' 0 C--N 1.329 -0.46 0 C-N-CA 120.251 0.634 . . . . 20.0 112.132 -172.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 20' ' ' GLY . . . . . . . . . . . . . . . -105.93 38.17 3.44 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 117.286 1.674 . . . . 20.0 117.286 -159.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 21' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -146.67 119.78 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 N-CA-C 107.175 -1.417 . . . . 20.0 107.175 159.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.08 171.21 8.89 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.452 0.644 . . . . 20.0 110.669 -166.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 23' ' ' GLY . . . . . . . . . . . . . . . 82.99 -33.29 2.89 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.477 -0.783 . . . . 20.0 114.003 -177.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 24' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -62.29 -178.36 0.17 Allowed 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 122.3 1.048 . . . . 20.0 109.602 172.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 25' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -57.91 -13.18 4.01 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-N 114.94 -1.027 . . . . 20.0 113.425 169.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 26' ' ' PHE . . . . . 0.492 ' O ' ' N ' ' L' ' 28' ' ' GLY . 0.0 OUTLIER -87.99 8.98 23.89 Favored 'General case' 0 C--N 1.345 0.391 0 CA-C-N 119.701 1.137 . . . . 20.0 113.771 178.558 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 27' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.61 11.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.444 1.646 . . . . 20.0 115.444 -154.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 28' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' L' ' 26' ' ' PHE . . . -53.24 -26.85 30.24 Favored Glycine 0 C--N 1.342 0.9 0 CA-C-N 119.784 1.174 . . . . 20.0 115.982 -172.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 29' ' ' ILE . . . . . 0.536 HD13 ' NH1' ' L' ' 184' ' ' ARG . 1.1 tt -59.59 -35.75 61.13 Favored 'Isoleucine or valine' 0 C--O 1.237 0.406 0 CA-C-N 118.151 0.976 . . . . 20.0 110.659 -178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 30' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 -54.32 -52.47 61.44 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.897 0.379 . . . . 20.0 110.404 178.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 31' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.18 -40.69 74.34 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 116.275 -0.421 . . . . 20.0 110.958 177.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 32' ' ' VAL . . . . . . . . . . . . . 11.4 t -63.19 -49.61 82.49 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 CA-C-O 121.081 0.467 . . . . 20.0 110.346 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 33' ' ' VAL . . . . . . . . . . . . . 53.8 t -64.26 -39.68 86.37 Favored 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 119.744 -0.782 . . . . 20.0 110.298 -175.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 34' ' ' ILE . . . . . . . . . . . . . 8.2 pt -75.75 -29.5 20.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.383 0 C-N-CA 118.762 -1.175 . . . . 20.0 111.134 179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 35' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -62.48 -30.97 71.65 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 118.003 0.365 . . . . 20.0 111.111 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -87.01 -56.71 3.26 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 112.16 0.43 . . . . 20.0 112.16 177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 37' ' ' ILE . . . . . . . . . . . . . 3.6 tt -64.26 -28.48 44.99 Favored 'Isoleucine or valine' 0 C--O 1.236 0.365 0 CA-C-N 116.502 -0.317 . . . . 20.0 111.516 -164.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 38' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -70.39 -26.38 63.68 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 119.936 -0.706 . . . . 20.0 112.212 -162.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 39' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -70.11 -23.52 63.05 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 118.958 -1.097 . . . . 20.0 111.683 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 40' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -101.91 -6.92 22.92 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 113.449 0.907 . . . . 20.0 113.449 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 41' ' ' VAL . . . . . . . . . . . . . 22.8 t -119.56 152.64 22.12 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 108.547 -0.908 . . . . 20.0 108.547 -176.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 42' ' ' ASP . . . . . . . . . . . . . 28.4 m-20 -66.1 -42.65 88.98 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 115.227 -0.897 . . . . 20.0 111.464 -175.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 43' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -157.56 158.31 35.38 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.509 -0.923 . . . . 20.0 108.509 -173.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 44' ' ' VAL . . . . . . . . . . . . . 3.3 p -149.5 147.16 16.63 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.282 -1.007 . . . . 20.0 108.282 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 45' ' ' LYS . . . . . . . . . . . . . 7.0 mtpt -148.11 159.26 44.11 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-O 121.523 0.678 . . . . 20.0 110.422 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 46' ' ' VAL . . . . . . . . . . . . . 61.5 t -117.06 128.96 74.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.349 -1.352 . . . . 20.0 107.349 179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 47' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -81.33 -176.09 5.81 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-O 121.807 0.813 . . . . 20.0 108.917 177.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 48' ' ' LYS . . . . . . . . . . . . . 6.0 mmtm -74.61 -34.55 62.84 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 119.94 -0.704 . . . . 20.0 111.14 -176.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 49' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.21 10.9 9.17 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 113.661 0.986 . . . . 20.0 113.661 -171.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 50' ' ' GLY . . . . . . . . . . . . . . . 88.48 -6.67 83.34 Favored Glycine 0 N--CA 1.445 -0.729 0 CA-C-O 119.134 -0.815 . . . . 20.0 114.514 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 51' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -62.07 151.45 35.43 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.466 1.133 . . . . 20.0 110.217 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 52' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -112.39 140.2 33.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 107.133 -1.432 . . . . 20.0 107.133 176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 53' ' ' ILE . . . . . 0.711 HD13 HG12 ' L' ' 207' ' ' VAL . 31.2 mm -130.2 115.64 33.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.324 -1.362 . . . . 20.0 107.324 -174.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 54' ' ' ALA . . . . . . . . . . . . . . . -116.9 119.79 36.46 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.619 -0.511 . . . . 20.0 109.619 174.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 55' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -113.98 100.02 8.1 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.582 -0.896 . . . . 20.0 108.582 -173.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 145.36 31.72 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 106.734 -1.58 . . . . 20.0 106.734 163.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 57' ' ' LYS . . . . . . . . . . . . . 3.3 tttt -105.55 154.49 20.31 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 123.47 0.481 . . . . 20.0 109.703 -175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 58' ' ' GLY . . . . . . . . . . . . . . . -174.38 -161.1 23.71 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.147 -0.781 . . . . 20.0 111.147 179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 59' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -122.12 105.58 10.39 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 123.904 0.882 . . . . 20.0 109.018 179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 60' ' ' GLY . . . . . . . . . . . . . . . 156.07 -168.59 33.53 Favored Glycine 0 N--CA 1.442 -0.9 0 C-N-CA 120.775 -0.726 . . . . 20.0 114.074 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 61' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -70.76 165.23 32.79 Favored 'Trans proline' 0 CA--C 1.517 -0.332 0 CA-C-O 121.747 0.645 . . . . 20.0 112.081 179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 62' ' ' LYS . . . . . . . . . . . . . 53.2 mttt -91.96 111.41 22.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.951 -1.022 . . . . 20.0 109.196 -176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 63' ' ' VAL . . . . . . . . . . . . . 45.8 t -103.74 137.97 30.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.405 0 N-CA-C 108.779 -0.823 . . . . 20.0 108.779 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 64' ' ' MET . . . . . . . . . . . . . 28.1 ttt -118.8 124.07 46.31 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 124.015 0.926 . . . . 20.0 109.022 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 65' ' ' ILE . . . . . . . . . . . . . 29.2 mm -116.23 114.27 45.6 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 N-CA-C 108.112 -1.07 . . . . 20.0 108.112 -176.122 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.56 124.55 51.3 Favored 'General case' 0 CA--C 1.514 -0.406 0 O-C-N 123.255 0.347 . . . . 20.0 110.993 -168.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 67' ' ' ALA . . . . . . . . . . . . . . . -128.43 154.6 45.88 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 123.902 0.881 . . . . 20.0 108.941 167.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 68' ' ' HIS . . . . . 0.484 ' NE2' ' OD1' ' L' ' 235' ' ' ASP . 0.0 OUTLIER -105.06 146.49 29.04 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.949 -0.569 . . . . 20.0 110.479 177.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 69' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.91 21.32 5.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.163 -0.926 . . . . 20.0 109.676 -178.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 70' ' ' ASP . . . . . 0.543 ' N ' ' OD1' ' L' ' 183' ' ' ASP . 12.0 t0 -97.38 67.95 2.15 Favored 'General case' 0 CA--C 1.516 -0.345 0 O-C-N 121.658 -0.651 . . . . 20.0 112.448 178.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.26 144.89 28.41 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.252 -1.018 . . . . 20.0 108.252 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 72' ' ' ILE . . . . . . . . . . . . . 4.4 tp -58.82 148.79 6.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 C-N-CA 123.736 0.814 . . . . 20.0 109.131 -178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 73' ' ' GLY . . . . . 0.471 ' C ' HD23 ' L' ' 74' ' ' LEU . . . -155.81 -175.66 27.07 Favored Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 110.597 -1.001 . . . . 20.0 110.597 173.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 74' ' ' LEU . . . . . 0.471 HD23 ' C ' ' L' ' 73' ' ' GLY . 5.0 mt -125.09 161.38 26.91 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-O 121.29 0.567 . . . . 20.0 109.995 178.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 75' ' ' MET . . . . . 0.52 ' HB2' HG23 ' L' ' 160' ' ' THR . 10.6 ttm -128.12 131.32 49.01 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.237 1.015 . . . . 20.0 109.679 -174.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 76' ' ' VAL . . . . . . . . . . . . . 17.0 m -74.51 137.06 23.87 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 N-CA-C 108.837 -0.801 . . . . 20.0 108.837 168.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 77' ' ' THR . . . . . . . . . . . . . 5.4 t -114.09 -29.32 7.02 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 113.055 0.761 . . . . 20.0 113.055 178.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -161.03 174.44 13.75 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.099 -1.075 . . . . 20.0 108.099 178.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 79' ' ' ILE . . . . . . . . . . . . . 32.5 mm -127.01 108.9 19.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 108.366 -0.976 . . . . 20.0 108.366 -175.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 80' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 166.34 5.59 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.82 0.819 . . . . 20.0 109.992 173.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -74.53 -27.07 60.37 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 119.732 -0.787 . . . . 20.0 112.708 -169.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 82' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -78.56 9.21 4.21 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.369 0.877 . . . . 20.0 113.369 -177.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.19 12.85 81.82 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-O 118.949 -0.917 . . . . 20.0 115.059 -178.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 84' ' ' PHE . . . . . . . . . . . . . 20.2 m-30 -107.81 145.07 34.1 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 118.384 1.092 . . . . 20.0 110.202 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 85' ' ' LEU . . . . . . . . . . . . . 7.0 mp -95.94 142.5 28.11 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 115.264 -0.88 . . . . 20.0 112.569 -172.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 86' ' ' ARG . . . . . . . . . . . . . 2.9 mmt-85 -97.38 174.59 6.61 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.878 -1.156 . . . . 20.0 107.878 158.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 87' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -150.71 163.79 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.617 0.722 . . . . 20.0 109.527 -170.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 88' ' ' ALA . . . . . . . . . . . . . . . -138.28 129.33 15.58 Favored Pre-proline 0 N--CA 1.449 -0.503 0 CA-C-N 115.012 -0.995 . . . . 20.0 109.756 171.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 89' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -79.79 160.21 24.59 Favored 'Trans proline' 0 CA--C 1.508 -0.802 0 CA-C-O 122.307 0.878 . . . . 20.0 112.72 -171.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 90' ' ' ILE . . . . . 0.49 HD11 HG21 ' L' ' 160' ' ' THR . 9.2 mt -88.81 150.28 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 CA-C-N 113.696 -1.593 . . . . 20.0 107.365 165.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 91' ' ' GLY . . . . . . . . . . . . . . . -58.94 140.9 47.46 Favored Glycine 0 N--CA 1.449 -0.443 0 CA-C-N 115.272 -0.876 . . . . 20.0 112.151 -168.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.9 -24.22 21.98 Favored Glycine 0 N--CA 1.441 -0.978 0 CA-C-O 118.912 -0.938 . . . . 20.0 115.204 176.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 93' ' ' VAL . . . . . . . . . . . . . 5.3 p -78.87 152.66 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 118.645 1.222 . . . . 20.0 109.237 -169.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 94' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -109.72 131.02 22.15 Favored Pre-proline 0 C--O 1.24 0.561 0 N-CA-C 108.419 -0.956 . . . . 20.0 108.419 173.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 95' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.14 -7.92 13.02 Favored 'Trans proline' 0 CA--C 1.514 -0.489 0 CA-C-N 120.573 1.24 . . . . 20.0 114.805 -170.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 96' ' ' LYS . . . . . . . . . . . . . 4.6 pttt -64.25 -15.27 59.74 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 119.155 0.889 . . . . 20.0 111.79 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 97' ' ' THR . . . . . 0.594 HG21 ' OG ' ' L' ' 324' ' ' SER . 44.7 p -89.48 35.54 0.82 Allowed 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.598 0.759 . . . . 20.0 112.461 178.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 98' ' ' LEU . . . . . 0.679 HD12 ' H ' ' L' ' 99' ' ' ILE . 0.5 OUTLIER -43.26 -66.43 0.38 Allowed 'General case' 0 C--O 1.234 0.242 0 C-N-CA 124.923 1.289 . . . . 20.0 113.407 -173.046 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 99' ' ' ILE . . . . . 0.679 ' H ' HD12 ' L' ' 98' ' ' LEU . 1.6 tt -173.19 156.11 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.344 0 N-CA-C 108.973 -0.751 . . . . 20.0 108.973 174.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 100' ' ' ALA . . . . . 0.485 ' HA ' ' HB2' ' J' ' 325' ' ' ASN . . . -123.94 -19.03 5.79 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.635 -1.166 . . . . 20.0 111.255 158.039 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 101' ' ' GLN . . . . . 0.425 ' NE2' ' O ' ' J' ' 165' ' ' ASP . 0.0 OUTLIER -169.37 141.61 2.51 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.651 -0.87 . . . . 20.0 108.651 176.754 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 102' ' ' ARG . . . . . 0.509 HH12 ' HB3' ' J' ' 167' ' ' ARG . 0.0 OUTLIER 55.94 74.52 0.38 Allowed 'General case' 0 N--CA 1.456 -0.173 0 N-CA-C 115.233 1.568 . . . . 20.0 115.233 150.539 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 103' ' ' PHE . . . . . 0.588 ' O ' ' N ' ' L' ' 115' ' ' GLY . 0.5 OUTLIER -79.35 134.25 36.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.325 0.966 . . . . 20.0 109.363 160.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 104' ' ' LYS . . . . . . . . . . . . . 13.1 ttpt -102.82 140.29 37.28 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.499 -0.773 . . . . 20.0 109.41 -173.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 105' ' ' VAL . . . . . 0.584 HG22 ' CG1' ' L' ' 162' ' ' ILE . 50.7 t -117.43 110.74 32.02 Favored 'Isoleucine or valine' 0 C--O 1.235 0.338 0 N-CA-C 108.237 -1.023 . . . . 20.0 108.237 -178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 106' ' ' TRP . . . . . . . . . . . . . 82.2 m95 -89.57 83.08 6.29 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.559 -0.291 . . . . 20.0 110.282 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 107' ' ' ILE . . . . . . . . . . . . . 26.9 mt -51.97 -54.23 14.48 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 O-C-N 123.361 0.413 . . . . 20.0 110.308 170.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 108' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -152.55 177.51 10.56 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.432 -0.951 . . . . 20.0 108.432 178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 109' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -59.02 126.28 27.06 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 114.914 -1.039 . . . . 20.0 110.48 -177.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 110' ' ' GLY . . . . . . . . . . . . . . . 72.21 11.21 75.2 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-O 118.899 -0.945 . . . . 20.0 115.291 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 111' ' ' LYS . . . . . . . . . . . . . 57.9 mttt -129.01 114.01 15.87 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 118.497 1.149 . . . . 20.0 108.62 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 112' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -139.25 141.54 37.82 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 109.399 -0.593 . . . . 20.0 109.399 -178.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 113' ' ' ILE . . . . . . . . . . . . . 3.6 pt -129.65 142.51 43.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 108.683 -0.858 . . . . 20.0 108.683 172.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 114' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -79.73 149.45 31.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.023 -0.989 . . . . 20.0 110.263 -172.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 115' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' L' ' 103' ' ' PHE . . . -147.95 157.79 27.47 Favored Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 110.256 -1.138 . . . . 20.0 110.256 -176.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 116' ' ' VAL . . . . . . . . . . . . . 6.5 m -128.78 154.44 39.71 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.358 0 N-CA-C 108.366 -0.975 . . . . 20.0 108.366 -177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 117' ' ' GLY . . . . . . . . . . . . . . . -143.26 34.15 1.76 Allowed Glycine 0 N--CA 1.444 -0.801 0 CA-C-N 115.319 -0.855 . . . . 20.0 114.606 -168.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 118' ' ' ALA . . . . . 0.498 ' O ' HD13 ' L' ' 98' ' ' LEU . . . -67.18 -47.99 69.29 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 114.334 1.235 . . . . 20.0 114.334 -156.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 119' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.57 121.16 11.78 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.52 1.055 . . . . 20.0 112.646 -155.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 120' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -86.47 136.13 35.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 102.635 -3.098 . . . . 20.0 102.635 159.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 121' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -68.16 123.82 11.04 Favored 'Trans proline' 0 C--N 1.328 -0.55 0 CA-C-N 120.743 1.301 . . . . 20.0 110.546 -178.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 122' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -63.83 149.79 89.89 Favored 'Trans proline' 0 C--O 1.233 0.26 0 CA-C-N 119.147 0.731 . . . . 20.0 110.7 177.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -63.13 165.42 7.2 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.864 0.84 . . . . 20.0 109.93 -178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 124' ' ' ILE . . . . . . . . . . . . . 5.2 mp -89.19 91.88 3.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 108.177 -1.045 . . . . 20.0 108.177 -175.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 125' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -164.92 160.84 19.66 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.872 0.368 . . . . 20.0 110.713 169.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 126' ' ' LYS . . . . . . . . . . . . . 4.4 tmtm? -79.91 -43.65 1.5 Allowed Pre-proline 0 C--O 1.237 0.409 0 C-N-CA 123.948 0.899 . . . . 20.0 113.088 -170.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 127' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -65.03 -24.92 59.39 Favored 'Trans proline' 0 C--N 1.359 1.114 0 CA-C-N 120.845 1.337 . . . . 20.0 112.008 170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 128' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -83.52 -26.52 30.09 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 111.824 0.305 . . . . 20.0 111.824 -177.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 129' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -58.91 -31.94 69.08 Favored 'General case' 0 C--O 1.241 0.61 0 C-N-CA 119.803 -0.759 . . . . 20.0 110.274 168.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 130' ' ' ARG . . . . . 0.412 HH22 ' HB3' ' J' ' 136' ' ' TRP . 10.8 tpt180 -74.82 -36.83 62.42 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 111.936 0.347 . . . . 20.0 111.936 172.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 131' ' ' LYS . . . . . 0.403 ' HG2' ' HG2' ' J' ' 131' ' ' LYS . 35.1 mttt -78.51 90.97 4.5 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.206 -0.664 . . . . 20.0 109.206 174.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 132' ' ' LYS . . . . . . . . . . . . . 7.2 mttm -87.18 14.33 7.91 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.115 0.413 . . . . 20.0 112.115 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.18 142.61 87.45 Favored Pre-proline 0 N--CA 1.445 -0.718 0 N-CA-C 108.513 -0.921 . . . . 20.0 108.513 172.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 134' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -67.76 153.63 75.28 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 CA-C-N 119.64 0.907 . . . . 20.0 112.365 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -66.64 153.62 42.67 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.531 -1.213 . . . . 20.0 107.968 177.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 136' ' ' TRP . . . . . 0.409 ' HB3' HH22 ' J' ' 130' ' ' ARG . 0.0 OUTLIER -77.65 -12.28 59.95 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 118.772 -0.632 . . . . 20.0 112.368 -175.254 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 137' ' ' ASP . . . . . 0.414 ' OD1' ' N ' ' L' ' 138' ' ' GLN . 14.2 p30 -55.34 -66.4 0.42 Allowed 'General case' 0 C--N 1.344 0.35 0 CA-C-O 118.894 -0.574 . . . . 20.0 111.416 -175.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 138' ' ' GLN . . . . . 0.414 ' N ' ' OD1' ' L' ' 137' ' ' ASP . 3.9 tp-100 174.62 174.12 0.2 Allowed 'General case' 0 C--O 1.235 0.295 0 N-CA-C 103.075 -2.935 . . . . 20.0 103.075 133.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 139' ' ' ILE . . . . . 0.408 ' H ' ' HG3' ' L' ' 138' ' ' GLN . 1.2 tp -74.85 168.19 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.068 0.947 . . . . 20.0 108.939 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 140' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -114.9 161.43 18.28 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.967 0.907 . . . . 20.0 110.464 177.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 141' ' ' ILE . . . . . 0.407 HD13 HD13 ' L' ' 162' ' ' ILE . 30.1 mt -124.65 147.46 29.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.316 0 N-CA-C 108.586 -0.894 . . . . 20.0 108.586 -177.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 142' ' ' ASP . . . . . 0.557 ' OD1' ' N ' ' L' ' 144' ' ' GLY . 0.5 OUTLIER -119.03 134.74 55.01 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 123.647 0.779 . . . . 20.0 109.613 175.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 143' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -119.17 7.86 6.69 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 O-C-N 123.719 0.637 . . . . 20.0 111.817 166.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 144' ' ' GLY . . . . . 0.557 ' N ' ' OD1' ' L' ' 142' ' ' ASP . . . 86.87 -6.61 82.68 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 115.495 0.958 . . . . 20.0 115.495 172.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 145' ' ' ALA . . . . . . . . . . . . . . . -69.17 144.05 53.9 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 118.472 1.136 . . . . 20.0 110.252 176.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 146' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -83.33 -20.94 33.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 113.608 0.966 . . . . 20.0 113.608 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 147' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -150.34 162.63 40.16 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-O 121.971 0.891 . . . . 20.0 111.468 -173.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 148' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -57.44 -41.48 80.58 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 113.943 -1.48 . . . . 20.0 111.243 177.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 149' ' ' GLU . . . . . . . . . . . . . 78.8 tt0 -60.39 -46.99 88.01 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.863 -0.335 . . . . 20.0 110.943 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 150' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -61.39 -35.18 76.77 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 120.524 -0.47 . . . . 20.0 110.787 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.72 -40.63 84.23 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 120.052 -0.659 . . . . 20.0 111.119 -175.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 152' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -74.76 -23.26 58.51 Favored 'General case' 0 C--O 1.236 0.359 0 C-N-CA 119.368 -0.933 . . . . 20.0 111.057 -178.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 153' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -70.75 -30.1 66.52 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 119.761 -0.776 . . . . 20.0 110.62 177.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 154' ' ' MET . . . . . . . . . . . . . 38.4 mtt -60.53 -40.65 92.25 Favored 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 120.584 -0.446 . . . . 20.0 111.657 171.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 155' ' ' GLY . . . . . . . . . . . . . . . 128.16 -8.8 6.68 Favored Glycine 0 N--CA 1.445 -0.765 0 CA-C-O 118.947 -0.918 . . . . 20.0 114.606 -172.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 156' ' ' VAL . . . . . . . . . . . . . 75.4 t -63.7 133.52 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 118.462 1.131 . . . . 20.0 108.547 178.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 157' ' ' LYS . . . . . . . . . . . . . 3.8 mttt -141.88 175.93 9.33 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.724 -1.213 . . . . 20.0 107.724 174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 158' ' ' ILE . . . . . . . . . . . . . 6.4 mm -71.32 147.32 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 107.681 -1.229 . . . . 20.0 107.681 174.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 159' ' ' GLY . . . . . . . . . . . . . . . 149.4 169.3 15.72 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 108.793 -1.723 . . . . 20.0 108.793 -176.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 160' ' ' THR . . . . . 0.52 HG23 ' HB2' ' L' ' 75' ' ' MET . 0.2 OUTLIER -79.43 113.61 17.7 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 107.651 -1.24 . . . . 20.0 107.651 165.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 161' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -132.72 -19.95 0.98 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 N-CA-C 113.739 1.015 . . . . 20.0 113.739 -166.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 162' ' ' ILE . . . . . 0.584 ' CG1' HG22 ' L' ' 105' ' ' VAL . 0.5 OUTLIER -111.71 155.64 13.01 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 118.626 0.648 . . . . 20.0 111.737 -159.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 163' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' L' ' 164' ' ' TRP . 3.5 t -145.34 -166.34 2.41 Favored 'General case' 0 C--O 1.233 0.212 0 C-N-CA 124.306 1.042 . . . . 20.0 110.445 171.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 164' ' ' TRP . . . . . 0.56 ' N ' ' OG1' ' L' ' 163' ' ' THR . 2.5 t-105 -100.78 -17.94 16.69 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 113.189 0.811 . . . . 20.0 113.189 -160.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 165' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.76 61.62 0.97 Allowed 'General case' 0 C--O 1.235 0.338 0 O-C-N 121.837 -0.539 . . . . 20.0 112.281 -177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 166' ' ' GLY . . . . . . . . . . . . . . . -87.86 158.62 29.59 Favored Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 110.089 -1.204 . . . . 20.0 110.089 172.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 167' ' ' ARG . . . . . 0.457 ' HB3' HH12 ' J' ' 102' ' ' ARG . 0.0 OUTLIER -142.38 148.31 37.68 Favored 'General case' 0 CA--C 1.509 -0.623 0 N-CA-C 107.739 -1.208 . . . . 20.0 107.739 170.569 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 168' ' ' LEU . . . . . . . . . . . . . 4.4 tt -94.95 117.58 30.37 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.133 -0.939 . . . . 20.0 110.206 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 169' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -129.38 159.8 35.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.829 0.823 . . . . 20.0 110.02 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 170' ' ' ARG . . . . . . . . . . . . . 2.8 mtt-85 -102.41 117.19 34.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.263 -1.335 . . . . 20.0 109.465 -173.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 171' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -111.93 151.65 28.96 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.486 -0.561 . . . . 20.0 109.486 168.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 172' ' ' GLY . . . . . 0.591 ' O ' ' N ' ' L' ' 175' ' ' ARG . . . 56.86 68.73 1.55 Allowed Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 109.202 -1.559 . . . . 20.0 109.202 -171.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 173' ' ' LYS . . . . . . . . . . . . . 11.2 ptpt -52.47 -21.93 4.24 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 112.802 0.667 . . . . 20.0 112.802 -174.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 174' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -53.12 -62.96 1.32 Allowed 'General case' 0 C--O 1.235 0.331 0 C-N-CA 119.73 -0.788 . . . . 20.0 111.211 157.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 175' ' ' ARG . . . . . 0.591 ' N ' ' O ' ' L' ' 172' ' ' GLY . 6.8 ptt-85 -169.9 121.97 0.69 Allowed 'General case' 0 C--O 1.231 0.096 0 CA-C-N 118.592 0.633 . . . . 20.0 112.633 172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 176' ' ' PHE . . . . . . . . . . . . . 1.4 m-30 175.52 169.39 0.35 Allowed 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.788 2.435 . . . . 20.0 106.185 157.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 177' ' ' VAL . . . . . . . . . . . . . 45.8 t -144.69 145.84 20.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.224 0 N-CA-C 108.457 -0.942 . . . . 20.0 108.457 177.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 178' ' ' SER . . . . . . . . . . . . . 46.6 t -78.16 -64.46 1.16 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 116.407 2.003 . . . . 20.0 116.407 -165.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 179' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -116.83 22.3 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 CA-C-N 118.752 0.705 . . . . 20.0 112.115 -171.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 180' ' ' ALA . . . . . . . . . . . . . . . -80.08 -0.72 36.9 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 114.393 1.257 . . . . 20.0 114.393 -170.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 181' ' ' PHE . . . . . 0.739 ' HB3' ' HB3' ' L' ' 327' ' ' GLU . 3.2 t80 -84.64 -66.98 0.83 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 118.606 0.639 . . . . 20.0 111.766 -162.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 182' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -80.21 127.84 32.81 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 122.062 0.934 . . . . 20.0 110.679 -152.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 183' ' ' ASP . . . . . 0.543 ' OD1' ' N ' ' L' ' 70' ' ' ASP . 0.6 OUTLIER 70.0 -6.76 1.04 Allowed 'General case' 0 C--O 1.234 0.262 0 C-N-CA 125.316 1.447 . . . . 20.0 113.166 174.638 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 184' ' ' ARG . . . . . 0.536 ' NH1' HD13 ' L' ' 29' ' ' ILE . 0.0 OUTLIER -153.76 83.89 1.16 Allowed 'General case' 0 N--CA 1.447 -0.621 0 CA-C-O 122.122 0.963 . . . . 20.0 110.783 157.175 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 185' ' ' ILE . . . . . 0.435 HG12 HG11 ' L' ' 317' ' ' VAL . 1.0 OUTLIER -126.13 -41.1 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.804 0 N-CA-C 104.515 -2.402 . . . . 20.0 104.515 149.886 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 186' ' ' ALA . . . . . 0.724 ' O ' ' OG1' ' L' ' 189' ' ' THR . . . -50.06 -43.05 50.97 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-N 115.364 -0.835 . . . . 20.0 111.536 173.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 187' ' ' VAL . . . . . . . . . . . . . 10.7 m -65.9 -36.01 76.49 Favored 'Isoleucine or valine' 0 C--O 1.237 0.412 0 C-N-CA 119.225 -0.99 . . . . 20.0 110.115 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 188' ' ' TYR . . . . . . . . . . . . . 77.4 t80 -63.86 -38.65 91.86 Favored 'General case' 0 C--O 1.237 0.415 0 C-N-CA 119.144 -1.022 . . . . 20.0 110.479 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 189' ' ' THR . . . . . 0.724 ' OG1' ' O ' ' L' ' 186' ' ' ALA . 25.2 p -59.11 -48.6 81.02 Favored 'General case' 0 C--O 1.237 0.42 0 C-N-CA 119.475 -0.89 . . . . 20.0 110.85 172.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 190' ' ' ILE . . . . . . . . . . . . . 12.8 mt -55.29 -50.57 63.8 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 120.897 0.379 . . . . 20.0 110.477 178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 191' ' ' LEU . . . . . . . . . . . . . 5.1 mt -64.14 -43.14 96.15 Favored 'General case' 0 C--O 1.237 0.421 0 C-N-CA 120.074 -0.65 . . . . 20.0 110.959 -178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 192' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -63.91 -36.5 84.16 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 119.984 -0.686 . . . . 20.0 110.315 177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 193' ' ' VAL . . . . . 0.414 HG23 ' O ' ' L' ' 189' ' ' THR . 11.5 t -60.61 -44.73 97.48 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 CA-C-O 121.045 0.45 . . . . 20.0 110.114 177.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 194' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.29 75.44 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 120.216 -0.594 . . . . 20.0 111.17 -176.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 195' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -71.58 -38.19 70.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 119.875 -0.73 . . . . 20.0 110.79 175.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 196' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -79.66 -26.17 41.11 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.52 0.563 . . . . 20.0 112.52 -175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 197' ' ' LEU . . . . . . . . . . . . . 34.1 tp -80.61 122.79 27.51 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.299 -0.63 . . . . 20.0 109.299 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 198' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -112.44 -57.06 2.33 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 123.273 0.358 . . . . 20.0 110.122 176.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 199' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 -98.11 105.35 17.48 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 109.735 -0.469 . . . . 20.0 109.735 -172.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 200' ' ' ALA . . . . . . . . . . . . . . . -78.02 91.29 4.24 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.165 -0.679 . . . . 20.0 109.165 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 201' ' ' LYS . . . . . . . . . . . . . 42.6 tptt -76.75 -14.56 59.92 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 120.047 -0.661 . . . . 20.0 111.386 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 202' ' ' ALA . . . . . . . . . . . . . . . -143.86 141.68 30.44 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 108.919 -0.771 . . . . 20.0 108.919 172.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 203' ' ' ASP . . . . . 0.619 ' OD1' ' N ' ' L' ' 203' ' ' ASP . 0.0 OUTLIER -78.58 112.99 16.22 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.468 -0.938 . . . . 20.0 108.468 -174.468 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 204' ' ' VAL . . . . . . . . . . . . . 2.4 m -102.98 151.54 6.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 N-CA-C 108.54 -0.911 . . . . 20.0 108.54 -170.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 205' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -128.87 106.63 9.03 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.017 -0.735 . . . . 20.0 109.017 173.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 206' ' ' PHE . . . . . . . . . . . . . 22.0 m-30 -82.95 125.37 31.32 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.752 -0.832 . . . . 20.0 108.752 177.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 207' ' ' VAL . . . . . 0.711 HG12 HD13 ' L' ' 53' ' ' ILE . 34.1 m -119.92 150.18 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.337 0 N-CA-C 108.867 -0.79 . . . . 20.0 108.867 174.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 208' ' ' ALA . . . . . . . . . . . . . . . -128.34 98.83 5.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 107.415 -1.328 . . . . 20.0 107.415 171.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 209' ' ' THR . . . . . . . . . . . . . 34.4 p -85.84 159.93 19.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.896 0.855 . . . . 20.0 111.121 -165.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 210' ' ' VAL . . . . . . . . . . . . . 1.6 m -118.76 166.44 13.12 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.366 0 CA-C-N 114.644 -1.162 . . . . 20.0 108.21 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 211' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 56.62 40.13 29.48 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 114.762 -1.108 . . . . 20.0 111.541 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 212' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -77.94 -49.59 13.84 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.412 -0.515 . . . . 20.0 110.952 176.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 213' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -20.35 64.75 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.212 -0.595 . . . . 20.0 111.483 -173.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 214' ' ' VAL . . . . . . . . . . . . . 90.0 t -131.22 121.11 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 N-CA-C 108.536 -0.913 . . . . 20.0 108.536 173.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 215' ' ' GLY . . . . . . . . . . . . . . . 65.03 60.99 6.19 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 119.67 -1.253 . . . . 20.0 111.433 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 216' ' ' LEU . . . . . 0.438 HD23 ' H ' ' L' ' 216' ' ' LEU . 0.5 OUTLIER -47.05 -25.52 0.85 Allowed 'General case' 0 C--O 1.235 0.333 0 N-CA-C 113.464 0.912 . . . . 20.0 113.464 -179.125 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 217' ' ' ARG . . . . . 0.46 ' HB3' ' HG ' ' B' ' 305' ' ' LEU . 1.3 mpt_? -63.54 -4.47 2.89 Favored 'General case' 0 C--O 1.234 0.261 0 N-CA-C 112.337 0.495 . . . . 20.0 112.337 173.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 218' ' ' GLY . . . . . . . . . . . . . . . -50.66 -40.56 40.79 Favored Glycine 0 C--N 1.337 0.59 0 C-N-CA 119.686 -1.245 . . . . 20.0 112.004 168.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 219' ' ' ALA . . . . . 0.448 ' O ' ' OG ' ' L' ' 222' ' ' SER . . . -65.27 -37.03 85.93 Favored 'General case' 0 C--O 1.237 0.411 0 O-C-N 122.28 -0.541 . . . . 20.0 111.335 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 220' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' L' ' 302' ' ' ALA . 16.6 ttm180 -52.77 -36.66 58.43 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 112.172 0.434 . . . . 20.0 112.172 -174.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 221' ' ' THR . . . . . . . . . . . . . 74.7 p -58.5 -45.82 87.95 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 120.055 -0.658 . . . . 20.0 110.82 -173.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 222' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' L' ' 219' ' ' ALA . 2.1 p -58.04 -35.77 71.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 120.78 -0.368 . . . . 20.0 111.438 175.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 223' ' ' ALA . . . . . . . . . . . . . . . -54.58 -50.06 68.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 112.587 0.588 . . . . 20.0 112.587 -169.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 224' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.12 -33.45 75.8 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 119.801 -0.76 . . . . 20.0 111.832 -165.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 225' ' ' GLY . . . . . . . . . . . . . . . -70.96 -16.69 74.93 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 118.894 -1.622 . . . . 20.0 112.117 179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 226' ' ' ILE . . . . . . . . . . . . . 25.1 mm -126.98 -45.59 1.2 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 112.011 0.374 . . . . 20.0 112.011 -158.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 227' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -56.4 -46.77 99.77 Favored Pre-proline 0 C--O 1.237 0.397 0 N-CA-C 118.185 2.661 . . . . 20.0 118.185 -158.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 228' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -43.93 143.75 2.93 Favored 'Trans proline' 0 N--CA 1.471 0.2 0 N-CA-C 115.966 1.487 . . . . 20.0 115.966 -134.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 229' ' ' ASP . . . . . . . . . . . . . 8.5 t70 86.12 -4.72 0.78 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 125.221 1.409 . . . . 20.0 113.4 162.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 230' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -166.87 171.23 11.5 Favored 'General case' 0 N--CA 1.465 0.301 0 C-N-CA 120.091 -0.643 . . . . 20.0 111.734 167.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 231' ' ' GLY . . . . . . . . . . . . . . . -170.51 151.51 16.5 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.925 -0.655 . . . . 20.0 112.266 -175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 232' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -144.76 170.76 15.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 114.555 -0.823 . . . . 20.0 108.791 178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 233' ' ' ALA . . . . . . . . . . . . . . . -156.67 149.04 23.31 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.178 0.513 . . . . 20.0 110.385 177.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 234' ' ' ILE . . . . . 0.484 HD11 ' CE ' ' L' ' 341' ' ' MET . 51.8 mt -133.18 90.46 1.13 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.357 0 N-CA-C 107.56 -1.274 . . . . 20.0 107.56 172.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 235' ' ' ASP . . . . . 0.484 ' OD1' ' NE2' ' L' ' 68' ' ' HIS . 25.5 t0 -135.17 173.25 11.93 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.963 -1.495 . . . . 20.0 106.963 173.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 236' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.17 149.38 14.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.704 0.764 . . . . 20.0 111.452 -173.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 237' ' ' THR . . . . . 0.46 HG21 ' HA3' ' L' ' 296' ' ' GLY . 9.1 t -165.6 122.73 1.46 Allowed 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.364 -1.347 . . . . 20.0 107.364 164.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 238' ' ' ILE . . . . . 0.413 HD13 ' O ' ' L' ' 237' ' ' THR . 17.9 mm -145.5 151.87 14.69 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 N-CA-C 108.244 -1.021 . . . . 20.0 108.244 -161.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 239' ' ' ALA . . . . . . . . . . . . . . . -123.22 105.2 9.68 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.901 -1.518 . . . . 20.0 106.901 158.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 240' ' ' ALA . . . . . . . . . . . . . . . -115.48 110.05 18.72 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.02 0.748 . . . . 20.0 113.02 -155.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 241' ' ' ASP . . . . . . . . . . . . . 20.6 t0 53.35 36.18 22.24 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 124.969 1.308 . . . . 20.0 112.477 158.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 242' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -77.98 128.41 78.94 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 105.181 -2.155 . . . . 20.0 105.181 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 243' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_exo -60.99 165.59 11.96 Favored 'Trans proline' 0 CA--C 1.516 -0.384 0 CA-C-N 120.842 1.336 . . . . 20.0 112.361 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 244' ' ' GLY . . . . . . . . . . . . . . . 76.39 -5.28 45.02 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.061 -0.972 . . . . 20.0 114.908 -173.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 245' ' ' THR . . . . . . . . . . . . . 33.1 p -92.15 164.52 22.93 Favored Pre-proline 0 N--CA 1.452 -0.334 0 CA-C-N 118.611 1.206 . . . . 20.0 110.653 177.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 246' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -70.97 -172.68 0.74 Allowed 'Trans proline' 0 C--N 1.327 -0.584 0 CA-C-O 121.804 0.668 . . . . 20.0 111.995 171.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 247' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -81.21 -10.77 59.56 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 114.73 -1.123 . . . . 20.0 112.036 179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 248' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -70.34 -18.59 63.07 Favored 'General case' 0 CA--C 1.518 -0.284 0 C-N-CA 119.833 -0.747 . . . . 20.0 112.878 -171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 249' ' ' LYS . . . . . 0.728 ' O ' ' OG1' ' L' ' 252' ' ' THR . 16.9 mttt -98.81 -15.13 19.38 Favored 'General case' 0 CA--C 1.513 -0.453 0 N-CA-C 113.233 0.827 . . . . 20.0 113.233 170.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 250' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.08 -37.86 88.99 Favored 'General case' 0 C--O 1.232 0.149 0 C-N-CA 120.338 -0.545 . . . . 20.0 111.342 -172.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 251' ' ' VAL . . . . . . . . . . . . . 10.5 m -68.64 -21.02 25.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 119.119 -1.032 . . . . 20.0 111.89 -178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 252' ' ' THR . . . . . 0.728 ' OG1' ' O ' ' L' ' 249' ' ' LYS . 39.7 p -57.07 -31.88 65.68 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 118.485 0.584 . . . . 20.0 111.35 173.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 253' ' ' HIS . . . . . 0.539 ' CD2' ' HB2' ' L' ' 319' ' ' ALA . 16.6 t-80 -162.37 132.08 4.51 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-O 121.373 0.606 . . . . 20.0 110.421 176.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 254' ' ' LEU . . . . . . . . . . . . . 5.9 mt -131.43 -1.27 3.94 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.996 -1.002 . . . . 20.0 112.302 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 255' ' ' GLY . . . . . . . . . . . . . . . 94.34 35.86 5.85 Favored Glycine 0 CA--C 1.504 -0.63 0 C-N-CA 126.151 1.834 . . . . 20.0 111.571 -177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 256' ' ' LYS . . . . . . . . . . . . . 17.0 ptmt -153.39 129.21 10.18 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.64 -0.874 . . . . 20.0 108.64 -167.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 257' ' ' GLY . . . . . . . . . . . . . . . 64.13 174.26 3.42 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 122.677 1.154 . . . . 20.0 113.333 169.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 258' ' ' THR . . . . . . . . . . . . . 6.0 t -98.77 175.13 6.08 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.534 -0.913 . . . . 20.0 108.534 -177.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 259' ' ' ALA . . . . . 0.402 ' O ' ' N ' ' L' ' 316' ' ' SER . . . -126.48 120.36 29.53 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.181 -0.918 . . . . 20.0 109.417 -169.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 260' ' ' ILE . . . . . . . . . . . . . 85.5 mt -98.08 139.95 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 107.736 -1.209 . . . . 20.0 107.736 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 261' ' ' LYS . . . . . 0.74 ' HE3' HG21 ' L' ' 298' ' ' THR . 1.9 mtmm -98.84 122.61 42.3 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.983 -0.747 . . . . 20.0 108.983 -177.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 262' ' ' ILE . . . . . . . . . . . . . 13.6 mt -95.77 -40.25 10.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 CA-C-O 121.384 0.611 . . . . 20.0 109.643 173.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 263' ' ' MET . . . . . . . . . . . . . 27.2 ttt -143.57 147.62 34.69 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.365 -0.606 . . . . 20.0 109.365 -174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 264' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -140.16 -169.97 2.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 CA-C-N 114.8 -1.091 . . . . 20.0 108.249 165.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 265' ' ' ARG . . . . . . . . . . . . . 16.5 tpp180 -54.94 -56.25 21.72 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 115.854 -0.612 . . . . 20.0 110.296 163.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 266' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.87 -46.2 11.54 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 113.65 0.981 . . . . 20.0 113.65 -165.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 267' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -115.79 143.64 25.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 109.414 -0.587 . . . . 20.0 109.414 -163.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 268' ' ' ILE . . . . . . . . . . . . . 9.7 mm -121.25 103.98 14.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 N-CA-C 106.107 -1.812 . . . . 20.0 106.107 171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 269' ' ' CYS . . . . . . . . . . . . . 69.4 m -66.37 137.11 56.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.25 0.548 . . . . 20.0 111.34 -171.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 270' ' ' HIS . . . . . . . . . . . . . 28.2 t60 -58.1 109.67 1.98 Allowed Pre-proline 0 C--O 1.24 0.591 0 CA-C-N 115.107 -0.951 . . . . 20.0 108.691 177.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 271' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.42 -20.03 48.62 Favored 'Trans proline' 0 CA--C 1.513 -0.546 0 N-CA-C 114.823 1.047 . . . . 20.0 114.823 -160.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 272' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.37 -42.98 74.69 Favored 'General case' 0 C--O 1.237 0.397 0 C-N-CA 120.193 -0.603 . . . . 20.0 110.576 176.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 273' ' ' ILE . . . . . . . . . . . . . 72.4 mt -55.55 -48.38 77.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.382 0 CA-C-O 121.15 0.5 . . . . 20.0 110.105 175.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 274' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.18 -52.49 60.09 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 CA-C-O 120.806 0.336 . . . . 20.0 110.674 -176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 275' ' ' ARG . . . . . . . . . . . . . 10.8 mtm180 -60.39 -31.9 70.8 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 119.824 -0.751 . . . . 20.0 110.554 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 276' ' ' TRP . . . . . 0.488 ' HH2' ' HB3' ' L' ' 347' ' ' ASN . 0.1 OUTLIER -68.48 -47.98 65.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 120.129 -0.628 . . . . 20.0 111.002 179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 277' ' ' LEU . . . . . . . . . . . . . 10.6 mp -62.06 -38.68 89.7 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 120.042 -0.663 . . . . 20.0 110.756 177.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 278' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -56.61 -48.02 78.36 Favored 'General case' 0 C--O 1.238 0.462 0 C-N-CA 120.61 -0.436 . . . . 20.0 110.117 173.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 279' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -59.79 -40.44 88.34 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 120.849 -0.34 . . . . 20.0 110.733 175.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 280' ' ' LEU . . . . . . . . . . . . . 5.4 tp -67.28 -44.96 78.0 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 120.251 -0.579 . . . . 20.0 111.126 -172.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 281' ' ' ALA . . . . . . . . . . . . . . . -64.09 -31.66 72.93 Favored 'General case' 0 C--O 1.236 0.343 0 C-N-CA 120.023 -0.671 . . . . 20.0 111.081 -175.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 282' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -72.47 -31.8 65.71 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 119.973 -0.691 . . . . 20.0 111.113 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 283' ' ' LYS . . . . . . . . . . . . . 12.3 ttpt -70.79 -37.69 73.33 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 119.905 -0.718 . . . . 20.0 111.019 -175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 284' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -102.6 15.47 29.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 113.306 0.854 . . . . 20.0 113.306 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 285' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 63.73 32.17 13.83 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-O 121.713 0.768 . . . . 20.0 111.572 173.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 286' ' ' ILE . . . . . . . . . . . . . 23.8 mm -87.26 143.37 34.42 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 108.324 -0.991 . . . . 20.0 108.324 -178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 287' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -83.18 149.39 13.44 Favored 'Trans proline' 0 CA--C 1.516 -0.389 0 CA-C-N 119.182 0.743 . . . . 20.0 111.36 175.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 288' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -156.03 148.13 23.35 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.63 -0.714 . . . . 20.0 109.705 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 289' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -114.01 175.11 5.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.693 -1.225 . . . . 20.0 107.693 168.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 290' ' ' LEU . . . . . . . . . . . . . 2.0 mp -126.64 113.73 17.1 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.898 -1.149 . . . . 20.0 107.898 167.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 291' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.95 144.69 43.72 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.471 -0.566 . . . . 20.0 109.471 -172.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 292' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.05 157.1 25.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 107.672 -1.232 . . . . 20.0 107.672 173.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 293' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -123.57 168.65 12.34 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.48 0.657 . . . . 20.0 110.294 175.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 294' ' ' LEU . . . . . . . . . . . . . 8.5 mt -94.72 -18.56 21.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.874 -1.057 . . . . 20.0 112.162 165.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 295' ' ' GLY . . . . . . . . . . . . . . . -146.61 -176.03 20.08 Favored Glycine 0 N--CA 1.448 -0.56 0 N-CA-C 111.011 -0.836 . . . . 20.0 111.011 -176.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 296' ' ' GLY . . . . . 0.46 ' HA3' HG21 ' L' ' 237' ' ' THR . . . 101.5 144.81 15.6 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 114.671 -0.764 . . . . 20.0 112.661 -178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 297' ' ' GLY . . . . . . . . . . . . . . . -121.89 119.58 4.08 Favored Glycine 0 N--CA 1.451 -0.326 0 N-CA-C 110.334 -1.106 . . . . 20.0 110.334 179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 298' ' ' THR . . . . . 0.74 HG21 ' HE3' ' L' ' 261' ' ' LYS . 20.3 p -110.25 172.92 6.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 121.995 0.902 . . . . 20.0 111.414 -174.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 299' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -64.9 -33.69 76.62 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 114.403 -1.271 . . . . 20.0 111.229 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.59 -35.3 74.03 Favored 'General case' 0 C--O 1.236 0.356 0 N-CA-C 111.789 0.292 . . . . 20.0 111.789 -171.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 301' ' ' GLY . . . . . . . . . . . . . . . -59.4 -41.21 96.9 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.221 -0.99 . . . . 20.0 112.042 -178.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 302' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' L' ' 220' ' ' ARG . . . -68.3 -26.89 65.86 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.162 -0.615 . . . . 20.0 111.189 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 303' ' ' ILE . . . . . . . . . . . . . 13.1 mm -70.92 -34.46 55.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 120.023 -0.671 . . . . 20.0 110.146 -178.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 304' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -65.19 -14.24 60.15 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 113.293 0.849 . . . . 20.0 113.293 -174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 305' ' ' LEU . . . . . . . . . . . . . 4.1 mp -103.73 -8.92 19.5 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 113.687 0.995 . . . . 20.0 113.687 -167.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 306' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -58.31 157.56 8.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.649 0.738 . . . . 20.0 110.519 171.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 307' ' ' LYS . . . . . . . . . . . . . 21.6 mmtt -61.69 -29.91 70.39 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 115.258 -0.883 . . . . 20.0 113.299 -161.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 308' ' ' ALA . . . . . . . . . . . . . . . -66.92 -25.15 66.23 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 119.709 -0.796 . . . . 20.0 111.233 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 309' ' ' GLY . . . . . . . . . . . . . . . 77.77 65.14 1.94 Allowed Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.821 -0.705 . . . . 20.0 113.307 -171.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 310' ' ' VAL . . . . . . . . . . . . . 20.2 t -80.27 139.64 52.41 Favored Pre-proline 0 C--O 1.238 0.493 0 CA-C-N 117.619 0.709 . . . . 20.0 111.079 -163.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 311' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -84.53 141.65 8.94 Favored 'Trans proline' 0 CA--C 1.513 -0.541 0 CA-C-N 119.456 0.841 . . . . 20.0 110.04 168.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 312' ' ' THR . . . . . . . . . . . . . 25.6 m -140.45 135.84 32.4 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.365 -0.834 . . . . 20.0 111.195 -169.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 313' ' ' GLY . . . . . . . . . . . . . . . -113.65 162.6 12.33 Favored Glycine 0 N--CA 1.442 -0.957 0 N-CA-C 109.144 -1.583 . . . . 20.0 109.144 164.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 314' ' ' ALA . . . . . . . . . . . . . . . -143.42 136.06 27.4 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 121.445 0.64 . . . . 20.0 110.052 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 315' ' ' LEU . . . . . . . . . . . . . 23.5 mt -104.06 153.27 21.08 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 114.621 -1.172 . . . . 20.0 109.212 174.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 316' ' ' SER . . . . . 0.402 ' N ' ' O ' ' L' ' 259' ' ' ALA . 4.2 m -138.47 133.51 32.83 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.295 -0.866 . . . . 20.0 109.48 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 317' ' ' VAL . . . . . 0.435 HG11 HG12 ' L' ' 185' ' ' ILE . 92.1 t -99.47 108.62 51.48 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 107.227 -1.397 . . . . 20.0 107.227 177.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 318' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -83.29 -169.02 0.64 Allowed 'Trans proline' 0 C--N 1.324 -0.727 0 CA-C-O 122.625 1.011 . . . . 20.0 113.606 -154.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 319' ' ' ALA . . . . . 0.539 ' HB2' ' CD2' ' L' ' 253' ' ' HIS . . . 79.84 35.46 0.15 Allowed 'General case' 0 CA--C 1.516 -0.336 0 CA-C-N 113.57 -1.65 . . . . 20.0 115.277 161.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 320' ' ' ARG . . . . . 0.423 ' HG3' ' O ' ' L' ' 321' ' ' TYR . 0.4 OUTLIER -75.61 157.58 33.59 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.71 0.766 . . . . 20.0 110.119 176.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 321' ' ' TYR . . . . . 0.423 ' O ' ' HG3' ' L' ' 320' ' ' ARG . 3.3 m-85 -113.06 166.13 11.71 Favored 'General case' 0 CA--C 1.516 -0.342 0 N-CA-C 106.78 -1.563 . . . . 20.0 106.78 160.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 322' ' ' ILE . . . . . . . . . . . . . 50.3 mm -49.18 113.67 0.25 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.388 0 C-N-CA 124.156 0.982 . . . . 20.0 108.401 -163.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 323' ' ' HIS . . . . . . . . . . . . . 34.5 p-80 -61.59 -7.38 3.25 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 114.421 1.267 . . . . 20.0 114.421 -140.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 324' ' ' SER . . . . . 0.594 ' OG ' HG21 ' L' ' 97' ' ' THR . 0.1 OUTLIER -59.54 -60.01 4.53 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 112.611 0.597 . . . . 20.0 112.611 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 325' ' ' ASN . . . . . 0.472 ' HB2' ' HA ' ' J' ' 100' ' ' ALA . 35.2 p-10 -101.97 -56.12 2.34 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 115.075 1.509 . . . . 20.0 115.075 -152.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 326' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.58 150.95 50.78 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.485 -1.302 . . . . 20.0 107.485 174.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 327' ' ' GLU . . . . . 0.739 ' HB3' ' HB3' ' L' ' 181' ' ' PHE . 82.8 mt-10 -142.55 52.81 1.42 Allowed 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 113.846 -1.525 . . . . 20.0 109.943 -153.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 328' ' ' VAL . . . . . . . . . . . . . 53.4 t -51.07 149.45 0.94 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.381 0 CA-C-O 121.411 0.624 . . . . 20.0 111.969 -171.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 329' ' ' VAL . . . . . 0.432 HG13 ' HB2' ' L' ' 181' ' ' PHE . 0.3 OUTLIER -139.43 179.41 2.94 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.254 0 CA-C-O 121.877 0.846 . . . . 20.0 109.419 175.677 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 330' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -125.52 119.22 27.58 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.581 -1.19 . . . . 20.0 108.802 178.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 331' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -54.06 -32.1 53.58 Favored 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.847 0.717 . . . . 20.0 111.497 179.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 332' ' ' ARG . . . . . . . . . . . . . 10.3 mtm180 -68.67 -44.76 73.36 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 120.289 -0.564 . . . . 20.0 110.211 -176.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 333' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -66.03 -44.9 83.32 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.727 -0.389 . . . . 20.0 111.068 -172.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 334' ' ' VAL . . . . . . . . . . . . . 7.8 p -63.67 -41.22 91.87 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 120.415 -0.514 . . . . 20.0 110.522 -173.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 335' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -71.05 -34.65 71.46 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 118.791 -1.164 . . . . 20.0 110.181 178.687 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 336' ' ' ALA . . . . . . . . . . . . . . . -65.48 -40.36 93.02 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 120.033 -0.667 . . . . 20.0 110.421 176.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 337' ' ' THR . . . . . . . . . . . . . 20.2 m -56.57 -43.83 80.4 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-O 120.761 0.315 . . . . 20.0 110.938 176.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 338' ' ' VAL . . . . . 0.684 ' O ' ' OG1' ' L' ' 342' ' ' THR . 42.6 t -60.2 -48.93 86.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 120.962 0.411 . . . . 20.0 110.276 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 339' ' ' GLU . . . . . 0.783 ' OE1' ' NZ ' ' L' ' 343' ' ' LYS . 1.3 mm-40 -54.87 -46.85 74.77 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-O 120.996 0.427 . . . . 20.0 110.778 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 340' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.86 -55.12 38.09 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-N 116.37 -0.377 . . . . 20.0 111.454 -176.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 341' ' ' MET . . . . . 0.484 ' CE ' HD11 ' L' ' 234' ' ' ILE . 31.9 tpp -60.2 -40.36 89.82 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 120.233 -0.587 . . . . 20.0 110.778 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 342' ' ' THR . . . . . 0.684 ' OG1' ' O ' ' L' ' 338' ' ' VAL . 1.3 m -56.45 -45.04 81.03 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.101 0.476 . . . . 20.0 110.423 -177.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 343' ' ' LYS . . . . . 0.783 ' NZ ' ' OE1' ' L' ' 339' ' ' GLU . 34.7 mttp -74.12 -37.48 64.09 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 119.952 -0.699 . . . . 20.0 110.806 -178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 344' ' ' ALA . . . . . . . . . . . . . . . -60.83 -42.48 97.83 Favored 'General case' 0 C--O 1.237 0.418 0 C-N-CA 120.554 -0.459 . . . . 20.0 111.126 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 345' ' ' LEU . . . . . 0.427 ' O ' HG22 ' L' ' 348' ' ' ILE . 1.0 OUTLIER -59.01 -50.41 74.2 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 120.524 -0.471 . . . . 20.0 110.827 -179.027 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 346' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -65.66 -39.0 90.88 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 119.682 -0.807 . . . . 20.0 110.625 -178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 347' ' ' ASN . . . . . 0.488 ' HB3' ' HH2' ' L' ' 276' ' ' TRP . 5.0 m-20 -84.53 4.77 30.43 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 119.475 -0.89 . . . . 20.0 112.538 -178.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 348' ' ' ILE . . . . . 0.427 HG22 ' O ' ' L' ' 345' ' ' LEU . 1.3 tt -65.23 -23.63 33.53 Favored 'Isoleucine or valine' 0 C--O 1.237 0.427 0 C-N-CA 119.525 -0.87 . . . . 20.0 110.93 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' L' L ' 349' ' ' HIS . . . . . . . . . . . . . 33.5 p-80 -63.77 -27.33 69.12 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 119.814 -0.755 . . . . 20.0 111.241 -175.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 350' ' ' GLU . . . . . . . . . . . . . 35.8 tp10 -85.88 -18.82 31.73 Favored 'General case' 0 C--O 1.234 0.287 0 O-C-N 122.085 -0.385 . . . . 20.0 111.512 177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 351' ' ' LEU . . . . . 0.439 ' O ' HD12 ' L' ' 351' ' ' LEU . 0.1 OUTLIER -69.74 -28.84 66.13 Favored 'General case' 0 C--O 1.232 0.175 0 N-CA-C 112.118 0.414 . . . . 20.0 112.118 -173.881 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' L' L ' 352' ' ' LYS . . . . . . . . . . . . . 40.1 pttt -42.03 -26.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 116.032 1.864 . . . . 20.0 116.032 -169.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' L' L ' 353' ' ' ILE . . . . . . . . . . . . . 2.5 mt . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.983 1.313 . . . . 20.0 108.408 -174.659 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' C' C 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' D' D 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' E' E 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' F' F 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' G' G 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' H' H 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' I' I 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' J' J 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' K' K 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L 1001 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' L' L 1002 ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_